Citrus Sinensis ID: 007991
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | 2.2.26 [Sep-21-2011] | |||||||
| Q2QMH1 | 591 | Serine/threonine-protein | yes | no | 0.953 | 0.939 | 0.639 | 0.0 | |
| A2ZMH2 | 591 | Serine/threonine-protein | N/A | no | 0.955 | 0.940 | 0.637 | 0.0 | |
| Q10GB1 | 599 | Serine/threonine-protein | no | no | 0.963 | 0.936 | 0.608 | 0.0 | |
| Q9CAU7 | 606 | Serine/threonine-protein | yes | no | 0.957 | 0.919 | 0.584 | 0.0 | |
| Q8RXT4 | 555 | Serine/threonine-protein | no | no | 0.878 | 0.920 | 0.565 | 1e-180 | |
| Q6ZEZ5 | 585 | Serine/threonine-protein | no | no | 0.951 | 0.947 | 0.591 | 1e-180 | |
| Q9SLI2 | 612 | Serine/threonine-protein | no | no | 0.929 | 0.883 | 0.593 | 1e-178 | |
| Q8RX66 | 568 | Serine/threonine-protein | no | no | 0.888 | 0.910 | 0.567 | 1e-164 | |
| Q0WPH8 | 956 | Serine/threonine-protein | no | no | 0.400 | 0.243 | 0.738 | 1e-112 | |
| Q94CU5 | 943 | Serine/threonine-protein | no | no | 0.400 | 0.247 | 0.725 | 1e-107 |
| >sp|Q2QMH1|NEK2_ORYSJ Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. japonica GN=NEK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/586 (63%), Positives = 429/586 (73%), Gaps = 31/586 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEM+LI+ VRNPFIVEYKDSWVEKGCYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMQLIATVRNPFIVEYKDSWVEKGCYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+ANG +F EEKLCKWLVQLLMAL+YLHANHILHRDVKCSNIF+ RDQ IRLGDFG
Sbjct: 90 AEAIKRANGTYFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFIARDQSIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDLASSVVGTPSYMCPELLADIPYG+KSDIWSLGCC+YEM+A + AFKAFDMQ
Sbjct: 150 LAKILTSDDLASSVVGTPSYMCPELLADIPYGTKSDIWSLGCCIYEMTALRPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKI KSIV+PLPT YSGAFRGL+KSMLRK+PE RPSAA+LL HP LQPYVL + LK
Sbjct: 210 ALINKITKSIVSPLPTKYSGAFRGLIKSMLRKSPEHRPSAAQLLKHPQLQPYVLQVQLK- 268
Query: 242 NGPRRNTFPLEWSDSN-FKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
+ P RN P+ S ++ KK F S +R S N+R + S E++S+S
Sbjct: 269 SSPTRNILPIHQSLTDKVKKMTFPSDVVDSARRRMARRNSLGNERTVTFSKPSPERNSVS 328
Query: 301 STLRGRAFGNY-MNQKFKELSIGVVHEELGVDMSTTPNVCNAG---KTPRLTPAKVSATP 356
ST R+ Y Q K LS+ E G ++++ + +TP+ PAK + T
Sbjct: 329 ST---RSIKEYTTTQSVKGLSVD--SSEAGDEVTSKAIITKTSSILRTPKSLPAK-TYTA 382
Query: 357 RRQATPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQPITCIMKSP 416
R Q P K ++ + R LP P K +RPARRASLPL+T I + SP
Sbjct: 383 RNQLEPPKTSYNRTYRSELPSKTTP-NKIARPARRASLPLSTYETPTKRSISILEQLDSP 441
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPI-PKTSSTSACCSSSSPDSIDCSITKDKCTIQVM 475
DVSVNAPRID+IAEFPLASSEDPLLPI K S C S+P I+ SITKDKCTIQV+
Sbjct: 442 DVSVNAPRIDRIAEFPLASSEDPLLPIHNKLSPGHGSC--STPPFINRSITKDKCTIQVL 499
Query: 476 DRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEG 535
T G NGS+ S N AT SS S +S+ +RFDTSSFQQRAEALEG
Sbjct: 500 ------------RTDG--DNGSDSSGRN-ATAASSRGSNDSRQQRFDTSSFQQRAEALEG 544
Query: 536 LLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETA 581
LLEFSA+LLQQER+EELG+LLKPFGPEK SPRETAIWL KSFKETA
Sbjct: 545 LLEFSAQLLQQERYEELGILLKPFGPEKASPRETAIWLTKSFKETA 590
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2ZMH2|NEK2_ORYSI Serine/threonine-protein kinase Nek2 OS=Oryza sativa subsp. indica GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/585 (63%), Positives = 428/585 (73%), Gaps = 29/585 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEM+LI+ VRNPFIVEYKDSWVEKGCYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMQLIATVRNPFIVEYKDSWVEKGCYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+ANG +F EEKLCKWLVQLLMAL+YLHANHILHRDVKCSNIF+ RDQ IRLGDFG
Sbjct: 90 AEAIKRANGTYFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFIARDQSIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDLASSVVGTPSYMCPELLADIPYG+KSDIWSLGCC+YEM+A + AFKAFDMQ
Sbjct: 150 LAKILTSDDLASSVVGTPSYMCPELLADIPYGTKSDIWSLGCCIYEMTALRPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKI KSIV+PLPT YSGAFRGL+KSMLRK+PE RPSAA+LL HP LQPYVL + LK
Sbjct: 210 ALINKITKSIVSPLPTKYSGAFRGLIKSMLRKSPEHRPSAAQLLKHPQLQPYVLQVQLK- 268
Query: 242 NGPRRNTFPLEWSDSN-FKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
+ P RN P+ S ++ KK F S +R S N+R + S E++S+S
Sbjct: 269 SSPTRNILPIHQSLTDKVKKMTFPSDVVDSARRRMARRNSLGNERTVTFSKPSPERNSVS 328
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAG---KTPRLTPAKVSATPR 357
ST R+ Y + E + V E G ++++ + +TP+ PAK + T R
Sbjct: 329 ST---RSIKEYTTTQSVE-GLSVDSSEAGDEVTSKAIITKTSSILRTPKSLPAK-TYTAR 383
Query: 358 RQATPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQPITCIMKSPD 417
Q P K ++ + R LP P K +RPARRASLPL+T I + SPD
Sbjct: 384 NQLEPPKTSYNRTYRSELPSKTTP-NKIARPARRASLPLSTYETPTKRSISILEQLDSPD 442
Query: 418 VSVNAPRIDKIAEFPLASSEDPLLPI-PKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
VSVNAPRID+IAEFPLASSEDPLLPI K S C S+P I+ SITKDKCTIQV+
Sbjct: 443 VSVNAPRIDRIAEFPLASSEDPLLPIHNKLSPGHGSC--STPPFINRSITKDKCTIQVL- 499
Query: 477 RTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGL 536
T G NGS+ S N AT SS S +S+ +RFDTSSFQQRAEALEGL
Sbjct: 500 -----------RTDG--DNGSDSSGRN-ATAASSRGSNDSRQQRFDTSSFQQRAEALEGL 545
Query: 537 LEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETA 581
LEFSA+LLQQER+EELG+LLKPFGPEK SPRETAIWL KSFKETA
Sbjct: 546 LEFSAQLLQQERYEELGILLKPFGPEKASPRETAIWLTKSFKETA 590
|
May be involved in plant development processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10GB1|NEK1_ORYSJ Serine/threonine-protein kinase Nek1 OS=Oryza sativa subsp. japonica GN=NEK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/590 (60%), Positives = 422/590 (71%), Gaps = 29/590 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEM+LI+ VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMQLIATVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+A G HF EEKLCKWLVQLLMAL+YLHANHILHRDVKCSNIFLTRDQ IRLGDFG
Sbjct: 90 AEAIKRATGDHFSEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTRDQSIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDLASSVVGTPSYMCPELLADIPYG+KSDIWSLGCC+YEM+A + AFKAFDMQ
Sbjct: 150 LAKILTSDDLASSVVGTPSYMCPELLADIPYGTKSDIWSLGCCIYEMTALRPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALI+KI KSIV+PLPT YSGAFRGL+KSMLRK+PE RPSAAELL HPHLQPYVL +HLK
Sbjct: 210 ALISKITKSIVSPLPTRYSGAFRGLIKSMLRKSPEHRPSAAELLKHPHLQPYVLQVHLK- 268
Query: 242 NGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 301
+ P RN P S K + M S+ ++ +R S N+R + S E+ SS
Sbjct: 269 SSPARNIIPSH--QSPIDKVKKMTFPTESMCRSKGRRNSLGNERIVTFSKPSPERKFTSS 326
Query: 302 TLRGRAFGNYMNQKFKELSIGV-VHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
+ + + K+LSI V + EE+ + T + KTP+ TP+K TP Q
Sbjct: 327 IQSIKDYST--TRSVKDLSIDVSLVEEVSSKTTFTTRTSSIVKTPKRTPSKTITTP--QL 382
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQPITCI-----MKS 415
P K ++ R L +S P + +R RRASLPL +SE+ + ++ I ++S
Sbjct: 383 EPPKVSYNRVNRSEL-LSRTPVNRSARVIRRASLPLPLP-SSETPKRGVSSISILEQLES 440
Query: 416 PDVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQ-- 473
PDVSVN+PRID+IAEFPLASSEDP P K + + ID SITKDKC ++
Sbjct: 441 PDVSVNSPRIDRIAEFPLASSEDP--PFLKLHGRRSPTPTPQHCVIDQSITKDKCMVEAF 498
Query: 474 -VMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEA 532
++D V G + S + A + SS ++ RRFDTSS+QQRAEA
Sbjct: 499 HIID---------VDDDDGRSDSSSGRNNAAAAASSRAGSSESTRQRRFDTSSYQQRAEA 549
Query: 533 LEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
LEGLLEFSA+LLQQER++ELGVLLKPFGPEKVSPRETAIWL KSFKET +
Sbjct: 550 LEGLLEFSAQLLQQERYDELGVLLKPFGPEKVSPRETAIWLTKSFKETGL 599
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAU7|NEK2_ARATH Serine/threonine-protein kinase Nek2 OS=Arabidopsis thaliana GN=NEK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 637 bits (1644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/594 (58%), Positives = 411/594 (69%), Gaps = 37/594 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+YVLKKIRLARQT R RRSAHQEMELIS++ NPFIVEYKDSWVEKGCYVCIIIGYC+GGD
Sbjct: 29 LYVLKKIRLARQTGRTRRSAHQEMELISKIHNPFIVEYKDSWVEKGCYVCIIIGYCKGGD 88
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
MAEAIKK NGVHF EEKLCKWLVQ+L+AL YLHANHILHRDVKCSNIFLT+DQDIRLGDF
Sbjct: 89 MAEAIKKTNGVHFTEEKLCKWLVQILLALEYLHANHILHRDVKCSNIFLTKDQDIRLGDF 148
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLAK+L SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDM
Sbjct: 149 GLAKVLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMTAMKPAFKAFDM 208
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
Q LIN+IN+SIV PLP YS AFRGLVKSMLRKNPE RPSAAELL P LQPY+ IHLK
Sbjct: 209 QGLINRINRSIVPPLPAQYSAAFRGLVKSMLRKNPELRPSAAELLRQPLLQPYIQKIHLK 268
Query: 241 LNGPRRNTFPLEWSDS-NFKKTRFMEPEAISIHSNREKRQSFSNDRALNPS-VSETEQDS 298
+N P N P +W +S + ++ F E ++R+ + PS +DS
Sbjct: 269 VNDPGSNVLPAQWPESESARRNSFPE----------QRRRPAGKSHSFGPSRFRGNLEDS 318
Query: 299 LSSTLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRR 358
+SS + Y+N +E + + + G D + A K+ R P + SA+P R
Sbjct: 319 VSSI--KKTVPAYLN---RERQVDLSTDASG-DGTVVRRTSEASKSSRYVPVRASASPVR 372
Query: 359 QATPSKNTHIGSKRDSLPISHN-PGGKPSRPARRASLPLTTTRASE---SHYQPITCIM- 413
P + +G LP+S KP+ RRAS+P + A E S Y T +
Sbjct: 373 PRQP--RSDLG----QLPVSSQLKNRKPAALIRRASMPSSRKPAKEIKDSLYISKTSFLH 426
Query: 414 --KSPDVSVNAPRIDKIAEFPLAS-SEDPLLPI----PKTSSTSACCSSSSPDSIDCSIT 466
SPDVS+NAPRIDKI EFPLAS E+P +P+ K +S+ S +DCSIT
Sbjct: 427 QINSPDVSMNAPRIDKI-EFPLASYEEEPFVPVVRGKKKKASSRGSYSPPPEPPLDCSIT 485
Query: 467 KDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSF 526
KDK T++ V+ +++ SE S+ N G SS +S + +RFD SS+
Sbjct: 486 KDKFTLEPGQNREGAIMKAVYEEDAYLEDRSESSDQNATAGASSRASSGVRRQRFDPSSY 545
Query: 527 QQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKET 580
QQRAEALEGLLEFSARLLQ ER++EL VLL+PFGP KVSPRETAIWL+KSFKET
Sbjct: 546 QQRAEALEGLLEFSARLLQDERYDELNVLLRPFGPGKVSPRETAIWLSKSFKET 599
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXT4|NEK4_ARATH Serine/threonine-protein kinase Nek4 OS=Arabidopsis thaliana GN=NEK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 632 bits (1630), Expect = e-180, Method: Compositional matrix adjust.
Identities = 337/596 (56%), Positives = 404/596 (67%), Gaps = 85/596 (14%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQ+DRARRSAHQEMELIS VRNPF+VEYKDSWVEKGCYVCI+IGYC+GGDM
Sbjct: 30 YVLKKIRLARQSDRARRSAHQEMELISTVRNPFVVEYKDSWVEKGCYVCIVIGYCQGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ IK+A GVHFPEEKLC+WLVQLLMAL+YLH+NHILHRDVKCSNIFLT++QDIRLGDFG
Sbjct: 90 TDTIKRACGVHFPEEKLCQWLVQLLMALDYLHSNHILHRDVKCSNIFLTKEQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDL SSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K FKA D+Q
Sbjct: 150 LAKILTSDDLTSSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMAAHKPPFKASDVQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
LI KI+K I+ P+P +YSG+FRGL+KSMLRKNPE RPSA ELL HPHLQPY+ +++KL
Sbjct: 210 TLITKIHKLIMDPIPAMYSGSFRGLIKSMLRKNPELRPSANELLNHPHLQPYISMVYMKL 269
Query: 242 NGPRRNTFPLEWS--DSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSL 299
PRR+TFPL++S D+ K+ R R SFSNDR LNPSVS+TE S+
Sbjct: 270 ESPRRSTFPLQFSERDATLKERR---------------RSSFSNDRRLNPSVSDTEAGSV 314
Query: 300 SSTLRGRAFGNYMNQKFKELSIGVVHEELGVD-MSTTPNVCNAGKTPRLTPAKVSATPRR 358
SS+ + + +K E+++GVV EE+ A +TPR+ A+ +R
Sbjct: 315 SSSGKASPTPMFNGRKVSEVTVGVVREEIVPQRQEEAKKQSGAARTPRVAGTSAKASTQR 374
Query: 359 QATPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQPIT--CIMKSP 416
K + + +S+ P+ RR SLPL ++ IT C + SP
Sbjct: 375 TVF---------KHELMKVSN-----PTERRRRVSLPLVVENPY-TYESDITALCSLNSP 419
Query: 417 DVSVNAPRIDKIAEFP----------LASSEDPLLPIPKTSSTSACCSSSSPDSIDCSIT 466
DVSVN PR DKIAEFP AS + + + S +S C D+ + SIT
Sbjct: 420 DVSVNTPRFDKIAEFPEDIFQNQNRETASRRE----VARHSFSSPPCPPHGEDNSNGSIT 475
Query: 467 KDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSF 526
KDKCT+Q R+ S E + RRFDTSS+
Sbjct: 476 KDKCTVQ--KRSVS----------------------------------EVKQRRFDTSSY 499
Query: 527 QQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
QQRAEALEGLLEFSA+LLQQER++ELGVLLKPFG E+VS RETAIWL KSFKE +V
Sbjct: 500 QQRAEALEGLLEFSAKLLQQERYDELGVLLKPFGAERVSSRETAIWLTKSFKEASV 555
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZEZ5|NEK3_ORYSJ Serine/threonine-protein kinase Nek3 OS=Oryza sativa subsp. japonica GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 632 bits (1629), Expect = e-180, Method: Compositional matrix adjust.
Identities = 345/583 (59%), Positives = 411/583 (70%), Gaps = 29/583 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEMELI++VRNP+IVEYKDSWVEKGCYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRCRRSAHQEMELIAKVRNPYIVEYKDSWVEKGCYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+EAIKKAN +F EE+LC WLVQLLMAL+YLH NHILHRDVKCSNIFLT+DQ+IRLGDFG
Sbjct: 90 SEAIKKANSNYFSEERLCMWLVQLLMALDYLHVNHILHRDVKCSNIFLTKDQNIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDL SSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDMQ
Sbjct: 150 LAKVLTSDDLTSSVVGTPSYMCPELLADIPYGSKSDIWSLGCCLYEMTALKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
LINKI+KS++APLPT+YSGAFRGL+KSMLRK+P+ RPSAAELL HPHLQP+VL + LK
Sbjct: 210 TLINKISKSVLAPLPTIYSGAFRGLIKSMLRKSPDHRPSAAELLKHPHLQPFVLELQLK- 268
Query: 242 NGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 301
+ P RN FP D+N E + +S K SF DR + SS
Sbjct: 269 SSPARNLFP----DTNKASCSDDENNWKAKYS---KSHSFKVDRIVKVDKVAANNGHPSS 321
Query: 302 TLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQAT 361
T + + + Q EL +G + E++ VD N K+P TP + S+TPR +
Sbjct: 322 TGTAKDYQELLKQPMDEL-LGQLTEKV-VDEVIHGNHSRVTKSPAPTPRRASSTPRIRLE 379
Query: 362 PSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHY-QPITCIMKSPDVSV 420
PSK H ++ P S + S+P RRAS P+ + E I +KSPDVSV
Sbjct: 380 PSKTFH--ARAAETPPSKCSLERASQPTRRASTPVNMLQTPEKRQGADILTRLKSPDVSV 437
Query: 421 NAPRIDKIAEFPLASSEDPLL-PIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMDRTA 479
N+PRID+IAEFP+ S +D L P K P D SITKDKCT QV+ R+
Sbjct: 438 NSPRIDRIAEFPIPSFDDEQLHPTTK-------LKLYPPSITDQSITKDKCTFQVL-RSD 489
Query: 480 SRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGLLEF 539
S N ++ +I ++ NP + + SS + RRFDT+S++QRAEALEGLLEF
Sbjct: 490 SSKNHTGDSSDPSILG----TDSNP---LITSSSDWMKQRRFDTTSYRQRAEALEGLLEF 542
Query: 540 SARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
SA+LLQQERFEELG+LLKPFGP K SPRETAIWL+KSFK T +
Sbjct: 543 SAQLLQQERFEELGILLKPFGPGKASPRETAIWLSKSFKGTGL 585
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SLI2|NEK1_ARATH Serine/threonine-protein kinase Nek1 OS=Arabidopsis thaliana GN=NEK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 355/598 (59%), Positives = 409/598 (68%), Gaps = 57/598 (9%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQT R RRSAHQEMELIS++R+PFIVEYKDSWVEK CYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTQRTRRSAHQEMELISKMRHPFIVEYKDSWVEKACYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
A+AIKK+NGVHF EEKLCKWLVQLLM L YLH+NHILHRDVKCSNIFLT++QDIRLGDFG
Sbjct: 90 AQAIKKSNGVHFQEEKLCKWLVQLLMGLEYLHSNHILHRDVKCSNIFLTKEQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDL SSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+ K AFKAFDMQ
Sbjct: 150 LAKILTSDDLTSSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMAYLKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINK+IV+PLP YSG FRGLVKSMLRKNPE RPSA++LL HPHLQPYVL + L+L
Sbjct: 210 ALINKINKTIVSPLPAKYSGPFRGLVKSMLRKNPEVRPSASDLLRHPHLQPYVLDVKLRL 269
Query: 242 NGPRRNTFPLEWSDSN--FKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSL 299
N RR T P E S KK F EP + +S NDRALNP E E+D+
Sbjct: 270 NNLRRKTLPPELPSSKRIMKKAHFSEPAVTCPAFGERQHRSLWNDRALNP---EAEEDTA 326
Query: 300 SSTLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQ 359
SS ++++ +LSI + + + + C K P AK S T RR
Sbjct: 327 SSI-------KCISRRISDLSIESSSKGTLICKQVSSSACKVSKYPL---AKSSVTSRRI 376
Query: 360 ATPSKNTHIGSKRDSL-PISHNPGGKPSR---PARRASLPLT--TTRASESHYQPITCIM 413
G + D L P+S GG S+ ARR SLPLT T + Y PI I+
Sbjct: 377 ------METGRRSDHLHPVSG--GGTTSKIIPSARRTSLPLTKRATNQEVAAYNPIVGIL 428
Query: 414 ---KSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKC 470
KSP+ S+N P++DKIA FPLA E + P TS+ SS S SITKDKC
Sbjct: 429 QNVKSPEYSINEPQVDKIAIFPLAPYEQDIFFTPMQRKTSSKSSSVSDR----SITKDKC 484
Query: 471 TIQVMDRTASRPNFVVHTTHGTIQ--------NGSEFSEPNPATGVSSHSSLESQHR-RF 521
T+Q HTT IQ +GS S+ N G SSH++ S R RF
Sbjct: 485 TVQ------------THTTWQGIQLNMVDNISDGSSSSDQNATAGASSHTTSSSSRRCRF 532
Query: 522 DTSSFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKE 579
D SS++QRA+ALEGLLEFSARLLQ+ R++EL VLLKPFGP KVSPRETAIW+AKS KE
Sbjct: 533 DPSSYRQRADALEGLLEFSARLLQEGRYDELNVLLKPFGPGKVSPRETAIWIAKSLKE 590
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RX66|NEK3_ARATH Serine/threonine-protein kinase Nek3 OS=Arabidopsis thaliana GN=NEK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1490), Expect = e-164, Method: Compositional matrix adjust.
Identities = 339/597 (56%), Positives = 400/597 (67%), Gaps = 80/597 (13%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+YVLKKIRLARQT R RRSAHQEMELIS++RNPFIVEYKDSWVEKGCYVCI+IGYC+GGD
Sbjct: 29 LYVLKKIRLARQTGRTRRSAHQEMELISKIRNPFIVEYKDSWVEKGCYVCIVIGYCKGGD 88
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
MAEAIKKANGV F EEKLCKWLVQLLMAL YLHA+HILHRDVKCSNIFLT+DQDIRLGDF
Sbjct: 89 MAEAIKKANGVEFSEEKLCKWLVQLLMALEYLHASHILHRDVKCSNIFLTKDQDIRLGDF 148
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLAK+L SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDM
Sbjct: 149 GLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMTALKPAFKAFDM 208
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
Q LIN+IN+SIVAPLP YS AFR LVKSMLRKNPE RPSA++LL P LQPYV + LK
Sbjct: 209 QGLINRINRSIVAPLPAQYSTAFRSLVKSMLRKNPELRPSASDLLRQPLLQPYVQKVLLK 268
Query: 241 LNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQ-DSL 299
L+ +T P E E S + + KR S + PS +Q DS+
Sbjct: 269 LSFREHDTLP-------------SESERRSSYPQQRKRTS-GKSVSFGPSRFGVDQEDSV 314
Query: 300 SSTLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQ 359
SS + Y+ H VD+S A T R+ +
Sbjct: 315 SSV---KPVHTYL------------HRHRPVDLS-------ANDTSRVVVRR-------- 344
Query: 360 ATPSKNTHIGSKRDSLPISHN---PGG--KPSRPARRASLPLTTTRA---SESHYQPITC 411
P+ ++ + + +P+ N GG KP+ RRASLP++ A +S Y P
Sbjct: 345 --PAVSSVVSNSSKYVPVRSNQPKSGGLLKPAVVTRRASLPISQKPAKGTKDSLYHPNIG 402
Query: 412 I---MKSPDVSVNAPRIDKIAEFPLASSED-PLLPIPKTSSTSACCSSSSPDS--IDCSI 465
I + SPDVSVN+PRID+I +FPLAS E+ P +P+ + S+ S S P +DCSI
Sbjct: 403 ILHQLNSPDVSVNSPRIDRI-KFPLASYEEMPFIPVVRKKKGSSRGSYSPPPEPPLDCSI 461
Query: 466 TKDKCTIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPN-PATGVSSHSSLESQHRRFDTS 524
TKDK T++ T S+ S+ N A S SS S+ +RFD S
Sbjct: 462 TKDKFTLEPERETK-----------------SDLSDQNATAGASSRASSGASRRQRFDPS 504
Query: 525 SFQQRAEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETA 581
S++QRAEALEGLLEFSARLL ER++EL VLLKPFGP KVSPRETAIWL+KSFKE++
Sbjct: 505 SYRQRAEALEGLLEFSARLLIDERYDELNVLLKPFGPGKVSPRETAIWLSKSFKESS 561
|
May be involved in plant development processes. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WPH8|NEK5_ARATH Serine/threonine-protein kinase Nek5 OS=Arabidopsis thaliana GN=NEK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1039), Expect = e-112, Method: Compositional matrix adjust.
Identities = 172/233 (73%), Positives = 209/233 (89%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQT+R RRSAHQEM LI+RV++P+IVE+K++WVEKGCYVCI+ GYCEGGDM
Sbjct: 34 YVLKKIRLARQTERCRRSAHQEMSLIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM 93
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AE +KK+NGV+FPEEKLCKW QLL+A+ YLH+N++LHRD+KCSNIFLT+DQD+RLGDFG
Sbjct: 94 AELMKKSNGVYFPEEKLCKWFTQLLLAVEYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK L +DDL SSVVGTP+YMCPELLADIPYG KSDIWSLGCC+YEM+A + AFKAFDM
Sbjct: 154 LAKTLKADDLTSSVVGTPNYMCPELLADIPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMA 213
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234
LI+K+N+S + PLP YS + + L+K MLRKNPE+RP+A+E+L HP+LQPYV
Sbjct: 214 GLISKVNRSSIGPLPPCYSPSLKALIKGMLRKNPEYRPNASEILKHPYLQPYV 266
|
Involved in epidermal-cell morphogenesis in hypocotyls and roots. May act on the microtubule function. May have a secondary role in trichome branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94CU5|NEK5_ORYSJ Serine/threonine-protein kinase Nek5 OS=Oryza sativa subsp. japonica GN=NEK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 169/233 (72%), Positives = 205/233 (87%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQT+R R+SAHQEM LI+R+++P+IVE+K++WVEKGCYVCI+ GYCEGGDM
Sbjct: 34 YVLKKIRLARQTERCRKSAHQEMALIARLQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM 93
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AE +KKANG +FPEEKL KW QL +A++YLH+N +LHRD+KCSNIFLT+DQDIRLGDFG
Sbjct: 94 AELMKKANGTYFPEEKLLKWFAQLALAVDYLHSNFVLHRDLKCSNIFLTKDQDIRLGDFG 153
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK L +DDL SSVVGTP+YMCPELLADIPYG KSDIWSLGCC+YEM+A + AFKAFDM
Sbjct: 154 LAKTLKADDLTSSVVGTPNYMCPELLADIPYGFKSDIWSLGCCMYEMAAHRPAFKAFDMA 213
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234
LI+KIN+S + PLP YS + + L+KSMLRK+PE RP+A+E+L P+LQPYV
Sbjct: 214 GLISKINRSSIGPLPPCYSPSMKSLIKSMLRKSPEHRPTASEILKSPYLQPYV 266
|
May be involved in plant development processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | ||||||
| 359479671 | 614 | PREDICTED: serine/threonine-protein kina | 0.996 | 0.944 | 0.757 | 0.0 | |
| 255567504 | 612 | ATP binding protein, putative [Ricinus c | 0.993 | 0.944 | 0.762 | 0.0 | |
| 296085239 | 585 | unnamed protein product [Vitis vinifera] | 0.946 | 0.941 | 0.735 | 0.0 | |
| 449491563 | 608 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.982 | 0.940 | 0.722 | 0.0 | |
| 449458518 | 608 | PREDICTED: serine/threonine-protein kina | 0.982 | 0.940 | 0.722 | 0.0 | |
| 224066438 | 606 | predicted protein [Populus trichocarpa] | 0.970 | 0.932 | 0.730 | 0.0 | |
| 356500172 | 609 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.942 | 0.714 | 0.0 | |
| 356536779 | 610 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.942 | 0.721 | 0.0 | |
| 224130678 | 620 | predicted protein [Populus trichocarpa] | 0.982 | 0.922 | 0.684 | 0.0 | |
| 18766642 | 621 | NIMA-related protein kinase [Populus tre | 0.982 | 0.921 | 0.684 | 0.0 |
| >gi|359479671|ref|XP_003632328.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/586 (75%), Positives = 497/586 (84%), Gaps = 6/586 (1%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAH EMELIS+VRNPFIVEYKDSWVEKGCYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHLEMELISKVRNPFIVEYKDSWVEKGCYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+ANGVHFPEEKLCKWLVQLL AL YLHANHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 AEAIKRANGVHFPEEKLCKWLVQLLTALEYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A + AFKAFDMQ
Sbjct: 150 LAKMLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTAHRPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKSIVAPLPT+YSGAFRGLVKSMLRKNPE RPSAAELL H HLQPY+L IHLK
Sbjct: 210 ALINKINKSIVAPLPTMYSGAFRGLVKSMLRKNPELRPSAAELLTHSHLQPYILKIHLKS 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRRNTFP +WSDSN+ KKTRF+EPEA+ + S+REKR+SFSNDR LNPS+S TEQDS
Sbjct: 270 NSPRRNTFPFQWSDSNYIKKTRFLEPEAVPMFSDREKRRSFSNDRTLNPSISGTEQDSPC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
S+ + + F +++N+KF ELS+G HE++G+D S +A KTPR TP+K S+TPRRQ
Sbjct: 330 SSQKMQEFSSHLNRKFAELSVGSTHEDIGIDKSVVTKFSSATKTPRSTPSKTSSTPRRQT 389
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRAS-ESHYQPITCIMK---SP 416
SK + IGS DS P+SH P K S RRASLP T A+ E+ Y+P +++ SP
Sbjct: 390 ATSKISRIGSNHDSFPVSHTPVSKSSWSTRRASLPFPTRAATLETPYRPNVRLLRSVESP 449
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
D+SVNAPRID+IAEFPLAS ++PL PI KTSSTSA CSS+SPDS DCSITKDKCT+Q++D
Sbjct: 450 DISVNAPRIDRIAEFPLASCDEPLFPIRKTSSTSAQCSSNSPDSGDCSITKDKCTVQILD 509
Query: 477 RTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGL 536
+ R NF HG +NGSE SE NP TGVSS SS +S+ RRFDTSS+QQRAEALEGL
Sbjct: 510 KAFVRQNF-TDADHGVPRNGSECSEHNPTTGVSSRSSSDSRQRRFDTSSYQQRAEALEGL 568
Query: 537 LEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
LEFSARLLQQERF+ELGVLLKPFGPEKVSPRETAIWL KSFKETA
Sbjct: 569 LEFSARLLQQERFDELGVLLKPFGPEKVSPRETAIWLTKSFKETAA 614
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567504|ref|XP_002524731.1| ATP binding protein, putative [Ricinus communis] gi|223535915|gb|EEF37574.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/586 (76%), Positives = 496/586 (84%), Gaps = 8/586 (1%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KKIRLARQTDRARRSAHQEMELIS+VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM
Sbjct: 30 YVMKKIRLARQTDRARRSAHQEMELISKVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
EAIKKAN VHFPEEKLCKWLVQLLMAL+YLH NHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 QEAIKKANSVHFPEEKLCKWLVQLLMALDYLHGNHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDMQ
Sbjct: 150 LAKMLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMAAHKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE RPSA+ELL HPHLQP++L IHLKL
Sbjct: 210 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPELRPSASELLSHPHLQPHLLKIHLKL 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRRNT P+ WSDS+F KKT+F EPEA+ ++REKR+SFSNDR LNPS+SETEQDSL
Sbjct: 270 NSPRRNTLPVRWSDSDFIKKTKFREPEAVPHFTDREKRRSFSNDRTLNPSISETEQDSLD 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
S+ R F +Y+N++F+ELS GV EE+ + + T + A KTPR+ P K SATPRRQ
Sbjct: 330 SSHRVEQFPSYLNRRFRELSFGVALEEIDIQNAVTTKISMAAKTPRMMPVKASATPRRQ- 388
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRAS-ESHYQPITCIM---KSP 416
TPSK H SKRDSLP+S P GK S+ RRASLP T + + Y+ ++ +SP
Sbjct: 389 TPSKIPHTCSKRDSLPVSCTPAGK-SQSTRRASLPFPTRAGNFPTPYRSNVGLLPSIESP 447
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
+VSVNAPRIDKIAEFPLASSEDP +PI TSSTSA CSSSSP S DCSITKDKCTIQV+D
Sbjct: 448 NVSVNAPRIDKIAEFPLASSEDPFIPIRGTSSTSAQCSSSSPGSADCSITKDKCTIQVLD 507
Query: 477 RTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGL 536
R ++P + ++ ++GSE SE NP +SS SS ES+ RRFDTSS+QQRAEALEGL
Sbjct: 508 RAIAKPA-LPDISNEITRSGSECSEHNPTVAISSRSSSESRLRRFDTSSYQQRAEALEGL 566
Query: 537 LEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
LEFSARLLQQERF ELGVLLKPFGPEKVSPRETAIWLAKSFKETAV
Sbjct: 567 LEFSARLLQQERFAELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 612
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085239|emb|CBI28734.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/586 (73%), Positives = 479/586 (81%), Gaps = 35/586 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAH EMELIS+VRNPFIVEYKDSWVEKGCYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHLEMELISKVRNPFIVEYKDSWVEKGCYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+ANGVHFPEEKLCKWLVQLL AL YLHANHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 AEAIKRANGVHFPEEKLCKWLVQLLTALEYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A + AFKAFDMQ
Sbjct: 150 LAKMLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTAHRPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKSIVAPLPT+YSGAFRGLVKSMLRKNPE RPSAAELL H HLQPY+L IHLK
Sbjct: 210 ALINKINKSIVAPLPTMYSGAFRGLVKSMLRKNPELRPSAAELLTHSHLQPYILKIHLKS 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRRNTFP +WSDSN+ KKTRF+EPEA+ + S+REKR+SFSNDR LNPS+S TEQDS
Sbjct: 270 NSPRRNTFPFQWSDSNYIKKTRFLEPEAVPMFSDREKRRSFSNDRTLNPSISGTEQDSPC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
S+ + + F +++N+KF ELS+G HE++G+D S +A KTPR TP+K S+TPRRQ
Sbjct: 330 SSQKMQEFSSHLNRKFAELSVGSTHEDIGIDKSVVTKFSSATKTPRSTPSKTSSTPRRQT 389
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRAS-ESHYQPITCIMKS---P 416
SK + IGS DS P+SH P K S RRASLP T A+ E+ Y+P +++S P
Sbjct: 390 ATSKISRIGSNHDSFPVSHTPVSKSSWSTRRASLPFPTRAATLETPYRPNVRLLRSVESP 449
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
D+SVNAPRID+IAEFPLAS ++PL PI KTSSTSA CSS+SPDS DCSITKDKCT
Sbjct: 450 DISVNAPRIDRIAEFPLASCDEPLFPIRKTSSTSAQCSSNSPDSGDCSITKDKCT----- 504
Query: 477 RTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGL 536
NP TGVSS SS +S+ RRFDTSS+QQRAEALEGL
Sbjct: 505 -------------------------HNPTTGVSSRSSSDSRQRRFDTSSYQQRAEALEGL 539
Query: 537 LEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
LEFSARLLQQERF+ELGVLLKPFGPEKVSPRETAIWL KSFKETA
Sbjct: 540 LEFSARLLQQERFDELGVLLKPFGPEKVSPRETAIWLTKSFKETAA 585
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449491563|ref|XP_004158937.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase Nek2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 839 bits (2167), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/588 (72%), Positives = 482/588 (81%), Gaps = 16/588 (2%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEMELIS+ RNPFIVEYKDSWVEKGC+VCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMELISKARNPFIVEYKDSWVEKGCFVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+ANGV FPEEKLC+WLVQLLMAL+YLH NHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 AEAIKRANGVXFPEEKLCRWLVQLLMALDYLHCNHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDMQ
Sbjct: 150 LAKMLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMAAHKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
+LINKINKSIVAPLPT+YSGAFRGLVKSMLRKNPE RPSAAELL HPHLQPY+L +HLKL
Sbjct: 210 SLINKINKSIVAPLPTMYSGAFRGLVKSMLRKNPELRPSAAELLNHPHLQPYILKVHLKL 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRRNTFPL+ SD+N+ KKTRF EP + S+ + REKR SFSNDRA+NPSVS TE +S
Sbjct: 270 NSPRRNTFPLQRSDTNYIKKTRFEEPGSDSLRAFREKRLSFSNDRAVNPSVSVTEAESQC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
S+ R +Y+N+KF+ELSI +E VD+S T + KTPRLT AKVSATP++Q
Sbjct: 330 SSRRSLQLPSYLNKKFEELSIA--GKESNVDLSRTSKLQTISKTPRLTNAKVSATPKKQT 387
Query: 361 TPSKNTHIGSKRDSLPISHNPGGK-PSRPARRASLPLTTTRAS-ESHYQPITCI---MKS 415
I SK +P SH+P + S RRASLPL+T A + Y+ T + M S
Sbjct: 388 -------ISSKFSPIPASHSPASRGSSHTNRRASLPLSTKTAGFGTPYRSNTGLLHGMNS 440
Query: 416 PDVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSP-DSIDCSITKDKCTIQV 474
PD+SVNAPRIDKIAEFPL SSEDPLL I TSSTSA CS++S DS +CSITKDKCT+QV
Sbjct: 441 PDISVNAPRIDKIAEFPLVSSEDPLLHIRGTSSTSAQCSNNSQDDSTNCSITKDKCTVQV 500
Query: 475 MDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALE 534
+D+T + + V+ ++ + S++ + NPA SS S ES+ RRFDTSS+QQRAEALE
Sbjct: 501 VDKTTIKKSDVLSSSFRVPGSESDYFDRNPAIASSSRLSFESRQRRFDTSSYQQRAEALE 560
Query: 535 GLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
GLLEFSA+LLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKE V
Sbjct: 561 GLLEFSAKLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKEATV 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458518|ref|XP_004146994.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 839 bits (2167), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/588 (72%), Positives = 482/588 (81%), Gaps = 16/588 (2%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEMELIS+ RNPFIVEYKDSWVEKGC+VCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMELISKARNPFIVEYKDSWVEKGCFVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIK+ANGV FPEEKLC+WLVQLLMAL+YLH NHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 AEAIKRANGVFFPEEKLCRWLVQLLMALDYLHCNHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDMQ
Sbjct: 150 LAKMLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMAAHKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
+LINKINKSIVAPLPT+YSGAFRGLVKSMLRKNPE RPSAAELL HPHLQPY+L +HLKL
Sbjct: 210 SLINKINKSIVAPLPTMYSGAFRGLVKSMLRKNPELRPSAAELLNHPHLQPYILKVHLKL 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRRNTFPL+ SD+N+ KKTRF EP + S+ + REKR SFSNDRA+NPSVS TE +S
Sbjct: 270 NSPRRNTFPLQRSDTNYIKKTRFEEPGSDSLRAFREKRLSFSNDRAVNPSVSVTEAESQC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
S+ R +Y+N+KF+ELSI +E VD+S T + KTPRLT AKVSATP++Q
Sbjct: 330 SSRRSLQLPSYLNKKFEELSIA--GKESNVDLSRTSKLQTISKTPRLTNAKVSATPKKQT 387
Query: 361 TPSKNTHIGSKRDSLPISHNPGGK-PSRPARRASLPLTTTRAS-ESHYQPITCI---MKS 415
I SK +P SH+P + S RRASLPL+T A + Y+ T + M S
Sbjct: 388 -------ISSKFSPIPASHSPASRGSSHTNRRASLPLSTKTAGFGTPYRSNTGLLHGMNS 440
Query: 416 PDVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSS-PDSIDCSITKDKCTIQV 474
PD+SVNAPRIDKIAEFPL SSEDPLL I TSSTSA CS++S DS +CSITKDKCT+QV
Sbjct: 441 PDISVNAPRIDKIAEFPLVSSEDPLLHIRGTSSTSAQCSNNSQDDSTNCSITKDKCTVQV 500
Query: 475 MDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALE 534
+D+T + + V+ ++ + S++ + NPA SS S ES+ RRFDTSS+QQRAEALE
Sbjct: 501 VDKTTIKKSDVLSSSFRVPGSESDYFDRNPAIASSSRLSFESRQRRFDTSSYQQRAEALE 560
Query: 535 GLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
GLLEFSA+LLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKE V
Sbjct: 561 GLLEFSAKLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKEATV 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066438|ref|XP_002302101.1| predicted protein [Populus trichocarpa] gi|222843827|gb|EEE81374.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 836 bits (2159), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/593 (73%), Positives = 481/593 (81%), Gaps = 28/593 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSA+QEMELIS+ NPFIVEYKDSWVEKGCYVCIIIGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAYQEMELISKASNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIKKA+GVHFPEEKLCKWLVQLLMAL+YLHANHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 AEAIKKASGVHFPEEKLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K+AFKAFD+Q
Sbjct: 150 LAKMLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMAAHKSAFKAFDIQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
LINKINKSIVAPLPTVYSG RGL+KSMLRKNPE RPSAAELL HPHLQPY+L IHLKL
Sbjct: 210 TLINKINKSIVAPLPTVYSGPLRGLIKSMLRKNPELRPSAAELLGHPHLQPYLLKIHLKL 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRRNTFP+EWSDS F KK F++P+A+ + REKR+SF+NDRALNPS+S TEQDS
Sbjct: 270 NSPRRNTFPVEWSDSTFVKKASFLDPQAVPSFTTREKRRSFNNDRALNPSISGTEQDSPH 329
Query: 301 STLRGRAFGN--YMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRR 358
S+ R + Y+NQ+F ELS+GVVHEE G +T +TPRL P+K+SATPRR
Sbjct: 330 SSQRDQESPAPIYLNQRFTELSVGVVHEEFG---NTAAKFSTYARTPRLMPSKISATPRR 386
Query: 359 QATPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTT--------TRASESHYQPIT 410
Q+TPSK ++I SK +S K S ARRASLP T T+ SH +
Sbjct: 387 QSTPSKISYITSKLSCTTVS-----KSSHTARRASLPFPTRAAAAAAGTQYKASH--GLL 439
Query: 411 CIMKSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKC 470
M SP+VSVNAPRIDKIAEFPLASSEDPL+PI TS+++ SSSP S+DCSITKDKC
Sbjct: 440 HSMDSPNVSVNAPRIDKIAEFPLASSEDPLIPIHGTSTSAQF--SSSPYSVDCSITKDKC 497
Query: 471 TIQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGV-SSHSSLESQHRRFDTSSFQQR 529
T+QV++R S+ T + GSE SE NP +GV S SS Q RRFDTSS+QQR
Sbjct: 498 TVQVLERAVSKHR----VTDACQRIGSECSEHNPTSGVSSRSSSDSRQQRRFDTSSYQQR 553
Query: 530 AEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 582
AEALEGLLEFSARLLQQERF ELGVLLKPFGPEKVSPRETAIWLAKSFKETAV
Sbjct: 554 AEALEGLLEFSARLLQQERFAELGVLLKPFGPEKVSPRETAIWLAKSFKETAV 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500172|ref|XP_003518907.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2134), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/585 (71%), Positives = 468/585 (80%), Gaps = 11/585 (1%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEMELIS+VRNPFIVEYKDSWVEKGC+VCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMELISKVRNPFIVEYKDSWVEKGCFVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
EAIKKANGVHFPEE+LCK LVQLLMAL+YLHANHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 TEAIKKANGVHFPEERLCKLLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM+A K AFKA DMQ
Sbjct: 150 LAKMLTCDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMAAHKPAFKALDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKS+VAPLPTVYSG+FRGLVKSMLRKNPE RPSAAELL HPHLQPY+L IHLKL
Sbjct: 210 ALINKINKSLVAPLPTVYSGSFRGLVKSMLRKNPELRPSAAELLNHPHLQPYILKIHLKL 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRR+T+P WSDSN+ ++T+F+EP ++S S+R KR SFSNDRALNPS+S TE S+
Sbjct: 270 NNPRRSTYPFPWSDSNYVRRTQFVEPGSVSTLSDRGKRFSFSNDRALNPSISGTELGSVC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
ST R F +K ELS+G VH+E + S + PRL AK ATPR Q
Sbjct: 330 STQRALGFSTCSKEKHYELSVGRVHKECNSNKSRDTKSSTVDRMPRLRTAKEYATPRWQT 389
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPL-TTTRASESHYQPITCIMK---SP 416
PSK +H GSKR+ LP PG K + P RRASLPL T T + Y+ +++ SP
Sbjct: 390 IPSKISHTGSKRELLP--STPGCKFTLPTRRASLPLPTRTTGMITSYRANVGLLRGVDSP 447
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
D+SVNAPRIDKIAEFPLAS ED L P+ TSSTSA CSS SP S DC IT+DKCTIQV+D
Sbjct: 448 DISVNAPRIDKIAEFPLASCEDSLFPVCGTSSTSAQCSSGSPKSADCLITQDKCTIQVVD 507
Query: 477 RTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGL 536
+ + + + +G+E SE +SSHSS ES+ RFDTSS+QQRA+ALEGL
Sbjct: 508 KASVPSSGSDACPAAPVSHGNECSE----HAISSHSSAESRKHRFDTSSYQQRAKALEGL 563
Query: 537 LEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETA 581
LEFSARLLQQ+RFEELGVLLKPFGPEKVSPRETAIWLAKSFKET
Sbjct: 564 LEFSARLLQQQRFEELGVLLKPFGPEKVSPRETAIWLAKSFKETV 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356536779|ref|XP_003536912.1| PREDICTED: serine/threonine-protein kinase Nek2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/585 (72%), Positives = 474/585 (81%), Gaps = 10/585 (1%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR RRSAHQEMELIS+VRNPFIVEYKDSWVEKGC+VCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRTRRSAHQEMELISKVRNPFIVEYKDSWVEKGCFVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIKKANGV+FPEE+LCKWLVQLLMAL+YLHANHILHRDVKCSNIFLT+DQDIRLGDFG
Sbjct: 90 AEAIKKANGVYFPEERLCKWLVQLLMALDYLHANHILHRDVKCSNIFLTKDQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAKML DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM+A K AFKA DMQ
Sbjct: 150 LAKMLTCDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMAAHKPAFKALDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKS+VAPLPTVYSG+FRGLVKSMLRKNPE RPSAAELL HPHLQPY+L IHLKL
Sbjct: 210 ALINKINKSLVAPLPTVYSGSFRGLVKSMLRKNPELRPSAAELLNHPHLQPYILKIHLKL 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PRR+T+P +WSDSN+ ++T+F+EP ++S S+R+KR SFSNDRALNPS+S TE S+
Sbjct: 270 NNPRRSTYPFQWSDSNYVRRTQFLEPGSVSTLSDRDKRLSFSNDRALNPSISGTELGSVC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
ST R F +K ELS+G+V EE + S + PRL AK ATPRRQ
Sbjct: 330 STQRALGFSTCSKEKHYELSVGLVREECNFNKSRDTKSSTVDRLPRLRSAKEYATPRRQT 389
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPL-TTTRASESHYQPITCIMK---SP 416
PSK ++ GSKR+ LP S GGK + P RRASLPL T T + + Y+ +++ SP
Sbjct: 390 IPSKISYTGSKRELLP-STPAGGKFTPPTRRASLPLPTRTMCTTTPYRANVGLLRGVDSP 448
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
D+SVNAPRIDK+AEFPLAS ED L P+ TSSTSA CSS SP S DC ITKDKCTIQV+D
Sbjct: 449 DISVNAPRIDKMAEFPLASCEDSLFPVRGTSSTSAQCSSGSPKSADCLITKDKCTIQVVD 508
Query: 477 RTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAEALEGL 536
+ + + + +G+E SE VSSHSS ES RFDTSS+QQRAEALEGL
Sbjct: 509 KASVPSSGSDACPAAPVSHGNECSE----HAVSSHSSAESSRHRFDTSSYQQRAEALEGL 564
Query: 537 LEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKETA 581
LEFSARLLQQ+RFEELGVLLKPFGPEKVSPRETAIWLAKSFKET
Sbjct: 565 LEFSARLLQQQRFEELGVLLKPFGPEKVSPRETAIWLAKSFKETV 609
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130678|ref|XP_002328349.1| predicted protein [Populus trichocarpa] gi|222838064|gb|EEE76429.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/590 (68%), Positives = 456/590 (77%), Gaps = 18/590 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR+RRSAHQE ELISR+RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRSRRSAHQEKELISRIRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIKKANGVHFPEEKLCKWLVQLLMAL+YLH NHILHRDVKCSNIFLT+ +DIRLGDFG
Sbjct: 90 AEAIKKANGVHFPEEKLCKWLVQLLMALDYLHMNHILHRDVKCSNIFLTKGKDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM++ K AFKAFDMQ
Sbjct: 150 LAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKSIVAPLPT YSGAFRGLVKSMLRKNPE RP AAELL HPHLQPYVL IHLK+
Sbjct: 210 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPGAAELLRHPHLQPYVLKIHLKM 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PR+NT P +W + ++ KKT+F+ PE + ++REKR S SNDRALNPS+S EQDS+
Sbjct: 270 NSPRQNTLPFQWPEPHYMKKTKFLVPEDNPLKAHREKRYSLSNDRALNPSISAAEQDSVC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
ST +Y+N+ + SI HE + S N KT + P K S T RR+
Sbjct: 330 STEGIHDTPSYLNRSLSDSSIESSHEGTVICRSIASKPSNIAKTTKPAPTKASVTTRRRT 389
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQ----PITCIMKSP 416
P K KR+SLP++ P K + RR SLPL + A ++ + I +KSP
Sbjct: 390 EPVK------KRESLPVTRTPTKKSNPTTRRTSLPLPSRTAIQNSARGTNNSILLQIKSP 443
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
DVSVNAPRID+IAEFPLAS E+P LP +TSSTSA SS+S D SITKDKCT+Q+ D
Sbjct: 444 DVSVNAPRIDRIAEFPLASYEEPFLPFRRTSSTSAQGSSNSLHHGDRSITKDKCTVQISD 503
Query: 477 RTASRPNFV---VHTTHGTIQ----NGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQR 529
RT+++PNF HG Q NGS S N G SSH+S + + RRFDTSSFQQR
Sbjct: 504 RTSAKPNFTEAWQGIEHGMFQVDEENGSNSSNQNATAGASSHTSSDMRRRRFDTSSFQQR 563
Query: 530 AEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKE 579
AEALEGLLEFSARLLQ R++ELGVLLKPFGP KVSPRETAIWL KSFKE
Sbjct: 564 AEALEGLLEFSARLLQDARYDELGVLLKPFGPGKVSPRETAIWLTKSFKE 613
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18766642|gb|AAL79042.1|AF469649_1 NIMA-related protein kinase [Populus tremula x Populus alba] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2035), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/590 (68%), Positives = 454/590 (76%), Gaps = 18/590 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQTDR+RRSAHQE ELISR+RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM
Sbjct: 30 YVLKKIRLARQTDRSRRSAHQEKELISRIRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AEAIKKANGVHFPEEKLCKWLVQLLMAL+YLH NHILHRDVKCSNIFLT+ QDIRLGDFG
Sbjct: 90 AEAIKKANGVHFPEEKLCKWLVQLLMALDYLHMNHILHRDVKCSNIFLTKGQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM++ K AFKAFDMQ
Sbjct: 150 LAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMTSLKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINKSIVAPLPT YSGAFRGLVKSMLRKNPE RPSAAELL HPHLQPYVL IH+K+
Sbjct: 210 ALINKINKSIVAPLPTKYSGAFRGLVKSMLRKNPELRPSAAELLRHPHLQPYVLKIHIKM 269
Query: 242 NGPRRNTFPLEWSDSNF-KKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLS 300
N PR+NT P +W + ++ KKT+F+ PE + ++REKR S SNDRALNPS+S EQDS+
Sbjct: 270 NSPRQNTLPFQWPEPHYMKKTKFLVPEDNPLKAHREKRYSLSNDRALNPSISAAEQDSVC 329
Query: 301 STLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
ST +Y+NQ + SI HE + S N KT + P K S T RR+
Sbjct: 330 STEGIHDTPSYLNQSLSDSSIESSHEGTVICRSIASKPSNFAKTTKPAPTKASVTTRRRT 389
Query: 361 TPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQ----PITCIMKSP 416
P K KR+SLP++ P K + RR SLPL + A ++ I +KSP
Sbjct: 390 EPVK------KRESLPVTRTPTKKSNPTTRRTSLPLPSRTAIQNSAHGTNNSILLQIKSP 443
Query: 417 DVSVNAPRIDKIAEFPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSITKDKCTIQVMD 476
DVSVNAPRID+IAEFPLAS + P LP +TSSTSA SS+S D SITKDKCT+Q+ D
Sbjct: 444 DVSVNAPRIDRIAEFPLASYDKPYLPFRRTSSTSAQGSSNSLHHGDRSITKDKCTVQISD 503
Query: 477 RTASRPNFV---VHTTHGTIQ----NGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQR 529
RT+++PNF HG Q NGS S N G SS +S + + RRFDTSSFQQR
Sbjct: 504 RTSAKPNFTEAWQGIEHGMFQVDEENGSNSSNQNATAGASSRTSSDIRRRRFDTSSFQQR 563
Query: 530 AEALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKE 579
AEALEGLLEFSARLLQ R++ELGVLLKPFGP KVSPRETAIWL KSFKE
Sbjct: 564 AEALEGLLEFSARLLQDARYDELGVLLKPFGPGKVSPRETAIWLTKSFKE 613
|
Source: Populus tremula x Populus alba Species: Populus tremula x Populus alba Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 582 | ||||||
| TAIR|locus:2114885 | 606 | NEK2 "NIMA-related kinase 2" [ | 0.965 | 0.927 | 0.565 | 9.9e-158 | |
| TAIR|locus:2077274 | 555 | NEK4 "NIMA-related kinase 4" [ | 0.630 | 0.661 | 0.627 | 4.5e-152 | |
| TAIR|locus:2185314 | 568 | NEK3 "NIMA-related kinase 3" [ | 0.432 | 0.443 | 0.829 | 2e-149 | |
| TAIR|locus:2020148 | 612 | NEK1 "NIMA-related serine/thre | 0.771 | 0.733 | 0.584 | 5.4e-134 | |
| TAIR|locus:2081383 | 956 | NEK6 ""NIMA (never in mitosis, | 0.503 | 0.306 | 0.619 | 1.9e-124 | |
| UNIPROTKB|P51957 | 841 | NEK4 "Serine/threonine-protein | 0.395 | 0.273 | 0.458 | 3.9e-63 | |
| UNIPROTKB|F6V6J5 | 785 | NEK4 "Uncharacterized protein" | 0.441 | 0.327 | 0.424 | 3.8e-60 | |
| UNIPROTKB|E2QRX7 | 839 | NEK4 "Uncharacterized protein" | 0.441 | 0.306 | 0.424 | 6.5e-60 | |
| ZFIN|ZDB-GENE-040426-1392 | 849 | nek4 "NIMA (never in mitosis g | 0.465 | 0.319 | 0.400 | 4.6e-59 | |
| UNIPROTKB|E1C5S2 | 786 | NEK4 "Uncharacterized protein" | 0.503 | 0.372 | 0.376 | 1.1e-58 |
| TAIR|locus:2114885 NEK2 "NIMA-related kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1537 (546.1 bits), Expect = 9.9e-158, P = 9.9e-158
Identities = 333/589 (56%), Positives = 391/589 (66%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+YVLKKIRLARQT R RRSAHQEMELIS++ NPFIVEYKDSWVEKGCYVCIIIGYC+GGD
Sbjct: 29 LYVLKKIRLARQTGRTRRSAHQEMELISKIHNPFIVEYKDSWVEKGCYVCIIIGYCKGGD 88
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
MAEAIKK NGVHF EEKLCKWLVQ+L+AL YLHANHILHRDVKCSNIFLT+DQDIRLGDF
Sbjct: 89 MAEAIKKTNGVHFTEEKLCKWLVQILLALEYLHANHILHRDVKCSNIFLTKDQDIRLGDF 148
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLAK+L SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDM
Sbjct: 149 GLAKVLTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMTAMKPAFKAFDM 208
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
Q LIN+IN+SIV PLP YS AFRGLVKSMLRKNPE RPSAAELL P LQPY+ IHLK
Sbjct: 209 QGLINRINRSIVPPLPAQYSAAFRGLVKSMLRKNPELRPSAAELLRQPLLQPYIQKIHLK 268
Query: 241 LNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETE-QDSL 299
+N P N P +W +S + R PE ++R+ + PS +DS+
Sbjct: 269 VNDPGSNVLPAQWPESESAR-RNSFPE--------QRRRPAGKSHSFGPSRFRGNLEDSV 319
Query: 300 SSTLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRRQ 359
SS + Y+N +E + + + G D + A K+ R P + SA+P R
Sbjct: 320 SSIKK--TVPAYLN---RERQVDLSTDASG-DGTVVRRTSEASKSSRYVPVRASASPVRP 373
Query: 360 ATPSKNTHIGSKRDSLPISHNPGGKPSRPARRASLPLTTTRASESHYQPITCIM---KSP 416
P + +G S + + R A S +S Y T + SP
Sbjct: 374 RQPRSD--LGQLPVSSQLKNRKPAALIRRASMPSSRKPAKEIKDSLYISKTSFLHQINSP 431
Query: 417 DVSVNAPRIDKIAEFPLAS-SEDPLLPI----PKXXXXXXXXXXXXXXXXXXXXXKDKCT 471
DVS+NAPRIDKI EFPLAS E+P +P+ K KDK T
Sbjct: 432 DVSMNAPRIDKI-EFPLASYEEEPFVPVVRGKKKKASSRGSYSPPPEPPLDCSITKDKFT 490
Query: 472 IQVMDRTASRPNFVVHTTHGTIQNGSEFSEPNPATGVSSHSSLESQHRRFDTSSFQQRAE 531
++ V+ +++ SE S+ N G SS +S + +RFD SS+QQRAE
Sbjct: 491 LEPGQNREGAIMKAVYEEDAYLEDRSESSDQNATAGASSRASSGVRRQRFDPSSYQQRAE 550
Query: 532 ALEGLLEFSARLLQQERFEELGVLLKPFGPEKVSPRETAIWLAKSFKET 580
ALEGLLEFSARLLQ ER++EL VLL+PFGP KVSPRETAIWL+KSFKET
Sbjct: 551 ALEGLLEFSARLLQDERYDELNVLLRPFGPGKVSPRETAIWLSKSFKET 599
|
|
| TAIR|locus:2077274 NEK4 "NIMA-related kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 4.5e-152, Sum P(2) = 4.5e-152
Identities = 243/387 (62%), Positives = 293/387 (75%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQ+DRARRSAHQEMELIS VRNPF+VEYKDSWVEKGCYVCI+IGYC+GGDM
Sbjct: 30 YVLKKIRLARQSDRARRSAHQEMELISTVRNPFVVEYKDSWVEKGCYVCIVIGYCQGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ IK+A GVHFPEEKLC+WLVQLLMAL+YLH+NHILHRDVKCSNIFLT++QDIRLGDFG
Sbjct: 90 TDTIKRACGVHFPEEKLCQWLVQLLMALDYLHSNHILHRDVKCSNIFLTKEQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDL SSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K FKA D+Q
Sbjct: 150 LAKILTSDDLTSSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMAAHKPPFKASDVQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
LI KI+K I+ P+P +YSG+FRGL+KSMLRKNPE RPSA ELL HPHLQPY+ +++KL
Sbjct: 210 TLITKIHKLIMDPIPAMYSGSFRGLIKSMLRKNPELRPSANELLNHPHLQPYISMVYMKL 269
Query: 242 NGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 301
PRR+TFPL++S E +A ++ R R SFSNDR LNPSVS+TE S+SS
Sbjct: 270 ESPRRSTFPLQFS----------ERDA-TLKERR--RSSFSNDRRLNPSVSDTEAGSVSS 316
Query: 302 TLRGRAFGNYMNQKFKELSIGVVHEELGVD-MSTTPNVCNAGKTPRLTPAKVSATPRRQA 360
+ + + +K E+++GVV EE+ A +TPR+ A+ +R
Sbjct: 317 SGKASPTPMFNGRKVSEVTVGVVREEIVPQRQEEAKKQSGAARTPRVAGTSAKASTQRTV 376
Query: 361 TPSKNTHIGS-----KRDSLP-ISHNP 381
+ + + +R SLP + NP
Sbjct: 377 FKHELMKVSNPTERRRRVSLPLVVENP 403
|
|
| TAIR|locus:2185314 NEK3 "NIMA-related kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 2.0e-149, Sum P(2) = 2.0e-149
Identities = 209/252 (82%), Positives = 226/252 (89%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+YVLKKIRLARQT R RRSAHQEMELIS++RNPFIVEYKDSWVEKGCYVCI+IGYC+GGD
Sbjct: 29 LYVLKKIRLARQTGRTRRSAHQEMELISKIRNPFIVEYKDSWVEKGCYVCIVIGYCKGGD 88
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
MAEAIKKANGV F EEKLCKWLVQLLMAL YLHA+HILHRDVKCSNIFLT+DQDIRLGDF
Sbjct: 89 MAEAIKKANGVEFSEEKLCKWLVQLLMALEYLHASHILHRDVKCSNIFLTKDQDIRLGDF 148
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLAK+L SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+A K AFKAFDM
Sbjct: 149 GLAKILTSDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCMYEMTALKPAFKAFDM 208
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
Q LIN+IN+SIVAPLP YS AFR LVKSMLRKNPE RPSA++LL P LQPYV + LK
Sbjct: 209 QGLINRINRSIVAPLPAQYSTAFRSLVKSMLRKNPELRPSASDLLRQPLLQPYVQKVLLK 268
Query: 241 LNGPRRNTFPLE 252
L+ +T P E
Sbjct: 269 LSFREHDTLPSE 280
|
|
| TAIR|locus:2020148 NEK1 "NIMA-related serine/threonine kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 281/481 (58%), Positives = 324/481 (67%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQT R RRSAHQEMELIS++R+PFIVEYKDSWVEK CYVCI+IGYCEGGDM
Sbjct: 30 YVLKKIRLARQTQRTRRSAHQEMELISKMRHPFIVEYKDSWVEKACYVCIVIGYCEGGDM 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
A+AIKK+NGVHF EEKLCKWLVQLLM L YLH+NHILHRDVKCSNIFLT++QDIRLGDFG
Sbjct: 90 AQAIKKSNGVHFQEEKLCKWLVQLLMGLEYLHSNHILHRDVKCSNIFLTKEQDIRLGDFG 149
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK+L SDDL SSVVGTPSYMCPELLADIPYGSKSDIWSLGCC+YEM+ K AFKAFDMQ
Sbjct: 150 LAKILTSDDLTSSVVGTPSYMCPELLADIPYGSKSDIWSLGCCIYEMAYLKPAFKAFDMQ 209
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
ALINKINK+IV+PLP YSG FRGLVKSMLRKNPE RPSA++LL HPHLQPYVL + L+L
Sbjct: 210 ALINKINKTIVSPLPAKYSGPFRGLVKSMLRKNPEVRPSASDLLRHPHLQPYVLDVKLRL 269
Query: 242 NGPRRNTFPLEWSDSN--FKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSL 299
N RR T P E S KK F EP + +S NDRALNP E E+D+
Sbjct: 270 NNLRRKTLPPELPSSKRIMKKAHFSEPAVTCPAFGERQHRSLWNDRALNP---EAEEDTA 326
Query: 300 SSTLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGKTPRLTPAKVSATPRR- 358
SS ++++ +LSI + + + + C K P AK S T RR
Sbjct: 327 SSI-------KCISRRISDLSIESSSKGTLICKQVSSSACKVSKYPL---AKSSVTSRRI 376
Query: 359 QATPSKNTHIGSKRDSLPISHNPGGKPSRP-ARRASLPLT--TTRASESHYQPITCIM-- 413
T ++ H+ P+S P ARR SLPLT T + Y PI I+
Sbjct: 377 METGRRSDHLH------PVSGGGTTSKIIPSARRTSLPLTKRATNQEVAAYNPIVGILQN 430
Query: 414 -KSPDVSVNAPRIDKIAEFPLASSEDPLLPIPKXXXXXXXXXXXXXXXXXXXXXKDKCTI 472
KSP+ S+N P++DKIA FPLA E + P KDKCT+
Sbjct: 431 VKSPEYSINEPQVDKIAIFPLAPYEQDIFFTPMQRKTSSKSSSVSDRSIT----KDKCTV 486
Query: 473 Q 473
Q
Sbjct: 487 Q 487
|
|
| TAIR|locus:2081383 NEK6 ""NIMA (never in mitosis, gene A)-related 6"" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 1.9e-124, Sum P(3) = 1.9e-124
Identities = 187/302 (61%), Positives = 237/302 (78%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YVLKKIRLARQT+R RRSAHQEM LI+RV++P+IVE+K++WVEKGCYVCI+ GYCEGGDM
Sbjct: 34 YVLKKIRLARQTERCRRSAHQEMSLIARVQHPYIVEFKEAWVEKGCYVCIVTGYCEGGDM 93
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
AE +KK+NGV+FPEEKLCKW QLL+A+ YLH+N++LHRD+KCSNIFLT+DQD+RLGDFG
Sbjct: 94 AELMKKSNGVYFPEEKLCKWFTQLLLAVEYLHSNYVLHRDLKCSNIFLTKDQDVRLGDFG 153
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
LAK L +DDL SSVVGTP+YMCPELLADIPYG KSDIWSLGCC+YEM+A + AFKAFDM
Sbjct: 154 LAKTLKADDLTSSVVGTPNYMCPELLADIPYGFKSDIWSLGCCIYEMAAYRPAFKAFDMA 213
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKL 241
LI+K+N+S + PLP YS + + L+K MLRKNPE+RP+A+E+L HP+LQPYV L
Sbjct: 214 GLISKVNRSSIGPLPPCYSPSLKALIKGMLRKNPEYRPNASEILKHPYLQPYVEQYRPTL 273
Query: 242 NGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALN---PSVSE--TEQ 296
+ + P + N ++ R E+ + +S+ EK + +D+ + PS TE
Sbjct: 274 SAA--SITPEK--PLNSREGRRSMAESQNSNSSSEKDNFYVSDKNIRYVVPSNGNKVTET 329
Query: 297 DS 298
DS
Sbjct: 330 DS 331
|
|
| UNIPROTKB|P51957 NEK4 "Serine/threonine-protein kinase Nek4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 578 (208.5 bits), Expect = 3.9e-63, Sum P(3) = 3.9e-63
Identities = 106/231 (45%), Positives = 158/231 (68%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KK+ L + R RR+A QE +L+S++++P IV YK+SW + I++G+CEGGD+
Sbjct: 32 YVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNIVTYKESWEGGDGLLYIVMGFCEGGDL 91
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+K+ G PE ++ +W VQ+ MAL YLH HILHRD+K N+FLTR I++GD G
Sbjct: 92 YRKLKEQKGQLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 151
Query: 122 LAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L + D+AS+++GTP YM PEL ++ PY KSD+W+LGCCVYEM+ K AF A DM
Sbjct: 152 IARVLENHCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 211
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+L+ +I + + P+P YS L+++ML K PE RPS +L P+++
Sbjct: 212 NSLVYRIIEGKLPPMPRDYSPELAELIRTMLSKRPEERPSVRSILRQPYIK 262
|
|
| UNIPROTKB|F6V6J5 NEK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 3.8e-60, Sum P(2) = 3.8e-60
Identities = 110/259 (42%), Positives = 172/259 (66%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KK+ L + R RR+A QE +L+S++++P IV YK+SW + I++G+CEGGD+
Sbjct: 32 YVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNIVTYKESWEGGDGLLYIVMGFCEGGDL 91
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+K+ G PE ++ +W VQ+ MAL YLH HILHRD+K N+FLTR I++GD G
Sbjct: 92 YRKLKERKGQLLPESQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 151
Query: 122 LAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L ++ D+A++++GTP YM PEL ++ PY KSD+W+LGCCVYEM+ K AF A DM
Sbjct: 152 IARVLENNGDMANTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 211
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
+L+ +I + + P+P YS L+++ML K PE RPS +L P+++ + + + L+
Sbjct: 212 NSLVYRIIEGKLPPMPKDYSPELSELIRTMLSKRPEERPSVRSILRQPYIK-HQISLFLE 270
Query: 241 LNGPRRNTFPLEWSDSNFK 259
+ + ++ SDS K
Sbjct: 271 ATKAKTSKSNIKSSDSKSK 289
|
|
| UNIPROTKB|E2QRX7 NEK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 6.5e-60, Sum P(2) = 6.5e-60
Identities = 110/259 (42%), Positives = 172/259 (66%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KK+ L + R RR+A QE +L+S++++P IV YK+SW + I++G+CEGGD+
Sbjct: 32 YVIKKLNLRNASSRERRAAEQEAQLLSQLKHPNIVTYKESWEGGDGLLYIVMGFCEGGDL 91
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+K+ G PE ++ +W VQ+ MAL YLH HILHRD+K N+FLTR I++GD G
Sbjct: 92 YRKLKERKGQLLPESQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 151
Query: 122 LAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L ++ D+A++++GTP YM PEL ++ PY KSD+W+LGCCVYEM+ K AF A DM
Sbjct: 152 IARVLENNGDMANTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 211
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
+L+ +I + + P+P YS L+++ML K PE RPS +L P+++ + + + L+
Sbjct: 212 NSLVYRIIEGKLPPMPKDYSPELSELIRTMLSKRPEERPSVRSILRQPYIK-HQISLFLE 270
Query: 241 LNGPRRNTFPLEWSDSNFK 259
+ + ++ SDS K
Sbjct: 271 ATKAKTSKSNIKSSDSKSK 289
|
|
| ZFIN|ZDB-GENE-040426-1392 nek4 "NIMA (never in mitosis gene a)-related kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 4.6e-59, Sum P(2) = 4.6e-59
Identities = 113/282 (40%), Positives = 179/282 (63%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KK+ L + R RR+A QE +L+S++++P IV Y++SW + C + I++G+CEGGD+
Sbjct: 30 YVIKKLNLRTSSRRERRAAEQEAQLLSQLKHPNIVMYRESWEGEDCQLYIVMGFCEGGDL 89
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+K+ G PE ++ +W VQ+ MAL YLH HILHRD+K NIFLT+ I++GD G
Sbjct: 90 YHRLKQQKGELLPERQVVEWFVQIAMALQYLHEKHILHRDLKTQNIFLTKTNIIKVGDLG 149
Query: 122 LAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L + +D+AS+++GTP YM PEL ++ PY KSD+W+LGCCVYEM+ K AF A DM
Sbjct: 150 IARVLENQNDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 209
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHL- 239
+L+ +I + + +P+ Y L+K ML K PE RP +L P+++ + + + L
Sbjct: 210 NSLVYRIVEGKLPQMPSKYDPQLGELIKRMLCKKPEDRPDVKHILRQPYIK-HQISMFLE 268
Query: 240 ----KLNGPRRNT----FPLEWSDSNFKKTRFMEPEAISIHS 273
K R+N SD++ K + ++P+ ++ S
Sbjct: 269 ATKEKTAKSRKNAANGKLNSAGSDASTKPNQVVQPQCLNSES 310
|
|
| UNIPROTKB|E1C5S2 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 1.1e-58, Sum P(2) = 1.1e-58
Identities = 111/295 (37%), Positives = 182/295 (61%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KK+ L + R R++A QE +L+S++++P IV Y++SW + + I++G+CEGGD+
Sbjct: 32 YVIKKLNLKHASSRERKAAEQEAQLLSQLKHPNIVAYRESWQGEDGLLYIVMGFCEGGDL 91
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+K+ G PE ++ +W VQ+ MAL YLH HILHRD+K N+FLTR I++GD G
Sbjct: 92 YHRLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 151
Query: 122 LAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L + D+AS+++GTP YM PEL ++ PY KSD+W+LGCCVYEM+ K AF A DM
Sbjct: 152 IARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 211
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
+L+ +I + + P+P YS ++++ML K PE RPS +L P+++ + + + L+
Sbjct: 212 NSLVYRIIEGKLPPMPKDYSPQLVEIIQTMLSKRPEQRPSVKSILRQPYIK-HQISLFLE 270
Query: 241 LNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETE 295
+ + + S K + + P H+ S+++ V+E +
Sbjct: 271 ATKMKAAKSHKKMAGSKLKDSSSVVPVKNESHNKNVIPPDSSSEQGRKCRVNEED 325
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2QMH1 | NEK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6399 | 0.9536 | 0.9390 | yes | no |
| A2ZMH2 | NEK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.6376 | 0.9553 | 0.9407 | N/A | no |
| Q9CAU7 | NEK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5841 | 0.9570 | 0.9191 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00023772001 | SubName- Full=Chromosome chr7 scaffold_31, whole genome shotgun sequence; (614 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 582 | |||
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-108 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-76 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-70 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-68 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-63 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-62 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-61 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-61 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-59 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-59 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-58 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-57 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-54 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-48 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-46 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-46 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-44 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-42 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-40 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-39 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-38 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-37 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-37 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-35 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-33 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-33 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-32 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-31 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-28 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-26 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-25 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-25 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-24 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-23 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-23 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-22 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-22 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-22 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-18 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-18 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 325 bits (836), Expect = e-108
Identities = 107/233 (45%), Positives = 158/233 (67%), Gaps = 4/233 (1%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+YVLK+I L+ +++ R A E++++ ++ +P I++Y +S+ EKG +CI++ Y +GGD
Sbjct: 27 LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-KLCIVMEYADGGD 85
Query: 61 MAEAIKKAN--GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
+++ IKK G FPEE++ W VQL +AL YLH+ ILHRD+K NIFLT + ++LG
Sbjct: 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLG 145
Query: 119 DFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFG++K+L S DLA +VVGTP Y+ PEL + PY KSDIWSLGC +YE+ K F+
Sbjct: 146 DFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205
Query: 178 FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
++ L KI K P+P+ YS R LV S+L+K+PE RPS A++L P +
Sbjct: 206 ENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 242 bits (618), Expect = 3e-76
Identities = 104/230 (45%), Positives = 157/230 (68%), Gaps = 1/230 (0%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+KK+ L + R R++A QE +L+S++++P IV Y++SW + + I++G+CEGGD+
Sbjct: 28 YVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL 87
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+K+ G PE ++ +W VQ+ MAL YLH HILHRD+K N+FLTR I++GD G
Sbjct: 88 YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 147
Query: 122 LAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L + D+AS+++GTP YM PEL ++ PY KSD+W+LGCCVYEM+ K AF A DM
Sbjct: 148 IARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 207
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
+L+ +I + + P+P YS L+ +ML K PE RPS +L P++
Sbjct: 208 NSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 225 bits (577), Expect = 4e-70
Identities = 80/230 (34%), Positives = 125/230 (54%), Gaps = 7/230 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K I+ + R +E++++ ++++P IV D + ++ + +++ YCEGGD+
Sbjct: 27 VAIKVIKKKKIKKD-RERILREIKILKKLKHPNIVRLYDVFEDED-KLYLVMEYCEGGDL 84
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +KK E++ +L Q+L AL YLH+ I+HRD+K NI L D ++L DFG
Sbjct: 85 FDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG 142
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-M 180
LA+ L + ++ VGTP YM PE+L YG DIWSLG +YE+ K F D +
Sbjct: 143 LARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQL 202
Query: 181 QALINKINKSIVAPLP--TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
L KI K P S + L++ +L K+PE R +A E L HP
Sbjct: 203 LELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHP 252
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 3e-68
Identities = 95/225 (42%), Positives = 152/225 (67%), Gaps = 2/225 (0%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
YV+K+I +++ + + R + +E+ ++S +++P IV+Y++S+ E G + I++ YCEGGD+
Sbjct: 28 YVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN-LYIVMDYCEGGDL 86
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ I GV FPE+++ W VQ+ +AL ++H ILHRD+K NIFLT+D I+LGDFG
Sbjct: 87 YKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFG 146
Query: 122 LAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A++L S +LA + +GTP Y+ PE+ + PY +KSDIW+LGC +YEM K AF+A +M
Sbjct: 147 IARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ L+ KI + P+ + YS R LV + ++NP RPS +L
Sbjct: 207 KNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 1e-63
Identities = 91/229 (39%), Positives = 143/229 (62%), Gaps = 2/229 (0%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
V K++ L R +++ RR A E+ ++S +++P I+ Y + +++ + I + Y GG +
Sbjct: 29 VWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLL-IEMEYANGGTLY 87
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+ I + G F EE + +L Q++ A++Y+H ILHRD+K NIFLT+ I+LGDFG+
Sbjct: 88 DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 123 AKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+K+L S+ +A +VVGTP YM PEL + Y KSDIW+LGC +YE+ K F A +
Sbjct: 148 SKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
L+ KI + P+ +VYS LV S+L+++PE RP+A E+L P L
Sbjct: 208 NLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 2e-62
Identities = 91/235 (38%), Positives = 134/235 (57%), Gaps = 9/235 (3%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVC-IIIGYCEGGDM 61
V K+I T++ ++ E+ ++ +++P IV Y D +++ I++ YCEGGD+
Sbjct: 29 VWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL 88
Query: 62 AEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLH-----ANHILHRDVKCSNIFLTRDQD 114
A+ I+K + EE + + L QLL+AL H N +LHRD+K +NIFL + +
Sbjct: 89 AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN 148
Query: 115 IRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
++LGDFGLAK+L A + VGTP YM PE L + Y KSDIWSLGC +YE+ A
Sbjct: 149 VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
F A + L +KI + +P YS ++KSML +P+ RPS ELL P
Sbjct: 209 PFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-61
Identities = 82/230 (35%), Positives = 140/230 (60%), Gaps = 2/230 (0%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
Y +K+I L++ R R A E +++++ + +I+ Y +S+++KG + I++ Y E GD+
Sbjct: 28 YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-KLNIVMEYAENGDL 86
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +K G PE+++ ++ +Q+L+ L +LH+ ILHRD+K N+FL ++++GD G
Sbjct: 87 HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLG 146
Query: 122 LAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+AK+L + + A+++VGTP Y+ PEL D PY KSD+W+LG +YE K F A +
Sbjct: 147 VAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
ALI KI + + P+ +YS L+ L K+ RP +LL +P L
Sbjct: 207 GALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 4e-61
Identities = 83/231 (35%), Positives = 139/231 (60%), Gaps = 4/231 (1%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
Y LK++ L + + R A E+ +++ V +P I+ YK+++++ G +CI++ Y GD+
Sbjct: 28 YALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVMEYAPFGDL 86
Query: 62 AEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++AI K PE+++ + +QLL L LH ILHRD+K +NI L + +++GD
Sbjct: 87 SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGD 146
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
G++K+L + +A + +GTP YM PE+ PY KSDIWSLGC +YEM+ F+A
Sbjct: 147 LGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
MQ L K+ + P+P +YS + ++SML+ P+ RP+ ++L P +
Sbjct: 206 MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 199 bits (506), Expect = 1e-59
Identities = 91/226 (40%), Positives = 145/226 (64%), Gaps = 3/226 (1%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
Y +K+IRL + + S +E L++++++P IV +K+S+ G ++ I++ YC+GGD
Sbjct: 27 KYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKESFEADG-HLYIVMEYCDGGD 84
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + IK G FPE+ + +W VQ+ + + ++H +LHRD+K NIFLT++ ++LGDF
Sbjct: 85 LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
G A++L S A + VGTP Y+ PE+ ++PY +KSDIWSLGC +YE+ K F+A
Sbjct: 145 GSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ LI K+ + PLP+ YS R L+K M ++NP RPSA +L
Sbjct: 205 WKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 2e-59
Identities = 80/236 (33%), Positives = 131/236 (55%), Gaps = 11/236 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ +K ++ + + ++A +E+ ++ R+ +P IV D++ +K ++ +++ YCEGGD
Sbjct: 26 IVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKD-HLYLVMEYCEGGD 84
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + + E++ K +Q+L L YLH+N I+HRD+K NI L + +++ DF
Sbjct: 85 LFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADF 142
Query: 121 GLAKMLI-SDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAF--- 175
GLAK L+ S ++ VGTP YM PE+L YG K D+WSLG +YE+ K F
Sbjct: 143 GLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGE 202
Query: 176 KAFDMQALINKINKSIV-APLPTVYSG--AFRGLVKSMLRKNPEFRPSAAELLCHP 228
D LI +I + P SG + L+K L K+P RP+A E+L HP
Sbjct: 203 NILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHP 258
|
Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 4e-58
Identities = 85/227 (37%), Positives = 141/227 (62%), Gaps = 2/227 (0%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
++K+I + + T R +A E +++ + +P I+EY ++++E + I++ Y GG +A
Sbjct: 29 IIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA-LMIVMEYAPGGTLA 87
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI-RLGDFG 121
E I+K E+ + + VQ+L+AL+++H ILHRD+K NI L + + + ++GDFG
Sbjct: 88 EYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFG 147
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
++K+L S A +VVGTP Y+ PEL PY KSDIW+LGC +YE+++ K AF+A ++
Sbjct: 148 ISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
AL+ KI AP+ YS R L+ SML +P RP ++++ P
Sbjct: 208 ALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 93/231 (40%), Positives = 146/231 (63%), Gaps = 5/231 (2%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
VLK+I + A+QE +L+S++ +P IV++ S++E+ + CII YCEG D+
Sbjct: 32 VLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF-CIITEYCEGRDLD 90
Query: 63 EAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
++ K G E ++C+W +QLL+ ++Y+H ILHRD+K NIFL ++ +++GDF
Sbjct: 91 CKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDF 149
Query: 121 GLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
G++++L+ S DLA++ GTP YM PE L Y SKSDIWSLGC +YEM AF+ +
Sbjct: 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
+++ +I + LP YS +++SML K+P RPSAAE+L +P +
Sbjct: 210 FLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 5e-57
Identities = 77/227 (33%), Positives = 129/227 (56%), Gaps = 6/227 (2%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+K I+L ++ + E++++ + ++P IV+Y S+++K + I++ +C GG + +
Sbjct: 30 IKVIKL--ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-ELWIVMEFCSGGSLKD 86
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+K N E ++ +LL L YLH+N I+HRD+K +NI LT D +++L DFGL+
Sbjct: 87 LLKSTNQT-LTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS 145
Query: 124 KMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
L +++VGTP +M PE++ PY K+DIWSLG E++ K +
Sbjct: 146 AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205
Query: 184 INKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ KI + L P +S F+ +K L+KNPE RP+A +LL HP
Sbjct: 206 LFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 5e-55
Identities = 81/234 (34%), Positives = 128/234 (54%), Gaps = 8/234 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS-WVEKGCYVCIIIGYCEGG 59
+ +K + L+ ++ + +E+ ++S +++P IV Y S E+ + I + Y GG
Sbjct: 27 LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ +KK G PE + K+ Q+L L YLH+N I+HRD+K +NI + D ++L D
Sbjct: 87 SLSSLLKK-FG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLAD 144
Query: 120 FGLAKMLISDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
FG AK L + SV GTP +M PE++ YG +DIWSLGC V EM+ K +
Sbjct: 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204
Query: 177 AF-DMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ A + KI S P +P S + ++ LR++P+ RP+A ELL HP
Sbjct: 205 ELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-54
Identities = 75/230 (32%), Positives = 121/230 (52%), Gaps = 38/230 (16%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K I+ + +E+E++ ++ +P IV+ + ++ +++ YCEGG +
Sbjct: 21 VAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL-YLVMEYCEGGSL 78
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDF 120
+ +K+ N E+++ + L+Q+L L YLH+N I+HRD+K NI L D ++L DF
Sbjct: 79 KDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADF 137
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAF 178
GL+K+L SD L ++VGTP+YM PE+L Y KSDIWSLG +YE+
Sbjct: 138 GLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELP--------- 188
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ L++ ML+K+PE RPSA E+L H
Sbjct: 189 -----------------------ELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-50
Identities = 84/230 (36%), Positives = 144/230 (62%), Gaps = 3/230 (1%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
V+K+I L + + + ++ +E+ L++++++P IV + S+ E G + I++ YC+GGD+
Sbjct: 29 VIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-RLFIVMEYCDGGDLM 87
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI-RLGDFG 121
+ I + GV F E+++ W VQ+ + L ++H ILHRD+K NIFL+++ + +LGDFG
Sbjct: 88 KRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFG 147
Query: 122 LAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
+A+ L S +LA + VGTP Y+ PE+ + PY +K+DIWSLGC +YE+ K F+ ++
Sbjct: 148 IARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
L+ KI + AP+ +S R L+ + + +P RPS +L P L
Sbjct: 208 HQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-48
Identities = 83/233 (35%), Positives = 125/233 (53%), Gaps = 18/233 (7%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+K+I L + + A +S QE++L+ +++P IV+Y S +E + II+ Y E G + +
Sbjct: 30 IKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS-IETSDSLYIILEYAENGSLRQ 88
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
IKK FPE + ++ Q+L L YLH ++HRD+K +NI T+D ++L DFG+A
Sbjct: 89 IIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146
Query: 124 KMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--- 179
L SVVGTP +M PE++ + SDIWSLGC V E+ + +D
Sbjct: 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY--YDLNP 204
Query: 180 MQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
M AL IV PLP S + + +K+P RP+A +LL HP
Sbjct: 205 MAALFR-----IVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 78/233 (33%), Positives = 130/233 (55%), Gaps = 8/233 (3%)
Query: 1 MYVLKKIRLARQTDRAR---RSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 57
+ +K++ LA + + QE+ L+S++++P IV+Y + E+ + I +
Sbjct: 27 FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN-LYIFLELVP 85
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
GG +A+ +KK FPE + + Q+L+ L YLH + +HRD+K +NI + + ++L
Sbjct: 86 GGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKL 143
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFK 176
DFG+AK ++ A S G+P +M PE++A YG +DIWSLGC V EM+ K +
Sbjct: 144 ADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203
Query: 177 AFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ A + KI +S P +P S + + L+++P RP+AAELL HP
Sbjct: 204 QLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 84/229 (36%), Positives = 133/229 (58%), Gaps = 8/229 (3%)
Query: 4 LKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
LKK+++ D +AR+ +E++L+ ++ +P +++Y S++E + I++ + GD++
Sbjct: 32 LKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-ELNIVLELADAGDLS 90
Query: 63 EAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
IK K PE + K+ VQL AL ++H+ I+HRD+K +N+F+T ++LGD
Sbjct: 91 RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDL 150
Query: 121 GLAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GL + S A+ S+VGTP YM PE + + Y KSDIWSLGC +YEM+A ++ F
Sbjct: 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 180 MQ--ALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELL 225
M +L KI K PLP YS R LV + +PE RP + +L
Sbjct: 211 MNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 77/239 (32%), Positives = 127/239 (53%), Gaps = 10/239 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+Y LKKI + + R+ +E++ + +P++V+ + K + I++ Y +GG
Sbjct: 28 IYALKKIHVDGDEEF-RKQLLRELKTLRSCESPYVVKCYGA-FYKEGEISIVLEYMDGGS 85
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGD 119
+A+ +KK PE L Q+L L+YLH HI+HRD+K SN+ + ++++ D
Sbjct: 86 LADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIAD 143
Query: 120 FGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA- 177
FG++K+L + D ++ VGT +YM PE + Y +DIWSLG + E + K F
Sbjct: 144 FGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203
Query: 178 --FDMQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L+ I LP +S FR + + L+K+P+ RPSAAELL HP ++
Sbjct: 204 GQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 77/234 (32%), Positives = 123/234 (52%), Gaps = 11/234 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME--LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K ++ + R + H E ++SR+ +PFIV+ ++ + + +++ Y G
Sbjct: 20 LYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLHYAFQTEE-KLYLVLEYAPG 77
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
G++ + K F EE+ + ++++AL YLH+ I++RD+K NI L D I+L
Sbjct: 78 GELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLT 135
Query: 119 DFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGLAK L S+ ++ GTP Y+ PE+L YG D WSLG +YEM K F A
Sbjct: 136 DFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
Query: 178 FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHP 228
D + + KI K + P S R L+ +L+K+P R A E+ HP
Sbjct: 196 EDRKEIYEKILKDPLR-FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHP 248
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 73/213 (34%), Positives = 116/213 (54%), Gaps = 14/213 (6%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
QE++ +S+ R+P+I +Y S++ KG + II+ YC GG + +K E +
Sbjct: 48 QEIQFLSQCRSPYITKYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFI 103
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPS 140
L ++L+ L YLH +HRD+K +NI L+ + D++L DFG++ L S ++ VGTP
Sbjct: 104 LREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF 163
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV- 198
+M PE++ Y K+DIWSLG E++ + M+ L I K+ P++
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKN---NPPSLE 219
Query: 199 ---YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+S F+ V L K+P+ RPSA ELL H
Sbjct: 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 73/215 (33%), Positives = 119/215 (55%), Gaps = 6/215 (2%)
Query: 10 ARQTDRARRSAHQEMELI-SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK-- 66
R+ D++ E+ +I ++R+P IV Y +++E + I++ EG + E
Sbjct: 45 KRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE-NDRLYIVMDLIEGAPLGEHFNSL 103
Query: 67 KANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125
K F EE++ VQ+++AL YLH I+HRD+ +NI L D + + DFGLAK
Sbjct: 104 KEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163
Query: 126 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN 185
+ +SVVGT Y CPE++ + PYG K+D+W+ GC +Y+M + F + +M +L
Sbjct: 164 KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223
Query: 186 KINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRP 219
KI +++ PLP +YS ++ S L + E RP
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 80/232 (34%), Positives = 129/232 (55%), Gaps = 10/232 (4%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK+RL +Q + E+ ++ ++P IV+Y DS++ + +++ Y +GG + +
Sbjct: 49 IKKMRLRKQN---KELIINEILIMKDCKHPNIVDYYDSYLVGD-ELWVVMEYMDGGSLTD 104
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
I + N V E ++ ++L L YLH+ +++HRD+K NI L++D ++L DFG A
Sbjct: 105 IITQ-NFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA 163
Query: 124 KMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQ 181
L + +SVVGTP +M PE++ YG K DIWSLG EM+ + + ++
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
Query: 182 ALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
AL I + PL P +S F+ + L K+PE RPSA ELL HP L+
Sbjct: 224 ALF-LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 77/237 (32%), Positives = 125/237 (52%), Gaps = 18/237 (7%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K+IR+ + + EM+++ +++P +V+Y V + V I + YC GG + E
Sbjct: 31 KEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-KVYIFMEYCSGGTLEEL 89
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
++ +G E + + +QLL L YLH++ I+HRD+K +NIFL + I+LGDFG A
Sbjct: 90 LE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147
Query: 125 MLISDDLA-----SSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAFK 176
L ++ S+ GTP+YM PE++ +G +DIWSLGC V EM+ K +
Sbjct: 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
Query: 177 AFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRK----NPEFRPSAAELLCHP 228
D + ++ + P+P S K L + +P+ RP+A+ELL HP
Sbjct: 208 ELDNEFQIMFHVGAGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 81/223 (36%), Positives = 133/223 (59%), Gaps = 8/223 (3%)
Query: 4 LKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
LKK+++ D +AR+ +E++L+ ++ +P +++Y DS++E + I++ + GD++
Sbjct: 32 LKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNIVLELADAGDLS 90
Query: 63 EAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ IK K PE + K+ VQL A+ ++H+ ++HRD+K +N+F+T ++LGD
Sbjct: 91 QMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDL 150
Query: 121 GLAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GL + S A+ S+VGTP YM PE + + Y KSDIWSLGC +YEM+A ++ F
Sbjct: 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 180 MQ--ALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRP 219
M +L KI + PLPT YS R LV + +P+ RP
Sbjct: 211 MNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 77/218 (35%), Positives = 117/218 (53%), Gaps = 23/218 (10%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG---DMAEAIKKANGVHFPEEKLC 79
E+ ++ + +P+IV+Y S+ + + I++ YC G D+ + K EE++
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNT-DLWIVMEYCGAGSVSDIMKITNKT----LTEEEIA 102
Query: 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGT 138
L Q L L YLH+N +HRD+K NI L + +L DFG++ L ++V+GT
Sbjct: 103 AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162
Query: 139 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPL 195
P +M PE++ +I Y +K+DIWSLG EM+ K + D M+A+ NK P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY--SDIHPMRAIFMIPNK----PP 216
Query: 196 PTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
PT+ +S F VK L K+PE RPSA +LL HP
Sbjct: 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 70/227 (30%), Positives = 121/227 (53%), Gaps = 12/227 (5%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
++ +E++L+ +++ IV+Y + ++ + I + + GG ++ + +
Sbjct: 42 AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISSILNRFGP-- 98
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML------ 126
PE CK+ Q+L + YLH N ++HRD+K +N+ L + I+L DFG A+ L
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 127 -ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN 185
++ S+ GTP +M PE++ + YG KSDIWS+GC V+EM+ K + D A +
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
Query: 186 KI--NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
I ++ ++ LP +S A V S L ++ RPSA +LL H L
Sbjct: 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 80/223 (35%), Positives = 132/223 (59%), Gaps = 8/223 (3%)
Query: 4 LKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
LKK+++ D +AR +E++L+ ++ +P +++Y S++E + I++ + GD++
Sbjct: 32 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLS 90
Query: 63 EAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
IK K PE+ + K+ VQL AL ++H+ ++HRD+K +N+F+T ++LGD
Sbjct: 91 RMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 150
Query: 121 GLAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF--KA 177
GL + S A+ S+VGTP YM PE + + Y KSDIWSLGC +YEM+A ++ F
Sbjct: 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 178 FDMQALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRP 219
++ +L KI + PLP+ YS R LV + +PE RP
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 81/245 (33%), Positives = 128/245 (52%), Gaps = 25/245 (10%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+K IRL + ++ +E++++ + +P+IV + ++ G + I + Y +GG + +
Sbjct: 31 VKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-DISICMEYMDGGSLDK 88
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGL 122
+K+ G PE L K V +L L YLH H I+HRDVK SNI + I+L DFG+
Sbjct: 89 ILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV 147
Query: 123 AKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA----- 177
+ L+ + LA + VGT SYM PE + Y KSDIWSLG + E++ + +
Sbjct: 148 SGQLV-NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206
Query: 178 ---FD-MQALINKINKSIVAPLPT----VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229
F+ +Q ++N+ P P +S F+ V L K+P RPS ELL HP
Sbjct: 207 DGIFELLQYIVNE-------PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259
Query: 230 LQPYV 234
++ Y
Sbjct: 260 IKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 74/212 (34%), Positives = 113/212 (53%), Gaps = 8/212 (3%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
E++L+ +++ IV+Y + + I + Y GG + + +K A G E K+
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDE-TLSIFMEYMPGGSVKDQLK-AYGA-LTETVTRKY 109
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML----ISDDLASSVVG 137
Q+L + YLH+N I+HRD+K +NI +++LGDFG +K L S SV G
Sbjct: 110 TRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 138 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LP 196
TP +M PE+++ YG K+D+WS+GC V EM +K + F+ A I KI P LP
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229
Query: 197 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ S R ++ +N + RPSA ELL H
Sbjct: 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 72/257 (28%), Positives = 125/257 (48%), Gaps = 42/257 (16%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVE----YKDSWVEKGCYVCIIIGYCE 57
+L K +L ++ + + E E+++R+ +P I++ ++D E +V + Y
Sbjct: 33 ILDKRQLIKE--KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLYFV---LEYAP 85
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
G++ + I+K + +EK ++ ++L+AL YLH+ I+HRD+K NI L +D I+
Sbjct: 86 NGELLQYIRKYGSL---DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIK 142
Query: 117 LGDFGLAKMLISDDL---------------------ASSVVGTPSYMCPELLADIPYGSK 155
+ DFG AK+L + +S VGT Y+ PELL + P G
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202
Query: 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 215
SD+W+LGC +Y+M K F+ + KI K + P + + L++ +L +P
Sbjct: 203 SDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDP 261
Query: 216 EFRP----SAAELLCHP 228
+ R EL HP
Sbjct: 262 QDRLGVNEGYDELKAHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 78/236 (33%), Positives = 121/236 (51%), Gaps = 18/236 (7%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+K I+L D QE+ ++ R+P IV Y S++ + + I++ YC GG + +
Sbjct: 33 IKVIKLEPGDDFE--IIQQEISMLKECRHPNIVAYFGSYL-RRDKLWIVMEYCGGGSLQD 89
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ G E ++ + L L YLH +HRD+K +NI LT D D++L DFG++
Sbjct: 90 IYQVTRG-PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148
Query: 124 KMLISDDLA--SSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMS-AQKAAFKA 177
++ +A S +GTP +M PE+ A Y K DIW+LG E++ Q F
Sbjct: 149 A-QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207
Query: 178 FDMQALINKINKSIVAPLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
M+AL I+KS P P + +S F +K L K+P+ RP+A +LL HP
Sbjct: 208 HPMRALF-LISKSNFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 21/223 (9%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLC 79
+E++ +S+ +P +V+Y S+V + +++ Y GG + + +K + G E +
Sbjct: 48 KEVQAMSQCNHPNVVKYYTSFVVGDE-LWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIA 105
Query: 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS----- 134
L ++L L YLH+N +HRD+K NI L D +++ DFG++ L +
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 135 VVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIV 192
VGTP +M PE++ Y K+DIWS G E++ A + K M+ L+ +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--- 222
Query: 193 AP--LPT-----VYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
P L T YS +FR ++ L+K+P RP+A ELL H
Sbjct: 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 75/217 (34%), Positives = 126/217 (58%), Gaps = 10/217 (4%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E++++S ++P IV +++ + + I+I +C+GG + ++I E ++
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYEN-KLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVC 109
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSY 141
Q+L ALN+LH++ ++HRD+K NI LT D D++L DFG+ AK + + +GTP +
Sbjct: 110 RQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW 169
Query: 142 MCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL- 195
M PE++A D PY K+DIWSLG + E++ + + ++ KI KS L
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229
Query: 196 -PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
P+ +S +F +KS L K+P+ RP+AAELL HP +
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-35
Identities = 81/216 (37%), Positives = 127/216 (58%), Gaps = 14/216 (6%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM-AEAIKKANGVHFPEEK-LCK 80
E+E+++ +P+IV+ ++ G + I+I +C GG + A ++ G+ P+ + +C+
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR 117
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTP 139
Q+L AL YLH+ I+HRD+K N+ LT D DI+L DFG+ AK + + S +GTP
Sbjct: 118 ---QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTP 174
Query: 140 SYMCPEL-----LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP 194
+M PE+ + D PY K+DIWSLG + EM+ + + ++ KI KS
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 195 L--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
L P+ +S FR +K+ L K+PE RPSAA+LL HP
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+E+ L++R+ +P I+ + E + + + + GG ++ + K F E + +
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHF-NLFVEWMAGGSVSHLLSKYGA--FKEAVIINY 108
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISD-----DLASSV 135
QLL L+YLH N I+HRDVK +N+ + + Q +R+ DFG A L + + +
Sbjct: 109 TEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKSIV 192
+GT ++M PE+L YG D+WS+GC + EM+ K + A ALI KI +
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 193 AP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
AP +P S R + L PE RP + ELL HP
Sbjct: 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 66/243 (27%), Positives = 116/243 (47%), Gaps = 22/243 (9%)
Query: 1 MYVLKK--IRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+ V+KK + Q D+ E +++S+ ++P++V+ S+ K + +++ Y G
Sbjct: 23 IKVIKKADMIRKNQVDQVL----TERDILSQAQSPYVVKLYYSFQGKK-NLYLVMEYLPG 77
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
GD+A ++ E+ ++ ++++AL YLH+N I+HRD+K NI + + ++L
Sbjct: 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLT 135
Query: 119 DFGLAK---------MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMS 169
DFGL+K + + +VGTP Y+ PE++ + D WSLGC +YE
Sbjct: 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL 195
Query: 170 AQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELL 225
F + + I N I P S L+ +L +PE R S E+
Sbjct: 196 VGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255
Query: 226 CHP 228
HP
Sbjct: 256 NHP 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 74/258 (28%), Positives = 109/258 (42%), Gaps = 35/258 (13%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
LKKIRL + + +A +E+ L+ +++P IV+ D + + ++ YC+ D+
Sbjct: 27 VALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK-LYLVFEYCDM-DL 84
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ + K + + QLL L Y H++ ILHRD+K NI + RD ++L DFG
Sbjct: 85 KKYLDK-RPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFG 143
Query: 122 LAKMLISDDLA-SSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
LA+ + V T Y PE LL Y + DIWS+GC EM K F
Sbjct: 144 LARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203
Query: 180 MQALINKI-------------------NKSIVAP----------LPTVYSGAFRGLVKSM 210
+ KI + P LP + L+ M
Sbjct: 204 EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID-LLSKM 262
Query: 211 LRKNPEFRPSAAELLCHP 228
L+ NP R SA E L HP
Sbjct: 263 LQYNPAKRISAKEALKHP 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 1 MYVLKKIRLARQTDRAR-RSAHQEMELISRVRNPFIV----EYKDSWVEKGCYVCIIIGY 55
M+ +K + + ++ R+ E ++ + +PF+V ++D E+ Y +++
Sbjct: 27 MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD---EENMY--LVVDL 81
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ + + V F EE++ W+ ++++AL YLH+ I+HRD+K NI L +
Sbjct: 82 LLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHV 139
Query: 116 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
+ DF +A + D L +S GTP YM PE+L Y D WSLG YE K +
Sbjct: 140 HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
Query: 176 KAFDMQALINKINKSIVA-------PLPTVYSGAFRGLVKSMLRKNPEFR 218
+ I I A P +S + +L ++P+ R
Sbjct: 200 RGHS-----RTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 61/225 (27%), Positives = 114/225 (50%), Gaps = 22/225 (9%)
Query: 1 MYVLKK---IRLARQTDRARRSAHQEMELISRVRNPFIVE----YKDSWVEKGCYVCIII 53
+ +L K ++L +Q + E ++ +R+PF+V ++D + +++
Sbjct: 31 LKILSKAKIVKL-KQVEHV----LNEKRILQSIRHPFLVNLYGSFQDDS-----NLYLVM 80
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
Y GG++ ++K+ FPE + Q+++AL YLH+ I++RD+K N+ L D
Sbjct: 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
I++ DFG AK + ++ GTP Y+ PE++ YG D W+LG +YEM A
Sbjct: 139 YIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
F + + KI + V P+ +S + L++++L+ + R
Sbjct: 197 PFFDDNPIQIYEKILEGKVR-FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 34/260 (13%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+KKI+L +++ ++A +E++L+ + +P I++ D + KG + ++ + + D+
Sbjct: 27 VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-DLYLVFEFMDT-DL 84
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ IK PE + +L QLL L + H++ ILHRD+K N+ + + ++L DFG
Sbjct: 85 YKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFG 143
Query: 122 LAKMLISD-DLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
LA+ S + V T Y PE LL D Y + DIWS+GC E+ +++ F
Sbjct: 144 LARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
Query: 180 MQALINKINKSIVAP----LPTVYSGAF-------------------------RGLVKSM 210
+ KI +++ P P S A L+ M
Sbjct: 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQM 263
Query: 211 LRKNPEFRPSAAELLCHPHL 230
L +P R +A + L HP+
Sbjct: 264 LHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 64/189 (33%), Positives = 96/189 (50%), Gaps = 16/189 (8%)
Query: 55 YCEGG---DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
C GG D+ + ++K EE + L + L L YLH N ++HRD+K NI LT+
Sbjct: 90 LCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK 148
Query: 112 DQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCV 165
+ +++L DFG++ L S ++ +GTP +M PE++A D Y ++SD+WSLG
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208
Query: 166 YEMSAQKAAFKAFDMQAL--INKI--NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221
E++ K DM + + KI N P +S F + L KN E RP
Sbjct: 209 IELADGKPPL--CDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM 266
Query: 222 AELLCHPHL 230
ELL HP +
Sbjct: 267 EELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-31
Identities = 64/195 (32%), Positives = 115/195 (58%), Gaps = 7/195 (3%)
Query: 49 VCIIIGYCEGGDMAEAIK---KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCS 105
+ +++ Y GD+ + IK K N F E + +Q+L+A++++H+ H++HRD+K +
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRT-FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 106 NIFLTRDQDIRLGDFGLAKML---ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG 162
NI L + ++LGDFG +KM +SDD+ + GTP Y+ PE+ PY K+D++SLG
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 163 CCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
+YE+ K F +M+ +++K PLP S + +V ++L +P+ RPS++
Sbjct: 233 VLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292
Query: 223 ELLCHPHLQPYVLGI 237
+LL P + ++ G+
Sbjct: 293 KLLNMPICKLFISGL 307
|
Length = 496 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 73/223 (32%), Positives = 115/223 (51%), Gaps = 28/223 (12%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYV-----CIIIGYCEG--GDMAEAIKKANGVHFP 74
+E+ + ++R+P +EYK GCY+ +++ YC G D+ E KK
Sbjct: 64 KEVRFLQQLRHPNTIEYK------GCYLREHTAWLVMEYCLGSASDILEVHKKP----LQ 113
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
E ++ L L YLH++ +HRD+K NI LT ++L DFG A ++ A+S
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANS 170
Query: 135 VVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINK 189
VGTP +M PE++ + Y K D+WSLG E++ +K F+M A+ + I +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQ 228
Query: 190 SIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+ L + +S FR V S L+K P+ RPS+ ELL H +
Sbjct: 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (308), Expect = 1e-30
Identities = 88/334 (26%), Positives = 148/334 (44%), Gaps = 28/334 (8%)
Query: 2 YVLKKIRLARQTDR-ARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
LK + ++ +E+++++ + P IV+ D + ++G + +++ Y +GG
Sbjct: 25 VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-SLYLVMEYVDGG 83
Query: 60 DMAEAIKK-ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRL 117
+ + +KK E + L Q+L AL YLH+ I+HRD+K NI L RD + ++L
Sbjct: 84 SLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKL 143
Query: 118 GDFGLAKMLISDD-------LASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYE 167
DFGLAK+L L S+ VGTP YM PE+L + S SDIWSLG +YE
Sbjct: 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203
Query: 168 MSAQKAAFKAFDMQALINKINKSI------------VAPLPTVYSGAFRGLVKSMLRKNP 215
+ F+ + ++ K I P + S A L+K +L K+P
Sbjct: 204 LLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDP 263
Query: 216 EFRPSAAELLCHP-HLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSN 274
+ R S++ L H + L ++ PL S + +++I +
Sbjct: 264 KNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGS 323
Query: 275 REKRQSFSNDRALNPSVSETEQDSLSSTLRGRAF 308
K + + L P+ + + SS L A
Sbjct: 324 DLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/259 (25%), Positives = 118/259 (45%), Gaps = 35/259 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LKK+ L R A +E++ + ++P++V+ D + +V +++ Y D++E
Sbjct: 30 LKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFV-LVMEYM-PSDLSE 87
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
++ PE ++ ++ LL + Y+HAN I+HRD+K +N+ ++ D +++ DFGLA
Sbjct: 88 VLRDEER-PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
Query: 124 KMLISDD--LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
++ ++ L S V T Y PELL Y D+W++GC E+ F +
Sbjct: 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206
Query: 181 QALINKINKSIVAPLPTVYSG----------AFR-------------------GLVKSML 211
+ + +++ P + G F L+K +L
Sbjct: 207 IEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLL 266
Query: 212 RKNPEFRPSAAELLCHPHL 230
+P R SAAE L HP+
Sbjct: 267 VYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-30
Identities = 70/214 (32%), Positives = 114/214 (53%), Gaps = 5/214 (2%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
QE+ ++S+ +P+I Y S++ KG + II+ Y GG + +K E +
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYL-KGTKLWIIMEYLGGGSALDLLKPGP---LEETYIAT 105
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTP 139
L ++L L+YLH+ +HRD+K +N+ L+ D++L DFG+A L + ++ VGTP
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 140 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY 199
+M PE++ Y K+DIWSLG E++ + ++ I K+ L Y
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY 225
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
S F+ V++ L K+P FRP+A ELL H + Y
Sbjct: 226 SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 76/217 (35%), Positives = 121/217 (55%), Gaps = 24/217 (11%)
Query: 22 QEMELISRVRN---PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78
+E+ L+S++R P I +Y S++ KG + II+ Y EGG + + KA + EK
Sbjct: 48 REVALLSQLRQSQPPNITKYYGSYL-KGPRLWIIMEYAEGGSV-RTLMKAGPI---AEKY 102
Query: 79 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVV 136
++ ++L+AL Y+H ++HRD+K +NI +T +++L DFG+A +L + S+ V
Sbjct: 103 ISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 137 GTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMS------AQKAAFKAFDMQALINKINK 189
GTP +M PE++ + Y +K+DIWSLG +YEM+ + AF+A + I K
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------IPK 216
Query: 190 SIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
S L YS R V + L + P+ R SA ELL
Sbjct: 217 SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 67/208 (32%), Positives = 115/208 (55%), Gaps = 5/208 (2%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
QE+ ++S+ +P++ +Y S++ KG + II+ Y GG + ++ F E ++
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYL-KGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIAT 105
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTP 139
L ++L L+YLH+ +HRD+K +N+ L+ D++L DFG+A L + ++ VGTP
Sbjct: 106 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 140 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY 199
+M PE++ Y SK+DIWSLG E++ + ++ I K+ L +
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEF 225
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCH 227
S F+ + + L K+P FRP+A ELL H
Sbjct: 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 17/227 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVE----YKDSWVEKGCYVCIIIG 54
+ LK ++ + + H E E++ +PFIV+ +KD Y+ +++
Sbjct: 20 TFALKCVKKRHIVET-GQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLME 73
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
YC GG++ ++ F E ++ +++A YLH I++RD+K N+ L +
Sbjct: 74 YCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY 131
Query: 115 IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
++L DFG AK L S + GTP Y+ PE++ + Y D WSLG +YE+ +
Sbjct: 132 VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
Query: 175 FKAFDMQALI--NKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFR 218
F D + N I K P A + L+K +LR+NPE R
Sbjct: 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 73/226 (32%), Positives = 119/226 (52%), Gaps = 9/226 (3%)
Query: 12 QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANG 70
+T + + E++L+ +++ IV+Y ++ + I + Y GG + + +K
Sbjct: 43 ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA 102
Query: 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML---- 126
+ E K+ Q+L ++YLH+N I+HRD+K +NI +++LGDFG +K L
Sbjct: 103 L--TESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160
Query: 127 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK 186
+S SV GTP +M PE+++ YG K+D+WSLGC V EM +K + ++ A I K
Sbjct: 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 187 I-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
I + LP+ S R + + + RPSA ELL HP Q
Sbjct: 221 IATQPTNPQLPSHISEHARDFLGCIFVEARH-RPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 74/238 (31%), Positives = 118/238 (49%), Gaps = 15/238 (6%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWV-EKGCYVCIIIGYCEGGDMAE 63
K ++ +E+E+ ++P+IV+Y +++ E + I + YCEGG +
Sbjct: 31 LKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS 90
Query: 64 AIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
KK G E+ L K +L L+YLH+ I+HRD+K SNI LTR ++L DFG
Sbjct: 91 IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
++ L++ LA + GT YM PE + PY SD+WSLG + E++ + F
Sbjct: 151 VSGELVN-SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209
Query: 182 AL--INKINKSIVAPLP---------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
L I ++ + P P +S F+ +K L K+P RP+ ++L HP
Sbjct: 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 75/265 (28%), Positives = 119/265 (44%), Gaps = 42/265 (15%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCE 57
+ LKKIR+ + + +A +E++L+ ++R+P IV K+ KG Y ++ Y +
Sbjct: 26 LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY--MVFEYMD 83
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
D+ + V F E ++ ++ QLL L YLH+N ILHRD+K SNI + D ++L
Sbjct: 84 H-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKL 141
Query: 118 GDFGLAKMLISD---DLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSAQKA 173
DFGLA+ D + V+ T Y PELL YG + D+WS+GC + E+ K
Sbjct: 142 ADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200
Query: 174 AFKAFDMQALINKI--------------------------NKSIVAPLPTVYSG----AF 203
F+ + KI K L + +
Sbjct: 201 IFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSA 260
Query: 204 RGLVKSMLRKNPEFRPSAAELLCHP 228
L+ +L +P+ R SA + L H
Sbjct: 261 LDLLDKLLTLDPKKRISADQALQHE 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 74/233 (31%), Positives = 127/233 (54%), Gaps = 15/233 (6%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK+ L +Q + R E+ ++ ++P IVE S++ G + +++ + EGG + +
Sbjct: 49 VKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDELWVVMEFLEGGALTD 105
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ EE++ + +L AL++LHA ++HRD+K +I LT D ++L DFG
Sbjct: 106 IVTHTR---MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162
Query: 124 KMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+S ++ S+VGTP +M PE+++ +PYG++ DIWSLG V EM + + F+
Sbjct: 163 AQ-VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY--FNEP 219
Query: 182 AL--INKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
L + +I ++ L S R + ML ++P R +AAELL HP L
Sbjct: 220 PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-28
Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 31/303 (10%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFP--EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+I+ Y GGD+ + IK+ H P E ++ Q+++AL+ +H+ ++HRD+K +NIF
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 109 LTRDQDIRLGDFGLAKML---ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCV 165
L I+LGDFG +K +S D+ASS GTP Y+ PEL Y K+D+WSLG +
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 166 YEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
YE+ FK + ++ ++ P P S + L+ +L KNP RP+ +LL
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
Query: 226 CHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDR 285
H YV +N + E IS H E +
Sbjct: 322 -HTEFLKYV---------------------ANLFQDIVRHSETISPHDREEILRQLQESG 359
Query: 286 ALNPSVSETEQDSLSS--TLRGRAFGNYMNQKFKELSIGVVHEELGVDMSTTPNVCNAGK 343
P S ++S T G + + ++K+ + + +L + +S P N G
Sbjct: 360 ERAPPPSSIRYGVVTSDVTHGGYLYKYSSDMRWKKRYFYIGNGQLRISLSENPE--NDGV 417
Query: 344 TPR 346
P+
Sbjct: 418 APK 420
|
Length = 478 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 74/248 (29%), Positives = 115/248 (46%), Gaps = 42/248 (16%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+E++++ +P+IV + ++ G + I + + +GG + + +KKA + PE L K
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRI--PENILGKI 104
Query: 82 LVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 140
+ +L L YL H I+HRDVK SNI + +I+L DFG++ LI D +A+S VGT S
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRS 163
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEM-----------SAQKAAFKAFDMQALINKINK 189
YM PE L Y +SDIWSLG + EM + + A + K +
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 190 SIVAPLPT--------------------------VYSGAFRGLVKSMLRKNPEFRPSAAE 223
V+ P +S F+ V L+KNP+ R E
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
Query: 224 LLCHPHLQ 231
L HP ++
Sbjct: 284 LTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 65/208 (31%), Positives = 111/208 (53%), Gaps = 5/208 (2%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
QE+ ++S+ +P++ +Y S++ K + II+ Y GG + ++ E ++
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIAT 105
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-VGTP 139
L ++L L+YLH+ +HRD+K +N+ L+ +++L DFG+A L + + VGTP
Sbjct: 106 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 140 SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY 199
+M PE++ Y SK+DIWSLG E++ + ++ I K+ L Y
Sbjct: 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY 225
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCH 227
S + V++ L K P FRP+A ELL H
Sbjct: 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 72/228 (31%), Positives = 122/228 (53%), Gaps = 15/228 (6%)
Query: 10 ARQTDRARRSAHQEMELISRVRNPFIVEY----KDSWVEKGCYVCIIIGYCEGGDMAEAI 65
+++T + + E++L+ +R+ IV+Y +D +K + I + Y GG + + +
Sbjct: 41 SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK---LSIFVEYMPGGSIKDQL 97
Query: 66 KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125
K + E ++ Q+L ++YLH+N I+HRD+K +NI +++LGDFG +K
Sbjct: 98 KAYGAL--TENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
Query: 126 L----ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+ +S SV GTP +M PE+++ YG K+D+WS+ C V EM +K + ++
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
Query: 182 ALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
A I KI P LP S A R +K + + + RP+A LL HP
Sbjct: 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 75/216 (34%), Positives = 119/216 (55%), Gaps = 14/216 (6%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM-AEAIKKANGVHFPEEKL-CK 80
E+++++ +P IV+ D++ + + I+I +C GG + A ++ + P+ ++ CK
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYEN-NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK 110
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTP 139
Q L ALNYLH N I+HRD+K NI T D DI+L DFG+ AK + S +GTP
Sbjct: 111 ---QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 140 SYMCPELL-----ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP 194
+M PE++ D PY K+D+WSLG + EM+ + + ++ KI KS
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 227
Query: 195 L--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
L P+ +S F+ +K L KN + R + +LL HP
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 80/235 (34%), Positives = 126/235 (53%), Gaps = 13/235 (5%)
Query: 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
M VLKK + R Q D A A E ++ V++PFIV+ ++ + G + +I+ Y GG
Sbjct: 29 MKVLKKATIVRNQKDTAHTKA--ERNILEAVKHPFIVDLIYAF-QTGGKLYLILEYLSGG 85
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ +++ G+ F E+ C +L ++ +AL +LH I++RD+K NI L ++L D
Sbjct: 86 ELFMHLER-EGI-FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTD 143
Query: 120 FGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
FGL K I + + + GT YM PE+L +G D WSLG +Y+M F A
Sbjct: 144 FGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR----PS-AAELLCHP 228
+ + I+KI K + LP + R L+K +L++NP R P AAE+ HP
Sbjct: 204 NRKKTIDKILKGKLN-LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 70/244 (28%), Positives = 109/244 (44%), Gaps = 24/244 (9%)
Query: 1 MYVLKKIRLARQTDRARRS-AHQEMELISRVRNPFIV------EYKDSWVEKGCYVCIII 53
MY KK+ R R + A E +++ +V + F+V E KD+ +C+++
Sbjct: 27 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-------LCLVL 79
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
GGD+ I F EE+ + ++ L LH I++RD+K NI L
Sbjct: 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG 139
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
IR+ D GLA + + VGT YM PE++ + Y D W LGC +YEM K+
Sbjct: 140 HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAF----RGLVKSMLRKNPEFR-----PSAAEL 224
F+ + ++ + V YS F R + + +L K+P FR A E+
Sbjct: 200 PFRQRKEKVKREEVERR-VKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV 258
Query: 225 LCHP 228
HP
Sbjct: 259 KAHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 70/216 (32%), Positives = 114/216 (52%), Gaps = 12/216 (5%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E+ L+ +++ IV+Y S ++ ++ I + Y GG +A + F E + ++
Sbjct: 56 EIALLKELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFV 112
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-------SV 135
Q+L LNYLH I+HRD+K +NI + I++ DFG++K L ++ L++ S+
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP 194
G+ +M PE++ Y K+DIWSLGC V EM K F +QA I KI ++
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKIGENASPE 231
Query: 195 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
+P+ S ++ + RP+AAELL HP L
Sbjct: 232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 57/182 (31%), Positives = 94/182 (51%), Gaps = 11/182 (6%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ ++ Y GGD+ I+++ F E + + ++++ L +LH I++RD+K N+
Sbjct: 71 LFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVL 128
Query: 109 LTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYE 167
L + I++ DFG+ K ++ S+ GTP Y+ PE+L+ PYG D W+LG +YE
Sbjct: 129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 168 MSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226
M A ++ F+ D L I + P S + ++KS L KNPE R L C
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR-----LGC 241
Query: 227 HP 228
P
Sbjct: 242 LP 243
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 73/266 (27%), Positives = 124/266 (46%), Gaps = 47/266 (17%)
Query: 2 YVLKKIRLARQTDRARR--SAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 57
Y +K +R ++D +R AH E ++++ +P+IV+ S+ ++ ++ +++ Y
Sbjct: 29 YAMKVLR---KSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-HLYLVMEYMP 84
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
GGD+ + + + E+ ++ + +L++AL+ +H +HRD+K NI + D I+
Sbjct: 85 GGDLMNLLIRKDVF---PEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIK 141
Query: 117 LGDFGLAKMLISDD------------------------------LASSVVGTPSYMCPEL 146
L DFGL K + A+S VGTP Y+ PE+
Sbjct: 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV 201
Query: 147 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVAPLPTVYSGAF 203
L PYG + D WSLG +YEM F + +Q NKI +S+ P S
Sbjct: 202 LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEA 261
Query: 204 RGLVKSMLRKNPEFR-PSAAELLCHP 228
L+ +L +PE R S E+ HP
Sbjct: 262 IDLICRLLC-DPEDRLGSFEEIKSHP 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 78/253 (30%), Positives = 131/253 (51%), Gaps = 22/253 (8%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK+ L +Q + R E+ ++ + +V+ +S++ G + +++ + EGG + +
Sbjct: 52 VKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYL-VGDELWVVMEFLEGGALTD 108
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ EE++ + +L AL+YLH ++HRD+K +I LT D I+L DFG
Sbjct: 109 IVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165
Query: 124 KMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDM 180
+S ++ S+VGTP +M PE+++ +PYG++ DIWSLG V EM + F +
Sbjct: 166 AQ-VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
Query: 181 QALINKINKSIVAPLPTVY--SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 238
QA+ +I ++ + + S RG + ML + P R +A ELL HP
Sbjct: 225 QAM-RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP---------F 274
Query: 239 LKLNGPRRNTFPL 251
LKL GP PL
Sbjct: 275 LKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 30/199 (15%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
D+A + K P E + K L+ QLL +++LH++ I+HRD+K NI +T D +++
Sbjct: 91 DLATYLSKCPKPGLPPETI-KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIA 149
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGLA++ + +SVV T Y PE+L Y + D+WS+GC E+ ++ F+
Sbjct: 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209
Query: 179 -DMQALINKINKSI-----------VAPLPTVYSGAFRG---------------LVKSML 211
+ L +KI I V+ + + L+K ML
Sbjct: 210 SEADQL-DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKML 268
Query: 212 RKNPEFRPSAAELLCHPHL 230
NP R SA E L HP+
Sbjct: 269 TFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 75/228 (32%), Positives = 117/228 (51%), Gaps = 21/228 (9%)
Query: 12 QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-------VCIIIGYCEGGDMAEA 64
+T + + E++L+ + + IV+Y GC + I + + GG + +
Sbjct: 43 ETSKEVNALECEIQLLKNLLHERIVQYY------GCLRDPMERTLSIFMEHMPGGSIKDQ 96
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
+K + E K+ Q+L ++YLH+N I+HRD+K +NI +++LGDFG +K
Sbjct: 97 LKSYGAL--TENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK 154
Query: 125 ML----ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
L +S SV GTP +M PE+++ YG K+DIWS+GC V EM +K + F+
Sbjct: 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
Query: 181 QALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
A I KI P LP S R +K + + + RPSA ELL H
Sbjct: 215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVE-AKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 77/246 (31%), Positives = 123/246 (50%), Gaps = 34/246 (13%)
Query: 9 LARQTDRARRSAHQEMELISRVRNPF---------------IVE-YKDSWVEKGCYVCII 52
+AR+ R+ A + M+L + R +VE YK V + +V +
Sbjct: 39 IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV--L 96
Query: 53 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD 112
+ + +GG + + + + EE++ +L AL YLH+ ++HRD+K +I LT D
Sbjct: 97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD 153
Query: 113 QDIRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-S 169
++L DFG IS D+ S+VGTP +M PE+++ PYG++ DIWSLG V EM
Sbjct: 154 GRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212
Query: 170 AQKAAFKAFDMQALINKINKSIVAPLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAEL 224
+ F +QA+ ++ S P P + S R ++ ML + P+ R +A EL
Sbjct: 213 GEPPYFSDSPVQAM-KRLRDS---PPPKLKNAHKISPVLRDFLERMLTREPQERATAQEL 268
Query: 225 LCHPHL 230
L HP L
Sbjct: 269 LDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 5/159 (3%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
++ R +E ++ ++ +P IV +G + I+ Y GGD+ + ++K +G
Sbjct: 41 SEEEREEFLEEASIMKKLSHPNIVRLL-GVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEK 98
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 132
+ L + +Q+ + YL + + +HRD+ N +T + +++ DFGL++ + DD
Sbjct: 99 LTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY 158
Query: 133 SSVVGTPS---YMCPELLADIPYGSKSDIWSLGCCVYEM 168
G +M PE L D + SKSD+WS G ++E+
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 10/237 (4%)
Query: 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
MY KK+ R R + A E +++ +V + FIV ++ E +C+++ GG
Sbjct: 20 MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-ETKDDLCLVMTLMNGG 78
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I FPE + + Q++ L +LH I++RD+K N+ L ++R+ D
Sbjct: 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISD 138
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GLA L GTP YM PE+L Y D ++LGC +YEM A ++ F+
Sbjct: 139 LGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
Query: 180 MQAL---INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ + + + P +S + L +++L+K+PE R SA E+ HP
Sbjct: 199 EKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 69/265 (26%), Positives = 122/265 (46%), Gaps = 45/265 (16%)
Query: 1 MYVLKKIRL---ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 57
+ +KKI+L D +A +E++L+ +++P I+ D + K + ++ + E
Sbjct: 27 IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN-INLVFEFME 85
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
D+ + IK + V P + +++ L L YLH+N ILHRD+K +N+ + D ++L
Sbjct: 86 T-DLEKVIKDKSIVLTPADIKS-YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKL 143
Query: 118 GDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKS-----DIWSLGCCVYEMSA 170
DFGLA+ S + + VV T Y PELL +G++ D+WS+GC E+
Sbjct: 144 ADFGLARSFGSPNRKMTHQVV-TRWYRAPELL----FGARHYGVGVDMWSVGCIFAELLL 198
Query: 171 QKA-------------AFKAF---------DMQALINKINKSIVAPLP--TVYSGAFR-- 204
+ F+A + +L + + P P ++ A
Sbjct: 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDA 258
Query: 205 -GLVKSMLRKNPEFRPSAAELLCHP 228
L++ +L NP R +A + L HP
Sbjct: 259 LDLLQRLLTLNPNKRITARQALEHP 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 12/241 (4%)
Query: 1 MYVLKKIRLARQTDRARRS-AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
MY K++ R R S A E +++ +V + F+V ++ K +C+++ GG
Sbjct: 27 MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA-LCLVLTIMNGG 85
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I F EE+ + ++L L LH + ++RD+K NI L IR+ D
Sbjct: 86 DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISD 145
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GLA + + VGT YM PE+L + Y D W LGC +YEM ++ F+
Sbjct: 146 LGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
Query: 180 MQALINKINKSIVAPLPTVYSGAF----RGLVKSMLRKNPEFR-----PSAAELLCHPHL 230
+ ++++ ++ VYS F + + K +L K+P+ R A E+ HP
Sbjct: 206 EKVKREEVDRRVLET-EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264
Query: 231 Q 231
+
Sbjct: 265 R 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 31 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 90
+P IV+ K+ + E + + Y EG ++ + +K G F E + + Q+L L
Sbjct: 56 EHPNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 91 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPE-LLAD 149
++H + HRD+K N+ ++ + +++ DFGLA+ + S + V T Y PE LL
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 150 IPYGSKSDIWSLGCCVYEMSAQKAAFK---AFDM-------------------QALINKI 187
Y S DIW+LGC + E+ + F D L +K+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 188 N--------KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
S+ +P A L+K MLR +P+ RP+A++ L HP
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAID-LIKDMLRWDPKKRPTASQALQHP 281
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 13/188 (6%)
Query: 48 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
Y+ +++ Y GGD A IK G+ PE+ +++ ++++ + LH I+HRD+K N+
Sbjct: 71 YLYLVMEYLNGGDCASLIKTLGGL--PEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENL 128
Query: 108 FLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVY 166
+ + ++L DFGL++ L + VGTP Y+ PE + + SD WSLGC ++
Sbjct: 129 LIDQTGHLKLTDFGLSRNGLENKKF----VGTPDYLAPETILGVGDDKMSDWWSLGCVIF 184
Query: 167 EMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRPSA-- 221
E F A A+ + I + + S L+ +L +P R A
Sbjct: 185 EFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG 244
Query: 222 -AELLCHP 228
E+ HP
Sbjct: 245 YQEIKSHP 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 70/233 (30%), Positives = 116/233 (49%), Gaps = 24/233 (10%)
Query: 10 ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV-----CIIIGYCEGG--DMA 62
+Q++ + +E+ + ++R+P ++Y+ GCY+ +++ YC G D+
Sbjct: 52 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR------GCYLREHTAWLVMEYCLGSASDLL 105
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
E KK E ++ L L YLH+++++HRDVK NI L+ ++LGDFG
Sbjct: 106 EVHKKP----LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 161
Query: 123 AKMLISDDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEMSAQKAA-FKAF 178
A ++ A+ VGTP +M PE++ + Y K D+WSLG E++ +K F
Sbjct: 162 ASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
M AL + A +S FR V S L+K P+ RP++ LL H +
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 37/261 (14%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK + + + +++A +E++++ ++R+ IV K+++ KG ++ Y E +
Sbjct: 31 IKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY-LVFEYVERTLLEL 89
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
G+ + W QLL A+ Y H+++I+HRD+K NI ++ ++L DFG A
Sbjct: 90 LEASPGGLPPDAVRSYIW--QLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147
Query: 124 KMLI--SDDLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSAQKAAF----- 175
+ L + V T Y PELL D YG D+W++GC + E+ + F
Sbjct: 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207
Query: 176 --------KAF-----DMQALINK---------INKSIVAPLPTVYSGAFRG----LVKS 209
K Q L + S L Y G +K+
Sbjct: 208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKA 267
Query: 210 MLRKNPEFRPSAAELLCHPHL 230
LR +P+ R + ELL HP+
Sbjct: 268 CLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 71/234 (30%), Positives = 127/234 (54%), Gaps = 11/234 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ +KK+ L +Q + R E+ ++ ++ +VE +S++ G + +++ + EGG
Sbjct: 47 LVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEGGA 103
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + EE++ + +L AL+ LHA ++HRD+K +I LT D ++L DF
Sbjct: 104 LTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 160
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
G + + S+VGTP +M PEL++ +PYG + DIWSLG V EM + F
Sbjct: 161 GFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220
Query: 179 DMQALINKINKSIVAPLPTVY--SGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
++A+ I ++ L ++ S + +G + +L ++P R +AAELL HP L
Sbjct: 221 PLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 24/229 (10%)
Query: 10 ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV-----CIIIGYCEGG--DMA 62
+QT+ + +E++ + ++++P +EYK GCY+ +++ YC G D+
Sbjct: 58 GKQTNEKWQDIIKEVKFLQQLKHPNTIEYK------GCYLKEHTAWLVMEYCLGSASDLL 111
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
E KK E ++ L L YLH+++++HRD+K NI LT ++L DFG
Sbjct: 112 EVHKKP----LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167
Query: 123 AKMLISDDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEMSAQKAA-FKAF 178
A A+S VGTP +M PE++ + Y K D+WSLG E++ +K F
Sbjct: 168 ASKS---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
M AL + ++ +FRG V L+K P+ RP++AELL H
Sbjct: 225 AMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 49/225 (21%), Positives = 104/225 (46%), Gaps = 8/225 (3%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K ++ +++ +E ++ ++ +P +V+ + + I++ Y EGGD+
Sbjct: 34 KTLK-EDASEQQIEEFLREARIMRKLDHPNVVKLL-GVCTEEEPLYIVMEYMEGGDLLSY 91
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
++K N L + +Q+ + YL + + +HRD+ N + + +++ DFGL++
Sbjct: 92 LRK-NRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
Query: 125 MLISDDLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDM 180
L DD G +M PE L + + SKSD+WS G ++E+ + + +
Sbjct: 151 DLYDDDYY-RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 209
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ ++ + P P L+ ++PE RP+ +EL+
Sbjct: 210 EEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 49/216 (22%), Positives = 101/216 (46%), Gaps = 4/216 (1%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
+++ +E ++ ++ +P IV+ + + I++ Y GGD+ + ++K
Sbjct: 41 SEQQIEEFLREARIMRKLDHPNIVKLL-GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE 99
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 132
L + +Q+ + YL + + +HRD+ N + + +++ DFGL++ L DD
Sbjct: 100 LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159
Query: 133 SSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINK 189
G P +M PE L + + SKSD+WS G ++E+ + + + ++ + K
Sbjct: 160 KVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219
Query: 190 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
P P L+ ++PE RP+ +EL+
Sbjct: 220 GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 77/279 (27%), Positives = 124/279 (44%), Gaps = 59/279 (21%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWV----------EKGCYVC 50
+ LKK+RL + + +A +E++++ ++ + IV K+ +KG +
Sbjct: 34 LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL 93
Query: 51 I-------IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVK 103
+ ++G E G VHF E+ + ++ QLL LNY H + LHRD+K
Sbjct: 94 VFEYMDHDLMGLLESG----------LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIK 143
Query: 104 CSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPE-LLADIPYGSKSDIWS 160
CSNI L I+L DFGLA++ S++ ++ V T Y PE LL + YG D+WS
Sbjct: 144 CSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWS 203
Query: 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR---------------- 204
GC + E+ +K F+A A + I++ +P P V+ +
Sbjct: 204 CGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRR 263
Query: 205 -------------GLVKSMLRKNPEFRPSAAELLCHPHL 230
L+ ML +P R +A E L P L
Sbjct: 264 LREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 25/232 (10%)
Query: 3 VLKK--IRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-----VCIIIGY 55
LKK I +AR + + E + R+PF+V C+ VC ++ Y
Sbjct: 31 ALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLF------ACFQTEDHVCFVMEY 83
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ I F E + + +++ L YLH N I++RD+K N+ L + +
Sbjct: 84 AAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFV 140
Query: 116 RLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
++ DFGL K + D S+ GTP ++ PE+L + Y D W LG +YEM ++
Sbjct: 141 KIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
Query: 175 FKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
F D + + + SIV P S +++ +LR+NPE R + E
Sbjct: 201 FPGDDEEEVFD----SIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/243 (27%), Positives = 123/243 (50%), Gaps = 18/243 (7%)
Query: 4 LKKIRLARQTDRAR-RSAHQEMELISRVRNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDM 61
+K+IRL + D ++ E++++ + +P+IV++ ++ +G Y+C+ Y + G +
Sbjct: 31 MKEIRL--ELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM--EYMDAGSL 86
Query: 62 AEAIKKANGVH-FPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGD 119
+ PE+ L + ++ L +L H I+HRDVK +N+ + + ++L D
Sbjct: 87 DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCD 146
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELL------ADIPYGSKSDIWSLGCCVYEMSAQKA 173
FG++ L++ LA + +G SYM PE + + Y +SD+WSLG + EM+ +
Sbjct: 147 FGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205
Query: 174 AFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
+ + +++ + LP+ YS + V L K P RP+ A+LL HP L
Sbjct: 206 PYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
Query: 231 QPY 233
Y
Sbjct: 266 VKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 71/224 (31%), Positives = 120/224 (53%), Gaps = 8/224 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M VLKK L + DR R E ++++ V +PFIV+ ++ +G + +I+ + GGD
Sbjct: 29 MKVLKKATL-KVRDRVR--TKMERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGD 84
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + K V F EE + +L +L +AL++LH+ I++RD+K NI L + I+L DF
Sbjct: 85 LFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDF 142
Query: 121 GLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GL+K I + A S GT YM PE++ + +D WS G ++EM F+ D
Sbjct: 143 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
+ + I K+ + +P S + L++++ ++NP R A
Sbjct: 203 RKETMTMILKAKLG-MPQFLSPEAQSLLRALFKRNPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 33 PFIVEYKDSWVEKGCYVCII-----------IGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
P+IV+ CY I + C + + K PE+ L K
Sbjct: 74 PYIVK---------CYGYFITDSDVFICMELMSTC-----LDKLLKRIQGPIPEDILGKM 119
Query: 82 LVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 140
V ++ AL+YL H ++HRDVK SNI L +++L DFG++ L+ + G +
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 141 YMCPELLADIP-----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKI--NKSIV 192
YM PE + D P Y ++D+WSLG + E++ + +K + ++ KI +
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238
Query: 193 APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
P +S F V L K+ RP ELL HP ++ Y
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 72/229 (31%), Positives = 115/229 (50%), Gaps = 24/229 (10%)
Query: 10 ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV-----CIIIGYCEGG--DMA 62
+Q++ + +E++ + R+++P +EYK GCY+ +++ YC G D+
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYK------GCYLREHTAWLVMEYCLGSASDLL 115
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
E KK E ++ L L YLH+++++HRD+K NI LT ++L DFG
Sbjct: 116 EVHKKP----LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 123 AKMLISDDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEMSAQKAA-FKAF 178
A + A+S VGTP +M PE++ + Y K D+WSLG E++ +K F
Sbjct: 172 ASIA---SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
M AL + +S FR V S L+K P+ RP++ ELL H
Sbjct: 229 AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 8/224 (3%)
Query: 14 DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-VH 72
R + H+E+ L S +++ IV+Y S E G + I + GG ++ ++ G +
Sbjct: 46 SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-FFKIFMEQVPGGSLSALLRSKWGPLK 104
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLIS-DD 130
E+ + + Q+L L YLH N I+HRD+K N+ + T +++ DFG +K L +
Sbjct: 105 DNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164
Query: 131 LASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKI 187
+ GT YM PE++ P YG+ +DIWSLGC + EM+ K F + QA + K+
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
Query: 188 NKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
+ P +P S + + +P+ R SA +LL P L
Sbjct: 225 GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 12/217 (5%)
Query: 20 AHQ--EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77
AH E ++ R+PF+ K S+ +C ++ Y GG++ + + V F E++
Sbjct: 40 AHTLTESRVLQNTRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSR-ERV-FSEDR 96
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVV 136
+ +++ AL YLH+ +++RD+K N+ L +D I++ DFGL K ISD +
Sbjct: 97 ARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP 196
GTP Y+ PE+L D YG D W LG +YEM + F D + L I + P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-FP 215
Query: 197 TVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
S + L+ +L+K+P+ R A E++ H
Sbjct: 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 7/212 (3%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E+ ++ ++P IV Y DS++ G + +++ Y GG + + + + +C+
Sbjct: 66 EILVMRENKHPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-- 122
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSY 141
+ L AL +LH+N ++HRD+K NI L D ++L DFG A++ S++VGTP +
Sbjct: 123 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVY 199
M PE++ YG K DIWSLG EM + ++AL + N + P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
S FR + L + E R SA ELL HP L+
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 71/240 (29%), Positives = 118/240 (49%), Gaps = 17/240 (7%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
KK+ R+ +E++++ R+P+IV + +++ + +C+ + + + G +
Sbjct: 35 KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-NICMCMEFMDCGSLDRI 93
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
KK + P E L K V ++ L YL+ + I+HRD+K SNI + I+L DFG++
Sbjct: 94 YKKGGPI--PVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
Query: 124 KMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF-------K 176
LI + +A + VGT +YM PE + Y KSD+WSLG + E++ K F
Sbjct: 152 GELI-NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
Query: 177 AFDMQALINKINKSIV-APLPTVYSGAF----RGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
D I + + IV P P + S F R V + L K+P RP+ +L P
Sbjct: 211 GQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 7/212 (3%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E+ ++ +NP IV Y DS++ G + +++ Y GG + + + + +C+
Sbjct: 66 EILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-- 122
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSY 141
+ L AL++LH+N ++HRD+K NI L D ++L DFG A++ S++VGTP +
Sbjct: 123 -ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVY 199
M PE++ YG K DIWSLG EM + ++AL + N + P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
S FR + L + + R SA ELL HP L+
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 33 PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 92
PFIV K S+ + + ++ Y GG++ ++K F E++ ++ +L++AL +L
Sbjct: 56 PFIVGLKFSF-QTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHL 112
Query: 93 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPE-LLADI 150
H I++RD+K NI L I L DFGL+K L + ++ GT Y+ PE LL +
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSM 210
Y D WSLG V+EM + F A D Q + I V V S R VK +
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL 232
Query: 211 LRKNPEFR----PSAAELLCHP 228
L +NP+ R A EL HP
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHP 254
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 53/229 (23%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEY-----KDSWVEKGCYVCIIIGYCEGGDMAEAIKK 67
++ R+ +E ++ ++ +P +V ++ + +++ Y EGGD+ + ++K
Sbjct: 36 SEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL------YLVLEYMEGGDLLDYLRK 89
Query: 68 ANGVHFPEEK-------LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ V EK L + +Q+ + YL + +HRD+ N + D +++ DF
Sbjct: 90 SRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDF 149
Query: 121 GLAKMLISDDLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFK 176
GL++ + DD G +M PE L D + SKSD+WS G ++E + +
Sbjct: 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ ++ + K P P L+ S + +PE RP+ +EL+
Sbjct: 210 GLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 72/231 (31%), Positives = 117/231 (50%), Gaps = 9/231 (3%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+K+I L +Q + E+ ++ ++NP IV + DS++ G + +++ Y GG + +
Sbjct: 49 IKQINLQKQPKK--ELIINEILVMKELKNPNIVNFLDSFL-VGDELFVVMEYLAGGSLTD 105
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL- 122
+ + E ++ + L AL +LHAN ++HRD+K N+ L D ++L DFG
Sbjct: 106 VVTETC---MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162
Query: 123 AKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQ 181
A++ S++VGTP +M PE++ YG K DIWSLG EM + ++
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222
Query: 182 AL-INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
AL + N + P S FR + L + E R SA ELL HP L+
Sbjct: 223 ALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 19/236 (8%)
Query: 8 RLARQTDRARRSA----HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+A + D ++ E+E + + + IV+Y + Y+ I + Y GG +
Sbjct: 39 TIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL-GFETTEEYLSIFLEYVPGGSIGS 97
Query: 64 AIKKANGVHFPEEKLCKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
++ EE+L ++ Q+L L YLH+ ILHRD+K N+ + D ++ DFG+
Sbjct: 98 CLRTYGRF---EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI 154
Query: 123 AKM---LISDDLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
+K + +D S+ G+ +M PE++ Y +K DIWSLGC V EM A + +
Sbjct: 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214
Query: 178 FDMQALINKINKSIVAP-----LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ A + K+ AP + S + + NP+ RP+A ELL HP
Sbjct: 215 EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 40/264 (15%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGG 59
+ VL K + + ++ +R E E+++ + +PF+ Y E Y+C+++ YC GG
Sbjct: 31 LKVLDK-KEMIKRNKVKR-VLTEQEILATLDHPFLPTLYASFQTET--YLCLVMDYCPGG 86
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ +++ G EE + ++L+AL YLH I++RD+K NI L I L D
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSD 146
Query: 120 FGLAKML----------------------ISDDLAS--------SVVGTPSYMCPELLAD 149
F L+K I + S S VGT Y+ PE+++
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA-LINKINKSIVAPLPTVYSGAFRGLVK 208
+GS D W+LG +YEM FK + N + K + P S + R L++
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIR 266
Query: 209 SMLRKNPE----FRPSAAELLCHP 228
+L K+P + AAE+ HP
Sbjct: 267 KLLVKDPSKRLGSKRGAAEIKQHP 290
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 69/238 (28%), Positives = 110/238 (46%), Gaps = 12/238 (5%)
Query: 1 MYVLKKIRLARQTDRARRS-AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
MY KK+ R R S A E +++ +V + F+V ++ K +C+++ GG
Sbjct: 27 MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVLTLMNGG 85
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I F E + + ++ L LH I++RD+K NI L IR+ D
Sbjct: 86 DLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISD 145
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GLA + VGT YM PE++ + Y D W+LGC +YEM A ++ F+
Sbjct: 146 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
Query: 180 MQALINKINKSIVAPLPTVYSGAF----RGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ ++ + +V + YS F R L K +L K+P+ R A E+ HP
Sbjct: 206 KKIKREEVER-LVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/243 (27%), Positives = 121/243 (49%), Gaps = 17/243 (6%)
Query: 1 MYVLKKIRLA--RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
M VLKK + +T R+ Q +E + R PF+V ++ + + +I+ Y G
Sbjct: 33 MKVLKKATIVQKAKTAEHTRTERQVLEAVRR--CPFLVTLHYAF-QTDTKLHLILDYVNG 89
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
G++ + + HF E ++ ++ ++++AL++LH I++RD+K NI L + + L
Sbjct: 90 GELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLT 147
Query: 119 DFGLAKMLISD--DLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQKAA 174
DFGL+K +++ + A S GT YM PE++ + D WSLG +E+ +
Sbjct: 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
Query: 175 FKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHP 228
F Q ++I++ I+ P P S R ++ +L K+P+ R A E+ HP
Sbjct: 208 FTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267
Query: 229 HLQ 231
Q
Sbjct: 268 FFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 69/241 (28%), Positives = 115/241 (47%), Gaps = 15/241 (6%)
Query: 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+Y KK+ R R A E ++++V + FIV ++ K +C+++ GG
Sbjct: 20 LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGG 78
Query: 60 DMAEAIKKANGVH--FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
D+ I + + FPE + C + Q++ L +LH I++RD+K N+ L D ++R+
Sbjct: 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRI 138
Query: 118 GDFGLA-KMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
D GLA ++ GTP +M PELL Y D ++LG +YEM A + F+
Sbjct: 139 SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198
Query: 177 A----FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCH 227
A + + L +I V P +S A + +++L K+PE R + L H
Sbjct: 199 ARGEKVENKELKQRILNDSVT-YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257
Query: 228 P 228
P
Sbjct: 258 P 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ + IK + ++ + +L Q+L L YLH+ +++HRD+K SNI + + D+++ D
Sbjct: 89 DLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146
Query: 120 FGLAKMLISDDLASSV----VGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAA 174
FGLA+ + D+ V T Y PELL +K+ DIWS+GC E+ +K
Sbjct: 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206
Query: 175 FK-------------------AFDMQALIN-KINKSIVA-------PLPTVYSGA---FR 204
F D++ + + K + + PL ++ GA
Sbjct: 207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAI 266
Query: 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L++ ML +P+ R +A E L HP+L
Sbjct: 267 DLLEKMLVFDPKKRITADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E ++ R+PF+ K S+ K +C ++ Y GG++ + + F E++ +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYG 101
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSY 141
+++ AL+YLH+ I++RD+K N+ L +D I++ DFGL K I+D + GTP Y
Sbjct: 102 AEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 201
+ PE+L D YG D W LG +YEM + F D + L I + P S
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSA 220
Query: 202 AFRGLVKSMLRKNPEFR 218
+ L+ +L K+P R
Sbjct: 221 DAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 40/240 (16%)
Query: 23 EMELISRVR-NPFIVEYKDSWVEK--GCYVCIIIGYCEGGDMA--EAIKKANGVHFPEEK 77
E++ + R+ +P I+ + ++ G + E DM E IK PE++
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALV----FELMDMNLYELIKGRK-RPLPEKR 101
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
+ ++ QLL +L+++H N I HRD+K NI L +D ++L DFG + + S + +
Sbjct: 102 VKSYMYQLLKSLDHMHRNGIFHRDIKPENI-LIKDDILKLADFGSCRGIYSKPPYTEYIS 160
Query: 138 TPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP 196
T Y PE LL D YG K DIW++GC +E+ + F + I KI+ + P
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220
Query: 197 TV----------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
V S L+K +L +P+ R +A + L HP
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 7/212 (3%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E+ ++ +NP IV Y DS++ G + +++ Y GG + + + + +C+
Sbjct: 67 EILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-- 123
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGTPSY 141
+ L AL +LH+N ++HRD+K NI L D ++L DFG A++ S++VGTP +
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL-INKINKSIVAPLPTVY 199
M PE++ YG K DIWSLG EM + ++AL + N + P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
S FR + L + E R SA ELL H L+
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 10/211 (4%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E ++ R+PF+ K ++ + +C ++ Y GG++ + + F EE+ +
Sbjct: 45 ESRVLQNTRHPFLTALKYAF-QTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYG 101
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSY 141
+++ AL YLH+ +++RD+K N+ L +D I++ DFGL K ISD + GTP Y
Sbjct: 102 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 201
+ PE+L D YG D W LG +YEM + F D + L I + P S
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FPRTLSP 220
Query: 202 AFRGLVKSMLRKNPEFR----PS-AAELLCH 227
+ L+ +L+K+P+ R PS A E++ H
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 33/190 (17%)
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
++ + + Q+L L Y+H+ I+HRD+K SNI + D ++++ DFGLA+ DD +
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMTG 174
Query: 135 VVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--------MQ---- 181
V T Y PE +L + Y DIWS+GC + E+ K F D M
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
Query: 182 ---ALINKIN----KSIVAPLPTV----YSGAFRG-------LVKSMLRKNPEFRPSAAE 223
L+ KI+ ++ + LP + + F G L++ ML +P+ R +AAE
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294
Query: 224 LLCHPHLQPY 233
L HP+L Y
Sbjct: 295 ALAHPYLAEY 304
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 37/187 (19%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--ISDDLASSV----VG 137
QLL AL Y+H+ +++HRD+K SNI L D ++L DFGLA+ L + ++ + V V
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 138 TPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAF-------------------KA 177
T Y PE LL Y D+WS+GC + EM K F A
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 178 FDMQAL--------INKINKSIVAPLPTVYSGAFR---GLVKSMLRKNPEFRPSAAELLC 226
D++++ ++ + PL + A L+K +L NP R +A E L
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
Query: 227 HPHLQPY 233
HP++ +
Sbjct: 295 HPYVAQF 301
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 69/235 (29%), Positives = 113/235 (48%), Gaps = 13/235 (5%)
Query: 1 MYVLKKIRLARQTDRARRS-AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+Y LK IR A R+ + E ++++V PFIV K S+ + +++ + GG
Sbjct: 20 IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-KLYLVLAFINGG 78
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ +++ F + + +LL AL LH ++++RD+K NI L I L D
Sbjct: 79 ELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCD 136
Query: 120 FGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
FGL K+ + D D ++ GTP Y+ PELL Y D W+LG +YEM F
Sbjct: 137 FGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196
Query: 179 DMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHP 228
++ + KI + PL P + + L+ +L ++P R A E+ HP
Sbjct: 197 NVNEMYRKI---LQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 37/258 (14%)
Query: 2 YVLKKIRLARQTDRARRSAHQ---EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+ +KKI +Q R Q E ++++ NPF+V S+ E ++C+++ Y EG
Sbjct: 29 FAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-ETKRHLCMVMEYVEG 85
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
GD A +K + P + + + ++AL YLH I+HRD+K N+ +T I+L
Sbjct: 86 GDCATLLKNIGAL--PVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLT 143
Query: 119 DFGLAKM------------LISDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLG 162
DFGL+K+ I D L V GTP Y+ PE++ YG D W++G
Sbjct: 144 DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 203
Query: 163 CCVYEMSAQKAAFKAFDMQALINK-INKSIVAP-----LPTVYSGAFRGLVKSMLRKNPE 216
+YE F + L + I+ I P LP + L+ +LR+NP
Sbjct: 204 IILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPA----DAQDLISRLLRQNPL 259
Query: 217 FR---PSAAELLCHPHLQ 231
R A E+ H
Sbjct: 260 ERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 16/239 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M V+KK L Q + +E +++S +P+I + + ++ +K + +++ Y GGD
Sbjct: 31 MKVMKKSVLLAQETVSF--FEEERDILSISNSPWIPQLQYAFQDKD-NLYLVMEYQPGGD 87
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + F E+ +L +L++A++ +H +HRD+K N+ + R I+L DF
Sbjct: 88 LLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADF 146
Query: 121 GLAKMLISDD--LASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCVYEMSAQK 172
G A L ++ + VGTP Y+ PE+L + YG + D WSLG YEM +
Sbjct: 147 GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
Query: 173 AAFKAFDMQALINKI---NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ F N I + + P S F L++S+L + R L CHP
Sbjct: 207 SPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHP 264
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 32/250 (12%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRN-PFIVE-YKDSWVEKGCYVCIIIGYCEGGDMA 62
K+IR ++ ++ +++++ R + P+IV+ Y + E C++C+ + M
Sbjct: 35 KRIRST-VDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL-------MD 86
Query: 63 EAIKK-------ANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQD 114
++ K PEE L K V + ALNYL I+HRDVK SNI L R+ +
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN 146
Query: 115 IRLGDFGLAKMLISDDLASSV-VGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSA 170
I+L DFG++ L+ D +A + G YM PE + Y +SD+WSLG +YE++
Sbjct: 147 IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205
Query: 171 QKAAFKAFDMQALINKINKSIVAPLP-------TVYSGAFRGLVKSMLRKNPEFRPSAAE 223
K + ++ ++ +++ + + P +S +F + L K+ RP E
Sbjct: 206 GKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263
Query: 224 LLCHPHLQPY 233
LL HP ++ Y
Sbjct: 264 LLEHPFIKDY 273
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 73/237 (30%), Positives = 117/237 (49%), Gaps = 19/237 (8%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
Y LK I D RR +E+E++ V +P +V+ D + + + +++ + +GG +
Sbjct: 102 YALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGEIQVLLEFMDGGSL 159
Query: 62 AEAIKKANGVHFPEEK-LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
G H +E+ L Q+L + YLH HI+HRD+K SN+ + +++++ DF
Sbjct: 160 -------EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPEL----LADIPY-GSKSDIWSLGCCVYEMSAQKAA 174
G++++L D +S VGT +YM PE L Y G DIWSLG + E +
Sbjct: 213 GVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
Query: 175 F---KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
F + D +L+ I S P S FR + L++ P R SA +LL HP
Sbjct: 273 FGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329
|
Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 6/169 (3%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
++ + GGD+ I+K+ F E + + ++ AL +LH I++RD+K N+ L
Sbjct: 74 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH 131
Query: 112 DQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+ +L DFG+ K I + S+ GTP Y+ PE+L ++ YG D W++G +YEM
Sbjct: 132 EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
Query: 171 QKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
A F+A + L I N +V PT S ++K+ + KNP R
Sbjct: 192 GHAPFEAENEDDLFEAILNDEVV--YPTWLSQDAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 67/232 (28%), Positives = 114/232 (49%), Gaps = 22/232 (9%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGG--DMAEAIKKAN 69
T ++ E+E++ + +P+I+ Y +VE +C + +GG D+ I
Sbjct: 39 TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT--EFMDGGSLDVYRKI---- 92
Query: 70 GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 129
PE L + V ++ L YL + ILHRDVK SN+ + ++L DFG++ L+ +
Sbjct: 93 ----PEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-N 147
Query: 130 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF-KAFDMQALINKIN 188
+A + VGT +YM PE ++ YG SD+WSLG E++ + + + Q + +
Sbjct: 148 SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ 207
Query: 189 --KSIVAPLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
+ IV P V +S F + +RK P+ RP+ L+ HP + Y
Sbjct: 208 LLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 52/168 (30%), Positives = 88/168 (52%), Gaps = 4/168 (2%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
++ Y GGD+ I+++ F E + + ++ +AL +LH + +++RD+K NI L
Sbjct: 74 VMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 112 DQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+ +L DFG+ K I + ++ GTP Y+ PE+L ++ YG D W+LG +YEM A
Sbjct: 132 EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191
Query: 171 QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
+ F+A + L I V P S ++K+ + KNP R
Sbjct: 192 GQPPFEADNEDDLFESILHDDVL-YPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 57/154 (37%), Positives = 91/154 (59%), Gaps = 5/154 (3%)
Query: 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76
R +E++++ +P+IV + ++ G + I + + +GG + + +KKA + PE+
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKKAGRI--PEQ 103
Query: 77 KLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
L K + ++ L YL H I+HRDVK SNI + +I+L DFG++ LI D +A+S
Sbjct: 104 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF 162
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMS 169
VGT SYM PE L Y +SDIWS+G + EM+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 13/216 (6%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79
QE+ ++ ++ IV Y S++ + ++C+ YC GG + + I G E ++
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQD-IYHVTG-PLSELQIA 109
Query: 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL-AKMLISDDLASSVVGT 138
+ L L YLH+ +HRD+K +NI LT + D++L DFG+ AK+ + S +GT
Sbjct: 110 YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 139 PSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAP 194
P +M PE+ A + Y DIW++G E++ Q F M+AL + P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229
Query: 195 L---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
T +S F VK L KNP+ RP+A LL H
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-22
Identities = 65/196 (33%), Positives = 100/196 (51%), Gaps = 20/196 (10%)
Query: 51 IIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+++ C GG + E +K G E + L L+ L +LH N I+HRDVK +NI
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160
Query: 109 LTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLG 162
LT + ++L DFG++ L S L ++ VGTP +M PE++A D Y ++ D+WSLG
Sbjct: 161 LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220
Query: 163 CCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV-----YSGAFRGLVKSMLRKNP 215
E+ FDM + + KI ++ P PT+ + +F + L K+
Sbjct: 221 ITAIELGDGDPPL--FDMHPVKTLFKIPRN---PPPTLLHPEKWCRSFNHFISQCLIKDF 275
Query: 216 EFRPSAAELLCHPHLQ 231
E RPS LL HP ++
Sbjct: 276 EARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGG 59
Y LK + + + + H E ++ V +PFI+ + ++ Y +++ Y GG
Sbjct: 29 YALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLY--MLMEYVPGG 86
Query: 60 DMAEAIKKAN------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
++ ++ + G+ + E +C AL YLH+ I++RD+K NI L ++
Sbjct: 87 ELFSYLRNSGRFSNSTGLFYASEIVC--------ALEYLHSKEIVYRDLKPENILLDKEG 138
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
I+L DFG AK L D ++ GTP Y+ PE++ + D W+LG +YEM
Sbjct: 139 HIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 174 AF 175
F
Sbjct: 197 PF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 30/273 (10%)
Query: 1 MYVLKKIRLARQTDRA-RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
MY KK+ R ++ + A E E++ +V +PFIV ++ E ++C+++ GG
Sbjct: 20 MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-ESKTHLCLVMSLMNGG 78
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I E++ + Q+ + +LH+ I++RD+K N+ L + RL D
Sbjct: 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD 138
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF- 178
GLA L + GT YM PE+L + PY D +++GC +YEM A + FK
Sbjct: 139 LGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
Query: 179 ---DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235
+ L + + V ++ + + + L K PE R L
Sbjct: 199 EKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR----------------L 242
Query: 236 GIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEA 268
G K + PR++ F FK F EA
Sbjct: 243 GSREKNDDPRKHEF--------FKTINFPRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 55/181 (30%), Positives = 76/181 (41%), Gaps = 35/181 (19%)
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS--DDLASSVVGTP 139
++QLL + +LH N ILHRD+K SN+ L +++ DFGLA+ S VV T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TL 170
Query: 140 SYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---- 194
Y PELL Y + D+WS+GC E+ +K F +NKI K + P
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230
Query: 195 ------LPTVYSGAFRG---------------------LVKSMLRKNPEFRPSAAELLCH 227
LP F L+ +L +P R SA + L H
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 228 P 228
P
Sbjct: 291 P 291
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 36/196 (18%)
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--- 131
EE + +L QLL L Y+H+ +++HRD+K SN+ + D ++R+GDFG+A+ L S
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 132 --ASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDM-------- 180
+ V T Y PELL +P Y + D+WS+GC EM ++ F +
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225
Query: 181 -------QALINKINKSIV------------APLPTVYSGA---FRGLVKSMLRKNPEFR 218
+ ++N+I V P ++ A L+ ML+ +PE R
Sbjct: 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285
Query: 219 PSAAELLCHPHLQPYV 234
+ + L HP L Y
Sbjct: 286 ITVEQALQHPFLAQYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 69/238 (28%), Positives = 122/238 (51%), Gaps = 17/238 (7%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK + + + + + + +E++++ ++ IVE K+++ +G + ++ Y E +M E
Sbjct: 31 IKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-KLYLVFEYVEK-NMLE 88
Query: 64 AIKK-ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+++ NGV P EK+ ++ QL+ A+++ H N I+HRD+K N+ ++ + ++L DFG
Sbjct: 89 LLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146
Query: 123 AKMLI--SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
A+ L S+ + V T Y PELL PYG D+WS+GC + E+S + F
Sbjct: 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH-LQPYVLGI 237
+ I K ++ PLP F NP F + HP L+ LGI
Sbjct: 207 IDQLFTIQK-VLGPLPAEQMKLF--------YSNPRFHGLRFPAVNHPQSLERRYLGI 255
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 45/116 (38%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
YC+ + E K GV PE + K + Q L A+N+ H ++ +HRDVK NI +T+
Sbjct: 81 YCDHTVLNELEKNPRGV--PEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ 138
Query: 115 IRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEM 168
I+L DFG A++L D + V T Y PELL D YG D+W++GC E+
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 56/173 (32%), Positives = 94/173 (54%), Gaps = 13/173 (7%)
Query: 70 GVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128
G+ PE+ L K V ++ AL YLH+ ++HRDVK SN+ + R+ ++L DFG++ L+
Sbjct: 97 GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV- 155
Query: 129 DDLASSV-VGTPSYMCPEL----LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
D +A ++ G YM PE L Y KSD+WSLG + E++ + + ++ +
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTP 213
Query: 184 INKINKSIVAPLPTV----YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232
++ + + P P + +S F+ V L+KN + RP+ ELL HP +
Sbjct: 214 FQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 59/168 (35%), Positives = 95/168 (56%), Gaps = 5/168 (2%)
Query: 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76
R +E++++ +P+IV + ++ G + I + + +GG + + +K+A + PEE
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRI--PEE 103
Query: 77 KLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
L K + +L L YL H I+HRDVK SNI + +I+L DFG++ LI D +A+S
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF 162
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
VGT SYM PE L Y +SDIWS+G + E++ + D + L
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 6/173 (3%)
Query: 48 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
++ ++ Y GGD+ I+ + F E + + +++ L +LH I++RD+K N+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNV 127
Query: 108 FLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVY 166
L +D I++ DFG+ K + + AS+ GTP Y+ PE+L Y D WS G +Y
Sbjct: 128 LLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187
Query: 167 EMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFR 218
EM ++ F D L + I P P S + + + ++P R
Sbjct: 188 EMLIGQSPFHGEDEDELFDSILNDR--PHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 8/220 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +LKK + + + A E ++ R+PF+ K S+ + +C ++ Y GG+
Sbjct: 25 MKILKKEVIVAKDEVAH--TLTENRVLQNSRHPFLTALKYSF-QTHDRLCFVMEYANGGE 81
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGD 119
+ + + F E++ + +++ AL+YLH+ ++++RD+K N+ L +D I++ D
Sbjct: 82 LFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITD 139
Query: 120 FGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
FGL K I D + GTP Y+ PE+L D YG D W LG +YEM + F
Sbjct: 140 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
D + L I + P S + L+ +L+K+P+ R
Sbjct: 200 DHEKLFELILMEEIR-FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 78/261 (29%), Positives = 124/261 (47%), Gaps = 36/261 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDMA 62
LKK+R+ + D S+ +E+ L+ +R+P IVE K+ V K + +++ YCE D+A
Sbjct: 37 LKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLA 95
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+ F E ++ ++QLL L YLH N I+HRD+K SN+ LT +++ DFGL
Sbjct: 96 SLLDN-MPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL 154
Query: 123 AKM--LISDDLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
A+ L + + VV T Y PELL Y + D+W++GC + E+ A K
Sbjct: 155 ARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 180 MQALINKI-------NKSI---VAPLPTV-------------------YSGAFRGLVKSM 210
++ I N+SI + LP V S A L+ +
Sbjct: 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL 273
Query: 211 LRKNPEFRPSAAELLCHPHLQ 231
L +P+ R +A E L + +
Sbjct: 274 LMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 12/238 (5%)
Query: 1 MYVLKKIRLARQTDRARRS-AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
MY KK+ R R + A E ++ +V + F+V ++ K +C+++ GG
Sbjct: 27 MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA-LCLVLTIMNGG 85
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I F E++ + +L L L I++RD+K NI L IR+ D
Sbjct: 86 DLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISD 145
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GLA + + VGT YM PE++ + Y D W LGC +YEM ++ F+
Sbjct: 146 LGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLR----KNPEFR-----PSAAELLCHP 228
+ ++++ + YS F KS+ R KNP+ R AA + HP
Sbjct: 206 ERVKREEVDRRVKEDQEE-YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 6e-21
Identities = 58/192 (30%), Positives = 103/192 (53%), Gaps = 17/192 (8%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
+++ +C G + + IK G EE + ++L L++LH + ++HRD+K N+ LT
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 111 RDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCC 164
+ +++L DFG++ L + ++ +GTP +M PE++A D Y KSD+WSLG
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 205
Query: 165 VYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV----YSGAFRGLVKSMLRKNPEFR 218
EM+ + A DM + + I ++ P P + +S F+ ++S L KN R
Sbjct: 206 AIEMA--EGAPPLCDMHPMRALFLIPRN---PAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
Query: 219 PSAAELLCHPHL 230
P+ +L+ HP +
Sbjct: 261 PTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 68/247 (27%), Positives = 122/247 (49%), Gaps = 27/247 (10%)
Query: 4 LKKIRLARQTDRARRSAHQEMELI---SRVRNPFIVEYKDSWVEKGC-----YVCIIIGY 55
L I++ T+ E+ ++ S RN I Y ++++K + +++ +
Sbjct: 43 LAAIKVMDVTEDEEEEIKLEINMLKKYSHHRN--IATYYGAFIKKSPPGHDDQLWLVMEF 100
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
C G + + +K G E+ + ++L L +LHA+ ++HRD+K N+ LT + ++
Sbjct: 101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV 160
Query: 116 RLGDFGLAKML-ISDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMS 169
+L DFG++ L + ++ +GTP +M PE++A D Y +SDIWSLG EM+
Sbjct: 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220
Query: 170 AQKAAFKAFDMQAL--INKINKSIVAPLPTV----YSGAFRGLVKSMLRKNPEFRPSAAE 223
+ A DM + + I ++ P P + +S F ++ L KN RPS +
Sbjct: 221 --EGAPPLCDMHPMRALFLIPRN---PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275
Query: 224 LLCHPHL 230
LL HP +
Sbjct: 276 LLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 43 VEKGCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 100
V+ G + +++ C GG + + +K G E + L + LM L +LH N +HR
Sbjct: 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHR 148
Query: 101 DVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLA-----DIPYGS 154
DVK +NI LT + ++L DFG++ L S L ++ VGTP +M PE++A D Y +
Sbjct: 149 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDA 208
Query: 155 KSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPL--PTVYSGAFRGLVKSML 211
+ D+WSLG E+ M+AL KI ++ L P ++S F ++ L
Sbjct: 209 RCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQPELWSNEFNDFIRKCL 267
Query: 212 RKNPEFRPSAAELLCH 227
K+ E RP+ ++LL H
Sbjct: 268 TKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 13/217 (5%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
QE+ ++ ++ IV Y S++ + + I + +C GG + + I G E ++
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRD-KLWICMEFCGGGSLQD-IYHVTG-PLSESQIAY 110
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGT 138
+ L L YLH+ +HRD+K +NI LT + ++L DFG++ I+ +A S +GT
Sbjct: 111 VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ-ITATIAKRKSFIGT 169
Query: 139 PSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAP 194
P +M PE+ A Y DIW++G E++ Q F M+AL + P
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 195 L---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+S +F VK L KNP+ RP+A +LL HP
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 64/264 (24%), Positives = 129/264 (48%), Gaps = 17/264 (6%)
Query: 6 KIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI 65
KI +Q D E ++++ + +PF V S+ ++ Y+ +++ + GG+ +
Sbjct: 68 KIIKQKQVDHV----FSERKILNYINHPFCVNLYGSFKDES-YLYLVLEFVIGGEFFTFL 122
Query: 66 KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125
++ FP + C + Q+++ YL + +I++RD+K N+ L +D I++ DFG AK
Sbjct: 123 RRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK- 179
Query: 126 LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALIN 185
+ D ++ GTP Y+ PE+L ++ +G +D W+LG +YE+ F A + +
Sbjct: 180 -VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ 238
Query: 186 KINKSIVAPLPTVYSGAFRGLVKSML-----RKNPEFRPSAAELLCHPHLQ--PYVLGIH 238
KI + I+ P + L+K +L ++ + A + HP +V +H
Sbjct: 239 KILEGIIY-FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLH 297
Query: 239 LKLNGPRRNTFPLEWSDSNFKKTR 262
+ P + + + SNF++ +
Sbjct: 298 KNVEVPYKPKYKNVFDSSNFERVQ 321
|
Length = 340 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 44/128 (34%), Positives = 73/128 (57%), Gaps = 8/128 (6%)
Query: 48 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
+ +++ Y GGD+ + K PE+ +L ++++A++ +H +HRD+K N+
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133
Query: 108 FLTRDQDIRLGDFG-LAKMLISDDLASSV-VGTPSYMCPELLADIP-----YGSKSDIWS 160
L ++ IRL DFG ++L + S+V VGTP Y+ PE+L + YG + D WS
Sbjct: 134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS 193
Query: 161 LGCCVYEM 168
LG C+YEM
Sbjct: 194 LGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-20
Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 35/235 (14%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGV--HFPEEKLC 79
E+ ++ +++ IV Y D ++ K + I++ +C+ GD++ I+K + E +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 80 KWLVQLLMALNYLH-------ANHILHRDVKCSNIFLTRDQDIR---------------- 116
QLL AL Y H +LHRD+K NIFL+ IR
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS--TGIRHIGKITAQANNLNGRP 179
Query: 117 ---LGDFGLAKMLISDDLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQ 171
+GDFGL+K + + +A S VGTP Y PELL Y KSD+W+LGC +YE+ +
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 172 KAAF-KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
K F KA + LI+++ + P+ S L+K++L + + RPSA + L
Sbjct: 240 KTPFHKANNFSQLISELKRGPDLPIKG-KSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 8e-20
Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
+I + GGD+ +++ PEE + ++ +ALN+LH I++RD+K N+ L
Sbjct: 74 VIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 112 DQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+ I+L D+G+ K I D S+ GTP+Y+ PE+L YG D W+LG ++EM A
Sbjct: 132 EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 171 QKAAFKAFDMQALINK----------INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
++ F M ++ + K I +P S ++K L K+P+ R
Sbjct: 192 GRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKASSVLKGFLNKDPKER-- 247
Query: 221 AAELLCHP 228
L CHP
Sbjct: 248 ---LGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 4/165 (2%)
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
Y GGD+ I++ F E + ++ + L +LH+ I++RD+K N+ L +
Sbjct: 82 YVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH 139
Query: 115 IRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
I++ DFG+ K + + GTP Y+ PE++A PYG D W+ G +YEM A +
Sbjct: 140 IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
F D L I + V+ P S + K +L K+P R
Sbjct: 200 PFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 49/145 (33%), Positives = 80/145 (55%), Gaps = 4/145 (2%)
Query: 32 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 91
NPF+V S + + ++I Y GGD+ +++ PEE + ++ +ALN+
Sbjct: 55 NPFLVGLH-SCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNF 111
Query: 92 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADI 150
LH I++RD+K N+ L D I+L D+G+ K + D S+ GTP+Y+ PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 151 PYGSKSDIWSLGCCVYEMSAQKAAF 175
YG D W+LG ++EM A ++ F
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 29/196 (14%)
Query: 2 YVLKKIR-LARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGG 59
Y +KK + Q +SA +E+ L+ +++ +V + ++E V ++ Y E
Sbjct: 30 YAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH- 88
Query: 60 DMAEAIK---KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-- 114
D+ + IK +A V P + L Q+L ++YLH+N +LHRD+K +NI + +
Sbjct: 89 DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER 148
Query: 115 --IRLGDFGLA-------KMLISDDLASSVVGTPSYMCPELLADIPYGSKS-----DIWS 160
+++GD GLA K L D VV T Y PELL G++ DIW+
Sbjct: 149 GVVKIGDLGLARLFNAPLKPLADLD---PVVVTIWYRAPELL----LGARHYTKAIDIWA 201
Query: 161 LGCCVYEMSAQKAAFK 176
+GC E+ + FK
Sbjct: 202 IGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 74/284 (26%), Positives = 141/284 (49%), Gaps = 22/284 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME--LISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCE 57
+Y +K ++ A +A+ H E ++ VR +PF+V ++ + + +I+ Y
Sbjct: 30 LYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-QTEAKLHLILDYVS 88
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
GG+M + + + +F E+++ + ++++AL +LH I++RD+K NI L + + L
Sbjct: 89 GGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVL 146
Query: 118 GDFGLAKMLISD--DLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSAQKAA 174
DFGL+K +S+ + S GT YM PE++ +G D WSLG ++E+ +
Sbjct: 147 TDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
Query: 175 FKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLC 226
F + +++++ I+ P P+ + L+ +LRK+P+ R A+E+
Sbjct: 207 FTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 227 HPHLQ--PYVLGIHLKLNGPRRNTFPLEWSDSNFKK--TRFMEP 266
HP + + K+N P R + E NF + T +EP
Sbjct: 267 HPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTN-LEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 11/193 (5%)
Query: 26 LISRVRNPFIVEYKDSW--VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV 83
L+ V++PF+V S+ +K +V + Y GG++ +++ FPE + +
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFV---LDYVNGGELFFHLQRER--SFPEPRARFYAA 103
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYM 142
++ AL YLH+ +I++RD+K NI L + L DFGL K I S+ GTP Y+
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 143 CPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSG 201
PE+L PY D W LG +YEM F + D + + I NK + L S
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--RLKPNISV 221
Query: 202 AFRGLVKSMLRKN 214
+ R L++ +L+K+
Sbjct: 222 SARHLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 36/193 (18%)
Query: 72 HFP----EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127
+P E ++ K+L Q+L + + H+++I+HRD+K NI +++ ++L DFG A+ L
Sbjct: 92 KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151
Query: 128 S-DDLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSAQKAAF---------- 175
+ ++ + V T Y PELL D YG DIW++GC V EM + F
Sbjct: 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211
Query: 176 ---KAF-----DMQALINKINKSIVAPLPTV------------YSGAFRGLVKSMLRKNP 215
K Q + K LP V SG L K LR +P
Sbjct: 212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDP 271
Query: 216 EFRPSAAELLCHP 228
+ RPS+++LL H
Sbjct: 272 DDRPSSSQLLHHE 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 65/246 (26%), Positives = 126/246 (51%), Gaps = 18/246 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQ--EMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCE 57
+Y +K ++ A +A+ + H E +++ +R +PF+V ++ + + +I+ Y
Sbjct: 30 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTDTKLHLILDYIN 88
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
GG++ + + F E+++ + ++++AL +LH I++RD+K NI L + + L
Sbjct: 89 GGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 146
Query: 118 GDFGLAKMLISDDL--ASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCVYEMSAQKA 173
DFGL+K D++ A S GT YM P+++ D + D WS+G +YE+ +
Sbjct: 147 TDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
Query: 174 AFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFR----PSAA-ELL 225
F + +I++ I+ P P S + +++ +L K+P+ R PS A E+
Sbjct: 207 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266
Query: 226 CHPHLQ 231
HP Q
Sbjct: 267 KHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 4/168 (2%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
++ Y GGD+ I++ F E + ++ + L +LH+ I++RD+K N+ L
Sbjct: 79 VMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136
Query: 112 DQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+ I++ DFG+ K + D + + + GTP Y+ PE++A PYG D W+ G +YEM A
Sbjct: 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 171 QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
+A F+ D L I + VA P S + K ++ K+P R
Sbjct: 197 GQAPFEGEDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 14/222 (6%)
Query: 2 YVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
Y K R+ + ++ H QE ++ + +PFIV S+ ++ V ++ + GG
Sbjct: 45 YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-RVYFLLEFVVGG 103
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ ++KA FP + + +L++A YLH+ I++RD+K N+ L +++ D
Sbjct: 104 ELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTD 161
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG AK + D ++ GTP Y+ PE++ +G D W++G +YE A F FD
Sbjct: 162 FGFAKKV--PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF--FD 217
Query: 180 MQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFR 218
+I + I+A P + G R LVK +L+ + R
Sbjct: 218 DTPF--RIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 5 KKIRLARQTDR---ARRSAHQEMELISRVRNPFIV--EYKDSWVEKGCYVCIIIGYCEGG 59
KKI L R+ + A R+ L+ V++PF+V Y EK +V + + GG
Sbjct: 30 KKIVLNRKEQKHIMAERNV-----LLKNVKHPFLVGLHYSFQTTEKLYFV---LDFVNGG 81
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ +++ FPE + + ++ AL YLH+ +I++RD+K NI L + L D
Sbjct: 82 ELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTD 139
Query: 120 FGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
FGL K I+ D ++ GTP Y+ PE++ PY + D W LG +YEM F
Sbjct: 140 FGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
D+ + + I + P A+ +++ +L K+ + R A E
Sbjct: 200 DVAEMYDNILHKPLVLRPGASLTAW-SILEELLEKDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 35/88 (39%), Positives = 53/88 (60%), Gaps = 2/88 (2%)
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 140
++ ++ A++ LH +HRD+K N + I+L DFGL+K +++ A+SVVG+P
Sbjct: 106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPD 163
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEM 168
YM PE+L Y D WSLGC +YE
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEF 191
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 51/147 (34%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 48 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
Y+ +++ Y GGD+ + K PE+ ++ ++++A++ +H H +HRD+K N+
Sbjct: 75 YLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 108 FLTRDQDIRLGDFG-LAKMLISDDLASSV-VGTPSYMCPELLADI-----PYGSKSDIWS 160
L + IRL DFG KM + SSV VGTP Y+ PE+L + YG + D WS
Sbjct: 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 193
Query: 161 LGCCVYEMSAQKAAFKAFDMQALINKI 187
LG C+YEM + F A + KI
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 33/261 (12%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK+ Q++ + A++E+ L+ +++ ++ D + Y M
Sbjct: 45 IKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT 104
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
++K G E+K+ + Q+L L Y+H+ I+HRD+K N+ + D ++++ DFGLA
Sbjct: 105 DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 124 KMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--- 179
+ +D + V T Y PE++ + + Y DIWS+GC + EM K FK D
Sbjct: 165 RH--ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 180 ----------------MQALINKINKSIVAPLPTVYSGAFR-----------GLVKSMLR 212
+Q L +K KS + LP F L++ ML
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLE 282
Query: 213 KNPEFRPSAAELLCHPHLQPY 233
+ + R +A E L HP+ +
Sbjct: 283 LDVDKRLTATEALEHPYFDSF 303
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ + K P E + + QLL L++LH++ ++HRD+K NI +T I+L D
Sbjct: 94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF---- 175
FGLA++ +SVV T Y PE+L Y + D+WS+GC EM +K F
Sbjct: 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213
Query: 176 ------KAFDMQALINK--------INKSIVAPLPTVYSGAF--------RGLVKSMLRK 213
K D+ L + + + F + L+ L
Sbjct: 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 273
Query: 214 NPEFRPSAAELLCHPH 229
NP R SA L HP+
Sbjct: 274 NPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 55/181 (30%), Positives = 91/181 (50%), Gaps = 21/181 (11%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
+I Y GGD+ +++ PEE + ++ +ALNYLH I++RD+K N+ L
Sbjct: 74 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 112 DQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+ I+L D+G+ K L D S+ GTP+Y+ PE+L YG D W+LG ++EM A
Sbjct: 132 EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 171 QKAAF-------------KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 217
++ F + + Q ++ K + +P S ++KS L K+P+
Sbjct: 192 GRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----IPRSLSVKAASVLKSFLNKDPKE 246
Query: 218 R 218
R
Sbjct: 247 R 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 33/181 (18%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMC 143
QLL L Y+H+ I+HRD+K SN+ + D ++R+ DFGLA+ +DD + V T Y
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRWYRA 183
Query: 144 PELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV---- 198
PE++ + + Y DIWS+GC + E+ KA F D + +I + + P P V
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 199 -------------------YSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPHLQP 232
FRG L++ ML + + R SA+E L HP+
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 233 Y 233
Y
Sbjct: 304 Y 304
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 67/257 (26%), Positives = 105/257 (40%), Gaps = 33/257 (12%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
++ Y GGD+ I+ + P + +++ L +LH+ I++RD+K NI L
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 112 DQDIRLGDFGLAK-MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
D I++ DFG+ K ++ D + GTP Y+ PE+L Y + D WS G +YEM
Sbjct: 132 DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191
Query: 171 QKAAFKAFDMQALINKIN--------------KSIVAPLPTVYSGAFRGLVKSMLRKNPE 216
++ F D + L I K I+ L V R VK +R++P
Sbjct: 192 GQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL-FVREPERRLGVKGDIRQHPF 250
Query: 217 FRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHS--- 273
FR L ++P P + SNF K E +S+
Sbjct: 251 FREIDWSALEEREIEP-----------PFKPKVKSANDCSNFDKEFLNEKPRLSVTDRML 299
Query: 274 -NREKRQSFSNDRALNP 289
N + F N +NP
Sbjct: 300 INSMDQNMFENFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 15/181 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE-----YKDSWVEKGCYVCI--II 53
+ LKK+ + + + +A +E++++ +++ +V + +
Sbjct: 39 IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVF 98
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
+CE D+A + N V F ++ K + LL L Y+H N ILHRD+K +NI +T+D
Sbjct: 99 EFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156
Query: 114 DIRLGDFGLAKMLI-----SDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYE 167
++L DFGLA+ + ++ V T Y PE LL + YG D+W GC + E
Sbjct: 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
Query: 168 M 168
M
Sbjct: 217 M 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 49/144 (34%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
+++ Y GGD+ + K PE+ +L ++++A++ +H H +HRD+K NI +
Sbjct: 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 111 RDQDIRLGDFGLAKMLISDDLASS--VVGTPSYMCPELLADIP-----YGSKSDIWSLGC 163
+ IRL DFG L+ D S VGTP Y+ PE+L + YG + D WSLG
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGV 196
Query: 164 CVYEMSAQKAAFKAFDMQALINKI 187
C+YEM + F A + KI
Sbjct: 197 CMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 77/262 (29%), Positives = 113/262 (43%), Gaps = 38/262 (14%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKD----SWVEKGCYVCIIIGYC 56
LK +R+ D S +E+ L+ R+ +P IV D S ++ V ++ +
Sbjct: 30 LKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV 89
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
+ D+ + K P E + + Q L L++LHAN I+HRD+K NI +T ++
Sbjct: 90 DQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVK 148
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF- 175
L DFGLA++ + VV T Y PE+L Y + D+WS+GC EM +K F
Sbjct: 149 LADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208
Query: 176 ---------KAFDMQAL-----------INKINKSIVAPLPTV-------YSGAFRGLVK 208
K FD+ L + + S P P SGA L+
Sbjct: 209 GNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGA--QLLL 266
Query: 209 SMLRKNPEFRPSAAELLCHPHL 230
ML NP R SA L HP
Sbjct: 267 EMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 62/184 (33%), Positives = 85/184 (46%), Gaps = 33/184 (17%)
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 140
+L Q+L L Y+H+ ++HRD+K SNI + + D+++ DFGLA+ I D + V T
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRY 170
Query: 141 YMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALI 184
Y PE +L Y + DIWS GC EM K F D +I
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 185 NKINKS----IVAPLP----TVYSGAF-------RGLVKSMLRKNPEFRPSAAELLCHPH 229
N I V LP +S F L++ ML +P+ R SAAE L HP+
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
Query: 230 LQPY 233
L PY
Sbjct: 291 LAPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 4/168 (2%)
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR 111
++ Y GGD+ I++ F E + + ++ + L +LH I++RD+K N+ L
Sbjct: 79 VMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 112 DQDIRLGDFGLAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+ I++ DFG+ K + D + + + GTP Y+ PE++A PYG D W+ G +YEM A
Sbjct: 137 EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196
Query: 171 QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
+ F D L I + V+ P S + K ++ K+P R
Sbjct: 197 GQPPFDGEDEDELFQSIMEHNVS-YPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 7e-18
Identities = 43/94 (45%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 85 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA-KMLISDDLASSV--VGTPSY 141
LL AL YLH I+HRDVK NIFL ++ LGDFG A K+ D GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
PELLA PY +K+DIWS G ++EMS +
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 4/157 (2%)
Query: 32 NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 91
NPF+ ++ K ++ ++ + GGD+ I+ F + + +++ L +
Sbjct: 55 NPFLTHLYCTFQTKE-HLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQF 111
Query: 92 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTPSYMCPELLADI 150
LH+ I++RD+K N+ L RD I++ DFG+ K + D+ AS+ GTP Y+ PE+L +
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI 187
Y D WS G +YEM ++ F D L I
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 69/265 (26%), Positives = 109/265 (41%), Gaps = 48/265 (18%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LKKIRL + + +A +E+ L+ + +P IV D V + ++ + + D+ +
Sbjct: 29 LKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV-VHSENKLYLVFEFLDL-DLKK 86
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ + + +L QLL + Y H++ +LHRD+K N+ + R+ ++L DFGLA
Sbjct: 87 YMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA 146
Query: 124 KMLISDDLASSV--------VGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
+ A V V T Y PE LL Y + DIWS+GC EM ++
Sbjct: 147 R-------AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPL 199
Query: 175 F----------KAFDMQALINKINKSIVAPLPTVYSGAF-------------------RG 205
F + F ++ V LP Y F
Sbjct: 200 FPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD-YKPTFPKWARQDLSKVVPNLDEDGLD 258
Query: 206 LVKSMLRKNPEFRPSAAELLCHPHL 230
L+ ML +P R SA L HP+
Sbjct: 259 LLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 36/261 (13%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS-WVEKGCYVCIIIGYCEGG 59
+ LKKIRL +T+ +A +E+ L+ + +P IV+ D E Y ++ +
Sbjct: 27 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY--LVFEFLHQ- 83
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ + + + P + +L QLL L + H++ +LHRD+K N+ + + I+L D
Sbjct: 84 DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLAD 143
Query: 120 FGLAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF-- 175
FGLA+ + + V T Y PE+L Y S + DIWSLGC EM ++A F
Sbjct: 144 FGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203
Query: 176 --------KAFDMQALINKINKSIVAPLPTVYSGAF-------------------RGLVK 208
+ F +++ V LP Y +F R L+
Sbjct: 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPD-YKPSFPKWARQDFSKVVPPLDEDGRDLLS 262
Query: 209 SMLRKNPEFRPSAAELLCHPH 229
ML +P R SA L HP
Sbjct: 263 QMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLV-QLLMALNYLHANHILHRDVKCSNIFL 109
+I+ Y + GD+ + +KK + E K ++ QL+ ALN LH ++I+H D+K N+
Sbjct: 86 LIMDYIKDGDLFDLLKKEGKL---SEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142
Query: 110 TRDQD-IRLGDFGLAKMLISDDLASSVVGTPS-------YMCPELLADIPYGSKSDIWSL 161
R +D I L D+GL K ++GTPS Y PE + Y D W++
Sbjct: 143 DRAKDRIYLCDYGLCK----------IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 162 GCCVYEMSAQKAAFKA-----FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 216
G YE+ K FK D+++L+ + K + P S V+SML+ N
Sbjct: 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL--PFIKNVSKNANDFVQSMLKYNIN 250
Query: 217 FR 218
+R
Sbjct: 251 YR 252
|
Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 56/189 (29%), Positives = 76/189 (40%), Gaps = 45/189 (23%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMC 143
Q+L L YLHA I+HRDVK NIF+ + +GD G A+ + + GT
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 144 PELLADIPYGSKSDIWSLGCCVYEM------------SAQKAAFKAFDMQALINKINKSI 191
PE+LA Y SK+DIWS G ++EM S + K+ L+ I+
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH-LLKIISTLK 283
Query: 192 VAP-----LPTV--------YSGAFRG-------------------LVKSMLRKNPEFRP 219
V P P Y+ R LV ML + RP
Sbjct: 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP 343
Query: 220 SAAELLCHP 228
SA E+L +P
Sbjct: 344 SAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 4/117 (3%)
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
G + + ++K HF LC + VQ+ + YL + +HRD+ NI L D +
Sbjct: 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136
Query: 116 RLGDFGLAKML-ISDDLASSV--VGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
++GDFGL + L ++D + P ++ PE L + SD+W G ++EM
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 65/271 (23%), Positives = 112/271 (41%), Gaps = 48/271 (17%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
+KKI L + + QE+ ++++P I+ Y S++ + ++ G
Sbjct: 29 AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAYGSCE 87
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+ +K PE + L +L AL+Y+H+ +HR VK S+I L+ D + L
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147
Query: 123 AKMLIS--------DDLASSVVGTPSYMCPELL-ADIP-YGSKSDIWSLGCCVYEMSAQK 172
+ +I D S V ++ PE+L ++ Y KSDI+S+G E++
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207
Query: 173 AAFKAFDMQA---LINKI----------------------------NKSIVAPLPTVY-- 199
FK DM A L+ K+ + + + Y
Sbjct: 208 VPFK--DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265
Query: 200 --SGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
S F V+ L+++PE RPSA++LL H
Sbjct: 266 TFSEHFHQFVELCLQRDPESRPSASQLLNHS 296
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 53/186 (28%), Positives = 81/186 (43%), Gaps = 36/186 (19%)
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVG 137
+L Q+L L YLH+ ILHRD+K N+ + + +++ DFGLA++ D+ + VV
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV- 166
Query: 138 TPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP 196
T Y PE+L Y S DIWS+GC E+ ++ F+A ++ I + P
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 197 TVYSGAFRGLVKSMLRK-------------------------------NPEFRPSAAELL 225
A G +LR +P+ R SAA+ L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 226 CHPHLQ 231
HP+L
Sbjct: 287 AHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 33/187 (17%)
Query: 79 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVV 136
C++ + QLL L Y+H+ ++LHRD+K SN+ L + D+++ DFGLA+ D + V
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV 169
Query: 137 GTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKIN--- 188
T Y PELL + Y + D+WS+GC E+ +K F D ++ + +
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229
Query: 189 ------------KSIVAPLPTVYSGAFR-----------GLVKSMLRKNPEFRPSAAELL 225
+ + LP +F L++ ML +P R + E L
Sbjct: 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289
Query: 226 CHPHLQP 232
HP+L
Sbjct: 290 AHPYLAS 296
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 43/222 (19%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
V I+ Y E D+A +++ EE ++ QLL L Y+H+ ++LHRD+K +N+F
Sbjct: 91 VYIVQEYMET-DLANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVF 146
Query: 109 L-TRDQDIRLGDFGLAKMLISD-----DLASSVVGTPSYMCPE-LLADIPYGSKSDIWSL 161
+ T D +++GDFGLA+++ L+ +V T Y P LL+ Y D+W+
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAA 205
Query: 162 GCCVYEMSAQKAAFKAFDMQALINKINKSI-------------VAP-------------- 194
GC EM K F + I +S+ V P
Sbjct: 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL 265
Query: 195 ---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
LP V A ++ +L NP R +A E L HP++ Y
Sbjct: 266 RDLLPGVNPEAL-DFLEQILTFNPMDRLTAEEALMHPYMSCY 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 49/258 (18%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+E+++++ +++ I+ D +VE ++ +++ D+ + + + E ++
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGD-FINLVMDIMAS-DLKKVVD--RKIRLTESQVKCI 124
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK----MLISDDLA----- 132
L+Q+L LN LH + +HRD+ +NIF+ ++ DFGLA+ SD L+
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 133 ------SSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQKAAF--------- 175
+S V T Y PELL A+ Y D+WS+GC E+ K F
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 176 -KAFDMQALINKIN--KSIVAPLPTVYSGAFR---------------GLVKSMLRKNPEF 217
+ F++ N+ N ++ PL T ++ L++S+L+ NP
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303
Query: 218 RPSAAELLCHPHLQPYVL 235
R SA E L H + + L
Sbjct: 304 RISAKEALKHEYFKSDPL 321
|
Length = 335 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 26 LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQL 85
L+ V++PF+V S+ + + ++ Y GG++ +++ P + + ++
Sbjct: 49 LLKNVKHPFLVGLHFSF-QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF--YAAEI 105
Query: 86 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCP 144
AL YLH+ +I++RD+K NI L I L DFGL K I + S+ GTP Y+ P
Sbjct: 106 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
Query: 145 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 204
E+L PY D W LG +YEM F + + + + I + P + + A R
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA-R 224
Query: 205 GLVKSMLRKN 214
L++ +L+K+
Sbjct: 225 HLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL 195
V T Y PE++ + Y DIWS+GC + EM K F D NK+ + + P
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 196 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232
P F ++ +R E RP A L P L P
Sbjct: 239 PE-----FMKKLQPTVRNYVENRPKYAG-LTFPKLFP 269
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 33/190 (17%)
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
E+++ + Q+L L Y+HA I+HRD+K N+ + D ++++ DFGLA+ +D +
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTG 174
Query: 135 VVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------- 179
V T Y PE++ + + Y DIWS+GC + EM K FK D
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234
Query: 180 -----MQALINKINKSIVAPLPTVYSGAFRGLVKS-----------MLRKNPEFRPSAAE 223
+Q L ++ K+ V LP FR L+ + ML + E R +AAE
Sbjct: 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294
Query: 224 LLCHPHLQPY 233
L HP+ + +
Sbjct: 295 ALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 53/277 (19%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE--------KGCYVCIII 53
LKKI + + D +A +E++++ ++++P +V D VE +G V ++
Sbjct: 36 VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS-VYMVT 94
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
Y + D++ ++ + V E ++ +++QLL +NYLH NHILHRD+K +NI +
Sbjct: 95 PYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG 152
Query: 114 DIRLGDFGLAKML------------ISDDLASSVVGTPSYMCPELLA-DIPYGSKSDIWS 160
+++ DFGLA+ +++V T Y PELL + Y + DIW
Sbjct: 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG 212
Query: 161 LGCCVYEMSAQKAAF----------KAFDM------------QALINKINKSIVAPLPTV 198
+GC EM ++ F + ++L P
Sbjct: 213 IGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT 272
Query: 199 YSGAFR-------GLVKSMLRKNPEFRPSAAELLCHP 228
F L+ +L +P R +A++ L HP
Sbjct: 273 LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 68/258 (26%), Positives = 120/258 (46%), Gaps = 36/258 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LK++RL + SA +E+ L+ +++ IV D + + ++ YC+ D+ +
Sbjct: 30 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-LHSDKKLTLVFEYCDQ-DLKK 87
Query: 64 AIKKANGVHFPEEKLCK-WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
NG + ++ K ++ QLL L + H++++LHRD+K N+ + ++ +++L DFGL
Sbjct: 88 YFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGL 145
Query: 123 AKML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMS-AQKAAFKAFD 179
A+ I S+ V T Y P+ L Y + D+WS GC E++ A + F D
Sbjct: 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205
Query: 180 MQALINKINKSIVAP----------LP----------------TVYSGAFRG--LVKSML 211
+ + +I + + P LP V G L++++L
Sbjct: 206 VDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLL 265
Query: 212 RKNPEFRPSAAELLCHPH 229
NP R SA E L HP+
Sbjct: 266 VCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIV--EYKDSWVEKGCYVCIIIGYCEGGD 60
VL+K + ++ ++ A + + L+ +++PF+V Y EK +V + Y GG+
Sbjct: 27 VLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLHYSFQTAEKLYFV---LDYVNGGE 82
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ +++ P + + ++ A+ YLH+ +I++RD+K NI L + L DF
Sbjct: 83 LFFHLQRERCFLEPRARF--YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDF 140
Query: 121 GLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GL K + ++ S+ GTP Y+ PE+L PY D W LG +YEM F + D
Sbjct: 141 GLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221
+ + + I + LP + A L+ +L K+ R A
Sbjct: 201 VSQMYDNILHKPLQ-LPGGKTVAACDLLVGLLHKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 45/208 (21%)
Query: 2 YVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
Y +KK+R + ++ + AH E ++++ NP++V+ S+ ++ Y+ +I+ Y GG
Sbjct: 29 YAMKKLRKSEMLEK-EQVAHVRAERDILAEADNPWVVKLYYSFQDEN-YLYLIMEYLPGG 86
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
DM + K + F EE+ ++ + ++A++ +H +HRD+K N+ L I+L D
Sbjct: 87 DMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSD 144
Query: 120 FGL------------------AKMLISDD---------------------LASSVVGTPS 140
FGL A D LA S VGTP
Sbjct: 145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPD 204
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEM 168
Y+ PE+ Y + D WSLG +YEM
Sbjct: 205 YIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 51/193 (26%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +L K + +++D A +E ++++ +P++V+ ++ + Y+ +++ Y GGD
Sbjct: 73 MKLLSKFEMIKRSDSA--FFWEERDIMAFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGD 129
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + PE+ + ++++AL+ +H+ +HRDVK N+ L + ++L DF
Sbjct: 130 LVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186
Query: 121 GLAKMLISDDLA--SSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCVYEMSAQKAA 174
G + + + + VGTP Y+ PE+L D YG + D WS+G +YEM
Sbjct: 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 175 FKAFDMQALINKI 187
F A + +KI
Sbjct: 247 FYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 52/224 (23%)
Query: 1 MYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K +R A R ++AH E ++++ N ++V+ S+ +K + ++ Y G
Sbjct: 28 LYAMKTLRKADVLMR-NQAAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFVMDYIPG 85
Query: 59 GD-MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
GD M+ I+ G+ F E+ ++ +L A+ +H +HRD+K NI + RD I+L
Sbjct: 86 GDMMSLLIRL--GI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKL 142
Query: 118 GDFGLA---------------------KMLISDD-----------------------LAS 133
DFGL M S++ LA
Sbjct: 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAH 202
Query: 134 SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
S+VGTP+Y+ PE+L Y D WS+G +YEM + F A
Sbjct: 203 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 67/257 (26%), Positives = 115/257 (44%), Gaps = 36/257 (14%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LK+I L + + +A +E+ L+ +++ IV D + + ++ Y + D+ +
Sbjct: 30 LKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDV-IHTENKLMLVFEYMDK-DLKK 86
Query: 64 AIKKANGVHFP-EEKLCKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +GV + K QLL + + H N +LHRD+K N+ + + +++L DFG
Sbjct: 87 YMD-THGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFG 145
Query: 122 LAKML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
LA+ I + S+ V T Y P+ LL Y + DIWS+GC + EM + F +
Sbjct: 146 LARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205
Query: 180 MQALINKINKSIVAP----LPTV-----YSGAFR-------------------GLVKSML 211
+ + KI + + P P + Y F L+ +L
Sbjct: 206 NEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLL 265
Query: 212 RKNPEFRPSAAELLCHP 228
+ NPE R SA + L HP
Sbjct: 266 QLNPELRISAHDALQHP 282
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 50/193 (25%), Positives = 100/193 (51%), Gaps = 12/193 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +L K + +++D A +E ++++ +P++V+ ++ + Y+ +++ Y GGD
Sbjct: 73 MKLLSKFEMIKRSDSA--FFWEERDIMAFANSPWVVQLFCAFQDDK-YLYMVMEYMPGGD 129
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + PE+ + ++++AL+ +H+ ++HRDVK N+ L + ++L DF
Sbjct: 130 LVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 121 GLAKMLISDDLA--SSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCVYEMSAQKAA 174
G + + + VGTP Y+ PE+L D YG + D WS+G ++EM
Sbjct: 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
Query: 175 FKAFDMQALINKI 187
F A + +KI
Sbjct: 247 FYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 37/191 (19%)
Query: 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV--- 135
+L Q+L L Y+H+ ++LHRD+K SN+ L + D+++ DFGLA++ + +
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 136 -VGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF------------------ 175
V T Y PE++ + +K+ DIWS+GC + EM + + F
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 176 ------------KAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
+A + +++L K P A L+ ML NP R +
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKAL-DLLDKMLTFNPHKRITVE 287
Query: 223 ELLCHPHLQPY 233
E L HP+L+ Y
Sbjct: 288 EALAHPYLEQY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 42/197 (21%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 118 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL 195
V T Y PE++ + Y DIWS+GC + EM F D NKI + + P
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 196 --------PTV---------YSG-AF------------------------RGLVKSMLRK 213
PTV Y+G +F R L+ ML
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 214 NPEFRPSAAELLCHPHL 230
+PE R S + L HP++
Sbjct: 298 DPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 68/252 (26%), Positives = 107/252 (42%), Gaps = 47/252 (18%)
Query: 22 QEMELISRVRNPFIVEYKDSWVE------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75
+E++L+ +R+P IVE K + K YV + D+ + IK AN PE
Sbjct: 48 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL---MESDLHQVIK-ANDDLTPE 103
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----L 131
+L QLL AL Y+H ++ HRD+K NI D +++ DFGLA++ +D
Sbjct: 104 HHQF-FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 132 ASSVVGTPSYMCPELLADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------MQA 182
+ V T Y PEL Y DIWS+GC E+ K F + +
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
Query: 183 LINKINKSIVA----------------PLPTVYSGAFRG-------LVKSMLRKNPEFRP 219
L+ + ++ P +S F L++ +L +P+ RP
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282
Query: 220 SAAELLCHPHLQ 231
+A E L P+ +
Sbjct: 283 TAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 41/196 (20%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ ++ + +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 182
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP- 194
V T Y PE++ + Y DIWS+GC + E+ F+ D NK+ + + P
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 195 -------LPTV---------YSG-AF-----------------------RGLVKSMLRKN 214
PTV Y G +F R L+ ML +
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302
Query: 215 PEFRPSAAELLCHPHL 230
P+ R S E L HP++
Sbjct: 303 PDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 39/87 (44%), Positives = 52/87 (59%), Gaps = 2/87 (2%)
Query: 85 LLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA--KMLISDDLASSVVGTPSYM 142
+L A+ YLH N I+HRD+K NIF+ D+ LGDFG A + I+ + GT +
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 143 CPELLADIPYGSKSDIWSLGCCVYEMS 169
PELLA PYG DIWS G ++EM+
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMA 277
|
Length = 391 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 38/197 (19%)
Query: 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA--KML 126
G+ +L +L QLL L Y H +LHRD+K N+ ++ +++L DFGLA K +
Sbjct: 98 GGLSMHNVRL--FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155
Query: 127 ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALI 184
S ++ VV T Y P+ LL Y + D+W +GC YEM+ + F D++ +
Sbjct: 156 PSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214
Query: 185 NKINKSI----------VAPLPTVYSGAFR---------------------GLVKSMLRK 213
+KI + + V+ P +F L L+
Sbjct: 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274
Query: 214 NPEFRPSAAELLCHPHL 230
P+ R SAAE + HP+
Sbjct: 275 EPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 5/147 (3%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
E++ L Q+L + +LH+ I+HRD+K SNI + D +++ DFGLA+ + + +
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 185
Query: 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL 195
V T Y PE++ + Y DIWS+GC + EM F D NK+ + + P
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 196 PTVYSGAFRGLVKSMLRKNPEFRPSAA 222
P F ++ +R E RP A
Sbjct: 246 P-----EFMKKLQPTVRTYVENRPKYA 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 14/184 (7%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
I++ G++ ++ N L + QL AL YL + +HRD+ N+ ++
Sbjct: 83 IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS 141
Query: 111 RDQDIRLGDFGLAKMLISDDL-ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYE- 167
++LGDFGL++ L + +S P +M PE + + S SD+W G C++E
Sbjct: 142 SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
Query: 168 MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVKSMLRKNPEFRPSAA 222
+ F+ +I +I P+P T+YS L+ +P RP
Sbjct: 202 LMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMTKCWAYDPSKRPRFT 256
Query: 223 ELLC 226
EL
Sbjct: 257 ELKA 260
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 24 MELISRVRNPFIV--EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+ L+S PFIV Y +K +C I+ GGD+ + + +GV F E+++ +
Sbjct: 48 LSLVSTGDCPFIVCMTYAFHTPDK---LCFILDLMNGGDLHYHLSQ-HGV-FSEKEMRFY 102
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY 141
++++ L ++H +++RD+K +NI L +R+ D GLA S + VGT Y
Sbjct: 103 ATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGY 161
Query: 142 MCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKINKSIVAPLPTV 198
M PE+L Y S +D +SLGC ++++ + F+ + I+++ ++ LP
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 199 YSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+S + L++ +L+ R + L C
Sbjct: 222 FSPELKSLLEGLLQ-----RDVSKRLGCL 245
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 68/258 (26%), Positives = 117/258 (45%), Gaps = 33/258 (12%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMA 62
+KKIRL + + +A +E+ L+ +++P IV +D +++ Y+ +
Sbjct: 30 MKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYL 89
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+++ K G + E + +L Q+L + + H+ +LHRD+K N+ + I+L DFGL
Sbjct: 90 DSLPK--GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGL 147
Query: 123 AKML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA--- 177
A+ I + + V T Y PE LL Y + DIWS+G EM+ +K F
Sbjct: 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207
Query: 178 ----FDMQALINKINKSI---VAPLPTVYS-------GAFRGLVKS-----------MLR 212
F + ++ + + V LP + G+ R VK+ ML
Sbjct: 208 IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLI 267
Query: 213 KNPEFRPSAAELLCHPHL 230
+P R SA + L HP+
Sbjct: 268 YDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 54/200 (27%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 24 MELISRVRNPFIV--EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+ L+S PFIV Y +K + I+ GGD+ + + +GV F E ++ +
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDK---LSFILDLMNGGDLHYHLSQ-HGV-FSEAEMRFY 102
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY 141
++++ L ++H +++RD+K +NI L +R+ D GLA S + VGT Y
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGY 161
Query: 142 MCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTV 198
M PE+L + Y S +D +SLGC ++++ + F+ + I+++ ++ LP
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 199 YSGAFRGLVKSMLRKNPEFR 218
+S R L++ +L+++ R
Sbjct: 222 FSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 8/204 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ LK+IRL + + A +A +E+ L+ +++ IV D + + ++ Y + D
Sbjct: 33 LVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDI-IHTEKSLTLVFEYLDK-D 89
Query: 61 MAEAIKK-ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ + + N ++ KL +L QLL LNY H +LHRD+K N+ + +++L D
Sbjct: 90 LKQYLDDCGNSINMHNVKL--FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLAD 147
Query: 120 FGLAKM-LISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
FGLA+ I S+ V T Y P+ LL Y ++ D+W +GC YEMS + F
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207
Query: 178 FDMQALINKINKSIVAPLPTVYSG 201
++ ++ I + + P + G
Sbjct: 208 STVEEQLHFIFRILGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 33/183 (18%)
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY 141
+ Q+L L Y+H+ I+HRD+K SN+ + D ++++ DFGLA+ +DD + V T Y
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWY 183
Query: 142 MCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------------QALIN 185
PE++ + + Y DIWS+GC + E+ + F D L+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 186 KIN----KSIVAPLPTV----YSGAFRG-------LVKSMLRKNPEFRPSAAELLCHPHL 230
KI+ ++ + L + ++ F G L++ ML + + R +AA+ L H +
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
Query: 231 QPY 233
Y
Sbjct: 304 AQY 306
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 12 QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK--GCYVCIIIGYCEGGDMAEAIKKAN 69
++ R +E+E++ + + IV+YK EK G + +I+ Y G + + +++ +
Sbjct: 45 GEEQHRSDFEREIEILRTLDHENIVKYK-GVCEKPGGRSLRLIMEYLPSGSLRDYLQR-H 102
Query: 70 GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 129
++L + Q+ ++YL + +HRD+ NI + + +++ DFGLAK+L D
Sbjct: 103 RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
Query: 130 DLASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYEM 168
V P + PE L + S SD+WS G +YE+
Sbjct: 163 K-DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ + I+ +G + ++ Q+L L Y+H+ ++LHRD+K N+ + D ++++ D
Sbjct: 91 DLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICD 148
Query: 120 FGLAKML-----ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKA 173
FGLA+ + + V T Y PE +L+ Y D+WS+GC + E+ +K
Sbjct: 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
Query: 174 AFKAFDMQALINKI-------NKSIVA--------------------PLPTVYSGAFR-- 204
FK D +N+I ++ ++ P +++ A
Sbjct: 209 VFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA 268
Query: 205 -GLVKSMLRKNPEFRPSAAELLCHPHL 230
L++ +L +P R S E L HP+L
Sbjct: 269 LDLLEKLLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 39/207 (18%)
Query: 60 DMAE-AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
D+A+ I+ G+H +L ++ QLL L Y+H HILHRD+K N+ ++ +++L
Sbjct: 88 DLAQYMIQHPGGLHPYNVRL--FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLA 145
Query: 119 DFGLA--KMLISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
DFGLA K + S +S VV T Y P+ LL Y S DIW GC EM + AF
Sbjct: 146 DFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
Query: 176 KAF-DMQALINKINKSIVAPLPTVYSG-------------------------------AF 203
D+ + KI + P + G
Sbjct: 205 PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKA 264
Query: 204 RGLVKSMLRKNPEFRPSAAELLCHPHL 230
L ML P+ R SA + L HP+
Sbjct: 265 EDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 57/232 (24%), Positives = 118/232 (50%), Gaps = 11/232 (4%)
Query: 2 YVLKKIRLARQTDR----ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 57
Y L+K ++A +T R + +E +++ ++ +P +V+ E+ +C++ + E
Sbjct: 24 YWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-ICLVFEFME 82
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
G +++ ++ G F +E L + + + YL +++++HRD+ N + +Q +++
Sbjct: 83 HGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKV 141
Query: 118 GDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKA 173
DFG+ + ++ D SS GT + PE+ + Y SKSD+WS G ++E+ S K
Sbjct: 142 SDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
++ ++ IN P + S + L++ ++ PE RPS + LL
Sbjct: 201 PYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 18/228 (7%)
Query: 10 ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN 69
Q R RR E L +R+ +P IV DS + + Y G + E + A+
Sbjct: 19 EHQRARFRR----ETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLA-AD 73
Query: 70 GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR---LGDFGLAKML 126
G P + + ++Q+L AL H I+HRD+K NI +++ + DFG+ +L
Sbjct: 74 GA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 127 --------ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
+ + V+GTP+Y PE L P SD+++ G E + +
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGA 192
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRG-LVKSMLRKNPEFRPSAAELL 225
+ ++ + + LP +G G +++ L K+P R ++A L
Sbjct: 193 SVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 49/178 (27%), Positives = 96/178 (53%), Gaps = 20/178 (11%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE----YKDSWVEKGCYVCIIIGYC 56
M +L K + +++D A +E ++++ + +IV+ ++D +K Y+ +++ Y
Sbjct: 73 MKLLSKFEMIKRSDSA--FFWEERDIMAHANSEWIVQLHYAFQD---DK--YLYMVMEYM 125
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
GGD+ + + PE+ + ++++AL+ +H+ +HRDVK N+ L + ++
Sbjct: 126 PGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182
Query: 117 LGDFGLAKMLISDDL--ASSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCVYEM 168
L DFG + ++ + + VGTP Y+ PE+L D YG + D WS+G +YEM
Sbjct: 183 LADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 6/181 (3%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I+ Y G + +++ G E L + A+ YL +N +HRD+ N
Sbjct: 74 IFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCL 132
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCV 165
+ D +++ DFGLA+ ++ D SS GT + PE+ + SKSD+WS G +
Sbjct: 133 VGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLM 191
Query: 166 YEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
+E+ S K ++ F ++ ++ P + ++ S + PE RP+ +L
Sbjct: 192 WEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
Query: 225 L 225
L
Sbjct: 252 L 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 14/169 (8%)
Query: 66 KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125
K G+H KL +L QLL L+Y+H +ILHRD+K N+ ++ +++L DFGLA+
Sbjct: 95 KHPGGLHPENVKL--FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA 152
Query: 126 -LISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQA 182
+ S+ V T Y P+ LL Y + D+W +GC EM AAF D+Q
Sbjct: 153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
Query: 183 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+ +I + P + G V S+ P F+P L +L+
Sbjct: 213 QLERIFLVLGTPNEDTWPG-----VHSL----PHFKPERFTLYSPKNLR 252
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
+E+E++ + + IV+YK E G + +I+ + G + E + + N ++ K
Sbjct: 55 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLK 113
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--------ISDDLA 132
+ VQ+ ++YL + +HRD+ N+ + + +++GDFGL K + + DDL
Sbjct: 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
S V + PE L + SD+WS G +YE+
Sbjct: 174 SPVF----WYAPECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG---LAKMLISDDLASSVVGTPS 140
QLL A++Y+H I+HRD+K N+ + +DI LGDFG A+ S + GT
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
PE+LA PY DIWS G ++E + A+
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS 361
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 65/289 (22%)
Query: 1 MYVLKKIRLARQTDRARRS--AH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 56
+Y +K +R + D R+ AH E ++++ N ++V S+ +K + ++ Y
Sbjct: 28 LYAMKTLR---KKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVMDYI 83
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
GGDM + + G+ FPE+ ++ +L A+ +H +HRD+K NI + RD I+
Sbjct: 84 PGGDMMSLLIRM-GI-FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIK 141
Query: 117 LGDFGL---------AKMLISDD------------------------------------- 130
L DFGL +K S D
Sbjct: 142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201
Query: 131 --LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA---FDMQALIN 185
LA S+VGTP+Y+ PE+L Y D WS+G +YEM + F A + Q +
Sbjct: 202 RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261
Query: 186 KINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQ 231
S+ P S L+ + R PE R A E+ HP +
Sbjct: 262 NWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 7/176 (3%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS-WVEKGCYVCIIIGYCEGGDMA 62
LKKIRL ++ + +A +E+ L+ +++ IV +D EK Y ++ Y + D+
Sbjct: 32 LKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY--LVFEYLDL-DLK 88
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFG 121
+ + + + +L Q+L + Y H++ +LHRD+K N+ + R + ++L DFG
Sbjct: 89 KHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148
Query: 122 LAKML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
LA+ I + V T Y PE LL Y + DIWS+GC EM QK F
Sbjct: 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 33/236 (13%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
+E+ ++ + + IV+YK E+G + +I+ Y G + + + K +L
Sbjct: 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLL 111
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--------ISDDLA 132
+ Q+ + YLH+ H +HRD+ N+ L D+ +++GDFGLAK + + +D
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-----SAQKAAFKAFDM----QAL 183
S V + E L + + SD+WS G +YE+ S Q K +M Q
Sbjct: 172 SPVF----WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227
Query: 184 INKI------NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
+ + + + P P L+K+ +FRP+ L+ P L+
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI--PILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 37/142 (26%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 88 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCP 144
+ YL + +HRD+ N + +++ DFGL++ ++ D+ SS VG+ + P
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPP 170
Query: 145 ELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAF 203
E+L + SKSD+W+ G ++E+ S K ++ F+ + K+++ + P + S
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKV 230
Query: 204 RGLVKSMLRKNPEFRPSAAELL 225
++ S + E RP+ +LL
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 2/178 (1%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
V II E G + ++ G P L Q+ + YL + +HRD+ NI
Sbjct: 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYE 167
+ D ++ DFGLA+++ D SS P + PE + + +KSD+WS G +YE
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYE 196
Query: 168 M-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
M + + + + + ++I P P ++ PE RPS L
Sbjct: 197 MFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 55/216 (25%)
Query: 6 KIRLARQTDRA--------RRSAHQEMELISRVR--NPFIVEYKDSWVEKGCY------- 48
++RL ++ D R++ E E ++ +R +VE +WV K Y
Sbjct: 16 EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ +I+ + GGDM + K + + EE ++ + ++A++ +H +HRD+K N+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTL--SEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 109 LTRDQDIRLGDFGLAKMLI----------------SD--------------------DLA 132
L ++L DFGL L SD LA
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
S VGTP Y+ PE+ Y D WSLG +YEM
Sbjct: 194 YSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 43/174 (24%), Positives = 88/174 (50%), Gaps = 15/174 (8%)
Query: 9 LARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM------- 61
L +D AR+ H+E EL++ +++ IV++ VE G + ++ Y + GD+
Sbjct: 43 LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAH 101
Query: 62 -AEAIKKANG---VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
+A+ A G + ++ Q+ + YL + H +HRD+ N + + +++
Sbjct: 102 GPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161
Query: 118 GDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
GDFG+++ + S D + + +M PE + + ++SD+WSLG ++E+
Sbjct: 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
L W VQ+ +NYL ++HRD+ N+ + Q +++ DFGLAK+L +D+ G
Sbjct: 111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 138 --TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
P +M E + Y +SD+WS G V+E+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ LK+IRL + + A +A +E+ L+ +++ IV D + C + ++ Y + D
Sbjct: 32 LVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC-LTLVFEYLDS-D 88
Query: 61 MAEAIKK-ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ + + N + K+ ++ QLL L+Y H ILHRD+K N+ + +++L D
Sbjct: 89 LKQYLDNCGNLMSMHNVKI--FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLAD 146
Query: 120 FGLAKM-LISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
FGLA+ + S+ V T Y P+ LL Y + D+W +GC +YEM+ + F
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206
Query: 178 FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
++ ++ I + + P + G + N EFR
Sbjct: 207 STVKEELHLIFRLLGTPTEETWPG---------ITSNEEFR 238
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
TD+ ++ +E L+S +P IV+ + II+ EGGD+ ++ A
Sbjct: 39 TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVER 97
Query: 73 FPEEKLCKWLVQLL-MALN------YLHANHILHRDVKCSNIFLT-----RDQDIRLGDF 120
F L L +LL + L+ YL H +HRD+ N ++ D+ +++GDF
Sbjct: 98 FGPPLLT--LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155
Query: 121 GLAKMLISDDLASSVVGTP----SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAF 175
GLA+ + D G +M PE L D + ++SD+WS G ++E ++ + +
Sbjct: 156 GLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
Query: 176 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
A + Q ++ + P L+ + ++P RP+
Sbjct: 215 PALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 46/203 (22%), Positives = 96/203 (47%), Gaps = 7/203 (3%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
QE +++ ++R+ +V+ E+ Y I+ Y G + + +K G + +L
Sbjct: 50 QEAQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-- 139
Q+ + Y+ + +HRD++ +NI + + ++ DFGLA+ LI D+ ++ G
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFP 166
Query: 140 -SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPT 197
+ PE + KSD+WS G + E++ + + + + +++++ + P P
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226
Query: 198 VYSGAFRGLVKSMLRKNPEFRPS 220
+ L+ RK PE RP+
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 55/216 (25%)
Query: 6 KIRLARQTDRA--------RRSAHQEMELISRVR--NPFIVEYKDSWVEKGCY------- 48
++RL ++ D R++ E E + +R +VE WV K Y
Sbjct: 16 EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ +I+ + GGDM + K + + EE+ ++ + ++A++ +H +HRD+K N+
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTL--TEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 109 LTRDQDIRLGDFGLAK----------------MLISD--------------------DLA 132
L ++L DFGL L SD LA
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
S VGTP Y+ PE+ Y D WSLG +YEM
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 12/158 (7%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---A 132
+K + ++ + YL A +HRD+ N + D +++GDFG+ + + D
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK-----I 187
+ +M PE L D + +KSD+WS G ++EM A Q L N+ +
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM----ATLAEQPYQGLSNEEVLKFV 234
Query: 188 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
LP L++ + NP+ RP+ E++
Sbjct: 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 16/136 (11%)
Query: 48 YVCIIIGYCEG------------GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 95
Y+ ++G C G G + + +++ P+ +L W VQ+ + YL +
Sbjct: 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ-RLLNWCVQIAKGMYYLEEH 128
Query: 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTP-SYMCPELLADIPY 152
++HR++ NI L D +++ DFG+A +L DD S TP +M E + Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 153 GSKSDIWSLGCCVYEM 168
+SD+WS G V+EM
Sbjct: 189 THQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 9/231 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+V K + T++ RR E ++ + +P I+ + V K V II + E G +
Sbjct: 34 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL-EGVVTKSRPVMIITEFMENGAL 92
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+++ +G F +L L + + YL + +HRD+ NI + + ++ DFG
Sbjct: 93 DSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 122 LAKML---ISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAA 174
L++ L SD +S +G + PE +A + S SD+WS G ++E MS +
Sbjct: 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
Query: 175 FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ Q +IN I + P P A L+ +K+ RP +++
Sbjct: 212 YWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 21/227 (9%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE-AIKKA--NGVHFPEEK- 77
QE EL+S +++P IV K C++ Y GD+ E ++ + + V
Sbjct: 57 QEAELMSDLQHPNIVCLLGV-CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 78 ----------LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127
+Q+ + YL ++H +HRD+ N + +++ DFGL++ +
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 128 SDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL 183
S D + S + +M PE + + ++SDIWS G ++E+ S + F Q +
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
I I + P P L+ + P RP ++ H L
Sbjct: 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI--HTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 40/178 (22%), Positives = 82/178 (46%), Gaps = 5/178 (2%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
II + G++ + +++ N L Q+ A+ YL + +HRD+ N +
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE 167
+ +++ DFGL++++ + D ++ G + PE LA + KSD+W+ G ++E
Sbjct: 139 ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197
Query: 168 MSAQK-AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
++ + + D+ + + K P L+++ + NP RPS AE+
Sbjct: 198 IATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 7/218 (3%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
T++ RR E ++ + +P I+ + V K V I+ Y E G + ++K +G
Sbjct: 45 TEKQRRDFLSEASIMGQFDHPNIIHL-EGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-Q 102
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL 131
F +L L + + YL +HRD+ NI + + ++ DFGL+++L D +
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 132 ASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKI 187
A + G + PE +A + S SD+WS G ++E MS + + Q +I I
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
Query: 188 NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ P P A L+ +K+ RP +++
Sbjct: 223 EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 36/123 (29%), Positives = 64/123 (52%), Gaps = 2/123 (1%)
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM-LISDDLASSVVGTP 139
+L Q+L L Y H +LHRD+K N+ + +++L DFGLA+ + S+ V T
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 140 SYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV 198
Y P+ LL Y ++ D+W +GC +EM++ + F ++ ++ I + + P
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228
Query: 199 YSG 201
+ G
Sbjct: 229 WPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 2/87 (2%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYM 142
QL AL Y+H+ I HRD+K N+ + ++L DFG AK L++ + S + + Y
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR 237
Query: 143 CPEL-LADIPYGSKSDIWSLGCCVYEM 168
PEL L Y + D+WSLGC + EM
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
L W VQ+ ++YL ++HRD+ N+ + Q +++ DFGLAK+L D+ G
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 138 --TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
P +M E + Y KSD+WS G V+E+
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 32/194 (16%)
Query: 67 KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKM 125
+ G P + + ++ QLL + + H + ++HRD+K N+ + + + +++ D GL +
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 126 L-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-FDMQA 182
I + + T Y PE LL Y + DIWS+GC EMS ++ F ++Q
Sbjct: 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ 220
Query: 183 LINKINKSIVAPLPTVYSG--AFRG-------------------------LVKSMLRKNP 215
L+ I K + P V+ G R L++ MLR +P
Sbjct: 221 LL-HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279
Query: 216 EFRPSAAELLCHPH 229
R SA L HP+
Sbjct: 280 AKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 30/175 (17%)
Query: 9 LARQTDRA-RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK 67
L + +++ R +E E++ ++ NP+IV +IG CE + ++
Sbjct: 30 LKNENEKSVRDEMMREAEIMHQLDNPYIVR--------------MIGVCEAEALMLVMEM 75
Query: 68 ANG-----------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
A+G + + + Q+ M + YL + +HRD+ N+ L +
Sbjct: 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK 135
Query: 117 LGDFGLAKMLISDD---LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYE 167
+ DFGL+K L +DD A S P + PE + + S+SD+WS G ++E
Sbjct: 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 3/103 (2%)
Query: 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128
P + L K++V + + + YL + +HRD+ N L D + + DFGL+K + S
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 129 DDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
D + P ++ E LAD Y SKSD+W+ G ++E+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 28/160 (17%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG------DMAE--AIKK--ANGV 71
+E ++ ++ NP+IV +IG CE ++AE + K
Sbjct: 45 REANVMQQLDNPYIVR--------------MIGICEAESWMLVMELAELGPLNKFLQKNK 90
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 131
H E+ + + + Q+ M + YL + +HRD+ N+ L ++ DFGL+K L +D+
Sbjct: 91 HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150
Query: 132 ASSVVGTP----SYMCPELLADIPYGSKSDIWSLGCCVYE 167
+ PE + + SKSD+WS G ++E
Sbjct: 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 37/87 (42%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV--VGTPSY 141
QLL A+ Y+H ++HRD+K NIFL D I LGDFG A + A VGT +
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 142 MCPELLADIPYGSKSDIWSLGCCVYEM 168
PE+LA Y +DIWS G + +M
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 47/207 (22%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E +++++R+ +V+ VE+ + I+ Y G + + ++ + L K+
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP--- 139
+ + A+ YL AN+ +HRD+ N+ ++ D ++ DFGL K ASS T
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE------ASSTQDTGKLP 162
Query: 140 -SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPT 197
+ PE L + + +KSD+WS G ++E+ S + + ++ ++ ++ K P
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 222
Query: 198 VYSGAFRGLVKSMLRKNPEFRPSAAEL 224
++K + RPS +L
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 4/160 (2%)
Query: 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD 130
+ P + L K++ + + YL + +HRD+ N L + ++ + DFGL+K + + D
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
Query: 131 L--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINK 186
+ P ++ E LAD Y +KSD+WS G ++E++ + + + + + +
Sbjct: 167 YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226
Query: 187 INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226
+ + P L+ S NP+ RPS L C
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 44/203 (21%), Positives = 97/203 (47%), Gaps = 7/203 (3%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
QE +++ ++R+ +V E+ Y I+ + G + + +K+ +G + +L
Sbjct: 50 QEAQIMKKLRHDKLVPLYAVVSEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-- 139
Q+ + Y+ + +HRD++ +NI + + ++ DFGLA+ LI D+ ++ G
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFP 166
Query: 140 -SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPT 197
+ PE + KSD+WS G + E+ + + + + ++ ++ + P P
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226
Query: 198 VYSGAFRGLVKSMLRKNPEFRPS 220
+ L+K +K+P+ RP+
Sbjct: 227 GCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 54/227 (23%)
Query: 1 MYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K +R +R + AH E ++++ N ++V+ S+ +K + ++ Y G
Sbjct: 28 LYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFVMDYIPG 85
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
GDM + + V FPE ++ +L +A+ +H +HRD+K NI + D I+L
Sbjct: 86 GDMMSLLIRM-EV-FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLT 143
Query: 119 DFGLAKML------------------------ISDD------------------------ 130
DFGL + DD
Sbjct: 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC 203
Query: 131 LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
LA S+VGTP+Y+ PE+L Y D WS+G ++EM + F A
Sbjct: 204 LAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIK-----KANG-- 70
SA +E+ L+ +++P ++ + ++ V ++ Y E D+ IK KAN
Sbjct: 44 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 102
Query: 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKML 126
V P + L Q+L ++YLHAN +LHRD+K +NI + + +++ D G A++
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 127 ISD-----DLASSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF 175
S DL VV T Y PELL + +K+ DIW++GC E+ + F
Sbjct: 163 NSPLKPLADL-DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 40/174 (22%), Positives = 83/174 (47%), Gaps = 24/174 (13%)
Query: 14 DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF 73
+ AR+ +E EL++ ++ IV++ E + ++ Y E GD+ + ++ ++G
Sbjct: 49 NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLR-SHGPDA 106
Query: 74 -------------PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+L + VQ+ + YL + H +HRD+ N + D +++GDF
Sbjct: 107 AFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDF 166
Query: 121 GLAKMLISDD---LASSVVGTPSYMCPELLADIPYG---SKSDIWSLGCCVYEM 168
G+++ + + D + + +M PE I Y ++SD+WS G ++E+
Sbjct: 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPE---SIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 52/230 (22%), Positives = 104/230 (45%), Gaps = 22/230 (9%)
Query: 16 ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM---------AEAIK 66
AR +E++++SR+++P I+ + +C+I Y E GD+ EA +
Sbjct: 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAE 120
Query: 67 KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126
KA+ V L Q+ + YL + + +HRD+ N + ++ I++ DFG+++ L
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 127 ISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQ 181
S D + V +M E + + + SD+W+ G ++E+ ++ + +
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 182 ALINKI-------NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
+I + + P P + + L+ S R+N + RPS E+
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 44/203 (21%), Positives = 93/203 (45%), Gaps = 7/203 (3%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+E +++ ++R+ +V+ E+ Y I+ Y G + + +K G L
Sbjct: 50 EEAQIMKKLRHDKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-- 139
Q+ + Y+ + +HRD++ +NI + ++ DFGLA+ LI D+ ++ G
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFP 166
Query: 140 -SYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPT 197
+ PE + KSD+WS G + E+ + + + + + ++ ++ + P P
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ 226
Query: 198 VYSGAFRGLVKSMLRKNPEFRPS 220
+ L+ +K+PE RP+
Sbjct: 227 DCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 4/178 (2%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
I+ + E G + +++ G ++ L + + YL N +HRD+ N ++
Sbjct: 76 IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS 134
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGT-PSYMC-PELLADIPYGSKSDIWSLGCCVYEM 168
+++ DFG+ + ++ D+ SS P PE+ Y SKSD+WS G ++E+
Sbjct: 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
Query: 169 -SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ K F+ ++ I++ P + S ++ S + PE RP+ AELL
Sbjct: 195 FTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 37/115 (32%), Positives = 68/115 (59%), Gaps = 4/115 (3%)
Query: 31 RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALN 90
++PFIV S ++ V +++ Y GGD+ + +F EE K++ ++ +AL+
Sbjct: 62 KSPFIVHLYYS-LQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALD 118
Query: 91 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCP 144
YLH + I+HRD+K N+ ++ + I+L DFGL+K+ ++ +L ++ TPS P
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 34/130 (26%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 45 KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKC 104
G + +I YC GD+ +++ E L + Q+ + +L + + +HRD+
Sbjct: 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 169
Query: 105 SNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS------YMCPELLADIPYGSKSDI 158
N+ LT + +++ DFGLA+ +++D S+ V + +M PE + + Y +SD+
Sbjct: 170 RNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDV 226
Query: 159 WSLGCCVYEM 168
WS G ++E+
Sbjct: 227 WSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 52/175 (29%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIK-----KANG-- 70
SA +E+ L+ +++P ++ + ++ V ++ Y E D+ IK KAN
Sbjct: 44 SACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 102
Query: 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD----IRLGDFGLAKML 126
+ P + L Q+L ++YLHAN +LHRD+K +NI + + +++ D G A++
Sbjct: 103 MQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 127 ISD-----DLASSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAF 175
S DL VV T Y PELL + +K+ DIW++GC E+ + F
Sbjct: 163 NSPLKPLADL-DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 19/97 (19%)
Query: 91 YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM--LISDDLASS-------------- 134
Y+H+ +LHRD+K NI L ++ + D+G A L +DL
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 135 ---VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+VGTP YM PE L +P +DI++LG +Y+M
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 11/177 (6%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
II Y E G + + +K G+ KL Q+ + ++ + +HRD++ +NI ++
Sbjct: 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGS---KSDIWSLGCC 164
++ DFGLA+ LI D+ ++ G + PE I YG+ KSD+WS G
Sbjct: 137 ETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEA---INYGTFTIKSDVWSFGIL 192
Query: 165 VYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
+ E+ + + + +I + + P P L++ ++ PE RP+
Sbjct: 193 LTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/145 (23%), Positives = 68/145 (46%), Gaps = 4/145 (2%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTP-S 140
Q+ + YL ++HRD+ N+ + + +++ DFGL++ + +D + S P
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAPLPTVY 199
+M E L D Y ++SD+WS G ++E+ + + L N + P
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENC 254
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAEL 224
S L+ + ++ P+ RP+ A++
Sbjct: 255 SEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 44/172 (25%), Positives = 80/172 (46%), Gaps = 18/172 (10%)
Query: 8 RLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY------VCIIIGYCEGGDM 61
+L T R +E+E++ +++ IV+YK CY + +++ Y G +
Sbjct: 40 KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGV-----CYSAGRRNLRLVMEYLPYGSL 94
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ ++K + KL + Q+ + YL + +HRD+ NI + + +++GDFG
Sbjct: 95 RDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 122 LAKMLISDDLASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYEM 168
L K+L D V P + PE L + + SD+WS G +YE+
Sbjct: 154 LTKVLPQDK-EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E +++++ +P IV + V KG + +++ G + + +KK P L +
Sbjct: 46 EASVMAQLDHPCIV--RLIGVCKGEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELA 101
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 139
Q+ M + YL + H +HRD+ N+ L ++ DFG+++ L + A++ P
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161
Query: 140 -SYMCPELLADIPYG---SKSDIWSLGCCVYEM 168
+ PE I YG SKSD+WS G ++E
Sbjct: 162 LKWYAPEC---INYGKFSSKSDVWSYGVTLWEA 191
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 60/205 (29%)
Query: 86 LMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV--------G 137
L LNYLH N +HR++K S+I ++ D + L L+ + + VV
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 138 TPSYMCPELLADIPYG--SKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINK------ 186
++ PELL YG KSDI+S+G E++ + F+ DM Q L+ K
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ--DMLRTQMLLQKLKGPPY 228
Query: 187 -------------------------INKSIVA--------------PLPTVYSGAFRGLV 207
I +S+VA P +S AF+ LV
Sbjct: 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288
Query: 208 KSMLRKNPEFRPSAAELLCHPHLQP 232
+ L+++PE RPSA+ LL H +
Sbjct: 289 ELCLQQDPEKRPSASSLLSHAFFKQ 313
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ +K +R A T AR +E++++SR++NP I+ V +C+I Y E GD
Sbjct: 46 LVAVKMLR-ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-LCMITEYMENGD 103
Query: 61 MAE---------AIKKANGV-HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
+ + AN + L VQ+ + YL + + +HRD+ N +
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 111 RDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYE 167
I++ DFG+++ L S D + V +M E + + + SD+W+ G ++E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 168 M 168
M
Sbjct: 224 M 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 45/193 (23%), Positives = 85/193 (44%), Gaps = 18/193 (9%)
Query: 51 IIIGYCEGGDMAEAIKKA---------NGVHFPEEKLC-KWLV----QLLMALNYLHANH 96
+I+ Y G++ E ++ N PEE+L K LV Q+ + YL +
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG---TPSYMCPELLADIPYG 153
+HRD+ N+ +T D +++ DFGLA+ + D +M PE L D Y
Sbjct: 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 220
Query: 154 SKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR 212
+SD+WS G ++E+ + + + ++ L + + P+ + +++
Sbjct: 221 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWH 280
Query: 213 KNPEFRPSAAELL 225
P RP+ +L+
Sbjct: 281 AVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 73 FPEEKL-CKWLV----QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127
PEE+L K LV Q+ + YL + +HRD+ N+ +T D +++ DFGLA+ +
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 128 SDDLASSVVG---TPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ D +M PE L D Y +SD+WS G ++E+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 53/198 (26%)
Query: 20 AH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77
AH E ++++ +P++V S+ + Y+ +I+ + GGD+ + K + F E+
Sbjct: 46 AHVKAERDVLAESDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDV 102
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA-------------K 124
++ + ++A+ +H +HRD+K NI + R I+L DFGL+ K
Sbjct: 103 TRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162
Query: 125 MLISDD-----------------------------------LASSVVGTPSYMCPELLAD 149
+L +A S VGTP Y+ PE+
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222
Query: 150 IPYGSKSDIWSLGCCVYE 167
YG + D WSLG ++E
Sbjct: 223 QGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 34/156 (21%), Positives = 74/156 (47%), Gaps = 4/156 (2%)
Query: 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-- 131
+K+ + ++ + YL+AN +HRD+ N + D +++GDFG+ + + D
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 132 -ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINK 189
+ +M PE L D + + SD+WS G ++E++ + ++ + ++ + +
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
Query: 190 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ P L++ + NP+ RPS E++
Sbjct: 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 8/204 (3%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
QE ++ + +P IV +K + I++ +GGD ++ G ++L +
Sbjct: 42 QEARILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGGDFLTFLR-TEGPRLKVKELIQM 99
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS- 140
+ + YL + H +HRD+ N +T +++ DFG+++ D + +S G
Sbjct: 100 VENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREE-EDGVYASTGGMKQI 158
Query: 141 ---YMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP 196
+ PE L Y S+SD+WS G ++E S + Q I + + P P
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP 218
Query: 197 TVYSGAFRGLVKSMLRKNPEFRPS 220
+ A L++ +P RPS
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 41/177 (23%), Positives = 81/177 (45%), Gaps = 11/177 (6%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
II Y G + + +K G KL + Q+ + Y+ + +HRD++ +N+ ++
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGS---KSDIWSLGCC 164
++ DFGLA+ +I D+ ++ G + PE I +GS KSD+WS G
Sbjct: 138 ESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGIL 193
Query: 165 VYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
+YE+ + K + +++ + + P ++K+ ++ E RP+
Sbjct: 194 LYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 3/103 (2%)
Query: 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128
P + L ++++ + + YL + + +HRD+ N L + + + DFGL+K + S
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
Query: 129 DDL--ASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
D P ++ E LAD Y + SD+W+ G ++E+
Sbjct: 166 GDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 17/135 (12%)
Query: 51 IIIGYCEGGDMAEAIKKA---------NGVHFPEEKLC-KWLV----QLLMALNYLHANH 96
+I+ Y G++ E ++ + PEE+L K LV Q+ + YL +
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTP-SYMCPELLADIPYG 153
+HRD+ N+ +T D +++ DFGLA+ + D +S P +M PE L D Y
Sbjct: 155 CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT 214
Query: 154 SKSDIWSLGCCVYEM 168
+SD+WS G ++E+
Sbjct: 215 HQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 53/204 (25%), Positives = 80/204 (39%), Gaps = 59/204 (28%)
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT-PS 140
L +L AL+Y+H +HR VK S+I ++ D + L +I+ VV P
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPK 166
Query: 141 Y-------MCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINKIN 188
Y + PE+L Y +KSDI+S+G E++ FK DM Q L+ K+N
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK--DMPATQMLLEKLN 224
Query: 189 KSIVAPLPT--------------------------------------------VYSGAFR 204
++ L T +S F
Sbjct: 225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH 284
Query: 205 GLVKSMLRKNPEFRPSAAELLCHP 228
V+ L++NP+ RPSA+ LL H
Sbjct: 285 HFVEQCLQRNPDARPSASTLLNHS 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 41/172 (23%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 63 EAIKKANGVHF---------PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
E + K N V+F +L ++ + + + YL + ++HRD+ NI ++ D
Sbjct: 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG 137
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQK 172
++ DFGLA+ + + + PE L + SKSD+WS G ++E+ S +
Sbjct: 138 VAKVSDFGLAR--VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
Query: 173 AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
A + ++ + + K P L+ S P+ RPS +L
Sbjct: 196 APYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 17/135 (12%)
Query: 51 IIIGYCEGGDMAEAIK---------KANGVHFPEEKL-CKWLV----QLLMALNYLHANH 96
+++ Y G++ + ++ + PEE L K LV Q+ + +L +
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152
Query: 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG--TP-SYMCPELLADIPYG 153
+HRD+ N+ +T D +++ DFGLA+ + D P +M PE L D Y
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT 212
Query: 154 SKSDIWSLGCCVYEM 168
+SD+WS G ++E+
Sbjct: 213 HQSDVWSFGVLLWEI 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 4/154 (2%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
+ L W VQ+ ++YL ++HRD+ N+ + +++ DFGLA++L D+
Sbjct: 109 QDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168
Query: 136 VGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSI 191
G +M E + + +SD+WS G V+E M+ + + + + + K
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228
Query: 192 VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
P P + + ++ + E RP EL+
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 34/124 (27%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
II + G + + +K G P KL + Q+ + ++ + +HRD++ +NI ++
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGS---KSDIWSLGCC 164
++ DFGLA+ +I D+ ++ G + PE I +GS KSD+WS G
Sbjct: 137 ASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGIL 192
Query: 165 VYEM 168
+ E+
Sbjct: 193 LMEI 196
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
L W VQ+ + YL ++HRD+ N+ + +++ DFGLA++L D+ + G
Sbjct: 111 LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170
Query: 138 TP---SYMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVA 193
+M E + + +SD+WS G ++E M+ + + + + + K
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 230
Query: 194 PLPTVYS-GAFRGLVKSML---RKNPEFRPSAAEL 224
P P + + + +VK + P+F+ AAE
Sbjct: 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 42/167 (25%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--KANGVHF--- 73
S + M++I + +N I+ + + G + +I+ Y G++ E ++ + G+ +
Sbjct: 69 SEMEMMKMIGKHKN--IINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 74 ----PEEKLC-KWLV----QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
P+E++ K LV Q+ + YL + +HRD+ N+ +T + +++ DFGLA+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 125 MLISDDLASSVVG---TPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ + D +M PE L D Y +SD+WS G ++E+
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 17/222 (7%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
++LK +R + + R R + +I P +V V + V +++ + EGG +
Sbjct: 21 FILKGLRKSSEYSRERLT------IIPHCV-PNMVCLHKYIVSEDS-VFLVLQHAEGGKL 72
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
I K ++ PEE + +W ++++AL+ LH I+ RD+ +NI L I+L F
Sbjct: 73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+ D V Y PE+ D WSLG ++E+ K ++
Sbjct: 131 RWSE-VEDSCDGEAVEN-MYCAPEVGGISEETEACDWWSLGAILFELLTGKTL-----VE 183
Query: 182 ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
+ IN +P S R L++ +L+ NP R A
Sbjct: 184 CHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 33/141 (23%), Positives = 63/141 (44%), Gaps = 4/141 (2%)
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 139
+Q+ + YL ++ +H+D+ NI + +++ D GL++ + S D + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 140 SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTV 198
+M PE + + S SDIWS G ++E+ S + F Q +I + K + P
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSED 250
Query: 199 YSGAFRGLVKSMLRKNPEFRP 219
L+ ++ P RP
Sbjct: 251 CPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 28/90 (31%), Positives = 53/90 (58%), Gaps = 7/90 (7%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS--- 140
Q+ +++L + + +HRDV N+ LT + ++ DFGLA+ +++D ++ VV +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVVKGNARLP 277
Query: 141 --YMCPELLADIPYGSKSDIWSLGCCVYEM 168
+M PE + D Y +SD+WS G ++E+
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 6/180 (3%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
II Y E G + + ++ +G F +L L + + YL + +HRD+ NI +
Sbjct: 83 IITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN 141
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTPS----YMCPELLADIPYGSKSDIWSLGCCVY 166
+ + ++ DFGL+++L D + + PE +A + S SD+WS G ++
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201
Query: 167 E-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
E MS + + ++ IN P P A L+ +++ RP +++
Sbjct: 202 EVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 36/171 (21%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 16 ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIK--------- 66
AR+ +E EL++ +++ IV++ + G + ++ Y + GD+ + ++
Sbjct: 50 ARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108
Query: 67 ------KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+A G ++ Q+ + YL + H +HRD+ N + + +++GDF
Sbjct: 109 VDGQPRQAKG-ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 167
Query: 121 GLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
G+++ + S D + + +M PE + + ++SD+WS G ++E+
Sbjct: 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 41/180 (22%), Positives = 83/180 (46%), Gaps = 25/180 (13%)
Query: 9 LARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA 68
L ++ AR+ +E EL++ +++ IV + E G + ++ Y GD+ ++
Sbjct: 43 LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLLMVFEYMRHGDLNRFLRS- 100
Query: 69 NGVHFPEEKL--------CKWL---------VQLLMALNYLHANHILHRDVKCSNIFLTR 111
H P+ K+ L Q+ + YL + H +HRD+ N + +
Sbjct: 101 ---HGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157
Query: 112 DQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+++GDFG+++ + S D + + +M PE + + ++SDIWS G ++E+
Sbjct: 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 36/151 (23%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 22 QEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
E +++ ++R+P +++ Y +E+ Y I+ + G + E ++ G +L
Sbjct: 50 AEAQIMKKLRHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQGGAGRALKLPQLID 107
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP- 139
Q+ + YL A + +HRD+ N+ + + ++ DFGLA+ +I +D+ + G
Sbjct: 108 MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKF 166
Query: 140 --SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ PE + KSD+WS G + E+
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 34/155 (21%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LAS 133
E L + Q+ + +L + +HRD+ NI L+ + +++ DFGLA+ + D +
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 134 SVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDM-QALINKINKS 190
P +M PE + D Y ++SD+WS G ++E+ S + + + + ++
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293
Query: 191 IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
P + ++ + + +P+ RP+ + L+
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I + + + E L + Q+ +++L + + +HRD+ NI LT + ++ D
Sbjct: 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICD 257
Query: 120 FGLAKMLISDDLASSVVGTP----SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
FGLA+ I +D V G +M PE + + Y +SD+WS G ++E+
Sbjct: 258 FGLARD-IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 44/202 (21%), Positives = 85/202 (42%), Gaps = 24/202 (11%)
Query: 34 FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL---N 90
FI++ D + +I+ YC G + E + K EK + +L MA+
Sbjct: 86 FIIDIVDDL----PRLSLILEYCTRGYLREVLDK--------EKDLSFKTKLDMAIDCCK 133
Query: 91 YLHANHIL----HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146
L+ + ++++ + +T + +++ GL K+L S V Y ++
Sbjct: 134 GLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKM 191
Query: 147 LADI--PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAF 203
L DI Y K DI+SLG ++E+ K F+ + + + I + LP
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEI 251
Query: 204 RGLVKSMLRKNPEFRPSAAELL 225
+ +V++ + RP+ E+L
Sbjct: 252 KCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 12/220 (5%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
+R QE E++ + +P IV+ V+K + I++ GG + ++K
Sbjct: 32 PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP-IYIVMELVPGGSLLTFLRK-KKNR 89
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK------ML 126
+KL + + + YL + + +HRD+ N + + +++ DFG+++
Sbjct: 90 LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149
Query: 127 ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALIN 185
+SD L + + PE L Y S+SD+WS G ++E S + Q
Sbjct: 150 VSDGLKQIPI---KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206
Query: 186 KINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+I P P + L+ +PE RPS +E+
Sbjct: 207 RIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 10/124 (8%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT 110
I+ Y G + + +K G +L Q+ + YL + + +HRD+ NI +
Sbjct: 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGS---KSDIWSLGCC 164
+ ++ DFGLA++ I DD ++ G P + PE YG KSD+WS G
Sbjct: 138 ENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEA---ANYGRFTIKSDVWSFGIL 193
Query: 165 VYEM 168
+ E+
Sbjct: 194 LTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 45/206 (21%), Positives = 85/206 (41%), Gaps = 35/206 (16%)
Query: 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE------------- 63
R E + SR+++P IV V K + +I YC D+ E
Sbjct: 52 REEFKHEAMMRSRLQHPNIVCLLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 64 ---------AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
++ A+ VH + Q+ + +L ++H++H+D+ N+ + +
Sbjct: 111 TDDDKTVKSTLEPADFVHI--------VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162
Query: 115 IRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SA 170
+++ D GL + + + D L + + +M PE + + SDIWS G ++E+ S
Sbjct: 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222
Query: 171 QKAAFKAFDMQALINKINKSIVAPLP 196
+ + Q +I I V P P
Sbjct: 223 GLQPYCGYSNQDVIEMIRNRQVLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 82 LVQLLMALN------YLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--AS 133
QL +A YL +HRD+ N + + +++ DFGL++ + S D AS
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 134 SVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
P +M PE + Y ++SD+W+ G ++E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 45/218 (20%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE---AIKKANGVHFPEEKL 78
+E+++ ++ + +V E + +I+ Y + GD+ + A K + P
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 79 CKWLV----QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LA 132
K V Q+ + +++L +HRD+ N ++ +++++ L+K + + +
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKI-NKS 190
+ + ++ PE + + + +KSD+WS G ++E+ + + F + ++N++
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235
Query: 191 IVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAAELL 225
+ P+P G L K M R NP+ RPS +EL+
Sbjct: 236 LELPVP---EGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV 135
E L + Q+ + +L + +HRD+ NI L+ + +++ DFGLA+ + D
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD------ 226
Query: 136 VGTPSY------------MCPELLADIPYGSKSDIWSLGCCVYEM 168
P Y M PE + D Y ++SD+WS G ++E+
Sbjct: 227 ---PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 24/166 (14%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
QE++ + +P +++ +E Y+ +++ +C GD+ ++ G+ ++ +
Sbjct: 44 QEVQPYRELNHPNVLQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGM---VAQMAQK 99
Query: 82 LVQLLMA------LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---A 132
V MA L +LH +H D+ N LT D +++GD+GLA +D
Sbjct: 100 DVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159
Query: 133 SSVVGTPSYMCPELL---------ADIPYGSKSDIWSLGCCVYEMS 169
++ PEL+ D KS+IWSLG ++E+
Sbjct: 160 DCHAVPLRWLAPELVEIRGQDLLPKDQT--KKSNIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 89 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPE 145
+ YL+A +HRD+ N + D +++GDFG+ + + D + +M PE
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 146 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFR 204
L D + + SD+WS G ++E+++ + ++ + ++ + P
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT 251
Query: 205 GLVKSMLRKNPEFRPSAAELL------CHPHLQ 231
L++ + NP+ RP+ E++ HP
Sbjct: 252 DLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 74 PEEKLCK----------WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+E L K + Q+ + +L + +HRD+ NI L+ + +++ DFGLA
Sbjct: 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 226
Query: 124 KMLISDD--LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ + D + P +M PE + D Y +SD+WS G ++E+
Sbjct: 227 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
L + Q+ + +L + + +HRD+ N+ L + + +++ DFGLA+ ++ D S
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 138 T---PSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
T +M PE + D Y + SD+WS G ++E+
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 42/188 (22%), Positives = 85/188 (45%), Gaps = 21/188 (11%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ V KI AR +E++++SR+++P I+ V++ +C+I Y E GD
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDP-LCMITEYMENGD 105
Query: 61 MAEAI-------KKANGVHFPEEKLCKWLV----------QLLMALNYLHANHILHRDVK 103
+ + + K+ NG C + Q+ + YL + + +HRD+
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 104 CSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWS 160
N + + I++ DFG+++ L + D + V +M E + + + SD+W+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 161 LGCCVYEM 168
G ++E+
Sbjct: 226 FGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 32/140 (22%), Positives = 61/140 (43%), Gaps = 5/140 (3%)
Query: 88 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP-SYMCPEL 146
+ YL + +HRD+ N+ ++ D ++ DFGLAK P + PE
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEA 170
Query: 147 LADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG 205
L + + +KSD+WS G ++E+ S + + ++ ++ + K P
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230
Query: 206 LVKSMLRKNPEFRPSAAELL 225
++K +P RP+ +L
Sbjct: 231 VMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 8/181 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I++ GGD ++K ++L K+ + + YL + + +HRD+ N
Sbjct: 67 IYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCL 125
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTPS----YMCPELLADIPYGSKSDIWSLGCC 164
+ + +++ DFG+++ DD S G + PE L Y S+SD+WS G
Sbjct: 126 VGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183
Query: 165 VYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
++E S + Q ++ K P +++ PE RP +E
Sbjct: 184 LWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSE 243
Query: 224 L 224
L
Sbjct: 244 L 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTP 139
+Q+ ++YLH ++H+D+ N + + +++ D L++ L D L +
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 140 SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+M E L + Y S SD+WS G ++E+
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 5/189 (2%)
Query: 43 VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV 102
V K V II Y E G + + +++ +G F +L L + + YL + +HRD+
Sbjct: 74 VTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132
Query: 103 KCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS---YMCPELLADIPYGSKSDIW 159
NI + + ++ DFGL++ L + + G + PE +A + S SD+W
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVW 192
Query: 160 SLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
S G ++E MS + + Q +I + P P A L+ +K+ R
Sbjct: 193 SFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNER 252
Query: 219 PSAAELLCH 227
P+ ++++
Sbjct: 253 PTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 29/131 (22%), Positives = 61/131 (46%), Gaps = 14/131 (10%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEK---LCKWLVQLLMALNYLHANHILHRDVKCSNI 107
++ YCE GD+ + + H + L + ++ + ++H ++ LH D+ N
Sbjct: 72 LVFEYCELGDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNC 130
Query: 108 FLTRDQDIRLGDFGLAKMLISDDLASS---VVGTPSYMCPELLADIPYG-------SKSD 157
FLT D +++GD+G+ +D + ++ PEL+ + G S+
Sbjct: 131 FLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSN 190
Query: 158 IWSLGCCVYEM 168
+W+LG ++E+
Sbjct: 191 VWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 31/131 (23%), Positives = 66/131 (50%), Gaps = 13/131 (9%)
Query: 51 IIIGYCEGGDMA---EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
+++ +C GD+ + +KA + L + ++ + L +LH N+ +H D+ N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131
Query: 108 FLTRDQDIRLGDFGLAKMLISDD--LASSVVGTP-SYMCPELLADI-------PYGSKSD 157
LT D +++GD+GL+ +D + + P ++ PEL+ ++ +S+
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 158 IWSLGCCVYEM 168
+WSLG ++E+
Sbjct: 192 VWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 25/84 (29%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 91 YLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCP 144
YL NH +HRD+ N LT + ++ DFG+A+ + + +M P
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 145 ELLADIPYGSKSDIWSLGCCVYEM 168
E D + SK+D+WS G ++E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 46/221 (20%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 23 EMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH----FPEE- 76
E+E++ ++ +P I+ + +G Y+ I I Y G++ + ++K+ + F +E
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRG-YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110
Query: 77 ---------KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK--- 124
+L ++ + + YL +HRD+ N+ + + ++ DFGL++
Sbjct: 111 GTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE 170
Query: 125 MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDMQAL 183
+ + + V +M E L Y +KSD+WS G ++E+ S + L
Sbjct: 171 VYVKKTMGRLPV---RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
K+ + P L++ R P RP A++
Sbjct: 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 16/104 (15%)
Query: 135 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF------KAFDMQALINKIN 188
++GTP Y+ PELL P+G D W+LG C++E F + F N +N
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQ-----NILN 594
Query: 189 KSIVAPLP---TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229
+ I P P S + ++ +L +P R EL HP
Sbjct: 595 RDI--PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 7/170 (4%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D A AI + ++L + + ++YL +HRD+ NI + + ++ D
Sbjct: 108 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 167
Query: 120 FGLAK---MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAF 175
FGL++ + + + V +M E L Y + SD+WS G ++E+ S +
Sbjct: 168 FGLSRGQEVYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
Query: 176 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
L K+ + P L++ R+ P RPS A++L
Sbjct: 225 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-S 140
Q+ + +L + + +HRD+ N+ + + +++ DFGLA+ ++ D S T P
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEM 168
+M PE + + Y + SD+WS G ++E+
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 33/158 (20%), Positives = 48/158 (30%), Gaps = 37/158 (23%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQ-------DIRLGDFGLAKMLISDDLASSVV 136
QL AL+YL ++H +V NI + R I+L D G +
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG--------------I 154
Query: 137 GTPSYMCPELLADIPY--------GSKS-----DIWSLGCCVYEM-SAQKAAFKAFDMQA 182
E + IP+ G S D WS G + E+ S +
Sbjct: 155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
Query: 183 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
P+P L+ +P RPS
Sbjct: 215 KERFYQDQHRLPMPD--CAELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 15/184 (8%)
Query: 51 IIIGYCEGGDMAEAIKKANGVHFPEEK-LCKWLVQLLMALNYLHANHILHRDVKCSNIFL 109
+++ Y + GD+ I+ H P K L + +Q+ + YL + +HRD+ N L
Sbjct: 74 VVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML 131
Query: 110 TRDQDIRLGDFGLAKMLISDDLAS----SVVGTP-SYMCPELLADIPYGSKSDIWSLGCC 164
+++ DFGLA+ + + S + P +M E L + +KSD+WS G
Sbjct: 132 DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 191
Query: 165 VYEMSAQKAA----FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
++E+ + A +FD + + + P ++ S PE RP+
Sbjct: 192 LWELMTRGAPPYPDVDSFD---ITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPT 248
Query: 221 AAEL 224
+EL
Sbjct: 249 FSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 46/231 (19%), Positives = 95/231 (41%), Gaps = 23/231 (9%)
Query: 13 TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGV 71
+ R E+E++ ++ +P I+ + +G Y+ + I Y G++ + ++K+ +
Sbjct: 35 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVL 93
Query: 72 H----FPEE----------KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
F +L + + ++YL +HRD+ NI + + ++
Sbjct: 94 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 153
Query: 118 GDFGLAK---MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKA 173
DFGL++ + + + V +M E L Y + SD+WS G ++E+ S
Sbjct: 154 ADFGLSRGQEVYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
+ L K+ + P L++ R+ P RPS A++
Sbjct: 211 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 36/165 (21%), Positives = 55/165 (33%), Gaps = 25/165 (15%)
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
EE++ +Q L AL LH NI LT D L G S
Sbjct: 16 EEEIWAVCLQCLGALRELHRQAKSG------NILLT--WDGLLKLDGSV--AFKTPEQSR 65
Query: 135 VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP 194
P +M PE++ Y K+DI+SLG +YE + + + L + +
Sbjct: 66 P--DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP--YNEERELSAILEILLNGM 121
Query: 195 LPTVYSGA-----------FRGLVKSMLRKNPEFRPSAAELLCHP 228
F ++ + P+ R +A L H
Sbjct: 122 PADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 34/126 (26%), Positives = 57/126 (45%), Gaps = 23/126 (18%)
Query: 73 FPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFL-TRDQDI--------------- 115
F L + + Q +AL+Y H H++H D+K NI + T D +
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 116 RLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
R+ D G D+ S ++V T Y PE++ + + +D+WS+GC +YE+ K
Sbjct: 288 RICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 174 AFKAFD 179
+ D
Sbjct: 344 LYDTHD 349
|
Length = 467 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 15/147 (10%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFLTRDQD--------IRLGDFGLAKMLISDDLASSV 135
QL AL++L + H +V N+ L R++D I+L D G++ ++ ++
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER 167
Query: 136 VGTPSYMCPELLADIPYGS-KSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVA 193
+ ++ PE + + S +D WS G ++E+ S A D Q +
Sbjct: 168 I---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL 224
Query: 194 PLPTVYSGAFRGLVKSMLRKNPEFRPS 220
P P A L+ + P+FRPS
Sbjct: 225 PAPKWTELA--NLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 60/260 (23%), Positives = 113/260 (43%), Gaps = 41/260 (15%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV----CIIIGYC 56
+ +K +R +D AR +E++++SR+ +P I + C V C+I+ Y
Sbjct: 48 LVAVKVLR-PDASDNAREDFLKEVKILSRLSDPNIAR-----LLGVCTVDPPLCMIMEYM 101
Query: 57 EGGDMAEAIKKA---------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
E GD+ + ++K N L Q+ + YL + + +HRD+ N
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161
Query: 108 FLTRDQDIRLGDFGLAKMLISDDLASSVVGTP----SYMCPELLADIPYGSKSDIWSLGC 163
+ ++ I++ DFG+++ L S D V G +M E + + +KSD+W+ G
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 164 CVYE--MSAQKAAFKAFDMQALINKI-------NKSIVAPLPTVYSGAFRGLVKSML--- 211
++E ++ ++ Q +I + I P P + + + ML
Sbjct: 221 TLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP---NCPKDIYELMLECW 277
Query: 212 RKNPEFRPSAAELLCHPHLQ 231
R++ E RP+ E+ H LQ
Sbjct: 278 RRDEEDRPTFREI--HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 26/126 (20%), Positives = 52/126 (41%), Gaps = 13/126 (10%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGYCEGG 59
YVLK +R+ R ++L++R P ++ +S G +++ + EG
Sbjct: 24 YVLKINP-SREKGADREREVAILQLLARKGLPVPKVLASGES---DGWSY-LLMEWIEGE 78
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ E +E + + L +LL L+ L + H D+ NI + + + + D
Sbjct: 79 TLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIID 132
Query: 120 FGLAKM 125
+ A
Sbjct: 133 WEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.98 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.7 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.58 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.47 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.38 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.1 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.83 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.49 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.32 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.16 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.82 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.76 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.49 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.79 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.46 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.41 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.64 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.48 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.34 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.42 | |
| PLN02236 | 344 | choline kinase | 94.37 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.08 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.79 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.78 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.01 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.51 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.65 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.35 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 89.62 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.44 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 86.61 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 85.95 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=418.62 Aligned_cols=228 Identities=32% Similarity=0.480 Sum_probs=199.1
Q ss_pred EEEEEecccccCHHH-----HHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRA-----RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~-----~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||+++........ ...+.+|++||++|+|||||+++++|... .+.|+||||++||+|.+.+-.++ .+.|.
T Consensus 200 vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-ds~YmVlE~v~GGeLfd~vv~nk--~l~ed 276 (475)
T KOG0615|consen 200 VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-DSSYMVLEYVEGGELFDKVVANK--YLRED 276 (475)
T ss_pred EEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-CceEEEEEEecCccHHHHHHhcc--ccccc
Confidence 899999775543311 13367999999999999999999977554 58899999999999999998765 78899
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC---CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY- 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y- 152 (582)
.-+.+++|||.||.|||++||+||||||+|||+..+ ..+||+|||+|+.......+.++||||.|.|||++....+
T Consensus 277 ~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~ 356 (475)
T KOG0615|consen 277 LGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVE 356 (475)
T ss_pred hhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCee
Confidence 999999999999999999999999999999999877 7799999999999988888999999999999999987653
Q ss_pred --CCCCcccchhHHHHhHhcCCccccccCHHH-HHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 153 --GSKSDIWSLGCCVYEMSAQKAAFKAFDMQA-LINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 153 --~~ksDIWSLG~iLyELltG~~PF~~~~~~~-l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
..++||||+||+||.+++|.+||.+..... +.++|..+. .++.+..+|+++++||++||..||++|||++|+|+
T Consensus 357 ~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 357 YYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 447899999999999999999998765444 666676554 44556779999999999999999999999999999
Q ss_pred CCCCch
Q 007991 227 HPHLQP 232 (582)
Q Consensus 227 hp~f~~ 232 (582)
||||+.
T Consensus 437 hpW~~~ 442 (475)
T KOG0615|consen 437 HPWFKD 442 (475)
T ss_pred Chhhhc
Confidence 999973
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=419.71 Aligned_cols=249 Identities=59% Similarity=1.034 Sum_probs=236.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||+|+|+.+..++..++.+++|+.+++++.|||||.++++|++++.++||||+||+||+|.+.|++.++..|+|+++..
T Consensus 31 ~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~ 110 (426)
T KOG0589|consen 31 LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILK 110 (426)
T ss_pred eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHH
Confidence 59999999999999999999999999999999999999999999998899999999999999999998889999999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.|++.|+.|||+++|+|||||+.|||++.++.|||+|||+|+.+.... ...+++|||.||+||++.+.+|+.++|||
T Consensus 111 ~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiW 190 (426)
T KOG0589|consen 111 WFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIW 190 (426)
T ss_pred HHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcch
Confidence 99999999999999999999999999999999999999999999998877 88999999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhhhc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHL 239 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~~~ 239 (582)
|||||+|||++.+++|++.+...++.+|......|+|..++.+++.||+.||..+|+.||++.++|.+|.++.++.....
T Consensus 191 sLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~~~~~~ 270 (426)
T KOG0589|consen 191 SLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYLVESQE 270 (426)
T ss_pred hhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHHHhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998866655
Q ss_pred ccCCCCCCCC
Q 007991 240 KLNGPRRNTF 249 (582)
Q Consensus 240 ~~~~p~~~~~ 249 (582)
........+.
T Consensus 271 ~~~~~~~~~~ 280 (426)
T KOG0589|consen 271 LETSIELPTL 280 (426)
T ss_pred cccccccCCC
Confidence 4444333333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=407.70 Aligned_cols=230 Identities=33% Similarity=0.621 Sum_probs=214.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||+|+|.. ...+..++++.+|+++++.++|||||.+|++|..++..++|+|||++||+|.++++..+ .++|..+..
T Consensus 106 i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ 182 (364)
T KOG0581|consen 106 IYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGK 182 (364)
T ss_pred EEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHH
Confidence 489999954 45577889999999999999999999999999877656999999999999999999864 699999999
Q ss_pred HHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.++|.||.|||+ ++||||||||+||||+..|.|||||||.++.+.+. ...+++||..|||||.+.+..|+.++|||
T Consensus 183 ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIW 261 (364)
T KOG0581|consen 183 IARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIW 261 (364)
T ss_pred HHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCccccee
Confidence 99999999999996 89999999999999999999999999999998777 78999999999999999999999999999
Q ss_pred chhHHHHhHhcCCcccccc-----CHHHHHHHHhhccCCCCCcc-ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 160 SLGCCVYEMSAQKAAFKAF-----DMQALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~-----~~~~l~~kI~~~~~~~lp~~-~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||++|+||++|+.||... +..+++..|..+..+.+|.. +|++|++||..||++||.+|+++.|+|+|||++.+
T Consensus 262 SLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 262 SLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred cccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 9999999999999999774 78899999999888888987 99999999999999999999999999999999865
Q ss_pred h
Q 007991 234 V 234 (582)
Q Consensus 234 ~ 234 (582)
.
T Consensus 342 ~ 342 (364)
T KOG0581|consen 342 E 342 (364)
T ss_pred c
Confidence 4
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=404.98 Aligned_cols=259 Identities=31% Similarity=0.528 Sum_probs=230.9
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|+++.+....+ ..+.+..|..||.+++||+||.++..|+.. ..+|+|+||+.||.|..+|++.+ .|+|..++
T Consensus 52 iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-~kLylVld~~~GGeLf~hL~~eg--~F~E~~ar 128 (357)
T KOG0598|consen 52 IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-EKLYLVLDYLNGGELFYHLQREG--RFSEDRAR 128 (357)
T ss_pred eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-CeEEEEEeccCCccHHHHHHhcC--CcchhHHH
Confidence 589999988776665 567889999999999999999999999765 59999999999999999999865 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.|+.+|+.||.|||++|||||||||+|||||.+|||+|+|||+++... .+....++|||+.|||||++.+.+|+..+|+
T Consensus 129 fYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDW 208 (357)
T KOG0598|consen 129 FYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDW 208 (357)
T ss_pred HHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccch
Confidence 999999999999999999999999999999999999999999999654 4456778899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC----CHHHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP----SAAELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp----Sa~EiL~hp~f~~~~ 234 (582)
||||+++|||++|.+||.+.+...++++|........+..++.++++||+++|.+||++|. .+++|-+||||..+.
T Consensus 209 WsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 209 WSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 9999999999999999999999999999999887777888999999999999999999995 799999999999877
Q ss_pred hhhhc--ccCCCCCCCCCCCCCCccccccc
Q 007991 235 LGIHL--KLNGPRRNTFPLEWSDSNFKKTR 262 (582)
Q Consensus 235 ~~~~~--~~~~p~~~~~~~~~~~s~~~~~~ 262 (582)
|.... .+.+|..+......+.++|+...
T Consensus 289 W~~l~~k~l~PpF~P~~~~~~~~~~Fd~ef 318 (357)
T KOG0598|consen 289 WEKLLAKKLSPPFKPNVTGLEDTSNFDNEF 318 (357)
T ss_pred HHHHHhcCCCCCeecCCCCccccccccHHH
Confidence 76553 44556666666666666665543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=416.85 Aligned_cols=227 Identities=31% Similarity=0.590 Sum_probs=211.2
Q ss_pred CEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|.+.... .....++.+.+||+|.++|+|||||++++.| ++..++|||.|+|..++|.++++++. .++|..++
T Consensus 45 ~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-EDs~nVYivLELC~~~sL~el~Krrk--~ltEpEar 121 (592)
T KOG0575|consen 45 VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-EDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEAR 121 (592)
T ss_pred EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-ecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHH
Confidence 48999997644 4567889999999999999999999999966 55679999999999999999999654 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.|++||+.||.|||+++|||||||..|+||+++-+|||+|||||..+..+ ....+.||||.|+|||++....++..+||
T Consensus 122 y~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDi 201 (592)
T KOG0575|consen 122 YFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDI 201 (592)
T ss_pred HHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhh
Confidence 99999999999999999999999999999999999999999999988755 67789999999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
||+|||||.|+.|+|||+..+..+.+.+|....+. +|..+|.++++||.+||+.||.+|||+++||.|+||.
T Consensus 202 WSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~-~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 202 WSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS-MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred hhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 99999999999999999999999999999776654 7889999999999999999999999999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=399.28 Aligned_cols=241 Identities=31% Similarity=0.518 Sum_probs=214.1
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++.......+ -.+-+.+|-.+|.+| +||.||+||..|.++ ..+|+|+||+++|+|.++|++.+ .|+|..+
T Consensus 100 eYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-~sLYFvLe~A~nGdll~~i~K~G--sfde~ca 176 (604)
T KOG0592|consen 100 EYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-ESLYFVLEYAPNGDLLDLIKKYG--SFDETCA 176 (604)
T ss_pred eeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-cceEEEEEecCCCcHHHHHHHhC--cchHHHH
Confidence 489998866554333 235678999999999 899999999998765 48999999999999999999976 7999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--------------cCcccCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--------------ASSVVGTPSYMCP 144 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--------------~~~~vGTp~Y~AP 144 (582)
+.|+.||+.||+|||++|||||||||+|||||.|+++||+|||.|+.+..... ..+++||-.|++|
T Consensus 177 R~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP 256 (604)
T KOG0592|consen 177 RFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSP 256 (604)
T ss_pred HHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCH
Confidence 99999999999999999999999999999999999999999999998753211 1469999999999
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
|+|.+...+..+|||+||||||.|+.|++||.+.+..-++++|....+ .+|..+++.+++||+++|..||.+|+|+++|
T Consensus 257 ElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 257 ELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred HHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence 999999999999999999999999999999999999999999987655 4889999999999999999999999999999
Q ss_pred HcCCCCchhhhhhhcccCCCC
Q 007991 225 LCHPHLQPYVLGIHLKLNGPR 245 (582)
Q Consensus 225 L~hp~f~~~~~~~~~~~~~p~ 245 (582)
.+||||....|.......+|.
T Consensus 336 k~HpFF~~Vdw~nlw~~~PP~ 356 (604)
T KOG0592|consen 336 KAHPFFEGVDWENLWQQTPPK 356 (604)
T ss_pred hhCcccccCChhhhhhcCCCc
Confidence 999999987777655544443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=403.35 Aligned_cols=230 Identities=26% Similarity=0.554 Sum_probs=214.7
Q ss_pred CEEEEEeccc-ccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~-~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+.|||.|... ...+.....+.+||.||+.|.|||++++|++|.+ +.++|+|.||++||.|++++.+++ .++|.++.
T Consensus 39 laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa 115 (786)
T KOG0588|consen 39 LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVLEYVPGGELFDYLVRKG--PLPEREAA 115 (786)
T ss_pred eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEEEecCCchhHHHHHhhC--CCCCHHHH
Confidence 4699999876 4555566779999999999999999999999865 569999999999999999999876 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDI 158 (582)
+|++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|.....+.+..+.||.|.|+|||++.+++| +.++||
T Consensus 116 ~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDV 195 (786)
T KOG0588|consen 116 HFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDV 195 (786)
T ss_pred HHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCcccc
Confidence 9999999999999999999999999999999999999999999999888889999999999999999999998 568999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||.|||||.|++|++||.+.+...++.+++.+.. .+|..+|.++++||.+||..||.+|+|.+||++|||+..+.
T Consensus 196 WSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 196 WSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred chhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999999999988765 48999999999999999999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=371.60 Aligned_cols=252 Identities=25% Similarity=0.476 Sum_probs=219.5
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.+....... ++.+-...|..+|+.+.||+++.+++.|.+. .++|+||||++||.|..++++.+ .|+|..++.
T Consensus 72 YAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arF 148 (355)
T KOG0616|consen 72 YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-SNLYMVMEYVPGGELFSYLRKSG--RFSEPHARF 148 (355)
T ss_pred eehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-CeEEEEEeccCCccHHHHHHhcC--CCCchhHHH
Confidence 8999997765433 5677889999999999999999999988764 59999999999999999999865 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
|+.||+.||+|||+.+|++|||||+|||||++|++||+|||+|+.+... ..+.||||.|+|||++...+|+.++|+||
T Consensus 149 YAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWa 226 (355)
T KOG0616|consen 149 YAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWA 226 (355)
T ss_pred HHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHH
Confidence 9999999999999999999999999999999999999999999987544 77899999999999999999999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCC-----CCHHHHHcCCCCchhhh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHPHLQPYVL 235 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~R-----pSa~EiL~hp~f~~~~~ 235 (582)
|||++|||++|.+||.+.+...++++|..+... +|..++.++++||+++|+.|-.+| ...++|..||||+...|
T Consensus 227 lGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 227 LGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred HHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc-CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 999999999999999999999999999887764 789999999999999999999999 35789999999997655
Q ss_pred hhh--cccCCCCCC-CCCCCCCCcccc
Q 007991 236 GIH--LKLNGPRRN-TFPLEWSDSNFK 259 (582)
Q Consensus 236 ~~~--~~~~~p~~~-~~~~~~~~s~~~ 259 (582)
.-. ..+..|..+ ......+.++|+
T Consensus 306 ~~i~~r~ie~P~~pp~~~~~gdtsnfd 332 (355)
T KOG0616|consen 306 EAILQRKIEPPFEPPNIHGPGDTSNFD 332 (355)
T ss_pred HHHhhccccCCCCCccccCCccccccc
Confidence 432 233444333 333334445543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=376.12 Aligned_cols=228 Identities=38% Similarity=0.672 Sum_probs=208.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeee-EEEecCcEEEEEEeecCCCCHHHHHHH--hCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKD-SWVEKGCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~-~~~~~~~~l~LVmEy~~GgsL~d~Ikk--~~~~~lse~~ 77 (582)
++|.|++.-...+...+..+..|+.+|++|+|||||++++ .|.+++.-++||||||++|+|.+.|+. ..+..++|..
T Consensus 46 l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~ 125 (375)
T KOG0591|consen 46 LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKT 125 (375)
T ss_pred hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHH
Confidence 4788999877788889999999999999999999999999 666666669999999999999999975 3456799999
Q ss_pred HHHHHHHHHHHHHHHHH--CC--ceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCC
Q 007991 78 LCKWLVQLLMALNYLHA--NH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs--~g--IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y 152 (582)
+++++.||+.||.+||. .. |+||||||.||+|+.+|.|||+|||+++.+.+.. ...+++|||.||+||.+.+.+|
T Consensus 126 Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y 205 (375)
T KOG0591|consen 126 VWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGY 205 (375)
T ss_pred HHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCC
Confidence 99999999999999999 44 9999999999999999999999999999987654 5678999999999999999999
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+.++||||+||++|||+...+||.+.+...+..+|..+..+++| ..+|.++..||..|+..||+.||+. +|+++
T Consensus 206 ~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~ 280 (375)
T KOG0591|consen 206 NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQ 280 (375)
T ss_pred CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHH
Confidence 99999999999999999999999999999999999999988899 8899999999999999999999986 45554
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
..
T Consensus 281 di 282 (375)
T KOG0591|consen 281 DI 282 (375)
T ss_pred HH
Confidence 43
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.86 Aligned_cols=228 Identities=31% Similarity=0.599 Sum_probs=211.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.|.....+.+.++.+..||.+|+.|+|||||++++++ +.++++|+|||||+||+|.++|++++ .++|..++.+
T Consensus 38 VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~F 114 (429)
T KOG0595|consen 38 VAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-EDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHF 114 (429)
T ss_pred EEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-ecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence 89999999998999999999999999999999999999965 45569999999999999999999876 7999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCC------CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRD------QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~------g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
+.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+....+..+.||+|.|||||++....|+.|
T Consensus 115 m~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAK 194 (429)
T KOG0595|consen 115 MQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAK 194 (429)
T ss_pred HHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccch
Confidence 9999999999999999999999999999875 3489999999999999999999999999999999999999999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc--CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~--~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+|+||+|+++|+|++|++||......++...+.+.. ...++..++....+|+...|+.++..|.+..+-+.|+++..
T Consensus 195 ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 195 ADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 999999999999999999999999999988876543 45567778999999999999999999999999999988753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=372.39 Aligned_cols=233 Identities=26% Similarity=0.480 Sum_probs=206.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||||++.-...++..++.+.|||++|++|+|+|+|.++++|... ..+++|+|||+ .++.+.+.+... .++++.++.
T Consensus 29 IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-rklhLVFE~~d-hTvL~eLe~~p~-G~~~~~vk~ 105 (396)
T KOG0593|consen 29 IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-RKLHLVFEYCD-HTVLHELERYPN-GVPSELVKK 105 (396)
T ss_pred EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-ceeEEEeeecc-hHHHHHHHhccC-CCCHHHHHH
Confidence 589999988888889999999999999999999999999998755 58999999996 566666666543 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+. ..+..+.++.|+||+|||++.+ .+|+..+||
T Consensus 106 ~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDi 185 (396)
T KOG0593|consen 106 YLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDI 185 (396)
T ss_pred HHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccc
Confidence 99999999999999999999999999999999999999999999987 6778889999999999999877 789999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC------------------------------ccccHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP------------------------------TVYSGAFRGLVK 208 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp------------------------------~~~S~~l~~LI~ 208 (582)
||+||++.||++|.+.|.+.+..++...|......-+| ..++..+.+|++
T Consensus 186 WAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k 265 (396)
T KOG0593|consen 186 WAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLK 265 (396)
T ss_pred hhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHH
Confidence 99999999999999999999888877777653322111 124567889999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCchhhhh
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
+||.+||.+|++.+++|.|+||+.|...
T Consensus 266 ~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 266 KCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred HHhcCCccccccHHHHhcChHHHHHHHH
Confidence 9999999999999999999999887655
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=387.19 Aligned_cols=229 Identities=29% Similarity=0.554 Sum_probs=206.4
Q ss_pred CEEEEEecccccC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQT---DRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~---~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.+...... ....+.+.+|+.+|+++. ||||+++++++.... .+|+|||||.||+|.+.|...+ .+.|.
T Consensus 44 ~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-~~~ivmEy~~gGdL~~~i~~~g--~l~E~ 120 (370)
T KOG0583|consen 44 KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-KIYIVMEYCSGGDLFDYIVNKG--RLKED 120 (370)
T ss_pred eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-eEEEEEEecCCccHHHHHHHcC--CCChH
Confidence 3899977665222 234567789999999999 999999999887655 6999999999999999999844 79999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhc-ccccccCcccCCCCCCCcccccCCC-CC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIP-YG 153 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~-~~~~~~~~~vGTp~Y~APE~l~~~~-y~ 153 (582)
.++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++... ..+....+.|||+.|+|||++.+.. |.
T Consensus 121 ~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~ 200 (370)
T KOG0583|consen 121 EARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYS 200 (370)
T ss_pred HHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcC
Confidence 999999999999999999999999999999999999 99999999999988 5677889999999999999999988 85
Q ss_pred -CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccc-cHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 154 -SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY-SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 154 -~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~-S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.++||||+||+||.|++|..||.+.+...++.+|..... .+|..+ |.+++.||.+||..||.+|+++.+|+.||||+
T Consensus 201 g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~ 279 (370)
T KOG0583|consen 201 GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQ 279 (370)
T ss_pred CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence 789999999999999999999999999999999766654 477777 99999999999999999999999999999998
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
..
T Consensus 280 ~~ 281 (370)
T KOG0583|consen 280 KE 281 (370)
T ss_pred cC
Confidence 63
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=387.25 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=225.1
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|+++....-. ...+-+..|-.||...++|+||++|.+|++. .++||||||++||++..+|.+.+ .|+|+.++
T Consensus 168 iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-~~LYLiMEylPGGD~mTLL~~~~--~L~e~~ar 244 (550)
T KOG0605|consen 168 IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-EYLYLIMEYLPGGDMMTLLMRKD--TLTEDWAR 244 (550)
T ss_pred EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-CeeEEEEEecCCccHHHHHHhcC--cCchHHHH
Confidence 58999998866533 3567788999999999999999999999765 59999999999999999999866 89999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc----------------------c-------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----------------------D------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~----------------------~------- 130 (582)
.|+.+++.||+-||+.|+|||||||+|+|||..||+||+||||+.-+... +
T Consensus 245 fYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (550)
T KOG0605|consen 245 FYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTP 324 (550)
T ss_pred HHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccc
Confidence 99999999999999999999999999999999999999999998543210 0
Q ss_pred -------------------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh--
Q 007991 131 -------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-- 189 (582)
Q Consensus 131 -------------------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~-- 189 (582)
...+.+|||.|||||++.+..|+..+|+|||||||||||.|.+||.+.+..+.+.+|..
T Consensus 325 ~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 325 RSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred cchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 11135899999999999999999999999999999999999999999999999998854
Q ss_pred -ccCCCCCccccHHHHHHHHHhccCCCCCCC---CHHHHHcCCCCchhhhhhhcccCCCCCCCCCCCCCCccccc
Q 007991 190 -SIVAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 190 -~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp---Sa~EiL~hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~~~ 260 (582)
....|-...+++++++||.+||. ||++|. +++||.+||||+...|.......+|..+....+.+.++|++
T Consensus 405 ~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFdd 478 (550)
T KOG0605|consen 405 ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDD 478 (550)
T ss_pred hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCccccccccc
Confidence 33445556689999999999999 999995 69999999999999888877777888888888888888875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=388.80 Aligned_cols=225 Identities=30% Similarity=0.533 Sum_probs=204.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++.+..+..+ +.+..|+.+|+..+|+|||.+++.|... ..+|+||||++||+|.+.+... .++|.++..
T Consensus 300 ~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~ 373 (550)
T KOG0578|consen 300 EVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEYMEGGSLTDVVTKT---RMTEGQIAA 373 (550)
T ss_pred eEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEeecCCCchhhhhhcc---cccHHHHHH
Confidence 389999999877554 7799999999999999999999999877 4899999999999999999875 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+++++|.||+|||.+||||||||.+|||++.+|.|||+|||+|..+.... ...+.+|||.|||||+.....|+.++|||
T Consensus 374 Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIW 453 (550)
T KOG0578|consen 374 ICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIW 453 (550)
T ss_pred HHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccch
Confidence 99999999999999999999999999999999999999999998876554 67889999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
|||+|++||+.|.+||-..+.-.-+..|...... ..+..+|..+++||.+||+.|+++|++|.|||+||||+
T Consensus 454 SLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 454 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred hhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 9999999999999999877766555556444333 34678999999999999999999999999999999994
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=394.72 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=231.0
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
+||||.++.... .+...+....|..|+.... ||++++++..|+.. .++|+||||+.||+|..+++.. .|+|..+
T Consensus 395 ~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-~~l~fvmey~~Ggdm~~~~~~~---~F~e~ra 470 (694)
T KOG0694|consen 395 YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-EHLFFVMEYVAGGDLMHHIHTD---VFSEPRA 470 (694)
T ss_pred EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-CeEEEEEEecCCCcEEEEEecc---cccHHHH
Confidence 499999987553 4456788999999999886 99999999988765 5999999999999976666542 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.+|+.||+|||++||||||||.+|||||.+|++||+||||++... .+....++||||.|||||++.+..|+.++|
T Consensus 471 rfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVD 550 (694)
T KOG0694|consen 471 RFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVD 550 (694)
T ss_pred HHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhh
Confidence 9999999999999999999999999999999999999999999999865 667889999999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~ 232 (582)
+|+|||+||||+.|..||.+.+.+++++.|..... ..|..+|.++.++++++|.+||++|.. +++|..||||+.
T Consensus 551 WW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 551 WWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999999999999999999999999999976544 478889999999999999999999953 799999999998
Q ss_pred hhhhhh--cccCCCCCCCCCCCCCCcccccccCCCc
Q 007991 233 YVLGIH--LKLNGPRRNTFPLEWSDSNFKKTRFMEP 266 (582)
Q Consensus 233 ~~~~~~--~~~~~p~~~~~~~~~~~s~~~~~~~~~~ 266 (582)
+.|... ..+.+|.++++...-+.++|++....+.
T Consensus 630 i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~ 665 (694)
T KOG0694|consen 630 IDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEK 665 (694)
T ss_pred CCHHHHhhccCCCCCCcccCChhhhcccchhhhcCC
Confidence 776554 3456778888888888888888766554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=371.28 Aligned_cols=229 Identities=35% Similarity=0.614 Sum_probs=197.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCc-EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~-~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.+|||.+....... .+.+.+|+.+|.+|+|||||++++....... .++|+|||+.||+|.+++++.++ .++|..++
T Consensus 44 ~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~ 120 (313)
T KOG0198|consen 44 LMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVR 120 (313)
T ss_pred ceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHH
Confidence 36899998873322 6789999999999999999999997444444 79999999999999999999877 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcC-CCCeEEeecccchhccc----ccccCcccCCCCCCCcccccCCC-CC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLIS----DDLASSVVGTPSYMCPELLADIP-YG 153 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~----~~~~~~~vGTp~Y~APE~l~~~~-y~ 153 (582)
.+.+|||.||.|||++|||||||||+||||+. ++.+||+|||+++.... ........||+.|||||++.... ..
T Consensus 121 ~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~ 200 (313)
T KOG0198|consen 121 RYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVAR 200 (313)
T ss_pred HHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCC
Confidence 99999999999999999999999999999999 79999999999987663 22345689999999999998633 33
Q ss_pred CCCcccchhHHHHhHhcCCccccc-cCHHHHHHHHh-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKIN-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~-~~~~~l~~kI~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.++|||||||++.||+||++||.. ......+..+. ....+.+|..+|.++++||.+||.+||++||||+++|.|||++
T Consensus 201 ~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 201 RESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 599999999999999999999998 44444444443 3345678899999999999999999999999999999999996
Q ss_pred h
Q 007991 232 P 232 (582)
Q Consensus 232 ~ 232 (582)
.
T Consensus 281 ~ 281 (313)
T KOG0198|consen 281 Q 281 (313)
T ss_pred c
Confidence 5
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=370.84 Aligned_cols=232 Identities=30% Similarity=0.448 Sum_probs=206.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++...+.+.-..++..||+++|+.++|+||+.+++++.. .-..+|+|+|++ +.+|.+.|+... .++++.
T Consensus 50 VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H 126 (359)
T KOG0660|consen 50 VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDH 126 (359)
T ss_pred eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHH
Confidence 8999999888988899999999999999999999999999875 345799999999 699999999753 599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc---ccccCcccCCCCCCCccccc-CCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPELLA-DIPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~---~~~~~~~vGTp~Y~APE~l~-~~~y~ 153 (582)
++.+++|||.||+|+|+.||+||||||.|+|++.++.+||+|||+|+.... ...++.++.|.||.|||++. ...|+
T Consensus 127 ~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt 206 (359)
T KOG0660|consen 127 AQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYT 206 (359)
T ss_pred HHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcccccc
Confidence 999999999999999999999999999999999999999999999998853 55677899999999999875 56799
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAF 203 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l 203 (582)
.++||||+|||++||++|++.|.|.+...+++.|....+.| +-...++.+
T Consensus 207 ~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~A 286 (359)
T KOG0660|consen 207 KAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLA 286 (359)
T ss_pred chhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHH
Confidence 99999999999999999999999999877777776544433 112467889
Q ss_pred HHHHHHhccCCCCCCCCHHHHHcCCCCchhhhh
Q 007991 204 RGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 204 ~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
.+|+.+||.+||.+|+|++|+|.||||.+|...
T Consensus 287 idLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 287 IDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 999999999999999999999999999987643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=381.54 Aligned_cols=229 Identities=24% Similarity=0.398 Sum_probs=205.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...-.-+. -.-.||++.|++|+ |||||++++++.+.+..+|+||||+ ..+|.++++.+ +..|+|..++
T Consensus 37 ~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~ir 113 (538)
T KOG0661|consen 37 LVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIR 113 (538)
T ss_pred eeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHH
Confidence 3788888775544221 23368999999999 9999999999998877999999999 59999999997 6789999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
.|++||+.||+|+|.+|+.||||||+|||+.....|||+|||+|+.+.+....+.++.|+||+|||++.. .-|+.++||
T Consensus 114 nim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~ 193 (538)
T KOG0661|consen 114 NIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDM 193 (538)
T ss_pred HHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHH
Confidence 9999999999999999999999999999999888999999999999999999999999999999998764 568999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-----------------------------CccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-----------------------------PTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-----------------------------p~~~S~~l~~LI~k 209 (582)
||+|||++|+++.++.|.|.+..+++.+|+..++.|. -..++.++.+||..
T Consensus 194 wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ 273 (538)
T KOG0661|consen 194 WAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIER 273 (538)
T ss_pred HHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHH
Confidence 9999999999999999999999999999987665541 11267889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCch
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||..||++||||+|+|+||||+.
T Consensus 274 ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 274 LLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HhcCCCccCccHHHHhcCccccc
Confidence 99999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=377.93 Aligned_cols=229 Identities=28% Similarity=0.489 Sum_probs=205.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|+++.....+.....+.|||.||++|+|||||+|.++.++. .+.+|+|+||++ .+|.-++.. ++.+|++.+++
T Consensus 144 ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~-p~vkft~~qIK 221 (560)
T KOG0600|consen 144 IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSS-PGVKFTEPQIK 221 (560)
T ss_pred EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcC-CCcccChHHHH
Confidence 699999999998888888999999999999999999999998877 569999999995 788888876 67889999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC-CCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI-PYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~-~y~~ks 156 (582)
.||.||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++.... ..+..+.|.||+|||++.+. .|+.++
T Consensus 222 c~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aV 301 (560)
T KOG0600|consen 222 CYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAV 301 (560)
T ss_pred HHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccce
Confidence 999999999999999999999999999999999999999999999765443 56788999999999998875 599999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---------CC-------------------ccccHHHHHHHH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------LP-------------------TVYSGAFRGLVK 208 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---------lp-------------------~~~S~~l~~LI~ 208 (582)
|+||+||||.||+.|++.|.+.+..+++.+|-+....| +| ..++..+.+|+.
T Consensus 302 DlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~ 381 (560)
T KOG0600|consen 302 DLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLE 381 (560)
T ss_pred eehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHH
Confidence 99999999999999999999999999888886544332 11 125677889999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCc
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.||..||.+|.||.++|+++||.
T Consensus 382 ~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 382 KLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred HHhccCccccccHHHHhcCcccc
Confidence 99999999999999999999994
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=349.87 Aligned_cols=228 Identities=29% Similarity=0.484 Sum_probs=206.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.|+.+....+.-+.+.+|+.|-+.|+|||||++++.+.+. .+.|+|+|+++|++|...|-++. .++|..+-.+
T Consensus 39 fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~ 115 (355)
T KOG0033|consen 39 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVARE--FYSEADASHC 115 (355)
T ss_pred HHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHH
Confidence 45677766666666678899999999999999999999988665 59999999999999998777653 7899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
++|||.+|.|+|.+||||||+||+|+|+.... -+||+|||+|..+........++|||.|||||++...+|+..+||
T Consensus 116 ~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDi 195 (355)
T KOG0033|consen 116 IQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDI 195 (355)
T ss_pred HHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchh
Confidence 99999999999999999999999999997654 399999999999987777888999999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccC---CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~---~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|+.|++||-|+.|.+||.+.+...+++.|..+.+ .+.+..+++++++||++||..||.+|+|+.|+|+|||+++
T Consensus 196 W~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 196 WACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred hhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 9999999999999999999999999999987653 3456779999999999999999999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=356.76 Aligned_cols=232 Identities=28% Similarity=0.506 Sum_probs=201.8
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .......+.+|+.+|++++||||++++++|... ..+|+||||+.|++|.+++.... .+++..++
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 98 (323)
T cd05571 22 YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRER--VFSEDRAR 98 (323)
T ss_pred EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 389999976443 233446678999999999999999999987654 58999999999999999998744 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||+.|+|||++.+..|+.++||
T Consensus 99 ~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 178 (323)
T cd05571 99 FYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178 (323)
T ss_pred HHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccC
Confidence 9999999999999999999999999999999999999999999876432 233456789999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~ 233 (582)
|||||++|||++|..||.+.+...+...+.... ..++..++.++.+||.+||+.||++|+ ++.++++||||+..
T Consensus 179 wSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999999988887777765543 346778999999999999999999999 89999999999875
Q ss_pred hhh
Q 007991 234 VLG 236 (582)
Q Consensus 234 ~~~ 236 (582)
.+.
T Consensus 258 ~~~ 260 (323)
T cd05571 258 NWQ 260 (323)
T ss_pred CHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=358.49 Aligned_cols=238 Identities=29% Similarity=0.478 Sum_probs=207.6
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|++....... .-..+++.|-+||+.++||+++.||..|.. +.+.|+|||||.||+|..++++..+..|+++.++
T Consensus 104 ~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aR 182 (459)
T KOG0610|consen 104 LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAAR 182 (459)
T ss_pred eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEEEEecCCCccHHHHHhhCCCCccchhhHH
Confidence 48999998766543 334678889999999999999999998865 4699999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-------------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS------------------------------- 128 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~------------------------------- 128 (582)
.|+.+++.||+|||-.|||+|||||+||||.++|||.|.||.|+.....
T Consensus 183 FYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~ 262 (459)
T KOG0610|consen 183 FYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRC 262 (459)
T ss_pred HHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccch
Confidence 9999999999999999999999999999999999999999998743210
Q ss_pred ----c----------------------cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHH
Q 007991 129 ----D----------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA 182 (582)
Q Consensus 129 ----~----------------------~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~ 182 (582)
. ....+++||-.|+|||++.+...+.++|||+|||++|||+.|..||++.+..+
T Consensus 263 ~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 263 LSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred hccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 0 01124789999999999999999999999999999999999999999999988
Q ss_pred HHHHHhhccC-CCCCccccHHHHHHHHHhccCCCCCCCC----HHHHHcCCCCchhhhhhhc
Q 007991 183 LINKINKSIV-APLPTVYSGAFRGLVKSMLRKNPEFRPS----AAELLCHPHLQPYVLGIHL 239 (582)
Q Consensus 183 l~~kI~~~~~-~~lp~~~S~~l~~LI~kmL~~dP~~RpS----a~EiL~hp~f~~~~~~~~~ 239 (582)
.+.+|..... .+-...++..++|||+++|.+||.+|.. |.||-+||||++..|.+..
T Consensus 343 Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir 404 (459)
T KOG0610|consen 343 TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIR 404 (459)
T ss_pred hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhee
Confidence 8888765443 3333468899999999999999999988 9999999999998777443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=365.34 Aligned_cols=232 Identities=32% Similarity=0.582 Sum_probs=211.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+.....+++..+.+.+|++|++.|+|||||.++++|. ...++|+|+|||.| +|..++...+ .++|+.++.
T Consensus 29 ~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-t~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~ 104 (808)
T KOG0597|consen 29 VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-TSAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRA 104 (808)
T ss_pred EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-ccceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHH
Confidence 3899999988888888899999999999999999999999774 55699999999976 9999999865 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+++|++.||.|||+++|+|||+||.||||+..|.+|+||||+|+...... ......|||.|||||++.+.+|+..+|+|
T Consensus 105 ~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlW 184 (808)
T KOG0597|consen 105 IAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLW 184 (808)
T ss_pred HHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHH
Confidence 99999999999999999999999999999999999999999999876544 45567899999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~ 237 (582)
||||++|||+.|++||...+...+...|...... +|...+..|.+||+.+|.+||..|.+..+++.|||.++-+...
T Consensus 185 slGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~ 261 (808)
T KOG0597|consen 185 SLGCILYELYVGQPPFYARSITQLVKSILKDPVK-PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIA 261 (808)
T ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhh
Confidence 9999999999999999999999999988776554 5668999999999999999999999999999999998755433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.04 Aligned_cols=228 Identities=29% Similarity=0.499 Sum_probs=202.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+|+.....+.....+.|||++|+.++|+||+.++++|-..+ .+.||+||++ .+|...|+.+ ...++...++.|
T Consensus 30 VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y 106 (318)
T KOG0659|consen 30 VAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLVFEFMP-TDLEVVIKDK-NIILSPADIKSY 106 (318)
T ss_pred EEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEEEEecc-ccHHHHhccc-ccccCHHHHHHH
Confidence 899999998877777788999999999999999999999987654 7889999995 8999999975 457999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc-CcccCCCCCCCcccccC-CCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLAD-IPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~-~~~vGTp~Y~APE~l~~-~~y~~ksDIW 159 (582)
+.|++.||+|||++.|+||||||.|+||+.+|.+||+|||+++.+...... ...+.|.||+|||++.+ +.|+..+|||
T Consensus 107 ~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmW 186 (318)
T KOG0659|consen 107 MLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMW 186 (318)
T ss_pred HHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhh
Confidence 999999999999999999999999999999999999999999998765433 33489999999998876 4599999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc---------------------------ccHHHHHHHHHhcc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV---------------------------YSGAFRGLVKSMLR 212 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~---------------------------~S~~l~~LI~kmL~ 212 (582)
|+||++.||+.|.+.|.+.+.-+++..|-..+..|-+.. .+.++.+|+.+||.
T Consensus 187 avGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ 266 (318)
T KOG0659|consen 187 AVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLT 266 (318)
T ss_pred hHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhc
Confidence 999999999999999999999888888876655443222 35678899999999
Q ss_pred CCCCCCCCHHHHHcCCCCch
Q 007991 213 KNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 213 ~dP~~RpSa~EiL~hp~f~~ 232 (582)
+||.+|+++.|+|+|+||..
T Consensus 267 ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 267 YNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cCchhcccHHHHhcchhhhc
Confidence 99999999999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.35 Aligned_cols=228 Identities=29% Similarity=0.493 Sum_probs=199.4
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.... .......+.+|+.+|++++||||++++++|.. +..+|+|||||.||+|.+++...+ .+++..+..
T Consensus 21 ~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~ 97 (312)
T cd05585 21 YALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGELFHHLQREG--RFDLSRARF 97 (312)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 79999876432 33445678899999999999999999998765 458999999999999999998754 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..|+.++|||
T Consensus 98 ~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 177 (312)
T cd05585 98 YTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177 (312)
T ss_pred HHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCcccee
Confidence 999999999999999999999999999999999999999999976432 2334567899999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC---CHHHHHcCCCCchh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPY 233 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp---Sa~EiL~hp~f~~~ 233 (582)
||||++|+|++|..||.+.+.......+.... ..++..++..+++||.+||..||.+|+ ++.++|.||||...
T Consensus 178 slGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred chhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999988888777765543 346778999999999999999999997 58999999999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.13 Aligned_cols=226 Identities=27% Similarity=0.536 Sum_probs=206.4
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.|+.....++ ..-.+.|||+||..|+||||+.+|++|... ..+.|||||..||.|.++|.+.+ .++|..++
T Consensus 80 ~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-dKIvivMEYaS~GeLYDYiSer~--~LsErEaR 156 (668)
T KOG0611|consen 80 EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-DKIVIVMEYASGGELYDYISERG--SLSEREAR 156 (668)
T ss_pred EeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-ceEEEEEEecCCccHHHHHHHhc--cccHHHHH
Confidence 489999988766554 345678999999999999999999998654 58999999999999999999876 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDI 158 (582)
.|++||+.|+.|||.++++|||||.+|||+|.++++||+|||++..+.......++||+|-|.+||+.++.+| ++.+|-
T Consensus 157 hfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDs 236 (668)
T KOG0611|consen 157 HFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDS 236 (668)
T ss_pred HHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccch
Confidence 9999999999999999999999999999999999999999999999988888999999999999999999998 578999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
||||++||.|+.|..||++.+...++.+|..+.+... .-+..+..||+.||..||++|.|+++|-.|=|+.
T Consensus 237 WsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP--~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 237 WSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP--ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC--CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999999999999999999999988766532 2456788999999999999999999999998774
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=350.28 Aligned_cols=227 Identities=26% Similarity=0.479 Sum_probs=199.9
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.... .....+.+.+|+.+|++++||||+++++++..+ ..+|+|||||.|++|.+++...+ .+++..++.
T Consensus 46 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 122 (329)
T PTZ00263 46 YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKF 122 (329)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHH
Confidence 78999876432 223456789999999999999999999988654 58999999999999999998754 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ....+||+.|+|||++.+..++.++||||
T Consensus 123 ~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diws 200 (329)
T PTZ00263 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWT 200 (329)
T ss_pred HHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeec
Confidence 9999999999999999999999999999999999999999999766432 33568999999999999999999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
|||++|+|++|..||.+.+....+..+.... ..++..++..+++||.+||+.||.+|++ +++++.||||....
T Consensus 201 lG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 201 MGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred hHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 9999999999999999988888777776543 3467779999999999999999999986 79999999998643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=353.58 Aligned_cols=228 Identities=24% Similarity=0.502 Sum_probs=200.7
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++..... .....+.+.+|+.+|+.++|||||++++++... ..+|+|||||.||+|.+++.... .+++..++.
T Consensus 59 vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~ 135 (340)
T PTZ00426 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCF 135 (340)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 78888865432 234456788999999999999999999988655 58999999999999999998754 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....+||+.|+|||++.+..++.++||||
T Consensus 136 ~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 213 (340)
T PTZ00426 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWT 213 (340)
T ss_pred HHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccc
Confidence 9999999999999999999999999999999999999999999765432 34678999999999999988999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchhhh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYVL 235 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~~~ 235 (582)
|||++|+|++|.+||.+.+....+..+..... .++..++..++++|++||+.||.+|+ +++++++||||+.+.+
T Consensus 214 lGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 214 LGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred hhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999999999999888877777766543 46778899999999999999999995 8999999999987544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.47 Aligned_cols=230 Identities=24% Similarity=0.425 Sum_probs=200.8
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .....+.+.+|+.+|++++||||+++++++.+ +.++|+||||+.|++|.+++...+ .+++..+.
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 104 (291)
T cd05612 28 YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGL 104 (291)
T ss_pred EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 379999876433 22455678999999999999999999987765 458999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ....+||+.|+|||++.+..++.++|||
T Consensus 105 ~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diw 182 (291)
T cd05612 105 FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWW 182 (291)
T ss_pred HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHH
Confidence 99999999999999999999999999999999999999999999876432 3356899999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
||||++|+|++|..||.+.+...++..+.... ..++..++..+++||++||+.||.+|++ ++++++||||+...
T Consensus 183 SlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 99999999999999999988888777776543 3466778999999999999999999995 99999999998654
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 262 ~~ 263 (291)
T cd05612 262 WD 263 (291)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=341.27 Aligned_cols=235 Identities=25% Similarity=0.457 Sum_probs=207.8
Q ss_pred EEEEEeccccc------CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQ------TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~------~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||+|+|..... ..+.++...+|+.||+++ +||||+.+.++|.. +.++++|+|.|..|.|+|++... ..++
T Consensus 45 ~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-~sF~FlVFdl~prGELFDyLts~--VtlS 121 (411)
T KOG0599|consen 45 FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-DAFVFLVFDLMPRGELFDYLTSK--VTLS 121 (411)
T ss_pred eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-cchhhhhhhhcccchHHHHhhhh--eeec
Confidence 67888866432 224567788999999999 69999999998754 56999999999999999999864 4899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-----
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD----- 149 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~----- 149 (582)
|...+.+|+||+.|++|||.++|+||||||+|||++++-++||+|||+++.+..+......||||+|.|||.+.+
T Consensus 122 EK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~ 201 (411)
T KOG0599|consen 122 EKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYEN 201 (411)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccC
Confidence 999999999999999999999999999999999999999999999999999999988999999999999998853
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
..|+..+|+|++|++||.|+.|.+||.-....-++..|..+. ..+-+..+|...++||.+||+.||.+|.|++|+|
T Consensus 202 ~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 202 HPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred CCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 347889999999999999999999998887777777776554 4456778999999999999999999999999999
Q ss_pred cCCCCchhhhhhhc
Q 007991 226 CHPHLQPYVLGIHL 239 (582)
Q Consensus 226 ~hp~f~~~~~~~~~ 239 (582)
+||||.++..+...
T Consensus 282 aHpff~q~~~~~~r 295 (411)
T KOG0599|consen 282 AHPFFIQIAQQQAR 295 (411)
T ss_pred cChHHHHHHHhccc
Confidence 99999988765544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.34 Aligned_cols=231 Identities=28% Similarity=0.512 Sum_probs=200.4
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|+++.... .......+.+|+++|+.++||||+++++.|... ..+|+||||++||+|.+++.+.. .+++..++.
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~ 99 (323)
T cd05595 23 YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRER--VFTEERARF 99 (323)
T ss_pred EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 79999976432 233456678899999999999999999987654 58999999999999999988654 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||
T Consensus 100 ~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 179 (323)
T cd05595 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179 (323)
T ss_pred HHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchh
Confidence 999999999999999999999999999999999999999999876432 2234457899999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~~ 234 (582)
||||++|+|++|..||...+.......+.... ..++..+++++.+||.+||+.||++|+ ++.++++|+||....
T Consensus 180 SlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999999999888877777665443 346778999999999999999999998 899999999998754
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 259 ~~ 260 (323)
T cd05595 259 WQ 260 (323)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=353.01 Aligned_cols=230 Identities=29% Similarity=0.518 Sum_probs=199.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++++...+.. .+.+.+|+..|+.++||||+.++..|+.+. .+|+||.|+.+|++.++|+..-...++|..+..
T Consensus 53 ~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~ 130 (516)
T KOG0582|consen 53 VVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS-ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIAT 130 (516)
T ss_pred EEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc-eeEEeehhhcCCcHHHHHHHHccccccHHHHHH
Confidence 489999999988777 778999999999999999999999998765 899999999999999999986556799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----cc-CcccCCCCCCCcccccC--CCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LA-SSVVGTPSYMCPELLAD--IPYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~-~~~vGTp~Y~APE~l~~--~~y~ 153 (582)
+++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.... .. .+++||++|||||++.. ..|+
T Consensus 131 iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd 210 (516)
T KOG0582|consen 131 ILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD 210 (516)
T ss_pred HHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCcc
Confidence 99999999999999999999999999999999999999999876654332 12 67899999999999643 4599
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHH-HHHhhccCCC--------CCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALI-NKINKSIVAP--------LPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~-~kI~~~~~~~--------lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
.|+||||||++..||.+|..||.......++ .++++....+ ....++..|+.+|..||++||.+|||++++
T Consensus 211 fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL 290 (516)
T KOG0582|consen 211 FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL 290 (516)
T ss_pred chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence 9999999999999999999999888766544 4444332211 123467789999999999999999999999
Q ss_pred HcCCCCch
Q 007991 225 LCHPHLQP 232 (582)
Q Consensus 225 L~hp~f~~ 232 (582)
|+|+||+.
T Consensus 291 lkh~FFk~ 298 (516)
T KOG0582|consen 291 LKHAFFKK 298 (516)
T ss_pred hccHHHhh
Confidence 99999975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=340.99 Aligned_cols=234 Identities=26% Similarity=0.446 Sum_probs=196.9
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++...... ......+.+|+.+|.+++|+||+.+++.|... ..+|+||||+.||+|.+++.......+++..+.
T Consensus 27 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05631 27 MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI 105 (285)
T ss_pred eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHH
Confidence 4899998765432 23345678999999999999999999987655 589999999999999998876555568999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..|+.++|||
T Consensus 106 ~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvw 185 (285)
T cd05631 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185 (285)
T ss_pred HHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCch
Confidence 99999999999999999999999999999999999999999999876544444567899999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHH---hhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI---~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~ 231 (582)
||||++|+|++|..||.+.+.......+ .......++..++..+.+||.+||+.||++|++ ++++++||||+
T Consensus 186 slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred hHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 9999999999999999876543222222 122233456678999999999999999999987 89999999998
Q ss_pred hhhh
Q 007991 232 PYVL 235 (582)
Q Consensus 232 ~~~~ 235 (582)
...+
T Consensus 266 ~~~~ 269 (285)
T cd05631 266 NINF 269 (285)
T ss_pred CCCH
Confidence 7543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=354.55 Aligned_cols=225 Identities=26% Similarity=0.486 Sum_probs=202.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+|||++..........+.|.+|+.+|.+|+|||||++++++.+....++|||||+++|+|.+++.......++...+..|
T Consensus 68 vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~ 147 (362)
T KOG0192|consen 68 VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRI 147 (362)
T ss_pred EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHH
Confidence 79999988777776688999999999999999999999998766547899999999999999998743457999999999
Q ss_pred HHHHHHHHHHHHHCC-ceecccCcccEEEcCCC-CeEEeecccchhcccc-cccCcccCCCCCCCccccc--CCCCCCCC
Q 007991 82 LVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA--DIPYGSKS 156 (582)
Q Consensus 82 l~QLL~aL~yLHs~g-IiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~--~~~y~~ks 156 (582)
+.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++..... .......||+.|||||++. ...|+.++
T Consensus 148 aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~ 227 (362)
T KOG0192|consen 148 ALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKS 227 (362)
T ss_pred HHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccc
Confidence 999999999999999 99999999999999998 9999999999877654 3445589999999999999 66899999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHh-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||+++|||++|+.||.+.........+. ......+|..+++.+..||..||..||..||++.+|+.
T Consensus 228 DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 228 DVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999998866666554 55666778889999999999999999999999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.70 Aligned_cols=232 Identities=28% Similarity=0.502 Sum_probs=200.4
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .......+.+|+++|+.++||||+++++.+.. +..+|+||||++||+|.+++.... .+++..++
T Consensus 22 ~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~ 98 (328)
T cd05593 22 YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNGGELFFHLSRER--VFSEDRTR 98 (328)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHH
Confidence 379999976433 23445678899999999999999999987765 458999999999999999987643 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||
T Consensus 99 ~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 178 (328)
T cd05593 99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178 (328)
T ss_pred HHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCc
Confidence 9999999999999999999999999999999999999999999876432 233455789999999999999899999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~ 233 (582)
|||||++|+|++|..||.+.+...+...+.... ..++..++.++.+||.+||+.||++|+ ++.++++||||...
T Consensus 179 wslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred cccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999999999888877776665433 346778999999999999999999997 89999999999875
Q ss_pred hhh
Q 007991 234 VLG 236 (582)
Q Consensus 234 ~~~ 236 (582)
.+.
T Consensus 258 ~~~ 260 (328)
T cd05593 258 NWQ 260 (328)
T ss_pred CHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=345.41 Aligned_cols=230 Identities=29% Similarity=0.436 Sum_probs=202.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|+++.....+..--...|||.+|.+++|||||.+.++.+..+ ..+|||||||+ .+|..++.... ..|....++
T Consensus 103 IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~-q~F~~~evK 180 (419)
T KOG0663|consen 103 IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMK-QPFLPGEVK 180 (419)
T ss_pred eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhcc-CCCchHHHH
Confidence 5899999998766655666789999999999999999999887543 57999999996 89999998754 579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksD 157 (582)
-++.|+|.||+|||.+.|+|||||++|+|++..|.+||+|||+|+.+.+.. .++..+.|.||+|||++.+. .|+.++|
T Consensus 181 ~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iD 260 (419)
T KOG0663|consen 181 TLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVD 260 (419)
T ss_pred HHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchh
Confidence 999999999999999999999999999999999999999999999987653 46678999999999998875 4999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC------------------------------Ccc-ccHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------------------PTV-YSGAFRGL 206 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l------------------------------p~~-~S~~l~~L 206 (582)
+||+|||+.||+.+++.|.+....+++.+|-..+..|- +.. +++...+|
T Consensus 261 MWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~L 340 (419)
T KOG0663|consen 261 MWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDL 340 (419)
T ss_pred hhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHH
Confidence 99999999999999999999999998888866544331 111 45888999
Q ss_pred HHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 207 VKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 207 I~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++.+|.+||.+|.||+|.|+|.||.+
T Consensus 341 ln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 341 LNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred HHHHhccCccccccHHHhhccccccc
Confidence 99999999999999999999999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.25 Aligned_cols=232 Identities=29% Similarity=0.481 Sum_probs=195.9
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .......+.+|+.+|..++||||++++++|.. +.++|+|||||.||+|.+++...+ .+++..++
T Consensus 28 ~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~ 104 (364)
T cd05599 28 IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETR 104 (364)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHH
Confidence 389999976432 23445678899999999999999999998765 458999999999999999998754 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------------------------- 130 (582)
.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 105 ~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (364)
T cd05599 105 FYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184 (364)
T ss_pred HHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999987543211
Q ss_pred ----------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCc
Q 007991 131 ----------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPT 197 (582)
Q Consensus 131 ----------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~ 197 (582)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+.... ..+...
T Consensus 185 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 264 (364)
T cd05599 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264 (364)
T ss_pred ccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 1123579999999999999899999999999999999999999999888777766664322 112223
Q ss_pred cccHHHHHHHHHhccCCCCCCCC---HHHHHcCCCCchhhhh
Q 007991 198 VYSGAFRGLVKSMLRKNPEFRPS---AAELLCHPHLQPYVLG 236 (582)
Q Consensus 198 ~~S~~l~~LI~kmL~~dP~~RpS---a~EiL~hp~f~~~~~~ 236 (582)
.+++.+++||.+||. +|.+|++ ++++|.||||+...+.
T Consensus 265 ~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 265 PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 579999999999997 9999987 9999999999876443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=347.06 Aligned_cols=230 Identities=29% Similarity=0.492 Sum_probs=201.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++............+.+|+++|++++||||+++++++... ..+|+|||||+|++|.+++.+.. .+++..++.
T Consensus 26 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~ 102 (318)
T cd05582 26 LYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKF 102 (318)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 378999877555445556788999999999999999999987654 58999999999999999997643 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++.++|||
T Consensus 103 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 182 (318)
T cd05582 103 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 182 (318)
T ss_pred HHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCcccee
Confidence 9999999999999999999999999999999999999999999765443 234457899999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
||||++|+|++|+.||.+.+.......+.... ..++..++..+.+||.+||+.||++||+ +++++.||||+...
T Consensus 183 slG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 183 SFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred ccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 99999999999999999988887777765543 3467778999999999999999999999 78899999998643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.60 Aligned_cols=233 Identities=25% Similarity=0.398 Sum_probs=195.1
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .......+.+|+.++.+++|+||+++++.+.+ +..+|+|||||+||+|.+++.+.+ .+++..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~ 104 (363)
T cd05628 28 VYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQ 104 (363)
T ss_pred EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 389999976443 23345678899999999999999999998765 458999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------------------------- 130 (582)
.++.||+.||+|||++||+||||||+||||+.++++||+|||+++......
T Consensus 105 ~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (363)
T cd05628 105 FYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184 (363)
T ss_pred HHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccch
Confidence 999999999999999999999999999999999999999999987543210
Q ss_pred -------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCcccc
Q 007991 131 -------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYS 200 (582)
Q Consensus 131 -------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S 200 (582)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.++.... ..+....++
T Consensus 185 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 264 (363)
T cd05628 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPIS 264 (363)
T ss_pred hhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCC
Confidence 1134689999999999999899999999999999999999999999988888777775422 122223478
Q ss_pred HHHHHHHHHhccCCCC---CCCCHHHHHcCCCCchhhhhh
Q 007991 201 GAFRGLVKSMLRKNPE---FRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 201 ~~l~~LI~kmL~~dP~---~RpSa~EiL~hp~f~~~~~~~ 237 (582)
+++++||.+|+. +|. .||+++||++||||+...+..
T Consensus 265 ~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 265 EKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 999999999875 444 458999999999998765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.09 Aligned_cols=232 Identities=31% Similarity=0.510 Sum_probs=199.3
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... .....+.+|+.+|..++|+||++++++|.. +.++|+||||+.|++|.+++.+.+ .+++..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~ 104 (350)
T cd05573 28 VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLVMEYMPGGDLMNLLIRKD--VFPEETAR 104 (350)
T ss_pred EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 38999997654333 445678899999999999999999998765 458999999999999999998753 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------------------------- 130 (582)
.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (350)
T cd05573 105 FYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184 (350)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999997654432
Q ss_pred -ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh---ccCCCCCccccHHHHHH
Q 007991 131 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGL 206 (582)
Q Consensus 131 -~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~---~~~~~lp~~~S~~l~~L 206 (582)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+......++.. ....+....+++.+.+|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~l 264 (350)
T cd05573 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDL 264 (350)
T ss_pred ccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHH
Confidence 23456899999999999999999999999999999999999999998887777666654 22222333479999999
Q ss_pred HHHhccCCCCCCCC-HHHHHcCCCCchhhhh
Q 007991 207 VKSMLRKNPEFRPS-AAELLCHPHLQPYVLG 236 (582)
Q Consensus 207 I~kmL~~dP~~RpS-a~EiL~hp~f~~~~~~ 236 (582)
|.+||. ||.+|++ ++++|+||||+...+.
T Consensus 265 i~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 265 ICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 999997 9999999 9999999999875544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.30 Aligned_cols=231 Identities=27% Similarity=0.498 Sum_probs=199.7
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .+...+.+.+|+.++..+ +||||+++++++.. +..+|+|||||.||+|.+++.+.. .+++..+
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~ 98 (320)
T cd05590 22 LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVNGGDLMFHIQKSR--RFDEARA 98 (320)
T ss_pred EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCCCchHHHHHHHcC--CCCHHHH
Confidence 389999876432 223456678899999877 69999999998765 458999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (320)
T cd05590 99 RFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVD 178 (320)
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccc
Confidence 9999999999999999999999999999999999999999999987543 223345678999999999999989999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH------HHHHcCCCCc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA------AELLCHPHLQ 231 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa------~EiL~hp~f~ 231 (582)
||||||++|+|++|..||.+.+...++..+..... ..+..++.++.+||.+||+.||++|+++ ++++.||||+
T Consensus 179 iwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~ 257 (320)
T cd05590 179 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257 (320)
T ss_pred hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence 99999999999999999999998888887765443 3566789999999999999999999998 9999999998
Q ss_pred hhhh
Q 007991 232 PYVL 235 (582)
Q Consensus 232 ~~~~ 235 (582)
.+.+
T Consensus 258 ~~~~ 261 (320)
T cd05590 258 ELDW 261 (320)
T ss_pred CCCH
Confidence 7544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.72 Aligned_cols=230 Identities=23% Similarity=0.418 Sum_probs=197.9
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++..... ....+.+.+|+.+|..++||||+++++++.. +.++|+|||||+|++|.+++...+ .+++..++
T Consensus 28 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~ 104 (333)
T cd05600 28 IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHAR 104 (333)
T ss_pred EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 3799998765432 2345678899999999999999999998765 458999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+..++.++|||
T Consensus 105 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 182 (333)
T cd05600 105 FYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYW 182 (333)
T ss_pred HHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCcccee
Confidence 9999999999999999999999999999999999999999999976544 34567899999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCC----ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLP----TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp----~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|||++|..||.+.+..+....+.... ..+.. ..+++++.+||.+||..+|.+|++++++++||||..
T Consensus 183 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred cchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 99999999999999999988877766654321 11111 246899999999999999999999999999999987
Q ss_pred hhh
Q 007991 233 YVL 235 (582)
Q Consensus 233 ~~~ 235 (582)
..+
T Consensus 263 ~~~ 265 (333)
T cd05600 263 VDW 265 (333)
T ss_pred CCH
Confidence 543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.94 Aligned_cols=229 Identities=30% Similarity=0.524 Sum_probs=199.1
Q ss_pred EEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~--~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||.++.... .......+.+|+.+|+.++||||+++++.|..+ ..+|+||||+.|++|.+++.+.+ .+++..++
T Consensus 27 ~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 103 (323)
T cd05584 27 FAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELFMHLEREG--IFMEDTAC 103 (323)
T ss_pred EEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEEeCCCCchHHHHHHHcC--CCCHHHHH
Confidence 78998876432 223345678999999999999999999988654 58999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||
T Consensus 104 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 183 (323)
T cd05584 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDW 183 (323)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCccee
Confidence 9999999999999999999999999999999999999999999875432 233445689999999999998889999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~ 233 (582)
|||||++|||++|..||.+.+.......+.... ..++..+++.+.+||.+||+.||++|+ ++++++.||||...
T Consensus 184 wslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 184 WSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred cccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999999999988887777776543 346778899999999999999999999 89999999999764
Q ss_pred h
Q 007991 234 V 234 (582)
Q Consensus 234 ~ 234 (582)
.
T Consensus 263 ~ 263 (323)
T cd05584 263 N 263 (323)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.41 Aligned_cols=232 Identities=25% Similarity=0.462 Sum_probs=193.6
Q ss_pred CEEEEEecccccCHH------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHH
Q 007991 1 MYVLKKIRLARQTDR------------ARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKK 67 (582)
Q Consensus 1 lyAIKki~~~~~~~~------------~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk 67 (582)
+||||++........ -.+.+++||.||++|.|||||+|+++.-+. ..++|||+|||..|.+...-..
T Consensus 124 l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d 203 (576)
T KOG0585|consen 124 LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD 203 (576)
T ss_pred EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC
Confidence 589999866432211 235789999999999999999999975432 3689999999998887644332
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc------cccccCcccCCCCC
Q 007991 68 ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI------SDDLASSVVGTPSY 141 (582)
Q Consensus 68 ~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~------~~~~~~~~vGTp~Y 141 (582)
...+++.++++|+++++.||+|||.+|||||||||+|+||+.+|+|||+|||.+.... .+......+|||.|
T Consensus 204 --~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF 281 (576)
T KOG0585|consen 204 --KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAF 281 (576)
T ss_pred --cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccc
Confidence 2238999999999999999999999999999999999999999999999999987652 22334457999999
Q ss_pred CCcccccCCC----CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-CCCCccccHHHHHHHHHhccCCCC
Q 007991 142 MCPELLADIP----YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-APLPTVYSGAFRGLVKSMLRKNPE 216 (582)
Q Consensus 142 ~APE~l~~~~----y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-~~lp~~~S~~l~~LI~kmL~~dP~ 216 (582)
+|||.+.+.. .+.+.||||+||+||-|+.|+.||-+....+++.+|..... .|....+.+.+++||.+||++||+
T Consensus 282 ~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~ 361 (576)
T KOG0585|consen 282 FAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPE 361 (576)
T ss_pred cchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChh
Confidence 9999987632 35689999999999999999999999999999999976543 333345789999999999999999
Q ss_pred CCCCHHHHHcCCCCchhh
Q 007991 217 FRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 217 ~RpSa~EiL~hp~f~~~~ 234 (582)
+|.++.+|..|||+....
T Consensus 362 ~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 362 QRITLPDIKLHPWVTRDG 379 (576)
T ss_pred heeehhhheecceeccCC
Confidence 999999999999997543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=335.58 Aligned_cols=228 Identities=29% Similarity=0.433 Sum_probs=192.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc---CCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L---~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||.++.....+.....+.+|+.+++.+ +||||+++++++.. .+..+|+||||+. ++|.+++.......++
T Consensus 30 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~ 108 (290)
T cd07862 30 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP 108 (290)
T ss_pred EEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCC
Confidence 78998877655444445567788887776 69999999998752 3457899999995 6999999876555689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............||+.|+|||++.+..++.
T Consensus 109 ~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 188 (290)
T cd07862 109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 188 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCC
Confidence 99999999999999999999999999999999999999999999999998765554556678999999999999889999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--------------------------CCccccHHHHHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--------------------------LPTVYSGAFRGLVK 208 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--------------------------lp~~~S~~l~~LI~ 208 (582)
++|||||||++|+|++|.+||.+....+.+.++......+ +...++..+.+||.
T Consensus 189 ~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (290)
T cd07862 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 268 (290)
T ss_pred ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHH
Confidence 9999999999999999999999887776666664322111 11246788899999
Q ss_pred HhccCCCCCCCCHHHHHcCCCC
Q 007991 209 SMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+||+.||++|||+.|+|+||||
T Consensus 269 ~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 269 KCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHhccCchhcCCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.35 Aligned_cols=227 Identities=27% Similarity=0.477 Sum_probs=188.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.....+...+.+.+|+.+++.++||||+++++++.. +..+|+||||++++.+..+... ...+++..++.
T Consensus 28 ~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~ 104 (287)
T cd07848 28 IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRS 104 (287)
T ss_pred EEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHH
Confidence 37999998766666667788999999999999999999998765 4589999999988776655443 23689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.++||
T Consensus 105 ~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 184 (287)
T cd07848 105 YIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDM 184 (287)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhH
Confidence 99999999999999999999999999999999999999999998764322 2335689999999999998889999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccC--------------------CC-----------CCccccHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--------------------AP-----------LPTVYSGAFRGLV 207 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--------------------~~-----------lp~~~S~~l~~LI 207 (582)
|||||++|+|++|++||.+.+..+....+..... .+ ....+|..+.+||
T Consensus 185 wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll 264 (287)
T cd07848 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLM 264 (287)
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHH
Confidence 9999999999999999988765443333221100 00 1123688899999
Q ss_pred HHhccCCCCCCCCHHHHHcCCCC
Q 007991 208 KSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 208 ~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
++||+.||++|||++++|+||||
T Consensus 265 ~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 265 KNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=349.48 Aligned_cols=231 Identities=26% Similarity=0.460 Sum_probs=192.2
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .....+.+.+|+++|++++|||||+++++|.. +.++|+|||||.||+|.+++.... .+++..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~ 104 (377)
T cd05629 28 IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTR 104 (377)
T ss_pred EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 379999866432 23445678899999999999999999998865 458999999999999999998643 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------------------------- 130 (582)
.|+.||+.||+|||+.||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (377)
T cd05629 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184 (377)
T ss_pred HHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999986321100
Q ss_pred -------------------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc-
Q 007991 131 -------------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS- 190 (582)
Q Consensus 131 -------------------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~- 190 (582)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 264 (377)
T cd05629 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR 264 (377)
T ss_pred cccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC
Confidence 011357999999999999989999999999999999999999999988877766666432
Q ss_pred --cCCCCCccccHHHHHHHHHhccCCCCCC---CCHHHHHcCCCCchhhh
Q 007991 191 --IVAPLPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQPYVL 235 (582)
Q Consensus 191 --~~~~lp~~~S~~l~~LI~kmL~~dP~~R---pSa~EiL~hp~f~~~~~ 235 (582)
...+....++.++.+||.+||. +|.+| +++.|++.||||+...+
T Consensus 265 ~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 265 ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 1222223588999999999998 67665 59999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=342.72 Aligned_cols=230 Identities=27% Similarity=0.423 Sum_probs=188.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++...........+.+|+.+|++++||||+++++++...+ ..+|+||||| +++|.+++.... .+++.
T Consensus 27 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~ 103 (338)
T cd07859 27 KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND--DLTPE 103 (338)
T ss_pred EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHH
Confidence 3899998765444444567889999999999999999999876432 3589999999 579999998644 68999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccC--C
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLAD--I 150 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~--~ 150 (582)
.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+ .
T Consensus 104 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 183 (338)
T cd07859 104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 183 (338)
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcccc
Confidence 999999999999999999999999999999999999999999999997643221 2245689999999999876 5
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---------------------------CC---Ccccc
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---------------------------PL---PTVYS 200 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---------------------------~l---p~~~S 200 (582)
.++.++|||||||++|+|++|++||.+.+.......+...... ++ ...++
T Consensus 184 ~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (338)
T cd07859 184 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNAD 263 (338)
T ss_pred ccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCC
Confidence 7889999999999999999999999877654433222111100 00 12357
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 201 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 201 ~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
..+.+||.+||+.||++||+++|+|+||||+..
T Consensus 264 ~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 264 PLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 788999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=349.19 Aligned_cols=232 Identities=28% Similarity=0.457 Sum_probs=193.7
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .......+.+|+.+|++++|+|||++++.|... .++|+|||||.||+|.+++.+.+ .+++..++
T Consensus 28 ~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~ 104 (382)
T cd05625 28 LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRMG--IFPEDLAR 104 (382)
T ss_pred EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 379999876433 234556789999999999999999999988765 58999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc------------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD------------------------------ 129 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~------------------------------ 129 (582)
.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+...
T Consensus 105 ~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (382)
T cd05625 105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184 (382)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999997532100
Q ss_pred ------------------cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc-
Q 007991 130 ------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS- 190 (582)
Q Consensus 130 ------------------~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~- 190 (582)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+...++...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 264 (382)
T cd05625 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ 264 (382)
T ss_pred ccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccC
Confidence 0112458999999999999999999999999999999999999999988776655555432
Q ss_pred --cCCCCCccccHHHHHHHHHhccCCCCCCCC---HHHHHcCCCCchhhhh
Q 007991 191 --IVAPLPTVYSGAFRGLVKSMLRKNPEFRPS---AAELLCHPHLQPYVLG 236 (582)
Q Consensus 191 --~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS---a~EiL~hp~f~~~~~~ 236 (582)
...+....+++++.++|.+|+ .+|.+|++ +++++.||||+...+.
T Consensus 265 ~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 265 TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 122233468999999999987 59999987 9999999999875443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.50 Aligned_cols=231 Identities=28% Similarity=0.518 Sum_probs=199.1
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+..... .......+.+|++++..++||||+++++.|... ..+|+||||++||+|.+++.... .+++..++.
T Consensus 23 ~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~~ 99 (325)
T cd05594 23 YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRER--VFSEDRARF 99 (325)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 78999876443 223445678899999999999999999877654 58999999999999999987644 689999999
Q ss_pred HHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||
T Consensus 100 ~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (325)
T cd05594 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179 (325)
T ss_pred HHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCcccc
Confidence 99999999999997 7999999999999999999999999999875432 233445789999999999999899999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~ 233 (582)
|||||++|+|++|..||.+.+...+...+.... ..++..+++++.+||.+||+.||++|+ ++.++++||||...
T Consensus 180 wslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999999999888877777665443 346778999999999999999999997 99999999999875
Q ss_pred hhh
Q 007991 234 VLG 236 (582)
Q Consensus 234 ~~~ 236 (582)
.+.
T Consensus 259 ~~~ 261 (325)
T cd05594 259 VWQ 261 (325)
T ss_pred CHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=347.91 Aligned_cols=233 Identities=26% Similarity=0.412 Sum_probs=193.4
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .....+.+.+|+.+|++++|+||+++++++.+. .++|+|||||.||+|.+++.+.. .+++..++
T Consensus 28 ~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~ 104 (381)
T cd05626 28 LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRME--VFPEVLAR 104 (381)
T ss_pred EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHH
Confidence 389999976543 334567789999999999999999999988754 58999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc------------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD------------------------------ 129 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~------------------------------ 129 (582)
.++.||+.||+|||+.||+||||||+||||+.++++||+|||++..+...
T Consensus 105 ~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (381)
T cd05626 105 FYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184 (381)
T ss_pred HHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccc
Confidence 99999999999999999999999999999999999999999997543100
Q ss_pred ------------------cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc-
Q 007991 130 ------------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS- 190 (582)
Q Consensus 130 ------------------~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~- 190 (582)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+.......+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~ 264 (381)
T cd05626 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE 264 (381)
T ss_pred cccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccc
Confidence 0123468999999999999989999999999999999999999999887766655555321
Q ss_pred --cCCCCCccccHHHHHHHHHhccC--CCCCCCCHHHHHcCCCCchhhhh
Q 007991 191 --IVAPLPTVYSGAFRGLVKSMLRK--NPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 191 --~~~~lp~~~S~~l~~LI~kmL~~--dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
...+....+++++.+||.+||.. ++..|+++++++.||||+...+.
T Consensus 265 ~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 265 NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 22223345899999999997755 44459999999999999875543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=348.17 Aligned_cols=231 Identities=28% Similarity=0.434 Sum_probs=192.8
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.+..... .......+.+|+.+|++++|+||+++++.|..+ ..+|+|||||+||+|.+++.+.+ .+++..++
T Consensus 28 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~ 104 (376)
T cd05598 28 LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLLIRLG--IFEEDLAR 104 (376)
T ss_pred EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 389999865432 223456788999999999999999999988654 58999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc------------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD------------------------------ 129 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~------------------------------ 129 (582)
.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 105 ~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (376)
T cd05598 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184 (376)
T ss_pred HHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999997532100
Q ss_pred --------------cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc---cC
Q 007991 130 --------------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS---IV 192 (582)
Q Consensus 130 --------------~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~---~~ 192 (582)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 264 (376)
T cd05598 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH 264 (376)
T ss_pred ccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc
Confidence 0112458999999999999999999999999999999999999999988877665555432 12
Q ss_pred CCCCccccHHHHHHHHHhccCCCCCCC---CHHHHHcCCCCchhhh
Q 007991 193 APLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVL 235 (582)
Q Consensus 193 ~~lp~~~S~~l~~LI~kmL~~dP~~Rp---Sa~EiL~hp~f~~~~~ 235 (582)
.+....++..+.+||.+|+ .+|.+|+ ++++++.||||+.+.+
T Consensus 265 ~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 265 IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 2233468999999999987 5999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=341.64 Aligned_cols=232 Identities=26% Similarity=0.462 Sum_probs=196.3
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.++.... .....+.+.+|+.+++.++|+||+++++++.. +..+|+||||++|++|.+++.+.. ..+++..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~ 105 (330)
T cd05601 28 IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQ 105 (330)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHH
Confidence 379999987543 33456778999999999999999999988765 458999999999999999998753 369999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCccccc------CCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLA------DIP 151 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~------~~~ 151 (582)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ....+||+.|+|||++. ...
T Consensus 106 ~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 185 (330)
T cd05601 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185 (330)
T ss_pred HHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCC
Confidence 9999999999999999999999999999999999999999999977644322 23457999999999986 456
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
++.++|||||||++|+|++|..||...+....+..+.... ..+....++..+.+||.+||. +|.+|+++++++.||
T Consensus 186 ~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 7889999999999999999999999888777666664322 122233589999999999998 999999999999999
Q ss_pred CCchhhh
Q 007991 229 HLQPYVL 235 (582)
Q Consensus 229 ~f~~~~~ 235 (582)
||+...+
T Consensus 265 ~~~~~~~ 271 (330)
T cd05601 265 FFSKIDW 271 (330)
T ss_pred CcCCCCH
Confidence 9987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.32 Aligned_cols=231 Identities=27% Similarity=0.498 Sum_probs=194.1
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++..... ....+.+.+|+.++..+ +||||++++++|... ..+|+|||||+||+|.+++.+.+ .+++..+
T Consensus 22 ~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~ 98 (329)
T cd05588 22 IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVSGGDLMFHMQRQR--KLPEEHA 98 (329)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHH
Confidence 3899999775433 34456788999999999 799999999987654 58999999999999999987654 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (329)
T cd05588 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178 (329)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccc
Confidence 9999999999999999999999999999999999999999999987532 233445678999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccC--------H-HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC------HH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFD--------M-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS------AA 222 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~--------~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS------a~ 222 (582)
||||||++|+|++|+.||.... . ..+.+.+.. ....+|..++..+.+||.+||+.||.+|++ ++
T Consensus 179 iwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 257 (329)
T cd05588 179 WWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFR 257 (329)
T ss_pred eechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHH
Confidence 9999999999999999996321 1 122333333 334567789999999999999999999987 79
Q ss_pred HHHcCCCCchhhh
Q 007991 223 ELLCHPHLQPYVL 235 (582)
Q Consensus 223 EiL~hp~f~~~~~ 235 (582)
++++||||....+
T Consensus 258 ~i~~hp~~~~~~~ 270 (329)
T cd05588 258 DIKSHPFFRNIDW 270 (329)
T ss_pred HHhcCCCCCCCCH
Confidence 9999999986443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.03 Aligned_cols=228 Identities=29% Similarity=0.514 Sum_probs=205.9
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||+|.+...... ....+.+.+|+.||++|. |||||.++++|... ..+|+|||+|.||.|.+.|.+. .++|..+
T Consensus 62 ~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-~~~~lvmEL~~GGeLfd~i~~~---~~sE~da 137 (382)
T KOG0032|consen 62 EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-DSVYLVMELCEGGELFDRIVKK---HYSERDA 137 (382)
T ss_pred eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-CeEEEEEEecCCchHHHHHHHc---cCCHHHH
Confidence 3899999775543 345678999999999998 99999999988655 4899999999999999999986 3999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCC----CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD----QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~----g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
..++.|++.+++|||+.||+||||||+|+|+... +.+|++|||++............|||+.|+|||++...+|+.
T Consensus 138 ~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~ 217 (382)
T KOG0032|consen 138 AGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGD 217 (382)
T ss_pred HHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCc
Confidence 9999999999999999999999999999999754 469999999999988777788999999999999999999999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.+||||+||++|.|++|.+||.+........+|.... ..+.+..++..+++||+.||..||.+|+++.++|+|||++
T Consensus 218 ~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 218 EVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred ccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 9999999999999999999999999888888887653 3445667899999999999999999999999999999987
Q ss_pred h
Q 007991 232 P 232 (582)
Q Consensus 232 ~ 232 (582)
.
T Consensus 298 ~ 298 (382)
T KOG0032|consen 298 S 298 (382)
T ss_pred C
Confidence 5
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.26 Aligned_cols=232 Identities=26% Similarity=0.478 Sum_probs=200.2
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++.... .....+.+..|++++..+ +||||++++++|... ..+|+|||||+|++|...+.+.. .+++..+
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~ 98 (321)
T cd05591 22 VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVNGGDLMFQIQRSR--KFDEPRS 98 (321)
T ss_pred EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 379999876432 234456678899999876 799999999987654 58999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (321)
T cd05591 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178 (321)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccc
Confidence 99999999999999999999999999999999999999999999875432 23345678999999999999989999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-------CHHHHHcCCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-------SAAELLCHPHL 230 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-------Sa~EiL~hp~f 230 (582)
||||||++|+|++|..||.+.+...++..+..... ..+..++.++.+||.+||+.||++|+ +++++++||||
T Consensus 179 vwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred eechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 99999999999999999999998888887765443 35667899999999999999999999 99999999999
Q ss_pred chhhhh
Q 007991 231 QPYVLG 236 (582)
Q Consensus 231 ~~~~~~ 236 (582)
..+.+.
T Consensus 258 ~~~~~~ 263 (321)
T cd05591 258 KEIDWV 263 (321)
T ss_pred CCCCHH
Confidence 875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.76 Aligned_cols=230 Identities=24% Similarity=0.475 Sum_probs=196.7
Q ss_pred EEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||.++..... +...+.+..|+.++..+ +||||++++++|... .++|+|||||.||+|.+++.... .+++..+.
T Consensus 23 ~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~ 99 (316)
T cd05620 23 FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLNGGDLMFHIQDKG--RFDLYRAT 99 (316)
T ss_pred EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 789998764321 23345667788888764 899999999988654 58999999999999999998743 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++||
T Consensus 100 ~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (316)
T cd05620 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179 (316)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccch
Confidence 999999999999999999999999999999999999999999987532 2233456789999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-HHHHcCCCCchhhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-AELLCHPHLQPYVL 235 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-~EiL~hp~f~~~~~ 235 (582)
|||||++|+|++|..||.+.+...+...+.... ..++..++.++++||.+||..||++|+++ +++++||||+...+
T Consensus 180 wslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT-PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 999999999999999999988888777765443 34566789999999999999999999997 68999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.74 Aligned_cols=230 Identities=28% Similarity=0.471 Sum_probs=195.0
Q ss_pred EEEEEecccccC-HHHHHHHHHHHH-HHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQT-DRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~-~~~~~~~~rEi~-iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||++...... ......+..|.. +++.++||||+++++.|... ..+|+||||+.||+|.+++.+.+ .+++..++
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~ 99 (323)
T cd05575 23 YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVNGGELFFHLQRER--SFPEPRAR 99 (323)
T ss_pred EEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCCCCCHHHHHHhcC--CCCHHHHH
Confidence 899998764322 222344555554 56889999999999987654 58999999999999999998744 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||
T Consensus 100 ~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 179 (323)
T cd05575 100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179 (323)
T ss_pred HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccc
Confidence 9999999999999999999999999999999999999999999876432 233455789999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH----HHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA----AELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa----~EiL~hp~f~~~~ 234 (582)
|||||++|+|++|..||.+.+..++...+..... .++..++..+.+||.+||+.||.+|+++ .+++.||||....
T Consensus 180 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999999999999888888777765433 3556689999999999999999999987 6999999998754
Q ss_pred h
Q 007991 235 L 235 (582)
Q Consensus 235 ~ 235 (582)
+
T Consensus 259 ~ 259 (323)
T cd05575 259 W 259 (323)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.87 Aligned_cols=262 Identities=26% Similarity=0.485 Sum_probs=228.8
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||||+++......+ ...-...|-++|+.++||++..+...|+..+ .+|+||||..||.|.-++.+.. .|+|..++
T Consensus 195 ~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-rlCFVMeyanGGeLf~HLsrer--~FsE~RtR 271 (516)
T KOG0690|consen 195 LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-RLCFVMEYANGGELFFHLSRER--VFSEDRTR 271 (516)
T ss_pred eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-eEEEEEEEccCceEeeehhhhh--cccchhhh
Confidence 589999988664332 3344567999999999999999999887654 9999999999999999998744 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.|-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++... .....+++||||.|.|||++.+..|+.++|+
T Consensus 272 FYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDW 351 (516)
T KOG0690|consen 272 FYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDW 351 (516)
T ss_pred hhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeeh
Confidence 999999999999999999999999999999999999999999998754 4567889999999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~ 233 (582)
|-+||+||||++|+.||.+.+...+++.|..... .+|..++++++.|+..+|.+||.+|. .+.||++|+||...
T Consensus 352 WG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 352 WGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999999999999999999998877654 37899999999999999999999996 48999999999987
Q ss_pred hhhhh--cccCCCCCCCCCCCCCCcccccccCCCc
Q 007991 234 VLGIH--LKLNGPRRNTFPLEWSDSNFKKTRFMEP 266 (582)
Q Consensus 234 ~~~~~--~~~~~p~~~~~~~~~~~s~~~~~~~~~~ 266 (582)
.|+-. .++.+|.++....+-+.+.|++.....+
T Consensus 431 ~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~ 465 (516)
T KOG0690|consen 431 DWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQP 465 (516)
T ss_pred CHHHHHHhccCCCCCCCcccccchhhhhhhhhcce
Confidence 76554 3566777777777777777777654433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=337.75 Aligned_cols=232 Identities=27% Similarity=0.406 Sum_probs=201.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCC-eeeeeeEEEecCc-----EEEEEEeecCCCCHHHHHHHhCC--CC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPF-IVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANG--VH 72 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn-IV~l~~~~~~~~~-----~l~LVmEy~~GgsL~d~Ikk~~~--~~ 72 (582)
.||+|+++.....+..-....||+-+|+.|+|+| ||.+++++...+. .+++|+||+ ..+|..++..... ..
T Consensus 38 ~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g 116 (323)
T KOG0594|consen 38 FVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQG 116 (323)
T ss_pred EEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccC
Confidence 4899999998775555667899999999999999 9999998876553 899999999 5899999988653 36
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCC-
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADI- 150 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~- 150 (582)
++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|+... ........++|.||+|||++.+.
T Consensus 117 ~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~ 196 (323)
T KOG0594|consen 117 LPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST 196 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC
Confidence 7889999999999999999999999999999999999999999999999999766 33446778999999999998876
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCc-----------------------------cccH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT-----------------------------VYSG 201 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~-----------------------------~~S~ 201 (582)
.|+..+||||+|||++||+++++.|.+....++...|-.....|-.. ..++
T Consensus 197 ~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~ 276 (323)
T KOG0594|consen 197 SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDP 276 (323)
T ss_pred cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCc
Confidence 69999999999999999999999999999888888775544333100 1234
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
...+++.+||+.+|.+|.|++.+|.||||+..
T Consensus 277 ~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 277 DGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 78899999999999999999999999999864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.11 Aligned_cols=231 Identities=25% Similarity=0.413 Sum_probs=213.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||||+|.......-..-.+.+|++.|+.++|||||++|++. +....+|+|+|.-+||+|+++|-++. ..+.|+.+++
T Consensus 45 kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~k 122 (864)
T KOG4717|consen 45 KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKK 122 (864)
T ss_pred eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHH
Confidence 589999999888888888899999999999999999999975 55579999999999999999998864 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEc-CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC-CCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG-SKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~-~ksDI 158 (582)
|+.||+.|+.|||..+||||||||+||.+- .-|-|||+|||++..+.......+.||...|.|||++.+..|+ +++||
T Consensus 123 YF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDi 202 (864)
T KOG4717|consen 123 YFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDI 202 (864)
T ss_pred HHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhh
Confidence 999999999999999999999999998765 4589999999999999888899999999999999999998886 57999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||||||||-|++|++||...+..+.+..|....+. .|..+|.++++||..||..||++|.+++||..++|+|+..
T Consensus 203 WSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt-vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 203 WSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT-VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hHHHHHHHHHHhCCCccccccchhhhhhhhccccc-CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999999999999988888888877665 7899999999999999999999999999999999998754
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.20 Aligned_cols=231 Identities=28% Similarity=0.534 Sum_probs=199.6
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++.... .......+.+|+.++..+ +||||+++++++... ..+|+|||||.|++|.+++.+.. .+++..+
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~ 98 (318)
T cd05570 22 LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVNGGDLMFHIQRSG--RFDEPRA 98 (318)
T ss_pred EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHHHHHHcC--CCCHHHH
Confidence 379999976542 223456678899999988 699999999987654 58999999999999999998754 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 178 (318)
T cd05570 99 RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178 (318)
T ss_pred HHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchh
Confidence 9999999999999999999999999999999999999999999987532 222344568999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-----HHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-----AELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-----~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||.+.+...+...+..... ..+..++..+.+||.+||..||.+||++ .+++.||||+.
T Consensus 179 iwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred hhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999999999999888887777655433 4567789999999999999999999999 99999999987
Q ss_pred hhh
Q 007991 233 YVL 235 (582)
Q Consensus 233 ~~~ 235 (582)
..+
T Consensus 258 ~~~ 260 (318)
T cd05570 258 IDW 260 (318)
T ss_pred CCH
Confidence 544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=320.60 Aligned_cols=230 Identities=45% Similarity=0.889 Sum_probs=204.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++..........+.+.+|++++++++|+||+++++.+...+..+|+||||+.+++|.+++....+..+++..+..
T Consensus 27 ~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~ 106 (257)
T cd08223 27 QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106 (257)
T ss_pred EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHH
Confidence 37899998766666667789999999999999999999998766666899999999999999999875555689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .......|++.|+|||++.+..++.++|||
T Consensus 107 ~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 186 (257)
T cd08223 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVW 186 (257)
T ss_pred HHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhH
Confidence 9999999999999999999999999999999999999999999766432 233456789999999999998899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
||||++|+|++|..||...+.......+........+..++..+.+||.+||+.||+.||++.++++||||
T Consensus 187 slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 187 ALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999888777766666666656777899999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.50 Aligned_cols=232 Identities=28% Similarity=0.505 Sum_probs=193.7
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||+|.++.... .....+.+.+|+.++.++ +||||+++++++... ..+|+||||+.||+|..++.+.. .+++..+
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~ 98 (329)
T cd05618 22 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHA 98 (329)
T ss_pred EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHH
Confidence 379999976543 334556788999998877 799999999987654 58999999999999999887654 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+||+.|+|||++.+..++.++|
T Consensus 99 ~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (329)
T cd05618 99 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178 (329)
T ss_pred HHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccc
Confidence 9999999999999999999999999999999999999999999987543 223345678999999999999999999999
Q ss_pred ccchhHHHHhHhcCCcccccc---------CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC------HH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAF---------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS------AA 222 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~---------~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS------a~ 222 (582)
||||||++|+|++|..||... ....+...+.. ....+|..++..+.+||.+||+.||++|++ ++
T Consensus 179 iwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~ 257 (329)
T cd05618 179 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 257 (329)
T ss_pred eecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHH
Confidence 999999999999999999521 11222333332 334567889999999999999999999998 58
Q ss_pred HHHcCCCCchhhhh
Q 007991 223 ELLCHPHLQPYVLG 236 (582)
Q Consensus 223 EiL~hp~f~~~~~~ 236 (582)
+++.||||+.+.+.
T Consensus 258 ~i~~hp~f~~~~~~ 271 (329)
T cd05618 258 DIQGHPFFRNVDWD 271 (329)
T ss_pred HHhcCCCCCCCCHH
Confidence 99999999875443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.89 Aligned_cols=232 Identities=24% Similarity=0.463 Sum_probs=197.9
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++..... +...+.+..|..++..+ +||||+++++++... ..+|+||||+.||+|.+++.... .+++..+
T Consensus 22 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~ 98 (316)
T cd05619 22 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLNGGDLMFHIQSCH--KFDLPRA 98 (316)
T ss_pred EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 3899999775421 23345567788888764 899999999988655 58999999999999999998743 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (316)
T cd05619 99 TFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178 (316)
T ss_pred HHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhh
Confidence 99999999999999999999999999999999999999999999875322 22345678999999999999989999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH-HHHcCCCCchhhhh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA-ELLCHPHLQPYVLG 236 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~-EiL~hp~f~~~~~~ 236 (582)
||||||++|+|++|..||.+.+..++...+.... ..++..++.++++||.+||+.||++|+++. ++++||||+...+.
T Consensus 179 vwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred hhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 9999999999999999999988888777775543 345667899999999999999999999996 99999999875543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.27 Aligned_cols=228 Identities=26% Similarity=0.400 Sum_probs=193.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++............+.+|+.+++.++||||+++++++...+ ..+|+||||+. ++|.+.+.. .+++.
T Consensus 52 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~ 126 (364)
T cd07875 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHE 126 (364)
T ss_pred EEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHH
Confidence 789999876666666678889999999999999999999876432 46899999996 578777764 48899
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..++.++
T Consensus 127 ~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 206 (364)
T cd07875 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206 (364)
T ss_pred HHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchh
Confidence 99999999999999999999999999999999999999999999999876555555667899999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-----------------------------------------
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL----------------------------------------- 195 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l----------------------------------------- 195 (582)
|||||||++|+|++|+.||.+.+..+.+.++......+.
T Consensus 207 DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (364)
T cd07875 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286 (364)
T ss_pred hHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccc
Confidence 999999999999999999998877665555433221111
Q ss_pred CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 196 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 196 p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
....+..+++||.+||+.||.+|||++|+|+||||+.+.
T Consensus 287 ~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred cccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 111356789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.96 Aligned_cols=233 Identities=26% Similarity=0.427 Sum_probs=195.6
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .......+.+|+.+|..++|+||+++++.|.. +.++|+|||||.||+|.+++.+.+ .+++..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~ 104 (360)
T cd05627 28 IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQ 104 (360)
T ss_pred EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHH
Confidence 379999875432 23455678899999999999999999998765 458999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------------------------- 130 (582)
.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 105 ~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (360)
T cd05627 105 FYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184 (360)
T ss_pred HHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccccccc
Confidence 999999999999999999999999999999999999999999987542210
Q ss_pred -------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCcccc
Q 007991 131 -------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYS 200 (582)
Q Consensus 131 -------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S 200 (582)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+....+.++.... ..+....++
T Consensus 185 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 264 (360)
T cd05627 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPIS 264 (360)
T ss_pred ccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCC
Confidence 1124689999999999999999999999999999999999999999988887777765421 122223479
Q ss_pred HHHHHHHHHhccCCCCCCC---CHHHHHcCCCCchhhhhh
Q 007991 201 GAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 201 ~~l~~LI~kmL~~dP~~Rp---Sa~EiL~hp~f~~~~~~~ 237 (582)
.++++||.+|+. ||.+|+ ++++++.||||+...+..
T Consensus 265 ~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 265 EKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred HHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999999874 999998 589999999999765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.59 Aligned_cols=230 Identities=24% Similarity=0.439 Sum_probs=194.6
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++....... .....+.+|+.+|+.++||||+++++++.. +.++|+|||||+||+|.+++... .+++..+.
T Consensus 70 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~ 145 (370)
T cd05596 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWAR 145 (370)
T ss_pred EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHH
Confidence 38999987543322 334567899999999999999999987764 55899999999999999999763 58999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC----CCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI----PYG 153 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~----~y~ 153 (582)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+. .++
T Consensus 146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 225 (370)
T cd05596 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225 (370)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCC
Confidence 999999999999999999999999999999999999999999997654332 23457899999999998653 378
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCC--CCCHHHHHcCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEF--RPSAAELLCHP 228 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~hp 228 (582)
.++|||||||++|||++|.+||.+.+....+.++.... ..+....+|.++.+||.+||+.+|.+ |+++++++.||
T Consensus 226 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 89999999999999999999999998887777775432 22223358999999999999999988 99999999999
Q ss_pred CCchhh
Q 007991 229 HLQPYV 234 (582)
Q Consensus 229 ~f~~~~ 234 (582)
||+...
T Consensus 306 ~~~~~~ 311 (370)
T cd05596 306 FFKNDQ 311 (370)
T ss_pred ccCCCC
Confidence 998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.07 Aligned_cols=230 Identities=25% Similarity=0.399 Sum_probs=191.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++............+.+|+.+++.++||||++++++|...+ ..+|+||||++ ++|.+.+.. .+++
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~ 122 (359)
T cd07876 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDH 122 (359)
T ss_pred eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCH
Confidence 3899999876666666678889999999999999999999886443 36899999996 567666653 4889
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++............||+.|+|||++.+..++.+
T Consensus 123 ~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 202 (359)
T cd07876 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKEN 202 (359)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcc
Confidence 99999999999999999999999999999999999999999999999987655545566789999999999999999999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-----------------------------------------C
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-----------------------------------------P 194 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-----------------------------------------~ 194 (582)
+|||||||++|+|++|..||.+.+....+..+...... .
T Consensus 203 ~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (359)
T cd07876 203 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESE 282 (359)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccc
Confidence 99999999999999999999877654433322211100 0
Q ss_pred CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 195 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 195 lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
.....+..+++||.+||..||++|||++|+|+||||+.+..
T Consensus 283 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 283 RDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred cccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 11124678999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.64 Aligned_cols=231 Identities=27% Similarity=0.515 Sum_probs=196.4
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHH---HhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELI---SRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL---~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.++.... .....+.+.+|++++ +.++||||+++++++.. +..+|+|||||+|++|..++... .+++.
T Consensus 26 ~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~~~L~~~~~~~---~l~~~ 101 (324)
T cd05589 26 LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCFVMEYAAGGDLMMHIHTD---VFSEP 101 (324)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEEEEcCCCCCcHHHHhhcC---CCCHH
Confidence 379999976432 223345677776665 56789999999998765 45899999999999999888652 68999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+|++.|+|||++.+..++.+
T Consensus 102 ~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 181 (324)
T cd05589 102 RAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181 (324)
T ss_pred HHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcc
Confidence 9999999999999999999999999999999999999999999999875432 233456789999999999999899999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHL 230 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f 230 (582)
+|||||||++|+|++|..||.+.+..++...+..... ..+..++..+.+||.+||+.||.+|| ++.++++||||
T Consensus 182 ~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred cchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 9999999999999999999999888888777765433 36677899999999999999999999 79999999999
Q ss_pred chhhhh
Q 007991 231 QPYVLG 236 (582)
Q Consensus 231 ~~~~~~ 236 (582)
+...+.
T Consensus 261 ~~~~~~ 266 (324)
T cd05589 261 RDINWD 266 (324)
T ss_pred CCCCHH
Confidence 875433
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.39 Aligned_cols=231 Identities=25% Similarity=0.472 Sum_probs=198.1
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCC-CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNP-FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~Hp-nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .....+.+..|++++..++|+ +|+.+++.|.. +..+|+|||||+||+|.+++.... .+++..+
T Consensus 27 ~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~ 103 (324)
T cd05587 27 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHA 103 (324)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHH
Confidence 389999976432 234456788999999999876 47777776654 458999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+.|+|||++.+..++.++|
T Consensus 104 ~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 183 (324)
T cd05587 104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVD 183 (324)
T ss_pred HHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccc
Confidence 9999999999999999999999999999999999999999999987532 223344578999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-----HHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-----AELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-----~EiL~hp~f~~ 232 (582)
||||||++|+|++|+.||.+.+..+++..+.... ..++..++..+.+||.+||..||.+|++. +++++||||+.
T Consensus 184 iwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999999998888888776543 34677899999999999999999999976 89999999987
Q ss_pred hhh
Q 007991 233 YVL 235 (582)
Q Consensus 233 ~~~ 235 (582)
..+
T Consensus 263 ~~~ 265 (324)
T cd05587 263 IDW 265 (324)
T ss_pred CCH
Confidence 543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.20 Aligned_cols=234 Identities=26% Similarity=0.499 Sum_probs=195.4
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++.... .....+.+.+|+.++.++ +||||+.+++.+... ..+|+|||||.||+|.+++.... .+++..+
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~ 98 (327)
T cd05617 22 IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVNGGDLMFHMQRQR--KLPEEHA 98 (327)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 378999976543 234556788999999998 599999999977654 58999999999999999988644 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (327)
T cd05617 99 RFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178 (327)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchhe
Confidence 9999999999999999999999999999999999999999999987532 233345678999999999999999999999
Q ss_pred ccchhHHHHhHhcCCcccccc------CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC------HHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAF------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS------AAELL 225 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~------~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS------a~EiL 225 (582)
||||||++|+|++|..||... +..+............+|..++..+.++|.+||+.||++|++ +++++
T Consensus 179 iwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 258 (327)
T cd05617 179 WWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258 (327)
T ss_pred eehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHH
Confidence 999999999999999999532 222222222233344577789999999999999999999987 57999
Q ss_pred cCCCCchhhhhh
Q 007991 226 CHPHLQPYVLGI 237 (582)
Q Consensus 226 ~hp~f~~~~~~~ 237 (582)
.||||+...+..
T Consensus 259 ~h~~f~~~~~~~ 270 (327)
T cd05617 259 SHTFFRSIDWDL 270 (327)
T ss_pred cCCCCCCCCHHH
Confidence 999998865544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=335.28 Aligned_cols=230 Identities=23% Similarity=0.466 Sum_probs=196.7
Q ss_pred EEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||.++..... +...+.+..|..++..+ +||||+++++++.. +.++|+||||++||+|.++++... .+++..+.
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~ 99 (316)
T cd05592 23 FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLNGGDLMFHIQSSG--RFDEARAR 99 (316)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 899999765432 23345566777777654 89999999998765 458999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||
T Consensus 100 ~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 179 (316)
T cd05592 100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179 (316)
T ss_pred HHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccc
Confidence 9999999999999999999999999999999999999999999976432 233456789999999999999899999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-HHHHcCCCCchhhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-AELLCHPHLQPYVL 235 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-~EiL~hp~f~~~~~ 235 (582)
|||||++|+|++|..||.+.+...+...+... ...++..++.++.+||.+||..||.+|+++ .++++||||....+
T Consensus 180 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 99999999999999999999888887777553 344677899999999999999999999986 58899999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.01 Aligned_cols=229 Identities=27% Similarity=0.495 Sum_probs=190.9
Q ss_pred EEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQ--TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~--~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||+|.+..... .....+.+.+|+.+|.+++ |+||+.+++++.. +..+|+|||||.||+|.+++.+.. .+++..+
T Consensus 31 ~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~ 107 (332)
T cd05614 31 YAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAKLHLILDYVSGGEMFTHLYQRD--NFSEDEV 107 (332)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 78898865432 2234567889999999995 8999999987765 458999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC-CCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI-PYGSK 155 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~-~y~~k 155 (582)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+. .++.+
T Consensus 108 ~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 187 (332)
T cd05614 108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKA 187 (332)
T ss_pred HHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCc
Confidence 9999999999999999999999999999999999999999999997653322 23456899999999999865 47889
Q ss_pred CcccchhHHHHhHhcCCccccccC----HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHc
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLC 226 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~----~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~ 226 (582)
+|||||||++|+|++|..||.... ...+...+. ....+++..++..+.+||.+||+.||++|+ +++++++
T Consensus 188 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 188 VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred cccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999999996432 223333332 233456778999999999999999999999 8999999
Q ss_pred CCCCchhh
Q 007991 227 HPHLQPYV 234 (582)
Q Consensus 227 hp~f~~~~ 234 (582)
||||+...
T Consensus 267 h~~~~~~~ 274 (332)
T cd05614 267 HPFFKGLD 274 (332)
T ss_pred CCCcCCCC
Confidence 99998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.15 Aligned_cols=226 Identities=26% Similarity=0.422 Sum_probs=186.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.... ......+.+|+.+|++++||||+++++++... ...|+||||+. ++|.+++...+ ..+++..+..
T Consensus 32 ~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~ 107 (288)
T cd07871 32 LVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKI 107 (288)
T ss_pred EEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHH
Confidence 378998876432 22334677999999999999999999987654 58999999997 59999887643 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......|++.|+|||++.+ ..++.++||
T Consensus 108 ~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (288)
T cd07871 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187 (288)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHH
Confidence 9999999999999999999999999999999999999999999765332 22345678999999999865 568899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~S~~l~~LI~k 209 (582)
|||||++|+|++|.+||.+.+..+.+..+......+ ....++.++++||.+
T Consensus 188 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 267 (288)
T cd07871 188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSS 267 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHH
Confidence 999999999999999999887766555443221110 012467889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCC
Q 007991 210 MLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f 230 (582)
||+.||.+|+|++|+|+||||
T Consensus 268 mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 268 LLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hcCcCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=342.08 Aligned_cols=228 Identities=24% Similarity=0.441 Sum_probs=191.6
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.+..... .....+.+.+|+.+++.++||||++++++|.. +.++|+|||||.||+|.+++... .+++..++.
T Consensus 71 ~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~ 146 (370)
T cd05621 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKF 146 (370)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHH
Confidence 78898865332 22344568899999999999999999998765 45899999999999999999763 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCC----CCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIP----YGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~----y~~ 154 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+.. ++.
T Consensus 147 ~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05621 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred HHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCc
Confidence 99999999999999999999999999999999999999999998764332 234678999999999987543 788
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCC--ccccHHHHHHHHHhccCCCCC--CCCHHHHHcCCC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLP--TVYSGAFRGLVKSMLRKNPEF--RPSAAELLCHPH 229 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp--~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~hp~ 229 (582)
++|||||||++|+|++|.+||.+.+....+..+.... ...++ ..++..++++|..||..++.+ |++++|+++|||
T Consensus 227 ~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 9999999999999999999999988877777775432 12223 357999999999999866544 899999999999
Q ss_pred Cchh
Q 007991 230 LQPY 233 (582)
Q Consensus 230 f~~~ 233 (582)
|+..
T Consensus 307 ~~~~ 310 (370)
T cd05621 307 FKND 310 (370)
T ss_pred cCCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.94 Aligned_cols=232 Identities=31% Similarity=0.484 Sum_probs=194.2
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc---CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV---RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L---~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.+..... .......+..|..++..+ +||||+.+++.|... ..+|+||||+.||+|.+++.+.. .+++.
T Consensus 20 ~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~ 96 (330)
T cd05586 20 IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMSGGELFWHLQKEG--RFSED 96 (330)
T ss_pred EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCCCChHHHHHHhcC--CCCHH
Confidence 379999865332 222334456677777766 699999999987654 58999999999999999998744 68999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCC-CCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADI-PYGS 154 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~-~y~~ 154 (582)
.++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+||+.|+|||++.+. .++.
T Consensus 97 ~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 176 (330)
T cd05586 97 RAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176 (330)
T ss_pred HHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCC
Confidence 9999999999999999999999999999999999999999999999876432 3334567899999999998754 4889
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC----CHHHHHcCCCC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP----SAAELLCHPHL 230 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp----Sa~EiL~hp~f 230 (582)
++|||||||++|+|++|..||.+.+...++..+...........+++.+.+||.+||+.||.+|+ +++++++||||
T Consensus 177 ~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred ccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 99999999999999999999999888888777765544333345899999999999999999998 79999999999
Q ss_pred chhhh
Q 007991 231 QPYVL 235 (582)
Q Consensus 231 ~~~~~ 235 (582)
....+
T Consensus 257 ~~~~~ 261 (330)
T cd05586 257 ADIDW 261 (330)
T ss_pred cCCCH
Confidence 86543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=328.75 Aligned_cols=232 Identities=28% Similarity=0.491 Sum_probs=196.4
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++....... .....+.+|+.+|+.++||||+++++.+... .++|+||||++||+|.+++.......+++..+.
T Consensus 27 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05605 27 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAV 105 (285)
T ss_pred eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHH
Confidence 48999987644332 3345678899999999999999999987654 589999999999999998876544569999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............+|++.|+|||++.+..++.++|||
T Consensus 106 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 185 (285)
T cd05605 106 FYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWW 185 (285)
T ss_pred HHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccch
Confidence 99999999999999999999999999999999999999999999776544444556899999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhh---ccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~---~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~ 231 (582)
|+||++|+|++|..||.+.+.......+.. ......+..++..+.+||.+||..||++|| +++++++||||.
T Consensus 186 s~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 186 GLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred hHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 999999999999999987665433332221 222335567899999999999999999999 999999999998
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
..
T Consensus 266 ~~ 267 (285)
T cd05605 266 TA 267 (285)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.59 Aligned_cols=228 Identities=34% Similarity=0.590 Sum_probs=207.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++.+....+ ..+.+++|+.+|.+++++||.++|+.|+.+ ..++++||||.||++.++++-.+ .++|..+..
T Consensus 40 ~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ 115 (467)
T KOG0201|consen 40 VVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAV 115 (467)
T ss_pred eEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHHHHhcCcchhhhhccCC--CCccceeee
Confidence 48999999876543 457899999999999999999999999864 58999999999999999999743 569999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++++++.||.|||.++.+|||||+.|||+..+|.|||+|||.+..+.... ...+++|||.|||||++.+..|+.++|||
T Consensus 116 ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIW 195 (467)
T KOG0201|consen 116 ILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIW 195 (467)
T ss_pred ehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhh
Confidence 99999999999999999999999999999999999999999998876554 34889999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++.|||++|.+||........+..|.+...+.+...+|..+++||..||++||+.||+|.++|+|.|++.
T Consensus 196 SLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 196 SLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999887777777777777777889999999999999999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.59 Aligned_cols=229 Identities=24% Similarity=0.402 Sum_probs=198.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHh--CCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKA--NGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~--~~~~ls 74 (582)
.||||++-.... --.+|+++|+.++|||||++..+|.... -++++||||+ ..+|.+.++.. .+..++
T Consensus 51 ~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp 123 (364)
T KOG0658|consen 51 EVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMP 123 (364)
T ss_pred eeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCc
Confidence 479999866443 2357999999999999999999887432 2567899999 58999999852 345799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPY 152 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y 152 (582)
.-.++-|.+||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+..+....++..|+.|+|||++.+ ..|
T Consensus 124 ~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Y 203 (364)
T KOG0658|consen 124 LLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 203 (364)
T ss_pred eeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCcccc
Confidence 99999999999999999999999999999999999988 8899999999999999988999999999999999876 469
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHH
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFR 204 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~ 204 (582)
+.+.||||.||+|+||+.|++.|.|.+..+++..|.+.++.| +....++++.
T Consensus 204 t~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~ 283 (364)
T KOG0658|consen 204 TTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDAL 283 (364)
T ss_pred CceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHH
Confidence 999999999999999999999999999888887776544433 2234678999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhhhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
+|+.++|+++|.+|.++.|+|.||||......
T Consensus 284 dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 284 DLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 99999999999999999999999999876544
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=339.27 Aligned_cols=228 Identities=27% Similarity=0.419 Sum_probs=191.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++..........+.+.+|+.+|+.++||||++++++|...+ ...|+||||++ ++|.+.+.. .+++.
T Consensus 45 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~ 119 (355)
T cd07874 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHE 119 (355)
T ss_pred EEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHH
Confidence 789999876666666778889999999999999999999886432 36799999996 567777764 48899
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.++.|++.||.|||++||+||||||+||||+.++.+||+|||+++...........+||+.|+|||++.+..++.++
T Consensus 120 ~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 199 (355)
T cd07874 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199 (355)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchh
Confidence 99999999999999999999999999999999999999999999999876555555667899999999999998999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------------------C
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------------------L 195 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------------------l 195 (582)
|||||||++|+|++|..||.+.+..+.+..+......+ .
T Consensus 200 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (355)
T cd07874 200 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279 (355)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccccc
Confidence 99999999999999999998877544433322111100 1
Q ss_pred CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 196 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 196 p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+...+..+++||.+||+.||++|||++|+|+||||+.+.
T Consensus 280 ~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred ccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 122456789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=332.31 Aligned_cols=231 Identities=27% Similarity=0.461 Sum_probs=193.7
Q ss_pred EEEEEecccccC-HHHHHHHHHH-HHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQT-DRARRSAHQE-MELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~-~~~~~~~~rE-i~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||+|.+...... ......+.+| ..+++.++||||++++++|... ..+|+||||+.|++|.+++.... .+++..++
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 99 (325)
T cd05602 23 YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHLQRER--CFLEPRAR 99 (325)
T ss_pred EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 789988754321 1222334444 4467889999999999987654 58999999999999999998744 68899999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||
T Consensus 100 ~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (325)
T cd05602 100 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179 (325)
T ss_pred HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCcccc
Confidence 9999999999999999999999999999999999999999999975432 333456789999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH----HHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA----ELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~----EiL~hp~f~~~~ 234 (582)
|||||++|+|++|.+||.+.+..+.+..+..... .++..++..+.++|.+||+.||.+|+++. ++++|+||..+.
T Consensus 180 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred ccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 9999999999999999999888887777655432 34567899999999999999999999865 899999998754
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 259 ~~ 260 (325)
T cd05602 259 WD 260 (325)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.02 Aligned_cols=233 Identities=26% Similarity=0.441 Sum_probs=192.0
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|++....... .....+..|+++|++++||||+++++.+.. +.++|+||||+.|++|.+++.......+++..+.
T Consensus 20 ~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~ 98 (277)
T cd05607 20 MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI 98 (277)
T ss_pred EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCCHHHHHHhccccCCCHHHHH
Confidence 37889886543322 233456779999999999999999987754 5689999999999999999877655568999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.............|++.|+|||++.+..++.++|||
T Consensus 99 ~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 178 (277)
T cd05607 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWF 178 (277)
T ss_pred HHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHH
Confidence 99999999999999999999999999999999999999999999776544444456799999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCH----HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH----HHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA----AELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~----~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa----~EiL~hp~f~ 231 (582)
||||++|+|++|..||..... ..+...+...........++.++++||.+||+.||++||++ ++++.|+||+
T Consensus 179 slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~ 258 (277)
T cd05607 179 AMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258 (277)
T ss_pred HHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence 999999999999999976532 22222222222222234689999999999999999999999 7788999998
Q ss_pred hhh
Q 007991 232 PYV 234 (582)
Q Consensus 232 ~~~ 234 (582)
.+.
T Consensus 259 ~~~ 261 (277)
T cd05607 259 TIN 261 (277)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.52 Aligned_cols=229 Identities=31% Similarity=0.529 Sum_probs=200.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~~ 79 (582)
||+|++... .......+.+|+.+|+.++|||||+++++|... ..+||||||++||+|.++++.. ....+++..+.
T Consensus 96 vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 96 VVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred EEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 677766443 334456778899999999999999999988665 5899999999999999988652 23468999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... .....+||+.|+|||++.+..++.++
T Consensus 173 ~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 252 (478)
T PTZ00267 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA 252 (478)
T ss_pred HHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHH
Confidence 999999999999999999999999999999999999999999998764332 24567899999999999998999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||||||++|+|++|..||.+.+..+++..+......+.+..++..+++||.+||..||++||+++++|.|+|++..
T Consensus 253 Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999998888888887776667788899999999999999999999999999999998754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.49 Aligned_cols=228 Identities=30% Similarity=0.431 Sum_probs=189.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc---CCCCeeeeeeEEEec----CcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVEK----GCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L---~HpnIV~l~~~~~~~----~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||.++...........+.+|+.+++.+ +||||+++++++... +..+++||||+. ++|.+++.......++
T Consensus 28 ~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~ 106 (288)
T cd07863 28 VALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLP 106 (288)
T ss_pred EEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCC
Confidence 78999876544333334566788877766 699999999987642 357899999996 5899998875555689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............||+.|+|||++.+..++.
T Consensus 107 ~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (288)
T cd07863 107 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYAT 186 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCC
Confidence 99999999999999999999999999999999999999999999999998765544455678999999999999888999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--------------------------CCCccccHHHHHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------------------------PLPTVYSGAFRGLVK 208 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--------------------------~lp~~~S~~l~~LI~ 208 (582)
++|||||||++|+|++|.+||.+........++...... .+...++..+.+||.
T Consensus 187 ~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 266 (288)
T cd07863 187 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLL 266 (288)
T ss_pred cchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHH
Confidence 999999999999999999999887766555554321110 011246788999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCC
Q 007991 209 SMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+||+.||++|||+.|+|.||||
T Consensus 267 ~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 267 EMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.52 Aligned_cols=228 Identities=36% Similarity=0.706 Sum_probs=204.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|++|.+............+.+|++++++++||||+++++.+... ...|+||||+.|++|.+++....+..+++..+..+
T Consensus 28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i 106 (256)
T cd08529 28 YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF 106 (256)
T ss_pred EEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHH
Confidence 78998877666667778899999999999999999999988765 58999999999999999998765567999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++...... ......|++.|+|||++.+..++.++|+||
T Consensus 107 ~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 186 (256)
T cd08529 107 FIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWA 186 (256)
T ss_pred HHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHH
Confidence 9999999999999999999999999999999999999999988664432 234567899999999999988999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||++|+|++|..||...+.......+......+++..++..+.++|.+||+.+|++||++.++++|||+
T Consensus 187 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 187 LGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999999999999999888877777777776667777899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.99 Aligned_cols=231 Identities=26% Similarity=0.459 Sum_probs=195.0
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHH-HHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||.+..... .......+.+|+. +++.++||||+++++.+.. +...|+|||||+|++|.+.+.... .+++..++
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 99 (321)
T cd05603 23 YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVNGGELFFHLQRER--CFLEPRAR 99 (321)
T ss_pred EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 78998865432 2233345555654 6889999999999987755 458999999999999999887643 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++... ........+||+.|+|||++.+..++.++||
T Consensus 100 ~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 179 (321)
T cd05603 100 FYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179 (321)
T ss_pred HHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcc
Confidence 999999999999999999999999999999999999999999987532 2233456789999999999999899999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH----HHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA----AELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa----~EiL~hp~f~~~~ 234 (582)
|||||++|+|++|.+||.+.+...+...+.... ..++...+..+.++|.+||+.||.+|+++ .++++|+||....
T Consensus 180 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred cccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 999999999999999999988888777776543 34566789999999999999999999865 5999999998754
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 259 ~~ 260 (321)
T cd05603 259 WD 260 (321)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=332.70 Aligned_cols=231 Identities=26% Similarity=0.473 Sum_probs=194.6
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHH-HHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++..... .......+.+|.. +++.++||||+++++.|... ..+|+||||+.||+|..++.+.. .+++..+
T Consensus 22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 98 (325)
T cd05604 22 CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVNGGELFFHLQRER--SFPEPRA 98 (325)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCCCCCHHHHHHHcC--CCCHHHH
Confidence 378999876433 2233345556655 57789999999999987654 58999999999999999988644 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|
T Consensus 99 ~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 178 (325)
T cd05604 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178 (325)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCc
Confidence 99999999999999999999999999999999999999999999875432 23345678999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH----HHHHcCCCCchh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA----AELLCHPHLQPY 233 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa----~EiL~hp~f~~~ 233 (582)
||||||++|+|++|.+||...+..+++..+..... .++..++..+.++|.+||+.||.+||++ ++++.||||...
T Consensus 179 vwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 179 WWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999999999888887777655432 3445689999999999999999999876 699999999864
Q ss_pred hh
Q 007991 234 VL 235 (582)
Q Consensus 234 ~~ 235 (582)
.+
T Consensus 258 ~~ 259 (325)
T cd05604 258 SW 259 (325)
T ss_pred CH
Confidence 43
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=333.66 Aligned_cols=226 Identities=31% Similarity=0.512 Sum_probs=191.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++... .+...+.+.+|+++|++++||||+++++++..+ ..+|+||||++|++|.+++.... .+++..+..+
T Consensus 33 ~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 108 (331)
T cd06649 33 MARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKEAK--RIPEEILGKV 108 (331)
T ss_pred EEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 6888887643 355667899999999999999999999988765 48999999999999999998754 6899999999
Q ss_pred HHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... .....+||+.|+|||++.+..++.++||||
T Consensus 109 ~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 187 (331)
T cd06649 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWS 187 (331)
T ss_pred HHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHH
Confidence 99999999999986 6999999999999999999999999999766432 345568999999999999989999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhh----------------------------------------------ccCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINK----------------------------------------------SIVAP 194 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~----------------------------------------------~~~~~ 194 (582)
|||++|+|++|+.||...+..++...+.. .....
T Consensus 188 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
T cd06649 188 MGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK 267 (331)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcC
Confidence 99999999999999977665444322211 11111
Q ss_pred C-CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 195 L-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 195 l-p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
. ...++.++++||.+||+.||++|||+++||+||||+.
T Consensus 268 ~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 268 LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 1 1247889999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=326.60 Aligned_cols=234 Identities=29% Similarity=0.507 Sum_probs=193.0
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~ 77 (582)
.||||++....... ...+.+..|+++|+.++|+||++++++|.. +..+|+||||++||+|.+++... ....+++..
T Consensus 20 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~ 98 (280)
T cd05608 20 LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR 98 (280)
T ss_pred EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHH
Confidence 37899987644322 234567889999999999999999987765 45899999999999999888542 234689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......||+.|+|||++.+..++.++
T Consensus 99 ~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 178 (280)
T cd05608 99 ACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178 (280)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccc
Confidence 99999999999999999999999999999999999999999999997654332 23456899999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHH----HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQ----ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~----~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~h 227 (582)
|||||||++|+|++|..||...+.. .....+... ...++..++..+.+|+.+||+.||++|+ +++++++|
T Consensus 179 DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 179 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999999765432 222222221 2235567899999999999999999999 88999999
Q ss_pred CCCchhhhh
Q 007991 228 PHLQPYVLG 236 (582)
Q Consensus 228 p~f~~~~~~ 236 (582)
|||+...+.
T Consensus 258 ~~~~~~~~~ 266 (280)
T cd05608 258 PLFRDLNWR 266 (280)
T ss_pred hhhhcCCHh
Confidence 999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=329.01 Aligned_cols=229 Identities=28% Similarity=0.422 Sum_probs=182.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++..... .....+.+|+.+|+.++||||+++++++... ...|+||||+. ++|.+++.+.. ..+++..++.
T Consensus 32 ~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~ 107 (303)
T cd07869 32 LVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKL 107 (303)
T ss_pred EEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHH
Confidence 3799998764332 2234567899999999999999999987654 58999999995 78888887643 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..++.++||
T Consensus 108 ~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (303)
T cd07869 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187 (303)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHH
Confidence 9999999999999999999999999999999999999999998754322 23345688999999999865 457889999
Q ss_pred cchhHHHHhHhcCCccccccC-HHHHHHHHhhccCCC----------------------CC---------ccccHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP----------------------LP---------TVYSGAFRGL 206 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~-~~~l~~kI~~~~~~~----------------------lp---------~~~S~~l~~L 206 (582)
|||||++|+|++|..||.+.. .......+......+ .+ ..+++.+.+|
T Consensus 188 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 267 (303)
T cd07869 188 WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDL 267 (303)
T ss_pred HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHH
Confidence 999999999999999998753 223232221111000 00 1245788999
Q ss_pred HHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 207 VKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 207 I~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|.+||+.||++|+|++|+|+||||+..
T Consensus 268 i~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 268 ASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HHHHhccCchhccCHHHHhcCcccccC
Confidence 999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.97 Aligned_cols=228 Identities=24% Similarity=0.435 Sum_probs=191.9
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|.+..... .......+.+|+.+++.++||||+++++.+.. +.++|+|||||+||+|.++++.. .+++..++
T Consensus 70 ~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~ 145 (371)
T cd05622 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWAR 145 (371)
T ss_pred EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHH
Confidence 378898865332 22344568899999999999999999998765 46899999999999999999764 58999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCC----CC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIP----YG 153 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~----y~ 153 (582)
.++.||+.||+|||++||+||||||+||||+.++++||+|||++....... .....+||+.|+|||++.+.. ++
T Consensus 146 ~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 225 (371)
T cd05622 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225 (371)
T ss_pred HHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCC
Confidence 999999999999999999999999999999999999999999998664332 234678999999999987543 78
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCC--CCCHHHHHcCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEF--RPSAAELLCHP 228 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~hp 228 (582)
.++|||||||++|+|++|.+||.+.+....+.++.... ..+....++..+++||..||..++.+ |+++++|++|+
T Consensus 226 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 89999999999999999999999998887777775432 22333468999999999999854443 78999999999
Q ss_pred CCch
Q 007991 229 HLQP 232 (582)
Q Consensus 229 ~f~~ 232 (582)
||+.
T Consensus 306 ~~~~ 309 (371)
T cd05622 306 FFKN 309 (371)
T ss_pred ccCC
Confidence 9976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=322.42 Aligned_cols=229 Identities=24% Similarity=0.436 Sum_probs=208.8
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
++|+|++....... ....++.||++|-..|+||||+++|++|.+ ...+|+++||..+|.|...++......++|..+.
T Consensus 49 IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a 127 (281)
T KOG0580|consen 49 IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAA 127 (281)
T ss_pred EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cceeEEEEEecCCchHHHHHHhcccccccccchh
Confidence 58999987654322 345678999999999999999999998765 4599999999999999999997667789999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|++|++.||.|||..+||||||||+|+|++.+|.+||+|||.+.... .....+.|||..|.+||...+..++..+|+|
T Consensus 128 ~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w 206 (281)
T KOG0580|consen 128 TYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLW 206 (281)
T ss_pred HHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHH
Confidence 999999999999999999999999999999999999999999986654 5668899999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++|++.||++.|.+||......+.+.+|.+.... +|..++..++++|.+||.++|.+|....|++.|||+..
T Consensus 207 ~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 207 SLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999999999876554 67899999999999999999999999999999999864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=311.95 Aligned_cols=228 Identities=40% Similarity=0.696 Sum_probs=204.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|++.....+....+.+.+|+++|++++|+||+++++++.+. ...++|||||.|++|.+++....+..+++..+..+
T Consensus 28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08221 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106 (256)
T ss_pred EEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHH
Confidence 78999988777777778899999999999999999999988764 58999999999999999998764557899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ......|++.|+|||.+.+..++.++|+||
T Consensus 107 ~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~s 186 (256)
T cd08221 107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWA 186 (256)
T ss_pred HHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHH
Confidence 9999999999999999999999999999999999999999997664433 344567999999999998888899999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||++|+|++|..||...+..+....+......+.+..++.++.++|.+||..+|.+||+++++|+|+|+
T Consensus 187 lG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999999999999999988888877776666666667789999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.83 Aligned_cols=233 Identities=28% Similarity=0.469 Sum_probs=194.9
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++...... ......+.+|+.+|++++|++|+.+++.+... ..+|+||||+.|++|.+++.......+++..+.
T Consensus 27 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~ 105 (285)
T cd05630 27 MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAV 105 (285)
T ss_pred eEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHH
Confidence 4899988764332 23345678899999999999999999987654 589999999999999999976555569999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++............+|+..|+|||++.+..++.++|||
T Consensus 106 ~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw 185 (285)
T cd05630 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 185 (285)
T ss_pred HHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccH
Confidence 99999999999999999999999999999999999999999998765444444456899999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccCHH---HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQ---ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~---~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~ 231 (582)
||||++|+|++|..||...... .....+........+..+++.+++||.+||+.||++|+| ++|++.||||+
T Consensus 186 slG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 186 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred HHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 9999999999999999864321 122222222223355678999999999999999999999 99999999998
Q ss_pred hhh
Q 007991 232 PYV 234 (582)
Q Consensus 232 ~~~ 234 (582)
...
T Consensus 266 ~~~ 268 (285)
T cd05630 266 QIN 268 (285)
T ss_pred ccC
Confidence 643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.13 Aligned_cols=227 Identities=23% Similarity=0.376 Sum_probs=186.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-------CcEEEEEEeecCCCCHHHHHHH--hCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------GCYVCIIIGYCEGGDMAEAIKK--ANGV 71 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-------~~~l~LVmEy~~GgsL~d~Ikk--~~~~ 71 (582)
.||||++..... ...+|+.+|+.++|||||+++++|... ..++|+|||||. ++|.+++.. ..+.
T Consensus 93 ~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~ 165 (440)
T PTZ00036 93 KVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNH 165 (440)
T ss_pred EEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCC
Confidence 378998854322 345799999999999999999876532 236889999996 578777753 2345
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccCC
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~ 150 (582)
.+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||+++..........++||+.|+|||++.+.
T Consensus 166 ~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245 (440)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCC
Confidence 799999999999999999999999999999999999999765 6999999999877655555678899999999998764
Q ss_pred -CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC----------------------------CCCccccH
Q 007991 151 -PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----------------------------PLPTVYSG 201 (582)
Q Consensus 151 -~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----------------------------~lp~~~S~ 201 (582)
.|+.++|||||||++|||++|.+||.+.+..+.+..+...... .+|...+.
T Consensus 246 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~ 325 (440)
T PTZ00036 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPD 325 (440)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCH
Confidence 6899999999999999999999999987765555444322111 12344678
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
++.+||.+||++||.+|+|+.|+|+||||+.+.
T Consensus 326 ~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 326 DAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 999999999999999999999999999998654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.22 Aligned_cols=235 Identities=28% Similarity=0.555 Sum_probs=208.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-------cEEEEEEeecCCCCHHHHHHHh--CCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-------CYVCIIIGYCEGGDMAEAIKKA--NGV 71 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-------~~l~LVmEy~~GgsL~d~Ikk~--~~~ 71 (582)
.||||.+............+.+|+.+|..++|+||+++++.+...+ ..+++||||+.+|+|.++++.. ...
T Consensus 59 ~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~ 138 (496)
T PTZ00283 59 PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR 138 (496)
T ss_pred EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCC
Confidence 3899999887777777788999999999999999999988776432 2578999999999999999753 234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc---ccccCcccCCCCCCCccccc
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPELLA 148 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~---~~~~~~~vGTp~Y~APE~l~ 148 (582)
.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+||+.|+|||++.
T Consensus 139 ~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 218 (496)
T PTZ00283 139 TFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218 (496)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhC
Confidence 689999999999999999999999999999999999999999999999999976543 22345678999999999999
Q ss_pred CCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
+..|+.++|||||||++|||++|..||.+.+...++..+......+++..+++++.+||.+||..||.+||++.++|.||
T Consensus 219 ~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 99999999999999999999999999999998888888877777778889999999999999999999999999999999
Q ss_pred CCchhhh
Q 007991 229 HLQPYVL 235 (582)
Q Consensus 229 ~f~~~~~ 235 (582)
|++.+..
T Consensus 299 ~~~~~~~ 305 (496)
T PTZ00283 299 ICKLFIS 305 (496)
T ss_pred HHHHhhh
Confidence 9987553
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=328.46 Aligned_cols=231 Identities=25% Similarity=0.463 Sum_probs=197.5
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++.... .....+.+..|+.++..+. |++|+.+++++.. +..+|+||||+.||+|.+.+.... .+++..+
T Consensus 27 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~ 103 (323)
T cd05616 27 LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHA 103 (323)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHH
Confidence 378999876432 2234456778888988885 7888888887655 458999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|
T Consensus 104 ~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 183 (323)
T cd05616 104 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183 (323)
T ss_pred HHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccc
Confidence 99999999999999999999999999999999999999999999975432 22344678999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||.+.+...+...+..... .++..++.++.+||.+||+.||.+|++ ..+++.||||+.
T Consensus 184 iwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred hhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999999999999998888887765443 467789999999999999999999997 489999999986
Q ss_pred hhh
Q 007991 233 YVL 235 (582)
Q Consensus 233 ~~~ 235 (582)
..+
T Consensus 263 ~~~ 265 (323)
T cd05616 263 IDW 265 (323)
T ss_pred CCH
Confidence 443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.39 Aligned_cols=232 Identities=24% Similarity=0.391 Sum_probs=190.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+.+++.++||||++++++|..+ ...|+||||+++++|.+++.......+++..++.
T Consensus 27 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~ 105 (327)
T cd08227 27 YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105 (327)
T ss_pred EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHH
Confidence 389999988766667777889999999999999999999988765 5899999999999999999875444689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--------ccCcccCCCCCCCcccccC--C
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLAD--I 150 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l~~--~ 150 (582)
++.||+.||+|||++||+||||||+|||++.++.++++|||.+....... .....+++..|+|||++.+ .
T Consensus 106 i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (327)
T cd08227 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ 185 (327)
T ss_pred HHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccC
Confidence 99999999999999999999999999999999999999998654432111 1223467788999999876 4
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC--------------------------------------
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-------------------------------------- 192 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-------------------------------------- 192 (582)
.|+.++|||||||++|+|++|..||.................
T Consensus 186 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (327)
T cd08227 186 GYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRP 265 (327)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCc
Confidence 588999999999999999999999987654433322211110
Q ss_pred -------CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 193 -------APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 193 -------~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.+....+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 266 SNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 01122357789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.50 Aligned_cols=233 Identities=25% Similarity=0.440 Sum_probs=191.5
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.... .....+.+.+|+.++..++|+||+.++++|..+ .++|+||||+.||+|.+++.+. +..+++..++.
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~ 106 (331)
T cd05597 29 YAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARF 106 (331)
T ss_pred EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHH
Confidence 79999875332 223456688999999999999999999987654 5899999999999999999864 33689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccC-----CCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLAD-----IPYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~-----~~y~ 153 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ....+||+.|+|||++.. ..++
T Consensus 107 ~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (331)
T cd05597 107 YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186 (331)
T ss_pred HHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCC
Confidence 999999999999999999999999999999999999999999876543322 223579999999999863 3578
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CC---CCCccccHHHHHHHHHhccCCCCC--CCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VA---PLPTVYSGAFRGLVKSMLRKNPEF--RPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~---~lp~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~h 227 (582)
.++|||||||++|+|++|..||.+.+..+.+..+.... .. +....++..+++||.+||..+++. |+++++++.|
T Consensus 187 ~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 89999999999999999999999888777776664322 11 222347999999999999764443 7899999999
Q ss_pred CCCchhhhh
Q 007991 228 PHLQPYVLG 236 (582)
Q Consensus 228 p~f~~~~~~ 236 (582)
|||....+.
T Consensus 267 p~~~~~~~~ 275 (331)
T cd05597 267 PFFEGIDWD 275 (331)
T ss_pred CCCCCCCHH
Confidence 999875443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=311.31 Aligned_cols=228 Identities=37% Similarity=0.688 Sum_probs=204.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+..........+.+.+|+++|++++||||+++++.+.. +...++||||++|++|.+++....+..+++..+..+
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08220 28 VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106 (256)
T ss_pred EEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHH
Confidence 7899998766666667889999999999999999999998765 458999999999999999998765556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||+|||++||+|+||+|+||+++.++ .+||+|||++.............|+..|+|||.+.+..++.++|+||
T Consensus 107 ~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 186 (256)
T cd08220 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWA 186 (256)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHH
Confidence 99999999999999999999999999998665 58999999998776554455678899999999999888899999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||++|+|++|..||.+.+.......+......+++..++..+.++|..||..+|++|||++|+|+||||
T Consensus 187 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 187 LGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999988887777777666666777899999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=312.09 Aligned_cols=226 Identities=31% Similarity=0.536 Sum_probs=193.2
Q ss_pred EEEEEecccccCH---HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTD---RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~---~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||.++...... ...+.+.+|++++++++||||+++++++... ..+|+|+||+.|++|.+++.... .+++..+
T Consensus 30 ~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~ 106 (263)
T cd06625 30 LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-ETLSIFMEYMPGGSVKDQLKAYG--ALTETVT 106 (263)
T ss_pred EEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-CeEEEEEEECCCCcHHHHHHHhC--CCCHHHH
Confidence 7889887544322 2346789999999999999999999988665 49999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
+.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++....... .....|+..|+|||++.+..++.
T Consensus 107 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (263)
T cd06625 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186 (263)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCc
Confidence 99999999999999999999999999999999999999999999876543211 13457889999999999988999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHh-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
++|||||||++|+|++|+.||...+.......+. ......++..++..+.++|.+||..+|.+||++.++|.|+||
T Consensus 187 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred hhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999998776655444433 233445677899999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.78 Aligned_cols=225 Identities=30% Similarity=0.504 Sum_probs=185.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++.... .....+.+.+|+++|+.++|+||++++++|.. +..+|+|||||+|++|.+. ....+..+..
T Consensus 101 ~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~ 172 (353)
T PLN00034 101 LYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEFMDGGSLEGT------HIADEQFLAD 172 (353)
T ss_pred EEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEecCCCCccccc------ccCCHHHHHH
Confidence 38999886543 34556789999999999999999999998755 4589999999999998642 2467888999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-----CCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-----IPYGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-----~~y~~ 154 (582)
++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ......+||..|+|||++.. ..++.
T Consensus 173 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 252 (353)
T PLN00034 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252 (353)
T ss_pred HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCc
Confidence 9999999999999999999999999999999999999999999876432 22345689999999998743 22456
Q ss_pred CCcccchhHHHHhHhcCCccccccC---HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~---~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
++|||||||++|||++|+.||.... ...+...+........+..++.++++||.+||..||++||++.|+|+||||.
T Consensus 253 ~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 253 AGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 8999999999999999999997433 2333333434444455677899999999999999999999999999999997
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
..
T Consensus 333 ~~ 334 (353)
T PLN00034 333 RA 334 (353)
T ss_pred cC
Confidence 63
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.45 Aligned_cols=233 Identities=25% Similarity=0.443 Sum_probs=192.6
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+..... .......+..|+.++..++|+||+++++.+... ..+|+||||+.||+|.+++.+.. ..+++..++.
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~ 106 (332)
T cd05623 29 FAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARF 106 (332)
T ss_pred EEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHH
Confidence 78888865322 223345688999999999999999999987654 58999999999999999998743 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCccccc-----CCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLA-----DIPYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~-----~~~y~ 153 (582)
|+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++. ...++
T Consensus 107 ~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (332)
T cd05623 107 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYG 186 (332)
T ss_pred HHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCC
Confidence 99999999999999999999999999999999999999999987654332 223468999999999986 34578
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-CCC---CccccHHHHHHHHHhccCCCCC--CCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-APL---PTVYSGAFRGLVKSMLRKNPEF--RPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-~~l---p~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~h 227 (582)
.++|||||||++|||++|..||.+.+....+.++..... .++ ...++.++++||.+||..++.. |++++++++|
T Consensus 187 ~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 899999999999999999999999888887777754331 122 2357999999999999765554 6899999999
Q ss_pred CCCchhhhh
Q 007991 228 PHLQPYVLG 236 (582)
Q Consensus 228 p~f~~~~~~ 236 (582)
|||+...+.
T Consensus 267 ~~f~~~~~~ 275 (332)
T cd05623 267 PFFTGIDWD 275 (332)
T ss_pred CCcCCCCHH
Confidence 999875443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=328.61 Aligned_cols=224 Identities=18% Similarity=0.382 Sum_probs=187.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++... .....+.+.+|+.+|.++ +|||||++++++...+..+|+|||||+||+|.+++....
T Consensus 40 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~ 118 (338)
T cd05102 40 VAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSP 118 (338)
T ss_pred hheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccch
Confidence 7888887543 334456789999999999 899999999988776778999999999999999997532
Q ss_pred -------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 007991 70 -------------------------------------------------GVHFPEEKLCKWLVQLLMALNYLHANHILHR 100 (582)
Q Consensus 70 -------------------------------------------------~~~lse~~~~~il~QLL~aL~yLHs~gIiHR 100 (582)
...+++..+..|+.||+.||+|||++||+||
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 198 (338)
T cd05102 119 KQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHR 198 (338)
T ss_pred hhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Confidence 1247888999999999999999999999999
Q ss_pred ccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCcccc
Q 007991 101 DVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFK 176 (582)
Q Consensus 101 DIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~ 176 (582)
||||+|||++.++.+||+|||+++...... ......+++.|+|||++.+..|+.++|||||||++|||++ |..||.
T Consensus 199 DiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 199 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred CCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998653321 1223456678999999999899999999999999999996 999998
Q ss_pred ccCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 177 AFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 177 ~~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+.... .+...+........+..++..+.+||.+||..||.+|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 279 GVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 76543 333444444445567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.61 Aligned_cols=229 Identities=26% Similarity=0.378 Sum_probs=191.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++..........+.+.+|+.+|+.++|+||+++++++...+ ..+|+||||+. ++|.+.+.... .+++..
T Consensus 28 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~ 104 (372)
T cd07853 28 VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDH 104 (372)
T ss_pred EEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC--CCCHHH
Confidence 899998765555555678899999999999999999999876543 27899999995 68888887533 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc--cccCcccCCCCCCCcccccCC-CCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELLADI-PYGS 154 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--~~~~~~vGTp~Y~APE~l~~~-~y~~ 154 (582)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......++|+.|+|||++.+. .|+.
T Consensus 105 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 184 (372)
T cd07853 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184 (372)
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCc
Confidence 9999999999999999999999999999999999999999999999765332 223446789999999998874 4789
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-------------------------------CCCccccHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-------------------------------PLPTVYSGAF 203 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-------------------------------~lp~~~S~~l 203 (582)
++|||||||++|||++|++||.+.+.......+...... .+....++++
T Consensus 185 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (372)
T cd07853 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEA 264 (372)
T ss_pred HHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHH
Confidence 999999999999999999999888766655554321110 1223457899
Q ss_pred HHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 204 RGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 204 ~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.+||.+||+.||++|||+.|+|.||||+..
T Consensus 265 ~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 265 VHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.09 Aligned_cols=227 Identities=27% Similarity=0.432 Sum_probs=187.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++..........+.+.+|+.+|++++|+||++++++|.... ..+|++|+++ |++|.++++.. .+++
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~ 117 (343)
T cd07878 42 KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSD 117 (343)
T ss_pred EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCH
Confidence 3899999765554455567889999999999999999999875322 4578999998 88999888642 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....+||+.|+|||++.+ ..++.
T Consensus 118 ~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 195 (343)
T cd07878 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCc
Confidence 99999999999999999999999999999999999999999999999986543 2456789999999999876 56889
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l~ 204 (582)
++|||||||++|+|++|..||.+.+..+.+..+......+ ....+++.+.
T Consensus 196 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (343)
T cd07878 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAI 275 (343)
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHH
Confidence 9999999999999999999998776555444432211110 0123566789
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+||.+||+.||.+|||+.|+|.||||..+
T Consensus 276 ~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 276 DLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 99999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=319.95 Aligned_cols=223 Identities=17% Similarity=0.268 Sum_probs=192.4
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEe--c-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVE--K-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~--~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.++...... ...+.+.+|+.+|++++|||||++++++.+ . ..++++|||||.||+|.+++.+.. .+++.
T Consensus 45 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~ 122 (283)
T PHA02988 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFK 122 (283)
T ss_pred EEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChh
Confidence 37999997654433 345788999999999999999999998875 2 357899999999999999998754 68999
Q ss_pred HHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC--CCCC
Q 007991 77 KLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--IPYG 153 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~--~~y~ 153 (582)
....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..... ....+|+..|+|||++.+ ..|+
T Consensus 123 ~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 200 (283)
T PHA02988 123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYT 200 (283)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhcccccc
Confidence 9999999999999999984 9999999999999999999999999999865432 234678999999999976 6799
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh-ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~-~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++|||||||++|||++|..||.+.+..++...+.. ....+++..++..+.+||.+||+.||++|||++|+++.
T Consensus 201 ~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999999999999999999888887777643 33445566789999999999999999999999999863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.41 Aligned_cols=231 Identities=25% Similarity=0.469 Sum_probs=196.5
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .....+.+..|+.++..+.| ++|+.+++.+.. +..+|+||||++||+|.+++...+ .+++..+
T Consensus 27 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~ 103 (323)
T cd05615 27 LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQA 103 (323)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHH
Confidence 389999876432 22344667889999998875 567778876654 458999999999999999998754 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..++.++|
T Consensus 104 ~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 183 (323)
T cd05615 104 VFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVD 183 (323)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccc
Confidence 999999999999999999999999999999999999999999998764322 2344567999999999999989999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~ 232 (582)
||||||++|+|++|.+||.+.+...+...+..... ..+..++..+.+|+.+||+++|.+|++ .+++++||||+.
T Consensus 184 iwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999999999999999999888887777765433 466778999999999999999999997 589999999987
Q ss_pred hhh
Q 007991 233 YVL 235 (582)
Q Consensus 233 ~~~ 235 (582)
..+
T Consensus 263 ~~~ 265 (323)
T cd05615 263 IDW 265 (323)
T ss_pred CCH
Confidence 543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.15 Aligned_cols=224 Identities=26% Similarity=0.430 Sum_probs=176.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHhC-------CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKAN-------GVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~~-------~~~l 73 (582)
||||++...... ..+.+|+++|++++||||++++++|.. .+..+|+||||+. ++|.+++.... ...+
T Consensus 31 ~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l 105 (317)
T cd07868 31 YALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQL 105 (317)
T ss_pred EEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccC
Confidence 789988654332 346789999999999999999998864 3457899999994 68988886421 2358
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEE----cCCCCeEEeecccchhccccc----ccCcccCCCCCCCcc
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPE 145 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL----~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE 145 (582)
++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...... .....+||+.|+|||
T Consensus 106 ~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07868 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCH
Confidence 999999999999999999999999999999999999 455789999999998654322 234578999999999
Q ss_pred cccC-CCCCCCCcccchhHHHHhHhcCCccccccCH---------HHHHHHHhhccCCC---------------------
Q 007991 146 LLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------QALINKINKSIVAP--------------------- 194 (582)
Q Consensus 146 ~l~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~---------~~l~~kI~~~~~~~--------------------- 194 (582)
++.+ ..|+.++||||+||++|+|++|.+||..... ...+..+......+
T Consensus 186 ~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (317)
T cd07868 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 265 (317)
T ss_pred HHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhh
Confidence 9876 4589999999999999999999999964331 11111111110000
Q ss_pred ----------------CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 195 ----------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 195 ----------------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.....+..+.+||.+||+.||.+|+|++|+|+||||
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 266 RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 011235678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.25 Aligned_cols=228 Identities=27% Similarity=0.511 Sum_probs=198.8
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .....+.+.+|+++|++++||||+++++.+.. +...|+||||+.|++|.+++.+.. .+++..+.
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~ 104 (290)
T cd05580 28 YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLVMEYVPGGELFSHLRKSG--RFPEPVAR 104 (290)
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHH
Confidence 378888865432 23455778999999999999999999998765 458999999999999999998754 78999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||+|||+.||+||||+|.||||+.++.+||+|||++...... ....+|++.|+|||.+.+..++.++|||
T Consensus 105 ~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 182 (290)
T cd05580 105 FYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWW 182 (290)
T ss_pred HHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHH
Confidence 99999999999999999999999999999999999999999999876544 4456799999999999888889999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~~ 234 (582)
|||+++|+|++|..||...+.......+... ...++..++..++++|.+||..||.+|+ +++|++.||||+...
T Consensus 183 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 183 ALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999999999999888876666665533 3456777899999999999999999999 999999999998644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=327.36 Aligned_cols=226 Identities=31% Similarity=0.527 Sum_probs=188.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+.... .+...+.+.+|+++|++++|+||++++++|..+ .++|+||||+.|++|.+++...+ .+++..+..+
T Consensus 33 ~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 108 (333)
T cd06650 33 MARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKV 108 (333)
T ss_pred EEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 6778776653 345567899999999999999999999988765 58999999999999999998754 6899999999
Q ss_pred HHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+..++.++||||
T Consensus 109 ~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 187 (333)
T cd06650 109 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWS 187 (333)
T ss_pred HHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHH
Confidence 99999999999985 7999999999999999999999999999765332 334568999999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHH--------------------------------------------hhccCCCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKI--------------------------------------------NKSIVAPLP 196 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI--------------------------------------------~~~~~~~lp 196 (582)
|||++|+|++|+.||.......+...+ ........+
T Consensus 188 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (333)
T cd06650 188 MGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP 267 (333)
T ss_pred HHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCC
Confidence 999999999999999765543332111 111111111
Q ss_pred -ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 197 -TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 197 -~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
..++.++++||.+||++||++|||++|+|.|+||+.
T Consensus 268 ~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 268 SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 236789999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.23 Aligned_cols=233 Identities=24% Similarity=0.436 Sum_probs=192.5
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+.... ........+.+|+.++..++|+||+.+++.+.. +.+.|+||||+.||+|.+++.+.+ ..+++..++.
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~ 106 (331)
T cd05624 29 YAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARF 106 (331)
T ss_pred EEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHH
Confidence 7899886532 222344568889999999999999999998765 458999999999999999998743 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccC-----CCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLAD-----IPYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~-----~~y~ 153 (582)
++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ....+||+.|+|||++.+ ..++
T Consensus 107 ~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 186 (331)
T cd05624 107 YIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 186 (331)
T ss_pred HHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCC
Confidence 999999999999999999999999999999999999999999976644322 234679999999999875 4578
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCC---ccccHHHHHHHHHhccCCCCC--CCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLP---TVYSGAFRGLVKSMLRKNPEF--RPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp---~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~h 227 (582)
.++|||||||++|+|++|+.||...+..+.+.++.... ..+++ ..++..+++||.+||..++.+ |++++++++|
T Consensus 187 ~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 89999999999999999999999888877777665432 12223 346899999999999876654 4799999999
Q ss_pred CCCchhhhh
Q 007991 228 PHLQPYVLG 236 (582)
Q Consensus 228 p~f~~~~~~ 236 (582)
+||+...+.
T Consensus 267 ~~f~~~~~~ 275 (331)
T cd05624 267 AFFEGIDWE 275 (331)
T ss_pred CCcCCCCHH
Confidence 999865443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.28 Aligned_cols=228 Identities=41% Similarity=0.803 Sum_probs=202.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+..........+.+.+|+.++++++|+||+++++.+.. +.+.|+||||+.|++|.+++....+..+++..+..|
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08218 28 YVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106 (256)
T ss_pred EEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 7899988766666666789999999999999999999997755 458999999999999999998755556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||++|++|+||+|+|||++.++.++|+|||++....... ......|++.|+|||++.+..++.++|+||
T Consensus 107 ~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s 186 (256)
T cd08218 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWA 186 (256)
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhH
Confidence 9999999999999999999999999999999999999999997654432 223456889999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||++|+|++|..||...+..+....+......+.+..++..+.++|.+||+.+|.+||++.++|.||||
T Consensus 187 lG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 187 LGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999999999999999888888887777666666778899999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.44 Aligned_cols=229 Identities=40% Similarity=0.692 Sum_probs=205.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~ 78 (582)
||+|.+..........+.+..|+++|++++|+||+++++.+.. .+...|++|||+.+++|.+++... .+..+++..+
T Consensus 28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 107 (265)
T cd08217 28 LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107 (265)
T ss_pred EEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHH
Confidence 7889888766677777889999999999999999999998764 346789999999999999999763 2346899999
Q ss_pred HHHHHHHHHHHHHHH-----HCCceecccCcccEEEcCCCCeEEeecccchhcccccc-cCcccCCCCCCCcccccCCCC
Q 007991 79 CKWLVQLLMALNYLH-----ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 79 ~~il~QLL~aL~yLH-----s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-~~~~vGTp~Y~APE~l~~~~y 152 (582)
..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++........ .....|++.|+|||.+.+..+
T Consensus 108 ~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~ 187 (265)
T cd08217 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSY 187 (265)
T ss_pred HHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCC
Confidence 999999999999999 99999999999999999999999999999987755433 445689999999999998889
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+.++|+||||+++|+|++|..||...+...+...+.......++..++..+.+++.+||..+|++||++++||+|||+
T Consensus 188 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 188 DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999988888888887777777888899999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.22 Aligned_cols=231 Identities=27% Similarity=0.499 Sum_probs=199.9
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.+..... .....+.+.+|+.+++.++||||+++++.+.. +..+|+||||++|++|.+++.+.. .+++..+.
T Consensus 20 ~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~ 96 (262)
T cd05572 20 TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGELWTILRDRG--LFDEYTAR 96 (262)
T ss_pred EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCcHHHHHhhcC--CCCHHHHH
Confidence 378999876543 33456789999999999999999999997654 458999999999999999998753 58999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.............|++.|++||.+.+..++.++|+|
T Consensus 97 ~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~ 176 (262)
T cd05572 97 FYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176 (262)
T ss_pred HHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhh
Confidence 99999999999999999999999999999999999999999999877654444456889999999999888899999999
Q ss_pred chhHHHHhHhcCCccccccC--HHHHHHHHhh-ccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFD--MQALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~--~~~l~~kI~~-~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~ 231 (582)
||||++|+|++|..||.... ......++.. ......+...+..+.++|.+||..||++|++ ++|+++||||+
T Consensus 177 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred hhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 99999999999999998776 5566665553 3344566667999999999999999999999 99999999998
Q ss_pred hhh
Q 007991 232 PYV 234 (582)
Q Consensus 232 ~~~ 234 (582)
++.
T Consensus 257 ~~~ 259 (262)
T cd05572 257 GFD 259 (262)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.25 Aligned_cols=226 Identities=31% Similarity=0.522 Sum_probs=194.8
Q ss_pred EEEEEecccccCH-------HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTD-------RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~-------~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||+|.+....... ...+.+.+|+.++++++||||+++++.+... .+.++||||+.+++|.+++...+ .++
T Consensus 28 ~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~ 104 (267)
T cd06628 28 MAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-DHLNIFLEYVPGGSVAALLNNYG--AFE 104 (267)
T ss_pred EEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CccEEEEEecCCCCHHHHHHhcc--Ccc
Confidence 7888886643321 2346788999999999999999999987654 58899999999999999998754 689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-------ccCcccCCCCCCCcccc
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-------LASSVVGTPSYMCPELL 147 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-------~~~~~vGTp~Y~APE~l 147 (582)
+..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++...... ......|+..|+|||.+
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 105 ETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHh
Confidence 99999999999999999999999999999999999999999999999988764221 12235688999999999
Q ss_pred cCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.+..++.++|+|||||++|+|++|..||...+....+..+.......++..++..+.++|.+||+.||.+||++.++++|
T Consensus 185 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 98889999999999999999999999998876665555555555556777899999999999999999999999999999
Q ss_pred CCC
Q 007991 228 PHL 230 (582)
Q Consensus 228 p~f 230 (582)
|||
T Consensus 265 ~~~ 267 (267)
T cd06628 265 PFL 267 (267)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.09 Aligned_cols=234 Identities=26% Similarity=0.477 Sum_probs=197.4
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|++....... .....+.+|+++|++++|+||+.+++.+..+ ..+|+||||+.+++|.+++...+...+++..+.
T Consensus 27 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05632 27 MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFEEERAL 105 (285)
T ss_pred EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHH
Confidence 37899887654332 3345678999999999999999999887654 589999999999999999876555579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.............|+..|+|||++.+..++.++|||
T Consensus 106 ~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~ 185 (285)
T cd05632 106 FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYW 185 (285)
T ss_pred HHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchH
Confidence 99999999999999999999999999999999999999999998765444344556899999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhc---cCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~---~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~ 231 (582)
||||++|+|++|..||.+.........+... .....+..++.++.+|+..||+.||++||+ +++++.|+||+
T Consensus 186 slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 186 GLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 9999999999999999887655443333221 123345668899999999999999999999 89999999998
Q ss_pred hhhh
Q 007991 232 PYVL 235 (582)
Q Consensus 232 ~~~~ 235 (582)
.+-+
T Consensus 266 ~~~~ 269 (285)
T cd05632 266 NMNF 269 (285)
T ss_pred cCCH
Confidence 7533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=343.47 Aligned_cols=227 Identities=22% Similarity=0.412 Sum_probs=182.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCC------CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNP------FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hp------nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
.||||+++.. ....+.+..|+++++.++|. +|+.++++|.....++|+|||++ |++|.+++.+.+ .++
T Consensus 156 ~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~ 229 (467)
T PTZ00284 156 YCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFS 229 (467)
T ss_pred EEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCC
Confidence 3899998642 22334567788888887654 58888888877667899999999 789999888754 699
Q ss_pred HHHHHHHHHHHHHHHHHHHH-CCceecccCcccEEEcCCC----------------CeEEeecccchhcccccccCcccC
Q 007991 75 EEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQ----------------DIRLGDFGLAKMLISDDLASSVVG 137 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g----------------~vKL~DFGla~~~~~~~~~~~~vG 137 (582)
+..++.|+.||+.||+|||+ .|||||||||+|||++.++ .+||+|||++.... ......+|
T Consensus 230 ~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~g 307 (467)
T PTZ00284 230 HRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVS 307 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc--cccccccC
Confidence 99999999999999999998 5999999999999998765 49999999886432 23456789
Q ss_pred CCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------
Q 007991 138 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------- 194 (582)
Q Consensus 138 Tp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------- 194 (582)
|+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.......
T Consensus 308 t~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 387 (467)
T PTZ00284 308 TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL 387 (467)
T ss_pred CccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccc
Confidence 999999999999999999999999999999999999998877655444433221100
Q ss_pred -----------------C-CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 195 -----------------L-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 195 -----------------l-p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
+ ....++.+.+||.+||++||++|+|++|+|+||||+.+..
T Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 388 RPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred cccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 0 0012456789999999999999999999999999987543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.12 Aligned_cols=218 Identities=35% Similarity=0.589 Sum_probs=196.9
Q ss_pred CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Q 007991 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL 92 (582)
Q Consensus 13 ~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yL 92 (582)
..+..+.+.-||+||..|+||+||.+++.|+.++ .++|+.|||.||-...++-..+ ..+.+.+++.+++|+|.||.||
T Consensus 69 seEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~L 146 (1187)
T KOG0579|consen 69 SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWL 146 (1187)
T ss_pred chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHH
Confidence 4456678899999999999999999999988765 8999999999999999988854 5799999999999999999999
Q ss_pred HHCCceecccCcccEEEcCCCCeEEeecccchhc-ccccccCcccCCCCCCCccccc-----CCCCCCCCcccchhHHHH
Q 007991 93 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVY 166 (582)
Q Consensus 93 Hs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~-~~~~~~~~~vGTp~Y~APE~l~-----~~~y~~ksDIWSLG~iLy 166 (582)
|+++|||||||..|||++.+|+|+|+|||.+... .......+++|||+|||||++. +.+|++++||||||++|.
T Consensus 147 Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI 226 (1187)
T KOG0579|consen 147 HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI 226 (1187)
T ss_pred hhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence 9999999999999999999999999999987443 3344677899999999999875 568999999999999999
Q ss_pred hHhcCCccccccCHHHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 167 EMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 167 ELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||..+.+|....+....+-+|.+...+.+ |..|+..|.+|+++||.+||..||++.+||+||||+.
T Consensus 227 EMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 227 EMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred HHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999999999999987765543 6789999999999999999999999999999999983
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.36 Aligned_cols=234 Identities=29% Similarity=0.491 Sum_probs=198.4
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.+....... ...+.+..|+++|+.++|+||+++++.+.. +...|+||||+.|++|.+++....+..+++..++
T Consensus 28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~ 106 (316)
T cd05574 28 LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR 106 (316)
T ss_pred EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHH
Confidence 37999997765443 455778999999999999999999998765 4589999999999999999987655679999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------------------------- 130 (582)
.++.||+.||+|||+.|++||||||+||||+.++.++|+|||++.......
T Consensus 107 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (316)
T cd05574 107 FYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186 (316)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhccccc
Confidence 999999999999999999999999999999999999999999987543211
Q ss_pred -ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHH
Q 007991 131 -LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVK 208 (582)
Q Consensus 131 -~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~ 208 (582)
....++||..|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+.... ..+....++..++++|.
T Consensus 187 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 266 (316)
T cd05574 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIR 266 (316)
T ss_pred CCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHH
Confidence 1123578999999999998889999999999999999999999999888776666554322 22222337999999999
Q ss_pred HhccCCCCCCCC----HHHHHcCCCCchhhh
Q 007991 209 SMLRKNPEFRPS----AAELLCHPHLQPYVL 235 (582)
Q Consensus 209 kmL~~dP~~RpS----a~EiL~hp~f~~~~~ 235 (582)
+||..||++||+ ++++|.||||+...+
T Consensus 267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred HHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=322.66 Aligned_cols=215 Identities=27% Similarity=0.439 Sum_probs=186.6
Q ss_pred HHHHHHHHHHhc-CCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007991 19 SAHQEMELISRV-RNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 94 (582)
Q Consensus 19 ~~~rEi~iL~~L-~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs 94 (582)
.+.||+++.-.. .|||||.++++|.+ ....+.+|||+++||.|+..|+.++...|+|.++..|++||..|+.|||+
T Consensus 100 KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~ 179 (400)
T KOG0604|consen 100 KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS 179 (400)
T ss_pred HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh
Confidence 356888886555 69999999998863 23467799999999999999999887789999999999999999999999
Q ss_pred CCceecccCcccEEEcCC---CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcC
Q 007991 95 NHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 171 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG 171 (582)
.+|.||||||+|+|.... ..+||+|||+|+.........+-|.||.|+|||++....|+..+|+||+||+||-|++|
T Consensus 180 ~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 180 MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred cchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 999999999999999764 45999999999988777778889999999999999999999999999999999999999
Q ss_pred CccccccCHH----HHHHHHhhcc---CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 172 KAAFKAFDMQ----ALINKINKSI---VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 172 ~~PF~~~~~~----~l~~kI~~~~---~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.+||...... .+..+|..+. ..+-+..+|++++++|+++|..+|.+|.|+++++.|||+..+
T Consensus 260 yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 260 YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 9999765432 3345554433 233455689999999999999999999999999999999764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=342.58 Aligned_cols=225 Identities=25% Similarity=0.385 Sum_probs=195.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-C-----CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-N-----PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-H-----pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
+||||+|+.. .....+...|+.+|..|+ | -|||+++++|...+ ++|||+|.+ +.+|.++|+.++...|+
T Consensus 213 ~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-HlciVfELL-~~NLYellK~n~f~Gls 287 (586)
T KOG0667|consen 213 IVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLCIVFELL-STNLYELLKNNKFRGLS 287 (586)
T ss_pred EEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-ceeeeehhh-hhhHHHHHHhcCCCCCC
Confidence 4899999763 445567788999999997 4 58999999987765 999999999 69999999998888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC--CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~--g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y 152 (582)
...++.|+.|||.||..||+.||||+||||+||||... ..|||+|||.+........ +++.++.|+|||++.+.+|
T Consensus 288 l~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY 365 (586)
T KOG0667|consen 288 LPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPY 365 (586)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce--eeeeccccccchhhccCCC
Confidence 99999999999999999999999999999999999865 4699999999987654433 8999999999999999999
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--------------------------------------
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-------------------------------------- 194 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-------------------------------------- 194 (582)
+.+.||||||||++||++|.+.|.+.+..+++..|......|
T Consensus 366 ~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~ 445 (586)
T KOG0667|consen 366 DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPE 445 (586)
T ss_pred CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchh
Confidence 999999999999999999999999999888887775433221
Q ss_pred -------------CC-----------ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 195 -------------LP-----------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 195 -------------lp-----------~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
.| ..-...|.+||++||..||.+|+|+.++|+||||..
T Consensus 446 ~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 446 VRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred hhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 01 011236789999999999999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.74 Aligned_cols=229 Identities=24% Similarity=0.396 Sum_probs=187.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++..... .....+.+|+.++++++||||+++++++..+ ...|+||||+. ++|.+++...+ ..+++..++.
T Consensus 33 ~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~ 108 (309)
T cd07872 33 LVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKI 108 (309)
T ss_pred eEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHH
Confidence 3799998765432 2334577899999999999999999987654 58999999996 58888887643 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||
T Consensus 109 ~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (309)
T cd07872 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188 (309)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHH
Confidence 9999999999999999999999999999999999999999998764332 22344678999999998865 458899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~S~~l~~LI~k 209 (582)
|||||++|+|++|.+||.+.+..+....+......+ ....++.++++||.+
T Consensus 189 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (309)
T cd07872 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTK 268 (309)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHH
Confidence 999999999999999998877655544443211110 112468899999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.||.+|+|++|+|+||||+..
T Consensus 269 ~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 269 FLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.70 Aligned_cols=231 Identities=23% Similarity=0.450 Sum_probs=212.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.|.....+...+..+.+|+++|+.|+|||||+++.++... ..+|+||||+.+|.+++++.+++ .+.+..++.+
T Consensus 84 VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~ 160 (596)
T KOG0586|consen 84 VAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-ATLYLVMEYASGGELFDYLVKHG--RMKEKEARAK 160 (596)
T ss_pred EEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-ceeEEEEEeccCchhHHHHHhcc--cchhhhhhhh
Confidence 79999999999888888899999999999999999999987654 48999999999999999999876 5778999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDIWS 160 (582)
+.|++.|++|||+++|+|||||.+||||+.+-++||+|||++..+....+..++||++.|+|||++.+..| ++.+|+||
T Consensus 161 F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Ws 240 (596)
T KOG0586|consen 161 FRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWS 240 (596)
T ss_pred hHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhh
Confidence 99999999999999999999999999999999999999999999998889999999999999999999887 57899999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
+|+++|-|+.|.+||++.+...+......... .++..++.++.++|++||..+|.+|++.++++.|.|+......
T Consensus 241 lgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 241 LGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhhhheeeeecccccCCcccccccchheeeee-cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99999999999999999988877766655443 3777899999999999999999999999999999999765544
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=306.75 Aligned_cols=226 Identities=32% Similarity=0.601 Sum_probs=192.9
Q ss_pred EEEEEecccccC----HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQT----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~----~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++...... .+....+.+|+++|++++|+||+++++.+... ...|+||||+.|++|.+++.+.. .+++..
T Consensus 27 ~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 103 (265)
T cd06631 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISSILNRFG--PLPEPV 103 (265)
T ss_pred EEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEEEEecCCCCcHHHHHHhcC--CCCHHH
Confidence 789988764322 23446789999999999999999999987654 68999999999999999998754 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-------ccccCcccCCCCCCCcccccCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-------DDLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-------~~~~~~~vGTp~Y~APE~l~~~ 150 (582)
+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..... ........|+..|+|||.+.+.
T Consensus 104 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 183 (265)
T cd06631 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183 (265)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC
Confidence 999999999999999999999999999999999999999999999876532 1123346789999999999988
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh--ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK--SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~--~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
.++.++|+|||||++|+|++|..||...+.......+.. ......+..++..+.++|.+||..+|.+||++.++|.||
T Consensus 184 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 263 (265)
T cd06631 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHD 263 (265)
T ss_pred CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 899999999999999999999999987665544333332 233456777999999999999999999999999999999
Q ss_pred CC
Q 007991 229 HL 230 (582)
Q Consensus 229 ~f 230 (582)
||
T Consensus 264 ~~ 265 (265)
T cd06631 264 FL 265 (265)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.58 Aligned_cols=227 Identities=32% Similarity=0.584 Sum_probs=198.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+..... ......+.+|+++++.++|+||+++++.+.+. ...|+|+||+.+++|.+++... .+++..+..
T Consensus 28 ~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~ 102 (274)
T cd06609 28 VVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAF 102 (274)
T ss_pred EEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHH
Confidence 378998876542 33445688999999999999999999987765 6899999999999999999864 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......|++.|+|||.+.+..++.++|||
T Consensus 103 ~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~ 182 (274)
T cd06609 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIW 182 (274)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999999876543 234456889999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc-ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~-~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|.+||...+.......+.......++.. ++..+.++|.+||..+|++||+++++++||||+.
T Consensus 183 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 183 SLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred HHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 999999999999999988777666666665555555555 8999999999999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.45 Aligned_cols=227 Identities=26% Similarity=0.401 Sum_probs=185.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-CCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~lse~~~~~ 80 (582)
||||+++.........+.+.+|+.++++++||||+++++++..+ ..+|+||||+. ++|.+++.... +..+++..++.
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 105 (285)
T cd07861 28 VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKS 105 (285)
T ss_pred EEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHH
Confidence 78999877655444556788999999999999999999988764 58899999997 68988887543 25689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDI 158 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+++.|+|||++.+. .++.++||
T Consensus 106 ~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 185 (285)
T cd07861 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185 (285)
T ss_pred HHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHH
Confidence 99999999999999999999999999999999999999999987653322 22345778999999988654 47889999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhcc----------------------------CCCCCccccHHHHHHHHHh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSI----------------------------VAPLPTVYSGAFRGLVKSM 210 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~----------------------------~~~lp~~~S~~l~~LI~km 210 (582)
|||||++|+|++|.+||.+.........+.... .......++.++.+||.+|
T Consensus 186 ~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 265 (285)
T cd07861 186 WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKM 265 (285)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHH
Confidence 999999999999999998765433222211100 0011234788999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|+.||.+|||+++|+.||||
T Consensus 266 l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 266 LIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hcCChhhCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=304.28 Aligned_cols=227 Identities=29% Similarity=0.534 Sum_probs=192.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~~~ 80 (582)
||||++....... ....+.+|+++|+.++|+||+++++.+... ...|+||||+.|++|.+++..... ..+++..++.
T Consensus 29 ~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 106 (267)
T cd06610 29 VAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106 (267)
T ss_pred EEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHH
Confidence 7888887655444 567899999999999999999999987654 589999999999999999986432 4689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCC-CCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADI-PYGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~-~y~~ 154 (582)
++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... .....+|+..|++||.+... .++.
T Consensus 107 ~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~ 186 (267)
T cd06610 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186 (267)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCc
Confidence 99999999999999999999999999999999999999999997765432 22445789999999998776 7889
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC-----ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp-----~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
++|+|||||++|+|++|+.||...+......++.......++ ..++..+.+||.+||..||++||++++|+.|||
T Consensus 187 ~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 187 KADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred ccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 999999999999999999999887765555554433222222 257889999999999999999999999999999
Q ss_pred C
Q 007991 230 L 230 (582)
Q Consensus 230 f 230 (582)
|
T Consensus 267 ~ 267 (267)
T cd06610 267 F 267 (267)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.33 Aligned_cols=211 Identities=28% Similarity=0.424 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 007991 18 RSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI 97 (582)
Q Consensus 18 ~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gI 97 (582)
..+.+|+++|++|+|||||+++++|... ...|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~I 203 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRI 203 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3567999999999999999999988654 5899999999 578998887644 68999999999999999999999999
Q ss_pred eecccCcccEEEcCCCCeEEeecccchhcccc--cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccc
Q 007991 98 LHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175 (582)
Q Consensus 98 iHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF 175 (582)
+||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||
T Consensus 204 vHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 204 IHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred ccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999999999754322 2334568999999999999989999999999999999999998776
Q ss_pred cccC-------HHHHHHHHhhcc---------------------------CCC----CC---ccccHHHHHHHHHhccCC
Q 007991 176 KAFD-------MQALINKINKSI---------------------------VAP----LP---TVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 176 ~~~~-------~~~l~~kI~~~~---------------------------~~~----lp---~~~S~~l~~LI~kmL~~d 214 (582)
-..+ ....+..+.... ..+ .. ..++.++.+||.+||+.|
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 4221 111111111000 000 00 124668999999999999
Q ss_pred CCCCCCHHHHHcCCCCch
Q 007991 215 PEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 215 P~~RpSa~EiL~hp~f~~ 232 (582)
|.+|||++|+|+||||+.
T Consensus 364 P~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 364 AHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhhCCCHHHHhcChhhcc
Confidence 999999999999999975
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=307.03 Aligned_cols=227 Identities=26% Similarity=0.498 Sum_probs=189.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
.||||.+..... ....+.+|+.+++++ +|+||+++++.|... ...+|+||||+.+++|.+++....+..++
T Consensus 33 ~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~ 109 (272)
T cd06637 33 LAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 109 (272)
T ss_pred EEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCC
Confidence 378888865432 235678999999999 699999999988753 24789999999999999999875555789
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc-----
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA----- 148 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~----- 148 (582)
+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .......|++.|+|||++.
T Consensus 110 ~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 189 (272)
T cd06637 110 EEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 189 (272)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCc
Confidence 9999999999999999999999999999999999999999999999998765332 2334568999999999986
Q ss_pred CCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+..|+.++|||||||++|+|++|..||...........+.... .......++..+.+||.+||..||.+|||+.+++.|
T Consensus 190 ~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 3458889999999999999999999998766555444443322 222344678999999999999999999999999999
Q ss_pred CCC
Q 007991 228 PHL 230 (582)
Q Consensus 228 p~f 230 (582)
|||
T Consensus 270 ~~~ 272 (272)
T cd06637 270 PFI 272 (272)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.10 Aligned_cols=224 Identities=22% Similarity=0.403 Sum_probs=195.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG----------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~----------- 70 (582)
||+|.++... .......+.+|+.+|.+++||||+++++++... ...|++|||+++++|.+++.....
T Consensus 38 v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (283)
T cd05048 38 VAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115 (283)
T ss_pred EEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-CceEEEEecCCCCcHHHHHHhcCCCcccccccccc
Confidence 6888886543 345567799999999999999999999987654 578999999999999999986421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCc
Q 007991 71 ---VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCP 144 (582)
Q Consensus 71 ---~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~AP 144 (582)
..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ......+++.|+||
T Consensus 116 ~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence 358899999999999999999999999999999999999999999999999997653322 23345678899999
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
|.+.+..++.++|||||||++|||++ |..||.+....++...+......+.+..++.++.+|+.+||+.||.+||++.+
T Consensus 196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~ 275 (283)
T cd05048 196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKD 275 (283)
T ss_pred HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99988889999999999999999998 99999999988888888777777778889999999999999999999999999
Q ss_pred HHcC
Q 007991 224 LLCH 227 (582)
Q Consensus 224 iL~h 227 (582)
|+++
T Consensus 276 i~~~ 279 (283)
T cd05048 276 IHTR 279 (283)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=300.85 Aligned_cols=229 Identities=46% Similarity=0.845 Sum_probs=206.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~~ 78 (582)
.||+|++............+.+|+++++.++|+|++++++.+... ...++|+||++|++|.+++.... +..+++..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (258)
T cd08215 27 LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105 (258)
T ss_pred EEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHH
Confidence 378999988777667778899999999999999999999988765 68999999999999999998753 357999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++.|+|||.+.+..++.++|
T Consensus 106 ~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D 185 (258)
T cd08215 106 LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSD 185 (258)
T ss_pred HHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCcccc
Confidence 9999999999999999999999999999999999999999999997765443 344568899999999999888999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+||+|+++|+|++|..||...+...+...+......+++..++..+.++|..||..+|++||++.++|.||||
T Consensus 186 v~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 186 IWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999888888877777776777888899999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.05 Aligned_cols=220 Identities=22% Similarity=0.426 Sum_probs=197.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++.....+ +.|.+|+++|++|+|++||++++++..++ -+||||||+..|+|.++++..++..+...+...|
T Consensus 233 vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~ 308 (468)
T KOG0197|consen 233 VAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDF 308 (468)
T ss_pred ccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEecccCcHHHHhhhcCCCccchHHHHHH
Confidence 6889887764443 46789999999999999999999887654 7999999999999999999877778999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccC--CCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG--TPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vG--Tp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.|++||+++++|||||...||||+.+..|||+|||||+...++......-+ ...|.|||.+....++.++|||
T Consensus 309 a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVW 388 (468)
T KOG0197|consen 309 AAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVW 388 (468)
T ss_pred HHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCccccccee
Confidence 99999999999999999999999999999999999999999995544433222222 2369999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
||||+|+||++ |+.|+.+++..++++.+..+..-+-|..+++++.+++..||..+|++|||++.+.
T Consensus 389 SFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 389 SFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999988 8999999999999999999999999999999999999999999999999999664
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=309.73 Aligned_cols=226 Identities=37% Similarity=0.631 Sum_probs=190.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..............+|+.++++++|+||+++++++.. +...|+||||+.+++|.+++.... .+++..+..+
T Consensus 27 ~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~ 103 (260)
T PF00069_consen 27 VAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKI 103 (260)
T ss_dssp EEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHH
T ss_pred EEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccccccccccccccccc--cccccccccc
Confidence 8999998887766666666779999999999999999998876 458899999999999999998544 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhc-ccccccCcccCCCCCCCccccc-CCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLA-DIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~-~~~~~~~~~vGTp~Y~APE~l~-~~~y~~ksDIW 159 (582)
+.||+.||+|||+.||+|+||||+|||++.++.++|+|||.+... ..........++..|+|||++. +..++.++|||
T Consensus 104 ~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 183 (260)
T PF00069_consen 104 AYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIW 183 (260)
T ss_dssp HHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999998753 2334455678999999999998 77889999999
Q ss_pred chhHHHHhHhcCCccccccCH---HHHHHHHhhc-cCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDM---QALINKINKS-IVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~---~~l~~kI~~~-~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||+++|+|++|..||..... .....+.... ..... ....+..+.++|.+||+.||++||++.++++||||
T Consensus 184 slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 184 SLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999999999998733 3333222211 11111 11224899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.54 Aligned_cols=232 Identities=26% Similarity=0.449 Sum_probs=191.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+++|++++|+||++++++|... ...|++|||+.+++|.+++....+..+++..++.
T Consensus 27 ~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 105 (314)
T cd08216 27 LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF 105 (314)
T ss_pred EEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHH
Confidence 489999987655566677899999999999999999999988765 4789999999999999999876555789999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--------ccCcccCCCCCCCcccccC--C
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLAD--I 150 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l~~--~ 150 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... ......++..|+|||++.+ .
T Consensus 106 ~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (314)
T cd08216 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185 (314)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCC
Confidence 99999999999999999999999999999999999999999886553221 1234567889999999876 3
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHH-HHHHhhccC--------------------------------CCCCc
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL-INKINKSIV--------------------------------APLPT 197 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l-~~kI~~~~~--------------------------------~~lp~ 197 (582)
.|+.++|||||||++|+|++|..||........ .+++..... .....
T Consensus 186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (314)
T cd08216 186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265 (314)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhh
Confidence 588899999999999999999999987654332 222221100 01122
Q ss_pred cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 198 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 198 ~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.++.++.+||..||+.||++|||++++|.||||+..
T Consensus 266 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 266 TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred HHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 346789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=309.08 Aligned_cols=226 Identities=27% Similarity=0.454 Sum_probs=186.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+.++++++|+||+++++++... ...|+||||++++.|..++.... .+++..+..+
T Consensus 29 ~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~ 105 (286)
T cd07847 29 VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKI 105 (286)
T ss_pred EEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHH
Confidence 78898876544444456788999999999999999999987654 58899999999988887776533 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccC-CCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD-IPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~-~~y~~ksDIW 159 (582)
+.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|||
T Consensus 106 ~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 185 (286)
T cd07847 106 IWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVW 185 (286)
T ss_pred HHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhH
Confidence 9999999999999999999999999999999999999999998765433 2345678899999999876 4578899999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccC--------------------CCC----------CccccHHHHHHHHH
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--------------------APL----------PTVYSGAFRGLVKS 209 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--------------------~~l----------p~~~S~~l~~LI~k 209 (582)
||||++|+|++|.+||.+.+..+....+..... .+. ...++..+.+||.+
T Consensus 186 slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (286)
T cd07847 186 AIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKG 265 (286)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHH
Confidence 999999999999999987765444333321110 000 12467889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCC
Q 007991 210 MLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f 230 (582)
||+.+|++||++.|++.||||
T Consensus 266 ~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 266 CLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HhcCCccccCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.16 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=224.8
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.++..- ...++.+-+..|-.||..++.|+||++|-.|.+ +.++|++||-|-||.|+..+++++ .|++..++.
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF 524 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYMLMEACLGGELWTILRDRG--SFDDYTARF 524 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhhHHhhcCchhhhhhhhcC--Ccccchhhh
Confidence 3445554322 233456778999999999999999999998865 469999999999999999999876 899999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
|+..++.|++|||++|||+|||||+|++++.+|-+||.|||+|+.+.......++||||.|.|||++.+...+.++|.||
T Consensus 525 ~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWa 604 (732)
T KOG0614|consen 525 YVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWA 604 (732)
T ss_pred hHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
||+++|||++|.+||.+.+....++.|.++. ...+|..++..+.+||+++...+|.+|.. +.+|-+|-||..+.
T Consensus 605 LGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 605 LGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 9999999999999999999999999998776 45678999999999999999999999975 89999999999877
Q ss_pred hhhh--cccCCCCCCCCCCCCCCcccccc
Q 007991 235 LGIH--LKLNGPRRNTFPLEWSDSNFKKT 261 (582)
Q Consensus 235 ~~~~--~~~~~p~~~~~~~~~~~s~~~~~ 261 (582)
|.-. ..+.+|..+......+.++|+..
T Consensus 685 weglr~~~L~pPi~~~va~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 685 WEGLRSRTLPPPIIPSVANPTDVSNFDNF 713 (732)
T ss_pred hhhhhhccCCCCccccCCCcccchhccCC
Confidence 6543 23445555555555666666653
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.85 Aligned_cols=227 Identities=31% Similarity=0.525 Sum_probs=191.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|++|.+... .....+.+.+|+++++.++|+||+++++.|... ...|+||||+.+++|..++.+.. ..+++..+..+
T Consensus 33 ~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~ 108 (282)
T cd06643 33 AAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVV 108 (282)
T ss_pred EEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 567777543 345567789999999999999999999988765 58899999999999999887533 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc-----CCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA-----DIPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~-----~~~y~~k 155 (582)
+.|++.||.|||+.||+||||||+|||++.++.+||+|||++...... .......|++.|+|||++. +..++.+
T Consensus 109 ~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 188 (282)
T cd06643 109 CKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188 (282)
T ss_pred HHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCcc
Confidence 999999999999999999999999999999999999999998765332 2234567899999999984 3457789
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+|||||||++|+|++|.+||...+.......+...... ..+..++..+++||.+||..||.+||+++++++||||..
T Consensus 189 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred chhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 99999999999999999999988776666555443322 235568999999999999999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.86 Aligned_cols=229 Identities=27% Similarity=0.402 Sum_probs=192.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||.+............+.+|+.++++++|+||++++++|...+ .+.|+||||+. ++|.+.+.. .+++.
T Consensus 44 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~ 118 (353)
T cd07850 44 VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHE 118 (353)
T ss_pred EEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHH
Confidence 789988765555556667889999999999999999999876432 36799999995 688888865 38999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............|++.|+|||++.+..++.++
T Consensus 119 ~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (353)
T cd07850 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 198 (353)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCch
Confidence 99999999999999999999999999999999999999999999999876554445566889999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-----------------------------------------
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL----------------------------------------- 195 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l----------------------------------------- 195 (582)
|||||||++|+|++|+.||...+....+..+......+.
T Consensus 199 DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
T cd07850 199 DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSES 278 (353)
T ss_pred hhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCccccc
Confidence 999999999999999999988776554444432111110
Q ss_pred -CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 196 -PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 196 -p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
+...+..+++||.+||+.||.+|||+.|+|.||||+.|..
T Consensus 279 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 279 HNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred ccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 1134667899999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=308.12 Aligned_cols=228 Identities=28% Similarity=0.495 Sum_probs=191.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++......+.....+.+|+.++++++|+||+++++++.. +...|+||||+ |++|.+++.... ..+++..++.
T Consensus 27 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~ 103 (286)
T cd07832 27 TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKS 103 (286)
T ss_pred eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHH
Confidence 37899998776656666789999999999999999999998765 45899999999 999999998644 4699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC-CCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI-PYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~-~y~~ksD 157 (582)
++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+. .++.++|
T Consensus 104 ~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 183 (286)
T cd07832 104 YMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183 (286)
T ss_pred HHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhH
Confidence 99999999999999999999999999999999999999999998765433 23456789999999998654 4688999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccccHHHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVYSGAFRGLVK 208 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~S~~l~~LI~ 208 (582)
||||||++|+|++|.++|.+.........+......+ .....+..+.+||.
T Consensus 184 i~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 263 (286)
T cd07832 184 LWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLK 263 (286)
T ss_pred HHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHH
Confidence 9999999999999999998776655544443321111 11235789999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCc
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+||..+|.+||+++++|.||||.
T Consensus 264 ~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 264 GLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHhccChhhCCCHHHHhhCcCcC
Confidence 99999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.95 Aligned_cols=224 Identities=40% Similarity=0.794 Sum_probs=198.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++.... ....+.+.+|+.+++.++|+||+++++.|... .++|+||||+++++|.+++....+..+++..+..|
T Consensus 28 ~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 105 (255)
T cd08219 28 YAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105 (255)
T ss_pred EEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 78998876443 34567788999999999999999999987654 58999999999999999998755557899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ......|++.|+|||++.+..++.++|+||
T Consensus 106 ~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 185 (255)
T cd08219 106 FVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWS 185 (255)
T ss_pred HHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhh
Confidence 9999999999999999999999999999999999999999987664332 334567999999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||+++|+|++|..||...+.......+......+++..++..+.+||.+||+.||++||++.+++.-
T Consensus 186 lG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 186 LGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999988888777777776667788899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.19 Aligned_cols=233 Identities=26% Similarity=0.407 Sum_probs=189.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.++..... .....+.+|+.+++.++|+||+++++++... ...|+||||+. ++|.+++.... ..+++..++.
T Consensus 33 ~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~ 108 (301)
T cd07873 33 LVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKL 108 (301)
T ss_pred EEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHH
Confidence 3789988764332 2234577899999999999999999988654 58999999996 68998887643 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDI 158 (582)
++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+++.|+|||++.+. .++.++||
T Consensus 109 ~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 188 (301)
T cd07873 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188 (301)
T ss_pred HHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHH
Confidence 99999999999999999999999999999999999999999997643322 23345778999999998654 47889999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~S~~l~~LI~k 209 (582)
|||||++|+|++|.+||.+.+..+....+......+ ....+++.+++||.+
T Consensus 189 ~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (301)
T cd07873 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSK 268 (301)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHH
Confidence 999999999999999999887766554443221110 112468889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchhhhhh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~~~~~ 237 (582)
||+.||.+|||++|+|+||||+.+-.+.
T Consensus 269 ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 269 LLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred HhcCCcccCcCHHHHhcCcccccccchh
Confidence 9999999999999999999998655433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.72 Aligned_cols=229 Identities=32% Similarity=0.558 Sum_probs=194.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||+|.+... .....+.+.+|++++++++|+||+++++.+.. +..+|+||||++|++|.+++.+.+ ..+++..++.
T Consensus 32 ~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~ 107 (280)
T cd06611 32 FAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRY 107 (280)
T ss_pred EEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHH
Confidence 3788888654 34455778899999999999999999998875 458999999999999999998743 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCccccc-----CCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLA-----DIPYGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~-----~~~y~~ 154 (582)
++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ......|++.|++||++. ...++.
T Consensus 108 ~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~ 187 (280)
T cd06611 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187 (280)
T ss_pred HHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCc
Confidence 99999999999999999999999999999999999999999987654322 234567899999999975 344677
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++|||||||++|+|++|.+||.+.+......++...... ..+..++..+.+||.+||+.+|.+||+++++|+||||..
T Consensus 188 ~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred cccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999988877766666554322 235568999999999999999999999999999999975
Q ss_pred h
Q 007991 233 Y 233 (582)
Q Consensus 233 ~ 233 (582)
.
T Consensus 268 ~ 268 (280)
T cd06611 268 Q 268 (280)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.21 Aligned_cols=222 Identities=20% Similarity=0.344 Sum_probs=194.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.........+.+.+|+.+|+.++|+||+++++.+. +...++||||+.+++|.+++.... .+++..+..+
T Consensus 25 ~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 100 (257)
T cd05116 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAELGPLNKFLQKNK--HVTEKNITEL 100 (257)
T ss_pred EEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 789998877666677888999999999999999999998763 346789999999999999998643 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|++.||+|||++||+||||||.|||++.++.+||+|||++........ .....++..|+|||.+....++.++|
T Consensus 101 ~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 180 (257)
T cd05116 101 VHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180 (257)
T ss_pred HHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhH
Confidence 99999999999999999999999999999999999999999977644321 12234457899999998888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|||++ |.+||.+.+...+...+......+.+..++.++.+||.+||+.||++||++++|...
T Consensus 181 i~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 181 VWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHH
Confidence 9999999999997 999999988888888888777777888899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=306.26 Aligned_cols=229 Identities=33% Similarity=0.582 Sum_probs=194.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ....+.+.+|++++++++||||+++++.+... ...|+|+||+.|++|.+++.... ..+++..+..+
T Consensus 29 ~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 105 (265)
T cd06605 29 MAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKI 105 (265)
T ss_pred EEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHH
Confidence 78888876543 35567788999999999999999999988765 58999999999999999998753 47899999999
Q ss_pred HHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+..++.++||||
T Consensus 106 ~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 184 (265)
T cd06605 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-AKTFVGTSSYMAPERIQGNDYSVKSDIWS 184 (265)
T ss_pred HHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-hhcccCChhccCHHHHcCCCCCchhhHHH
Confidence 9999999999999 999999999999999999999999999987664332 22378899999999999889999999999
Q ss_pred hhHHHHhHhcCCcccccc-----CHHHHHHHHhhccCCCCCcc-ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 161 LGCCVYEMSAQKAAFKAF-----DMQALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~-----~~~~l~~kI~~~~~~~lp~~-~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
|||++|+|++|..||... ...+....+.......++.. ++..+++||.+||..||++||++.+++.||||+.|.
T Consensus 185 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 185 LGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 999999999999999654 23334444433333334444 899999999999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.84 Aligned_cols=225 Identities=22% Similarity=0.423 Sum_probs=199.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-------CCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-------GVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-------~~~l 73 (582)
.|+||.++...... ..+.+.+|++++..++|+||+++++++.. +..+++||||+.|++|.+++.... +..+
T Consensus 25 ~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 102 (262)
T cd00192 25 EVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102 (262)
T ss_pred eEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEeccCCcHHHHHhhccccccccccccC
Confidence 37889887765544 56789999999999999999999998766 568999999999999999998751 2479
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+...... .......++..|+|||.+...
T Consensus 103 ~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 103 SLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC
Confidence 99999999999999999999999999999999999999999999999999876543 223456778899999999888
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++.++|||||||++|+|++ |..||.......+...+........+..++.++.+++.+||..||.+|||+++++++
T Consensus 183 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 89999999999999999998 699999999888888888766667788889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=356.98 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=217.5
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|+++.-....+ ....|..|-.||..-+.+-||+++.+|.++ .++|+||||+.||+|..++.+.. .++|.+++
T Consensus 102 VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-~~LYlVMdY~pGGDlltLlSk~~--~~pE~~Ar 178 (1317)
T KOG0612|consen 102 VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWAR 178 (1317)
T ss_pred chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-cceEEEEecccCchHHHHHhhcC--CChHHHHH
Confidence 477787766332222 224577899999999999999999998765 59999999999999999999875 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCccccc----C-CCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLA----D-IPY 152 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~----~-~~y 152 (582)
.|+.+|+.||+-||+.|+|||||||+|||||..|||||+|||.|-.+..+. ....-+|||.|++||++. + ..|
T Consensus 179 FY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~y 258 (1317)
T KOG0612|consen 179 FYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEY 258 (1317)
T ss_pred HHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCcccc
Confidence 999999999999999999999999999999999999999999997776554 345679999999999984 2 469
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc---cCCCCCccccHHHHHHHHHhccCCCCCCCC---HHHHHc
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEFRPS---AAELLC 226 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~---~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS---a~EiL~ 226 (582)
+..+|+||+||++|||+.|..||...+..+.+.+|... +..|-...+|.++++||.+++ .+|+.|.. ++++..
T Consensus 259 G~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 259 GRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 99999999999999999999999999999999999764 233323569999999999988 46788877 999999
Q ss_pred CCCCchhhhhhhcccCCCCCCCCCCCCCCccc
Q 007991 227 HPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNF 258 (582)
Q Consensus 227 hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~ 258 (582)
||||.+..|..--...+|..+....+-+.++|
T Consensus 338 HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 338 HPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred CccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 99999988866666677888888888888888
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.18 Aligned_cols=224 Identities=29% Similarity=0.498 Sum_probs=184.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.++.... .....+.+|+.+++.++||||+++++.+... ...|+||||+++++|.+++...+ .+++..+..
T Consensus 36 ~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 110 (267)
T cd06645 36 LAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICMEFCGGGSLQDIYHVTG--PLSESQIAY 110 (267)
T ss_pred EEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHH
Confidence 378998876533 2335678999999999999999999988765 58899999999999999998754 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ......|+..|+|||++. ...++.++
T Consensus 111 ~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 190 (267)
T cd06645 111 VSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190 (267)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchh
Confidence 99999999999999999999999999999999999999999987654321 234568999999999974 44588899
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-CC-C--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-AP-L--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-~~-l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
|+|||||++|+|++|..||...........+..... .+ . ...++..+.+||.+||..+|++||+++++++|||
T Consensus 191 DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 191 DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999866554333322222211 11 1 1247889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=309.20 Aligned_cols=233 Identities=29% Similarity=0.501 Sum_probs=194.8
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|.+....... ...+.+..|+++|++++||||+++++++... ...|+||||++|++|.+++.+.....+++..+.
T Consensus 20 ~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 98 (277)
T cd05577 20 MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI 98 (277)
T ss_pred EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHH
Confidence 37888886543322 2345667899999999999999999987654 589999999999999999987655579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.............++..|+|||.+.+..++.++|||
T Consensus 99 ~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 178 (277)
T cd05577 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWF 178 (277)
T ss_pred HHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhH
Confidence 99999999999999999999999999999999999999999999776544444556788999999999888899999999
Q ss_pred chhHHHHhHhcCCccccccCH----HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~----~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f 230 (582)
||||++|+|++|+.||..... ..+...+ .......+..+++.+.++|.+||+.||.+|| ++.+++.||||
T Consensus 179 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred HHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 999999999999999976543 2222222 2223345667899999999999999999999 89999999999
Q ss_pred chhhh
Q 007991 231 QPYVL 235 (582)
Q Consensus 231 ~~~~~ 235 (582)
..+.+
T Consensus 258 ~~~~~ 262 (277)
T cd05577 258 KDLNW 262 (277)
T ss_pred hcCCh
Confidence 76543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=303.06 Aligned_cols=228 Identities=36% Similarity=0.735 Sum_probs=198.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..........+.+.+|++++++++|+||+++++.+.. +...|+|+||+.+++|.+++....+..+++..+..+
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (257)
T cd08225 28 CVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106 (257)
T ss_pred EEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 6889887755544556778899999999999999999997755 568999999999999999998766556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCC-eEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~-vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+....... ......|++.|+|||++.+..++.++|+|
T Consensus 107 ~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~ 186 (257)
T cd08225 107 FVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIW 186 (257)
T ss_pred HHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHH
Confidence 999999999999999999999999999998864 6999999997765432 22345689999999999888899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
||||++|+|++|..||...+.......+......+....++..+.++|.+||..+|++|||++++++||||
T Consensus 187 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 187 SLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99999999999999999888777776666655556666789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=302.12 Aligned_cols=224 Identities=32% Similarity=0.589 Sum_probs=191.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||+|.+..... .+.+.+|++++++++|+||+++++.+... ..+|+++||+.+++|.+++... +..+++..+..
T Consensus 30 ~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~ 103 (256)
T cd06612 30 VVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAA 103 (256)
T ss_pred EEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHH
Confidence 378888865422 57899999999999999999999988765 5899999999999999999763 34689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.|++.||.|||+.||+||||+|.||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||
T Consensus 104 ~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 183 (256)
T cd06612 104 ILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183 (256)
T ss_pred HHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHH
Confidence 99999999999999999999999999999999999999999998765433 33445688999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
||||++|+|++|..||...........+..... ...+..++..+.++|.+||+.||++|||+.|+|.||||
T Consensus 184 s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999987765554433332221 12344578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.43 Aligned_cols=236 Identities=28% Similarity=0.447 Sum_probs=206.7
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
|||.|++...+...+ .-.....|-+||.+++.++||.+-.+|... ..+|+||..+.||+|.-+|...++..|+|+.++
T Consensus 212 MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~ 290 (591)
T KOG0986|consen 212 MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRAR 290 (591)
T ss_pred hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-CceEEEEEeecCCceeEEeeccCCCCCchHHHH
Confidence 678888866665443 335678999999999999999998888655 599999999999999999999888889999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|+.||+.||++||+.+||+|||||+|||+|+.|||+|.|.|||..+.........+||.+|||||++.+..|+...|+|
T Consensus 291 FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf 370 (591)
T KOG0986|consen 291 FYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWF 370 (591)
T ss_pred HHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHH
Confidence 99999999999999999999999999999999999999999999998888777788999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHH---HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALI---NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~---~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~ 231 (582)
+|||+||||+.|..||.......-. ..........++..+|+++++|.+.+|.+||.+|. .++++.+||||+
T Consensus 371 ~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 371 SLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred HHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 9999999999999999876543332 23333344457788999999999999999999996 578999999999
Q ss_pred hhhhhh
Q 007991 232 PYVLGI 237 (582)
Q Consensus 232 ~~~~~~ 237 (582)
...++.
T Consensus 451 ~lnw~r 456 (591)
T KOG0986|consen 451 DLNWRR 456 (591)
T ss_pred cCCHhH
Confidence 866554
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.53 Aligned_cols=226 Identities=33% Similarity=0.557 Sum_probs=188.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+.... .......+.+|+++|++++||||+++++.|..+ .++|+||||++|++|.+++.+.. .+++..+..+
T Consensus 29 ~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~ 104 (308)
T cd06615 29 MARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAG--RIPENILGKI 104 (308)
T ss_pred EEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 6778776542 345566788999999999999999999988764 58999999999999999998753 6899999999
Q ss_pred HHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+ .|++||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+..++.++|+||
T Consensus 105 ~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Diws 183 (308)
T cd06615 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWS 183 (308)
T ss_pred HHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHH
Confidence 9999999999998 59999999999999999999999999998765332 345678999999999998888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhcc------------------------------------CCCCC-ccccHHH
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSI------------------------------------VAPLP-TVYSGAF 203 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~------------------------------------~~~lp-~~~S~~l 203 (582)
|||++|+|++|..||...+.......+.... ....+ ..++.++
T Consensus 184 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (308)
T cd06615 184 LGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF 263 (308)
T ss_pred HHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHH
Confidence 9999999999999997665444333221110 00111 2367899
Q ss_pred HHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 204 RGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 204 ~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++||.+||..||++||+++++++||||..
T Consensus 264 ~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 264 QDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.98 Aligned_cols=224 Identities=31% Similarity=0.514 Sum_probs=189.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|++|.+...... ..+.+.+|+.++++++||||+++++.+... ..+|++|||+.|++|.+++.... ..+++..+..+
T Consensus 31 ~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~ 106 (262)
T cd06613 31 VAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYV 106 (262)
T ss_pred EEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHH
Confidence 788888765432 457889999999999999999999987654 58999999999999999998742 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC---CCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI---PYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~---~y~~ksD 157 (582)
+.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ......|+..|+|||.+... .++.++|
T Consensus 107 ~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~D 186 (262)
T cd06613 107 CRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186 (262)
T ss_pred HHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhh
Confidence 9999999999999999999999999999999999999999997765432 33456889999999999876 7889999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC----CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+|||||++|+|++|.+||.+.+.......+...... ..+..++.++.+||.+||..+|..||++.+++.|+|
T Consensus 187 i~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 187 IWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999887755554444333111 123346789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.78 Aligned_cols=224 Identities=26% Similarity=0.424 Sum_probs=175.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHh-------CCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKA-------NGVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~-------~~~~l 73 (582)
||+|.+...... ..+.+|+++|++++||||+++++++.. .+..+|+||||+. ++|.+++... ....+
T Consensus 31 ~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l 105 (317)
T cd07867 31 YALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQL 105 (317)
T ss_pred EEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccC
Confidence 788888654332 346789999999999999999998864 3568899999995 6888887532 12358
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEE----cCCCCeEEeecccchhccccc----ccCcccCCCCCCCcc
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPE 145 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL----~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE 145 (582)
++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... .....+||+.|+|||
T Consensus 106 ~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE 185 (317)
T cd07867 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185 (317)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcH
Confidence 999999999999999999999999999999999999 456789999999998764332 234568899999999
Q ss_pred cccC-CCCCCCCcccchhHHHHhHhcCCccccccCHH---------HHHHHHhhccC-----------------------
Q 007991 146 LLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---------ALINKINKSIV----------------------- 192 (582)
Q Consensus 146 ~l~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~---------~l~~kI~~~~~----------------------- 192 (582)
++.+ ..++.++|||||||++|||++|.+||...... .....+.....
T Consensus 186 ~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (317)
T cd07867 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDF 265 (317)
T ss_pred HhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhh
Confidence 9876 45889999999999999999999999643311 11111110000
Q ss_pred --------------CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 193 --------------APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 193 --------------~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 266 RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00111245678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.25 Aligned_cols=226 Identities=35% Similarity=0.639 Sum_probs=194.6
Q ss_pred EEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~---~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||.+..... ..+..+.+.+|+.+++.++|+||+++++.+.. +..+|+||||++|++|.+++.+.. .+++..+
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~ 104 (258)
T cd06632 28 FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYIFLELVPGGSLAKLLKKYG--SFPEPVI 104 (258)
T ss_pred EEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEEEEEecCCCcHHHHHHhcC--CCCHHHH
Confidence 78898866432 24456789999999999999999999997654 458999999999999999998753 5899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCC-CCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP-YGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~-y~~ksD 157 (582)
..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.............|+..|++||.+.... ++.++|
T Consensus 105 ~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D 184 (258)
T cd06632 105 RLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184 (258)
T ss_pred HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhh
Confidence 9999999999999999999999999999999999999999999988765544445678999999999987766 889999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhh-ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~-~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+|||||++|+|++|..||...........+.. .....++..++..+.+|+.+||..+|.+||+++++|.|||+
T Consensus 185 ~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 185 IWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999987775555544444 33444567789999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.47 Aligned_cols=226 Identities=25% Similarity=0.479 Sum_probs=187.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEe-----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE-----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~-----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||+|.+... ......+.+|+.+++++ +|+||+++++.|.. .+.++|+||||+.+|+|.+++....+..+++
T Consensus 44 ~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~ 120 (282)
T cd06636 44 AAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120 (282)
T ss_pred EEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCH
Confidence 678877553 23445688999999999 69999999998863 2468999999999999999998765567899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc-----C
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA-----D 149 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~-----~ 149 (582)
..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...... ......+|++.|+|||.+. .
T Consensus 121 ~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~ 200 (282)
T cd06636 121 DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcC
Confidence 999999999999999999999999999999999999999999999998765422 2234567999999999885 3
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
..++.++|||||||++|+|++|..||...........+...... .....++..+.+||.+||..||.+||++.|||.||
T Consensus 201 ~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~ 280 (282)
T cd06636 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHP 280 (282)
T ss_pred cCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCC
Confidence 45788999999999999999999999776654444333332221 22345889999999999999999999999999999
Q ss_pred CC
Q 007991 229 HL 230 (582)
Q Consensus 229 ~f 230 (582)
||
T Consensus 281 ~~ 282 (282)
T cd06636 281 FI 282 (282)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=303.49 Aligned_cols=228 Identities=32% Similarity=0.537 Sum_probs=190.3
Q ss_pred CEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQT---DRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~---~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||+|++...... ....+.+.+|+.++++++||||+++++.+... +..++++|||+.+++|.+++.... .+++.
T Consensus 29 ~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~ 106 (266)
T cd06651 29 ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTES 106 (266)
T ss_pred EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHH
Confidence 3788988764332 23456789999999999999999999987653 468899999999999999998644 58999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc----cccCcccCCCCCCCcccccCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----DLASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~----~~~~~~vGTp~Y~APE~l~~~~y 152 (582)
.+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...... .......|+..|+|||.+.+..+
T Consensus 107 ~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC
Confidence 99999999999999999999999999999999999999999999998765321 11223568899999999998889
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+.++|||||||++|+|++|..||...+.......+.... ...++..++..++++| .||..+|++||+++|++.||||+
T Consensus 187 ~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999999999999999999999998776555544443322 3345667889999999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=336.37 Aligned_cols=211 Identities=29% Similarity=0.590 Sum_probs=190.1
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007991 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 96 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~g 96 (582)
++.-+.+|+-|++|+|+|||.+.++|.... -+|||||||..|-|.++++... .+.......|..+|+.|++|||.+.
T Consensus 156 ~elkETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK 232 (904)
T KOG4721|consen 156 RELKETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK 232 (904)
T ss_pred hhhhhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh
Confidence 344467899999999999999999987654 7889999999999999999744 7899999999999999999999999
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCcccc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~ 176 (582)
|||||||.=||||..+..|||+|||-++..........++||..|||||++...+++.++|||||||+||||+||..||+
T Consensus 233 IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 233 IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 99999999999999999999999999998876666778999999999999999999999999999999999999999999
Q ss_pred ccCHHHHHHHH-hhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 177 AFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 177 ~~~~~~l~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+.+...++.-+ ...+.-+.|..+++-|+-||+.||+-.|..||++.+||.|--+
T Consensus 313 dVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 313 DVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 98877665443 2344557888999999999999999999999999999998544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.54 Aligned_cols=230 Identities=33% Similarity=0.567 Sum_probs=192.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||+|.+... .....+.+.+|+.+++.++|+||+++++.+..+ ...|+||||+.|++|..++.+.. ..+++..+..
T Consensus 39 ~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~ 114 (292)
T cd06644 39 LAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV 114 (292)
T ss_pred eEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHH
Confidence 3778887653 445567788999999999999999999987665 48999999999999998887643 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc-----CCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA-----DIPYGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~-----~~~y~~ 154 (582)
++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .......+++.|+|||++. ...++.
T Consensus 115 ~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 194 (292)
T cd06644 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194 (292)
T ss_pred HHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCc
Confidence 9999999999999999999999999999999999999999998654322 2234567899999999984 345778
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++|||||||++|+|++|.+||...+......++...... ..+..++.++.+||.+||..||++||+++++++||||..
T Consensus 195 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred hhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999887766555555433222 234568899999999999999999999999999999975
Q ss_pred hh
Q 007991 233 YV 234 (582)
Q Consensus 233 ~~ 234 (582)
..
T Consensus 275 ~~ 276 (292)
T cd06644 275 VT 276 (292)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=304.81 Aligned_cols=225 Identities=27% Similarity=0.528 Sum_probs=195.6
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.+....... ...+.+.+|++++++++||||+++++.+.. +...|+|+||+.|++|.+++... ..+++..+..
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~ 104 (258)
T cd05578 28 FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKF 104 (258)
T ss_pred EEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHH
Confidence 7889887654333 556789999999999999999999997754 55899999999999999999875 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............|+..|+|||.+....++.++|+||
T Consensus 105 ~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 184 (258)
T cd05578 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWS 184 (258)
T ss_pred HHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchh
Confidence 99999999999999999999999999999999999999999998765544445677899999999998888999999999
Q ss_pred hhHHHHhHhcCCccccccCH---HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH--HHHHcCCCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDM---QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA--AELLCHPHL 230 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~---~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa--~EiL~hp~f 230 (582)
|||++|+|++|..||...+. ..+..... ......+..++..+.++|.+||+.||.+|+++ +|++.||||
T Consensus 185 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 185 LGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999987773 44333332 24455677889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=310.17 Aligned_cols=226 Identities=27% Similarity=0.448 Sum_probs=183.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++...........+.+|+.++++++|+||+++++++... ..+|+|+||++ ++|.+++.... ..+++..++.+
T Consensus 28 ~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~ 104 (284)
T cd07839 28 VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSF 104 (284)
T ss_pred EEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHH
Confidence 78898876544444446678899999999999999999988654 58999999996 68888887643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-CCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~-~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+. .++.++|||
T Consensus 105 ~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 184 (284)
T cd07839 105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 184 (284)
T ss_pred HHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHH
Confidence 999999999999999999999999999999999999999999765332 223345788999999998764 478899999
Q ss_pred chhHHHHhHhcCCcc-ccccCHHHHHHHHhhccCC----------------------------CCCccccHHHHHHHHHh
Q 007991 160 SLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVA----------------------------PLPTVYSGAFRGLVKSM 210 (582)
Q Consensus 160 SLG~iLyELltG~~P-F~~~~~~~l~~kI~~~~~~----------------------------~lp~~~S~~l~~LI~km 210 (582)
||||++|+|++|..| |.+.+..+....+...... .....+++++++||.+|
T Consensus 185 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (284)
T cd07839 185 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNL 264 (284)
T ss_pred HHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHH
Confidence 999999999998776 4555554444433221100 01124688999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|+.||.+|||++++|.||||
T Consensus 265 l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 265 LVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hcCChhhcCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.84 Aligned_cols=229 Identities=33% Similarity=0.601 Sum_probs=200.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++...... ...+.+.+|+.++.+++|+||+++++.+... ...|+||||+.|++|.+++.... .+++..+..
T Consensus 28 ~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~ 103 (264)
T cd06623 28 IYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKVG--KIPEPVLAY 103 (264)
T ss_pred EEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHH
Confidence 3788988775443 5567899999999999999999999988765 58999999999999999998753 789999999
Q ss_pred HHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhccccccc-CcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~-~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++......... ....++..|+|||.+....++.++|+
T Consensus 104 ~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 183 (264)
T cd06623 104 IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADI 183 (264)
T ss_pred HHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhH
Confidence 99999999999999 99999999999999999999999999999876543322 35678899999999998889999999
Q ss_pred cchhHHHHhHhcCCcccccc---CHHHHHHHHhhccCCCCCcc-ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~---~~~~l~~kI~~~~~~~lp~~-~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||||+++|+|++|..||... ...+....+.......++.. ++..+.++|..||..+|++||+++++++||||+.+
T Consensus 184 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999777 55666666666655666666 89999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.23 Aligned_cols=227 Identities=29% Similarity=0.559 Sum_probs=189.7
Q ss_pred EEEEEecccccC----HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQT----DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~----~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++...... ....+.+.+|+++|++++|+||+++++++... ..+++||||+.|++|.+++.+.. .+++..
T Consensus 28 ~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~ 104 (268)
T cd06630 28 MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-SHFNLFVEWMAGGSVSHLLSKYG--AFKEAV 104 (268)
T ss_pred EEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-CeEEEEEeccCCCcHHHHHHHhC--CCCHHH
Confidence 789988764422 23457889999999999999999999987654 58899999999999999998754 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~ 151 (582)
+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....... .....+|+..|+|||.+.+..
T Consensus 105 ~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 184 (268)
T cd06630 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184 (268)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC
Confidence 999999999999999999999999999999998876 59999999987664331 123457899999999998888
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHH---h-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---N-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI---~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
++.++|+|||||++|+|++|..||...+.......+ . .......+..++..+.+++.+||..+|.+||++.++++|
T Consensus 185 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 999999999999999999999999755432222222 1 122344566789999999999999999999999999999
Q ss_pred CCCc
Q 007991 228 PHLQ 231 (582)
Q Consensus 228 p~f~ 231 (582)
|||+
T Consensus 265 ~~~~ 268 (268)
T cd06630 265 PVFR 268 (268)
T ss_pred cccC
Confidence 9984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.09 Aligned_cols=217 Identities=29% Similarity=0.554 Sum_probs=191.9
Q ss_pred ccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 007991 11 RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 89 (582)
Q Consensus 11 ~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL 89 (582)
.++++..++|+.|+.+|+.|+|||||++|++|++.. ..+.+|+|.+..|+|.+++++.+ .++...++.|++|||.||
T Consensus 79 ~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL 156 (632)
T KOG0584|consen 79 TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGL 156 (632)
T ss_pred hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHh
Confidence 345566789999999999999999999999999654 46889999999999999999976 688999999999999999
Q ss_pred HHHHHCC--ceecccCcccEEEcCC-CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHH
Q 007991 90 NYLHANH--ILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVY 166 (582)
Q Consensus 90 ~yLHs~g--IiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLy 166 (582)
.|||++. |||||||++||||+.+ |.|||+|+|||....... ....+|||.|||||++- ..|+..+||||||+||.
T Consensus 157 ~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmL 234 (632)
T KOG0584|consen 157 VYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCML 234 (632)
T ss_pred hhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHH
Confidence 9999995 9999999999999876 899999999999876544 55599999999999998 68999999999999999
Q ss_pred hHhcCCccccc-cCHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 167 EMSAQKAAFKA-FDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 167 ELltG~~PF~~-~~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||+|+..||.. .+...++.++..+..+ .+...-++++++||.+||.. ...|+|+.|+|.||||+.
T Consensus 235 EMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 235 EMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 99999999964 5667777777666543 24445588999999999999 999999999999999986
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=310.01 Aligned_cols=229 Identities=31% Similarity=0.579 Sum_probs=196.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+..... ....+.+.+|++++++++|+||+++++.+.. +...|+||||+.|++|.+++... .+++..++.+
T Consensus 32 vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 106 (277)
T cd06642 32 VAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEYLGGGSALDLLKPG---PLEETYIATI 106 (277)
T ss_pred EEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHH
Confidence 78888875533 3455789999999999999999999998765 45899999999999999998752 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|+||
T Consensus 107 ~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 186 (277)
T cd06642 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186 (277)
T ss_pred HHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHH
Confidence 9999999999999999999999999999999999999999997654332 223457889999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
|||++|+|++|..||...........+.......++..++..+.+||.+||+.+|++||++.++++||||..+..
T Consensus 187 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 187 LGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred HHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 999999999999999877666655555444444455678899999999999999999999999999999986543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.97 Aligned_cols=224 Identities=20% Similarity=0.382 Sum_probs=194.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
.||||.++.... ....+.+.+|+++|+.++|+||+++++++... ...|+||||+.|++|.+++...+
T Consensus 37 ~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 114 (280)
T cd05049 37 LVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114 (280)
T ss_pred eEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCeEEEEecCCCCCHHHHHHhcCCchhhhccccc
Confidence 378998876433 34567899999999999999999999987765 58999999999999999998642
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcc
Q 007991 70 -GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 145 (582)
Q Consensus 70 -~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE 145 (582)
...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ......+++.|+|||
T Consensus 115 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05049 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE 194 (280)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChh
Confidence 1347899999999999999999999999999999999999999999999999987643322 123445678899999
Q ss_pred cccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 146 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 146 ~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
++.+..++.++|||||||++|+|++ |..||.+.+.......+........+..++..+.+||.+||+.||++||+++|+
T Consensus 195 ~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 195 SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred hhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 9999899999999999999999998 999998888888888877666666677899999999999999999999999999
Q ss_pred Hc
Q 007991 225 LC 226 (582)
Q Consensus 225 L~ 226 (582)
++
T Consensus 275 l~ 276 (280)
T cd05049 275 HE 276 (280)
T ss_pred HH
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.24 Aligned_cols=228 Identities=29% Similarity=0.439 Sum_probs=188.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++...........+.+|++++++++||||+++++++.. +...|+||||+. ++|.+++....+..+++..+..
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~ 104 (284)
T cd07860 27 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKS 104 (284)
T ss_pred EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHH
Confidence 37899887765555555678999999999999999999998765 458999999995 6899998876556799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC-CCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP-YGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~-y~~ksDI 158 (582)
++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++....... ......+++.|+|||++.+.. ++.++||
T Consensus 105 ~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 184 (284)
T cd07860 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184 (284)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHH
Confidence 99999999999999999999999999999999999999999987654322 233456788999999887644 6788999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC----------------------------CCCccccHHHHHHHHHh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----------------------------PLPTVYSGAFRGLVKSM 210 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----------------------------~lp~~~S~~l~~LI~km 210 (582)
|||||++|+|++|+.||.+.+......++...... .+...++.++++||.+|
T Consensus 185 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 264 (284)
T cd07860 185 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQM 264 (284)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHh
Confidence 99999999999999999876654433332211110 01224678899999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|+.||.+||+++++|.||||
T Consensus 265 l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 265 LHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=300.37 Aligned_cols=226 Identities=21% Similarity=0.361 Sum_probs=195.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHh----CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKA----NGVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~----~~~~ 72 (582)
||||.++...........+.+|+.+|+.++|+||+++++.+...+ ...++||||+.+++|..++... ....
T Consensus 30 vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~ 109 (273)
T cd05035 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK 109 (273)
T ss_pred EEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCccc
Confidence 899999876666666778999999999999999999999876543 2478999999999999998653 1236
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~ 149 (582)
+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....... .....++..|+|||.+.+
T Consensus 110 ~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence 89999999999999999999999999999999999999999999999999986543321 112335678999999988
Q ss_pred CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
..++.++|||||||++|||++ |.+||.+....++...+........+..++..+.++|.+||+.||++||++.|++++
T Consensus 190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999998 999999888888888887776667788899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=300.36 Aligned_cols=227 Identities=32% Similarity=0.525 Sum_probs=190.7
Q ss_pred EEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~---~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||+++.... .....+.+.+|+.++++++||||+++++.+.+. +..+|+||||++|++|.+++.... .+++..
T Consensus 30 v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~ 107 (265)
T cd06652 30 LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENV 107 (265)
T ss_pred EEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHH
Confidence 78998865432 234557889999999999999999999987654 357889999999999999998653 589999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
+..++.|++.||+|||++||+|+||||+|||++.++.++|+|||++....... ......|+..|+|||++.+..++
T Consensus 108 ~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 187 (265)
T cd06652 108 TRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG 187 (265)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCC
Confidence 99999999999999999999999999999999999999999999987653211 12345789999999999888899
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.++|||||||++|+|++|..||...+.......+.... ....+..++..+.++|.+||. +|+.||+++++++|||+.
T Consensus 188 ~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 188 RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999999999999999999998776555444443322 334566788999999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=303.49 Aligned_cols=222 Identities=18% Similarity=0.294 Sum_probs=191.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++.... ....+.+.+|+.+|++++||||+++++++.. +...|+||||+.+|+|.+++.... ..+++..+..+
T Consensus 36 vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~ 112 (266)
T cd05064 36 VAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGM 112 (266)
T ss_pred EEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHH
Confidence 68888876433 3445678999999999999999999998765 458999999999999999998743 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccC--cccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~--~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++|++||||||+||||+.++.++++|||.+.......... ...++..|+|||.+.+..++.++|||
T Consensus 113 ~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 192 (266)
T cd05064 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVW 192 (266)
T ss_pred HHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHH
Confidence 9999999999999999999999999999999999999999876543322221 23456789999999998999999999
Q ss_pred chhHHHHhHh-cCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELl-tG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|||+ +|..||.+.+..++...+......+.+..++..+.+++.+||+.+|.+||++++|++
T Consensus 193 slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 193 SFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999976 499999998888888888777666778889999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.67 Aligned_cols=227 Identities=29% Similarity=0.545 Sum_probs=188.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHHhC--CCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKKAN--GVH 72 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~~--~~~ 72 (582)
.|++|.+..... ..+.+.+|+.+++++ +|+||+++++.+... +..+|+||||+++++|.+++.... +..
T Consensus 33 ~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 109 (275)
T cd06608 33 LVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR 109 (275)
T ss_pred EEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCC
Confidence 378888765433 335789999999999 799999999988753 346899999999999999987643 457
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC--
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-- 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-- 149 (582)
+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... .......|+..|+|||++..
T Consensus 110 ~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (275)
T cd06608 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE 189 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccc
Confidence 899999999999999999999999999999999999999999999999998765332 22345678999999998754
Q ss_pred ---CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 150 ---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 150 ---~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
..++.++|||||||++|+|++|.+||...........+.......+ +..++..+.+||.+||..||++|||++++
T Consensus 190 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 3467889999999999999999999987766555555544332222 23478899999999999999999999999
Q ss_pred HcCCCC
Q 007991 225 LCHPHL 230 (582)
Q Consensus 225 L~hp~f 230 (582)
+.|||+
T Consensus 270 l~~~~~ 275 (275)
T cd06608 270 LEHPFI 275 (275)
T ss_pred hcCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.17 Aligned_cols=220 Identities=29% Similarity=0.464 Sum_probs=177.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+... ....+|+++|++|+|||||+++++|... ..+|+||||+. ++|.+++... ..+++..+..|
T Consensus 122 v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i 190 (392)
T PHA03207 122 VIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK-STVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITI 190 (392)
T ss_pred EEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHH
Confidence 566666432 2356899999999999999999987654 58999999995 7899888543 37999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....+||+.|+|||++.+..|+.++||
T Consensus 191 ~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 270 (392)
T PHA03207 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270 (392)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhH
Confidence 9999999999999999999999999999999999999999997654322 2235689999999999999899999999
Q ss_pred cchhHHHHhHhcCCccccccCHH---HHHHHHhhc--------------------------cCC--CCC-----ccccHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKS--------------------------IVA--PLP-----TVYSGA 202 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~---~l~~kI~~~--------------------------~~~--~lp-----~~~S~~ 202 (582)
|||||++|||++|..||.+.... ..+..+... ... .++ ..++.+
T Consensus 271 wslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (392)
T PHA03207 271 WSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD 350 (392)
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchh
Confidence 99999999999999999654321 111111110 000 011 235678
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 203 FRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 203 l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+.+||.+||..||++||++.|+|.||||..
T Consensus 351 ~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 351 VEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 899999999999999999999999999975
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=304.62 Aligned_cols=224 Identities=28% Similarity=0.524 Sum_probs=185.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+.... .....+.+.+|+++|++++||||+++++.+... ...++||||+++++|..+. .+++..+..
T Consensus 28 ~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~------~~~~~~~~~ 99 (279)
T cd06619 28 ILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTEFMDGGSLDVYR------KIPEHVLGR 99 (279)
T ss_pred EEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEecCCCCChHHhh------cCCHHHHHH
Confidence 37899886643 344556789999999999999999999988765 5788999999999996441 478999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... .....+||..|+|||.+.+..++.++|+||
T Consensus 100 ~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 178 (279)
T cd06619 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWS 178 (279)
T ss_pred HHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHH
Confidence 9999999999999999999999999999999999999999999765432 344578999999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCH-------HHHHHHHhhccCCCC-CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDM-------QALINKINKSIVAPL-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~-------~~l~~kI~~~~~~~l-p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||..... ......+.......+ ...++.++++||.+||+.||++||+++|+++||||+.
T Consensus 179 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 99999999999999965321 122222222222222 2347889999999999999999999999999999975
Q ss_pred h
Q 007991 233 Y 233 (582)
Q Consensus 233 ~ 233 (582)
.
T Consensus 259 ~ 259 (279)
T cd06619 259 Y 259 (279)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=297.94 Aligned_cols=227 Identities=36% Similarity=0.738 Sum_probs=203.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~~ 79 (582)
||||.+......+.....+.+|+.++++++|+||+++++++... ...|+||||+.|++|.+++.+. .+..+++..+.
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (256)
T cd08530 28 YALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106 (256)
T ss_pred EEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHH
Confidence 78999987766666677888999999999999999999988765 6899999999999999998762 23468999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ......|++.|++||.+.+..++.++|+|
T Consensus 107 ~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~ 185 (256)
T cd08530 107 RIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIW 185 (256)
T ss_pred HHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHH
Confidence 99999999999999999999999999999999999999999999876554 34456789999999999998899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||+++|+|++|..||...+...+...+......+.+..++.+++++|.+||..+|++||++.++++||++
T Consensus 186 slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 186 SLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999888777777777677777899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.97 Aligned_cols=230 Identities=27% Similarity=0.504 Sum_probs=191.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-CCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~lse~~~~ 79 (582)
.||+|.++... .+.....+.+|+.++++++|+||+++++.+... ..+|+||||++|++|..++.... ...+++..+.
T Consensus 28 ~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 105 (286)
T cd06622 28 TMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR 105 (286)
T ss_pred EEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHH
Confidence 37899887643 344457789999999999999999999987654 58999999999999999887631 2368999999
Q ss_pred HHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCC------CC
Q 007991 80 KWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI------PY 152 (582)
Q Consensus 80 ~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~------~y 152 (582)
.++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++...... ......|++.|+|||.+.+. .+
T Consensus 106 ~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 184 (286)
T cd06622 106 RITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTY 184 (286)
T ss_pred HHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCC
Confidence 999999999999997 59999999999999999999999999998765332 33456789999999998543 35
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHH---HhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK---INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~k---I~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+.++|||||||++|+|++|..||........... +.......++..++.++.+||.+||+.+|++||++++++.|||
T Consensus 185 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred CcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 7899999999999999999999976655444333 3334445566779999999999999999999999999999999
Q ss_pred Cchh
Q 007991 230 LQPY 233 (582)
Q Consensus 230 f~~~ 233 (582)
|..+
T Consensus 265 ~~~~ 268 (286)
T cd06622 265 LVKY 268 (286)
T ss_pred hhhc
Confidence 9654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.09 Aligned_cols=227 Identities=30% Similarity=0.585 Sum_probs=196.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+..... ......+.+|+.++++++|+||+++++.+.. +...|+||||+.|++|.+++... .+++..+..
T Consensus 31 ~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~ 105 (277)
T cd06640 31 VVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEYLGGGSALDLLRAG---PFDEFQIAT 105 (277)
T ss_pred EEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHH
Confidence 378888875433 3445788999999999999999999998765 45899999999999999999753 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+|
T Consensus 106 ~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~ 185 (277)
T cd06640 106 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185 (277)
T ss_pred HHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHH
Confidence 99999999999999999999999999999999999999999997654332 23345788899999999888899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|.+||...........+.......++..++..+.++|.+||+.+|++||++++++.|+||..
T Consensus 186 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred HHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 9999999999999999888777666655554455566678899999999999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.37 Aligned_cols=226 Identities=29% Similarity=0.546 Sum_probs=192.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++.... ....+.+.+|+.+++.++|+||+++++.+... .+.|+||||+.|++|.+++... .+++..+..
T Consensus 49 ~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~ 122 (292)
T cd06658 49 QVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFLEGGALTDIVTHT---RMNEEQIAT 122 (292)
T ss_pred EEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHH
Confidence 37899886533 34456789999999999999999999987654 5899999999999999988642 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... .....+|+..|+|||.+.+..++.++|||
T Consensus 123 ~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 202 (292)
T cd06658 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202 (292)
T ss_pred HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHH
Confidence 99999999999999999999999999999999999999999987653322 23456789999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|||++|..||...+.......+........ ...++..+.++|.+||..||.+|||++++++||||..
T Consensus 203 slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 999999999999999988776665555544333322 2357889999999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.28 Aligned_cols=228 Identities=29% Similarity=0.449 Sum_probs=189.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||||+++.....+.....+.+|+.++++++||||+++++++...+ ...|+||||+. ++|.+++.... ..+++..++
T Consensus 32 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~ 109 (293)
T cd07843 32 IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVK 109 (293)
T ss_pred EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHH
Confidence 3789999876555445556789999999999999999999877552 68999999996 59999988744 368999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCC-CCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP-YGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~-y~~ksD 157 (582)
.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++...... .......+++.|+|||.+.+.. ++.++|
T Consensus 110 ~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D 189 (293)
T cd07843 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAID 189 (293)
T ss_pred HHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhh
Confidence 99999999999999999999999999999999999999999999876543 2334467889999999987644 688999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccC------------------------------CCCCcc-ccHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------------------APLPTV-YSGAFRGL 206 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~------------------------------~~lp~~-~S~~l~~L 206 (582)
||||||++|+|++|.+||...+......++..... ..++.. +++.+.+|
T Consensus 190 i~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 269 (293)
T cd07843 190 MWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDL 269 (293)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHH
Confidence 99999999999999999988776655554432111 112222 58889999
Q ss_pred HHHhccCCCCCCCCHHHHHcCCCC
Q 007991 207 VKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 207 I~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|.+||+.||++|||+.|+|.||||
T Consensus 270 i~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 270 LNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHhccCccccCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.58 Aligned_cols=227 Identities=30% Similarity=0.501 Sum_probs=186.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|++......+....-+.+||.+|.+|+ |.+||+++++-+. ++++|+||||- ..+|.++|++..+. ++.-.++
T Consensus 387 iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk 463 (677)
T KOG0596|consen 387 IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLK 463 (677)
T ss_pred chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEEeecc-cccHHHHHHhccCC-CchHHHH
Confidence 4788888887777888899999999999995 8999999997665 56999999987 59999999987654 3434889
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCC-----
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIP----- 151 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~----- 151 (582)
.|..|+|.|++++|.+||||.||||.|+|+ -.|.+||+|||+|..+..+. ...+.+||+.||+||.+....
T Consensus 464 ~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~ 542 (677)
T KOG0596|consen 464 FYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSREN 542 (677)
T ss_pred HHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccC
Confidence 999999999999999999999999999988 46789999999999886653 345789999999999886543
Q ss_pred ------CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC----CCCccccHH-HHHHHHHhccCCCCCCCC
Q 007991 152 ------YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGA-FRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 152 ------y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----~lp~~~S~~-l~~LI~kmL~~dP~~RpS 220 (582)
.+.++||||||||||+|+.|++||.... .++.++.....+ ++|..-+.. +.++++.||..||++||+
T Consensus 543 ~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~s 620 (677)
T KOG0596|consen 543 GKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWS 620 (677)
T ss_pred CCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCC
Confidence 4568999999999999999999997543 223333322221 233333333 999999999999999999
Q ss_pred HHHHHcCCCCchh
Q 007991 221 AAELLCHPHLQPY 233 (582)
Q Consensus 221 a~EiL~hp~f~~~ 233 (582)
+.++|+|||++.+
T Consensus 621 i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 621 IPELLQHPFLQIQ 633 (677)
T ss_pred cHHHhcCcccccc
Confidence 9999999999874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=306.29 Aligned_cols=230 Identities=28% Similarity=0.470 Sum_probs=192.9
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+..... .......+.+|+++++.++||||+++++.+.. +.++|+||||++|++|.++++..+ .+++..+..
T Consensus 29 v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~ 105 (305)
T cd05609 29 FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARM 105 (305)
T ss_pred EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 78898866432 22345678899999999999999999988765 458999999999999999998753 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc----------------cccCcccCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----------------DLASSVVGTPSYMCP 144 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~----------------~~~~~~vGTp~Y~AP 144 (582)
++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..... .......|+..|+||
T Consensus 106 ~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 185 (305)
T cd05609 106 YFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185 (305)
T ss_pred HHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCc
Confidence 9999999999999999999999999999999999999999998642110 011235678899999
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-CC-CCccccHHHHHHHHHhccCCCCCCCC--
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-AP-LPTVYSGAFRGLVKSMLRKNPEFRPS-- 220 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-~~-lp~~~S~~l~~LI~kmL~~dP~~RpS-- 220 (582)
|.+.+..++.++|||||||++|+|++|..||.+....++...+..... .+ ....++..+.+||.+||+.||++||+
T Consensus 186 E~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred hhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCcc
Confidence 999888899999999999999999999999998887777776654432 11 22357899999999999999999997
Q ss_pred -HHHHHcCCCCchhh
Q 007991 221 -AAELLCHPHLQPYV 234 (582)
Q Consensus 221 -a~EiL~hp~f~~~~ 234 (582)
+.++|.||||...-
T Consensus 266 ~~~~ll~~~~~~~~~ 280 (305)
T cd05609 266 GAFEVKQHRFFLGLD 280 (305)
T ss_pred CHHHHHhCccccCCC
Confidence 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=297.13 Aligned_cols=227 Identities=33% Similarity=0.609 Sum_probs=192.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.++.........+.+.+|+.++++++|+||+++++.+.. ...+++|+||+.+++|.+++.... .+++..+..
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 103 (264)
T cd06626 27 LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRV 103 (264)
T ss_pred EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHH
Confidence 37899998876666677889999999999999999999997654 458999999999999999998743 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc-----cCcccCCCCCCCcccccCCC---C
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-----ASSVVGTPSYMCPELLADIP---Y 152 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-----~~~~vGTp~Y~APE~l~~~~---y 152 (582)
++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........ .....++..|+|||.+.+.. +
T Consensus 104 i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 183 (264)
T cd06626 104 YTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183 (264)
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCC
Confidence 999999999999999999999999999999999999999999887644322 22357889999999998766 8
Q ss_pred CCCCcccchhHHHHhHhcCCccccccC-HHHHHHHHhhccCCCCCcc--ccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV--YSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~-~~~l~~kI~~~~~~~lp~~--~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+.++|||||||++|+|++|..||...+ .......+.......++.. ++..+.+||.+||+.+|.+||++++++.|||
T Consensus 184 ~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 184 GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred CcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 899999999999999999999997653 3333333333333334444 4899999999999999999999999999999
Q ss_pred C
Q 007991 230 L 230 (582)
Q Consensus 230 f 230 (582)
+
T Consensus 264 ~ 264 (264)
T cd06626 264 V 264 (264)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.14 Aligned_cols=220 Identities=20% Similarity=0.367 Sum_probs=192.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++... ..+.+.+|+.++++++|+||+++++++...+...|+||||+.+++|.+++++.....+++..+..+
T Consensus 32 ~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd05082 32 VAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107 (256)
T ss_pred EEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 6788875432 345688999999999999999999987777778999999999999999998766556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .....++..|+|||++.+..++.++|||||
T Consensus 108 ~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 185 (256)
T cd05082 108 SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred HHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--CCCCccceeecCHHHHccCCCCchhhhHHH
Confidence 999999999999999999999999999999999999999998754332 233445678999999988889999999999
Q ss_pred hHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 162 GCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 162 G~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||++|+|++ |+.||...+...+...+........+..++..+.++|.+||+.+|++|||+.+++++
T Consensus 186 G~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 186 GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999997 999999888888877777666666677889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=303.42 Aligned_cols=227 Identities=27% Similarity=0.482 Sum_probs=187.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHh--CCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKA--NGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~--~~~~ls 74 (582)
||+|.+.... .....+.+|+.++.++ +||||++++++|...+ ...|+||||+.|++|.++++.. .+..++
T Consensus 50 ~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~ 126 (291)
T cd06639 50 AAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126 (291)
T ss_pred EEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCC
Confidence 6788875432 2235678899999999 8999999999887543 4689999999999999998642 234689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC--
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP-- 151 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~-- 151 (582)
+..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++....... ......|+..|+|||.+....
T Consensus 127 ~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 206 (291)
T cd06639 127 EAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCc
Confidence 99999999999999999999999999999999999999999999999988654332 233467899999999986432
Q ss_pred ---CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 152 ---YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 152 ---y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
++.++|||||||++|+|++|++||...+.......+....... .+..++..+.+||.+||+.+|++||++.+|++
T Consensus 207 ~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 6789999999999999999999998877655555554332222 24457789999999999999999999999999
Q ss_pred CCCCc
Q 007991 227 HPHLQ 231 (582)
Q Consensus 227 hp~f~ 231 (582)
||||+
T Consensus 287 ~~~~~ 291 (291)
T cd06639 287 HPFIK 291 (291)
T ss_pred CcccC
Confidence 99985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=307.33 Aligned_cols=225 Identities=29% Similarity=0.507 Sum_probs=190.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|+||.+....... .+.+.+|+.+++.++|+||+++++.|... .+.|+||||+.|++|.+++... .+++..+..+
T Consensus 48 v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i 121 (296)
T cd06654 48 VAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAV 121 (296)
T ss_pred EEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeecccCCCCHHHHHHhc---CCCHHHHHHH
Confidence 7888887654432 36688999999999999999999987754 5899999999999999999753 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+.||+||||||+|||++.++.++|+|||++....... ......|++.|+|||.+.+..++.++||||
T Consensus 122 ~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 201 (296)
T cd06654 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201 (296)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHH
Confidence 9999999999999999999999999999999999999999987654322 233457899999999999888899999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|++||...+.......+..... .+.+..++..+.+||.+||..+|++||+++++++|+||..
T Consensus 202 ~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 99999999999999987765443333322221 1235568899999999999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=317.53 Aligned_cols=226 Identities=28% Similarity=0.527 Sum_probs=198.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
++|||++... ...+.+..||.||++++.||+|++|+.|+.. ..++||||||..|++.++++-++ ..++|+.+..
T Consensus 60 v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~ 133 (502)
T KOG0574|consen 60 VLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-SDLWIVMEYCGAGSISDIMRARR-KPLSEQEISA 133 (502)
T ss_pred EEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC-CceEeehhhcCCCcHHHHHHHhc-CCccHHHHHH
Confidence 4789988654 3345688899999999999999999999864 57999999999999999998754 5799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+++..|.||+|||...-||||||..|||++.+|+.||+|||.|..+.... ...+.+|||.|||||++....|+.++|||
T Consensus 134 iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIW 213 (502)
T KOG0574|consen 134 VLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIW 213 (502)
T ss_pred HHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHh
Confidence 99999999999999999999999999999999999999999998876542 46789999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++..||..|++||.+......+..|.....+ .-|+.||.+|-+||++||.++|++|.|+-++++|||++.
T Consensus 214 SLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 214 SLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred hhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 9999999999999999988776555444333222 235679999999999999999999999999999999974
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.81 Aligned_cols=227 Identities=26% Similarity=0.454 Sum_probs=189.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+++|++++|+||+++++.+.. +...|+||||+.++.+..++.+.. .+++..+..
T Consensus 28 ~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~ 104 (288)
T cd07833 28 IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEYVERTLLELLEASPG--GLPPDAVRS 104 (288)
T ss_pred EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHH
Confidence 37899887766666667889999999999999999999998876 458999999998877766655432 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC-CCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI-PYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~-~y~~ksD 157 (582)
++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....... .....+++..|+|||++.+. .++.++|
T Consensus 105 ~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~D 184 (288)
T cd07833 105 YIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVD 184 (288)
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhh
Confidence 99999999999999999999999999999999999999999998765443 34457889999999999887 7889999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-------------------------------CCCCccccHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-------------------------------APLPTVYSGAFRGL 206 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-------------------------------~~lp~~~S~~l~~L 206 (582)
||||||++|+|++|.+||.+.+..+....+..... ...+..++.++++|
T Consensus 185 v~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 264 (288)
T cd07833 185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDF 264 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHH
Confidence 99999999999999999987665443332221000 01233458899999
Q ss_pred HHHhccCCCCCCCCHHHHHcCCCC
Q 007991 207 VKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 207 I~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|++||..+|++||++++++.||||
T Consensus 265 i~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 265 LKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHhccCchhcccHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.71 Aligned_cols=261 Identities=25% Similarity=0.435 Sum_probs=222.6
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
+||||+++....- +...+-...|-++|.... -|++++++..|+.- ..+|+||||+.||+|.-.|++.+ .|.|..+
T Consensus 376 LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-DRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~A 452 (683)
T KOG0696|consen 376 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQVG--KFKEPVA 452 (683)
T ss_pred hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-hheeeEEEEecCchhhhHHHHhc--ccCCchh
Confidence 6899999875532 233455567888888876 46788888766554 58999999999999999999976 7999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhc-ccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~-~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..|+.+|+.||-+||++|||+||||.+|||++.+|+|||+|||+++.- ..+....++||||.|+|||++...+|+.++|
T Consensus 453 vFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvD 532 (683)
T KOG0696|consen 453 VFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 532 (683)
T ss_pred hhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchh
Confidence 999999999999999999999999999999999999999999999874 3445678899999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-----HHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-----AELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-----~EiL~hp~f~~ 232 (582)
+||+||+||||+.|++||.+.+..++++.|...... .|..+|.++.++++.+|.+.|.+|... .+|-.||||+.
T Consensus 533 WWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 533 WWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999999999999999999999999876654 789999999999999999999999643 78899999997
Q ss_pred hhhhhh--cccCCCCCCCCCCCCCCcccccccCCC
Q 007991 233 YVLGIH--LKLNGPRRNTFPLEWSDSNFKKTRFME 265 (582)
Q Consensus 233 ~~~~~~--~~~~~p~~~~~~~~~~~s~~~~~~~~~ 265 (582)
+.|... ..+..|.++.+....+.+||++....+
T Consensus 612 iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~ 646 (683)
T KOG0696|consen 612 IDWEKLERREIQPPFKPKIKCGRDAENFDKFFTRE 646 (683)
T ss_pred ccHHHHhhccCCCCCCCccccCCchhhhhHHHhcC
Confidence 665443 345677777776777778887754433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.02 Aligned_cols=229 Identities=27% Similarity=0.514 Sum_probs=196.5
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.+..... .....+.+.+|++++++++|+||+++++.+.. +...|+||||+.|++|.+++.+.+ .+++..+.
T Consensus 20 ~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 96 (265)
T cd05579 20 IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGDLASLLENVG--SLDEDVAR 96 (265)
T ss_pred EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHH
Confidence 378998866433 23456788999999999999999999987754 568999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---------ccCcccCCCCCCCcccccCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---------LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---------~~~~~vGTp~Y~APE~l~~~ 150 (582)
.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+...
T Consensus 97 ~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 176 (265)
T cd05579 97 IYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176 (265)
T ss_pred HHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCC
Confidence 999999999999999999999999999999999999999999987654331 22345788899999999888
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc--ccHHHHHHHHHhccCCCCCCCCH---HHHH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV--YSGAFRGLVKSMLRKNPEFRPSA---AELL 225 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~--~S~~l~~LI~kmL~~dP~~RpSa---~EiL 225 (582)
.++.++|+|||||++|+|++|..||...........+..... ..+.. ++..+.+||.+||+.+|.+||++ .++|
T Consensus 177 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 889999999999999999999999998888877777655332 23333 48999999999999999999999 9999
Q ss_pred cCCCCchh
Q 007991 226 CHPHLQPY 233 (582)
Q Consensus 226 ~hp~f~~~ 233 (582)
+||||..+
T Consensus 256 ~~~~~~~~ 263 (265)
T cd05579 256 NHPFFKGI 263 (265)
T ss_pred cCccccCC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.39 Aligned_cols=225 Identities=31% Similarity=0.537 Sum_probs=192.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++...... ..+.+.+|+.+++.++||||+++++.+.. +..+|+|+||+.|++|.+++... .+++..+..+
T Consensus 47 v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i 120 (296)
T cd06655 47 VAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAV 120 (296)
T ss_pred EEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHH
Confidence 788988765443 34678899999999999999999998765 45899999999999999999763 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ......|+..|+|||.+.+..++.++||||
T Consensus 121 ~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 200 (296)
T cd06655 121 CRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (296)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHH
Confidence 9999999999999999999999999999999999999999987654432 233457899999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||.+.+.......+..... ...+..++..+.+||.+||..||.+||++.+++.||||+.
T Consensus 201 lGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 99999999999999988776554444433222 2245668899999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.10 Aligned_cols=230 Identities=31% Similarity=0.470 Sum_probs=189.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...........+.+|+.++++++|+||+++++++.... ..+|+||||+. ++|.+++.... ..+++..+.
T Consensus 34 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~ 111 (309)
T cd07845 34 IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVK 111 (309)
T ss_pred EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHH
Confidence 3789998765544333345678999999999999999999887543 57899999996 58988887643 468999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksD 157 (582)
.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+ ..++.++|
T Consensus 112 ~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 191 (309)
T cd07845 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAID 191 (309)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHH
Confidence 99999999999999999999999999999999999999999999876543 22333456889999999865 45789999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------C-----------CccccHHHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------L-----------PTVYSGAFRGLVK 208 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------l-----------p~~~S~~l~~LI~ 208 (582)
||||||++|+|++|.+||.+.+..+.+..+......+ + ...++..+.+||.
T Consensus 192 vwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 271 (309)
T cd07845 192 MWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLN 271 (309)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHH
Confidence 9999999999999999999888777666554321110 0 0125788999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCch
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+||+.||++|||++++|.||||+.
T Consensus 272 ~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 272 FLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred HHhcCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.08 Aligned_cols=229 Identities=28% Similarity=0.455 Sum_probs=190.4
Q ss_pred CEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQT---DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~---~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||+++..... ......+..|++++++++|+||+++++++.. +...|+||||+ +++|.+++.... ..+++..
T Consensus 27 ~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~ 103 (298)
T cd07841 27 IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLVFEFM-ETDLEKVIKDKS-IVLTPAD 103 (298)
T ss_pred EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEEEccc-CCCHHHHHhccC-CCCCHHH
Confidence 3899999876544 3445667889999999999999999998876 56899999999 899999998643 3689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccC-CCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD-IPYGSK 155 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~-~~y~~k 155 (582)
+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.+
T Consensus 104 ~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 183 (298)
T cd07841 104 IKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVG 183 (298)
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcH
Confidence 99999999999999999999999999999999999999999999997765432 2334567889999998854 457889
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---------------------------CCccccHHHHHHHH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------------------LPTVYSGAFRGLVK 208 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---------------------------lp~~~S~~l~~LI~ 208 (582)
+|||||||++|+|++|.++|.+.+..+.+.++......+ .....+..+.+||.
T Consensus 184 ~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 263 (298)
T cd07841 184 VDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQ 263 (298)
T ss_pred HHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHH
Confidence 999999999999999999998777655554443221110 11335788999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCch
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+||+.||++|||+.|+|.|+||++
T Consensus 264 ~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 264 RLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred HHhcCCcccCcCHHHHhhCccccC
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=299.46 Aligned_cols=222 Identities=19% Similarity=0.351 Sum_probs=191.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+... ......+.+|+++|++++|+||+++++++..+ ..+++||||+.+++|.+++.......+++..+..+
T Consensus 34 ~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~ 109 (263)
T cd05052 34 VAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 109 (263)
T ss_pred EEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHH
Confidence 678877643 23345788999999999999999999987654 57899999999999999998765556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc--CcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~--~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||.|||++|++||||||+|||++.++.+||+|||++......... ....++..|+|||.+.+..++.++|||
T Consensus 110 ~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 189 (263)
T cd05052 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189 (263)
T ss_pred HHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHH
Confidence 999999999999999999999999999999999999999999776543221 122345689999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||.+.+..+....+........+..++..+.++|.+||+.||++||++.++++.
T Consensus 190 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 190 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99999999998 999999988888888877766666778899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.94 Aligned_cols=234 Identities=24% Similarity=0.366 Sum_probs=190.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+..........+.+.+|+.+++.++||||++++++|... .++|+||||+.+++|.+++++.....+++..+..
T Consensus 27 ~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 105 (328)
T cd08226 27 LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN 105 (328)
T ss_pred EEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEecccCCCHHHHHHhhcccCCCHHHHHH
Confidence 489999988776666778899999999999999999999988765 5889999999999999999876555699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--------cCcccCCCCCCCcccccCC--
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--------ASSVVGTPSYMCPELLADI-- 150 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--------~~~~vGTp~Y~APE~l~~~-- 150 (582)
++.||+.||+|||+.||+||||||+|||++.++.++++|||.+........ .....++..|+|||++.+.
T Consensus 106 ~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (328)
T cd08226 106 ILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185 (328)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCC
Confidence 999999999999999999999999999999999999999986543322110 1112356679999998763
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---------------------------------------
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--------------------------------------- 191 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~--------------------------------------- 191 (582)
.++.++|||||||++|+|++|.+||.+.........+....
T Consensus 186 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (328)
T cd08226 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQ 265 (328)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccc
Confidence 47889999999999999999999998766444332221110
Q ss_pred -------CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 192 -------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 192 -------~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
..+.+..++..+.+||.+||+.||++|||++|+|+||||.....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 266 TMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 01112346778999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.21 Aligned_cols=227 Identities=34% Similarity=0.600 Sum_probs=199.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.|+||.+......+.....+.+|++++.+++|+|++++++++... ...|+||||+++++|.+++.... .+++..+..
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~ 103 (254)
T cd06627 27 FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILEYAENGSLRQIIKKFG--PFPESLVAV 103 (254)
T ss_pred EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHH
Confidence 378999988766666778899999999999999999999987654 68999999999999999998753 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc-cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........ .....|+..|+|||.+.+..++.++|||
T Consensus 104 ~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~ 183 (254)
T cd06627 104 YVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIW 183 (254)
T ss_pred HHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHH
Confidence 999999999999999999999999999999999999999999987654332 2346789999999999888889999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+||+++|+|++|..||...+......++.......++..++..+.++|.+||..+|++||++++++.||||
T Consensus 184 ~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 184 SLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999998777655555555555566777889999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=300.44 Aligned_cols=225 Identities=26% Similarity=0.421 Sum_probs=183.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||+++......... ...+|+.++.++. |+||+++++++... +..+|+||||+. ++|.+.+.... ..+++..+.
T Consensus 27 ~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~ 103 (282)
T cd07831 27 YAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVK 103 (282)
T ss_pred EEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHH
Confidence 7899887654333322 3457999999995 99999999988754 157899999996 58888887643 368999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
.++.||+.||+|||+.|++||||+|+||+++. +.+||+|||++.............+++.|+|||++.. ..++.++||
T Consensus 104 ~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 182 (282)
T cd07831 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDI 182 (282)
T ss_pred HHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhH
Confidence 99999999999999999999999999999999 9999999999987655544455678999999997654 457889999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC----------------------------CCCccccHHHHHHHHHh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----------------------------PLPTVYSGAFRGLVKSM 210 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----------------------------~lp~~~S~~l~~LI~km 210 (582)
|||||++|+|++|.+||.+.+..+.+..+...... .+...++..+.+||.+|
T Consensus 183 ~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (282)
T cd07831 183 WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKL 262 (282)
T ss_pred HHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHH
Confidence 99999999999999999887765554444321111 01124689999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|..+|++||+++++|.||||
T Consensus 263 l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 263 LAYDPDERITAKQALRHPYF 282 (282)
T ss_pred hccCcccccCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=299.18 Aligned_cols=226 Identities=20% Similarity=0.364 Sum_probs=192.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHHh----CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKKA----NGVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~----~~~~ 72 (582)
||||.++.........+.+.+|+++|+.++|+||+++++.+... ....++||||+.+|+|.+++... ....
T Consensus 29 ~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~ 108 (272)
T cd05075 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108 (272)
T ss_pred EEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCccc
Confidence 78898887766667778899999999999999999999876532 13578999999999999988532 2235
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~ 149 (582)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....+++.|++||.+.+
T Consensus 109 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence 89999999999999999999999999999999999999999999999999987643321 122345678999999999
Q ss_pred CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
..++.++|||||||++|+|++ |..||.+.....+...+......+.+..++..+.++|.+||+.||++|||+++|+++
T Consensus 189 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 889999999999999999998 899999888888777777665555667789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=303.30 Aligned_cols=222 Identities=22% Similarity=0.425 Sum_probs=192.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------C
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-----------G 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-----------~ 70 (582)
||+|.++.. .......+.+|+++|++++|+||+++++.+... ...|+||||+.+++|.+++...+ .
T Consensus 38 ~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 114 (288)
T cd05093 38 VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114 (288)
T ss_pred EEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHHHHHHcCCccccccccCCC
Confidence 677777643 345567899999999999999999999987654 58899999999999999997542 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccc
Q 007991 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELL 147 (582)
Q Consensus 71 ~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l 147 (582)
..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++....... ......++..|+|||++
T Consensus 115 ~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 115 AELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 248999999999999999999999999999999999999999999999999997654322 12234557789999999
Q ss_pred cCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.+..++.++|||||||++|+|++ |.+||...........+........+..++.++.+|+.+||+.||.+|||+++++.
T Consensus 195 ~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 195 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 98889999999999999999998 99999988888888888777666677789999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=305.47 Aligned_cols=223 Identities=20% Similarity=0.371 Sum_probs=184.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
||||.++... ....+..+.+|+++|.+++||||+++++++... ...|+||||+.+++|.+++....
T Consensus 49 vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (304)
T cd05096 49 VAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126 (304)
T ss_pred EEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecC-CceEEEEecCCCCcHHHHHHhcccccccccccccc
Confidence 7899887643 345567899999999999999999999988765 47899999999999999986532
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCC
Q 007991 70 -----GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSY 141 (582)
Q Consensus 70 -----~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y 141 (582)
...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ......++..|
T Consensus 127 ~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y 206 (304)
T cd05096 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRW 206 (304)
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccc
Confidence 1246788899999999999999999999999999999999999999999999997654322 22334567889
Q ss_pred CCcccccCCCCCCCCcccchhHHHHhHhc--CCccccccCHHHHHHHHhhc-------cCCCCCccccHHHHHHHHHhcc
Q 007991 142 MCPELLADIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQALINKINKS-------IVAPLPTVYSGAFRGLVKSMLR 212 (582)
Q Consensus 142 ~APE~l~~~~y~~ksDIWSLG~iLyELlt--G~~PF~~~~~~~l~~kI~~~-------~~~~lp~~~S~~l~~LI~kmL~ 212 (582)
+|||++.+..++.++|||||||++|+|++ +..||.+.+..+....+... .....+..++..+.+||.+||.
T Consensus 207 ~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 286 (304)
T cd05096 207 MAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWS 286 (304)
T ss_pred cCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHcc
Confidence 99999988889999999999999999986 67888877766655544221 1112345678999999999999
Q ss_pred CCCCCCCCHHHHHc
Q 007991 213 KNPEFRPSAAELLC 226 (582)
Q Consensus 213 ~dP~~RpSa~EiL~ 226 (582)
.||++|||+++|.+
T Consensus 287 ~~p~~RPs~~~i~~ 300 (304)
T cd05096 287 RDCRERPSFSDIHA 300 (304)
T ss_pred CCchhCcCHHHHHH
Confidence 99999999999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=297.27 Aligned_cols=221 Identities=18% Similarity=0.346 Sum_probs=191.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ..+.+.+|+.+++.++|+||+++++.+.. +...|+||||+.+++|.+++....+..+++..+..+
T Consensus 33 v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 108 (261)
T cd05072 33 VAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108 (261)
T ss_pred EEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHH
Confidence 68888765322 34678999999999999999999988765 457899999999999999998766667899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||
T Consensus 109 ~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05072 109 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188 (261)
T ss_pred HHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhh
Confidence 99999999999999999999999999999999999999999976543221 1233456789999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |..||...........+......+....++.++.++|.+||..+|++||+++++++
T Consensus 189 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred hhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999998 99999988888887777766655666678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=299.46 Aligned_cols=223 Identities=29% Similarity=0.466 Sum_probs=183.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++...... ....+.+|+.++++++||||+++++++... ..+|+||||+.+++|.+++.... .+++..+..+
T Consensus 37 ~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~ 111 (267)
T cd06646 37 AAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYV 111 (267)
T ss_pred EEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 788888754332 235688999999999999999999988765 58899999999999999997643 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCccccc---CCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLA---DIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~---~~~y~~ksD 157 (582)
+.|++.||+|||+.||+||||||+||+++.++.++|+|||++....... ......|++.|+|||.+. ...++.++|
T Consensus 112 ~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~D 191 (267)
T cd06646 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191 (267)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhh
Confidence 9999999999999999999999999999999999999999998664322 234567899999999884 344778999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC----CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+|||||++|+|++|..||...........+...... .....++..+.+||.+||..+|++||++++||+|+|
T Consensus 192 vws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999765543332222221111 112347899999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.19 Aligned_cols=210 Identities=30% Similarity=0.444 Sum_probs=169.4
Q ss_pred HHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 007991 20 AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 99 (582)
Q Consensus 20 ~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiH 99 (582)
...|+.+|++++|+||+++++++... ...|+||||+. ++|.+++... ...+++..+..|+.||+.||.|||++||+|
T Consensus 104 ~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (357)
T PHA03209 104 TLIEAMLLQNVNHPSVIRMKDTLVSG-AITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIH 180 (357)
T ss_pred cHHHHHHHHhCCCCCCcChhheEEeC-CeeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 35699999999999999999988765 48899999994 6888888764 346899999999999999999999999999
Q ss_pred cccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcC-Ccccccc
Q 007991 100 RDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAF 178 (582)
Q Consensus 100 RDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG-~~PF~~~ 178 (582)
|||||+|||++.++.+||+|||+++............||+.|+|||++.+..|+.++|||||||++|||+++ .++|...
T Consensus 181 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~ 260 (357)
T PHA03209 181 RDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260 (357)
T ss_pred CCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCC
Confidence 999999999999999999999999765444444567899999999999998999999999999999999985 4444432
Q ss_pred CH----------HHHHHHHhhcc--CCCCC------------------------------ccccHHHHHHHHHhccCCCC
Q 007991 179 DM----------QALINKINKSI--VAPLP------------------------------TVYSGAFRGLVKSMLRKNPE 216 (582)
Q Consensus 179 ~~----------~~l~~kI~~~~--~~~lp------------------------------~~~S~~l~~LI~kmL~~dP~ 216 (582)
.. ..+...+.... ...++ ..++..+.+||.+||+.||.
T Consensus 261 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 340 (357)
T PHA03209 261 PSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340 (357)
T ss_pred CCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcc
Confidence 11 11111111100 00000 13466778899999999999
Q ss_pred CCCCHHHHHcCCCCch
Q 007991 217 FRPSAAELLCHPHLQP 232 (582)
Q Consensus 217 ~RpSa~EiL~hp~f~~ 232 (582)
+|||++|+|+||||+.
T Consensus 341 ~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 341 MRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCcCHHHHhcCchhcc
Confidence 9999999999999975
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=295.85 Aligned_cols=222 Identities=22% Similarity=0.357 Sum_probs=187.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+.... .......+.+|+++|++++||||+++++++... ...|+||||+.+++|.+++... +..+++..+..+
T Consensus 23 ~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ 99 (252)
T cd05084 23 VAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM 99 (252)
T ss_pred EEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHH
Confidence 7888776433 345567899999999999999999999987654 5889999999999999999764 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccC---cccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS---SVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~---~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ...++..|+|||.+.+..++.++||
T Consensus 100 ~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 179 (252)
T cd05084 100 VENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179 (252)
T ss_pred HHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHH
Confidence 9999999999999999999999999999999999999999987644321111 1122356999999998889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||++|+|++ |.+||...........+......+.+..++..+.+|+.+||+.+|++||++.++++
T Consensus 180 ~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999997 99999887777666666665555677788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=304.22 Aligned_cols=231 Identities=25% Similarity=0.455 Sum_probs=184.8
Q ss_pred CEEEEEecccccCHH-HHHHHHHHHHHHH---hcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDR-ARRSAHQEMELIS---RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~-~~~~~~rEi~iL~---~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.++....... ....+.+|..++. ..+|+||+.+++.+... ...|+||||+.|++|.+++...+ .+++.
T Consensus 21 ~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~--~l~~~ 97 (279)
T cd05633 21 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLMNGGDLHYHLSQHG--VFSEK 97 (279)
T ss_pred EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecCCCCCHHHHHHhcC--CCCHH
Confidence 478998876443222 2233445554444 44799999999887654 48899999999999999998754 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc-CCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-DIPYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~-~~~y~~k 155 (582)
.+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++...... ......|++.|+|||.+. +..++.+
T Consensus 98 ~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~ 176 (279)
T cd05633 98 EMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSS 176 (279)
T ss_pred HHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCch
Confidence 99999999999999999999999999999999999999999999998755432 233457999999999986 4568899
Q ss_pred CcccchhHHHHhHhcCCccccccCHH--HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQ--ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHP 228 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~--~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp 228 (582)
+||||+||++|+|++|..||...... .............++..++.++.++|.+||..||.+|+ +++++++||
T Consensus 177 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred hhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 99999999999999999999754321 12222222333456777899999999999999999999 699999999
Q ss_pred CCchhhh
Q 007991 229 HLQPYVL 235 (582)
Q Consensus 229 ~f~~~~~ 235 (582)
||+.+.+
T Consensus 257 ~~~~~~~ 263 (279)
T cd05633 257 FFKGIDW 263 (279)
T ss_pred cccCCCH
Confidence 9987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.67 Aligned_cols=225 Identities=31% Similarity=0.571 Sum_probs=193.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++.... ....+.+.+|+.+++.++|+||+++++.+.. +.+.|+|+||+.|++|.+++.. . .+++..+..+
T Consensus 47 ~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~-~--~~~~~~~~~~ 120 (285)
T cd06648 47 VAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLEGGALTDIVTH-T--RMNEEQIATV 120 (285)
T ss_pred EEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccCCCCHHHHHHh-C--CCCHHHHHHH
Confidence 7888886533 2345668899999999999999999998765 4588999999999999999987 2 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++||+||||+|+||+++.++.++|+|||++....... ......|++.|+|||.+.+..++.++||||
T Consensus 121 ~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 200 (285)
T cd06648 121 CLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWS 200 (285)
T ss_pred HHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHH
Confidence 9999999999999999999999999999999999999999887654332 233467999999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...+.......+.......+ +..++..+.+||.+||..+|++||++.++++|+||+.
T Consensus 201 lGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 201 LGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 99999999999999988777766666655433222 2237899999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.65 Aligned_cols=222 Identities=20% Similarity=0.382 Sum_probs=192.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++..... ...+.+.+|+.++++++|+||+++++.+.. ...++||||+++++|.+++.......+++..+..+
T Consensus 26 vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (257)
T cd05040 26 VAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY 102 (257)
T ss_pred EEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHH
Confidence 788988776554 666789999999999999999999998876 68999999999999999998754346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++|
T Consensus 103 ~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D 182 (257)
T cd05040 103 AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182 (257)
T ss_pred HHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhh
Confidence 9999999999999999999999999999999999999999998764421 122346778999999999888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhh-ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~-~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|+|++ |..||...+..++...+.. ......+..++..+.+++..||+.+|++||++.++++
T Consensus 183 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 183 VWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999998 9999988877777666653 2233345668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.23 Aligned_cols=233 Identities=25% Similarity=0.458 Sum_probs=187.5
Q ss_pred CEEEEEecccccCH-HHHHHHHHH---HHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQE---MELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rE---i~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.+....... .....+..| +.+++...||+|+.+++.+... ..+|+||||+.|++|.+++...+ .+++.
T Consensus 21 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~g~~L~~~l~~~~--~l~~~ 97 (278)
T cd05606 21 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHG--VFSEA 97 (278)
T ss_pred EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecCCCCcHHHHHHhcC--CCCHH
Confidence 38999887654322 112223334 3445556899999999877654 58999999999999999987643 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCC-CCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~-~y~~k 155 (582)
.++.|+.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .....+|+..|+|||++.+. .++.+
T Consensus 98 ~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~ 176 (278)
T cd05606 98 EMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSS 176 (278)
T ss_pred HHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcc
Confidence 99999999999999999999999999999999999999999999998765432 23456899999999998754 68899
Q ss_pred CcccchhHHHHhHhcCCcccccc---CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~---~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~h 227 (582)
+||||+||++|+|++|..||.+. ....... ........++..++..+.++|.+||..+|.+|+ ++.++++|
T Consensus 177 ~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-HhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999999999999876 3333222 223334456677899999999999999999999 99999999
Q ss_pred CCCchhhhhhh
Q 007991 228 PHLQPYVLGIH 238 (582)
Q Consensus 228 p~f~~~~~~~~ 238 (582)
|||..+.+...
T Consensus 256 ~~~~~~~~~~~ 266 (278)
T cd05606 256 PFFRSLDWQMV 266 (278)
T ss_pred ccccCCCchHh
Confidence 99987654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.93 Aligned_cols=224 Identities=20% Similarity=0.382 Sum_probs=192.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
|++|.++.... ......+.+|+.++++++||||+++++.+... ...|+||||+.+++|.+++....
T Consensus 37 ~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 114 (283)
T cd05090 37 VAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114 (283)
T ss_pred EEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceEEEEEcCCCCcHHHHHHhcCCCCccccccccc
Confidence 68888875433 34456789999999999999999999987654 57899999999999999986432
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ......++..|+|
T Consensus 115 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 194 (283)
T cd05090 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMP 194 (283)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecC
Confidence 1247899999999999999999999999999999999999999999999999997654322 2234456778999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||.+.+..++.++|||||||++|||++ |.+||.+.....+.+.+......+.+..++..+.+++.+||+.||.+||++.
T Consensus 195 PE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 274 (283)
T cd05090 195 PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFK 274 (283)
T ss_pred hHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence 999988889999999999999999998 9999998888777777777666667788999999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
+|+++
T Consensus 275 ~i~~~ 279 (283)
T cd05090 275 DIHTR 279 (283)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=349.06 Aligned_cols=231 Identities=31% Similarity=0.519 Sum_probs=192.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~~ 78 (582)
||+|.+............+.+|+.+|++|+|||||+++++|... +..+|||||||.+++|.++|.... ...+++..+
T Consensus 41 vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~I 120 (1021)
T PTZ00266 41 FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120 (1021)
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHH
Confidence 78898887766677778899999999999999999999988754 458999999999999999997531 236999999
Q ss_pred HHHHHHHHHHHHHHHHC-------CceecccCcccEEEcCC-----------------CCeEEeecccchhcccccccCc
Q 007991 79 CKWLVQLLMALNYLHAN-------HILHRDVKCSNIFLTRD-----------------QDIRLGDFGLAKMLISDDLASS 134 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~-------gIiHRDIKP~NILL~~~-----------------g~vKL~DFGla~~~~~~~~~~~ 134 (582)
+.|+.||+.||.|||+. +||||||||+||||+.+ +.+||+|||++...........
T Consensus 121 l~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s 200 (1021)
T PTZ00266 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200 (1021)
T ss_pred HHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccc
Confidence 99999999999999995 49999999999999642 3489999999987655555566
Q ss_pred ccCCCCCCCcccccC--CCCCCCCcccchhHHHHhHhcCCccccccCH-HHHHHHHhhccCCCCCccccHHHHHHHHHhc
Q 007991 135 VVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPLPTVYSGAFRGLVKSML 211 (582)
Q Consensus 135 ~vGTp~Y~APE~l~~--~~y~~ksDIWSLG~iLyELltG~~PF~~~~~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL 211 (582)
.+||+.|+|||++.+ ..++.++||||||||||+|++|..||...+. ..++..+...... ....++..+.+||..||
T Consensus 201 ~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L 279 (1021)
T PTZ00266 201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLL 279 (1021)
T ss_pred cCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHh
Confidence 789999999999864 3488999999999999999999999976543 3344433333222 22357899999999999
Q ss_pred cCCCCCCCCHHHHHcCCCCchh
Q 007991 212 RKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 212 ~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
..+|.+||++.|+|.|+|++..
T Consensus 280 ~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 280 NLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCChhHCcCHHHHhccHHHhhc
Confidence 9999999999999999999754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.03 Aligned_cols=222 Identities=21% Similarity=0.351 Sum_probs=190.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+.... .....+.+.+|+.+|++++|+||+++++++. ....|+||||++|++|.+++.... ..+++..+..+
T Consensus 25 vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 100 (257)
T cd05115 25 VAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVEL 100 (257)
T ss_pred EEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHH
Confidence 6888886543 3455678999999999999999999999764 346889999999999999997633 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||.|||++|++||||||+|||++.++.+||+|||++........ .....++..|+|||.+....++.++|
T Consensus 101 ~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 180 (257)
T cd05115 101 MHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180 (257)
T ss_pred HHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhh
Confidence 99999999999999999999999999999999999999999976543321 11122356899999998888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|+|++ |..||.+....+....+........+..+++++.++|.+||..+|++||++.++++.
T Consensus 181 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 181 VWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999996 999999988888887777766667778889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=291.08 Aligned_cols=227 Identities=34% Similarity=0.601 Sum_probs=197.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
|+||++..........+.+.+|+.++++++|+||+++++.+.... ...++|+||+.+++|.+++.... .+++..+..
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 105 (260)
T cd06606 28 MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRK 105 (260)
T ss_pred EEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHH
Confidence 788988776665667788999999999999999999999876541 58899999999999999998754 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+..++.++|
T Consensus 106 ~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D 185 (260)
T cd06606 106 YTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185 (260)
T ss_pred HHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhh
Confidence 999999999999999999999999999999999999999999987765443 45567899999999998888999999
Q ss_pred ccchhHHHHhHhcCCccccccC-HHHHHHHHhh-ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFD-MQALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~-~~~l~~kI~~-~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||||+++|+|++|..||...+ .......+.. .....++..++..+.+||.+||..||.+||++.+++.||||
T Consensus 186 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 186 IWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999998776 2233333322 34455677789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=289.45 Aligned_cols=224 Identities=34% Similarity=0.629 Sum_probs=192.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|+++.... ...+.+.+|+.++++++|+||+++++.+... ...++++||+.|++|.+++.... ..+++..+..+
T Consensus 28 ~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i 103 (253)
T cd05122 28 VAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYV 103 (253)
T ss_pred EEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHH
Confidence 78888876544 4557889999999999999999999987655 58899999999999999998753 46899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.............|+..|++||.+.+..++.++|+|||
T Consensus 104 ~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 183 (253)
T cd05122 104 CKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSL 183 (253)
T ss_pred HHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHH
Confidence 99999999999999999999999999999999999999999987655433456788999999999988888999999999
Q ss_pred hHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc--ccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 162 GCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV--YSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 162 G~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~--~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
||++|+|++|..||...+.......+........+.. ++..+.++|..||+.||++|||+.++|.|||
T Consensus 184 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 184 GITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999988755554444443333333333 4899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.39 Aligned_cols=226 Identities=27% Similarity=0.498 Sum_probs=185.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHh--CCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKA--NGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~ls 74 (582)
||||++.... .....+.+|+.+++.+ +|+||+++++++.. .+..+|+||||++|++|.+++... .+..++
T Consensus 46 ~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 122 (286)
T cd06638 46 AAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122 (286)
T ss_pred eEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCcccc
Confidence 7788775422 2235678899999999 69999999998753 345799999999999999988642 234689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccC----
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD---- 149 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~---- 149 (582)
+..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....... ......|++.|+|||++..
T Consensus 123 ~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (286)
T cd06638 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhc
Confidence 99999999999999999999999999999999999999999999999987654332 2344579999999998853
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
..++.++|||||||++|+|++|..||...+.......+..... ...+..++..+.+||.+||+.||++||++.|||+
T Consensus 203 ~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 4478899999999999999999999987765444443332221 1234557889999999999999999999999999
Q ss_pred CCCC
Q 007991 227 HPHL 230 (582)
Q Consensus 227 hp~f 230 (582)
|+||
T Consensus 283 ~~~~ 286 (286)
T cd06638 283 HVFI 286 (286)
T ss_pred cccC
Confidence 9997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.35 Aligned_cols=220 Identities=21% Similarity=0.378 Sum_probs=188.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+...... .+.+.+|+.+|++++||||+++++++.. +...|+||||++||+|.+++....+ .+++..+..+
T Consensus 31 ~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~ 105 (256)
T cd05114 31 VAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSM 105 (256)
T ss_pred EEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHH
Confidence 688877644332 3468889999999999999999997755 4588999999999999999986433 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc--CcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~--~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||+|||++||+||||||+||+++.++.+||+|||+++........ ....++..|+|||.+.+..++.++|||
T Consensus 106 ~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 185 (256)
T cd05114 106 CQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhH
Confidence 999999999999999999999999999999999999999998765432221 123455689999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |+.||...+..+....+........+...+..+.+|+.+||..+|++||+++++++
T Consensus 186 s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 186 SFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999 89999998888888887766555567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.45 Aligned_cols=224 Identities=20% Similarity=0.361 Sum_probs=194.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
||||+++... .....+.+.+|+.++..++||||+++++++... ...++++||+.+++|.+++....
T Consensus 38 vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~ 115 (283)
T cd05091 38 VAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115 (283)
T ss_pred EEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-CceEEEEEcCCCCcHHHHHHhcCCCcccccccccc
Confidence 7899987543 344567789999999999999999999987655 47899999999999999986321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCc
Q 007991 70 --GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCP 144 (582)
Q Consensus 70 --~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~AP 144 (582)
...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+++.|+||
T Consensus 116 ~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05091 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195 (283)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCH
Confidence 1247899999999999999999999999999999999999999999999999987654322 22344567899999
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
|.+.+..++.++|||||||++|||++ |..||.+....+....+......+.+..++..+.+|+..||+.+|.+||++++
T Consensus 196 E~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~ 275 (283)
T cd05091 196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKD 275 (283)
T ss_pred HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 99988889999999999999999997 89999998888888888877777778889999999999999999999999999
Q ss_pred HHcC
Q 007991 224 LLCH 227 (582)
Q Consensus 224 iL~h 227 (582)
|+..
T Consensus 276 i~~~ 279 (283)
T cd05091 276 IHSR 279 (283)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.64 Aligned_cols=224 Identities=18% Similarity=0.383 Sum_probs=192.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA------------ 68 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~------------ 68 (582)
||+|.+..... ......+.+|+.+++++ +|+||+++++++... ..+|++|||+.+++|.+++...
T Consensus 45 ~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 122 (293)
T cd05053 45 VAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122 (293)
T ss_pred EEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-CCeEEEEEeCCCCcHHHHHHhcCCCccccccccc
Confidence 68888875433 44456789999999999 799999999987654 5789999999999999999752
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCC
Q 007991 69 --NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMC 143 (582)
Q Consensus 69 --~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~A 143 (582)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|
T Consensus 123 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 202 (293)
T cd05053 123 RPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA 202 (293)
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccC
Confidence 234689999999999999999999999999999999999999999999999999987644321 122334568999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..++.++|||||||++|+|++ |..||.+....++...+........+..++..+.+|+.+||..||++|||+.
T Consensus 203 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 282 (293)
T cd05053 203 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK 282 (293)
T ss_pred HHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence 999988889999999999999999997 9999999888888887777666666778899999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
+++++
T Consensus 283 eil~~ 287 (293)
T cd05053 283 QLVED 287 (293)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.95 Aligned_cols=224 Identities=20% Similarity=0.362 Sum_probs=189.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC--------CCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG--------VHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~--------~~l 73 (582)
||||++.... .......+.+|+.+++.++|+||+++++++.. +...|+||||+.+++|.+++..... ..+
T Consensus 39 ~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 116 (277)
T cd05062 39 VAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116 (277)
T ss_pred EEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCeEEEEecCCCCCHHHHHHHcCccccccccccCC
Confidence 7888876533 23445678899999999999999999997754 4588999999999999999976321 235
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~ 150 (582)
++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ .....+++.|+|||++.+.
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05062 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 196 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence 7888999999999999999999999999999999999999999999999876543221 1223557789999999988
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++.++|||||||++|||++ |..||.+.........+........+..++..+.+||.+||+.||++|||+.|++.+
T Consensus 197 ~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 197 VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999998 799999888887777766655556677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=297.04 Aligned_cols=227 Identities=24% Similarity=0.471 Sum_probs=188.0
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHH-HHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~i-L~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.++..... ......+..|..+ ...++|+||+++++.+.. +..+|+||||+.|++|.++++... .+++..+
T Consensus 23 ~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 99 (260)
T cd05611 23 YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLNGGDCASLIKTLG--GLPEDWA 99 (260)
T ss_pred eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccCCCCHHHHHHHcC--CCCHHHH
Confidence 3789988754332 2222344555554 455689999999998765 458999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|+..|++||.+.+..++.++||
T Consensus 100 ~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv 176 (260)
T cd05611 100 KQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDW 176 (260)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhh
Confidence 99999999999999999999999999999999999999999999876533 334578899999999988888999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccC---CCCCccccHHHHHHHHHhccCCCCCCC---CHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~---~~lp~~~S~~l~~LI~kmL~~dP~~Rp---Sa~EiL~hp~f~~ 232 (582)
||||+++|+|++|..||...+.......+..... ......++..+.++|.+||+.||++|| +++|+|.||||..
T Consensus 177 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 9999999999999999998888777666644322 123345789999999999999999999 5589999999975
Q ss_pred h
Q 007991 233 Y 233 (582)
Q Consensus 233 ~ 233 (582)
.
T Consensus 257 ~ 257 (260)
T cd05611 257 I 257 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.36 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=206.7
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||.|.++.+..-. ....-++.|-.||..-+++.||+||..|.+++ .+|+||+|+.||+|..+|-+.+ .|+|+.++
T Consensus 656 lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFVMdYIPGGDmMSLLIrmg--IFeE~LAR 732 (1034)
T KOG0608|consen 656 LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFVMDYIPGGDMMSLLIRMG--IFEEDLAR 732 (1034)
T ss_pred HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEEEeccCCccHHHHHHHhc--cCHHHHHH
Confidence 57888887765433 34456788999999999999999999998765 7999999999999999998865 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---------c--------------------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---------D-------------------- 130 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---------~-------------------- 130 (582)
.|+.+|.+|+++.|..|+|||||||+|||||.+|+|||+|||||.-+... +
T Consensus 733 FYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~l 812 (1034)
T KOG0608|consen 733 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCL 812 (1034)
T ss_pred HHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccc
Confidence 99999999999999999999999999999999999999999999644210 0
Q ss_pred --------------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHH---hhccCC
Q 007991 131 --------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI---NKSIVA 193 (582)
Q Consensus 131 --------------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI---~~~~~~ 193 (582)
.....+||+.|+|||++....|+..+|+||.|||||||+.|++||-.....+...++ ...+..
T Consensus 813 kvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~ 892 (1034)
T KOG0608|consen 813 KVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHI 892 (1034)
T ss_pred hHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccc
Confidence 112358999999999999999999999999999999999999999766544332222 223334
Q ss_pred CCCccccHHHHHHHHHhccCCCCCCC---CHHHHHcCCCCchhhhhhhcccCCCCCCCCCCCCCCccccc
Q 007991 194 PLPTVYSGAFRGLVKSMLRKNPEFRP---SAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 194 ~lp~~~S~~l~~LI~kmL~~dP~~Rp---Sa~EiL~hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~~~ 260 (582)
+....+|.++.+||.++. .+++.|. .++++..||||+.+.+....+...|-.+++.-..+.+||+.
T Consensus 893 ~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 893 PYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDP 961 (1034)
T ss_pred ccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCCc
Confidence 456679999999999865 5777885 47789999999987655544445555555555567777654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.06 Aligned_cols=225 Identities=30% Similarity=0.531 Sum_probs=189.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ..+.+.+|+.+++.++|+||+++++.|.. +.+.|+||||++|++|.+++.+. .+++..+..+
T Consensus 47 vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 120 (297)
T cd06656 47 VAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAV 120 (297)
T ss_pred EEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHH
Confidence 789988765443 33668899999999999999999998765 45899999999999999999763 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+.||+||||||+|||++.++.++|+|||++....... ......|++.|+|||.+.+..++.++|+||
T Consensus 121 ~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 200 (297)
T cd06656 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (297)
T ss_pred HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHH
Confidence 9999999999999999999999999999999999999999987654332 233467899999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhcc--CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSI--VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~--~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...+.......+.... ....+..++..+++||.+||..+|++||+++++++||||+.
T Consensus 201 lGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred HHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 9999999999999998765433322222211 11235568899999999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=303.77 Aligned_cols=231 Identities=27% Similarity=0.405 Sum_probs=188.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|++++++++|+||+++++++... .+.|+||||+. ++|.+++.......+++..+..
T Consensus 29 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~ 106 (294)
T PLN00009 29 TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKT 106 (294)
T ss_pred EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHH
Confidence 378998877655445556788999999999999999999987654 58999999995 6888888765555578999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksD 157 (582)
++.||+.||+|||++||+||||+|+||+++.+ +.+||+|||++...... .......|++.|+|||.+.+ ..++.++|
T Consensus 107 ~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 186 (294)
T PLN00009 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVD 186 (294)
T ss_pred HHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHH
Confidence 99999999999999999999999999999864 56999999999765332 22344578899999998865 45788999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKS 209 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~k 209 (582)
||||||++|+|++|.+||...+..+.+.++......+ ....++..+.++|.+
T Consensus 187 v~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 266 (294)
T PLN00009 187 IWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266 (294)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHH
Confidence 9999999999999999998776655544432211100 113468899999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.+|++||+++++|.||||..+
T Consensus 267 ~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 267 MLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred HccCChhhCcCHHHHhcCchHhHH
Confidence 999999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.95 Aligned_cols=222 Identities=20% Similarity=0.375 Sum_probs=190.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
+++|.+.. ......+.+.+|++++++++|+||+++++.+.. +...++||||+.+++|.+++....
T Consensus 38 ~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 114 (291)
T cd05094 38 VAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114 (291)
T ss_pred eEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceEEEEecCCCCcHHHHHHhcCcccccccccccc
Confidence 56666643 233445678999999999999999999998765 457899999999999999997643
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCc
Q 007991 70 --GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCP 144 (582)
Q Consensus 70 --~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~AP 144 (582)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......|+..|+||
T Consensus 115 ~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 115 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred cCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 1348999999999999999999999999999999999999999999999999997654332 22345678899999
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
|.+.+..++.++|||||||++|+|++ |..||...+..+..+.+........+..++..+.+|+.+||+.+|++||++++
T Consensus 195 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 274 (291)
T cd05094 195 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE 274 (291)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 99998889999999999999999998 99999888888887777776666667778999999999999999999999999
Q ss_pred HHc
Q 007991 224 LLC 226 (582)
Q Consensus 224 iL~ 226 (582)
+++
T Consensus 275 v~~ 277 (291)
T cd05094 275 IYK 277 (291)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=327.82 Aligned_cols=225 Identities=28% Similarity=0.541 Sum_probs=196.2
Q ss_pred CEEEEEecc-cccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~-~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||||++.- ..++.+-...+..|+..|.+|+|||+|.|.++|..+ ...|+||||| -|+-.|++.-.. .++-|-.+.
T Consensus 53 vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIA 129 (948)
T KOG0577|consen 53 VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-HTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIA 129 (948)
T ss_pred eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-chHHHHHHHH-hccHHHHHHHHh-ccchHHHHH
Confidence 489999965 345556678899999999999999999999988765 4788999999 577777776542 368999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
.|..+.|.||.|||+++.||||||..|||++..|.|||+|||.|..... ..+++|||.|||||++. .+.|+-++
T Consensus 130 Ai~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkv 206 (948)
T KOG0577|consen 130 AITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 206 (948)
T ss_pred HHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCcc
Confidence 9999999999999999999999999999999999999999999876543 67899999999999874 45699999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
||||||++..||...+||+-+++....+.-|.....+.++ ..||+.|++||..||++-|.+|||.+++|+|+|+.
T Consensus 207 DvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 207 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred ceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 9999999999999999998888877666667655554443 45999999999999999999999999999999995
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.22 Aligned_cols=221 Identities=19% Similarity=0.369 Sum_probs=190.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++..... .+.+.+|+.++++++||||+++++++... ..+|+||||+.+++|.+++..... .+++..+..+
T Consensus 31 ~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~ 105 (256)
T cd05113 31 VAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEM 105 (256)
T ss_pred EEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHH
Confidence 788988754332 35688999999999999999999987654 478999999999999999987433 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc--CcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~--~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++........ ....++..|++||.+.+..++.++|||
T Consensus 106 ~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~ 185 (256)
T cd05113 106 CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHH
Confidence 999999999999999999999999999999999999999998765433211 123455679999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||...........+........+...+..+.+++.+||..||.+||++.+|+.+
T Consensus 186 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 186 AFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999998 999999888877777776666555677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.17 Aligned_cols=223 Identities=21% Similarity=0.387 Sum_probs=192.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... .......+.+|+.++++++||||+++++.+.. +...|+||||+.+++|.+++....+ .+++..+..+
T Consensus 35 vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~ 111 (266)
T cd05033 35 VAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGM 111 (266)
T ss_pred EEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHH
Confidence 6888887644 34456678899999999999999999997765 4578999999999999999987543 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cc--cCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DL--ASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~--~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|++.||.|||++||+||||||+|||++.++.++|+|||++...... .. .....++..|+|||.+.+..++.++||
T Consensus 112 ~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv 191 (266)
T cd05033 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDV 191 (266)
T ss_pred HHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccch
Confidence 999999999999999999999999999999999999999999876421 11 112344578999999998889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|+|++ |..||.......+...+......+.+..++..+.+|+..||+.+|++||++++++++
T Consensus 192 ~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 192 WSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999987 999998888888888877666666677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.55 Aligned_cols=224 Identities=19% Similarity=0.362 Sum_probs=188.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
+++|.++.. ......+.+.+|++++.++ +||||+++++.+... ...|+||||+.+++|.+++.+..
T Consensus 32 ~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 109 (297)
T cd05089 32 AAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE 109 (297)
T ss_pred eEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceEEEEecCCCcHHHHHHhccccccccccccc
Confidence 466666532 2334456789999999999 799999999987654 57899999999999999997632
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccc
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~ 146 (582)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............++..|+|||.
T Consensus 110 ~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 189 (297)
T cd05089 110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIES 189 (297)
T ss_pred cCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchh
Confidence 12488999999999999999999999999999999999999999999999999864322211122233457999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
+.+..++.++|||||||++|+|++ |..||.......+..++........+..++..+.+||.+||+.+|.+||++++++
T Consensus 190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 269 (297)
T cd05089 190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQIS 269 (297)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 998889999999999999999997 9999999888888888877666667778999999999999999999999999998
Q ss_pred cC
Q 007991 226 CH 227 (582)
Q Consensus 226 ~h 227 (582)
+.
T Consensus 270 ~~ 271 (297)
T cd05089 270 VQ 271 (297)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.25 Aligned_cols=226 Identities=29% Similarity=0.559 Sum_probs=189.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|++..... ....+.+.+|+++++.++||||+++++.+... ..+|+||||+++++|.+++.+.+ .+++..+..+
T Consensus 33 ~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~ 108 (284)
T cd06620 33 MAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKI 108 (284)
T ss_pred EEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHH
Confidence 78888765433 45567899999999999999999999988765 58999999999999999998743 6899999999
Q ss_pred HHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+ .|++||||||+||+++.++.++|+|||++...... .....+|+..|+|||++.+..++.++||||
T Consensus 109 ~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s 187 (284)
T cd06620 109 AVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWS 187 (284)
T ss_pred HHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHH
Confidence 9999999999997 69999999999999999999999999998654332 234568999999999998888999999999
Q ss_pred hhHHHHhHhcCCccccccCHH-----------HHHHHHhhccCCCCCcc-ccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQ-----------ALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~-----------~l~~kI~~~~~~~lp~~-~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
|||++|+|++|..||...... +....+.......++.. ++..+.+||.+||+.||++||+++|+++|+
T Consensus 188 lG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 188 LGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 999999999999999865431 22333332222233333 788999999999999999999999999999
Q ss_pred CCch
Q 007991 229 HLQP 232 (582)
Q Consensus 229 ~f~~ 232 (582)
||..
T Consensus 268 ~~~~ 271 (284)
T cd06620 268 PFIQ 271 (284)
T ss_pred cccc
Confidence 9864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=294.47 Aligned_cols=220 Identities=20% Similarity=0.364 Sum_probs=189.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+...... ...+.+.+|+.+|+.++|+|||++++++. +...++||||+.+++|.+++.... .+++..+..+
T Consensus 26 ~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 100 (257)
T cd05060 26 VAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKEL 100 (257)
T ss_pred EEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHH
Confidence 788888765543 45567899999999999999999998654 346789999999999999998754 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc----CcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA----SSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~----~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|++.||+|||+.|++||||||+|||++.++.+||+|||+++........ ....++..|+|||.+.+..++.++|
T Consensus 101 ~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 180 (257)
T cd05060 101 AHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD 180 (257)
T ss_pred HHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccch
Confidence 999999999999999999999999999999999999999999866433211 1112345799999999888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|+|++ |.+||...+..++...+......+.+..++..++++|.+||..+|++||++.++++
T Consensus 181 i~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 181 VWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999997 99999988888777777766655677789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=295.30 Aligned_cols=221 Identities=17% Similarity=0.339 Sum_probs=190.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++..... .+.+.+|+.++++++|+||+++++++.. +...|+||||+.|++|.+++....+..+++..+..+
T Consensus 33 v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 108 (261)
T cd05068 33 VAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108 (261)
T ss_pred EEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHH
Confidence 788888764332 3568899999999999999999997655 457899999999999999998765567899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccC--cccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~--~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......... ...++..|+|||.+.+..++.++|||
T Consensus 109 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05068 109 AAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188 (261)
T ss_pred HHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999998765332111 12223579999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |..||.+.....+...+......+.+..++..+.+++.+||+.+|.+||++++++.
T Consensus 189 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 189 SFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999998 99999998888777777666555566778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.50 Aligned_cols=224 Identities=20% Similarity=0.371 Sum_probs=187.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
+++|.+... ........+.+|++++.++ +|+||+++++++... ...|+||||+.+++|.+++.+..
T Consensus 37 ~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (303)
T cd05088 37 AAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114 (303)
T ss_pred EEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCceEEEEeCCCCcHHHHHHhccccccccccccc
Confidence 466665532 2344567788999999999 899999999987654 58999999999999999997642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccc
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~ 146 (582)
+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............++..|+|||.
T Consensus 115 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 194 (303)
T cd05088 115 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 194 (303)
T ss_pred ccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHH
Confidence 23588999999999999999999999999999999999999999999999999864322111222234567999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
+.+..++.++|||||||++|+|++ |.+||...+..+....+........+..++..+.+||.+||+.+|++||+++++|
T Consensus 195 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 274 (303)
T cd05088 195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274 (303)
T ss_pred HhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 988889999999999999999998 9999998888877777765555555667889999999999999999999999999
Q ss_pred cC
Q 007991 226 CH 227 (582)
Q Consensus 226 ~h 227 (582)
.+
T Consensus 275 ~~ 276 (303)
T cd05088 275 VS 276 (303)
T ss_pred HH
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.78 Aligned_cols=224 Identities=19% Similarity=0.343 Sum_probs=192.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--------CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--------GVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--------~~~l 73 (582)
||||.+.... .......+.+|+.+|+.++|+||+++++++... ...|+||||+.+++|.+++.... ...+
T Consensus 39 ~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 116 (277)
T cd05032 39 VAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116 (277)
T ss_pred EEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCC
Confidence 6888875433 334456788999999999999999999987654 58999999999999999997532 1246
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ......++..|+|||.+.+.
T Consensus 117 ~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05032 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence 888999999999999999999999999999999999999999999999997654432 22345677899999999888
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++.++|||||||++|+|++ |..||.+.+.......+........+..++..+.+||.+||+.+|++|||+.+++..
T Consensus 197 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 197 VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999998 999999888888877777665666778889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=305.76 Aligned_cols=225 Identities=29% Similarity=0.515 Sum_probs=191.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+..... ...+.+.+|+.++..++||||+++++.+... ...|+||||+++++|..++... .+++..+..+
T Consensus 49 v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 122 (297)
T cd06659 49 VAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQT---RLNEEQIATV 122 (297)
T ss_pred EEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHH
Confidence 78998866433 2346788999999999999999999987654 5899999999999999988653 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .....+|+..|+|||++.+..++.++||||
T Consensus 123 ~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 202 (297)
T cd06659 123 CESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202 (297)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHH
Confidence 9999999999999999999999999999999999999999987654332 234568999999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...+.......+..... ...+..++..+.++|.+||+.+|++||+++++++||||..
T Consensus 203 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 99999999999999987776665555543321 1223457889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=294.80 Aligned_cols=221 Identities=21% Similarity=0.396 Sum_probs=189.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ...+.+|++++++++|+||+++++++... ...|+||||++|++|.+++....+ .+++..+..+
T Consensus 31 ~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i 105 (256)
T cd05059 31 VAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDM 105 (256)
T ss_pred EEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHH
Confidence 788888654332 24578899999999999999999977544 588999999999999999987543 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc--CcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~--~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||+.||+||||||+||+++.++.+||+|||+++........ ....++..|+|||.+.+..++.++|||
T Consensus 106 ~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~ 185 (256)
T cd05059 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHH
Confidence 999999999999999999999999999999999999999998765432211 112234579999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |.+||...+..+....+........+..++..+.+|+.+||..+|++|||++++++.
T Consensus 186 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 186 SFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999998 899998888888777777666666677899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.23 Aligned_cols=229 Identities=28% Similarity=0.527 Sum_probs=182.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHH-HHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~i-L~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~ 77 (582)
.||||+++........ ..+.+|+.+ ++.++||||+++++.+..+ ..+|+||||++ ++|.+++... .+..+++..
T Consensus 28 ~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~ 104 (283)
T cd06617 28 IMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFRE-GDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDI 104 (283)
T ss_pred EEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecC-CcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHH
Confidence 3899998776544333 345556665 6777899999999987654 57999999996 7888887653 234689999
Q ss_pred HHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC----CCC
Q 007991 78 LCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD----IPY 152 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~----~~y 152 (582)
+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.............|+..|+|||.+.+ ..+
T Consensus 105 ~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 184 (283)
T cd06617 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 184 (283)
T ss_pred HHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCccccccc
Confidence 999999999999999998 999999999999999999999999999987654333344678999999998864 457
Q ss_pred CCCCcccchhHHHHhHhcCCccccccC--HHHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~--~~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+.++|+|||||++|+|++|..||.... ...+.. +.......++ ..++.++.+||.+||..+|++||++++++.|||
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 185 DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred CccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 889999999999999999999996532 222222 2222222232 358899999999999999999999999999999
Q ss_pred Cchh
Q 007991 230 LQPY 233 (582)
Q Consensus 230 f~~~ 233 (582)
|+..
T Consensus 264 ~~~~ 267 (283)
T cd06617 264 FELH 267 (283)
T ss_pred hhhc
Confidence 9763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.16 Aligned_cols=222 Identities=22% Similarity=0.373 Sum_probs=193.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+|+|.+..... .....+.+|+.+|+.++|+||+++++.+.. +...|+||||+.+++|.+++....+..+++..+..+
T Consensus 33 ~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 109 (261)
T cd05148 33 VAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM 109 (261)
T ss_pred EEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHH
Confidence 67888765432 345678899999999999999999997755 457899999999999999998765667899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc-cCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....++..|++||.+.+..++.++||||
T Consensus 110 ~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diws 189 (261)
T cd05148 110 ACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189 (261)
T ss_pred HHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHH
Confidence 99999999999999999999999999999999999999999977643321 22334567899999998888999999999
Q ss_pred hhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 161 LGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 161 LG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||++|+|++ |..||...+..+....+......+.+..+++.+.++|.+||+.||.+|||+.+|++
T Consensus 190 lG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 190 FGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999998 89999988888888888776666777889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.30 Aligned_cols=223 Identities=20% Similarity=0.373 Sum_probs=186.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
+++|.++.. ......+.+.+|++++.++ +||||+++++++... ...|+||||+.+++|.+++....
T Consensus 25 ~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 102 (270)
T cd05047 25 AAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 102 (270)
T ss_pred EEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-CCceEEEEeCCCCcHHHHHHhccccccccccccc
Confidence 466666532 2344556789999999999 799999999987654 47899999999999999997632
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccc
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~ 146 (582)
...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.............++..|+|||+
T Consensus 103 ~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~ 182 (270)
T cd05047 103 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 182 (270)
T ss_pred cCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHH
Confidence 12478999999999999999999999999999999999999999999999999864322111122234567999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
+....++.++|||||||++|+|++ |..||.+.+.......+........+..++.++.+|+.+||..||.+|||+++++
T Consensus 183 ~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (270)
T cd05047 183 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 262 (270)
T ss_pred HccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 988889999999999999999996 9999998888887777766555556667889999999999999999999999998
Q ss_pred c
Q 007991 226 C 226 (582)
Q Consensus 226 ~ 226 (582)
.
T Consensus 263 ~ 263 (270)
T cd05047 263 V 263 (270)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.07 Aligned_cols=228 Identities=28% Similarity=0.426 Sum_probs=182.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-------cEEEEEEeecCCCCHHHHHHHhCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-------CYVCIIIGYCEGGDMAEAIKKANGVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-------~~l~LVmEy~~GgsL~d~Ikk~~~~~l 73 (582)
.||||++............+.+|++++++++||||+++++++...+ ...|+||||+. ++|.+++.... ..+
T Consensus 39 ~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~ 116 (310)
T cd07865 39 IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKF 116 (310)
T ss_pred EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCC
Confidence 4889988765444444456678999999999999999999876432 35799999995 68888887643 368
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCccccc
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLA 148 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~ 148 (582)
++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... .....+++..|+|||.+.
T Consensus 117 ~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (310)
T cd07865 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196 (310)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhc
Confidence 999999999999999999999999999999999999999999999999997654322 123456788999999886
Q ss_pred CC-CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---C----------------------------CC
Q 007991 149 DI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---P----------------------------LP 196 (582)
Q Consensus 149 ~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~----------------------------lp 196 (582)
+. .++.++|||||||++|+|++|.+||.+.+.......+...... . .+
T Consensus 197 ~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 276 (310)
T cd07865 197 GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP 276 (310)
T ss_pred CCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc
Confidence 64 4788999999999999999999999877655443333221100 0 01
Q ss_pred ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 197 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 197 ~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
...+..+.+||.+||..||.+|||++++|+||||
T Consensus 277 ~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 277 YVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1235778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.10 Aligned_cols=224 Identities=21% Similarity=0.391 Sum_probs=184.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||.++..... ...+.+.+|+++|+.+ +|+|||++++.+... ..+|+|||||.+|+|.+++.+..
T Consensus 71 vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~ 148 (374)
T cd05106 71 VAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHG-GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALP 148 (374)
T ss_pred eEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCC-CCeEEeHhhccCCcHHHHHHhhhhhhcccccccc
Confidence 789999765443 3456788999999999 899999999987665 48899999999999999986531
Q ss_pred ---------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 007991 70 ---------------------------------------------------------GVHFPEEKLCKWLVQLLMALNYL 92 (582)
Q Consensus 70 ---------------------------------------------------------~~~lse~~~~~il~QLL~aL~yL 92 (582)
...+++..+..++.||+.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL 228 (374)
T cd05106 149 EISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL 228 (374)
T ss_pred ccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHH
Confidence 12478899999999999999999
Q ss_pred HHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHh
Q 007991 93 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMS 169 (582)
Q Consensus 93 Hs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELl 169 (582)
|++||+||||||+|||++.++.+||+|||+++...... ......++..|+|||++.+..|+.++|||||||++|+|+
T Consensus 229 H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 308 (374)
T cd05106 229 ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308 (374)
T ss_pred HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999999997654322 112234556799999999889999999999999999999
Q ss_pred c-CCccccccCHHHHH-HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 170 A-QKAAFKAFDMQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 170 t-G~~PF~~~~~~~l~-~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+ |+.||........+ ..+........+..++.++.++|.+||+.||.+||+++++++.
T Consensus 309 t~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 309 SLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred hCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7 99999876654433 3333333444566679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=300.06 Aligned_cols=229 Identities=17% Similarity=0.345 Sum_probs=192.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--------CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--------GVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--------~~~l 73 (582)
||+|.+..... ......+.+|+.+++.++|+||+++++++... ...|+||||+.+|+|.+++.+.. ...+
T Consensus 39 vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 116 (288)
T cd05061 39 VAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116 (288)
T ss_pred EEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCC
Confidence 68888765432 33445678999999999999999999987654 57899999999999999997632 1234
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~ 150 (582)
+...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....... .....++..|+|||.+.+.
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 196 (288)
T cd05061 117 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC
Confidence 6778899999999999999999999999999999999999999999999876543221 1223456789999999988
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc---
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC--- 226 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~--- 226 (582)
.++.++|+|||||++|||++ |..||.+....+....+........+..++..+.++|.+||+.||++|||+.++++
T Consensus 197 ~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 197 VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 89999999999999999998 79999988888877777666556667778899999999999999999999999986
Q ss_pred ---CCCCch
Q 007991 227 ---HPHLQP 232 (582)
Q Consensus 227 ---hp~f~~ 232 (582)
||||++
T Consensus 277 ~~~~~~~~~ 285 (288)
T cd05061 277 DDLHPSFPE 285 (288)
T ss_pred hhcCCCCCC
Confidence 777754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.42 Aligned_cols=231 Identities=28% Similarity=0.459 Sum_probs=185.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHH---HHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI---KKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~I---kk~~~~~lse~ 76 (582)
.||||++...... .....+.+|+.++.++. |+||+++++++... ...+++|||+. ++|.++. .......+++.
T Consensus 31 ~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~ 107 (288)
T cd06616 31 IMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEE 107 (288)
T ss_pred EEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHH
Confidence 3789998765443 44567889999999996 99999999987654 57889999995 5655443 33233469999
Q ss_pred HHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCC---CC
Q 007991 77 KLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI---PY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~---~y 152 (582)
.+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++.............|++.|+|||++.+. .+
T Consensus 108 ~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 187 (288)
T cd06616 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187 (288)
T ss_pred HHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCC
Confidence 9999999999999999985 9999999999999999999999999999876555444556789999999999776 68
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCH-HHHHHHHhhccCCC----CCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAP----LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~-~~l~~kI~~~~~~~----lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+.++|||||||++|+|++|++||..... ......+....... .+..++.++.+||.+||+.||++|||+++|+.|
T Consensus 188 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8999999999999999999999976542 11222222211111 223478999999999999999999999999999
Q ss_pred CCCchhh
Q 007991 228 PHLQPYV 234 (582)
Q Consensus 228 p~f~~~~ 234 (582)
|||+.+.
T Consensus 268 ~~~~~~~ 274 (288)
T cd06616 268 PFIKDYE 274 (288)
T ss_pred hhhhchh
Confidence 9998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.69 Aligned_cols=230 Identities=25% Similarity=0.392 Sum_probs=184.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCc----EEEEEEeecCCCCHHHHHHHhC---CCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGC----YVCIIIGYCEGGDMAEAIKKAN---GVH 72 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~----~l~LVmEy~~GgsL~d~Ikk~~---~~~ 72 (582)
.||||+++...........+.+|+.+++.+. |+||+++++++...+. ..|+||||+++ +|.+++.... +..
T Consensus 28 ~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 106 (295)
T cd07837 28 LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRP 106 (295)
T ss_pred EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCC
Confidence 3789988776544444567889999999995 6999999998875442 48999999975 8988886532 246
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC-CCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD- 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~- 149 (582)
+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... .......+++.|+|||.+.+
T Consensus 107 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 186 (295)
T cd07837 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGS 186 (295)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCC
Confidence 899999999999999999999999999999999999999 889999999998765332 22233467889999998865
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---------------------------CCccccHH
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------------------LPTVYSGA 202 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---------------------------lp~~~S~~ 202 (582)
..++.++|||||||++|+|++|.+||.+.+.......+......+ ....++..
T Consensus 187 ~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (295)
T cd07837 187 THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPE 266 (295)
T ss_pred CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHH
Confidence 457899999999999999999999998776554443332211000 01247889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 203 FRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 203 l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+.+||.+||..||.+||+++|+|.||||+
T Consensus 267 ~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 267 GLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.60 Aligned_cols=222 Identities=22% Similarity=0.379 Sum_probs=190.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.. ......+.+.+|+.+++.++||||+++++++... ..++|+||+.+|+|.+++.... ..+++..+..+
T Consensus 39 vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~ 114 (316)
T cd05108 39 VAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNW 114 (316)
T ss_pred EEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHH
Confidence 788888653 3345566788999999999999999999987653 4679999999999999998743 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc---CcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~---~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ....++..|+|||.+.+..++.++||
T Consensus 115 ~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 194 (316)
T cd05108 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 194 (316)
T ss_pred HHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhh
Confidence 999999999999999999999999999999999999999999876543221 22334668999999999899999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|||++ |..||.+....++...+......+.+..++..+.+++.+||..||.+||++.+++.+
T Consensus 195 ~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 195 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999987 999999888777766666666666677889999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.31 Aligned_cols=227 Identities=30% Similarity=0.519 Sum_probs=194.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCC--CHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF--PEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~l--se~~~~ 79 (582)
.|||.|.-... +..+-++.||.+.++|+|.|||++++.+.+ ++++-|.||-++||+|..+++...| ++ .|..+.
T Consensus 603 IaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLSsLLrskWG-PlKDNEstm~ 678 (1226)
T KOG4279|consen 603 IAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLSSLLRSKWG-PLKDNESTMN 678 (1226)
T ss_pred EEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHHHHHHhccC-CCccchhHHH
Confidence 47777754332 344568899999999999999999998655 5599999999999999999998766 35 899999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcC-CCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCC--CCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADI--PYGSK 155 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~--~y~~k 155 (582)
.|.+|||.||+|||++.|||||||-+||||+. .|.+||.|||-++.+.. .....++.||..|||||++..+ .|+.+
T Consensus 679 fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~a 758 (1226)
T KOG4279|consen 679 FYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKA 758 (1226)
T ss_pred HHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCch
Confidence 99999999999999999999999999999976 58999999999988643 4457789999999999999865 49999
Q ss_pred CcccchhHHHHhHhcCCccccccC--HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~--~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+|||||||++.||.||++||.... ...++.--....-+++|..++.++++||.+|+..+|..||+|.++|.+||++.
T Consensus 759 ADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 759 ADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred hhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 999999999999999999997543 33333333344467899999999999999999999999999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=311.36 Aligned_cols=229 Identities=27% Similarity=0.409 Sum_probs=201.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.+|||++-..+.+....++.++|..+|..++|+||+.++++|.... ..+|+||||+ ..+|.+.+.. .++.
T Consensus 43 ~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH 117 (369)
T KOG0665|consen 43 PVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM----ELDH 117 (369)
T ss_pred ceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcch
Confidence 3789998777777777889999999999999999999999987432 4689999999 5899999984 5789
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
..+..+++|+++|++|||+.||+||||||+||++..++.+||.|||+++....+..++.++.|+.|.|||++.+..|...
T Consensus 118 ~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~ 197 (369)
T KOG0665|consen 118 ETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN 197 (369)
T ss_pred HHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCccc
Confidence 99999999999999999999999999999999999999999999999988777667889999999999999999999999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC---------------------------------------
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP--------------------------------------- 196 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp--------------------------------------- 196 (582)
+||||+||++.||+.|...|.+.+.-+.+.++......+-+
T Consensus 198 vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e 277 (369)
T KOG0665|consen 198 VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLE 277 (369)
T ss_pred chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccccc
Confidence 99999999999999999999999988887777654433310
Q ss_pred --ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 197 --TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 197 --~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
..-+..+++++.+||..||++|.+++++|+|||++-|.
T Consensus 278 ~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 278 GSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred CCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 01234688999999999999999999999999998543
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=293.50 Aligned_cols=220 Identities=19% Similarity=0.361 Sum_probs=189.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++..... .+.+.+|+.+|++++|+||+++++.+. . ...|+||||+.+++|.+++.......+++..+..+
T Consensus 33 ~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (260)
T cd05070 33 VAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-E-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM 107 (260)
T ss_pred eEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-C-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 688888765443 246889999999999999999998763 3 46789999999999999998755556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||.|||++||+||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||
T Consensus 108 ~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 187 (260)
T cd05070 108 AAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhH
Confidence 99999999999999999999999999999999999999999976543321 1223456689999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |.+||.+.+..+....+......+.+..++..+.+|+.+||..+|++|||+++++.
T Consensus 188 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 188 SFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999998 89999998888888887766666677788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=298.41 Aligned_cols=231 Identities=32% Similarity=0.573 Sum_probs=189.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~ 77 (582)
.||+|.+..... ......+.+|+++|++++||||+++++.|... +..+|+||||++|++|.+++... ....+++..
T Consensus 28 ~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 106 (287)
T cd06621 28 IFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106 (287)
T ss_pred EEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHH
Confidence 378888875433 24457789999999999999999999988643 45789999999999999887642 234689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|
T Consensus 107 ~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~D 185 (287)
T cd06621 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSD 185 (287)
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhh
Confidence 99999999999999999999999999999999999999999999987654322 23456888999999999889999999
Q ss_pred ccchhHHHHhHhcCCcccccc-----CHHHHHHHHhhccCCCCC------ccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAF-----DMQALINKINKSIVAPLP------TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~-----~~~~l~~kI~~~~~~~lp------~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|+|++|..||... ...++...+.......++ ..+++.+.+||.+||..||.+|||+.|++.
T Consensus 186 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 186 VWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 999999999999999999765 223334433332211111 235789999999999999999999999999
Q ss_pred CCCCchh
Q 007991 227 HPHLQPY 233 (582)
Q Consensus 227 hp~f~~~ 233 (582)
||||+..
T Consensus 266 ~~~~~~~ 272 (287)
T cd06621 266 HPWIKAQ 272 (287)
T ss_pred Ccccccc
Confidence 9999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=297.38 Aligned_cols=226 Identities=34% Similarity=0.614 Sum_probs=193.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|++..... ..+.+.+|+++++.++|+||+++++.+... ...|+|+||++|++|.+++.... ..+++..+..+
T Consensus 47 ~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i 121 (286)
T cd06614 47 VAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYV 121 (286)
T ss_pred EEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHH
Confidence 78898876544 456788999999999999999999988765 58999999999999999998754 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.+..++.++|+||
T Consensus 122 ~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 201 (286)
T cd06614 122 CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201 (286)
T ss_pred HHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHH
Confidence 9999999999999999999999999999999999999999987654322 223456889999999999888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...+.......+........ +..++..+.+||.+||+.+|.+||++.++|.|+||..
T Consensus 202 lGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999988776655555443332222 2337899999999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.67 Aligned_cols=219 Identities=19% Similarity=0.361 Sum_probs=192.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..... ..+.+.+|+.+++.++|+||+++++.+.. +...|+||||+.+++|.++++......+++..+..+
T Consensus 32 v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd05039 32 VAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107 (256)
T ss_pred EEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 78999876543 45678999999999999999999998765 568899999999999999998765557899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ....++..|+|||.+....++.++|||||
T Consensus 108 ~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~sl 185 (256)
T cd05039 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSF 185 (256)
T ss_pred HHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--ccCCCcccccCchhhcCCcCCcHHHHHHH
Confidence 9999999999999999999999999999999999999999998763322 13345567999999988889999999999
Q ss_pred hHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 162 GCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 162 G~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||++|+|++ |..||.......+...+........+..+++.+.++|..||..+|++||++++++.
T Consensus 186 G~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 186 GILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999997 99999998888887777666555567778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=294.17 Aligned_cols=225 Identities=29% Similarity=0.513 Sum_probs=184.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCC--CHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF--PEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~l--se~~~~ 79 (582)
||+|.+.... ....+.+.+|+.++++++|+||+++++++... ...|+|+||+.|++|.+++..... .+ ++..+.
T Consensus 36 v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 111 (268)
T cd06624 36 IAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTII 111 (268)
T ss_pred EEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHH
Confidence 6788776543 34456789999999999999999999987654 589999999999999999986432 34 889999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcC-CCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC--CCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP--YGSK 155 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~--y~~k 155 (582)
.++.||+.||.|||++||+||||||+||+++. ++.++|+|||++....... ......|++.|+|||.+.... ++.+
T Consensus 112 ~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~ 191 (268)
T cd06624 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAP 191 (268)
T ss_pred HHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCch
Confidence 99999999999999999999999999999987 6789999999987654322 233456899999999986543 7889
Q ss_pred CcccchhHHHHhHhcCCccccccCHHH--HHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~--l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+|+||||+++|+|++|..||....... ............++..+++++++|+.+||..+|.+|||+.+++.||||
T Consensus 192 ~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 192 ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997654222 111112223345677789999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=293.12 Aligned_cols=224 Identities=18% Similarity=0.309 Sum_probs=188.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+... ......+.+.+|+.+++.++||||+++++++...+...|+||||+.+++|.+++.+.. ..+++..+..+
T Consensus 26 ~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 103 (262)
T cd05058 26 CAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGF 103 (262)
T ss_pred EEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 688887542 2334556788999999999999999999987766667889999999999999998643 34678888999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
+.||+.||.|||+.|++||||||+|||++.++.+||+|||++....... ......++..|+|||.+....++.++
T Consensus 104 ~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 183 (262)
T cd05058 104 GLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKS 183 (262)
T ss_pred HHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHH
Confidence 9999999999999999999999999999999999999999997653321 11234557789999999888899999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|||++ |.+||...+...+...+........+..+++.+.+++.+||..+|++||++.+++..
T Consensus 184 Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 184 DVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999998 577888888777777666555555566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.56 Aligned_cols=228 Identities=29% Similarity=0.571 Sum_probs=196.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+..... ......+.+|+.++.+++||||+++++.+... .+.|+||||+.+++|.+++... .+++..+..
T Consensus 31 ~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~ 105 (277)
T cd06641 31 VVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPG---PLDETQIAT 105 (277)
T ss_pred EEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHH
Confidence 378888765443 34456789999999999999999999987654 5899999999999999998753 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++|+|
T Consensus 106 ~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~ 185 (277)
T cd06641 106 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185 (277)
T ss_pred HHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHH
Confidence 99999999999999999999999999999999999999999987654332 22345788999999999888888999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||||++|+|++|..||...........+.......++..++..+.++|.+||..+|.+||++.++++||||...
T Consensus 186 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999998877766666665554445666789999999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=300.87 Aligned_cols=226 Identities=27% Similarity=0.450 Sum_probs=186.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..........+.+.+|+++|+.++||||+++++++.. +...|+||||++++.|.+++.... .+++..+..+
T Consensus 29 ~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~ 105 (286)
T cd07846 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKY 105 (286)
T ss_pred EEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHH
Confidence 7888876655544556778999999999999999999998764 568999999999999988776533 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDIW 159 (582)
+.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+. .++.++|||
T Consensus 106 ~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 185 (286)
T cd07846 106 LFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185 (286)
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHH
Confidence 9999999999999999999999999999999999999999987654332 23446789999999998753 477899999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccC---------------------C---------CCCccccHHHHHHHHH
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---------------------A---------PLPTVYSGAFRGLVKS 209 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~---------------------~---------~lp~~~S~~l~~LI~k 209 (582)
||||++|+|++|.+||......+....+..... . .....++..+.+||.+
T Consensus 186 slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (286)
T cd07846 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ 265 (286)
T ss_pred HHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHH
Confidence 999999999999999976665443333221000 0 0123468889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCC
Q 007991 210 MLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f 230 (582)
||..+|++||++.++++||||
T Consensus 266 ~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 266 CLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhcCCcccchhHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.69 Aligned_cols=226 Identities=19% Similarity=0.395 Sum_probs=189.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC---------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG--------- 70 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~--------- 70 (582)
.||+|+++.... ....+.+.+|+.++.++ +|+||+++++++...+..++++|||+.+++|.+++.....
T Consensus 39 ~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~ 117 (337)
T cd05054 39 TVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKS 117 (337)
T ss_pred eeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccc
Confidence 378998876543 33446778999999999 7999999999888777789999999999999999865321
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 007991 71 --------------------------------------------------VHFPEEKLCKWLVQLLMALNYLHANHILHR 100 (582)
Q Consensus 71 --------------------------------------------------~~lse~~~~~il~QLL~aL~yLHs~gIiHR 100 (582)
..+++..+..++.||+.||+|||++||+||
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHr 197 (337)
T cd05054 118 TRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHR 197 (337)
T ss_pred ccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 257899999999999999999999999999
Q ss_pred ccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCcccc
Q 007991 101 DVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFK 176 (582)
Q Consensus 101 DIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~ 176 (582)
||||+|||++.++.++|+|||++..+.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 198 Dikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 198 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred CCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999998764322 1233456778999999999999999999999999999997 999997
Q ss_pred ccCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 177 AFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 177 ~~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+.... .+...+........+..++.++.+++.+||+.+|++||+++|+++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 278 GVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 75433 3334444444445566788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.77 Aligned_cols=227 Identities=26% Similarity=0.406 Sum_probs=186.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+++++.++|+||+++++++... ...|+||||+. ++|.+++.......+++..+..+
T Consensus 27 ~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 104 (283)
T cd07835 27 VALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSY 104 (283)
T ss_pred EEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHH
Confidence 78999877654444456788899999999999999999987654 68999999994 78999998755456899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDIW 159 (582)
+.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ......++..|+|||++.+. .++.++|||
T Consensus 105 ~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 184 (283)
T cd07835 105 LYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIW 184 (283)
T ss_pred HHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHH
Confidence 9999999999999999999999999999999999999999987653222 22334678899999988664 578899999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccC----------------------------CCCCccccHHHHHHHHHhc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----------------------------APLPTVYSGAFRGLVKSML 211 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~----------------------------~~lp~~~S~~l~~LI~kmL 211 (582)
||||++|+|++|++||...+.......+..... ......++..+.++|.+||
T Consensus 185 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 264 (283)
T cd07835 185 SIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKML 264 (283)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHh
Confidence 999999999999999987665443333221100 0112457789999999999
Q ss_pred cCCCCCCCCHHHHHcCCCC
Q 007991 212 RKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 212 ~~dP~~RpSa~EiL~hp~f 230 (582)
+.+|.+||+++|++.||||
T Consensus 265 ~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 265 VYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=295.07 Aligned_cols=229 Identities=30% Similarity=0.455 Sum_probs=191.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc---CCCCeeeeeeEEEecCc----EEEEEEeecCCCCHHHHHHHhCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVEKGC----YVCIIIGYCEGGDMAEAIKKANGVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L---~HpnIV~l~~~~~~~~~----~l~LVmEy~~GgsL~d~Ikk~~~~~l 73 (582)
.||||.++.....+.....+.+|+.+++++ +|+||+++++++...+. .+|++|||+. ++|.+++.......+
T Consensus 26 ~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l 104 (287)
T cd07838 26 FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGL 104 (287)
T ss_pred EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCC
Confidence 389999987655555556677888888777 59999999998876542 4899999996 589998887554469
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.............++..|+|||.+.+..++
T Consensus 105 ~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 184 (287)
T cd07838 105 PPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYA 184 (287)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCC
Confidence 99999999999999999999999999999999999999999999999999876554444456788999999999988899
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--------------------------CCccccHHHHHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--------------------------LPTVYSGAFRGLV 207 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--------------------------lp~~~S~~l~~LI 207 (582)
.++|||||||++|+|++|.+||.+....+...++......+ ....++..+.+||
T Consensus 185 ~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 264 (287)
T cd07838 185 TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLL 264 (287)
T ss_pred CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHH
Confidence 99999999999999999999999887766665553321100 0113467889999
Q ss_pred HHhccCCCCCCCCHHHHHcCCCC
Q 007991 208 KSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 208 ~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
..||+.||.+||++++++.||||
T Consensus 265 ~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 265 KKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHhccCCccCCCHHHHhcCcCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.34 Aligned_cols=231 Identities=27% Similarity=0.417 Sum_probs=188.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++...........+.+|+.+|+.++|+||+++++++.... ..+|+||||+. ++|.+++.... .+++.
T Consensus 32 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~ 108 (337)
T cd07858 32 KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDD 108 (337)
T ss_pred eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHH
Confidence 4899998765544444566788999999999999999999776432 35899999995 78999988643 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
.+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... .......|+..|+|||.+.+ ..++.
T Consensus 109 ~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 188 (337)
T cd07858 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT 188 (337)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCC
Confidence 99999999999999999999999999999999999999999999999866443 33445678999999998865 45889
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC------------------------------CCCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------------------------PLPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~------------------------------~lp~~~S~~l~ 204 (582)
++|||||||++|+|++|.+||.+.+.......+...... .....++..+.
T Consensus 189 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (337)
T cd07858 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAI 268 (337)
T ss_pred cccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHH
Confidence 999999999999999999999876644333222211000 01234788999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||.+||+.+|++|||++++|+||||..+.
T Consensus 269 ~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 269 DLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.74 Aligned_cols=224 Identities=20% Similarity=0.313 Sum_probs=188.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-----CCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-----VHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-----~~lse~ 76 (582)
||+|.+... ........+.+|+.+++.++|+||+++++++.+.+ ..|+||||+.|++|.+++..... ..+++.
T Consensus 39 v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~ 116 (277)
T cd05036 39 VAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-PRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116 (277)
T ss_pred EEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHH
Confidence 677776543 33444567899999999999999999999877654 67899999999999999986531 258999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccccc---cCcccCCCCCCCcccccCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~ 150 (582)
.+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||+++....... .....++..|+|||++.+.
T Consensus 117 ~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05036 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG 196 (277)
T ss_pred HHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC
Confidence 9999999999999999999999999999999998765 599999999987633221 1122335679999999988
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++.++|||||||++|+|++ |..||.+.+...+...+........+..++..+.+|+.+||+.+|++||++.++|+|
T Consensus 197 ~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 197 IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 89999999999999999996 999999888888777776665566677889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=310.66 Aligned_cols=231 Identities=28% Similarity=0.452 Sum_probs=188.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||++............+.+|+.+|++++||||++++++|.. ....+|+||||+. ++|.+++.... .+++..
T Consensus 32 ~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~ 108 (334)
T cd07855 32 KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEH 108 (334)
T ss_pred EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHH
Confidence 38899987765544556778899999999999999999987753 3357899999995 68999887543 599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccC-CC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLAD-IP 151 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~-~~ 151 (582)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+|+..|+|||.+.+ ..
T Consensus 109 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (334)
T cd07855 109 IRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE 188 (334)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcc
Confidence 99999999999999999999999999999999999999999999987654322 2234588999999999865 45
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-------------------------CC-----CCccccH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-------------------------AP-----LPTVYSG 201 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-------------------------~~-----lp~~~S~ 201 (582)
++.++|||||||++|+|++|.+||.+.+....+..+..... .. +...++.
T Consensus 189 ~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (334)
T cd07855 189 YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASP 268 (334)
T ss_pred cccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCH
Confidence 88999999999999999999999987765443332221110 00 1134688
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
++.++|.+||+.+|++||++++++.||||+.+-
T Consensus 269 ~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 269 EALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.41 Aligned_cols=221 Identities=23% Similarity=0.392 Sum_probs=181.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.++... .......+.+|+++|++++||||+++++.+... +..+|+||||+.+++|.+++... .+++..++.
T Consensus 36 vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~ 111 (283)
T cd05080 36 VAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLL 111 (283)
T ss_pred EEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHH
Confidence 7888887653 234556788999999999999999999977643 45789999999999999999864 589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.|++.||+|||++||+||||||+|||++.++.++|+|||++........ .....++..|+|||.+.+..++.++
T Consensus 112 i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 191 (283)
T cd05080 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS 191 (283)
T ss_pred HHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCccc
Confidence 999999999999999999999999999999999999999999986643321 1223456679999999888899999
Q ss_pred cccchhHHHHhHhcCCccccccCH---------------HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~---------------~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
|||||||++|+|++|..||..... ..+...+......+.+..++..+.+|+..||+.+|++||++
T Consensus 192 Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~ 271 (283)
T cd05080 192 DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF 271 (283)
T ss_pred ccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH
Confidence 999999999999999999854321 11111122223334466788999999999999999999999
Q ss_pred HHHHc
Q 007991 222 AELLC 226 (582)
Q Consensus 222 ~EiL~ 226 (582)
++++.
T Consensus 272 ~~i~~ 276 (283)
T cd05080 272 RSLIP 276 (283)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=294.64 Aligned_cols=220 Identities=19% Similarity=0.357 Sum_probs=188.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++..... .+.+.+|++++++++|+||+++++.+. ....|+||||+.+++|.+++.+..+..+++..+..+
T Consensus 33 valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (262)
T cd05071 33 VAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107 (262)
T ss_pred EEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHH
Confidence 788888764443 246889999999999999999998763 346789999999999999998755556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ .....++..|+|||++.+..++.++|||
T Consensus 108 ~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvw 187 (262)
T cd05071 108 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (262)
T ss_pred HHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHH
Confidence 99999999999999999999999999999999999999999976543321 2234566789999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |.+||.+.........+......+.+..++..+.+||.+||+.||++||++++++.
T Consensus 188 slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999 89999988877777777665555566778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=308.36 Aligned_cols=231 Identities=29% Similarity=0.420 Sum_probs=195.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||++..........+.+.+|+.+++.++|+||+++++++...+ ..+|+||||+. ++|.+++.... .+++.
T Consensus 27 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~ 103 (330)
T cd07834 27 KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDD 103 (330)
T ss_pred EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC--CCCHH
Confidence 3789998876554556678999999999999999999999877653 47899999996 68999987643 79999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCC-C
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADI-P 151 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~-~ 151 (582)
.+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......+++.|+|||++.+. .
T Consensus 104 ~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 183 (330)
T cd07834 104 HIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183 (330)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccC
Confidence 999999999999999999999999999999999999999999999998765442 24456789999999999887 7
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC------------------------------CccccH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------------------PTVYSG 201 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l------------------------------p~~~S~ 201 (582)
++.++|||||||++|+|++|.+||.+.+..+.+..+......+. ...++.
T Consensus 184 ~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T cd07834 184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP 263 (330)
T ss_pred CCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCH
Confidence 89999999999999999999999998887766655543222111 123578
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
.+.+||..||+.+|++||+++++|.||||+.+.
T Consensus 264 ~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 264 EAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.97 Aligned_cols=211 Identities=28% Similarity=0.393 Sum_probs=170.1
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 007991 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 98 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIi 98 (582)
.+.+|+++|++|+|+|||++++++... ...|+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+
T Consensus 206 ~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIv 282 (461)
T PHA03211 206 SSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGII 282 (461)
T ss_pred CHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 356899999999999999999987655 5889999999 478988887643 3699999999999999999999999999
Q ss_pred ecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccc
Q 007991 99 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175 (582)
Q Consensus 99 HRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF 175 (582)
||||||+||||+.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 283 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 283 HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99999999999999999999999997653321 223467999999999999999999999999999999999886543
Q ss_pred ccc--------CHHHHHHHHhhccC--CCC-------------------------------CccccHHHHHHHHHhccCC
Q 007991 176 KAF--------DMQALINKINKSIV--APL-------------------------------PTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 176 ~~~--------~~~~l~~kI~~~~~--~~l-------------------------------p~~~S~~l~~LI~kmL~~d 214 (582)
-.. ....+...+..... ..+ ...++..+.+||.+||+.|
T Consensus 363 f~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~D 442 (461)
T PHA03211 363 FSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD 442 (461)
T ss_pred ccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccC
Confidence 211 11222222221110 000 0134568999999999999
Q ss_pred CCCCCCHHHHHcCCCCch
Q 007991 215 PEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 215 P~~RpSa~EiL~hp~f~~ 232 (582)
|.+|||+.|+|+||||+.
T Consensus 443 P~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 443 GARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhhCcCHHHHhhCcccCC
Confidence 999999999999999964
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.43 Aligned_cols=229 Identities=24% Similarity=0.401 Sum_probs=194.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+|... ....+.++.||++++.+++ |+||++++++| +++..+|+|||.+.||+|...|+++. +|+|..+.+
T Consensus 106 YAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-Edd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~ 180 (463)
T KOG0607|consen 106 YAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-EDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASR 180 (463)
T ss_pred hhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-cccceEEEEEecccCchHHHHHHHhh--hccHHHHHH
Confidence 899999775 4467889999999999995 99999999965 56679999999999999999999876 899999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhcccc--------cccCcccCCCCCCCccccc-
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISD--------DLASSVVGTPSYMCPELLA- 148 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~--------~~~~~~vGTp~Y~APE~l~- 148 (582)
++.+|..||++||.+||.||||||+|||-....+ ||||||.+...+... ....+.||+-.|||||+..
T Consensus 181 vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~ 260 (463)
T KOG0607|consen 181 VVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDV 260 (463)
T ss_pred HHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhh
Confidence 9999999999999999999999999999866544 999999987543211 1234568888999999753
Q ss_pred ----CCCCCCCCcccchhHHHHhHhcCCccccccC---------------HHHHHHHHhhccCCC---CCccccHHHHHH
Q 007991 149 ----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------------MQALINKINKSIVAP---LPTVYSGAFRGL 206 (582)
Q Consensus 149 ----~~~y~~ksDIWSLG~iLyELltG~~PF~~~~---------------~~~l~~kI~~~~~~~---lp~~~S~~l~~L 206 (582)
..-|+.++|+||||+|+|-|++|.+||.+.- ...+++.|+.+.+.. -+..+|.+++++
T Consensus 261 fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdl 340 (463)
T KOG0607|consen 261 FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL 340 (463)
T ss_pred hccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHH
Confidence 2358999999999999999999999997542 456778887766542 245689999999
Q ss_pred HHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 207 VKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 207 I~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
|..+|..++..|.++.++++|||++....
T Consensus 341 isnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHhccHHhhhhhhhccCCccccccch
Confidence 99999999999999999999999986443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.02 Aligned_cols=222 Identities=19% Similarity=0.364 Sum_probs=189.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG----------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~----------- 70 (582)
|++|++... .......+.+|+++++.++|+||+++++++... ...|+||||+.+++|.+++.....
T Consensus 38 ~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 114 (280)
T cd05092 38 VAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114 (280)
T ss_pred EEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-CceEEEEecCCCCCHHHHHHhcCcchhhhcccccC
Confidence 566766543 345567899999999999999999999977654 578999999999999999986431
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcc
Q 007991 71 --VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 145 (582)
Q Consensus 71 --~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE 145 (582)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+++.|+|||
T Consensus 115 ~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 194 (280)
T cd05092 115 APGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194 (280)
T ss_pred CccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHH
Confidence 358899999999999999999999999999999999999999999999999987553322 122344577899999
Q ss_pred cccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 146 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 146 ~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
.+.+..++.++|||||||++|+|++ |.+||...........+........+..+++.+.+||.+||+.||.+||++++|
T Consensus 195 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 195 SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred HhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9998889999999999999999998 999998888777777776655555667789999999999999999999999999
Q ss_pred Hc
Q 007991 225 LC 226 (582)
Q Consensus 225 L~ 226 (582)
++
T Consensus 275 ~~ 276 (280)
T cd05092 275 HS 276 (280)
T ss_pred HH
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.78 Aligned_cols=226 Identities=27% Similarity=0.448 Sum_probs=179.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+...... .....+.+|++++++++|+||+++++++.. +.+.|+||||+. ++|.+++....+ .+++..++.
T Consensus 32 ~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~ 107 (291)
T cd07844 32 LVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRL 107 (291)
T ss_pred EEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHH
Confidence 3899998764332 222356789999999999999999998765 458999999997 599999887543 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......++..|+|||++.+ ..++.++||
T Consensus 108 ~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 187 (291)
T cd07844 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187 (291)
T ss_pred HHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHH
Confidence 99999999999999999999999999999999999999999987543221 1223457889999999865 458899999
Q ss_pred cchhHHHHhHhcCCccccccC-HHHHHHHHhhccCCC-----------------------------CCcccc--HHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAP-----------------------------LPTVYS--GAFRGL 206 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~-~~~l~~kI~~~~~~~-----------------------------lp~~~S--~~l~~L 206 (582)
||+||++|+|++|..||.+.. ..+....+......+ ....++ ..+.++
T Consensus 188 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (291)
T cd07844 188 WGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEEL 267 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHH
Confidence 999999999999999997655 333222221110000 001233 788999
Q ss_pred HHHhccCCCCCCCCHHHHHcCCCC
Q 007991 207 VKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 207 I~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|.+||+.+|++|||+.++|.||||
T Consensus 268 i~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 268 ALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=288.97 Aligned_cols=224 Identities=23% Similarity=0.419 Sum_probs=194.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||+|.++..... ...+.+.+|+.+|+.++|+||+++++.+... ...|++|||+.|++|.+++.......+++..+..
T Consensus 30 ~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 107 (258)
T smart00219 30 EVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLS 107 (258)
T ss_pred eEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHH
Confidence 3789998665432 3567889999999999999999999987665 5899999999999999999875433389999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccC--cccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~--~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......... ...+++.|+|||.+.+..++.++||
T Consensus 108 ~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di 187 (258)
T smart00219 108 FALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDV 187 (258)
T ss_pred HHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhH
Confidence 99999999999999999999999999999999999999999997765442221 1336789999999988889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||++|+|++ |.+||...+...+...+........+..++.++.+++.+||..||++|||+.++++
T Consensus 188 ~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 188 WSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999998 89999988888888888777666677779999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=296.01 Aligned_cols=226 Identities=34% Similarity=0.569 Sum_probs=190.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC---CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~---HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||.++.... ......+.+|+.++++++ ||||+++++++.. +...|+||||+.|++|.++++.. .+++..+
T Consensus 29 ~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~ 103 (277)
T cd06917 29 VALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWIIMEYAEGGSVRTLMKAG---PIAEKYI 103 (277)
T ss_pred EEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEEEecCCCCcHHHHHHcc---CCCHHHH
Confidence 78898876433 334567889999999997 9999999998765 45899999999999999998753 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccC-CCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD-IPYGSKS 156 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~-~~y~~ks 156 (582)
..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+ ..++.++
T Consensus 104 ~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 183 (277)
T cd06917 104 SVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183 (277)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccch
Confidence 9999999999999999999999999999999999999999999987764432 2344578999999998864 4578899
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCc-cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~-~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|+|||||++|+|++|..||.+.........+.......++. .++.++.+++.+||+.||++||++.+++.|+||+.
T Consensus 184 Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 99999999999999999998877665554443333333333 37889999999999999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=291.99 Aligned_cols=220 Identities=20% Similarity=0.391 Sum_probs=191.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+...... .+.+.+|+.+|++++|+||+++++.+. ....|+||||+.+++|.+++....+..+++..+..+
T Consensus 33 ~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i 107 (260)
T cd05067 33 VAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107 (260)
T ss_pred EEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHH
Confidence 789988765443 346889999999999999999998753 346899999999999999998766667999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .....++..|+|||.+....++.++|||
T Consensus 108 ~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~ 187 (260)
T cd05067 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchH
Confidence 99999999999999999999999999999999999999999976543221 2234556789999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |.+||.+.+..+....+......+.+..++.++.++|.+||+.+|++||++++++.
T Consensus 188 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 188 SFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999998 99999988888877777766666677788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=292.94 Aligned_cols=220 Identities=18% Similarity=0.348 Sum_probs=188.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+|||.+..... ..+.+.+|+.++++++|+||+++++++. +...|+||||+.+++|.+++....+..+++..+..+
T Consensus 33 ~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (260)
T cd05069 33 VAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107 (260)
T ss_pred EEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHH
Confidence 68888765433 2356889999999999999999998763 346889999999999999998765556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|||
T Consensus 108 ~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~ 187 (260)
T cd05069 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHH
Confidence 9999999999999999999999999999999999999999997654322 12233466789999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |.+||.+....+....+......+.+..++..+.+++.+||..||++||+++++++
T Consensus 188 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999998 99999988887777777666555667778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=291.88 Aligned_cols=227 Identities=30% Similarity=0.532 Sum_probs=191.3
Q ss_pred CEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLAR---QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~---~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||+|.+.... ........+.+|++++++++|+||+++++.+... +..+++||||+.|++|.+++...+ .+++.
T Consensus 29 ~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~ 106 (264)
T cd06653 29 ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTEN 106 (264)
T ss_pred EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHH
Confidence 37889875432 2234557889999999999999999999987654 357889999999999999998644 58999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc----cccCcccCCCCCCCcccccCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----DLASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~----~~~~~~vGTp~Y~APE~l~~~~y 152 (582)
.+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++..... .......|+..|+|||++.+..+
T Consensus 107 ~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (264)
T cd06653 107 VTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186 (264)
T ss_pred HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCC
Confidence 99999999999999999999999999999999999999999999999765321 11234678999999999998888
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc-cCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS-IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~-~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+.++|+|||||++|+|++|..||..........++... ....++..+++.+.++|.+||+ +|..||++.+++.|||+
T Consensus 187 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999999999999999999887666555554432 2344678899999999999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=290.35 Aligned_cols=226 Identities=33% Similarity=0.577 Sum_probs=197.4
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||+|.++..... ......+..|+.++++++|+||+++++.+.. +...|+||||+.+++|.+++.... .+++..+.
T Consensus 20 ~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~ 96 (250)
T cd05123 20 LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGELFSHLSKEG--RFSEERAR 96 (250)
T ss_pred EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHH
Confidence 3788888765432 2355678999999999999999999988754 568999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......|+..|++||.+.+..++.++|+
T Consensus 97 ~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~ 176 (250)
T cd05123 97 FYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176 (250)
T ss_pred HHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhH
Confidence 99999999999999999999999999999999999999999998776443 23455678999999999988888899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH---HHHHcCCCC
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA---AELLCHPHL 230 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa---~EiL~hp~f 230 (582)
||||+++|+|++|..||...+.......+.. ....++..++..+.++|.+||..||+.||++ ++++.||||
T Consensus 177 ~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999999988887666666655 3455777889999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.99 Aligned_cols=226 Identities=29% Similarity=0.463 Sum_probs=190.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|++|+++.....+.....+.+|+.+|++++|+||+++++++... ...|+||||+. ++|.+.+.... ..+++..+..+
T Consensus 27 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~ 103 (283)
T cd05118 27 VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSY 103 (283)
T ss_pred EEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHH
Confidence 78999887666656667889999999999999999999987654 58999999996 58888887743 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDIW 159 (582)
+.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+|
T Consensus 104 ~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~ 183 (283)
T cd05118 104 LYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIW 183 (283)
T ss_pred HHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHH
Confidence 9999999999999999999999999999999999999999987765443 23345788899999998776 688999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccccHHHHHHHHHh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVYSGAFRGLVKSM 210 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~S~~l~~LI~km 210 (582)
||||++|+|++|+.||...+..+.+.++......+ ....++.++.+||.+|
T Consensus 184 slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 263 (283)
T cd05118 184 SVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQM 263 (283)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHH
Confidence 99999999999999998877666554443221111 1223678999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|+.||.+||++.+++.||||
T Consensus 264 l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 264 LHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccCcccCcCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.38 Aligned_cols=224 Identities=20% Similarity=0.354 Sum_probs=184.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++.... ....+.+.+|+.+|..+ +|||||++++++... ...|+|||||.||+|.+++....
T Consensus 68 vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 145 (375)
T cd05104 68 VAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVG-GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDH 145 (375)
T ss_pred EEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-CcceeeehhccCCcHHHHHHhcccccccccccch
Confidence 78998875433 23456788999999999 899999999987654 57899999999999999997532
Q ss_pred --------------------------------------------------------------CCCCCHHHHHHHHHHHHH
Q 007991 70 --------------------------------------------------------------GVHFPEEKLCKWLVQLLM 87 (582)
Q Consensus 70 --------------------------------------------------------------~~~lse~~~~~il~QLL~ 87 (582)
+..+++..+..++.||+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 225 (375)
T cd05104 146 AEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAK 225 (375)
T ss_pred hhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHH
Confidence 124788999999999999
Q ss_pred HHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCCCCCCCCcccchhHH
Q 007991 88 ALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 164 (582)
Q Consensus 88 aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~i 164 (582)
||.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||++.+..++.++|||||||+
T Consensus 226 ~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~ 305 (375)
T cd05104 226 GMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 305 (375)
T ss_pred HHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHH
Confidence 99999999999999999999999999999999999976543321 122345567999999999899999999999999
Q ss_pred HHhHhc-CCccccccCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 165 VYEMSA-QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 165 LyELlt-G~~PF~~~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|+|++ |..||...... .....+........+...+.++.+||.+||+.||++||++.||++.
T Consensus 306 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 306 LWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999997 89999876543 3444444444444566678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=296.22 Aligned_cols=227 Identities=26% Similarity=0.424 Sum_probs=185.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-CCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~lse~~~~ 79 (582)
.||||+++..... ...+.+.+|+.++++++|+||+++++.+... ...|+||||+. ++|.+++.... ...+++..+.
T Consensus 27 ~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~ 103 (284)
T cd07836 27 IVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVK 103 (284)
T ss_pred EEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHH
Confidence 3789998775432 2335677899999999999999999988765 47899999997 58988887643 2358999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksD 157 (582)
.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ......++..|++||++.+. .++.++|
T Consensus 104 ~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 183 (284)
T cd07836 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183 (284)
T ss_pred HHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHH
Confidence 999999999999999999999999999999999999999999997654321 23345788999999988654 4688999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKS 209 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~k 209 (582)
||||||++|+|++|.+||.+.+..+....+......+ +...++..++++|.+
T Consensus 184 v~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 263 (284)
T cd07836 184 IWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHR 263 (284)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHH
Confidence 9999999999999999998877665544432211100 112457889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCC
Q 007991 210 MLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f 230 (582)
||+.||.+||++++++.||||
T Consensus 264 ~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 264 LLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=354.54 Aligned_cols=227 Identities=31% Similarity=0.529 Sum_probs=200.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
-|+|.|+......+....+.+|+.+|..|+|||+|++|++-+.. ..+||.||||+||+|.+++... .-.+|...+.|
T Consensus 1263 lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-ekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vy 1339 (1509)
T KOG4645|consen 1263 LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-EKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVY 1339 (1509)
T ss_pred hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-HHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHH
Confidence 47888888777666667889999999999999999999987765 4889999999999999999863 35789999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCC---CC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIP---YG 153 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~---y~ 153 (582)
..|++.|+.|||++|||||||||+||||+.+|.+|++|||.|..+.... ....++||+.|||||++.+.. ..
T Consensus 1340 t~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~ 1419 (1509)
T KOG4645|consen 1340 TKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHG 1419 (1509)
T ss_pred HHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCC
Confidence 9999999999999999999999999999999999999999998765432 234679999999999997643 56
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.++|||||||++.||+||+-||...+.. +++.++..+..+++|..+|.+.++||..||+.||+.|+++.|||.|-|-+
T Consensus 1420 ~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1420 GAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred cchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 7899999999999999999999876644 55667777888899999999999999999999999999999999997764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.24 Aligned_cols=223 Identities=28% Similarity=0.508 Sum_probs=189.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|+||.++. ....+..+.+.+|+++|++++||||+++++++... ...++|||||.+|+|.+++.......+++..+..|
T Consensus 31 V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i 108 (259)
T PF07714_consen 31 VAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSI 108 (259)
T ss_dssp EEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHH
T ss_pred EEEEEecc-ccccccceeeeeccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc
Confidence 78899855 34455678899999999999999999999988844 45889999999999999999874567999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||+++++|+||++.|||++.++.+||+|||++...... .......+...|+|||.+.+..++.++||
T Consensus 109 ~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDV 188 (259)
T PF07714_consen 109 AIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDV 188 (259)
T ss_dssp HHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999776322 12334456778999999988889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||+++|||++ |+.||.+.+..++..++......+.+..++..+.++|..||..||++||++++|++
T Consensus 189 ysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 189 YSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 999999999999 78999999999988888777777778889999999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=287.81 Aligned_cols=223 Identities=18% Similarity=0.315 Sum_probs=189.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++... .......+.+|++++++++||||+++++++... ...|+||||+.|++|.+++.... ..+++..+..+
T Consensus 22 ~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 98 (250)
T cd05085 22 VAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKF 98 (250)
T ss_pred EEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 7888876543 345556789999999999999999999987654 57899999999999999997643 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc--CcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~--~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ....++..|+|||++....++.++|||
T Consensus 99 ~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 178 (250)
T cd05085 99 ALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178 (250)
T ss_pred HHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHH
Confidence 999999999999999999999999999999999999999998754332211 122445679999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|++||++.++++.
T Consensus 179 slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 179 SYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99999999998 999999888777777776665555667789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=293.23 Aligned_cols=226 Identities=29% Similarity=0.495 Sum_probs=185.4
Q ss_pred EEEEEecccccC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCC
Q 007991 2 YVLKKIRLARQT--------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~--------~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~l 73 (582)
||||.++..... ....+.+.+|+.++++++|+||+++++++.. +..+++||||+.|++|.+++.+.+ .+
T Consensus 29 ~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l 105 (272)
T cd06629 29 MAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-EEYLSIFLEYVPGGSIGSCLRTYG--RF 105 (272)
T ss_pred eeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-CCceEEEEecCCCCcHHHHHhhcc--CC
Confidence 788887643211 1234578899999999999999999997655 458899999999999999998753 68
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...... .......|+..|+|||.+...
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (272)
T cd06629 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185 (272)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccc
Confidence 99999999999999999999999999999999999999999999999998764322 123345788999999998765
Q ss_pred C--CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh-ccCCCC----CccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 151 P--YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK-SIVAPL----PTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 151 ~--y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~-~~~~~l----p~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
. ++.++|+||||+++|+|++|..||...+.......+.. .....+ ...++..+.++|.+||..+|+.||++++
T Consensus 186 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 4 78899999999999999999999976665443333322 112222 2346899999999999999999999999
Q ss_pred HHcCCCC
Q 007991 224 LLCHPHL 230 (582)
Q Consensus 224 iL~hp~f 230 (582)
+|+||||
T Consensus 266 il~~~~~ 272 (272)
T cd06629 266 LLQHPFI 272 (272)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=288.62 Aligned_cols=223 Identities=22% Similarity=0.351 Sum_probs=190.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|+++..... .....+.+|++++++++|+||+++++.+... ...|+||||+.|++|.+++.+.. ..+++..+..+
T Consensus 22 v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~ 98 (251)
T cd05041 22 VAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQM 98 (251)
T ss_pred EEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 788988765543 4567899999999999999999999977654 57899999999999999997643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc---CcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~---~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|++.||+|||++|++||||||+|||++.++.+||+|||++......... ....++..|+|||.+.+..++.++||
T Consensus 99 ~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 178 (251)
T cd05041 99 SLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178 (251)
T ss_pred HHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhH
Confidence 999999999999999999999999999999999999999999765422111 12234567999999988889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|+|++ |..||...........+......+.+..++..+.+|+.+||+.+|.+||+++|+++.
T Consensus 179 ~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 179 WSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 999999999998 899998888777777776655555667789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.81 Aligned_cols=224 Identities=21% Similarity=0.371 Sum_probs=189.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||+|.++.... ......+.+|+++++++ +||||+++++++... ..+|+||||+.+|+|.+++....
T Consensus 47 ~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~ 124 (314)
T cd05099 47 VAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQE-GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124 (314)
T ss_pred EEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-CceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence 67888765433 44456788999999999 599999999987654 57899999999999999997642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~A 143 (582)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 204 (314)
T cd05099 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA 204 (314)
T ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccC
Confidence 13588999999999999999999999999999999999999999999999999976543221 112234467999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..++.++|||||||++|+|++ |..||.+....++...+........+..++.++.+||.+||..||++||++.
T Consensus 205 PE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 284 (314)
T cd05099 205 PEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK 284 (314)
T ss_pred HHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 999988889999999999999999998 8999999888888887776655556777899999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
++++.
T Consensus 285 ~ll~~ 289 (314)
T cd05099 285 QLVEA 289 (314)
T ss_pred HHHHH
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.53 Aligned_cols=229 Identities=28% Similarity=0.450 Sum_probs=180.6
Q ss_pred CEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhC---CCCCCH
Q 007991 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKAN---GVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~---~~~lse 75 (582)
.||||.+.... ..+...+.+.+|+.++++++||||+++++++... +..+|+||||++ ++|.+++.... ...+++
T Consensus 29 ~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 107 (316)
T cd07842 29 EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPP 107 (316)
T ss_pred eEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCH
Confidence 38999987743 2223345678899999999999999999988765 258999999996 57777775432 236899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC----CCCeEEeecccchhccccc----ccCcccCCCCCCCcccc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR----DQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELL 147 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~----~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l 147 (582)
..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....... .....++++.|+|||++
T Consensus 108 ~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (316)
T cd07842 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL 187 (316)
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHH
Confidence 999999999999999999999999999999999999 8999999999988654322 23345789999999988
Q ss_pred cC-CCCCCCCcccchhHHHHhHhcCCccccccCHHH---------HHHHHhhc------------------------c-C
Q 007991 148 AD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---------LINKINKS------------------------I-V 192 (582)
Q Consensus 148 ~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~---------l~~kI~~~------------------------~-~ 192 (582)
.+ ..++.++|||||||++|+|++|.+||.+..... .+..+... . .
T Consensus 188 ~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (316)
T cd07842 188 LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKT 267 (316)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccC
Confidence 66 457899999999999999999999997654321 01111000 0 0
Q ss_pred CCCC-----------ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 193 APLP-----------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 193 ~~lp-----------~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
...+ ...+..+.++|.+||+.||++|||+.|++.||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 268 KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0011 1467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.54 Aligned_cols=230 Identities=27% Similarity=0.460 Sum_probs=189.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh---CCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA---NGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~---~~~~lse~~~ 78 (582)
||||+++...........+-|||.+++.|+|||+|.+..+|...+..+++++||.+ .+|.++|+-+ ....++...+
T Consensus 56 yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mv 134 (438)
T KOG0666|consen 56 YAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMV 134 (438)
T ss_pred hHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHH
Confidence 78888877644444445678999999999999999999999987789999999996 8999999743 2356899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCC----CCeEEeecccchhccccc----ccCcccCCCCCCCcccccCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD----QDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~----g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~ 150 (582)
+.+++|||.|+.|||++-|+||||||.||||..+ |.|||+|||+++.+.+.- .....+.|.||+|||++.+.
T Consensus 135 KsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa 214 (438)
T KOG0666|consen 135 KSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA 214 (438)
T ss_pred HHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc
Confidence 9999999999999999999999999999999988 899999999999876542 23457889999999998875
Q ss_pred -CCCCCCcccchhHHHHhHhcCCccccccCH---------HHHHHHHhhccCCCC----------Cc-------------
Q 007991 151 -PYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---------QALINKINKSIVAPL----------PT------------- 197 (582)
Q Consensus 151 -~y~~ksDIWSLG~iLyELltG~~PF~~~~~---------~~l~~kI~~~~~~~l----------p~------------- 197 (582)
.|+.+.|||++|||+.||++.++.|.+... .+++.+|...+..|- |+
T Consensus 215 ~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~ 294 (438)
T KOG0666|consen 215 RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYY 294 (438)
T ss_pred ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhc
Confidence 599999999999999999999999976542 233344433332221 10
Q ss_pred -------------cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 198 -------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 198 -------------~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
.-++...+|+.+||++||.+|.|++++|+|+||..
T Consensus 295 ~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 295 DNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred CcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 12344779999999999999999999999999975
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=289.45 Aligned_cols=224 Identities=36% Similarity=0.647 Sum_probs=190.0
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~ 78 (582)
||+|.++... ......+.+.+|++++++++|+||+++++.+... ...++||||+.|++|.+++... .+..+++..+
T Consensus 30 ~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 108 (267)
T cd08224 30 VALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108 (267)
T ss_pred EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHH
Confidence 7889887543 3334567899999999999999999999988765 5889999999999999998752 2346899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++|
T Consensus 109 ~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D 188 (267)
T cd08224 109 WKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188 (267)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhc
Confidence 9999999999999999999999999999999999999999999987654332 233467899999999998888999999
Q ss_pred ccchhHHHHhHhcCCccccccC--HHHHHHHHhhccCCCCCc-cccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~--~~~l~~kI~~~~~~~lp~-~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+|||||++|+|++|..||.... ...+...+......+.+. .++..+.++|.+||..+|++||++.+|+.
T Consensus 189 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999996543 344555555555555555 78899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.63 Aligned_cols=231 Identities=27% Similarity=0.413 Sum_probs=199.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.|...+-..+...++..|+.||..+.||.||.+...|. ....+++|||.+ .|++.+.|-......++|...+.+
T Consensus 592 VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-T~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFl 669 (888)
T KOG4236|consen 592 VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-TPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFL 669 (888)
T ss_pred eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-CCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHH
Confidence 799999877766666688999999999999999999887664 456899999999 578888776655568999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|||.||.|||-+||+|+||||+|||+.... .+||||||+|+++.......+.+|||.|.|||++....|+...|+
T Consensus 670 vtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDM 749 (888)
T KOG4236|consen 670 VTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDM 749 (888)
T ss_pred HHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccc
Confidence 99999999999999999999999999997653 599999999999998888899999999999999999999999999
Q ss_pred cchhHHHHhHhcCCcccccc-CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~-~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||+|+|+|.-+.|..||... +..++++.-..-+....+..++.++.+||+.+|+..=.+|.|++..|.|||+|.|-
T Consensus 750 WSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 750 WSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred eeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 99999999999999999643 33333332222223334566899999999999999999999999999999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.68 Aligned_cols=224 Identities=19% Similarity=0.373 Sum_probs=191.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||+|.+.... .....+.+.+|+.+++.+ +||||+++++.+... ...|+||||+.+++|.+++....
T Consensus 50 v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 127 (304)
T cd05101 50 VAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127 (304)
T ss_pred EEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC-CceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 6777776443 334456789999999999 899999999987654 58899999999999999998642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+++.|+|
T Consensus 128 ~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~a 207 (304)
T cd05101 128 RVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA 207 (304)
T ss_pred cCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeC
Confidence 1357888999999999999999999999999999999999999999999999998664322 1223455678999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+..++..+++||.+||..+|.+||++.
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~ 287 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK 287 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence 999988889999999999999999998 8999999988888888876665566777899999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
|+++.
T Consensus 288 e~l~~ 292 (304)
T cd05101 288 QLVED 292 (304)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=303.70 Aligned_cols=292 Identities=24% Similarity=0.435 Sum_probs=230.6
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
+||+|+++..-.++ +...-++.|-.+..+- +||++|.++..|..+ ..+++|.||+.||+|.-++++.. +++|+.+
T Consensus 277 iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-srlffvieyv~ggdlmfhmqrqr--klpeeha 353 (593)
T KOG0695|consen 277 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHA 353 (593)
T ss_pred eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-ceEEEEEEEecCcceeeehhhhh--cCcHHHh
Confidence 58999887765444 4556778888888877 699999999877654 58999999999999998888754 7999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhc-ccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~-~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|..+|..||.|||++|||+||||.+||||+..|++||+|+|+++.. ...+..+++||||.|+|||++.+..|+..+|
T Consensus 354 rfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvd 433 (593)
T KOG0695|consen 354 RFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 433 (593)
T ss_pred hhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceeh
Confidence 999999999999999999999999999999999999999999999874 5567888999999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccc-------cCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC------CHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKA-------FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP------SAAEL 224 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~-------~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp------Sa~Ei 224 (582)
+|+||++|+||+.|..||.- .+-++.+.++.-...-.+|..+|-.+..+++..|++||.+|. .+.++
T Consensus 434 wwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~di 513 (593)
T KOG0695|consen 434 WWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDI 513 (593)
T ss_pred HHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhh
Confidence 99999999999999999953 233444444444444458889999999999999999999995 47899
Q ss_pred HcCCCCchhhhhhh--cccCCCCCCCCCCCCCCcccccccCCCcchhccc----cchhhccccCCCCCCCCCCCccc
Q 007991 225 LCHPHLQPYVLGIH--LKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIH----SNREKRQSFSNDRALNPSVSETE 295 (582)
Q Consensus 225 L~hp~f~~~~~~~~--~~~~~p~~~~~~~~~~~s~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~~ 295 (582)
..|+||+...|... ....+|..+.+.-+....+|+.....++...... ..+.....|......||-..+++
T Consensus 514 k~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~ridqsefegfeyinpl~ms~e 590 (593)
T KOG0695|consen 514 KSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGFEYINPLLMSTE 590 (593)
T ss_pred hcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHHhcchhhcCcceecchhhcccc
Confidence 99999997665543 2344666666666666677766555444222111 12223344556666666555443
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=299.54 Aligned_cols=224 Identities=20% Similarity=0.378 Sum_probs=191.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||+|.++... .......+.+|+.+++.+ +|+||+++++.+... ...|+||||+.+++|.+++.....
T Consensus 53 ~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 130 (307)
T cd05098 53 VAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130 (307)
T ss_pred EEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 7888887543 344456788999999999 799999999987655 488999999999999999986421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCC
Q 007991 71 ----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMC 143 (582)
Q Consensus 71 ----~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~A 143 (582)
..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++........ .....+++.|+|
T Consensus 131 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~a 210 (307)
T cd05098 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 210 (307)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeC
Confidence 2488999999999999999999999999999999999999999999999999876543221 112234568999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||.+.+..++.++|||||||++|+|++ |..||.+....++...+........+..++.++.+||.+||..+|.+||++.
T Consensus 211 PE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 290 (307)
T cd05098 211 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 290 (307)
T ss_pred hHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH
Confidence 999998889999999999999999998 8999998888888777776666667778899999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
+++++
T Consensus 291 evl~~ 295 (307)
T cd05098 291 QLVED 295 (307)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=298.99 Aligned_cols=226 Identities=29% Similarity=0.525 Sum_probs=191.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++.... ......+.+|+.+++.++|+||+++++.+... .+.|+||||+.+++|.+++... .+++..++.+
T Consensus 48 v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 121 (292)
T cd06657 48 VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHT---RMNEEQIAAV 121 (292)
T ss_pred EEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHH
Confidence 7888886532 34456799999999999999999999987654 5899999999999999987643 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ......|++.|+|||.+.+..++.++|+||
T Consensus 122 ~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s 201 (292)
T cd06657 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201 (292)
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHH
Confidence 9999999999999999999999999999999999999999987654322 233467899999999998888899999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+||++|+|++|..||.+.+.......+....... ....++..+.++|.+||..+|.+||++.++|.||||...
T Consensus 202 lGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 9999999999999998877666555554333222 233578899999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.04 Aligned_cols=221 Identities=19% Similarity=0.367 Sum_probs=189.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.. ......+.+.+|+.++..++|+||+++++++.. ...++++||+.+|+|.+++.... ..+++..+..+
T Consensus 39 va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~ 114 (279)
T cd05109 39 VAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNW 114 (279)
T ss_pred EEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHH
Confidence 688888654 334556778999999999999999999998764 35779999999999999998743 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++||
T Consensus 115 ~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 194 (279)
T cd05109 115 CVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDV 194 (279)
T ss_pred HHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHH
Confidence 99999999999999999999999999999999999999999987643322 122344678999999998889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||++|||++ |..||.......+...+......+.+..++..+.++|.+||..||+.||++.+++.
T Consensus 195 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 195 WSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999988 99999988877777777666666667778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.60 Aligned_cols=227 Identities=29% Similarity=0.450 Sum_probs=183.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-------cEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-------CYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-------~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||++......+.....+.+|++++++++|+||+++++.+.... ..+|+||||+. ++|...+... +..++
T Consensus 36 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~ 113 (311)
T cd07866 36 VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLT 113 (311)
T ss_pred EEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCC
Confidence 789988765544444456789999999999999999999876433 35899999995 5777777653 34699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc------------cCcccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL------------ASSVVGTPSYM 142 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~------------~~~~vGTp~Y~ 142 (582)
+..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ .....|++.|+
T Consensus 114 ~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 193 (311)
T cd07866 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193 (311)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcC
Confidence 999999999999999999999999999999999999999999999999976543221 12346788999
Q ss_pred CcccccCC-CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------C----
Q 007991 143 CPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------L---- 195 (582)
Q Consensus 143 APE~l~~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------l---- 195 (582)
|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+......+ .
T Consensus 194 aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (311)
T cd07866 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL 273 (311)
T ss_pred ChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccH
Confidence 99988654 58899999999999999999999998877666555443211100 0
Q ss_pred ---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 196 ---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 196 ---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
...++..+.+||.+||+.||.+|||+.|++.||||
T Consensus 274 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 274 EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 01245688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=334.23 Aligned_cols=221 Identities=29% Similarity=0.542 Sum_probs=187.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeee-EEEec-----CcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKD-SWVEK-----GCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~-~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||+|++... ++...+.+.+||.+|++|. |+|||.|++ ..... ...++|+||||.||.|-+++.++....|+
T Consensus 65 ~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lt 142 (738)
T KOG1989|consen 65 YALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLT 142 (738)
T ss_pred eeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCC
Confidence 899999876 6778899999999999997 999999999 43321 24688999999999999999977666799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCC--ceecccCcccEEEcCCCCeEEeecccchhcccccc----------cCcccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----------ASSVVGTPSYM 142 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----------~~~~vGTp~Y~ 142 (582)
|..+.+|++|+++|+.+||... |||||||-|||||+.+|+.||||||-|........ .-...-|+.|+
T Consensus 143 e~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YR 222 (738)
T KOG1989|consen 143 EDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYR 222 (738)
T ss_pred hHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcccc
Confidence 9999999999999999999998 99999999999999999999999999865433221 11235689999
Q ss_pred Ccccc---cCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC
Q 007991 143 CPELL---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 143 APE~l---~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
|||.+ .+.+.+.|+|||+|||+||.|+....||.....-.+ +...+..|....++..+.+||..||+.||++||
T Consensus 223 sPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI---lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 223 SPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI---LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred ChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE---EeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 99975 577899999999999999999999999998754332 233334444467999999999999999999999
Q ss_pred CHHHHHcC
Q 007991 220 SAAELLCH 227 (582)
Q Consensus 220 Sa~EiL~h 227 (582)
++-+++.+
T Consensus 300 nI~Qv~~~ 307 (738)
T KOG1989|consen 300 NIYQVLEE 307 (738)
T ss_pred CHHHHHHH
Confidence 99999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.41 Aligned_cols=230 Identities=29% Similarity=0.444 Sum_probs=184.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||++..... ......+.+|+.++++++|+||+++++++.... ..+|+|+||+. ++|.+++... .+++.
T Consensus 32 ~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~ 106 (336)
T cd07849 32 KVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQ---HLSND 106 (336)
T ss_pred eEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcC---CCCHH
Confidence 378998865332 234456788999999999999999998765432 46899999995 6888888653 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccC-CC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLAD-IP 151 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~-~~ 151 (582)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+|++.|+|||.+.+ ..
T Consensus 107 ~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (336)
T cd07849 107 HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186 (336)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCC
Confidence 999999999999999999999999999999999999999999999987654322 1234678999999998754 56
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSG 201 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~ 201 (582)
++.++|||||||++|+|++|++||.+.+.......+......+ ....++.
T Consensus 187 ~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (336)
T cd07849 187 YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADP 266 (336)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCc
Confidence 8899999999999999999999998766544332221111000 0123578
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
.+.+||.+||+.+|++|||+.|++.||||..+..
T Consensus 267 ~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 267 KALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 8999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.78 Aligned_cols=222 Identities=22% Similarity=0.378 Sum_probs=190.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++.... ....+.+.+|+.+|++++||||+++++++.. +...|+||||++|++|.+++.... ..+++..+..+
T Consensus 35 ~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i 111 (267)
T cd05066 35 VAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGM 111 (267)
T ss_pred EEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 68888866443 4456789999999999999999999998765 458999999999999999998754 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|++.||.|||++|++||||||+|||++.++.++|+|||++........ .....++..|++||.+.+..++.++|
T Consensus 112 ~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~D 191 (267)
T cd05066 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD 191 (267)
T ss_pred HHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhh
Confidence 99999999999999999999999999999999999999999987643321 11122356799999999888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+|||||++|+|++ |..||...+..+....+......+.+..++..+.+++.+||+.+|.+||++.++++
T Consensus 192 v~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 192 VWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999886 99999888877777777766555666778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.46 Aligned_cols=225 Identities=34% Similarity=0.618 Sum_probs=187.6
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~ 78 (582)
||||+++... ........+.+|+++++.++||||+++++.+... ...|+||||+++++|.+++... ....+++..+
T Consensus 30 ~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 108 (267)
T cd08228 30 VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIVLELADAGDLSQMIKYFKKQKRLIPERTV 108 (267)
T ss_pred EEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHH
Confidence 7899886533 3445667789999999999999999999988765 5889999999999999988642 2335899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ......|++.|+|||.+.+..++.++|
T Consensus 109 ~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 188 (267)
T cd08228 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188 (267)
T ss_pred HHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhh
Confidence 9999999999999999999999999999999999999999999987654332 223457889999999998888999999
Q ss_pred ccchhHHHHhHhcCCccccccC--HHHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~--~~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||++|+|++|..||.... ...+...+......+.+ ..++..+.++|.+||..+|++||+++++++.
T Consensus 189 i~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 189 IWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999986543 34455555443333333 4578899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.26 Aligned_cols=224 Identities=18% Similarity=0.316 Sum_probs=192.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC------CCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG------VHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~------~~lse 75 (582)
|++|++... ......+.+.+|+.+|++++|+||+++++++...+...++++||+.+++|.+++..... ..+++
T Consensus 38 v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~ 116 (280)
T cd05043 38 VFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116 (280)
T ss_pred EEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCH
Confidence 677777543 34556678899999999999999999999887767788999999999999999976421 45899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y 152 (582)
..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.+.... ......++..|+|||++.+..+
T Consensus 117 ~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 196 (280)
T cd05043 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY 196 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence 9999999999999999999999999999999999999999999999997654322 1223456678999999998889
Q ss_pred CCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 153 GSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+.++|||||||++|+|++ |.+||...+..++...+........+..+++.+.+++.+||..||++|||+.++++
T Consensus 197 ~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 197 SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999998 99999988888877777666555566678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=293.62 Aligned_cols=226 Identities=29% Similarity=0.546 Sum_probs=194.5
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||.+..... .....+.+.+|+++++++. |+||+++++.+.. +...|+||||+++++|.+++.+.. .+++..+
T Consensus 28 ~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~ 104 (280)
T cd05581 28 EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYFVLEYAPNGELLQYIRKYG--SLDEKCT 104 (280)
T ss_pred EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEEEEcCCCCCcHHHHHHHcC--CCCHHHH
Confidence 378888866332 3344567889999999999 9999999997754 458999999999999999998754 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---------------------ccCcccC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---------------------LASSVVG 137 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---------------------~~~~~vG 137 (582)
..++.|++.||.|||+.|++|+||+|+||+++.+++++|+|||++....... ......|
T Consensus 105 ~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (280)
T cd05581 105 RFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184 (280)
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccC
Confidence 9999999999999999999999999999999999999999999987654322 1234578
Q ss_pred CCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCC
Q 007991 138 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 217 (582)
Q Consensus 138 Tp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~ 217 (582)
+..|+|||.+....++.++|||||||++++|++|..||...+....+..+. .....++..+++.+.+||.+||+.+|.+
T Consensus 185 ~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 263 (280)
T cd05581 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQD 263 (280)
T ss_pred CccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hcCCCCCCccCHHHHHHHHHHhcCCHhh
Confidence 899999999988888999999999999999999999999887666555554 3344567788999999999999999999
Q ss_pred CCCH----HHHHcCCCC
Q 007991 218 RPSA----AELLCHPHL 230 (582)
Q Consensus 218 RpSa----~EiL~hp~f 230 (582)
||++ +++|+||||
T Consensus 264 R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 264 RLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCcccCHHHHhcCCCC
Confidence 9999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.68 Aligned_cols=221 Identities=20% Similarity=0.371 Sum_probs=191.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... .+.+.+|+.++++++|+||+++++.+.. +...|+||||+++++|.+++....+..+++..+..+
T Consensus 33 ~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 108 (261)
T cd05034 33 VAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108 (261)
T ss_pred EEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHH
Confidence 688888754432 3568899999999999999999997754 457899999999999999998766567999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||
T Consensus 109 ~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 188 (261)
T cd05034 109 AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188 (261)
T ss_pred HHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHH
Confidence 99999999999999999999999999999999999999999876543211 1223345689999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |+.||.+.........+......+.+...+..+.+++.+||+.+|++||++++++.
T Consensus 189 slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999998 99999998888888888776666677778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.02 Aligned_cols=223 Identities=22% Similarity=0.392 Sum_probs=190.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+.... .+.....+..|+.++++++||||+++++.+.. +...++||||+.+++|.+++.... ..+++..+..+
T Consensus 35 vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 111 (269)
T cd05065 35 VAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGM 111 (269)
T ss_pred EEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHH
Confidence 7888886543 45566789999999999999999999998754 457899999999999999998743 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCc----cc--CCCCCCCcccccCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS----VV--GTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~----~v--GTp~Y~APE~l~~~~y~~k 155 (582)
+.|++.||.|||++|++||||||+||+++.++.+||+|||++........... .. ++..|+|||.+.+..++.+
T Consensus 112 ~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (269)
T cd05065 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA 191 (269)
T ss_pred HHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccch
Confidence 99999999999999999999999999999999999999999876543221111 11 2347999999998899999
Q ss_pred CcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||||++|||++ |..||...+.......+......+.+..++..+.+++..||..+|.+||++++|+..
T Consensus 192 ~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 192 SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999886 999999888888877776665556667789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=291.44 Aligned_cols=212 Identities=25% Similarity=0.362 Sum_probs=177.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|+++... .+.+|...+....||||+++++.+... ...|+||||+.|++|.+++.+.. .+++..+..+
T Consensus 21 ~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~ 90 (237)
T cd05576 21 FILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRW 90 (237)
T ss_pred EEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHH
Confidence 7899987643 234566666677899999999987654 58999999999999999998754 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.|++.||+|||+.||+||||||+||+++.++.++|+|||++...... .....++..|+|||.+....++.++|+||+
T Consensus 91 ~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 168 (237)
T cd05576 91 AAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSL 168 (237)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHH
Confidence 999999999999999999999999999999999999999987655432 234566788999999988889999999999
Q ss_pred hHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-----HHHHcCCCC
Q 007991 162 GCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-----AELLCHPHL 230 (582)
Q Consensus 162 G~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-----~EiL~hp~f 230 (582)
||++|+|++|..+|...... +.......++..++..+++||.+||+.||++|+++ ++++.||||
T Consensus 169 G~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 169 GAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 99999999999887643321 11112223566789999999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.14 Aligned_cols=224 Identities=19% Similarity=0.373 Sum_probs=190.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
+++|.+..... ......+.+|+.+|+.++||||+++++.+... ...|+||||+.+++|.+++....
T Consensus 33 ~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (290)
T cd05045 33 VAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110 (290)
T ss_pred EEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCcEEEEEecCCCCHHHHHHhcCCccccccccccc
Confidence 56666654433 34456789999999999999999999987654 57889999999999999987521
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCccc
Q 007991 70 ----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVV 136 (582)
Q Consensus 70 ----------~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~v 136 (582)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... ......
T Consensus 111 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 190 (290)
T cd05045 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGR 190 (290)
T ss_pred cccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCC
Confidence 1347899999999999999999999999999999999999999999999999997653322 122335
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCC
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 215 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP 215 (582)
++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....+.+.+......+.+..++.++.+||..||+.+|
T Consensus 191 ~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 191 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred CCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 5678999999988889999999999999999998 999999988888888777666666778899999999999999999
Q ss_pred CCCCCHHHHHcC
Q 007991 216 EFRPSAAELLCH 227 (582)
Q Consensus 216 ~~RpSa~EiL~h 227 (582)
++||++.+++..
T Consensus 271 ~~Rp~~~~i~~~ 282 (290)
T cd05045 271 DKRPTFADISKE 282 (290)
T ss_pred ccCCCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.87 Aligned_cols=217 Identities=19% Similarity=0.345 Sum_probs=187.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|+++... ..+.+.+|+.++++++||||+++++.+..+ ..|+||||+.|++|.+++.......+++..+..+
T Consensus 32 ~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 105 (254)
T cd05083 32 VAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF 105 (254)
T ss_pred eEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHH
Confidence 7888886532 235688999999999999999999987654 4689999999999999998765556899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+..++.++|+|||
T Consensus 106 ~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred HHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHH
Confidence 999999999999999999999999999999999999999998754321 223344568999999988889999999999
Q ss_pred hHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 162 GCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 162 G~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||++|+|++ |.+||...+..+....+........+..++..+.+||.+||+.+|+.||++++++.
T Consensus 184 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 184 GVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999997 99999998888877777666555556778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=292.47 Aligned_cols=227 Identities=31% Similarity=0.491 Sum_probs=188.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|+++.....+.....+.+|+.++++++|+|++++++++... +...|+||||+. ++|.+++.... ..+++..+..
T Consensus 27 ~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~ 104 (287)
T cd07840 27 VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKC 104 (287)
T ss_pred EEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHH
Confidence 78999987664555566788999999999999999999988765 368999999996 58998887643 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccC-CCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLAD-IPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~-~~y~~ksD 157 (582)
++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+ ..++.++|
T Consensus 105 i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 184 (287)
T cd07840 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVD 184 (287)
T ss_pred HHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHH
Confidence 99999999999999999999999999999999999999999997765432 2334567889999998765 45789999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHHHHHH
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFRGLV 207 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l~~LI 207 (582)
||||||++|+|++|..||...+.......+......+ +...++..+.++|
T Consensus 185 v~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 264 (287)
T cd07840 185 MWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLL 264 (287)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHH
Confidence 9999999999999999998877665555443321110 0111388899999
Q ss_pred HHhccCCCCCCCCHHHHHcCCCC
Q 007991 208 KSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 208 ~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.+||..+|.+||++++++.||||
T Consensus 265 ~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 265 DKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHcCCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.02 Aligned_cols=224 Identities=20% Similarity=0.340 Sum_probs=190.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
.||||.+.... .....+.+.+|+.++++++||||+++++++.. +...|+||||+.+++|.+++....
T Consensus 37 ~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (288)
T cd05050 37 MVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114 (288)
T ss_pred eEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCccEEEEecCCCCCHHHHHHHcCccccccccccc
Confidence 37888887543 34555778999999999999999999997765 457899999999999999997532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccC
Q 007991 70 ---------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVG 137 (582)
Q Consensus 70 ---------~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vG 137 (582)
...+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++........ .....+
T Consensus 115 ~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 194 (288)
T cd05050 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI 194 (288)
T ss_pred cccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCcc
Confidence 12478889999999999999999999999999999999999999999999999876533221 223345
Q ss_pred CCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCC
Q 007991 138 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPE 216 (582)
Q Consensus 138 Tp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~ 216 (582)
+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+......+.+..++..+.+||.+||+.+|.
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 274 (288)
T cd05050 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPS 274 (288)
T ss_pred ChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 667999999988889999999999999999997 8889988888888777776666666778899999999999999999
Q ss_pred CCCCHHHHHc
Q 007991 217 FRPSAAELLC 226 (582)
Q Consensus 217 ~RpSa~EiL~ 226 (582)
+||+++|+++
T Consensus 275 ~Rpt~~el~~ 284 (288)
T cd05050 275 DRPSFASINR 284 (288)
T ss_pred cCCCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=306.37 Aligned_cols=228 Identities=23% Similarity=0.380 Sum_probs=187.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++..........+.+.+|+.++++++|+||+++++++.... ..+|++++++ |++|.++++.. .+++
T Consensus 44 ~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~ 119 (345)
T cd07877 44 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTD 119 (345)
T ss_pred EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCH
Confidence 3789999775554555667889999999999999999999876332 3578899988 78999888753 5899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..... ......|++.|+|||.+.+ ..++.
T Consensus 120 ~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (345)
T cd07877 120 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQ 197 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCc
Confidence 99999999999999999999999999999999999999999999999876532 2345688999999999866 56888
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC------------------------------CCCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------------------------PLPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~------------------------------~lp~~~S~~l~ 204 (582)
++|||||||++|+|++|.+||...+.......+...... ......+..+.
T Consensus 198 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (345)
T cd07877 198 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 277 (345)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHH
Confidence 999999999999999999999876654443332211110 01123578899
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||..||+.||.+|+++.++|.||||+++.
T Consensus 278 ~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 278 DLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=303.26 Aligned_cols=230 Identities=25% Similarity=0.389 Sum_probs=186.7
Q ss_pred CEEEEEecccccCHH------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh
Q 007991 1 MYVLKKIRLARQTDR------------ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA 68 (582)
Q Consensus 1 lyAIKki~~~~~~~~------------~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~ 68 (582)
.||||+++....... ....+.+|+++|++++|+||+++++++... .+.|+||||+. ++|.+++...
T Consensus 36 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~ 113 (335)
T PTZ00024 36 IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG-DFINLVMDIMA-SDLKKVVDRK 113 (335)
T ss_pred eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC-CcEEEEEeccc-cCHHHHHHhc
Confidence 378998866433221 112577999999999999999999988654 58999999996 6999998764
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---------------cccC
Q 007991 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---------------DLAS 133 (582)
Q Consensus 69 ~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---------------~~~~ 133 (582)
. .+++..+..++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++...... ....
T Consensus 114 ~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (335)
T PTZ00024 114 I--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191 (335)
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccc
Confidence 3 6899999999999999999999999999999999999999999999999998765411 1122
Q ss_pred cccCCCCCCCcccccCC-CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------
Q 007991 134 SVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------ 194 (582)
Q Consensus 134 ~~vGTp~Y~APE~l~~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------ 194 (582)
...+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+....+......+
T Consensus 192 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
T PTZ00024 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT 271 (335)
T ss_pred ccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccC
Confidence 34678899999998764 46889999999999999999999999887766555543321111
Q ss_pred ---------CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 195 ---------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 195 ---------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
....++..+.+||.+||+.+|++||+++|+|.||||+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 272 PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred cCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 0123578899999999999999999999999999998653
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.42 Aligned_cols=223 Identities=20% Similarity=0.386 Sum_probs=186.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.++.... ....+.+.+|+++++++ +|+||+++++.+... ...|+||||+.+++|.++++......+++..+..
T Consensus 68 vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~ 145 (302)
T cd05055 68 VAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIG-GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145 (302)
T ss_pred EEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHH
Confidence 67887765433 34557789999999999 799999999987654 5789999999999999999875544589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
++.|++.||+|||++||+|+||||+|||++.++.++|+|||+++...... ......++..|+|||.+.+..++.++|
T Consensus 146 i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 225 (302)
T cd05055 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 225 (302)
T ss_pred HHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhH
Confidence 99999999999999999999999999999999999999999997654322 122345678899999999888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHH-HhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINK-INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~k-I~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|+|++ |..||..........+ +........+...+..+.+|+.+||..+|++||++.|++.
T Consensus 226 iwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 226 VWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999998 9999987765544333 3333333455668899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=291.63 Aligned_cols=213 Identities=41% Similarity=0.816 Sum_probs=185.2
Q ss_pred HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLH 93 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~~~il~QLL~aL~yLH 93 (582)
....+.+|+.+++.++||||+++++.+... ...|+||||+.+++|.+++... .+..+++..+..++.|++.||.|||
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999987654 4789999999999999988642 3346899999999999999999999
Q ss_pred HCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCC
Q 007991 94 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQK 172 (582)
Q Consensus 94 s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~ 172 (582)
+.|++|+||+|+||+++. +.++|+|||++...... .......|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 124 ~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 124 QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred HcCccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999975 56999999998765432 2334567899999999998888889999999999999999999
Q ss_pred ccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 173 AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 173 ~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.||...........+........+..++.++.++|.+||..||++||+++++++||||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 203 HAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9998887777777766665666677889999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.75 Aligned_cols=222 Identities=20% Similarity=0.362 Sum_probs=189.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++... .....+.+.+|++++++++|+||+++++++... ...|+||||+.+++|.+++.... ..+++..+..+
T Consensus 36 ~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 112 (268)
T cd05063 36 VAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGM 112 (268)
T ss_pred EEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 6788886543 344567789999999999999999999987654 57899999999999999998743 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc----CcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA----SSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~----~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|++.||+|||+.|++||||||+||+++.++.+||+|||++......... .....+..|+|||++.+..++.++|
T Consensus 113 ~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 192 (268)
T cd05063 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASD 192 (268)
T ss_pred HHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhH
Confidence 999999999999999999999999999999999999999998765432211 1112345799999998888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|+|++ |..||...+...+...+......+.+..++..+.+|+.+||..+|++||++.++++
T Consensus 193 v~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 193 VWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999987 99999888888888887766666666778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.95 Aligned_cols=228 Identities=26% Similarity=0.438 Sum_probs=190.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++............+.+|+.++++++|+||+++++++...+ ..+|+|+||+ |++|.+++... .+++
T Consensus 42 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~ 117 (343)
T cd07851 42 KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSD 117 (343)
T ss_pred EEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC---CCCH
Confidence 3789988765555555567889999999999999999998776443 2489999999 78999999762 6899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.
T Consensus 118 ~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 195 (343)
T cd07851 118 DHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQ 195 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCc
Confidence 999999999999999999999999999999999999999999999999765432 445678999999999865 46788
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l~ 204 (582)
++|||||||++|+|++|..||.+.+....+..+......+ ....++..+.
T Consensus 196 ~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~ 275 (343)
T cd07851 196 TVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAI 275 (343)
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHH
Confidence 9999999999999999999998777665554443221110 1123688999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||.+||..||++|||+.+||.||||+.+.
T Consensus 276 dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 276 DLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.56 Aligned_cols=220 Identities=17% Similarity=0.353 Sum_probs=189.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+... ....+.+.+|+.+|++++|+||+++++.+.. ...|++|||+.+++|.+++.+..+..+++..+..+
T Consensus 33 ~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (260)
T cd05073 33 VAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107 (260)
T ss_pred EEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHH
Confidence 678877643 2345678899999999999999999998765 57889999999999999998765667899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||+.|++||||||+||+++.++.+||+|||++........ .....++..|+|||++....++.++|+|
T Consensus 108 ~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 187 (260)
T cd05073 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187 (260)
T ss_pred HHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccch
Confidence 99999999999999999999999999999999999999999876543221 1223456779999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|+|++ |.+||.+.+...+...+......+.+..++.++.+++.+||..+|++||++.+++.
T Consensus 188 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999998 99999998888877777766655666778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.78 Aligned_cols=224 Identities=20% Similarity=0.381 Sum_probs=183.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.++.... ....+.+.+|+++|++++||||+++++++... +...++||||++|++|.+++.+.. ..+++..+..
T Consensus 36 va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~ 113 (284)
T cd05079 36 VAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLK 113 (284)
T ss_pred EEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHH
Confidence 78898875432 44456799999999999999999999987765 357899999999999999997643 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++
T Consensus 114 i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~ 193 (284)
T cd05079 114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS 193 (284)
T ss_pred HHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccc
Confidence 99999999999999999999999999999999999999999998764332 12345667789999999888899999
Q ss_pred cccchhHHHHhHhcCCcccccc---------------CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAF---------------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~---------------~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
|||||||++|+|+++..|+... ........+......+.+..++..+.+||.+||+.||++||++
T Consensus 194 Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 273 (284)
T cd05079 194 DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTF 273 (284)
T ss_pred cchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence 9999999999999976654211 1112222233333445566789999999999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
++++++
T Consensus 274 ~~il~~ 279 (284)
T cd05079 274 QNLIEG 279 (284)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.37 Aligned_cols=226 Identities=29% Similarity=0.537 Sum_probs=188.1
Q ss_pred CEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++.... ......+.+.+|+++++.++||||+++++++... ...|+||||+. |+|.+++.... ..+++..+.
T Consensus 42 ~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~ 118 (307)
T cd06607 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-HTAWLVMEYCL-GSASDILEVHK-KPLQEVEIA 118 (307)
T ss_pred EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-CeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHH
Confidence 37899886543 3445556789999999999999999999988765 47899999996 67777776533 368999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
.++.||+.||.|||+.||+||||+|.||+++.++.++|+|||++..... .....|++.|+|||++. ...++.++
T Consensus 119 ~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~s 195 (307)
T cd06607 119 AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 195 (307)
T ss_pred HHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---CCCccCCccccCceeeeccCCCCCCccc
Confidence 9999999999999999999999999999999999999999999865432 33567889999999874 35688899
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|+|++|.+||.+.+.......+........ +..++..+.++|.+||..+|++||++.+++.||||..
T Consensus 196 Dv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred chHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 999999999999999999988776665544443322222 3457889999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.61 Aligned_cols=225 Identities=35% Similarity=0.622 Sum_probs=186.8
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~ 77 (582)
.||||++..... .......+.+|+.+++.++|+||+++++.|... ...++||||+.|++|.+++... ....+++..
T Consensus 29 ~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~ 107 (267)
T cd08229 29 PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPEKT 107 (267)
T ss_pred eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHH
Confidence 378898866443 334567889999999999999999999988765 4889999999999999998742 234689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .....+|+..|+|||.+.+..++.++
T Consensus 108 ~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~ 187 (267)
T cd08229 108 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187 (267)
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchh
Confidence 99999999999999999999999999999999999999999999987654332 23356789999999999888899999
Q ss_pred cccchhHHHHhHhcCCccccccCH--HHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~--~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|+|||||++|+|++|..||.+... ......+......+.+ ..++..+++||.+||..||++|||+++|++
T Consensus 188 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 188 DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999999975543 3344444433333333 458899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.87 Aligned_cols=224 Identities=23% Similarity=0.392 Sum_probs=187.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC---------CCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---------GVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~---------~~~ 72 (582)
||+|.+..... ....+.+.+|+++|++++||||+++++++..+ ...++||||+.+++|.+++.+.. ...
T Consensus 49 va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (296)
T cd05051 49 VAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126 (296)
T ss_pred EEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCC
Confidence 68888876533 35667899999999999999999999987654 58999999999999999997643 125
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~ 149 (582)
+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ......+++.|+|||.+.+
T Consensus 127 ~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 8999999999999999999999999999999999999999999999999987654332 2334566788999999988
Q ss_pred CCCCCCCcccchhHHHHhHhc--CCccccccCHHHHHHHHhhc-------cCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQALINKINKS-------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt--G~~PF~~~~~~~l~~kI~~~-------~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
..++.++|||||||++|+|++ +..||........+..+... ...+.+..++.++.+||.+||+.||.+|||
T Consensus 207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 286 (296)
T cd05051 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT 286 (296)
T ss_pred CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence 889999999999999999987 78888877766665554332 112234567899999999999999999999
Q ss_pred HHHHHcC
Q 007991 221 AAELLCH 227 (582)
Q Consensus 221 a~EiL~h 227 (582)
+.+|++.
T Consensus 287 ~~el~~~ 293 (296)
T cd05051 287 FREIHLF 293 (296)
T ss_pred HHHHHHH
Confidence 9999753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=291.34 Aligned_cols=222 Identities=20% Similarity=0.348 Sum_probs=187.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|++|.+.... .......+..|+.++++++||||+++++++. +...++++||+.+|+|.+++.... ..+++..+..|
T Consensus 39 ~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i 114 (279)
T cd05111 39 VAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNW 114 (279)
T ss_pred EEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHH
Confidence 5677765432 2334467888999999999999999999764 346789999999999999998643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++|++||||||+|||++.++.+||+|||+++...... ......++..|++||.+.+..++.++||
T Consensus 115 ~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 194 (279)
T cd05111 115 CVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDV 194 (279)
T ss_pred HHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhH
Confidence 9999999999999999999999999999999999999999998654322 1233456778999999988889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|||++ |..||.+.....+...+......+.+..++..+.+++..||..||.+|||+.|+++.
T Consensus 195 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 195 WSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999998 999999888777766666655555667788899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.36 Aligned_cols=230 Identities=26% Similarity=0.468 Sum_probs=189.6
Q ss_pred EEEEEecccccC--HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQT--DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~--~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||+|.++..... ....+.+.+|+++|+++ +|+||+.+++.+.. +..+|+||||+.|++|.+++.... .+++..+
T Consensus 31 ~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~ 107 (290)
T cd05613 31 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTKLHLILDYINGGELFTHLSQRE--RFKEQEV 107 (290)
T ss_pred EEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCeEEEEEecCCCCcHHHHHHHcC--CCCHHHH
Confidence 788888764332 23456788999999999 58999999987755 458999999999999999998754 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC--CCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI--PYGS 154 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~--~y~~ 154 (582)
..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++....... ......|+..|+|||.+... .++.
T Consensus 108 ~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 187 (290)
T cd05613 108 QIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDK 187 (290)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCc
Confidence 9999999999999999999999999999999999999999999997654332 22346789999999998753 4678
Q ss_pred CCcccchhHHHHhHhcCCccccccC----HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELL 225 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~----~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL 225 (582)
++|||||||++|+|++|..||.... ...+...+.. ...+.+..++..+.+|+.+||+.||++|+ ++++++
T Consensus 188 ~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 188 AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred cccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 9999999999999999999996433 2233332222 23456777899999999999999999997 899999
Q ss_pred cCCCCchhhh
Q 007991 226 CHPHLQPYVL 235 (582)
Q Consensus 226 ~hp~f~~~~~ 235 (582)
.||||+...+
T Consensus 267 ~~~~~~~~~~ 276 (290)
T cd05613 267 KHPFFQKINW 276 (290)
T ss_pred cCcccccCCH
Confidence 9999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.18 Aligned_cols=229 Identities=30% Similarity=0.432 Sum_probs=187.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++............+.+|+.+++++ +|+||+++++++... +...|+||||+. ++|.+++... .+++..+
T Consensus 34 ~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~ 109 (337)
T cd07852 34 VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHK 109 (337)
T ss_pred EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHH
Confidence 378998866544455556788999999999 999999999987644 457899999996 6999988763 6889999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc------ccCcccCCCCCCCcccccC-CC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD------LASSVVGTPSYMCPELLAD-IP 151 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~------~~~~~vGTp~Y~APE~l~~-~~ 151 (582)
..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ....+.|+..|+|||.+.+ ..
T Consensus 110 ~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 189 (337)
T cd07852 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTR 189 (337)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecccc
Confidence 9999999999999999999999999999999999999999999998654322 2334678999999998765 45
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC------------------------------CCCCccccH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------------------APLPTVYSG 201 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~------------------------------~~lp~~~S~ 201 (582)
++.++|||||||++|+|++|.+||.+........++..... ......++.
T Consensus 190 ~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (337)
T cd07852 190 YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASD 269 (337)
T ss_pred ccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCH
Confidence 78899999999999999999999987665444333221110 011123688
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
++.+||.+||+.||.+|||+.++++|||++.+
T Consensus 270 ~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 270 DALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 99999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.13 Aligned_cols=228 Identities=32% Similarity=0.503 Sum_probs=185.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC---------cEEEEEEeecCCCCHHHHHHHhCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---------CYVCIIIGYCEGGDMAEAIKKANGV 71 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~---------~~l~LVmEy~~GgsL~d~Ikk~~~~ 71 (582)
.||||.++...........+.+|++++++++||||+++++++...+ .++|+|+||+.+ +|...+... ..
T Consensus 34 ~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~ 111 (302)
T cd07864 34 LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LV 111 (302)
T ss_pred EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CC
Confidence 3789998775544444567789999999999999999999876532 379999999975 777777653 33
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccC
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~ 149 (582)
.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ......++..|+|||.+.+
T Consensus 112 ~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 191 (302)
T cd07864 112 HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG 191 (302)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcC
Confidence 68999999999999999999999999999999999999999999999999997664332 2223456788999998865
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccc
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVY 199 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~ 199 (582)
..++.++|||||||++|+|++|++||...+.......+......+ ....+
T Consensus 192 ~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (302)
T cd07864 192 EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI 271 (302)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCC
Confidence 357889999999999999999999998776655544443321111 11246
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 200 S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+..+.++|..||..||.+||++++++.||||
T Consensus 272 ~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 272 PTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.15 Aligned_cols=217 Identities=29% Similarity=0.438 Sum_probs=176.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.+....... .|+.+...+ +|+||+++++.|...+ ..|+||||+.|++|.+++.... .+++..++.
T Consensus 44 ~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~ 113 (267)
T PHA03390 44 FVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLK-GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKK 113 (267)
T ss_pred EEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCC-eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 6777775533221 133333222 7999999999887654 8999999999999999998754 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++..... .....|+..|+|||++.+..++.++|||
T Consensus 114 ~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 190 (267)
T PHA03390 114 IIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT---PSCYDGTLDYFSPEKIKGHNYDVSFDWW 190 (267)
T ss_pred HHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC---CccCCCCCcccChhhhcCCCCCchhhHH
Confidence 999999999999999999999999999999998 999999999876543 2345789999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHH-HHHHhh--ccCCCCCccccHHHHHHHHHhccCCCCCCCC-HHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQAL-INKINK--SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-AAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l-~~kI~~--~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-a~EiL~hp~f~ 231 (582)
||||++|+|++|..||.......+ ...+.. ....+.+..++..+.+||.+||+.+|.+|++ ++++|+||||.
T Consensus 191 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 191 AVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999975543221 111111 2222345579999999999999999999996 69999999996
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.92 Aligned_cols=230 Identities=24% Similarity=0.391 Sum_probs=186.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++..........+.+.+|+.+++++ +||||+++++.+.. ....+|+++||+. ++|.+++.... .+++..
T Consensus 30 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~ 106 (332)
T cd07857 30 VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ--PLTDAH 106 (332)
T ss_pred EEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC--CCCHHH
Confidence 79999876544444556788999999999 59999999986542 2246889999995 78999887533 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccC-CC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLAD-IP 151 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~-~~ 151 (582)
++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+|++.|+|||++.+ ..
T Consensus 107 ~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 186 (332)
T cd07857 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186 (332)
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCC
Confidence 99999999999999999999999999999999999999999999997654321 2234689999999998765 56
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC------------------------------CCCccccH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------------------------PLPTVYSG 201 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~------------------------------~lp~~~S~ 201 (582)
++.++|||||||++|+|++|.+||...+.......+...... .....++.
T Consensus 187 ~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (332)
T cd07857 187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP 266 (332)
T ss_pred CCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCH
Confidence 889999999999999999999999877654443332211100 11223578
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
.+.+||.+||+.||++|||+.+++.||||+.+.
T Consensus 267 ~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 267 LALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.86 Aligned_cols=228 Identities=27% Similarity=0.432 Sum_probs=189.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++............+.+|+.+|++++|+||+++++++...+ ..+|+||||+ |++|.+++... .+++
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~ 117 (343)
T cd07880 42 KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSE 117 (343)
T ss_pred EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCH
Confidence 3899998766555666678899999999999999999999886543 2568999999 78999888753 6899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+ ..++.
T Consensus 118 ~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 195 (343)
T cd07880 118 DRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQ 195 (343)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCc
Confidence 999999999999999999999999999999999999999999999999765432 334578999999999876 45788
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC------------------------------CCCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------------------------PLPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~------------------------------~lp~~~S~~l~ 204 (582)
++|+|||||++|+|++|.+||.+.+.......+...... .+...++..+.
T Consensus 196 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (343)
T cd07880 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAV 275 (343)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHH
Confidence 999999999999999999999877655444333221100 11234678899
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
++|.+||..||.+|||+.+++.||||+.+.
T Consensus 276 ~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 276 NVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=289.14 Aligned_cols=221 Identities=22% Similarity=0.374 Sum_probs=190.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ......+.+|+.+|++++|+||+++++++.. ...++||||+.+|+|.+++....+ .+++..+..+
T Consensus 39 ~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~ 114 (279)
T cd05057 39 VAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNW 114 (279)
T ss_pred EEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHH
Confidence 67777765433 4556778999999999999999999998765 578899999999999999987433 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc---CcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~---~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ....++..|+|||.+....++.++||
T Consensus 115 ~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 194 (279)
T cd05057 115 CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV 194 (279)
T ss_pred HHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhH
Confidence 999999999999999999999999999999999999999999876433211 11223567999999988889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||++|||++ |..||.+....++...+......+.+..++..+.+++.+||..||..||++.++++
T Consensus 195 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 195 WSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999998 99999999888888888776666677788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.33 Aligned_cols=225 Identities=30% Similarity=0.515 Sum_probs=188.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ...+.+.+|+.+++.++||||+++++.+... ...|+|+||++|++|.+++.+. .+++..+..+
T Consensus 47 v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i 120 (293)
T cd06647 47 VAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAV 120 (293)
T ss_pred EEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHH
Confidence 78888865433 2346788999999999999999999988664 4889999999999999999864 5789999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ......|++.|++||.+.+..++.++|+||
T Consensus 121 ~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s 200 (293)
T cd06647 121 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200 (293)
T ss_pred HHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHH
Confidence 9999999999999999999999999999999999999999887654332 233457899999999998888999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...+.......+..... ...+..++..++++|.+||..+|++||++++++.|+||+.
T Consensus 201 lG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred HHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999999999987765443333222111 1234457889999999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=288.16 Aligned_cols=222 Identities=23% Similarity=0.398 Sum_probs=189.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||...... .....+.+.+|+.+++.++|+||+++++++.. ...|+||||+.+++|.+++.+.. ..+++..+..+
T Consensus 37 v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 112 (270)
T cd05056 37 VAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILY 112 (270)
T ss_pred eEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHH
Confidence 6777775543 24556789999999999999999999997653 45789999999999999998743 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||+|||+.|++||||||+|||++.++.+||+|||+++....... .....++..|+|||.+....++.++|||
T Consensus 113 ~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 192 (270)
T cd05056 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVW 192 (270)
T ss_pred HHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhH
Confidence 99999999999999999999999999999999999999999876544322 1122344679999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||...+..+....+......+.+..++..+.+||.+||..+|.+|||+.+++..
T Consensus 193 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 193 MFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999885 999999888777777777666666778899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=279.07 Aligned_cols=229 Identities=27% Similarity=0.476 Sum_probs=198.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||+|.+++....+.......|||-+|+.|+|.|||+++++.-. +..+-+|+||| ..+|..+....+| .++.+.++.
T Consensus 29 ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe~c-dqdlkkyfdslng-~~d~~~~rs 105 (292)
T KOG0662|consen 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRS 105 (292)
T ss_pred eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHH
Confidence 58999999988887778889999999999999999999997644 55888999999 5788888877655 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC-CCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP-YGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~-y~~ksDI 158 (582)
++.|++.||.++|+++++||||||.|+||+.+|.+||+|||+++.+.-.. -.+..+.|.||.+|.++.+.. |+...|+
T Consensus 106 fmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidm 185 (292)
T KOG0662|consen 106 FMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_pred HHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHh
Confidence 99999999999999999999999999999999999999999998875443 345568899999999998765 8999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCc----------------------------cccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPT----------------------------VYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~----------------------------~~S~~l~~LI~k 209 (582)
||.||++.|+.. |.+.|.+.+..++..+|-.....+... .++..-++|+++
T Consensus 186 wsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqk 265 (292)
T KOG0662|consen 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQK 265 (292)
T ss_pred hhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHH
Confidence 999999999965 899999999999888876544332111 123457899999
Q ss_pred hccCCCCCCCCHHHHHcCCCCch
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+|..+|..|++++++|+||||..
T Consensus 266 ll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 266 LLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred HhccCcccccCHHHHhcCccccc
Confidence 99999999999999999999975
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.23 Aligned_cols=223 Identities=22% Similarity=0.387 Sum_probs=186.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----CCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-----GVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-----~~~lse~ 76 (582)
||||.+.... .......+.+|+.+|+.++||||+++++++... ...|+||||+.|++|.+++.... ...+++.
T Consensus 29 ~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 106 (269)
T cd05044 29 VAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLK 106 (269)
T ss_pred ehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHH
Confidence 5666664432 223456788999999999999999999987654 47899999999999999997532 2347899
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-----CeEEeecccchhcccccc---cCcccCCCCCCCccccc
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-----DIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLA 148 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-----~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~ 148 (582)
.+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++........ .....++..|+|||.+.
T Consensus 107 ~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 107 ELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHc
Confidence 9999999999999999999999999999999999887 899999999976543321 22335578899999999
Q ss_pred CCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+..++.++|||||||++|+|++ |..||...+.......+........+..++..+.+||.+||+.+|.+||+++++++
T Consensus 187 ~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 187 DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8889999999999999999998 99999887777776666555555566778999999999999999999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.30 Aligned_cols=227 Identities=31% Similarity=0.447 Sum_probs=189.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||+|.+......+...+.+.+|+.++++++|+||+++++++... ...|+||||+. ++|.+++.+.. ..+++..+..
T Consensus 26 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~ 102 (282)
T cd07829 26 IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKS 102 (282)
T ss_pred EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHH
Confidence 378998887654445556788999999999999999999987654 58999999997 69999998753 3689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDI 158 (582)
++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. .++.++||
T Consensus 103 ~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 182 (282)
T cd07829 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDI 182 (282)
T ss_pred HHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccH
Confidence 99999999999999999999999999999999999999999997764432 23345667889999998766 78899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHHh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKSM 210 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~km 210 (582)
|||||++|+|++|.+||.+.+....+.++......+ ....++..+.++|.+|
T Consensus 183 ~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 262 (282)
T cd07829 183 WSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKM 262 (282)
T ss_pred HHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHh
Confidence 999999999999999998877665554443211100 0112477899999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|..||++||++++++.||||
T Consensus 263 l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 263 LQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hccCcccCCCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.52 Aligned_cols=224 Identities=20% Similarity=0.376 Sum_probs=191.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||+|.++.. ......+.+.+|+++++++ +|+||+++++.+... ..+|++|||+.+|+|.+++.+..
T Consensus 47 vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 47 VAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred EEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-CceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 678877643 3345567889999999999 799999999987654 48899999999999999998642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~A 143 (582)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 204 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMA 204 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcC
Confidence 23478888999999999999999999999999999999999999999999999876543221 122334567999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..++.++|||||||++|+|++ |..||.+.+..+....+........+..++..+.+||.+||..+|.+||++.
T Consensus 205 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 284 (334)
T cd05100 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK 284 (334)
T ss_pred HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence 999999889999999999999999998 8999999998888888877666667778899999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
|++.+
T Consensus 285 ell~~ 289 (334)
T cd05100 285 QLVED 289 (334)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=284.68 Aligned_cols=221 Identities=22% Similarity=0.458 Sum_probs=188.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ...+.+|++++++++||||+++++.+... ...|+||||+.|++|.+++....+ .+++..+..+
T Consensus 31 ~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~ 105 (256)
T cd05112 31 VAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGM 105 (256)
T ss_pred EEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHH
Confidence 678887654433 24688999999999999999999987554 578999999999999999986433 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||
T Consensus 106 ~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~ 185 (256)
T cd05112 106 CLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185 (256)
T ss_pred HHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHH
Confidence 99999999999999999999999999999999999999999876543321 1223455689999999888899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||.......+...+........+...+..+.+|+.+||..+|++||++++++++
T Consensus 186 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 186 SFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999998 999999888888887776655444566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.97 Aligned_cols=223 Identities=21% Similarity=0.374 Sum_probs=186.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++.... ....+.+.+|+++|+++. |||||+++++|... ...|||||||++|+|.++|.+..
T Consensus 70 vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (400)
T cd05105 70 VAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKP 147 (400)
T ss_pred EEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CceEEEEEecCCCcHHHHHHHhhhhhhccccccc
Confidence 79999876433 445678999999999996 99999999988654 58999999999999999886531
Q ss_pred --------------------------------------------------------------------------------
Q 007991 70 -------------------------------------------------------------------------------- 69 (582)
Q Consensus 70 -------------------------------------------------------------------------------- 69 (582)
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 227 (400)
T cd05105 148 KKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLS 227 (400)
T ss_pred cccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHH
Confidence
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...... ......+++.|+|
T Consensus 228 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a 307 (400)
T cd05105 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMA 307 (400)
T ss_pred hcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEC
Confidence 1247888999999999999999999999999999999999999999999999997654322 1233457788999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
||++.+..++.++|||||||++|+|++ |..||...... .+...+......+.+..++..+.+||.+||+.||++||++
T Consensus 308 PE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 308 PESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 999998889999999999999999986 89999875443 3344455444455667789999999999999999999999
Q ss_pred HHHHc
Q 007991 222 AELLC 226 (582)
Q Consensus 222 ~EiL~ 226 (582)
.++.+
T Consensus 388 ~~l~~ 392 (400)
T cd05105 388 LHLSD 392 (400)
T ss_pred HHHHH
Confidence 99876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=287.56 Aligned_cols=222 Identities=22% Similarity=0.382 Sum_probs=177.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC---CCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---VHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---~~lse~~~ 78 (582)
+|+|.+.... .......+.+|+.+++.++|+||+++++.+... ..+|+||||+.+|+|.+++..... ..+++..+
T Consensus 25 ~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 102 (269)
T cd05042 25 VVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102 (269)
T ss_pred EEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-CceEEEEEeCCCCcHHHHHHhccccccccccHHHH
Confidence 5777765433 344556788999999999999999999987654 578999999999999999987432 23568889
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccC------
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLAD------ 149 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~------ 149 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....++..|+|||++..
T Consensus 103 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (269)
T cd05042 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLL 182 (269)
T ss_pred HHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccccc
Confidence 99999999999999999999999999999999999999999999865433221 223455678999998743
Q ss_pred -CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCC-----CCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA-----PLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~-----~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
..++.++|||||||++|+|++ |..||......+....+...... .++..++..+.+++..|+ .||++||+++
T Consensus 183 ~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~ 261 (269)
T cd05042 183 PKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAE 261 (269)
T ss_pred ccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence 356789999999999999998 78999877766555544333221 234468899999999998 5999999999
Q ss_pred HHHc
Q 007991 223 ELLC 226 (582)
Q Consensus 223 EiL~ 226 (582)
+|+.
T Consensus 262 ~v~~ 265 (269)
T cd05042 262 EVHE 265 (269)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=289.29 Aligned_cols=226 Identities=27% Similarity=0.446 Sum_probs=186.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++....... ......+|+..+++++ |+||+++++++.. +...|+||||+ +++|.+++....+..+++..+..
T Consensus 27 ~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~ 103 (283)
T cd07830 27 VAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS 103 (283)
T ss_pred EEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHH
Confidence 7889887654432 2234567999999999 9999999998766 56899999999 88999999876545789999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDIW 159 (582)
++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.............|+..|+|||++.+ ..++.++|+|
T Consensus 104 ~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 183 (283)
T cd07830 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIW 183 (283)
T ss_pred HHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchh
Confidence 999999999999999999999999999999999999999999987655444556788999999998754 4578999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----------------------------CCccccHHHHHHHHHh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-----------------------------LPTVYSGAFRGLVKSM 210 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-----------------------------lp~~~S~~l~~LI~km 210 (582)
|||+++++|++|.+||......+...++......+ .....+..+.+||.+|
T Consensus 184 s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 263 (283)
T cd07830 184 ALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDM 263 (283)
T ss_pred hHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHh
Confidence 99999999999999998776655544433211111 0112367899999999
Q ss_pred ccCCCCCCCCHHHHHcCCCC
Q 007991 211 LRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f 230 (582)
|+.+|++||+++|++.||||
T Consensus 264 l~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 264 LRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccCcccCCCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.79 Aligned_cols=225 Identities=28% Similarity=0.387 Sum_probs=176.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+..... ......+.+|+.+|+.++|+||+++++++.. +...|+||||+. ++|.+.+.... ..+++..++.+
T Consensus 33 ~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~ 108 (291)
T cd07870 33 VALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLF 108 (291)
T ss_pred EEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHH
Confidence 78898865432 2223456789999999999999999998765 458999999995 77877776543 35789999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-CCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~-~y~~ksDIW 159 (582)
+.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++..... .......+++.|+|||.+.+. .++.++|||
T Consensus 109 ~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 188 (291)
T cd07870 109 MFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIW 188 (291)
T ss_pred HHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHH
Confidence 999999999999999999999999999999999999999998764322 223445689999999998753 578899999
Q ss_pred chhHHHHhHhcCCccccccCHH-HHHHHHhhccCCC----------------------CC---------ccccHHHHHHH
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAP----------------------LP---------TVYSGAFRGLV 207 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~----------------------lp---------~~~S~~l~~LI 207 (582)
||||++|+|++|..||.+.+.. +.+.++......+ .+ ...+..+.++|
T Consensus 189 slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 268 (291)
T cd07870 189 GAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA 268 (291)
T ss_pred HHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHH
Confidence 9999999999999999765432 2222221100000 00 01356889999
Q ss_pred HHhccCCCCCCCCHHHHHcCCCC
Q 007991 208 KSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 208 ~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.+||..||.+|||++|+|.||||
T Consensus 269 ~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 269 SQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHhCcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=290.16 Aligned_cols=223 Identities=22% Similarity=0.431 Sum_probs=183.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC---------CC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------VH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------~~ 72 (582)
||+|.++... .......+.+|+++|+.++|+||+++++++... ...|+||||+.+++|.+++..... ..
T Consensus 49 ~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (296)
T cd05095 49 VAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS-DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126 (296)
T ss_pred EEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEeCCCCcHHHHHHhcCcccccccccccc
Confidence 6888887543 345667899999999999999999999987654 478999999999999999976421 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~ 149 (582)
+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+.... ......++..|++||.+.+
T Consensus 127 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 6788999999999999999999999999999999999999999999999997654322 1223345678999999888
Q ss_pred CCCCCCCcccchhHHHHhHhc--CCccccccCHHHHHHHHhh-------ccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQALINKINK-------SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt--G~~PF~~~~~~~l~~kI~~-------~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
..++.++|||||||++|||++ |..||...+..+.+..... ....+.+..++..+.+|+..||+.||++||+
T Consensus 207 ~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 286 (296)
T cd05095 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS 286 (296)
T ss_pred CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 889999999999999999998 7889987766555443311 1223445668899999999999999999999
Q ss_pred HHHHHc
Q 007991 221 AAELLC 226 (582)
Q Consensus 221 a~EiL~ 226 (582)
+.+|++
T Consensus 287 ~~~i~~ 292 (296)
T cd05095 287 FQEIHA 292 (296)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=287.89 Aligned_cols=217 Identities=19% Similarity=0.263 Sum_probs=176.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+++|.+.... ......+..|+.++..++||||+++++++..+ ...++||||+++++|..++.... ..+++..+..+
T Consensus 35 v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i 110 (262)
T cd05077 35 VILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD-VENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKV 110 (262)
T ss_pred EEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 5667665432 33456788999999999999999999987654 47789999999999998887643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCC-------eEEeecccchhcccccccCcccCCCCCCCccccc-CCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-------IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-DIPYG 153 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~-------vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~-~~~y~ 153 (582)
+.||+.||+|||++||+||||||+|||++.++. ++++|||++..... .....|+..|+|||++. +..++
T Consensus 111 ~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 187 (262)
T cd05077 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLS 187 (262)
T ss_pred HHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcCCCCCC
Confidence 999999999999999999999999999987664 89999999865533 23456888999999886 46688
Q ss_pred CCCcccchhHHHHhHh-cCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyELl-tG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++|||||||++|+|+ .|..||......+........ .......+.++.+||.+||+.||++||++.+|+++
T Consensus 188 ~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 188 IAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ--CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC--ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 9999999999999997 689998876654443322221 12233456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.52 Aligned_cols=227 Identities=26% Similarity=0.415 Sum_probs=184.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++......+.....+.+|+.++++++|+||+++++++.... ..+|+||||+. .+|..++. ..+++
T Consensus 42 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~ 116 (342)
T cd07879 42 KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSE 116 (342)
T ss_pred EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCH
Confidence 3789998765555555567889999999999999999999876432 35689999995 57766653 26899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.... ......|++.|+|||.+.+ ..++.
T Consensus 117 ~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 194 (342)
T cd07879 117 DKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQ 194 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCc
Confidence 99999999999999999999999999999999999999999999999876432 2345678999999999876 46889
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l~ 204 (582)
++|||||||++|+|++|+.||.+.+....+..+......+ ....++..+.
T Consensus 195 ~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07879 195 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAV 274 (342)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHH
Confidence 9999999999999999999998877554444332211000 0123677899
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||.+||+.||++||+++++|.||||+.+.
T Consensus 275 ~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 275 DLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=293.18 Aligned_cols=225 Identities=28% Similarity=0.542 Sum_probs=188.5
Q ss_pred CEEEEEeccc-ccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~-~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++... .........+.+|+++|++++|+|++++++++... ...|+||||+. |+|.+++.... ..+++..+.
T Consensus 52 ~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~ 128 (317)
T cd06635 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIA 128 (317)
T ss_pred EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHH
Confidence 3789988654 23445556789999999999999999999987664 47899999996 57888776543 368999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... .....|++.|+|||.+. ...++.++
T Consensus 129 ~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 205 (317)
T cd06635 129 AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 205 (317)
T ss_pred HHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccc
Confidence 9999999999999999999999999999999999999999999865432 34567899999999874 45688899
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
|||||||++|+|++|..||...+.......+...... .....++..+++||.+||+.+|.+||++.++++|+|+.
T Consensus 206 Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred cHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 9999999999999999999887766666555444332 23446889999999999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.70 Aligned_cols=216 Identities=26% Similarity=0.339 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHH
Q 007991 15 RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---GVHFPEEKLCKWLVQLLMALNY 91 (582)
Q Consensus 15 ~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~---~~~lse~~~~~il~QLL~aL~y 91 (582)
.....+.+|+.+|++++|+|||++++++... ...|+|++++ +++|.+++.... ........++.|+.||+.||+|
T Consensus 205 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~y 282 (501)
T PHA03210 205 RAAIQLENEILALGRLNHENILKIEEILRSE-ANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEY 282 (501)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcEeEEEEEC-CeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHH
Confidence 3456688999999999999999999987655 4789999999 467777775421 1123467788999999999999
Q ss_pred HHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHh
Q 007991 92 LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMS 169 (582)
Q Consensus 92 LHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELl 169 (582)
||++||+||||||+||||+.++.+||+|||+++.+.... .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 283 LH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 283 IHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred HHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998765432 233578999999999999999999999999999999999
Q ss_pred cCCcc-cccc--CH-HHHHHHHhh---------------------ccCCCC---------CccccHHHHHHHHHhccCCC
Q 007991 170 AQKAA-FKAF--DM-QALINKINK---------------------SIVAPL---------PTVYSGAFRGLVKSMLRKNP 215 (582)
Q Consensus 170 tG~~P-F~~~--~~-~~l~~kI~~---------------------~~~~~l---------p~~~S~~l~~LI~kmL~~dP 215 (582)
+|..+ |... .. ..+...+.. ...... ...++..+.++|.+||+.||
T Consensus 363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP 442 (501)
T PHA03210 363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW 442 (501)
T ss_pred HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence 98754 4322 11 122111110 000000 01246678889999999999
Q ss_pred CCCCCHHHHHcCCCCch
Q 007991 216 EFRPSAAELLCHPHLQP 232 (582)
Q Consensus 216 ~~RpSa~EiL~hp~f~~ 232 (582)
.+|||+.|+|.||||..
T Consensus 443 ~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 443 HLRPGAAELLALPLFSA 459 (501)
T ss_pred ccCcCHHHHhhChhhhc
Confidence 99999999999999975
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=292.97 Aligned_cols=226 Identities=28% Similarity=0.539 Sum_probs=187.9
Q ss_pred CEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++.... ........+.+|+++++.++|+||+++++++... ...|+||||+. ++|.+++.... ..+++..+.
T Consensus 48 ~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~ 124 (313)
T cd06633 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIA 124 (313)
T ss_pred EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHH
Confidence 37889886543 3334556788999999999999999999988765 58899999995 67888877643 368999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.... ......|+..|+|||++. ...++.++
T Consensus 125 ~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~s 201 (313)
T cd06633 125 AITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKV 201 (313)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchh
Confidence 999999999999999999999999999999999999999999986432 234568899999999984 35578899
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|+|++|.+||...+.......+....... ....++..+++||.+||+.+|.+||++.+++.||||+.
T Consensus 202 Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999998877655555554332222 23457889999999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=284.55 Aligned_cols=214 Identities=19% Similarity=0.268 Sum_probs=175.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+++|.+..... ....+.+|+.+|++++||||+++++.+.. ...|+||||+.+++|.+++..... .+++..+..+
T Consensus 33 v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 106 (259)
T cd05037 33 VVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDV 106 (259)
T ss_pred eeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHH
Confidence 45555443222 15778999999999999999999998876 467899999999999999987543 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCC-------CeEEeecccchhcccccccCcccCCCCCCCcccccCC--CC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI--PY 152 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-------~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~--~y 152 (582)
+.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .....++..|+|||++.+. .+
T Consensus 107 ~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 183 (259)
T cd05037 107 AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASL 183 (259)
T ss_pred HHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCc
Confidence 99999999999999999999999999999888 799999999986543 3345677889999999876 78
Q ss_pred CCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 153 GSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+.++|||||||++|+|++ |..||...+........... ...+......+.++|.+||..+|.+||++.++++
T Consensus 184 ~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 184 TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 899999999999999998 68888776544433333322 2223333489999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=284.94 Aligned_cols=226 Identities=18% Similarity=0.333 Sum_probs=190.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhC----CCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKAN----GVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~----~~~ 72 (582)
||||.+..........+.+.+|+++|++++||||+++++++.... ...+++++|+.+|+|.+++.... ...
T Consensus 30 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 109 (273)
T cd05074 30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT 109 (273)
T ss_pred EEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCC
Confidence 789999877666667788999999999999999999999876432 13478999999999998875421 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~ 149 (582)
+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...... ......+++.|++||.+..
T Consensus 110 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05074 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD 189 (273)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc
Confidence 7899999999999999999999999999999999999999999999999998654322 1223345678999999998
Q ss_pred CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
..++.++|||||||++|+|++ |.+||.+.+...+...+........+..++..+.+++.+||..+|+.||++.+++.+
T Consensus 190 ~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 190 NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999998 899999888877777776555444556688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.37 Aligned_cols=227 Identities=28% Similarity=0.437 Sum_probs=186.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+.++++++||||++++++|...+...|+||||+ +++|.++++.. .+++..+..+
T Consensus 38 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~ 113 (328)
T cd07856 38 VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYF 113 (328)
T ss_pred EEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHH
Confidence 7899887655444556778899999999999999999999877667899999999 67899888753 5889999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDIWS 160 (582)
+.||+.||.|||+.||+||||+|.|||++.++.++|+|||++..... ......+++.|+|||.+.+ ..++.++||||
T Consensus 114 ~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 191 (328)
T cd07856 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWS 191 (328)
T ss_pred HHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHH
Confidence 99999999999999999999999999999999999999999875432 2345678899999998765 56889999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhcc-------------------------CCCC-----CccccHHHHHHHHHh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSI-------------------------VAPL-----PTVYSGAFRGLVKSM 210 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~-------------------------~~~l-----p~~~S~~l~~LI~km 210 (582)
|||++|+|++|.+||...+.......+.... ..+. ...++..++++|.+|
T Consensus 192 lG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 271 (328)
T cd07856 192 AGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKM 271 (328)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHH
Confidence 9999999999999998766433222111100 0011 124678999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCCchhh
Q 007991 211 LRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
|+.+|++||++++++.||||+.+.
T Consensus 272 l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 272 LVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred cCCChhhCCCHHHHhcCCcccccc
Confidence 999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=290.37 Aligned_cols=223 Identities=22% Similarity=0.373 Sum_probs=184.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC----------CC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------GV 71 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------~~ 71 (582)
||||+++... ....+..+.+|+++|++++|+||+++++.+... ...|+||||+.+++|.+++.... ..
T Consensus 47 vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 47 VAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred EEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 7899887643 355667899999999999999999999987654 58899999999999999996532 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCccccc
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLA 148 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~ 148 (582)
.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....... ......++..|+|||.+.
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 36889999999999999999999999999999999999999999999999997654322 122334567899999998
Q ss_pred CCCCCCCCcccchhHHHHhHhc--CCccccccCHHHHHHHHhh-------ccCCCCCccccHHHHHHHHHhccCCCCCCC
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSA--QKAAFKAFDMQALINKINK-------SIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELlt--G~~PF~~~~~~~l~~kI~~-------~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
+..++.++|||||||++|+|++ |..||......+....+.. ......+..+++.+.+||.+||..||++||
T Consensus 205 ~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 284 (295)
T cd05097 205 LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP 284 (295)
T ss_pred cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 8889999999999999999987 6788887776665554422 111223556789999999999999999999
Q ss_pred CHHHHHc
Q 007991 220 SAAELLC 226 (582)
Q Consensus 220 Sa~EiL~ 226 (582)
++++|++
T Consensus 285 s~~~i~~ 291 (295)
T cd05097 285 TFNKIHH 291 (295)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=284.80 Aligned_cols=222 Identities=19% Similarity=0.359 Sum_probs=177.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC---CCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---GVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~---~~~lse~~~ 78 (582)
||+|+++..... .....+.+|+.++++++||||+++++.+.+. ..+|+||||+.+|+|.+++.... ....++..+
T Consensus 25 ~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 102 (269)
T cd05087 25 VVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102 (269)
T ss_pred EEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHH
Confidence 688888765543 3345788899999999999999999977654 57899999999999999997532 234677888
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCC-----
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADI----- 150 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~----- 150 (582)
..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++....... .....|+..|+|||++.+.
T Consensus 103 ~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (269)
T cd05087 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLL 182 (269)
T ss_pred HHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccccc
Confidence 89999999999999999999999999999999999999999999875443321 2235678899999998642
Q ss_pred --CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCC-----CCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 151 --PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA-----PLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 151 --~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~-----~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
.++.++|||||||++|+|++ |..||......+........... .+....+..+.+++..|+ .+|++|||++
T Consensus 183 ~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~ 261 (269)
T cd05087 183 VVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAE 261 (269)
T ss_pred ccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence 35789999999999999996 99999877766554433222211 123346889999999998 6899999999
Q ss_pred HHHc
Q 007991 223 ELLC 226 (582)
Q Consensus 223 EiL~ 226 (582)
||+.
T Consensus 262 ~l~~ 265 (269)
T cd05087 262 EVHL 265 (269)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.05 Aligned_cols=232 Identities=27% Similarity=0.495 Sum_probs=190.2
Q ss_pred EEEEEecccccC--HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQT--DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~--~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||.++..... ....+.+.+|++++.++ +||||+++++.+.. +..+|+||||+.|++|.+++.... .+++..+
T Consensus 31 ~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~ 107 (288)
T cd05583 31 YAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTKLHLILDYVNGGELFTHLYQRE--HFTESEV 107 (288)
T ss_pred EEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCEEEEEEecCCCCcHHHHHhhcC--CcCHHHH
Confidence 788888754332 23456788999999999 59999999988755 458999999999999999998643 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCC--CCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIP--YGS 154 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~--y~~ 154 (582)
+.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++........ ....+|+..|++||.+.+.. ++.
T Consensus 108 ~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 187 (288)
T cd05583 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDK 187 (288)
T ss_pred HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcc
Confidence 99999999999999999999999999999999999999999999876543321 23457899999999987654 678
Q ss_pred CCcccchhHHHHhHhcCCccccccC----HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC---HHHHHcC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS---AAELLCH 227 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~----~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS---a~EiL~h 227 (582)
++||||||+++|+|++|..||...+ ...+...+.. ...+.+..++..+.++|.+||+.||++||| +.++|+|
T Consensus 188 ~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 188 AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred hhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999999999999999999996433 2222333322 234567778999999999999999999998 5788999
Q ss_pred CCCchhhhhh
Q 007991 228 PHLQPYVLGI 237 (582)
Q Consensus 228 p~f~~~~~~~ 237 (582)
|||+.+.+..
T Consensus 267 ~~~~~~~~~~ 276 (288)
T cd05583 267 PFFQGIDWDD 276 (288)
T ss_pred cccccCCHHH
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.97 Aligned_cols=226 Identities=19% Similarity=0.395 Sum_probs=186.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC---------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG--------- 70 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~--------- 70 (582)
.||||.++..... .....+.+|+.+|.++ +|+||+++++++...+..+|+|||||++|+|.+++....+
T Consensus 39 ~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~ 117 (343)
T cd05103 39 TVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKD 117 (343)
T ss_pred eEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccc
Confidence 3899999765433 3446788999999999 6899999999888777789999999999999999875321
Q ss_pred --------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 007991 71 --------------------------------------------------------VHFPEEKLCKWLVQLLMALNYLHA 94 (582)
Q Consensus 71 --------------------------------------------------------~~lse~~~~~il~QLL~aL~yLHs 94 (582)
..+++..+..++.||+.||.|||+
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 197 (343)
T cd05103 118 ARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS 197 (343)
T ss_pred cccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh
Confidence 236788899999999999999999
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA- 170 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt- 170 (582)
+||+||||||+|||++.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 198 ~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 277 (343)
T cd05103 198 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277 (343)
T ss_pred CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999999999999997653321 1222345678999999988889999999999999999996
Q ss_pred CCccccccCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 171 QKAAFKAFDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 171 G~~PF~~~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|..||...... .....+........+..+++.+.+++..||+.||++||++.||++|
T Consensus 278 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 278 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999775433 3333344444445566688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=319.70 Aligned_cols=202 Identities=27% Similarity=0.474 Sum_probs=175.9
Q ss_pred HHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 007991 20 AHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 98 (582)
Q Consensus 20 ~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIi 98 (582)
...|+.++... +||||+++++++. ++.+.|+|||++.|+-|.+.|.... .....+..|++||+.|+.|||++|||
T Consensus 362 ~~~e~~~~~~~~~h~niv~~~~v~~-~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvv 437 (612)
T KOG0603|consen 362 NQDEIPISLLVRDHPNIVKSHDVYE-DGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVV 437 (612)
T ss_pred cccccchhhhhcCCCcceeecceec-CCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCee
Confidence 45678676666 6999999999875 5679999999999999999888753 33378888999999999999999999
Q ss_pred ecccCcccEEE-cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccc
Q 007991 99 HRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177 (582)
Q Consensus 99 HRDIKP~NILL-~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~ 177 (582)
||||||+|||+ +..|+++|+|||.++..... ..+.|-|..|.|||++....|+.++||||||++||+|++|..||..
T Consensus 438 hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 438 HRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred ecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 99999999999 68899999999999887665 4456778999999999999999999999999999999999999987
Q ss_pred cCHH-HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 178 FDMQ-ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 178 ~~~~-~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.... ++...|... ++...+|+.+++||..||+.||.+|+++.+++.||||
T Consensus 516 ~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 516 HPAGIEIHTRIQMP---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCchHHHHHhhcCC---ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 7665 455544433 3347899999999999999999999999999999999
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.33 Aligned_cols=225 Identities=27% Similarity=0.528 Sum_probs=187.5
Q ss_pred EEEEEeccc-ccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~-~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++... .......+.+.+|+++++.++|+|++++++++... ...|+||||+. |+|.+++.... ..+++..+..
T Consensus 43 ~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~ 119 (308)
T cd06634 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAA 119 (308)
T ss_pred EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHH
Confidence 788888653 23444556788999999999999999999988765 58899999996 68888776533 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc---CCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~~~y~~ksD 157 (582)
++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|++.|+|||.+. ...++.++|
T Consensus 120 ~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~D 196 (308)
T cd06634 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVD 196 (308)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---cccccCCccccCHHHHhhcccCCCCcccc
Confidence 999999999999999999999999999999999999999999876543 33567899999999974 345788999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||...+.......+...... .....++..+.+||.+||..+|++||++++++.|+|+..
T Consensus 197 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred hHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999877665554444433322 234468899999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=285.60 Aligned_cols=224 Identities=17% Similarity=0.359 Sum_probs=187.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-------CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-------VHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-------~~ls 74 (582)
|++|.+.... .....+.+.+|+++|++++|+||+++++.+.. +...|+||||+++++|.+++..... ..++
T Consensus 38 ~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~ 115 (275)
T cd05046 38 VLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115 (275)
T ss_pred EEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcceEEEEecCCCcHHHHHHhcccccccccccCCC
Confidence 6677665432 23456789999999999999999999997654 4588999999999999999986542 1589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y 152 (582)
+..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... ......++..|+|||.+.+..+
T Consensus 116 ~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 195 (275)
T cd05046 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195 (275)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCC
Confidence 99999999999999999999999999999999999999999999999987543222 2234466778999999988888
Q ss_pred CCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 153 GSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+.++|||||||++|+|++ |..||...........+.... .++.+..++..+.++|.+||+.+|.+||++.+++.+
T Consensus 196 ~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 196 STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 899999999999999998 889998777666666665332 344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=300.35 Aligned_cols=227 Identities=29% Similarity=0.443 Sum_probs=181.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-------------cEEEEEEeecCCCCHHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-------------CYVCIIIGYCEGGDMAEAIKK 67 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-------------~~l~LVmEy~~GgsL~d~Ikk 67 (582)
.||||++..... ...+.+.+|+++|++++||||+++++.+...+ ...|+||||+. ++|.+++..
T Consensus 32 ~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~ 108 (342)
T cd07854 32 RVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ 108 (342)
T ss_pred EEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc
Confidence 378998866543 34467889999999999999999998765432 36789999996 689888865
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhccccc----ccCcccCCCCCC
Q 007991 68 ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDD----LASSVVGTPSYM 142 (582)
Q Consensus 68 ~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~ 142 (582)
. .+++..++.++.||+.||+|||+.||+||||||+||+++.+ +.+||+|||++....... .....+|+..|+
T Consensus 109 ~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 185 (342)
T cd07854 109 G---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185 (342)
T ss_pred C---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccccccccc
Confidence 2 58999999999999999999999999999999999999854 568999999987653221 122346889999
Q ss_pred CcccccC-CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC----------------------C------
Q 007991 143 CPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----------------------A------ 193 (582)
Q Consensus 143 APE~l~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~----------------------~------ 193 (582)
|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+..... .
T Consensus 186 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (342)
T cd07854 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL 265 (342)
T ss_pred CHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCH
Confidence 9998754 5578899999999999999999999987665444333221110 0
Q ss_pred -CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 194 -PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 194 -~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.+...++.++.+||.+||+.||++|||++++|.||||+.+
T Consensus 266 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 266 RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0112477899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=287.75 Aligned_cols=217 Identities=22% Similarity=0.272 Sum_probs=177.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+|+|.+.... ......+.+|+.+++.++||||+++++++... ...|+|||||++++|..++.+.. ..+++..+..+
T Consensus 47 v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i 122 (274)
T cd05076 47 VVLKVLDPSH--RDIALAFFETASLMSQVSHIHLAFVHGVCVRG-SENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITV 122 (274)
T ss_pred EEEEecChHH--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-CceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 6777775532 23446788999999999999999999987755 48889999999999999987643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCC-------CeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYG 153 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-------~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~ 153 (582)
+.||+.||+|||++||+||||||+|||++.++ .+|++|||++...... ....++..|+|||.+.+ ..++
T Consensus 123 ~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~ 199 (274)
T cd05076 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLS 199 (274)
T ss_pred HHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCC
Confidence 99999999999999999999999999998654 3899999988654322 23467889999998865 5688
Q ss_pred CCCcccchhHHHHhH-hcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyEL-ltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++|||||||++||| ++|..||.+.........+.. ....+...+..+.++|.+||+.+|++||+++++|++
T Consensus 200 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 200 TAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 999999999999998 579999987765554333322 223445567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=285.92 Aligned_cols=206 Identities=20% Similarity=0.309 Sum_probs=173.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007991 15 RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 94 (582)
Q Consensus 15 ~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs 94 (582)
...+.+..|+.+|+.+.||||+++++++... ...++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~ 118 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCG-DESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED 118 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeC-CCcEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3446788899999999999999999988764 47889999999999999998743 368999999999999999999999
Q ss_pred CCceecccCcccEEEcCCCC--------eEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCCCcccchhHHH
Q 007991 95 NHILHRDVKCSNIFLTRDQD--------IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCV 165 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~--------vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDIWSLG~iL 165 (582)
+||+||||||+|||++.++. ++++|||++..... .....++..|+|||++.+ ..++.++|||||||++
T Consensus 119 ~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred CCeecCCCccceEEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999999988765 69999998865432 234578899999999976 4578999999999999
Q ss_pred HhHhcC-CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 166 YEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 166 yELltG-~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|+|++| .+||...+.......... ...++...+.++.+||.+||+.||++|||+++|++.
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 999998 577777665554433222 334566677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.60 Aligned_cols=229 Identities=27% Similarity=0.471 Sum_probs=191.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+.|||+++..... +..+++.+.+.++...+ +|+||+.+++|+.+ ..++|.||.+ +.-+..++++. ...++|..+-
T Consensus 119 iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-~dV~IcMelM-s~C~ekLlkri-k~piPE~ilG 194 (391)
T KOG0983|consen 119 IIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITN-TDVFICMELM-STCAEKLLKRI-KGPIPERILG 194 (391)
T ss_pred EEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-chHHHHHHHH-HHHHHHHHHHh-cCCchHHhhh
Confidence 4689999886554 44567778888877775 99999999999865 4678899987 34555666554 3469999999
Q ss_pred HHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC---CCCCCC
Q 007991 80 KWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD---IPYGSK 155 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~---~~y~~k 155 (582)
++.+-++.||.||.++ ||||||+||+|||+|..|+|||||||++..+..........|-+.|||||.+.- ..|+..
T Consensus 195 k~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiR 274 (391)
T KOG0983|consen 195 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIR 274 (391)
T ss_pred hhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchh
Confidence 9999999999999975 899999999999999999999999999998887776677789999999999863 358999
Q ss_pred CcccchhHHHHhHhcCCccccccC-HHHHHHHHhhccCCCCCc--cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPT--VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~-~~~l~~kI~~~~~~~lp~--~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+||||||+.++||.||..||.+.+ ..+.+.++.....+.++. .+|+.|.+|+..||++|+.+||.+.++|+|||+..
T Consensus 275 aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 275 ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 999999999999999999999843 345566666655444443 38999999999999999999999999999999975
Q ss_pred h
Q 007991 233 Y 233 (582)
Q Consensus 233 ~ 233 (582)
|
T Consensus 355 y 355 (391)
T KOG0983|consen 355 Y 355 (391)
T ss_pred c
Confidence 4
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.45 Aligned_cols=222 Identities=23% Similarity=0.405 Sum_probs=178.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++... .....+.+.+|+++|++++||||+++++++.. ++..+|+||||+.+++|.+++.... ..+++..+..
T Consensus 36 v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~ 112 (284)
T cd05081 36 VAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLL 112 (284)
T ss_pred EEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHH
Confidence 788887653 34556788999999999999999999997653 3457899999999999999997643 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc----CcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA----SSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~----~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... ....++..|+|||++.+..++.++
T Consensus 113 ~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 192 (284)
T cd05081 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVAS 192 (284)
T ss_pred HHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHH
Confidence 9999999999999999999999999999999999999999999876433211 112234469999999988899999
Q ss_pred cccchhHHHHhHhcCCccccccCHH----------------HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQ----------------ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~----------------~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
|||||||++|||++|..++...... .+.+.+......+.+..++..+.+||.+||..+|++|||
T Consensus 193 Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 272 (284)
T cd05081 193 DVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272 (284)
T ss_pred HHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999999999987665432211 111222223333455678899999999999999999999
Q ss_pred HHHHHc
Q 007991 221 AAELLC 226 (582)
Q Consensus 221 a~EiL~ 226 (582)
+++|+.
T Consensus 273 ~~ei~~ 278 (284)
T cd05081 273 FSELAL 278 (284)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.39 Aligned_cols=229 Identities=27% Similarity=0.492 Sum_probs=183.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.++...... ....+.+|+.++.++. |+||+++++++... ...|+||||+ ++.|..++....+ .+++..+.
T Consensus 42 ~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~ 117 (296)
T cd06618 42 VMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFICMELM-STCLDKLLKRIQG-PIPEDILG 117 (296)
T ss_pred EEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEEeecc-CcCHHHHHHHhcC-CCCHHHHH
Confidence 37899987654333 3455667887777775 99999999987654 5899999999 4688888776443 78999999
Q ss_pred HHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCC----CCC
Q 007991 80 KWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP----YGS 154 (582)
Q Consensus 80 ~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~----y~~ 154 (582)
.++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.............++..|+|||.+.+.. ++.
T Consensus 118 ~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 197 (296)
T cd06618 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDI 197 (296)
T ss_pred HHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCcccccc
Confidence 999999999999997 599999999999999999999999999998765444344456888999999987553 788
Q ss_pred CCcccchhHHHHhHhcCCccccccCH-HHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~-~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
++|||||||++|+|++|+.||..... .+....+.......+ ...++.++.+||.+||..||.+||++++++.|+||+
T Consensus 198 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 198 RADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred chhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 99999999999999999999976432 233333333222222 234789999999999999999999999999999997
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
.+
T Consensus 278 ~~ 279 (296)
T cd06618 278 RY 279 (296)
T ss_pred cc
Confidence 64
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.07 Aligned_cols=225 Identities=33% Similarity=0.631 Sum_probs=190.5
Q ss_pred EEEEEecccc--------cCHHHHHHHHHHHHHHHh-cCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CC
Q 007991 2 YVLKKIRLAR--------QTDRARRSAHQEMELISR-VRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NG 70 (582)
Q Consensus 2 yAIKki~~~~--------~~~~~~~~~~rEi~iL~~-L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~ 70 (582)
+|+|.+.... ........+.+|+.++.+ ++|+||+++++.+..+ .+.|+||||++|++|.+++... .+
T Consensus 29 ~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l~~~~~~~ 107 (269)
T cd08528 29 LALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN-DRLYIVMDLIEGAPLGEHFNSLKEKK 107 (269)
T ss_pred eeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-CeEEEEEecCCCCcHHHHHHHHHhcc
Confidence 6888876532 223345667889998875 7999999999987654 5899999999999999988542 33
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC
Q 007991 71 VHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 71 ~~lse~~~~~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~ 149 (582)
..+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++.++|+|||++.............|+..|++||.+.+
T Consensus 108 ~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 108 QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred CCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcC
Confidence 468999999999999999999996 6899999999999999999999999999987655444556788999999999998
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCc-cccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~-~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
..++.++|+||||+++|+|++|.+||...+.......+......+.+. .++..+.++|.+||+.||++||++.|+..+
T Consensus 188 ~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 188 EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 889999999999999999999999998888777776666555554444 688999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=281.88 Aligned_cols=222 Identities=20% Similarity=0.361 Sum_probs=178.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~~~ 79 (582)
+++|.+..... ....+.+.+|+.+++.++||||+++++.+... ...|+||||+++|+|.+++.+.. ...+++..+.
T Consensus 25 ~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 102 (268)
T cd05086 25 VVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102 (268)
T ss_pred EEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCCCCcHHHHHHhhhcccccccHHHHH
Confidence 45666654332 34567899999999999999999999987654 58899999999999999998642 2346778889
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC-------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD------- 149 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~------- 149 (582)
.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... .....+|+..|+|||++..
T Consensus 103 ~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 182 (268)
T cd05086 103 RMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLIT 182 (268)
T ss_pred HHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcccc
Confidence 999999999999999999999999999999999999999999986432221 2235678899999998753
Q ss_pred CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccC-----CCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIV-----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~-----~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
..++.++|||||||++|||++ |..||...+..+.+..+..... ..++..+++.+.+++..|| .+|++||++++
T Consensus 183 ~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 183 AEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence 235678999999999999986 6889987777666665433321 2234558899999999999 68999999999
Q ss_pred HHc
Q 007991 224 LLC 226 (582)
Q Consensus 224 iL~ 226 (582)
|++
T Consensus 262 i~~ 264 (268)
T cd05086 262 VHR 264 (268)
T ss_pred HHH
Confidence 976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=272.30 Aligned_cols=225 Identities=35% Similarity=0.620 Sum_probs=195.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+........ .+.+.+|++++++++|+||+++++.+... ...++++||+.+++|.+++.... .+++..+..+
T Consensus 17 ~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~ 92 (244)
T smart00220 17 VAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLKKRG--RLSEDEARFY 92 (244)
T ss_pred EEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHHhcc--CCCHHHHHHH
Confidence 78898876554332 57899999999999999999999987654 58899999999999999998754 3899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.+++.+|.|||+.|++|+||+|.||+++.++.++|+|||++.............++..|++||.+....++.++|||+|
T Consensus 93 ~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~sl 172 (244)
T smart00220 93 ARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSL 172 (244)
T ss_pred HHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHH
Confidence 99999999999999999999999999999999999999999988766555667788999999999998889999999999
Q ss_pred hHHHHhHhcCCccccc-cCHHHHHHHHhhccCCCCCcc--ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 162 GCCVYEMSAQKAAFKA-FDMQALINKINKSIVAPLPTV--YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 162 G~iLyELltG~~PF~~-~~~~~l~~kI~~~~~~~lp~~--~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|+++|+|++|..||.. .+...+...+........... ++..+.+++.+||..+|++||++.++++||||
T Consensus 173 G~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 173 GVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999987 566666655554443332222 88999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=318.73 Aligned_cols=223 Identities=23% Similarity=0.433 Sum_probs=201.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--------CCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--------GVH 72 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--------~~~ 72 (582)
+||||.++.... ...+..|+||+++|..|+|||||++++++.+++ -+|+|+||+..|||.++|+... +..
T Consensus 518 lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~ 595 (774)
T KOG1026|consen 518 LVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGD-PLCMVFEYMDHGDLHEFLRARSPKADKLASGQD 595 (774)
T ss_pred ehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-eeEEEEEecccccHHHHHHhhCCccccccCCCC
Confidence 589999987644 456789999999999999999999999987654 8899999999999999997642 233
Q ss_pred ----CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcc---cCCCCCCCcc
Q 007991 73 ----FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV---VGTPSYMCPE 145 (582)
Q Consensus 73 ----lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~---vGTp~Y~APE 145 (582)
++..+...|+.||+.|++||-++.+|||||-..|+||..+-.|||+||||++..-+.++.... .-...|||||
T Consensus 596 ~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE 675 (774)
T KOG1026|consen 596 TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE 675 (774)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence 889999999999999999999999999999999999999999999999999987766544322 2235899999
Q ss_pred cccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 146 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 146 ~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
.+...+|+.++||||+||+|||+++ |+.||.+...++.++.|..+...+.|+.++.++.+|+..||+.+|.+||++.||
T Consensus 676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 9999999999999999999999987 899999999999999999999999999999999999999999999999999998
Q ss_pred H
Q 007991 225 L 225 (582)
Q Consensus 225 L 225 (582)
-
T Consensus 756 ~ 756 (774)
T KOG1026|consen 756 H 756 (774)
T ss_pred H
Confidence 4
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.35 Aligned_cols=222 Identities=18% Similarity=0.337 Sum_probs=187.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ......+.+|+.+++.++||||+++++.+... ..++++||+.+|+|.+++.... ..+++..+..+
T Consensus 39 vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~ 114 (303)
T cd05110 39 VAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNW 114 (303)
T ss_pred EEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHH
Confidence 57777765433 34445688999999999999999999987643 4679999999999999998743 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||
T Consensus 115 ~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di 194 (303)
T cd05110 115 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV 194 (303)
T ss_pred HHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHH
Confidence 99999999999999999999999999999999999999999986543221 223445778999999998889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|||++ |..||.+.........+......+.+..++..+.+++..||..+|++||+++++++.
T Consensus 195 wslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 195 WSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999987 899998887777666666655555667788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=319.03 Aligned_cols=121 Identities=30% Similarity=0.544 Sum_probs=108.2
Q ss_pred CEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++... ........+.+|+.++..++|+||+++++.+.. +.++||||||+.|++|.+++...+ .+++..++
T Consensus 31 ~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~ 107 (669)
T cd05610 31 LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAV 107 (669)
T ss_pred EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHH
Confidence 38999997644 344566789999999999999999999987755 458999999999999999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccch
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.|+.||+.||+|||.+||+||||||+||||+.++.+||+|||+++
T Consensus 108 ~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 108 KYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=280.87 Aligned_cols=224 Identities=23% Similarity=0.400 Sum_probs=184.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.++..... ...+.+.+|+++++.+.|+||+++++++... +.+.|+||||+.+++|.+++.... ..+++..+.
T Consensus 35 ~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~ 112 (284)
T cd05038 35 QVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLL 112 (284)
T ss_pred EEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHH
Confidence 3789998765554 4567899999999999999999999876542 457899999999999999998743 258999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ .....++..|++||.+.+..++.+
T Consensus 113 ~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~ 192 (284)
T cd05038 113 LFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSA 192 (284)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcc
Confidence 9999999999999999999999999999999999999999999987653211 112344567999999988889999
Q ss_pred CcccchhHHHHhHhcCCccccccCH---------------HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~---------------~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
+|||||||++|+|++|..||..... ..+...+......+.+..++.++.+|+.+||+.+|++||+
T Consensus 193 ~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 272 (284)
T cd05038 193 SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS 272 (284)
T ss_pred cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCC
Confidence 9999999999999999998865322 2223333344444456677899999999999999999999
Q ss_pred HHHHHc
Q 007991 221 AAELLC 226 (582)
Q Consensus 221 a~EiL~ 226 (582)
+.|++.
T Consensus 273 ~~ei~~ 278 (284)
T cd05038 273 FADLIL 278 (284)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=310.02 Aligned_cols=222 Identities=23% Similarity=0.447 Sum_probs=192.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++...-++...+.|+.|+.+|++-+|.||+-+.+++...+ + .||+-+|+|.+|+.+|.... ..|...+.+.|
T Consensus 417 VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idI 493 (678)
T KOG0193|consen 417 VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDI 493 (678)
T ss_pred eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-e-eeeehhccCchhhhhccchh-hhhhHHHHHHH
Confidence 899999999999999999999999999999999999999876654 4 89999999999999997643 47999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc---ccccCcccCCCCCCCcccccC---CCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPELLAD---IPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~---~~~~~~~vGTp~Y~APE~l~~---~~y~~k 155 (582)
+.||+.|+.|||.++|||||||..||||.+++.|||+||||+..-.. ........|...|||||++.. .+|+..
T Consensus 494 AqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~q 573 (678)
T KOG0193|consen 494 AQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQ 573 (678)
T ss_pred HHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcc
Confidence 99999999999999999999999999999999999999999865321 122344567789999999864 468999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----CCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+||||||||+|||++|..||.....+.++..+..++..+ ....++.++++|+..||.+++++||.+.+||.
T Consensus 574 SDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 574 SDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999999777777666665554332 23446789999999999999999999999986
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.31 Aligned_cols=224 Identities=20% Similarity=0.377 Sum_probs=186.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||+++.... ....+.+.+|+++|.++. |||||++++++... ..+|+|||||.+|+|.+++.+...
T Consensus 70 vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (401)
T cd05107 70 VAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKN 147 (401)
T ss_pred EEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-CCcEEEEeccCCCcHHHHHHhccccchhhhcccc
Confidence 79999976543 334457889999999998 99999999988765 478999999999999999975321
Q ss_pred --------------------------------------------------------------------------------
Q 007991 71 -------------------------------------------------------------------------------- 70 (582)
Q Consensus 71 -------------------------------------------------------------------------------- 70 (582)
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (401)
T cd05107 148 RDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRD 227 (401)
T ss_pred cccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchh
Confidence
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCC
Q 007991 71 ------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSY 141 (582)
Q Consensus 71 ------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y 141 (582)
..+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...... .....+++..|
T Consensus 228 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y 307 (401)
T cd05107 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307 (401)
T ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCce
Confidence 236778889999999999999999999999999999999999999999999997653321 12334678899
Q ss_pred CCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHH-HHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC
Q 007991 142 MCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 142 ~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l-~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
+|||.+.+..++.++|||||||++|||++ |..||......+. ...+........+..++.++.+||.+||..+|..||
T Consensus 308 ~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP 387 (401)
T cd05107 308 MAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP 387 (401)
T ss_pred eChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc
Confidence 99999998889999999999999999998 8999987654443 344444444556777899999999999999999999
Q ss_pred CHHHHHcC
Q 007991 220 SAAELLCH 227 (582)
Q Consensus 220 Sa~EiL~h 227 (582)
++++|++.
T Consensus 388 s~~ell~~ 395 (401)
T cd05107 388 DFSQLVHL 395 (401)
T ss_pred CHHHHHHH
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.84 Aligned_cols=223 Identities=19% Similarity=0.384 Sum_probs=199.0
Q ss_pred EEEEEecc-cccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~-~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||..+. .......+..+.+|+++|++++|||||++||+...+ .-+|||||+|.||+|.+++++.++ .++..+...
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~ 266 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLR 266 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHH
Confidence 79999987 447778889999999999999999999999987755 478999999999999999999654 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCccc-CCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVV-GTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~v-GTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++++.+.||+|||++++|||||-..|+|++.++.+||+|||+++...........+ -...|+|||.+...-|+.++|||
T Consensus 267 ~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~ 346 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVW 346 (474)
T ss_pred HHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchh
Confidence 99999999999999999999999999999999999999999987664322222222 33579999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHH-hhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++||+++ |..||.+....++..+| ......+.+...+.++..++..|+..+|+.|+++.++.+
T Consensus 347 sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 347 SFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred heeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999999988 78899999999999999 667777888889999999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=295.37 Aligned_cols=224 Identities=27% Similarity=0.420 Sum_probs=179.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++....... .+.|.+|+.+|.+++|||+|+++++|.+.+...+||+||+..|+|.+++....+..++|....+
T Consensus 101 ~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~k 178 (361)
T KOG1187|consen 101 VVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLK 178 (361)
T ss_pred EEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHH
Confidence 37999887755543 3349999999999999999999998876654588999999999999999875433789999999
Q ss_pred HHHHHHHHHHHHHHCC---ceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcc-cCCCCCCCcccccCCCCCCC
Q 007991 81 WLVQLLMALNYLHANH---ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSV-VGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 81 il~QLL~aL~yLHs~g---IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~-vGTp~Y~APE~l~~~~y~~k 155 (582)
|+.+++.||+|||... |||||||++|||||.+.+.||+|||+|+.... .....+. .||.+|++||.+.....+.+
T Consensus 179 Ia~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~K 258 (361)
T KOG1187|consen 179 IALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEK 258 (361)
T ss_pred HHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcc
Confidence 9999999999999864 99999999999999999999999999976654 3333333 89999999999988889999
Q ss_pred CcccchhHHHHhHhcCCccccccC---HHHHHHH----H-----hhccCCCCC-cccc-----HHHHHHHHHhccCCCCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFD---MQALINK----I-----NKSIVAPLP-TVYS-----GAFRGLVKSMLRKNPEF 217 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~---~~~l~~k----I-----~~~~~~~lp-~~~S-----~~l~~LI~kmL~~dP~~ 217 (582)
+||||||++|.||++|+.+..... ...+... + .......+. ..++ ..+..+...|++.+|..
T Consensus 259 sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~ 338 (361)
T KOG1187|consen 259 SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKE 338 (361)
T ss_pred cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCc
Confidence 999999999999999998776432 1112221 1 111122222 2233 23567889999999999
Q ss_pred CCCHHHHHc
Q 007991 218 RPSAAELLC 226 (582)
Q Consensus 218 RpSa~EiL~ 226 (582)
||+..|+++
T Consensus 339 RP~m~~Vv~ 347 (361)
T KOG1187|consen 339 RPTMSQVVK 347 (361)
T ss_pred CcCHHHHHH
Confidence 999999754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=312.21 Aligned_cols=228 Identities=27% Similarity=0.520 Sum_probs=200.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.|||++...... .+.++-|.+||+.+ .|||++.+|++|.- .++.+|||||||.||+..|+++...+..+.|.
T Consensus 47 aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~ 123 (953)
T KOG0587|consen 47 AAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEE 123 (953)
T ss_pred eeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhH
Confidence 567777664433 34678899999888 59999999999883 35689999999999999999998878899999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-----
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI----- 150 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~----- 150 (582)
.+..|++.++.||.+||.+.+||||||-.|||++.++.|||+|||.+..+... ....+.+|||.|||||++...
T Consensus 124 ~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~ 203 (953)
T KOG0587|consen 124 WIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDA 203 (953)
T ss_pred HHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCC
Confidence 99999999999999999999999999999999999999999999999887654 356789999999999999754
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
.|+..+|+||||++..||..|.+|+-++.....+.+|.....+.+ |..|+.+|.+||..||.+|.+.||+..++|+||
T Consensus 204 tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 204 TYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred CcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 377899999999999999999999999998888777766554433 567999999999999999999999999999999
Q ss_pred CCch
Q 007991 229 HLQP 232 (582)
Q Consensus 229 ~f~~ 232 (582)
|+..
T Consensus 284 Fi~e 287 (953)
T KOG0587|consen 284 FITE 287 (953)
T ss_pred cccc
Confidence 9974
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=318.43 Aligned_cols=224 Identities=22% Similarity=0.293 Sum_probs=180.2
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC---------CC
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---------GV 71 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~---------~~ 71 (582)
||||+++... ..+...+.+.+|++++++++||||+++++++.. +...|+||||++|++|.+++.... ..
T Consensus 30 VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~ 108 (932)
T PRK13184 30 VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108 (932)
T ss_pred EEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhc
Confidence 7999997643 334566789999999999999999999998765 458999999999999999987421 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-------------------ccc
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-------------------DLA 132 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-------------------~~~ 132 (582)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..... ...
T Consensus 109 ~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~ 188 (932)
T PRK13184 109 KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIP 188 (932)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccC
Confidence 3566778999999999999999999999999999999999999999999999765211 011
Q ss_pred CcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc--CCCCCccccHHHHHHHHHh
Q 007991 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--VAPLPTVYSGAFRGLVKSM 210 (582)
Q Consensus 133 ~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~--~~~lp~~~S~~l~~LI~km 210 (582)
...+||+.|+|||++.+..++.++|||||||++|||++|..||...+...+........ .......+++.+.+++.+|
T Consensus 189 g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rc 268 (932)
T PRK13184 189 GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKA 268 (932)
T ss_pred CCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHH
Confidence 23579999999999999999999999999999999999999998765544332211111 1111235788999999999
Q ss_pred ccCCCCCCCCHHHHHc
Q 007991 211 LRKNPEFRPSAAELLC 226 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~ 226 (582)
|..||++|++..+.|.
T Consensus 269 L~~DP~kR~ss~eeLl 284 (932)
T PRK13184 269 LAVDPAERYSSVQELK 284 (932)
T ss_pred ccCChhhCcCHHHHHH
Confidence 9999999977655554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=281.76 Aligned_cols=228 Identities=28% Similarity=0.456 Sum_probs=183.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-------cCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-------KGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-------~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||+|++-........-....+|+++|..|+|+|++.+++++.. ....+|+|+.+|+ .+|.-++... ...|+
T Consensus 45 valkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~s 122 (376)
T KOG0669|consen 45 VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFS 122 (376)
T ss_pred hHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCc-ccccc
Confidence 3444444433333334557899999999999999999987652 2246999999996 7899888763 35799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~ 149 (582)
...++.++.+++.||.|+|...|+|||+|++|+||+.+|.+||+|||+++.+.... .....+.|.||.+||.+.+
T Consensus 123 ls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG 202 (376)
T KOG0669|consen 123 LSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG 202 (376)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc
Confidence 99999999999999999999999999999999999999999999999997764322 2445678999999998775
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc------CCC---------------CCc----------
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI------VAP---------------LPT---------- 197 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~------~~~---------------lp~---------- 197 (582)
+.|+.+.|||..||+|.||.++.+.|.+......+..|.... .|| ++.
T Consensus 203 ~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~ 282 (376)
T KOG0669|consen 203 DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRL 282 (376)
T ss_pred ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhc
Confidence 569999999999999999999999999888777666554321 111 111
Q ss_pred ---cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 198 ---VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 198 ---~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.-++++.+|+.+||..||.+|+.++++|.|.||.
T Consensus 283 kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 283 KPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred ccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 1235788999999999999999999999999995
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=288.27 Aligned_cols=224 Identities=26% Similarity=0.463 Sum_probs=181.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC--C----CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN--P----FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H--p----nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
+|||+++. ....++...-||++|.+|.+ | -+|++.++| +-.++.|||+|.+ |.++.++++.++...|+.
T Consensus 117 vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dyrghiCivfell-G~S~~dFlk~N~y~~fpi 191 (415)
T KOG0671|consen 117 VALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-DYRGHICIVFELL-GLSTFDFLKENNYIPFPI 191 (415)
T ss_pred ehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hccCceEEEEecc-ChhHHHHhccCCccccch
Confidence 56666643 45667888899999999953 2 367776654 4456999999999 789999999988889999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC--------------------CCCeEEeecccchhcccccccCcc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR--------------------DQDIRLGDFGLAKMLISDDLASSV 135 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~--------------------~g~vKL~DFGla~~~~~~~~~~~~ 135 (582)
..++.|.+||+.+++|||+.+++|.||||+|||+.+ +..|||+|||.|...... ..+.
T Consensus 192 ~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~i 269 (415)
T KOG0671|consen 192 DHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTI 269 (415)
T ss_pred HHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--ccee
Confidence 999999999999999999999999999999999842 234899999999765433 4778
Q ss_pred cCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHH---HHHHHhhccCCC-----------------C
Q 007991 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---LINKINKSIVAP-----------------L 195 (582)
Q Consensus 136 vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~---l~~kI~~~~~~~-----------------l 195 (582)
+.|..|.|||++.+.+++..+||||+||||+||++|...|...+..+ +++.|.+..... +
T Consensus 270 VsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw 349 (415)
T KOG0671|consen 270 VSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDW 349 (415)
T ss_pred eeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccC
Confidence 99999999999999999999999999999999999999998766443 444443311000 0
Q ss_pred Ccc-------------------------ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 196 PTV-------------------------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 196 p~~-------------------------~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+.. .-..+.+||++||.+||.+|+|+.|+|.||||..
T Consensus 350 ~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 350 PEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred ccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 110 0125789999999999999999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=314.80 Aligned_cols=224 Identities=33% Similarity=0.602 Sum_probs=182.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec------------------------------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK------------------------------------ 45 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~------------------------------------ 45 (582)
||||+|.+.. +++.-..+.+|+.+|.+|+|||||+||..|++.
T Consensus 507 YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~ 585 (1351)
T KOG1035|consen 507 YAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSS 585 (1351)
T ss_pred hhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCC
Confidence 8999999987 677778899999999999999999999876520
Q ss_pred ----------------------------C---------------------------------------------------
Q 007991 46 ----------------------------G--------------------------------------------------- 46 (582)
Q Consensus 46 ----------------------------~--------------------------------------------------- 46 (582)
+
T Consensus 586 p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~ 665 (1351)
T KOG1035|consen 586 PSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPV 665 (1351)
T ss_pred cccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCcccccccc
Confidence 0
Q ss_pred ---cEEEEEEeecCCCCHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecc
Q 007991 47 ---CYVCIIIGYCEGGDMAEAIKKANGVHF--PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121 (582)
Q Consensus 47 ---~~l~LVmEy~~GgsL~d~Ikk~~~~~l--se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFG 121 (582)
..+||-||||+...|.++|.++. + ....++++++||++||.|+|++|||||||||.||||+.+++|||+|||
T Consensus 666 q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 666 QKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred ccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccc
Confidence 35799999999888888888753 4 478899999999999999999999999999999999999999999999
Q ss_pred cchhcc----c---------------ccccCcccCCCCCCCcccccCCC---CCCCCcccchhHHHHhHhcCCccc-ccc
Q 007991 122 LAKMLI----S---------------DDLASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAF-KAF 178 (582)
Q Consensus 122 la~~~~----~---------------~~~~~~~vGTp~Y~APE~l~~~~---y~~ksDIWSLG~iLyELltG~~PF-~~~ 178 (582)
+|+... . ....+..+||--|+|||++.+.. |+.|+|+||||++++||+.- | ..+
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM 819 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM 819 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchH
Confidence 998721 0 11234579999999999997655 99999999999999999743 4 344
Q ss_pred CHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 179 DMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 179 ~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
.....+..+..+..+.. ...--+.-..+|..||+.||.+||||.|+|++.||.+
T Consensus 820 ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 820 ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 44555555554333221 1112234567999999999999999999999999973
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=273.15 Aligned_cols=225 Identities=28% Similarity=0.411 Sum_probs=182.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHh--CCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKA--NGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~ls 74 (582)
.||+|++.... .+..+.+.+||+..++++|||+++++++.+. .....||++.|...|+|.+.|... ++..++
T Consensus 48 ~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~s 125 (302)
T KOG2345|consen 48 LYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVS 125 (302)
T ss_pred chhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccC
Confidence 48999998765 4667889999999999999999999887652 234699999999999999999753 456899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCC--ceecccCcccEEEcCCCCeEEeecccchhcccccc----------cCcccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----------ASSVVGTPSYM 142 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----------~~~~vGTp~Y~ 142 (582)
|.++..|+.+|+.||++||+.. ++||||||.|||+...+.++|.|||.+....-.-. -.....|..|+
T Consensus 126 E~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyR 205 (302)
T KOG2345|consen 126 EAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYR 205 (302)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCccc
Confidence 9999999999999999999999 99999999999999999999999998865432110 11245788999
Q ss_pred CcccccCC---CCCCCCcccchhHHHHhHhcCCccccccCHHH--HHHHH-hhccCCCCCccccHHHHHHHHHhccCCCC
Q 007991 143 CPELLADI---PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA--LINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPE 216 (582)
Q Consensus 143 APE~l~~~---~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~--l~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP~ 216 (582)
|||++.-. ..+.++|||||||++|.|+.|..||.-.-... +.-.+ +..+..|-...+|+.+.+||+.||+.||.
T Consensus 206 APELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~ 285 (302)
T KOG2345|consen 206 APELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPN 285 (302)
T ss_pred CchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcc
Confidence 99998654 46789999999999999999999996321100 00001 12333444556999999999999999999
Q ss_pred CCCCHHHHHcC
Q 007991 217 FRPSAAELLCH 227 (582)
Q Consensus 217 ~RpSa~EiL~h 227 (582)
+||++.+++.+
T Consensus 286 qRP~i~~ll~~ 296 (302)
T KOG2345|consen 286 QRPTIPELLSK 296 (302)
T ss_pred cCCCHHHHHHH
Confidence 99999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=309.36 Aligned_cols=223 Identities=22% Similarity=0.383 Sum_probs=195.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh-----CCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA-----NGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~-----~~~~lse~ 76 (582)
||||.++.... ......|.+|..+|+.++|||||+++++++.. ...+|++||++||+|..+|++. ....+...
T Consensus 725 vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~ 802 (1025)
T KOG1095|consen 725 VAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMR 802 (1025)
T ss_pred EEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHH
Confidence 78888877543 45667899999999999999999999999984 4778999999999999999985 13468999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc-cCcccCC--CCCCCcccccCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGT--PSYMCPELLADIPYG 153 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-~~~~vGT--p~Y~APE~l~~~~y~ 153 (582)
.+..++.||+.|++||+++++|||||...|+||+....|||+|||||+.+...++ .....+. ..|||||.+....++
T Consensus 803 dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt 882 (1025)
T KOG1095|consen 803 DLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT 882 (1025)
T ss_pred HHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccc
Confidence 9999999999999999999999999999999999999999999999996543332 2222233 379999999999999
Q ss_pred CCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 154 SKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 154 ~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.++|||||||+|||+++ |..||.+.+..+++.....+-.-+.|..+++.+.+|+..||+-+|++||++..|++
T Consensus 883 skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 883 SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999988 89999999999988866555577789999999999999999999999999999987
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=293.46 Aligned_cols=221 Identities=24% Similarity=0.425 Sum_probs=200.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.-+..+..+. .+.|.+|+-+|+.++|||||++++++.+. -.+||||.+.-|.|.++++.+. ..++......|
T Consensus 421 VAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e~--P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly 496 (974)
T KOG4257|consen 421 VAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLY 496 (974)
T ss_pred eeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeecc--ceeEEEecccchhHHHHHHhcc-ccchHHHHHHH
Confidence 78888877655444 88999999999999999999999998754 6889999999999999999854 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCC--CCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP--SYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp--~Y~APE~l~~~~y~~ksDIW 159 (582)
++||..||.|||+..+|||||-..|||+.....|||+|||+++.+..+.......|.. -|||||-++-++++.++|||
T Consensus 497 ~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVW 576 (974)
T KOG4257|consen 497 CYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVW 576 (974)
T ss_pred HHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHH
Confidence 9999999999999999999999999999999999999999999988776665555654 59999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.|||||||++. |..||.+....+.+..|.++...|.|..+++.+..|+.+||.++|.+||.+.+|..
T Consensus 577 MFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 577 MFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999765 89999999988999999999999999999999999999999999999999988854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=290.30 Aligned_cols=225 Identities=23% Similarity=0.403 Sum_probs=185.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC------CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-CCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN------PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-GVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H------pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~ls 74 (582)
||||+|+.+ +-..+.-.+|++||++|+. -|+++|+-.|... +++|||+|-+ ..+|.+++++.+ +..|.
T Consensus 460 vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-nHLClVFE~L-slNLRevLKKyG~nvGL~ 534 (752)
T KOG0670|consen 460 VAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK-NHLCLVFEPL-SLNLREVLKKYGRNVGLH 534 (752)
T ss_pred eEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-ceeEEEehhh-hchHHHHHHHhCccccee
Confidence 899999764 3345567899999999963 4899999988765 4999999999 589999999864 45688
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
...++.|+.||+.||..|...||+|.||||.|||++... .+||||||.|....... ...|..+..|.|||++.+.+|+
T Consensus 535 ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd 613 (752)
T KOG0670|consen 535 IKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYD 613 (752)
T ss_pred ehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCccc
Confidence 899999999999999999999999999999999999874 59999999998776554 4556777899999999999999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---------------------------------------
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--------------------------------------- 194 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--------------------------------------- 194 (582)
...|+||+||+||||++|+..|.+.....++..........
T Consensus 614 ~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~ 693 (752)
T KOG0670|consen 614 YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMV 693 (752)
T ss_pred CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEec
Confidence 99999999999999999999999887655544332211000
Q ss_pred --CC---------------c---cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 195 --LP---------------T---VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 195 --lp---------------~---~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
-| . .+=..|++||.+||..||++|.|+.++|.||||+.
T Consensus 694 ~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 694 NVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred ccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00 0 01136889999999999999999999999999963
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=264.07 Aligned_cols=226 Identities=26% Similarity=0.432 Sum_probs=185.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+|||.++... .+.+.||+.||..|. |||||.++++..+.. ....+|+||+++.+...+... ++.-.++
T Consensus 66 ~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIr 135 (338)
T KOG0668|consen 66 CVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIR 135 (338)
T ss_pred EEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHH
Confidence 6788886643 367899999999997 999999999876543 345689999999888877764 7788999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccccccCcccCCCCCCCcccccCCC-CCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP-YGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~-y~~ksD 157 (582)
.+++|||.||.|||++||+|||+||.|++||.. ..++|+|+|+|.+..........+.+..|.-||++-+.+ |+...|
T Consensus 136 yY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD 215 (338)
T KOG0668|consen 136 YYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLD 215 (338)
T ss_pred HHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHH
Confidence 999999999999999999999999999999976 469999999999887777777788899999999997755 899999
Q ss_pred ccchhHHHHhHhcCCccc-cccCHHHHHHHHhhccCCC------------------------------------CCcccc
Q 007991 158 IWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIVAP------------------------------------LPTVYS 200 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF-~~~~~~~l~~kI~~~~~~~------------------------------------lp~~~S 200 (582)
+|||||+++.|+..+-|| .+.+..+++-+|.+.++.. ....++
T Consensus 216 ~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~ 295 (338)
T KOG0668|consen 216 MWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVS 295 (338)
T ss_pred HHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCC
Confidence 999999999998876665 6666555444443211110 011257
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhh
Q 007991 201 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 201 ~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~ 237 (582)
+++.+||.++|..|-.+|+||.|++.||||.+.....
T Consensus 296 peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 296 PEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred hHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 8999999999999999999999999999998765443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=270.33 Aligned_cols=200 Identities=19% Similarity=0.239 Sum_probs=160.4
Q ss_pred HHHHHHHhcCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 007991 22 QEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 98 (582)
Q Consensus 22 rEi~iL~~L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIi 98 (582)
+++..+..+.|++|+++++.+.... .+.++++|++ +.++.+.+.... .+++..+..++.|++.||+|||+.||+
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ii 148 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGIS 148 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4455667789999999998765433 2557888888 467777776542 468999999999999999999999999
Q ss_pred ecccCcccEEEcCCCCeEEeecccchhccccc--------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhc
Q 007991 99 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170 (582)
Q Consensus 99 HRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt 170 (582)
||||||+|||++.++.++|+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 149 HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 149 HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999997653221 1233579999999999999999999999999999999999
Q ss_pred CCccccccCH-HH--------HHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 171 QKAAFKAFDM-QA--------LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 171 G~~PF~~~~~-~~--------l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|.+||.+... .. .+..+..... .....+..+.++++.|+..+|++||++++|++
T Consensus 229 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 229 IKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CCCCCCccccchHHHHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999987732 22 1222222111 23346889999999999999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=270.21 Aligned_cols=232 Identities=26% Similarity=0.422 Sum_probs=188.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHH-HHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHH---hCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK---ANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~i-L~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk---~~~~~lse~ 76 (582)
+.|||+|+.... +...+++..|.++ |+.=++||||++|++.+.++ -.||.||.+ ..+|..+.+. .....++|+
T Consensus 91 ~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~ 167 (361)
T KOG1006|consen 91 LMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-DCWICMELM-DISLDKLYKRVYSVQKSRIPEN 167 (361)
T ss_pred EEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHh
Confidence 369999998776 4445667778876 45557899999999988765 577999999 4777665542 234479999
Q ss_pred HHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC--CCCC
Q 007991 77 KLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--IPYG 153 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~--~~y~ 153 (582)
.+-.+..-.+.||+||... +|||||+||+||||+..|.|||||||++..+....-.+...|-..|||||.+.. ..|+
T Consensus 168 Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyD 247 (361)
T KOG1006|consen 168 ILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYD 247 (361)
T ss_pred hhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcc
Confidence 9999999999999999976 899999999999999999999999999998877665566789999999999863 3599
Q ss_pred CCCcccchhHHHHhHhcCCccccccCH-HHHHHHHhhccCCCC--C---ccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPL--P---TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~-~~l~~kI~~~~~~~l--p---~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++|+||||++|||+.+|+.|+...+. .+++..+..+..+.+ + ..++..+..+|.-||.+|-..||.+.+++.+
T Consensus 248 iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 248 IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 999999999999999999999987653 333444433332222 1 2378999999999999999999999999999
Q ss_pred CCCchhhh
Q 007991 228 PHLQPYVL 235 (582)
Q Consensus 228 p~f~~~~~ 235 (582)
||.+-|..
T Consensus 328 ~fyr~y~~ 335 (361)
T KOG1006|consen 328 PFYRMYAV 335 (361)
T ss_pred chhhhhhh
Confidence 99987653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=286.24 Aligned_cols=223 Identities=18% Similarity=0.352 Sum_probs=199.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++....+. ....|.+|+.+|.+|+|+|+|+||++..+ ..+.+|||.|.+|+|.+.+.+.....|....++.|
T Consensus 141 VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdy 217 (1039)
T KOG0199|consen 141 VAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDY 217 (1039)
T ss_pred EEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhcccchHHHHHhhccccceeHHHHHHH
Confidence 8999999877765 56789999999999999999999998775 46779999999999999999866668999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcc----cCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV----VGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~----vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.|+.||..+++|||||-..||||-....|||+||||.+-+...+.+..+ ---..|+|||.+..+.++.++|
T Consensus 218 a~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSD 297 (1039)
T KOG0199|consen 218 AMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASD 297 (1039)
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccch
Confidence 999999999999999999999999999999999999999999987654322222 1224699999999999999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|++||+||||++ |..||.+.....++++|.....-+-|..+++++.++++.||..+|.+||++..|...
T Consensus 298 vWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 298 VWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred hhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 9999999999988 799999999999999999888878899999999999999999999999999988644
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.78 Aligned_cols=231 Identities=27% Similarity=0.444 Sum_probs=189.7
Q ss_pred EEEEEecccccCHH-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDR-----ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~-----~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||+|+-.++..... ..+-+-||..|.+.|+||.||++|++|.-+...+|-|+|||+|.+|.-+++.+. .++|.
T Consensus 491 vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEK 568 (775)
T KOG1151|consen 491 VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEK 568 (775)
T ss_pred eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHH
Confidence 56776655443322 234567999999999999999999999988889999999999999999999865 78999
Q ss_pred HHHHHHHHHHHHHHHHHHC--CceecccCcccEEEcCC---CCeEEeecccchhccccc--------ccCcccCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHAN--HILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDD--------LASSVVGTPSYMC 143 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~--gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~A 143 (582)
.++.|+.||+.||.||... .|||-||||.||||-.. |.+||+||||++....+. ......||.||++
T Consensus 569 EARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLP 648 (775)
T KOG1151|consen 569 EARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLP 648 (775)
T ss_pred HHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecC
Confidence 9999999999999999987 59999999999999654 679999999999875432 2345789999999
Q ss_pred cccccCC----CCCCCCcccchhHHHHhHhcCCcccccc-CHHHHHHH--Hhhc--cCCCCCccccHHHHHHHHHhccCC
Q 007991 144 PELLADI----PYGSKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINK--INKS--IVAPLPTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 144 PE~l~~~----~y~~ksDIWSLG~iLyELltG~~PF~~~-~~~~l~~k--I~~~--~~~~lp~~~S~~l~~LI~kmL~~d 214 (582)
||.+.-. ..+.++||||+|||+|.++.|+.||... ...++++. |.+. ...|....++.++++||++||.+.
T Consensus 649 PEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYR 728 (775)
T KOG1151|consen 649 PECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYR 728 (775)
T ss_pred cceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhh
Confidence 9987532 2678999999999999999999999654 33333332 2222 233445679999999999999999
Q ss_pred CCCCCCHHHHHcCCCCchhh
Q 007991 215 PEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 215 P~~RpSa~EiL~hp~f~~~~ 234 (582)
-+.|..+.++-.||||.+.+
T Consensus 729 KeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 729 KEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred hhhhhhHHHHccCccccchh
Confidence 99999999999999998743
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=272.02 Aligned_cols=234 Identities=26% Similarity=0.364 Sum_probs=193.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||+|++..-.++-...+.+.+|+++|..++|.|++..+++..... ..+|+++|.+ ..+|..+|-.- ..++.+.
T Consensus 81 valkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DH 157 (449)
T KOG0664|consen 81 VALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSP--QALTPDH 157 (449)
T ss_pred hhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccC--CCCCcch
Confidence 567777666666667788999999999999999999998765432 2467888888 57888888753 3799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCC-CCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADI-PYGS 154 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~-~y~~ 154 (582)
++-+++|||.||+|||+.||+||||||.|+|++.++.+||||||+++....++ .+...+.|-.|.|||++.+. .|+.
T Consensus 158 vKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~ 237 (449)
T KOG0664|consen 158 VKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTG 237 (449)
T ss_pred hhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcC
Confidence 99999999999999999999999999999999999999999999998765433 34556788999999998875 5999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-------------------------C--------ccccH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-------------------------P--------TVYSG 201 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-------------------------p--------~~~S~ 201 (582)
++||||+|||+.||+..+..|...+..+.++.|...+..|- + ..-..
T Consensus 238 AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~h 317 (449)
T KOG0664|consen 238 AVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNH 317 (449)
T ss_pred ccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccch
Confidence 99999999999999999999999888887777766554431 0 01123
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhhh
Q 007991 202 AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 238 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~~ 238 (582)
+...++.+||.+||++|.+.++++.|+|+.......+
T Consensus 318 eav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~ 354 (449)
T KOG0664|consen 318 EAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFH 354 (449)
T ss_pred HHHHHHHHHhCCCCcccccHhhhcccccccccceeee
Confidence 6778999999999999999999999999976554444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.67 Aligned_cols=224 Identities=22% Similarity=0.372 Sum_probs=192.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||+|+++.... ...++.|.+||++|.+|+|||||.++++|+.++ -+|+|+||++.|+|.+++.++.-..+.-.....
T Consensus 564 kVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~EYmEnGDLnqFl~aheapt~~t~~~vs 641 (807)
T KOG1094|consen 564 KVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITEYMENGDLNQFLSAHELPTAETAPGVS 641 (807)
T ss_pred EEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHHHHhcCcHHHHHHhccCcccccchhHH
Confidence 589999988655 456889999999999999999999999998765 899999999999999999987443445566677
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccC---cccCCCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS---SVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~---~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
|+.||+.|++||.+.+++||||.+.|+|++.++++||+|||+++.+...+... ..+-...|||+|.+...+++.++|
T Consensus 642 i~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSD 721 (807)
T KOG1094|consen 642 ICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASD 721 (807)
T ss_pred HHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhh
Confidence 99999999999999999999999999999999999999999999876655332 234456899999999999999999
Q ss_pred ccchhHHHHhH--hcCCccccccCHHHHHHHHhhcc-------CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEM--SAQKAAFKAFDMQALINKINKSI-------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyEL--ltG~~PF~~~~~~~l~~kI~~~~-------~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+|+||++|||+ ++...||.....++..+...... ....|..++..+.+++-.||+.+-++||+++++-.
T Consensus 722 vWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 722 VWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 99999999997 55789999888887777654432 23457789999999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=289.13 Aligned_cols=223 Identities=24% Similarity=0.416 Sum_probs=201.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... +++++..|..|+.||.+++||||++|.++.. ...-+.||+||+++|+|..+|+++.|. |...++..|
T Consensus 660 VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-ks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgM 736 (996)
T KOG0196|consen 660 VAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-KSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGM 736 (996)
T ss_pred EEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-cCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHH
Confidence 8999998754 4788999999999999999999999999865 456889999999999999999998775 999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCC--CCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGT--PSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGT--p~Y~APE~l~~~~y~~ksD 157 (582)
++.|+.|++||-+.|+|||||-..|||++.+-.+|++|||+++.+.++. ...+.-|. ..|.|||.+..+.++.++|
T Consensus 737 LrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASD 816 (996)
T KOG0196|consen 737 LRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASD 816 (996)
T ss_pred HHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhh
Confidence 9999999999999999999999999999999999999999999775543 12222232 4799999999999999999
Q ss_pred ccchhHHHHhHh-cCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMS-AQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELl-tG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+||+|++|||.+ .|.-||.++..++.+..|..++.-|.|-.++..+..|+..||++|-.+||.+.+|+.+
T Consensus 817 VWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 817 VWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999954 5999999999999999999999999999999999999999999999999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=287.64 Aligned_cols=219 Identities=31% Similarity=0.493 Sum_probs=173.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHh-CCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKA-NGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~-~~~~ls 74 (582)
+||||.++... ..+.++..-+|+++|++|+|+|||+++++-.+.. ..-.+|||||.||+|...+.+- +...++
T Consensus 40 ~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLp 118 (732)
T KOG4250|consen 40 LVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLP 118 (732)
T ss_pred chhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCC
Confidence 47888887754 3456677889999999999999999998633221 2345899999999999999752 335699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC--CCC--eEEeecccchhcccccccCcccCCCCCCCccccc-C
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR--DQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-D 149 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~--~g~--vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~-~ 149 (582)
|..+..++..+..||.|||++||+||||||.||++-. +|. .||+|||.|+.+..+....+++||+.|.+||++- .
T Consensus 119 E~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q 198 (732)
T KOG4250|consen 119 ESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQ 198 (732)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhc
Confidence 9999999999999999999999999999999998743 343 8999999999998888899999999999999998 4
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHH-----HHHHHHhhc-------------------cCCCCCccccHH---
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-----ALINKINKS-------------------IVAPLPTVYSGA--- 202 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~-----~l~~kI~~~-------------------~~~~lp~~~S~~--- 202 (582)
..|+..+|.|||||++|+++||..||...... .++..+.+. ...|.|..++..
T Consensus 199 ~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~ 278 (732)
T KOG4250|consen 199 KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLAT 278 (732)
T ss_pred cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHh
Confidence 88999999999999999999999999543221 122222110 111234444443
Q ss_pred -HHHHHHHhccCCCCCCCC
Q 007991 203 -FRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 203 -l~~LI~kmL~~dP~~RpS 220 (582)
+-..+..||..+|++|..
T Consensus 279 ~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 279 RLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred hhhHHHHHHHhhhHHHhCC
Confidence 446788889999999973
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=286.97 Aligned_cols=188 Identities=23% Similarity=0.276 Sum_probs=139.0
Q ss_pred cCcEEEEEEeecCCCCHHHHHHHhCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCccc
Q 007991 45 KGCYVCIIIGYCEGGDMAEAIKKANG------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 106 (582)
Q Consensus 45 ~~~~l~LVmEy~~GgsL~d~Ikk~~~------------------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~N 106 (582)
.+..+++||||+.+++|.+++..... ....+..+..++.||+.||+|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45678999999999999999975421 112244577899999999999999999999999999
Q ss_pred EEEcC-CCCeEEeecccchhcccc--cccCcccCCCCCCCcccccCC----------------------CCCCCCcccch
Q 007991 107 IFLTR-DQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELLADI----------------------PYGSKSDIWSL 161 (582)
Q Consensus 107 ILL~~-~g~vKL~DFGla~~~~~~--~~~~~~vGTp~Y~APE~l~~~----------------------~y~~ksDIWSL 161 (582)
||++. ++.+||+|||+++.+... .....++|++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 578999999999865432 234567899999999976432 23456799999
Q ss_pred hHHHHhHhcCCccccccCHHHHHHHHhhcc----------CC----------CCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 162 GCCVYEMSAQKAAFKAFDMQALINKINKSI----------VA----------PLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 162 G~iLyELltG~~PF~~~~~~~l~~kI~~~~----------~~----------~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
||++|||+++..++... ...+...+.... .. .+....+...++||.+||++||++|||+
T Consensus 366 GviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 99999999877664422 111111111100 00 0011123456699999999999999999
Q ss_pred HHHHcCCCCchh
Q 007991 222 AELLCHPHLQPY 233 (582)
Q Consensus 222 ~EiL~hp~f~~~ 233 (582)
+++|+||||+..
T Consensus 445 ~e~L~Hpff~~~ 456 (566)
T PLN03225 445 KAALAHPYFDRE 456 (566)
T ss_pred HHHhCCcCcCCC
Confidence 999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=277.50 Aligned_cols=220 Identities=20% Similarity=0.375 Sum_probs=195.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++-.. ...+.|..|+.+|+.|+|||+|+++++|..+. -+|||+||+..|+|.+++++.+...++.-.+.+|
T Consensus 295 vAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyM 370 (1157)
T KOG4278|consen 295 VAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYM 370 (1157)
T ss_pred eehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-CeEEEEecccCccHHHHHHHhchhhcchhHHHHH
Confidence 5677665432 34578999999999999999999999987654 7899999999999999999877777888888999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccC---CCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG---TPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vG---Tp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||..|++||..+++|||||-..|+|+..+..||++||||++.+..+.+ ....| ..-|.|||-+.-..+..++||
T Consensus 371 AtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDV 449 (1157)
T KOG4278|consen 371 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDV 449 (1157)
T ss_pred HHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhh
Confidence 99999999999999999999999999999999999999999998765432 22333 346999999999999999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|+|||+|||+.+ |..||.+.+....+..+.+++...-|..+++.+.+|+..||+.+|.+||++.||-+
T Consensus 450 WAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 450 WAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 999999999977 89999999999999999999988899999999999999999999999999999844
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=269.32 Aligned_cols=227 Identities=29% Similarity=0.483 Sum_probs=180.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-----C---CCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-----N---PFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANG 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-----H---pnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~ 70 (582)
||+|+.+-+ +...+....||++|++++ | .+||+|++.|.. ++.++|+|+|++ |.+|..+|++.+.
T Consensus 106 VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y 181 (590)
T KOG1290|consen 106 VALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY 181 (590)
T ss_pred EEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC
Confidence 788888664 455678899999999994 2 579999999874 457999999999 8999999999888
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCcccEEEc---------------------------------------
Q 007991 71 VHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLT--------------------------------------- 110 (582)
Q Consensus 71 ~~lse~~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~--------------------------------------- 110 (582)
..++...++.|++|||.||.|||.. ||||.||||+|||+.
T Consensus 182 rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~ 261 (590)
T KOG1290|consen 182 RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMA 261 (590)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhh
Confidence 8899999999999999999999986 999999999999994
Q ss_pred ---------------------------------------------------------------------------CC---
Q 007991 111 ---------------------------------------------------------------------------RD--- 112 (582)
Q Consensus 111 ---------------------------------------------------------------------------~~--- 112 (582)
..
T Consensus 262 ~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~ 341 (590)
T KOG1290|consen 262 AEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPEN 341 (590)
T ss_pred ccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccc
Confidence 00
Q ss_pred -------------------------------------------------CCeEEeecccchhcccccccCcccCCCCCCC
Q 007991 113 -------------------------------------------------QDIRLGDFGLAKMLISDDLASSVVGTPSYMC 143 (582)
Q Consensus 113 -------------------------------------------------g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~A 143 (582)
-.|||+|||.|+.... ....-+.|..|+|
T Consensus 342 ~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRa 419 (590)
T KOG1290|consen 342 FRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRA 419 (590)
T ss_pred cccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccC
Confidence 0167788887766533 2445678999999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhcCCccccccC---------HH----HHHHHHh----------------------
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------MQ----ALINKIN---------------------- 188 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~---------~~----~l~~kI~---------------------- 188 (582)
||++.+..|+..+||||++|++|||+||...|.-.+ .- +++..|.
T Consensus 420 pEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~Lrh 499 (590)
T KOG1290|consen 420 PEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRH 499 (590)
T ss_pred cceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceec
Confidence 999999999999999999999999999999995221 11 1111111
Q ss_pred --hccCCCC----------CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 189 --KSIVAPL----------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 189 --~~~~~~l----------p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
....|++ +..-..+|.+||.-||+++|++|+||.++|+|||+.+..
T Consensus 500 I~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 500 IRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred ccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence 1112221 222345788999999999999999999999999998643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=277.81 Aligned_cols=231 Identities=21% Similarity=0.251 Sum_probs=167.0
Q ss_pred EEEEEecccccCHH------------HHHHHHHHHHHHHhcCCCCe-----eeeeeEEEe-------cCcEEEEEEeecC
Q 007991 2 YVLKKIRLARQTDR------------ARRSAHQEMELISRVRNPFI-----VEYKDSWVE-------KGCYVCIIIGYCE 57 (582)
Q Consensus 2 yAIKki~~~~~~~~------------~~~~~~rEi~iL~~L~HpnI-----V~l~~~~~~-------~~~~l~LVmEy~~ 57 (582)
||||+++....... ..+....|+.++.+++|.++ +.++++|.. .....|+||||+.
T Consensus 189 VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~ 268 (507)
T PLN03224 189 VVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFES 268 (507)
T ss_pred EEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCC
Confidence 79999876433211 11234458888888877655 556665542 1246789999999
Q ss_pred CCCHHHHHHHhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCe
Q 007991 58 GGDMAEAIKKANG----------------------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115 (582)
Q Consensus 58 GgsL~d~Ikk~~~----------------------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~v 115 (582)
+++|.+++....+ ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+
T Consensus 269 ~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~ 348 (507)
T PLN03224 269 DATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348 (507)
T ss_pred CCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcE
Confidence 9999999874211 124677899999999999999999999999999999999999999
Q ss_pred EEeecccchhcccccccCc--ccCCCCCCCcccccCCC--------------------CC--CCCcccchhHHHHhHhcC
Q 007991 116 RLGDFGLAKMLISDDLASS--VVGTPSYMCPELLADIP--------------------YG--SKSDIWSLGCCVYEMSAQ 171 (582)
Q Consensus 116 KL~DFGla~~~~~~~~~~~--~vGTp~Y~APE~l~~~~--------------------y~--~ksDIWSLG~iLyELltG 171 (582)
||+|||++........... ..+|+.|+|||++.... |+ ...||||+||++|+|++|
T Consensus 349 kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~ 428 (507)
T PLN03224 349 KIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVP 428 (507)
T ss_pred EEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhC
Confidence 9999999976543332222 24478999999875432 22 247999999999999998
Q ss_pred Cc-cccccCHHHH-----------HHHH-hhccCCCCCccccHHHHHHHHHhccCCC---CCCCCHHHHHcCCCCch
Q 007991 172 KA-AFKAFDMQAL-----------INKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNP---EFRPSAAELLCHPHLQP 232 (582)
Q Consensus 172 ~~-PF~~~~~~~l-----------~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP---~~RpSa~EiL~hp~f~~ 232 (582)
.. ||.+...... +..+ ............++..++||.+||.++| .+|+|++|+|.||||.+
T Consensus 429 ~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 429 ELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 75 6653221110 0111 1112223345578999999999999866 68999999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=287.69 Aligned_cols=213 Identities=26% Similarity=0.392 Sum_probs=167.0
Q ss_pred HHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYL 92 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~~~il~QLL~aL~yL 92 (582)
.-..+.|||.+|+.-+ |||||++|+.- .+..+.||..|.| ..+|.+++... ..........+.++.|++.||++|
T Consensus 545 ~~~~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL 622 (903)
T KOG1027|consen 545 FFDFAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL 622 (903)
T ss_pred hHHHHHHHHHHHHhccCCCceEEEEeec-cCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHH
Confidence 3356789999999995 99999999864 3456999999999 59999999874 111111134578899999999999
Q ss_pred HHCCceecccCcccEEEcC---CC--CeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCcccchhH
Q 007991 93 HANHILHRDVKCSNIFLTR---DQ--DIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 163 (582)
Q Consensus 93 Hs~gIiHRDIKP~NILL~~---~g--~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~ 163 (582)
|+.+||||||||.||||+. ++ .++|.|||+++.+..+. ...+..||-+|+|||++....-+.++|||||||
T Consensus 623 Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGC 702 (903)
T KOG1027|consen 623 HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGC 702 (903)
T ss_pred HhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCc
Confidence 9999999999999999987 34 58999999999876543 245678999999999999888788999999999
Q ss_pred HHHhHhcC-CccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 164 CVYEMSAQ-KAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 164 iLyELltG-~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++|+.++| ..||.+.-..+ .+ |..+.. ..+...-..++.+||..||..+|..||+|.++|.||+|=.
T Consensus 703 vfyYvltgG~HpFGd~~~R~-~N-Il~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 703 VFYYVLTGGSHPFGDSLERQ-AN-ILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred eEEEEecCCccCCCchHHhh-hh-hhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 99987775 99997644332 11 222111 1111112228999999999999999999999999999943
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=280.78 Aligned_cols=223 Identities=25% Similarity=0.446 Sum_probs=196.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--------C--
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--------G-- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--------~-- 70 (582)
||||.++..... ...+.+..|+++|+.+. |+|||.+++.+.. ++.+++|+|||+.|+|.+++++.. +
T Consensus 331 VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~ 408 (609)
T KOG0200|consen 331 VAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVF 408 (609)
T ss_pred EEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCC
Confidence 789998876665 77889999999999996 9999999998776 668999999999999999998754 0
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc--CcccCCC--CCC
Q 007991 71 ----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA--SSVVGTP--SYM 142 (582)
Q Consensus 71 ----~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~--~~~vGTp--~Y~ 142 (582)
..++...+..+++||+.|++||++.++|||||-..||||..+..+||+|||+++........ ....|+. .||
T Consensus 409 ~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWm 488 (609)
T KOG0200|consen 409 PNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWM 488 (609)
T ss_pred ccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeec
Confidence 23889999999999999999999999999999999999999999999999999876554433 2233333 399
Q ss_pred CcccccCCCCCCCCcccchhHHHHhHhc-CCccccccC-HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 143 CPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 143 APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~-~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
|||.+....|+.++||||+|++||||++ |..||.+.. ..++++.+..+.....|..+++++.++++.||+.+|++||+
T Consensus 489 ApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~ 568 (609)
T KOG0200|consen 489 APESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPT 568 (609)
T ss_pred CHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence 9999999999999999999999999988 799999866 77778888888888899999999999999999999999999
Q ss_pred HHHHHc
Q 007991 221 AAELLC 226 (582)
Q Consensus 221 a~EiL~ 226 (582)
+.++..
T Consensus 569 F~~~~~ 574 (609)
T KOG0200|consen 569 FSECVE 574 (609)
T ss_pred HHHHHH
Confidence 999975
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=298.27 Aligned_cols=203 Identities=13% Similarity=0.133 Sum_probs=151.4
Q ss_pred HHhcCC-CCeeeeeeEEEe------cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 007991 27 ISRVRN-PFIVEYKDSWVE------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 99 (582)
Q Consensus 27 L~~L~H-pnIV~l~~~~~~------~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiH 99 (582)
.+.+.| .||+.+++.|.. ....+++++||+ +++|.++|... ...+++..+..|++||+.||+|||++||+|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 345566 688888887621 123577888887 67999999753 346999999999999999999999999999
Q ss_pred cccCcccEEEcCC-------------------CCeEEeecccchhcccc-----------------cccCcccCCCCCCC
Q 007991 100 RDVKCSNIFLTRD-------------------QDIRLGDFGLAKMLISD-----------------DLASSVVGTPSYMC 143 (582)
Q Consensus 100 RDIKP~NILL~~~-------------------g~vKL~DFGla~~~~~~-----------------~~~~~~vGTp~Y~A 143 (582)
|||||+||||+.. +.+|++|||+++..... ......+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 44566666666532100 00112468999999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
||++.+..|+.++|||||||+||||++|.+|+.... ..+..+......+..........+++.+||..+|.+||++.|
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999998876432 122222222222111122456678999999999999999999
Q ss_pred HHcCCCCchh
Q 007991 224 LLCHPHLQPY 233 (582)
Q Consensus 224 iL~hp~f~~~ 233 (582)
+|+||||...
T Consensus 262 il~h~~~~~~ 271 (793)
T PLN00181 262 LLQSEFINEP 271 (793)
T ss_pred Hhhchhhhhh
Confidence 9999999764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=280.64 Aligned_cols=228 Identities=30% Similarity=0.525 Sum_probs=194.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+.|+|.+++.-..+- .-+++||-+++.++|||||.|++.|...+ .++|+||||.||+|++...--+ .++|.++..
T Consensus 42 laavkvVkLep~dd~--~~iqqei~~~~dc~h~nivay~gsylr~d-klwicMEycgggslQdiy~~Tg--plselqiay 116 (829)
T KOG0576|consen 42 LAAVKVVKLEPGDDF--SGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICMEYCGGGSLQDIYHVTG--PLSELQIAY 116 (829)
T ss_pred hhhheeeeccCCccc--cccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEEecCCCcccceeeecc--cchhHHHHH
Confidence 357888888665443 45789999999999999999999998654 8999999999999998887543 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
+.++.+.||+|||++|-+|||||-.|||++..|+|||+|||.+..+... ....+++|||.|||||+.. ...|+..+
T Consensus 117 vcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlc 196 (829)
T KOG0576|consen 117 VCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 196 (829)
T ss_pred HHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccc
Confidence 9999999999999999999999999999999999999999998765432 3567899999999999864 45699999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC----CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL----PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l----p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+...|+..-++|.-..........+.+....+. +..+++.|.+|++.+|.++|++||+++.+|.|||+..
T Consensus 197 diwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 197 DIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred cccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999998888666665555555555544432 4569999999999999999999999999999999975
Q ss_pred h
Q 007991 233 Y 233 (582)
Q Consensus 233 ~ 233 (582)
-
T Consensus 277 ~ 277 (829)
T KOG0576|consen 277 T 277 (829)
T ss_pred c
Confidence 3
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=287.06 Aligned_cols=210 Identities=19% Similarity=0.264 Sum_probs=163.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++...... ...|+++|++++|||||++++++... ...|+||||++||+|.++++ .+++..+..+
T Consensus 718 vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i 785 (968)
T PLN00113 718 FVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-KGAYLIHEYIEGKNLSEVLR-----NLSWERRRKI 785 (968)
T ss_pred EEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-CCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHH
Confidence 788988654331 23568999999999999999988665 47899999999999999996 3789999999
Q ss_pred HHHHHHHHHHHH---HCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLH---ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLH---s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.|++.||+||| +.+|+||||||+||+++.++..++. ||....... .....||+.|+|||++.+..|+.++||
T Consensus 786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv 861 (968)
T PLN00113 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDI 861 (968)
T ss_pred HHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccch
Confidence 999999999999 6699999999999999998887775 665543322 223478999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccC-----HHHHHHHHhh------ccCC------CCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFD-----MQALINKINK------SIVA------PLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~-----~~~l~~kI~~------~~~~------~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
|||||++|||++|+.||.... ..+....... .... ..+.....++.+++.+||+.||++||++
T Consensus 862 ~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~ 941 (968)
T PLN00113 862 YGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA 941 (968)
T ss_pred hhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence 999999999999999985321 1111111000 0000 0111223457789999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
+|+++.
T Consensus 942 ~evl~~ 947 (968)
T PLN00113 942 NDVLKT 947 (968)
T ss_pred HHHHHH
Confidence 999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=220.66 Aligned_cols=192 Identities=38% Similarity=0.721 Sum_probs=168.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|+||++....... ..+.+.+|+++++.+.|++|+++++++... ...++++||+.|++|.+++.... ..+++..+..+
T Consensus 21 ~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~ 97 (215)
T cd00180 21 VAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRI 97 (215)
T ss_pred EEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHH
Confidence 6888887655432 456799999999999999999999987654 58899999999999999998742 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcC-CCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDI 158 (582)
+.+++.+|+|||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|++||.+... .++.+.|+
T Consensus 98 ~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ 177 (215)
T cd00180 98 LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177 (215)
T ss_pred HHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhh
Confidence 999999999999999999999999999999 8999999999997654432 23446688899999999887 78899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
|++|+++++| ..+.+++..|+..||.+||+++++++|+
T Consensus 178 ~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 178 WSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999 6889999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=226.26 Aligned_cols=160 Identities=24% Similarity=0.335 Sum_probs=131.2
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCC
Q 007991 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT 138 (582)
Q Consensus 59 gsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGT 138 (582)
|+|.+++...+ ..+++..++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 78999998743 36999999999999999999999999 999999999999999 9998765432 23789
Q ss_pred CCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCH-HHHHHHHhhccCCC------CCccccH--HHHHHHHH
Q 007991 139 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAP------LPTVYSG--AFRGLVKS 209 (582)
Q Consensus 139 p~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~-~~l~~kI~~~~~~~------lp~~~S~--~l~~LI~k 209 (582)
+.|||||++.+..|+.++|||||||++|||++|..||..... ......+....... .+..++. .+.++|..
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543 22233332222111 1223444 69999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCc
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~ 231 (582)
||..||.+||++.|++.|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=226.94 Aligned_cols=192 Identities=27% Similarity=0.507 Sum_probs=154.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk--~~~~~lse~~~ 78 (582)
.|+|.++.... .+..+...+|+.+..+. .+|++|.+|+.+..++ .++|.||.+ ..+|..+.++ ..+..++|.-+
T Consensus 74 mAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vl 150 (282)
T KOG0984|consen 74 MAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVL 150 (282)
T ss_pred EEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHh
Confidence 58888877554 44455677888886555 6999999999988765 789999999 4788766654 24568999999
Q ss_pred HHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc----CCCCC
Q 007991 79 CKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA----DIPYG 153 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~----~~~y~ 153 (582)
-+++..++.||.|||++ .|||||+||+||||+.+|+||+||||++..+.+.--.+...|-..|||||.+. ...|+
T Consensus 151 GkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~ 230 (282)
T KOG0984|consen 151 GKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYS 230 (282)
T ss_pred hHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccce
Confidence 99999999999999987 89999999999999999999999999998876654333367888999999874 34699
Q ss_pred CCCcccchhHHHHhHhcCCcccccc-CHHHHHHHHhhccCCCCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVAPLP 196 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~-~~~~l~~kI~~~~~~~lp 196 (582)
.++||||||++++||.++..||... ...+++.++.....+.+|
T Consensus 231 vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 231 VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 9999999999999999999999753 455555555554444343
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=218.02 Aligned_cols=190 Identities=32% Similarity=0.559 Sum_probs=161.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ...+.+.+|++.+.+++|+|++++++.+... ...++++||+.+++|.+++..... .+++..+..+
T Consensus 27 ~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~ 103 (225)
T smart00221 27 VAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFY 103 (225)
T ss_pred EEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHH
Confidence 788888765443 3567899999999999999999999987654 588899999999999999987542 1899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccc-cCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELL-ADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l-~~~~y~~ksDI 158 (582)
+.|++.+|.|||+.|++|+||+|.||+++.++.++|+|||++....... ......++..|++||.+ ....++.++|+
T Consensus 104 ~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv 183 (225)
T smart00221 104 LRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDI 183 (225)
T ss_pred HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhH
Confidence 9999999999999999999999999999999999999999998775543 34567888999999998 66678889999
Q ss_pred cchhHHHHhHhcCCccccc--cCHHHHHHHHhhccCCC
Q 007991 159 WSLGCCVYEMSAQKAAFKA--FDMQALINKINKSIVAP 194 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~--~~~~~l~~kI~~~~~~~ 194 (582)
|+||+++++|++|+.||.. .+...+.+.+..+...+
T Consensus 184 ~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 184 WSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred HHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 9999999999999999977 44446667776655443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=255.97 Aligned_cols=222 Identities=18% Similarity=0.317 Sum_probs=195.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+||||++..... .+.-..+..|+-+|.+|+|||++++++++... .+-||++|+.+|.|.++++.+.+ .+-.+....
T Consensus 727 pVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLn 802 (1177)
T KOG1025|consen 727 PVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVTQLMPLGCLLDYVREHRD-NIGSQDLLN 802 (1177)
T ss_pred eeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHHHhcccchHHHHHHHhhc-cccHHHHHH
Confidence 589998876544 44456789999999999999999999987754 47799999999999999998543 688999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCc-ccC--CCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS-VVG--TPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~-~vG--Tp~Y~APE~l~~~~y~~ksD 157 (582)
|.+||+.|+.|||.++++||||-..|||+..-.+|||.|||+++.+..+..... ..| -+.|||-|.+....|+.++|
T Consensus 803 w~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSD 882 (1177)
T KOG1025|consen 803 WCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSD 882 (1177)
T ss_pred HHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhh
Confidence 999999999999999999999999999999999999999999998876543222 222 34689999999999999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|||+| |..|+.+....++-..+..+..-+.|..++-++.-++.+||..|+..||+++++..
T Consensus 883 VWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 883 VWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred hhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999877 89999999999999988888888889999999999999999999999999998865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=238.92 Aligned_cols=221 Identities=28% Similarity=0.390 Sum_probs=171.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.|....... .+..|+++|..+. +.||+++.+.+- .+...++|+||++.....+++.. ++...++.
T Consensus 67 valk~i~~ts~p~----ri~~El~~L~~~gG~~ni~~~~~~~r-nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~ 136 (418)
T KOG1167|consen 67 VALKAIYRTSSPS----RILNELEMLYRLGGSDNIIKLNGCFR-NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRW 136 (418)
T ss_pred EeeeecccccCch----HHHHHHHHHHHhccchhhhcchhhhc-cCCeeEEEecccCccCHHHHHhc-----CCHHHHHH
Confidence 7899998876654 4889999999995 889999998654 45689999999999998888874 67889999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhccc--------c-------c--------------
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLIS--------D-------D-------------- 130 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~--------~-------~-------------- 130 (582)
|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|..... . .
T Consensus 137 Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~ 216 (418)
T KOG1167|consen 137 YLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATA 216 (418)
T ss_pred HHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccc
Confidence 99999999999999999999999999999876 6789999999972100 0 0
Q ss_pred ----------------ccCcccCCCCCCCcccccCCC-CCCCCcccchhHHHHhHhcCCccccc-cCH-HHHHH------
Q 007991 131 ----------------LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFKA-FDM-QALIN------ 185 (582)
Q Consensus 131 ----------------~~~~~vGTp~Y~APE~l~~~~-y~~ksDIWSLG~iLyELltG~~PF~~-~~~-~~l~~------ 185 (582)
..-...||++|.|||++...+ -+.++||||.|+|+.-++++..||-. .+. ..+.+
T Consensus 217 ~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG 296 (418)
T KOG1167|consen 217 SKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG 296 (418)
T ss_pred cCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhC
Confidence 001246999999999987654 67899999999999999999998721 111 00000
Q ss_pred -----HHhh--cc--CC----------------------------------CCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 186 -----KINK--SI--VA----------------------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 186 -----kI~~--~~--~~----------------------------------~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
+.-. +. .+ .....++..+.+|+.+||+.||.+|.|++
T Consensus 297 ~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAE 376 (418)
T KOG1167|consen 297 SAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAE 376 (418)
T ss_pred hHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHH
Confidence 0000 00 00 01122455788999999999999999999
Q ss_pred HHHcCCCCch
Q 007991 223 ELLCHPHLQP 232 (582)
Q Consensus 223 EiL~hp~f~~ 232 (582)
++|+||||.+
T Consensus 377 eALkHpFF~~ 386 (418)
T KOG1167|consen 377 DALKHPFFDE 386 (418)
T ss_pred HHhcCcCCcc
Confidence 9999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=246.18 Aligned_cols=172 Identities=26% Similarity=0.397 Sum_probs=148.4
Q ss_pred EEEEEecccccCHH--HH----HHHHHHHHHHHhcC---CCCeeeeeeEEEecCcEEEEEEeec-CCCCHHHHHHHhCCC
Q 007991 2 YVLKKIRLARQTDR--AR----RSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVCIIIGYC-EGGDMAEAIKKANGV 71 (582)
Q Consensus 2 yAIKki~~~~~~~~--~~----~~~~rEi~iL~~L~---HpnIV~l~~~~~~~~~~l~LVmEy~-~GgsL~d~Ikk~~~~ 71 (582)
||||-|...+.-.. .+ =.+-.||+||..|+ |+||++++++| +++.++||+||-. +|.+|+++|..+.
T Consensus 589 VViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-Eddd~yyl~te~hg~gIDLFd~IE~kp-- 665 (772)
T KOG1152|consen 589 VVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-EDDDYYYLETEVHGEGIDLFDFIEFKP-- 665 (772)
T ss_pred EEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-ecCCeeEEEecCCCCCcchhhhhhccC--
Confidence 78888876553221 11 12567999999998 99999999966 5566999999976 5889999999766
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCC
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~ 151 (582)
.++|..++.|++|++.|+++||++||||||||-+||.++.+|-+||+|||.+....+ .....++||..|.|||++.+..
T Consensus 666 ~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~ 744 (772)
T KOG1152|consen 666 RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEK 744 (772)
T ss_pred ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCc
Confidence 789999999999999999999999999999999999999999999999998876544 4577899999999999999998
Q ss_pred C-CCCCcccchhHHHHhHhcCCccccc
Q 007991 152 Y-GSKSDIWSLGCCVYEMSAQKAAFKA 177 (582)
Q Consensus 152 y-~~ksDIWSLG~iLyELltG~~PF~~ 177 (582)
| +..-|||+||++||.++....||.+
T Consensus 745 y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 745 YLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7 5668999999999999998888764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=204.86 Aligned_cols=229 Identities=33% Similarity=0.504 Sum_probs=186.2
Q ss_pred EEEEEecccccCHH-HHHHHHHHHHHHHhcCCC-CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHH
Q 007991 2 YVLKKIRLARQTDR-ARRSAHQEMELISRVRNP-FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~-~~~~~~rEi~iL~~L~Hp-nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~ 78 (582)
+++|.+........ ....+.+|+.++..+.|+ +|+.+++.+.. ....+++++|+.|+++.+++..... ..+.+..+
T Consensus 25 ~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 103 (384)
T COG0515 25 VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA 103 (384)
T ss_pred EEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHH
Confidence 67888877665543 678899999999999998 79999998844 4468999999999999977776421 25899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhccccc-------ccCcccCCCCCCCcccccC-
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDD-------LASSVVGTPSYMCPELLAD- 149 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~-------~~~~~vGTp~Y~APE~l~~- 149 (582)
..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||++....... .....+||..|++||.+.+
T Consensus 104 ~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~ 183 (384)
T COG0515 104 LFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183 (384)
T ss_pred HHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCC
Confidence 99999999999999999999999999999999998 79999999998654432 3467899999999999987
Q ss_pred --CCCCCCCcccchhHHHHhHhcCCccccccCH----HHHHHHHhhccCC----CCCccc----cHHHHHHHHHhccCCC
Q 007991 150 --IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM----QALINKINKSIVA----PLPTVY----SGAFRGLVKSMLRKNP 215 (582)
Q Consensus 150 --~~y~~ksDIWSLG~iLyELltG~~PF~~~~~----~~l~~kI~~~~~~----~lp~~~----S~~l~~LI~kmL~~dP 215 (582)
..+....|+|++|+++++++.|..||..... ......+...... ...... ...+.+++..++..+|
T Consensus 184 ~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (384)
T COG0515 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDP 263 (384)
T ss_pred CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCc
Confidence 5788899999999999999999999887763 4444444433322 111111 2578999999999999
Q ss_pred CCCCCHHHHHcCCCCc
Q 007991 216 EFRPSAAELLCHPHLQ 231 (582)
Q Consensus 216 ~~RpSa~EiL~hp~f~ 231 (582)
..|.+..+...+++..
T Consensus 264 ~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 264 KNRLSSSSDLSHDLLA 279 (384)
T ss_pred hhcCCHHHHhhchHhh
Confidence 9999999988875443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=227.20 Aligned_cols=218 Identities=19% Similarity=0.319 Sum_probs=165.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHh--cCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~--L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++.. ..++.++.|-+|.+. ++|+||++++..-.. ....++||++|.+.|+|.++++.+ .+++
T Consensus 235 ~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw 306 (534)
T KOG3653|consen 235 LVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISW 306 (534)
T ss_pred eeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc---cccH
Confidence 489999854 445677777777665 479999999875321 123688999999999999999985 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHC---------CceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHAN---------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~---------gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...++++.-++.||+|||+. .|+|||||..||||..|+...|+|||+|..+.... .....+||..|||
T Consensus 307 ~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMA 386 (534)
T KOG3653|consen 307 NSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMA 386 (534)
T ss_pred HHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcC
Confidence 99999999999999999964 59999999999999999999999999998875432 2334799999999
Q ss_pred cccccCCC-CC-----CCCcccchhHHHHhHhcCCcc------------cc-----ccCHHHHHHHHhhcc-CCCCCcc-
Q 007991 144 PELLADIP-YG-----SKSDIWSLGCCVYEMSAQKAA------------FK-----AFDMQALINKINKSI-VAPLPTV- 198 (582)
Q Consensus 144 PE~l~~~~-y~-----~ksDIWSLG~iLyELltG~~P------------F~-----~~~~~~l~~kI~~~~-~~~lp~~- 198 (582)
||++-+.- +. ...||||+|.+|+||++.... |. .-..+++.+.+.... .+.++..
T Consensus 387 PEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W 466 (534)
T KOG3653|consen 387 PEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW 466 (534)
T ss_pred HHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhh
Confidence 99996532 22 358999999999999775332 22 011233333332222 2333332
Q ss_pred ----ccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 199 ----YSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 199 ----~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.-.-+.+.+..||..|++.|.|+.-+.+
T Consensus 467 ~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 467 RKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred hcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 2456889999999999999999876643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=251.72 Aligned_cols=210 Identities=23% Similarity=0.334 Sum_probs=174.4
Q ss_pred HHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 007991 20 AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILH 99 (582)
Q Consensus 20 ~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiH 99 (582)
+..|+.+-..|.|+||+..+..+.+.....+ +||||++ +|..++.... .+....+..++.||+.|++|||+.||.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~-~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~Giah 443 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQ-SMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAH 443 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchh-hhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCcee
Confidence 6778888889999999988877666554444 4999998 9999998753 6889999999999999999999999999
Q ss_pred cccCcccEEEcCCCCeEEeecccchhcccc-----cccCcccCCCCCCCcccccCCCCCC-CCcccchhHHHHhHhcCCc
Q 007991 100 RDVKCSNIFLTRDQDIRLGDFGLAKMLISD-----DLASSVVGTPSYMCPELLADIPYGS-KSDIWSLGCCVYEMSAQKA 173 (582)
Q Consensus 100 RDIKP~NILL~~~g~vKL~DFGla~~~~~~-----~~~~~~vGTp~Y~APE~l~~~~y~~-ksDIWSLG~iLyELltG~~ 173 (582)
||||++|+++..+|.+||+|||.+..+... ......+|+..|+|||++.+..|++ .+||||.|++++.|++|+.
T Consensus 444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 999999999999999999999998776432 3456789999999999999999976 5899999999999999999
Q ss_pred cccccCHHHHH-HHHhhc-------cCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 174 AFKAFDMQALI-NKINKS-------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 174 PF~~~~~~~l~-~kI~~~-------~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.....+.. ...... ....+...++...+.+|.+||+.||.+|.|+++|++.+||+..
T Consensus 524 ~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 524 PWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 99765443321 111111 1122344578899999999999999999999999999999863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=242.24 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=202.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||+|.++.+....+.+.....|..++..++ ||++|.++..|+.+ ..++++++|..||+|...+.+.. .+.+...+
T Consensus 24 ~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-~kl~l~ld~~rgg~lft~l~~~~--~f~~~~~~ 100 (612)
T KOG0603|consen 24 LYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-GKLYLILDFLRGGDLFTRLSKEV--MFDELDVA 100 (612)
T ss_pred hhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-cchhHhhhhcccchhhhccccCC--chHHHHHH
Confidence 4677777776655554446678999999998 99999999888765 58999999999999999888654 78999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.+...++.+++++|+.||+|||+|++||+++.+|++++.|||+.+........ |||..|||||++. .+...+|+|
T Consensus 101 ~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~w 175 (612)
T KOG0603|consen 101 FYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWW 175 (612)
T ss_pred HHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccch
Confidence 99999999999999999999999999999999999999999999988765544 9999999999998 567899999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
|||+++|+|++|..||.. ++...|.+.. ..+|..++..+++++..|+..+|..|.- +.|+++|+||+...
T Consensus 176 s~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 176 SFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred hhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 999999999999999998 4455555433 3478889999999999999999999953 58999999999876
Q ss_pred hh--hhcccCCCCCCCCCCCCCCccccc
Q 007991 235 LG--IHLKLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 235 ~~--~~~~~~~p~~~~~~~~~~~s~~~~ 260 (582)
|. .......|.++...-+.+...|+.
T Consensus 251 ~~~l~~r~~~~~fkp~~~~e~~~~~fd~ 278 (612)
T KOG0603|consen 251 WNELEARSRPPPFKPGSITERDVAQFDP 278 (612)
T ss_pred HhhHhhcCCCCCCCCcccchhhhhhcCc
Confidence 65 223333444444443344444443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=223.98 Aligned_cols=216 Identities=22% Similarity=0.368 Sum_probs=164.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHh--cCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~--L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++.-..- +...||.+|.+. |+|+||+.++++-..++ ..+|||++|.+.|+|+|++.+. .++.+
T Consensus 237 VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~ 308 (513)
T KOG2052|consen 237 VAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTE 308 (513)
T ss_pred eEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHH
Confidence 78999854322 456677777665 59999999988755333 3799999999999999999984 79999
Q ss_pred HHHHHHHHHHHHHHHHHHC--------CceecccCcccEEEcCCCCeEEeecccchhcccc-----cccCcccCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-----DLASSVVGTPSYMC 143 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~--------gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-----~~~~~~vGTp~Y~A 143 (582)
.+.+++.-++.||.|||.. .|.|||||..|||+.++|.+.|+|+|||-..... ......+||..|||
T Consensus 309 ~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMA 388 (513)
T KOG2052|consen 309 GMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMA 388 (513)
T ss_pred HHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccC
Confidence 9999999999999999964 4999999999999999999999999999765443 13456799999999
Q ss_pred cccccCCC----C--CCCCcccchhHHHHhHhc----------CCcccccc-----CHHHHHHHHh-hccCCCCCcccc-
Q 007991 144 PELLADIP----Y--GSKSDIWSLGCCVYEMSA----------QKAAFKAF-----DMQALINKIN-KSIVAPLPTVYS- 200 (582)
Q Consensus 144 PE~l~~~~----y--~~ksDIWSLG~iLyELlt----------G~~PF~~~-----~~~~l~~kI~-~~~~~~lp~~~S- 200 (582)
||++...- + -..+||||||.++||++. -++||.+. +.+++..-+. ....+.+|..+.
T Consensus 389 PEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s 468 (513)
T KOG2052|consen 389 PEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS 468 (513)
T ss_pred hHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccccc
Confidence 99996531 1 135899999999999854 25677432 3334333332 223344454443
Q ss_pred ----HHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 201 ----GAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 201 ----~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
..+..|++.||.-||..|.|+--|-
T Consensus 469 ~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 469 DPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 2456789999999999999986654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=217.39 Aligned_cols=212 Identities=19% Similarity=0.268 Sum_probs=188.2
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh------CCCCCCHHHHHHHHHHHHHH
Q 007991 15 RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA------NGVHFPEEKLCKWLVQLLMA 88 (582)
Q Consensus 15 ~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~------~~~~lse~~~~~il~QLL~a 88 (582)
-+...+.+|..+|.-+.|||+.++.++.+++...-++++.+..-|+|..+++.- ....++-.++..++.|+.+|
T Consensus 329 iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~a 408 (563)
T KOG1024|consen 329 IQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMA 408 (563)
T ss_pred HHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999888888999999999999999832 22457788889999999999
Q ss_pred HHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc---CcccCCCCCCCcccccCCCCCCCCcccchhHHH
Q 007991 89 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCV 165 (582)
Q Consensus 89 L~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~---~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iL 165 (582)
++|||++||||.||-..|.+|++.-.|||+|=.+++.+...++. ...-....||+||.+....|+.++|+||||++|
T Consensus 409 m~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 409 MEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 99999999999999999999999999999999999887654422 222334579999999999999999999999999
Q ss_pred HhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 166 YEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 166 yELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||++ |+.|+...+..++...+.++..-..|.++++++..++..||...|++||+++++..
T Consensus 489 WELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 99877 89999999999999999999988889999999999999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=211.73 Aligned_cols=222 Identities=20% Similarity=0.271 Sum_probs=167.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+|||-+..... ..+.|++|...=-.|. |.|||.-|++-++..+++.++||||+.|+|..-+... .+-|...+.
T Consensus 52 ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~ 125 (378)
T KOG1345|consen 52 IVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKK 125 (378)
T ss_pred EEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc---cccHHHHHH
Confidence 45665544333 3457899988776775 8899998887776667888999999999999988764 478999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcC--CCCeEEeecccchhcccccccCcccCCCCCCCcccccCC-----CCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-----PYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~--~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~-----~y~ 153 (582)
++.|+++||+|||+.++||||||.+||||-. ...|||||||+....... ....--+..|.+||+.... ..+
T Consensus 126 v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ 203 (378)
T KOG1345|consen 126 VFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVN 203 (378)
T ss_pred HHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEec
Confidence 9999999999999999999999999999854 347999999998654332 1222335579999976432 246
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHH----HHHHHHhhccCCCCCc---cccHHHHHHHHHhccCCCCCC---CCHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQ----ALINKINKSIVAPLPT---VYSGAFRGLVKSMLRKNPEFR---PSAAE 223 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~----~l~~kI~~~~~~~lp~---~~S~~l~~LI~kmL~~dP~~R---pSa~E 223 (582)
+..|||.||+++|.+++|++||...... .-+.+..+......|. .+++.+..+.++-|..++++| .++..
T Consensus 204 ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 204 PSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 7899999999999999999999743322 1223333333334443 478999999999999999999 55555
Q ss_pred HHcCCCCc
Q 007991 224 LLCHPHLQ 231 (582)
Q Consensus 224 iL~hp~f~ 231 (582)
.....|..
T Consensus 284 ~rk~~w~E 291 (378)
T KOG1345|consen 284 MRKCLWKE 291 (378)
T ss_pred HHHHHHHH
Confidence 55555543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=204.10 Aligned_cols=223 Identities=20% Similarity=0.286 Sum_probs=175.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC----CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN----PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H----pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||+|.......... ..+..|+.+|..+.. +++..+++.+...+.+.||||+.+ |.+|.++.+......|+...
T Consensus 47 ~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T 123 (322)
T KOG1164|consen 47 YAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKT 123 (322)
T ss_pred EEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhH
Confidence 56776655433222 157889999999973 688888887744456899999999 89999999877667899999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-----CCeEEeecccch--hccccc--------c-cCcccCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-----QDIRLGDFGLAK--MLISDD--------L-ASSVVGTPSY 141 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-----g~vKL~DFGla~--~~~~~~--------~-~~~~vGTp~Y 141 (582)
+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++ ...... . ...+.||..|
T Consensus 124 ~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry 203 (322)
T KOG1164|consen 124 VLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRY 203 (322)
T ss_pred HHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcccc
Confidence 99999999999999999999999999999999875 359999999998 321111 1 2346799999
Q ss_pred CCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh---ccCCC-CCccccHHHHHHHHHhccCCCCC
Q 007991 142 MCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK---SIVAP-LPTVYSGAFRGLVKSMLRKNPEF 217 (582)
Q Consensus 142 ~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~---~~~~~-lp~~~S~~l~~LI~kmL~~dP~~ 217 (582)
+++..+.+...+.+.|+||+++++.+|+.|..||.+........++.. ..... .....+..+..+...+-..+...
T Consensus 204 ~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (322)
T KOG1164|consen 204 ASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYED 283 (322)
T ss_pred ccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcC
Confidence 999999999999999999999999999999999977664332332222 11111 33445678888888888899999
Q ss_pred CCCHHHHHcC
Q 007991 218 RPSAAELLCH 227 (582)
Q Consensus 218 RpSa~EiL~h 227 (582)
+|.+..+...
T Consensus 284 ~Pdy~~~~~~ 293 (322)
T KOG1164|consen 284 KPDYEKLAEL 293 (322)
T ss_pred CCCHHHHHHH
Confidence 9999888764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=214.67 Aligned_cols=168 Identities=29% Similarity=0.466 Sum_probs=139.7
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---------
Q 007991 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--------- 129 (582)
Q Consensus 59 gsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--------- 129 (582)
|+-..+++..+ .++.+. +.+++|||+.||+|||+||+|++|+.-|++|++|||+.+.....
T Consensus 136 gDc~tllk~~g--~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 136 GDCATLLKNIG--PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred chhhhhcccCC--CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 55555666433 455544 78999999999999999999999999999999999998764211
Q ss_pred -------cccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--Ccccc
Q 007991 130 -------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--PTVYS 200 (582)
Q Consensus 130 -------~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--p~~~S 200 (582)
......||||.|+|||++....|+..+|||++|+|+||++.|+.||.+...++++..+........ ...+.
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p 285 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALP 285 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCC
Confidence 123356999999999999999999999999999999999999999999999999888765443322 33478
Q ss_pred HHHHHHHHHhccCCCCCC---CCHHHHHcCCCCchhhhh
Q 007991 201 GAFRGLVKSMLRKNPEFR---PSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 201 ~~l~~LI~kmL~~dP~~R---pSa~EiL~hp~f~~~~~~ 236 (582)
.+++++|..+|+.+|..| ..+-++.+|+||+.+.|.
T Consensus 286 ~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 286 PEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 899999999999999999 467889999999987665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-20 Score=194.17 Aligned_cols=152 Identities=22% Similarity=0.229 Sum_probs=113.1
Q ss_pred EEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~---~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||++..... .+..++.+.+|+++|++|+|+||++.+..+ ...|+|||||+|++|.. +.. .. .
T Consensus 47 vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~-----~~---~ 113 (365)
T PRK09188 47 RAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-ARP-----HG---D 113 (365)
T ss_pred EEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hCc-----cc---h
Confidence 68888764322 345677899999999999999999643322 25789999999999963 211 11 1
Q ss_pred HHHHHHHHHHHHHHHHCCceeccc-CcccEEEcCCCCeEEeecccchhccccc---------ccCcccCCCCCCCccccc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDV-KCSNIFLTRDQDIRLGDFGLAKMLISDD---------LASSVVGTPSYMCPELLA 148 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDI-KP~NILL~~~g~vKL~DFGla~~~~~~~---------~~~~~vGTp~Y~APE~l~ 148 (582)
..++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+++.+.... ...+.++++.|+|||.+.
T Consensus 114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 468899999999999999999999 9999999999999999999998654332 113568889999999986
Q ss_pred CCCC------CCCCccc-chhHHHH
Q 007991 149 DIPY------GSKSDIW-SLGCCVY 166 (582)
Q Consensus 149 ~~~y------~~ksDIW-SLG~iLy 166 (582)
-... +...|-| .-|-+.+
T Consensus 194 ~~~~~~~~~~~~~~dgW~~TGDlg~ 218 (365)
T PRK09188 194 PRERKILARKSLPSRIWLATGKKVY 218 (365)
T ss_pred hhhhccccccccccCcEEeCCCEEE
Confidence 4432 2335555 4444443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=188.70 Aligned_cols=187 Identities=25% Similarity=0.360 Sum_probs=147.9
Q ss_pred CCCCeeeeeeEEEe--------------------------cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHH
Q 007991 31 RNPFIVEYKDSWVE--------------------------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQ 84 (582)
Q Consensus 31 ~HpnIV~l~~~~~~--------------------------~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~Q 84 (582)
+|||||+++..|++ .+..+|+||... ..+|.+++-.+ +.+....+-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999887763 245799999988 58999999875 6788899999999
Q ss_pred HHHHHHHHHHCCceecccCcccEEEcCCC----CeEEeecccchhccccc-------ccCcccCCCCCCCcccccCCCC-
Q 007991 85 LLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISDD-------LASSVVGTPSYMCPELLADIPY- 152 (582)
Q Consensus 85 LL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~~~-------~~~~~vGTp~Y~APE~l~~~~y- 152 (582)
+|+|+.|||.+||.|||+|.+||||.-+. .+.|+|||++--...-. .....-|.-..||||+....+-
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999985443 38889999874332211 1123356778899999875441
Q ss_pred -----CCCCcccchhHHHHhHhcCCccccccCHHHHH-HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 153 -----GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 153 -----~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~-~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
-.++|.|+.|.+.||+++...||.......+- ........+++|..+++.+++||..+|+.||.+|++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 14799999999999999999999874433221 1133445677899999999999999999999999884
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.6e-21 Score=217.41 Aligned_cols=219 Identities=21% Similarity=0.268 Sum_probs=158.9
Q ss_pred CEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~--~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++-.... .-+.-.+-..|++ ...+++||.+++..+ ...+...|+|-+|+ ..+|.|.|..++ .+..-+.
T Consensus 48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylvRqyv-khnLyDRlSTRP--FL~~iEK 122 (1431)
T KOG1240|consen 48 LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLVRQYV-KHNLYDRLSTRP--FLVLIEK 122 (1431)
T ss_pred eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHHHHHH-hhhhhhhhccch--HHHHHHH
Confidence 378888755432 1122233344555 667789999998875 44566889999999 589999998866 6778888
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhc--ccccc--cCcc----cCCCCCCCcccccCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML--ISDDL--ASSV----VGTPSYMCPELLADI 150 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~--~~~~~--~~~~----vGTp~Y~APE~l~~~ 150 (582)
+.|+.|||.||..+|..||+|||||.+||||+.-+.+.|+||.--+.. ..++. ...+ ....+|+|||.+...
T Consensus 123 kWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 123 KWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred HHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence 899999999999999999999999999999999999999999876542 22221 1122 233479999977431
Q ss_pred ----------C-CCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCC
Q 007991 151 ----------P-YGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNP 215 (582)
Q Consensus 151 ----------~-y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP 215 (582)
+ .+++.||||+||+++||++ |.++|.-.. ++..-..+... -+...-+..+++||..|++.||
T Consensus 203 ~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdP 279 (1431)
T KOG1240|consen 203 LGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDP 279 (1431)
T ss_pred ccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCc
Confidence 2 5678999999999999876 799985321 11111110000 0112234578999999999999
Q ss_pred CCCCCHHHHHcC
Q 007991 216 EFRPSAAELLCH 227 (582)
Q Consensus 216 ~~RpSa~EiL~h 227 (582)
.+|.+|++.|+.
T Consensus 280 s~RlSAedyL~~ 291 (1431)
T KOG1240|consen 280 SKRLSAEDYLQK 291 (1431)
T ss_pred hhccCHHHHHHh
Confidence 999999999985
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-20 Score=201.04 Aligned_cols=206 Identities=28% Similarity=0.431 Sum_probs=154.1
Q ss_pred HHHHHHHHHHhcCCCCeeeeee-------EEEe----cCcEEEEEEeecCCCCHHHHHHH-hCCCCCCHHHHHHHHHHHH
Q 007991 19 SAHQEMELISRVRNPFIVEYKD-------SWVE----KGCYVCIIIGYCEGGDMAEAIKK-ANGVHFPEEKLCKWLVQLL 86 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~-------~~~~----~~~~l~LVmEy~~GgsL~d~Ikk-~~~~~lse~~~~~il~QLL 86 (582)
...+++-.+.-..|.+..-+.+ .+.. ...++||.|++|+..+|.++|.. ..+...+......++.|+.
T Consensus 290 ~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~ 369 (516)
T KOG1033|consen 290 YTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIA 369 (516)
T ss_pred hhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhc
Confidence 3455666666665554443333 1111 12369999999999999999974 3445678889999999999
Q ss_pred HHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-------ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 87 MALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-------LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 87 ~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-------~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|++| +|.+|||+||.||+...++.+||+|||+........ .....+||.+||+||++.+..|+.++|||
T Consensus 370 ~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIy 446 (516)
T KOG1033|consen 370 PAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIY 446 (516)
T ss_pred cchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchh
Confidence 99999 999999999999999999999999999997766554 45567999999999999999999999999
Q ss_pred chhHHHHhHhcC-CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG-~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|||+++|||+.- ...| ........+..+..++.-..--+.-.+|+..||.+.|.+||++.+.-.|.|.
T Consensus 447 aLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 447 ALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 999999999872 2222 2222233333333332212222345589999999999999988777777664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=177.46 Aligned_cols=217 Identities=18% Similarity=0.223 Sum_probs=176.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
+||||-.......+. +..|....+.|. .+.|...|. |-.++.+-.+|||.+ |-+|.|+..- .+..|+...+.
T Consensus 55 ~VAIKfEPrkS~APQ----LrdEYr~YKlL~g~~GIP~vYY-FGqeG~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~ 127 (449)
T KOG1165|consen 55 PVAIKFEPRKSEAPQ----LRDEYRTYKLLGGTEGIPQVYY-FGQEGKYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVA 127 (449)
T ss_pred eEEEEeccccCCcch----HHHHHHHHHHHcCCCCCCceee-eccccchhhhhhhhh-CcCHHHHHHH-hcCcccHHhHH
Confidence 478888766555444 556788888875 688888775 445677888999999 8999999986 45689999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-----CeEEeecccchhccccc--------ccCcccCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-----DIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPEL 146 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-----~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~ 146 (582)
.++.|++.-++|+|++++|+|||||+|+||..-+ .|.|+|||+|+...... ..++..||-.||+-..
T Consensus 128 miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINT 207 (449)
T KOG1165|consen 128 MIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINT 207 (449)
T ss_pred HHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeec
Confidence 9999999999999999999999999999998654 39999999999876543 2456789999999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhcCCccccccC---HHHHHHHHhhccC----CCCCccccHHHHHHHHHhccCCCCCCC
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~---~~~l~~kI~~~~~----~~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
+.++.-+...|+-|||.+++.++.|.+||.+.. ..+-+++|-.... ..+...++.+|..-+...-..+-.+-|
T Consensus 208 HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 208 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred cccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 999999999999999999999999999998754 4445566543222 123456888999999999888988888
Q ss_pred CHHHH
Q 007991 220 SAAEL 224 (582)
Q Consensus 220 Sa~Ei 224 (582)
..+-+
T Consensus 288 DYdyl 292 (449)
T KOG1165|consen 288 DYDYL 292 (449)
T ss_pred CHHHH
Confidence 87654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=173.69 Aligned_cols=145 Identities=17% Similarity=0.266 Sum_probs=112.3
Q ss_pred EEEEEecccccCHH-HHHH------HHHHHHHHHhcCCCCeeeeeeEEEecC-------cEEEEEEeecCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDR-ARRS------AHQEMELISRVRNPFIVEYKDSWVEKG-------CYVCIIIGYCEGGDMAEAIKK 67 (582)
Q Consensus 2 yAIKki~~~~~~~~-~~~~------~~rEi~iL~~L~HpnIV~l~~~~~~~~-------~~l~LVmEy~~GgsL~d~Ikk 67 (582)
||||.++....... .... +.+|+..+.+|.|++|..+.+.+.... ...+|||||++|.+|.++..
T Consensus 57 ~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~- 135 (232)
T PRK10359 57 YILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE- 135 (232)
T ss_pred EEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-
Confidence 79999987554333 3333 689999999999999999988766432 35789999999999988732
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccc
Q 007991 68 ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 147 (582)
Q Consensus 68 ~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l 147 (582)
+++. .+.+++.+|..||+.|++||||||+||+++.+| ++|+|||............ .+.
T Consensus 136 -----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d-----------~~v 194 (232)
T PRK10359 136 -----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD-----------RID 194 (232)
T ss_pred -----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH-----------HHH
Confidence 3333 456999999999999999999999999999999 9999999886553322111 134
Q ss_pred cCCCCCCCCcccchhHHHHhH
Q 007991 148 ADIPYGSKSDIWSLGCCVYEM 168 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyEL 168 (582)
..+.|+.++|+|+||+++..+
T Consensus 195 ler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 195 LERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred HHhHhcccccccceeEeehHH
Confidence 455678899999999976654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=167.30 Aligned_cols=148 Identities=16% Similarity=0.085 Sum_probs=113.9
Q ss_pred HHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007991 17 RRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 95 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~ 95 (582)
...+.+|+++|++|.| ++|+.++++ ...|++|||+.|.+|.+.+.. . ...++.|++.+|++||++
T Consensus 45 ~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~ 110 (218)
T PRK12274 45 WWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRC 110 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHC
Confidence 3468999999999964 778888874 236899999999999754422 1 135788999999999999
Q ss_pred Cceeccc-CcccEEEcCCCCeEEeecccchhcccccc--------------cCcccCCCCCCCcccccCC-CCC-CCCcc
Q 007991 96 HILHRDV-KCSNIFLTRDQDIRLGDFGLAKMLISDDL--------------ASSVVGTPSYMCPELLADI-PYG-SKSDI 158 (582)
Q Consensus 96 gIiHRDI-KP~NILL~~~g~vKL~DFGla~~~~~~~~--------------~~~~vGTp~Y~APE~l~~~-~y~-~ksDI 158 (582)
||+|||| ||+|||++.+|.++|+|||++........ .....+++.|+.|+..... ..+ ...++
T Consensus 111 GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w 190 (218)
T PRK12274 111 GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELW 190 (218)
T ss_pred cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHH
Confidence 9999999 79999999999999999999985443221 0112357888888865432 222 56789
Q ss_pred cchhHHHHhHhcCCcccccc
Q 007991 159 WSLGCCVYEMSAQKAAFKAF 178 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~ 178 (582)
++.|+.+|.++|+..++-+.
T Consensus 191 ~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 191 FATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHhcchHHHHHhccCCcccc
Confidence 99999999999998876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=162.36 Aligned_cols=102 Identities=17% Similarity=0.196 Sum_probs=82.1
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHCCc
Q 007991 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYL-HANHI 97 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yL-Hs~gI 97 (582)
...+|+++|.++.++++........ .+ .+|||||++|+++...+.+. ..+++..+..++.|++.+|.|| |+.||
T Consensus 65 ~~~~E~~~l~~l~~~~v~~p~~~~~-~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~gi 139 (190)
T cd05147 65 WAEKEMRNLKRLVTAGIPCPEPILL-KS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRL 139 (190)
T ss_pred HHHHHHHHHHHHHHCCCCCCcEEEe-cC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3456999999999887744333222 22 37999999988776554332 2689999999999999999999 79999
Q ss_pred eecccCcccEEEcCCCCeEEeecccchhc
Q 007991 98 LHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 98 iHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
+||||||+|||++ ++.++|+|||++...
T Consensus 140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 140 VHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred ccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=161.91 Aligned_cols=215 Identities=16% Similarity=0.206 Sum_probs=168.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||........+ ++..|..+.+.|.+ ..|..+..+ ..+..+-.+||+.+ |-+|.++..-- ...|+...+.-
T Consensus 43 VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y-~~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLM 115 (341)
T KOG1163|consen 43 VAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHY-GTEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLM 115 (341)
T ss_pred EEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhh-ccccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHH
Confidence 7888876654443 35679999999976 445555543 44456888999999 89999998753 34699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC---CCeEEeecccchhccccc--------ccCcccCCCCCCCcccccC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l~~ 149 (582)
++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||+++...+.. ......||..|++-..+.+
T Consensus 116 LaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g 195 (341)
T KOG1163|consen 116 LADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG 195 (341)
T ss_pred HHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh
Confidence 99999999999999999999999999998755 348999999998865432 2345789999999888888
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHHH---HHHHHhhcc----CCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQA---LINKINKSI----VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~---l~~kI~~~~----~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
..-+...|+-|+|++|..+..|..||.+..... -+++|.... ...+...++.+|.-.+..|-..--++-|...
T Consensus 196 ~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 196 IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 888889999999999999999999998865433 344443222 2224566889999999999988888888754
Q ss_pred H
Q 007991 223 E 223 (582)
Q Consensus 223 E 223 (582)
-
T Consensus 276 y 276 (341)
T KOG1163|consen 276 Y 276 (341)
T ss_pred H
Confidence 3
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.2e-17 Score=155.92 Aligned_cols=103 Identities=16% Similarity=0.146 Sum_probs=84.3
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHH-HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Q 007991 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA-IKKANGVHFPEEKLCKWLVQLLMALNYLHA-NH 96 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~-Ikk~~~~~lse~~~~~il~QLL~aL~yLHs-~g 96 (582)
.+.+|+..+.++.|++|.....++.. ..||||||++|+++... +.. . .+++..+..++.|++.+|.|||. +|
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~-~--~~~~~~~~~i~~~l~~~l~~lH~~~g 138 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLK---KNVLVMEFIGDDGSPAPRLKD-V--PLEEEEAEELYEQVVEQMRRLYQEAG 138 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEec---CCEEEEEEecCCCchhhhhhh-c--cCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 45789999999999987554443332 23799999998865443 433 2 57889999999999999999999 99
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
|+||||||+|||++ ++.++|+|||++.....
T Consensus 139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999998 88999999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=167.26 Aligned_cols=217 Identities=18% Similarity=0.300 Sum_probs=178.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+|.|+++....+.+..+.|..|.-.|+-+.||||+++++.+... ..+.++..|+.-|+|+.++.+..+..++..++.++
T Consensus 216 ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~f 294 (448)
T KOG0195|consen 216 IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRF 294 (448)
T ss_pred hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceEeeeeccchHHHHHHhcCccEEEecchHHHH
Confidence 35677777777777778899999999999999999999998665 47789999999999999999887778899999999
Q ss_pred HHHHHHHHHHHHHCC--ceecccCcccEEEcCCCCeEE--eecccchhcccccccCcccCCCCCCCcccccCCCCC---C
Q 007991 82 LVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRL--GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG---S 154 (582)
Q Consensus 82 l~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~vKL--~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~---~ 154 (582)
+.+++.|+.|||+.. |.--.|....|+||++-..+| +|--++- ......-.|.||+||.+...+-+ .
T Consensus 295 aldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~r 368 (448)
T KOG0195|consen 295 ALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIR 368 (448)
T ss_pred HHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchh
Confidence 999999999999974 334468899999999877666 3322211 11223446899999999876643 4
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHH-hhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
++|+|||.++++||.+...||.+....+.--+| ..++...+|..++..+..|++-|++.||.+||.++.|+
T Consensus 369 aadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 369 AADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred hhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 799999999999999999999998877766555 34566678999999999999999999999999987765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=157.94 Aligned_cols=115 Identities=19% Similarity=0.177 Sum_probs=91.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCCeeeeeeEEEecC--cE-EEEEEee--cCCCCHHHHHHHhCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-----RNPFIVEYKDSWVEKG--CY-VCIIIGY--CEGGDMAEAIKKANGV 71 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-----~HpnIV~l~~~~~~~~--~~-l~LVmEy--~~GgsL~d~Ikk~~~~ 71 (582)
.+||++...... ..+.+.+|+.+++.| .||||+++++++..+. .+ +.+|||| +.+++|.+++++.
T Consensus 27 k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--- 101 (210)
T PRK10345 27 RCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--- 101 (210)
T ss_pred eEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---
Confidence 468888764332 346789999999999 6799999999887653 34 3378999 5579999999763
Q ss_pred CCCHHHHHHHHHHHHHHH-HHHHHCCceecccCcccEEEcCC----CCeEEeecccc
Q 007991 72 HFPEEKLCKWLVQLLMAL-NYLHANHILHRDVKCSNIFLTRD----QDIRLGDFGLA 123 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL-~yLHs~gIiHRDIKP~NILL~~~----g~vKL~DFGla 123 (582)
.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+-+
T Consensus 102 ~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 102 RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 36666 36688988888 99999999999999999999753 37999995434
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=172.84 Aligned_cols=198 Identities=22% Similarity=0.357 Sum_probs=156.9
Q ss_pred HHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecccCcc
Q 007991 27 ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHI-LHRDVKCS 105 (582)
Q Consensus 27 L~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gI-iHRDIKP~ 105 (582)
|+.+.|.|+.++++.++.. ..+++|.+||..|+|.|.+.. ....+++.-...++++|+.||.|||.-.| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678999999999998876 588899999999999999997 34568888899999999999999998865 99999999
Q ss_pred cEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCC-------CCCCCcccchhHHHHhHhcCCccc
Q 007991 106 NIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIP-------YGSKSDIWSLGCCVYEMSAQKAAF 175 (582)
Q Consensus 106 NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~-------y~~ksDIWSLG~iLyELltG~~PF 175 (582)
|.+++....+||+|||+....... .......-..-|.|||++.... .+.+.||||+|++++|++....||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766421 1111122334689999997642 355799999999999999999999
Q ss_pred cc----cCHHHHHHHHhh-ccCCCCCc-----cccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 176 KA----FDMQALINKINK-SIVAPLPT-----VYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 176 ~~----~~~~~l~~kI~~-~~~~~lp~-----~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.. .+..+++.++.+ ......|. ...+++..++..||..+|..||+++++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 65 233456666555 22112222 23457889999999999999999988853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-18 Score=191.03 Aligned_cols=230 Identities=22% Similarity=0.336 Sum_probs=185.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
+|.|.+..........+.+..|..+-+.+. |+|++.+++..... .+.+++++|..|+++.+.+........+...+..
T Consensus 49 ~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~ 127 (601)
T KOG0590|consen 49 SATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASR 127 (601)
T ss_pred eeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-cccccccCcccccccccccccCCccCCCCcchhh
Confidence 345555554444455566777999988887 99999999987654 5788999999999999999533333678888999
Q ss_pred HHHHHHHHHHHHH-HCCceecccCcccEEEcCCC-CeEEeecccchhccc-cc---ccCcccC-CCCCCCcccccCCC-C
Q 007991 81 WLVQLLMALNYLH-ANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLIS-DD---LASSVVG-TPSYMCPELLADIP-Y 152 (582)
Q Consensus 81 il~QLL~aL~yLH-s~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~-~~---~~~~~vG-Tp~Y~APE~l~~~~-y 152 (582)
++.|+..+|.|+| ..++.||||||+|.+++..+ .+++.|||+|..... .. .....+| ++.|+|||.+.+.. .
T Consensus 128 ~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~ 207 (601)
T KOG0590|consen 128 YLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYR 207 (601)
T ss_pred hhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhc
Confidence 9999999999999 99999999999999999999 999999999987765 22 3445688 99999999998854 4
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHH--HHHhh--ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI--NKINK--SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~--~kI~~--~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
....|+||.|+++.-|++|..||......... ..+.. ......+..++....+++.++|..+|..|.+.+++-.++
T Consensus 208 ~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 208 GPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred CCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence 67899999999999999999999765543321 11111 112345667899999999999999999999999999999
Q ss_pred CCch
Q 007991 229 HLQP 232 (582)
Q Consensus 229 ~f~~ 232 (582)
|+..
T Consensus 288 ~~~~ 291 (601)
T KOG0590|consen 288 WLSS 291 (601)
T ss_pred cccc
Confidence 9976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.64 E-value=8e-17 Score=166.19 Aligned_cols=209 Identities=21% Similarity=0.262 Sum_probs=126.8
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCC----------CCeeeeeeEEE--------ecC---c-----EEEEEEe
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRN----------PFIVEYKDSWV--------EKG---C-----YVCIIIG 54 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~H----------pnIV~l~~~~~--------~~~---~-----~l~LVmE 54 (582)
+|||+........ ...+.+++|.-....+.+ -.++-.++... ..+ . ..+++|.
T Consensus 40 ~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P 119 (288)
T PF14531_consen 40 FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMP 119 (288)
T ss_dssp EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE
T ss_pred EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccc
Confidence 6888886655322 245677777655555432 12222222211 111 1 1356777
Q ss_pred ecCCCCHHHHHHH---hCCCCCC-HHHHHH-HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc
Q 007991 55 YCEGGDMAEAIKK---ANGVHFP-EEKLCK-WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 129 (582)
Q Consensus 55 y~~GgsL~d~Ikk---~~~~~ls-e~~~~~-il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~ 129 (582)
-. .++|.+++.- ....... ...++. +..|++..+++||..||+|+||+|+|+|++.+|.++|+||+........
T Consensus 120 ~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~ 198 (288)
T PF14531_consen 120 RA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR 198 (288)
T ss_dssp ---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE
T ss_pred hh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCce
Confidence 66 5888877653 2221111 223333 3389999999999999999999999999999999999999877654432
Q ss_pred cccCcccCCCCCCCcccccC--------CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccH
Q 007991 130 DLASSVVGTPSYMCPELLAD--------IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSG 201 (582)
Q Consensus 130 ~~~~~~vGTp~Y~APE~l~~--------~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~ 201 (582)
... ...+..|.+||.... ..++.+.|.|+||+++|.|.+|..||........... ...... .+++
T Consensus 199 ~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~-~~Pe 271 (288)
T PF14531_consen 199 YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCR-DMPE 271 (288)
T ss_dssp EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS----H
T ss_pred eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcC-CcCH
Confidence 221 445578999997744 2478899999999999999999999976543222111 122233 7899
Q ss_pred HHHHHHHHhccCCCCCC
Q 007991 202 AFRGLVKSMLRKNPEFR 218 (582)
Q Consensus 202 ~l~~LI~kmL~~dP~~R 218 (582)
.++.||..||+.||.+|
T Consensus 272 ~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCcccC
Confidence 99999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-15 Score=177.03 Aligned_cols=205 Identities=20% Similarity=0.264 Sum_probs=152.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC---CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~---HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
+||||+-+.....+ |+-=.+++.+|+ -+.|+.+...++..+ .-+||+||.+.|+|.+++.. ...++|..
T Consensus 724 ~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-~S~lv~ey~~~Gtlld~~N~--~~~m~e~l 795 (974)
T KOG1166|consen 724 LVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQN-ASVLVSEYSPYGTLLDLINT--NKVMDEYL 795 (974)
T ss_pred EEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCC-cceeeeeccccccHHHhhcc--CCCCCchh
Confidence 48899988877642 333455566665 244555555555544 45699999999999999994 44799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-------CCeEEeecccchhc---ccccccCcccCCCCCCCcccc
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-------QDIRLGDFGLAKML---ISDDLASSVVGTPSYMCPELL 147 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-------g~vKL~DFGla~~~---~~~~~~~~~vGTp~Y~APE~l 147 (582)
+..++.|+|..+++||..||||+||||+|.||... --++|+|||.+..+ .........++|-.+-++|..
T Consensus 796 v~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~ 875 (974)
T KOG1166|consen 796 VMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR 875 (974)
T ss_pred hhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh
Confidence 99999999999999999999999999999999643 23999999998653 333456778999999999999
Q ss_pred cCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCc----cccH-HHHHHHHHhccCCCCCCCCHH
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT----VYSG-AFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~----~~S~-~l~~LI~kmL~~dP~~RpSa~ 222 (582)
.++++++..|.|.|..+++.|+.|+. ++ ...+..+.... .+-. .+-.|...||+.|-..=|...
T Consensus 876 ~grpWtYq~DyfGlAa~~h~mLFG~y----------~q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~ 944 (974)
T KOG1166|consen 876 EGRPWTYQIDYFGLAATVHVMLFGKY----------ME-VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQ 944 (974)
T ss_pred cCCCCchhhhhHHHHHHHHHHHHHHH----------HH-hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHH
Confidence 99999999999999999999999976 22 22333332222 2322 344678888884333335555
Q ss_pred HH
Q 007991 223 EL 224 (582)
Q Consensus 223 Ei 224 (582)
+|
T Consensus 945 ~l 946 (974)
T KOG1166|consen 945 EL 946 (974)
T ss_pred HH
Confidence 44
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-14 Score=138.68 Aligned_cols=116 Identities=25% Similarity=0.307 Sum_probs=94.1
Q ss_pred EEEEEeccccc-CH-----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQ-TD-----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~-~~-----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
+|||+...... .+ .....+.+|+.++..+.|++|.....++... ...++||||++|++|.+++.... .
T Consensus 22 ~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~~~G~~L~~~~~~~~-----~ 95 (211)
T PRK14879 22 AVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVMEYIEGEPLKDLINSNG-----M 95 (211)
T ss_pred eEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEEEEeCCcCHHHHHHhcc-----H
Confidence 67887654332 11 1235688999999999999887666555544 46789999999999999987532 2
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 96 -~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 -EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred -HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7889999999999999999999999999999999 78899999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.4e-14 Score=144.42 Aligned_cols=104 Identities=16% Similarity=0.164 Sum_probs=81.4
Q ss_pred HHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 007991 18 RSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH- 96 (582)
Q Consensus 18 ~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~g- 96 (582)
..+.+|+.+++++.+.. +.+...+... ..|+||||+.|++|........ .+.+..+..++.||+.+|+|||++|
T Consensus 95 ~~~~~E~~~L~~L~~~~-i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~ 169 (237)
T smart00090 95 LWAEKEFRNLQRLYEAG-VPVPKPIAWR--RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGE 169 (237)
T ss_pred HHHHHHHHHHHHHHhcC-CCCCeeeEec--CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCC
Confidence 45689999999997633 2222222222 3479999999988876653322 4667778899999999999999999
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhcc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~~ 127 (582)
|+||||||+||+++ ++.++|+|||++....
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999999 8899999999987543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.4e-14 Score=142.68 Aligned_cols=104 Identities=22% Similarity=0.308 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHHHhcCCCCe--eeeeeEEEecCcE---EEEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVRNPFI--VEYKDSWVEKGCY---VCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 89 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~HpnI--V~l~~~~~~~~~~---l~LVmEy~~G-gsL~d~Ikk~~~~~lse~~~~~il~QLL~aL 89 (582)
....+.+|+.++.+|.|++| +..+++....... .++||||++| .+|.+++... .+++.. +.||+.+|
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l 155 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLI 155 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHH
Confidence 34568899999999998875 5666654433332 3599999997 6999988752 456543 57899999
Q ss_pred HHHHHCCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 90 NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 90 ~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
.+||++||+||||||+|||++.++.++|+|||.+...
T Consensus 156 ~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 156 ARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 9999999999999999999999999999999988653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.3e-14 Score=136.11 Aligned_cols=113 Identities=27% Similarity=0.334 Sum_probs=88.4
Q ss_pred EEEEEecccc-cCH-----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLAR-QTD-----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~-~~~-----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
+|||+..... ..+ ...+.+.+|++++..+.|+++....-++... ...++||||++|++|.+++.... .
T Consensus 20 ~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~~~g~~l~~~~~~~~---~-- 93 (199)
T TIGR03724 20 AVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVMEYIEGKPLKDVIEEGN---D-- 93 (199)
T ss_pred EEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEEEECCccHHHHHhhcH---H--
Confidence 6788754322 111 1236678999999999988755444334433 35689999999999999886531 1
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
.++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 94 ----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 7899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.6e-14 Score=164.06 Aligned_cols=216 Identities=25% Similarity=0.366 Sum_probs=175.4
Q ss_pred HHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 007991 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHR 100 (582)
Q Consensus 21 ~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHR 100 (582)
.++-.++-...+|.++.....+. .....++|++|..|++|...+...+ ..+++-++.++..+..+++|||...+.||
T Consensus 852 r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~ 928 (1205)
T KOG0606|consen 852 RSKSNILITPRSPAVVRSFPSFP-CRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHR 928 (1205)
T ss_pred CCccCccccCCCCceecccCCCC-CCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcc
Confidence 33444444445677776555433 3457889999999999999998765 57889999999999999999999999999
Q ss_pred ccCcccEEEcCCCCeEEeecccchhcc-------c--------------c-----------cccCcccCCCCCCCccccc
Q 007991 101 DVKCSNIFLTRDQDIRLGDFGLAKMLI-------S--------------D-----------DLASSVVGTPSYMCPELLA 148 (582)
Q Consensus 101 DIKP~NILL~~~g~vKL~DFGla~~~~-------~--------------~-----------~~~~~~vGTp~Y~APE~l~ 148 (582)
|++|.|+|+..+|+.++.|||...... . . ......+||+.|.+||.+.
T Consensus 929 ~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 929 DLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred cccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc
Confidence 999999999999999999998432210 0 0 0122358999999999999
Q ss_pred CCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC-CC-CCccccHHHHHHHHHhccCCCCCCCCHH---H
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV-AP-LPTVYSGAFRGLVKSMLRKNPEFRPSAA---E 223 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~-~~-lp~~~S~~l~~LI~kmL~~dP~~RpSa~---E 223 (582)
+...+..+|+|++|++++|.++|.+||.....+..++.|..... |+ -+...+..+++++..+|..++.+|..+. +
T Consensus 1009 g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1009 GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred cccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence 99999999999999999999999999999999888887755443 22 3456899999999999999999998876 9
Q ss_pred HHcCCCCchhhhhhhc
Q 007991 224 LLCHPHLQPYVLGIHL 239 (582)
Q Consensus 224 iL~hp~f~~~~~~~~~ 239 (582)
+-.|+||++..|....
T Consensus 1089 ~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1089 VKGHPFFQDVDWENLA 1104 (1205)
T ss_pred cccCCccCCCCccccc
Confidence 9999999987766544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.4e-13 Score=152.32 Aligned_cols=98 Identities=24% Similarity=0.303 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007991 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 96 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~g 96 (582)
.+.+.+|+++|..++|++|+....++... ...++||||++|++|.+++. ....++.|++.+|.|||+.|
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDP-EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeC-CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC
Confidence 46688999999999999988766655543 35679999999999998886 24678999999999999999
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
|+||||||+|||+ .++.++|+|||+++..
T Consensus 449 iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 449 IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999 6788999999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.7e-13 Score=133.42 Aligned_cols=98 Identities=16% Similarity=0.151 Sum_probs=79.3
Q ss_pred HHHHHHHHHHHhcCCCC--eeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007991 18 RSAHQEMELISRVRNPF--IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 95 (582)
Q Consensus 18 ~~~~rEi~iL~~L~Hpn--IV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~ 95 (582)
..+.+|+.++..+.|.+ +...++ . ...|+||||++|++|.++... .....++.+++.++.++|..
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~-~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----W-NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----c-CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC
Confidence 34788999999998874 444332 1 245899999999998765431 34567889999999999999
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
||+||||||+||+++.++.++|+|||++.....
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-13 Score=139.50 Aligned_cols=203 Identities=25% Similarity=0.434 Sum_probs=147.2
Q ss_pred HHHHhcCCCCeeeeeeEEEec----CcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 007991 25 ELISRVRNPFIVEYKDSWVEK----GCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLHAN--H 96 (582)
Q Consensus 25 ~iL~~L~HpnIV~l~~~~~~~----~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~~~il~QLL~aL~yLHs~--g 96 (582)
.-|-++.|.|||+++.+|.+. .....+++||++.|+|..++++- +...+.....++|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345666799999999988743 23678999999999999999853 445688888999999999999999988 4
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchh---cc--cccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcC
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKM---LI--SDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 171 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~---~~--~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG 171 (582)
|+|+.+.+.-|++..+|-||+.--.-... .. .........|-++|.+||.=.....+.++|||++|.|..+|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888743111100 00 01112234567899999988777778899999999999999887
Q ss_pred Cccc-cccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 172 KAAF-KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 172 ~~PF-~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
..-- .+.+....-..|..... ..-.+--+++|.+||+-.|..||++.++|.||.+=
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~----~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVII----GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhhhee----eccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 6532 11111111111111111 01122346899999999999999999999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-13 Score=151.09 Aligned_cols=226 Identities=23% Similarity=0.307 Sum_probs=172.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|+-+.....+.....=.+|+...+.++ |++.++.+..|.. +...|+-+|+| |.+|..+.... ...+++..++.
T Consensus 146 ~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~ 222 (524)
T KOG0601|consen 146 FAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWN 222 (524)
T ss_pred cccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCcceeeeccc-cchhHHhhhcc-cccCCchhhhh
Confidence 566765554444444455678888888886 8999998887755 45899999999 58888777763 34689999999
Q ss_pred HHHHHHH----HHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccccccCcc------cCCCCCCCcccccC
Q 007991 81 WLVQLLM----ALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSV------VGTPSYMCPELLAD 149 (582)
Q Consensus 81 il~QLL~----aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~------vGTp~Y~APE~l~~ 149 (582)
.+.+.+. ||.++|..+++|-|+||+||++..+ ..++++|||+...+........+ -|..-|++||.+.+
T Consensus 223 ~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~ 302 (524)
T KOG0601|consen 223 SLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG 302 (524)
T ss_pred HHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc
Confidence 9999999 9999999999999999999999999 88999999999887665533222 46678999999987
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
-++...|||++|.++.+-.+|...+....... +..+.... ...+....+..+..++..|++.+|..|++++.++.|+
T Consensus 303 -l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~ 380 (524)
T KOG0601|consen 303 -LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALN 380 (524)
T ss_pred -ccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence 46789999999999999888765543221000 11111111 1112334566777799999999999999999999999
Q ss_pred CCch
Q 007991 229 HLQP 232 (582)
Q Consensus 229 ~f~~ 232 (582)
++..
T Consensus 381 ~i~s 384 (524)
T KOG0601|consen 381 VIHS 384 (524)
T ss_pred cccc
Confidence 9864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=117.12 Aligned_cols=110 Identities=20% Similarity=0.228 Sum_probs=90.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC--CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H--pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
|+||....... ...+.+|+.++..+.| .++++++..+.. ....|++|||+.|+.+..+ +.....
T Consensus 24 ~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~~~~~~---------~~~~~~ 89 (155)
T cd05120 24 YVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGETLDEV---------SEEEKE 89 (155)
T ss_pred EEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCeecccC---------CHHHHH
Confidence 67787765433 4578899999999987 488888876543 3578999999998877643 456667
Q ss_pred HHHHHHHHHHHHHHHC---CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 80 KWLVQLLMALNYLHAN---HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~---gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
.++.+++.+|.+||.. +++|+||+|.||+++..+.++++|||++..
T Consensus 90 ~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 90 DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.6e-12 Score=120.60 Aligned_cols=97 Identities=16% Similarity=0.201 Sum_probs=72.4
Q ss_pred HHHHHHHHhcCCCC--eeeeeeEEEecCcEEEEEEeecCCCCHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Q 007991 21 HQEMELISRVRNPF--IVEYKDSWVEKGCYVCIIIGYCEGGDMAE-AIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NH 96 (582)
Q Consensus 21 ~rEi~iL~~L~Hpn--IV~l~~~~~~~~~~l~LVmEy~~GgsL~d-~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs-~g 96 (582)
..|...+.++.+.. +...+.. ...++||||+.|+.+.. .+.... .. ..++.++.|++.++.++|. .|
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec-----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC
Confidence 46788888886554 3333332 13589999999854431 222211 11 6678999999999999999 99
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhcc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~~ 127 (582)
|+||||||+||+++ ++.++|+|||++....
T Consensus 136 ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 136 LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999999 8899999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.3e-12 Score=138.80 Aligned_cols=220 Identities=26% Similarity=0.258 Sum_probs=163.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
|++|.+............-..|+.+...+. |.++++++..|...+ ..||-.|||+|+++...+.-. ..+++...++
T Consensus 294 Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~ 370 (524)
T KOG0601|consen 294 YAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-QGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLR 370 (524)
T ss_pred EeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-cccCchhhhcCcchhhhhHHH--HhcCcchhhh
Confidence 566666554444444555567888877775 999999999987665 667999999999988766433 2689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccccccCcccCCCCCC--CcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYM--CPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~--APE~l~~~~y~~ksD 157 (582)
+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+...+.. ......+.-++. +++.+....+..+.|
T Consensus 371 ~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~ 448 (524)
T KOG0601|consen 371 LTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKAD 448 (524)
T ss_pred hHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--ecccccccccccccchhhccccccccccc
Confidence 99999999999999999999999999999886 7899999998865221 112222333444 566667778899999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+++||..+++.+++.+.-..... ...|..+... ........+..+.+.|+..++..|+.+.++..|.-|
T Consensus 449 ~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 449 IFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccccccccccccCcccCccccc---ceeeeccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 99999999999998654322211 1122222222 233344889999999999999999999999888655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=128.69 Aligned_cols=158 Identities=22% Similarity=0.356 Sum_probs=121.0
Q ss_pred EEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHH
Q 007991 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82 (582)
Q Consensus 3 AIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il 82 (582)
.|........ .....+.+-++-|+.|+||||++|++.+..++ .+|||+|-+ ..|..++++. ....++.-+
T Consensus 41 sVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV--~Pl~~~lk~l-----~~~~v~~Gl 110 (690)
T KOG1243|consen 41 SVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERV--RPLETVLKEL-----GKEEVCLGL 110 (690)
T ss_pred EEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeecc--ccHHHHHHHh-----HHHHHHHHH
Confidence 3444444333 44566788899999999999999999887655 899999999 6888888874 377888999
Q ss_pred HHHHHHHHHHH-HCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 83 VQLLMALNYLH-ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 83 ~QLL~aL~yLH-s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+||+.||.+|| +.+++|++|.-..|+++..|+-||++|.++....... ......---.|..|+.+.... -..|.|-
T Consensus 111 ~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 111 FQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhh
Confidence 99999999998 5689999999999999999999999999875432211 112222222466666654332 3579999
Q ss_pred hhHHHHhHhcCC
Q 007991 161 LGCCVYEMSAQK 172 (582)
Q Consensus 161 LG~iLyELltG~ 172 (582)
|||++++++.|.
T Consensus 189 Lg~li~el~ng~ 200 (690)
T KOG1243|consen 189 LGCLIEELFNGS 200 (690)
T ss_pred HHHHHHHHhCcc
Confidence 999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-10 Score=108.07 Aligned_cols=107 Identities=19% Similarity=0.152 Sum_probs=78.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
|+||....... ....+.+|+.+++.+.+.++++..-.+.. . ..++||||++|.++.+. ......+
T Consensus 24 ~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-~-~~~lv~e~i~G~~l~~~----------~~~~~~~ 88 (170)
T cd05151 24 YVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP-E-TGVLITEFIEGSELLTE----------DFSDPEN 88 (170)
T ss_pred EEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC-C-CCeEEEEecCCCccccc----------cccCHHH
Confidence 67887654322 12346789999999976665543322322 2 34699999999887643 0112345
Q ss_pred HHHHHHHHHHHHHCCc-----eecccCcccEEEcCCCCeEEeecccch
Q 007991 82 LVQLLMALNYLHANHI-----LHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 82 l~QLL~aL~yLHs~gI-----iHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
+.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 89 ~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 89 LEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7899999999999985 9999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.7e-10 Score=122.34 Aligned_cols=105 Identities=18% Similarity=0.202 Sum_probs=73.7
Q ss_pred HHHHHHHHHhcC----CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 007991 20 AHQEMELISRVR----NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLM-ALNYLHA 94 (582)
Q Consensus 20 ~~rEi~iL~~L~----HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~-aL~yLHs 94 (582)
+.+|+..+.++. |.+-|.+-.+|.+-....++||||++|++|.++...... .+. ...++.+++. .+..+|.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh
Confidence 455676666663 333333333343323346799999999999987754211 122 2345555555 4788999
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
.|++|+|+||.||+++.+|.++|+|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999977643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.9e-09 Score=108.67 Aligned_cols=107 Identities=15% Similarity=0.056 Sum_probs=81.5
Q ss_pred HHHHHHHHHHhcCCCCe--eeeeeEEEec----CcEEEEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 007991 19 SAHQEMELISRVRNPFI--VEYKDSWVEK----GCYVCIIIGYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 91 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnI--V~l~~~~~~~----~~~l~LVmEy~~Gg-sL~d~Ikk~~~~~lse~~~~~il~QLL~aL~y 91 (582)
.+.+|...+.+|..-+| ..+..++... ...-+||||+++|. +|.+++........++.....++.++...+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47899999988853332 2333333221 23577999999876 89999865322346677888999999999999
Q ss_pred HHHCCceecccCcccEEEcC-------CCCeEEeecccchh
Q 007991 92 LHANHILHRDVKCSNIFLTR-------DQDIRLGDFGLAKM 125 (582)
Q Consensus 92 LHs~gIiHRDIKP~NILL~~-------~g~vKL~DFGla~~ 125 (582)
||..||+|+|+++.|||++. +..+.|+||+.+..
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999985 35799999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-09 Score=106.50 Aligned_cols=99 Identities=16% Similarity=0.223 Sum_probs=75.2
Q ss_pred HHHHHHHHHhcCC--CCeeeeeeEEEecCcEEEEEEeecCCCCHH-HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HHC
Q 007991 20 AHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGYCEGGDMA-EAIKKANGVHFPEEKLCKWLVQLLMALNYL-HAN 95 (582)
Q Consensus 20 ~~rEi~iL~~L~H--pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~-d~Ikk~~~~~lse~~~~~il~QLL~aL~yL-Hs~ 95 (582)
..+|+..|++|.. -++..+++. . .-+|||||+.+..+. ..++.. .+++..+..++.|++.+|.+| |..
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~--~---~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL--K---KHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe--c---CCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3499999999964 345555542 1 345899999765442 233321 456677788899999999999 899
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhcc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~ 127 (582)
||||+||++.|||++ ++.+.|+|||.+....
T Consensus 145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999999996 5789999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.8e-09 Score=113.00 Aligned_cols=199 Identities=20% Similarity=0.316 Sum_probs=145.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe---cCcEEEEEEeecC-CCCHHHHHHH----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVCIIIGYCE-GGDMAEAIKK---------- 67 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~-GgsL~d~Ikk---------- 67 (582)
||+|.++..+..... ....-+++++++.|.|||++.++|.. .+..+++|++|.+ .++|.++.-.
T Consensus 304 YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~ 381 (655)
T KOG3741|consen 304 YVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNS 381 (655)
T ss_pred eeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccccc
Confidence 788888443321111 11234788999999999999999883 3568999999987 4677766522
Q ss_pred ---hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCc
Q 007991 68 ---ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 144 (582)
Q Consensus 68 ---~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~AP 144 (582)
..+...+|..++.|+.||..||.++|+.|+.-+-|.+.+||++.+-+++|...|+...+..+. +
T Consensus 382 ~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------~------- 448 (655)
T KOG3741|consen 382 FYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------T------- 448 (655)
T ss_pred ccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC------C-------
Confidence 134568899999999999999999999999999999999999988888888777766554443 1
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhcCCcc-ccccCHHHH-HHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSAQKAA-FKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELltG~~P-F~~~~~~~l-~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
|.+. --.+-|.=.||.+++.|.+|... +.....+.. ... +...+|.+++++|..+...++++ -+++
T Consensus 449 ~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------I~~~yS~D~rn~v~yl~s~~~~~-ksI~ 516 (655)
T KOG3741|consen 449 EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------ITTTYSTDLRNVVEYLESLNFRE-KSIQ 516 (655)
T ss_pred cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------hhhhhhHHHHHHHHHHHhcCccc-ccHH
Confidence 1111 12457999999999999999653 222221111 222 34568999999999999999987 6788
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
++|.+
T Consensus 517 ~llp~ 521 (655)
T KOG3741|consen 517 DLLPM 521 (655)
T ss_pred HHHHH
Confidence 88764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.1e-09 Score=101.50 Aligned_cols=98 Identities=26% Similarity=0.344 Sum_probs=75.0
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007991 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 96 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~g 96 (582)
++...+|+.+|.++.--.|.-..-++++.+ ...|+|||++|..|.+.+... .-.++..+=.-+.-||..|
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~-~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g 112 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPD-NGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG 112 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC
Confidence 466789999999997544332222233333 455999999999999898864 1446667777778899999
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchh
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
|+|+||.++||++..++ +.++||||+..
T Consensus 113 ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999997665 99999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.90 E-value=3e-09 Score=119.01 Aligned_cols=100 Identities=17% Similarity=0.270 Sum_probs=67.9
Q ss_pred HHHHHHHHhcC----CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHH--HHhCCC---CCCHHHHHHHHHHHHHHHHH
Q 007991 21 HQEMELISRVR----NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI--KKANGV---HFPEEKLCKWLVQLLMALNY 91 (582)
Q Consensus 21 ~rEi~iL~~L~----HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~I--kk~~~~---~lse~~~~~il~QLL~aL~y 91 (582)
.+|+..+.++. +.+.|.+-.+|.+-....+||||||+|+.|.++. .. .+. .+.+..+..++.|++
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHHHHHHHHH-----
Confidence 34554554442 3334444444433233567999999999998743 32 221 244555666666664
Q ss_pred HHHCCceecccCcccEEEcCCC----CeEEeecccchhccc
Q 007991 92 LHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLIS 128 (582)
Q Consensus 92 LHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~ 128 (582)
..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999988 899999999987644
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.5e-09 Score=119.67 Aligned_cols=153 Identities=18% Similarity=0.260 Sum_probs=117.3
Q ss_pred HHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccc----------cCcccCCCCCCCccccc
Q 007991 80 KWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----------ASSVVGTPSYMCPELLA 148 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----------~~~~vGTp~Y~APE~l~ 148 (582)
.=+.+...||.|+|.. ++||+.|-|++|.++..|..||+.|+.+........ .....-...|.|||++.
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3345666899999976 899999999999999999999999998865433110 11123445799999999
Q ss_pred CCCCCCCCcccchhHHHHhHh-cCCccccccCHHHHHHHHhh---ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 149 DIPYGSKSDIWSLGCCVYEMS-AQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELl-tG~~PF~~~~~~~l~~kI~~---~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
....+.++|+||+||++|.+. +|+..+.+.+....+..-.. ....-....++.++++=|.++|..+...||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 988899999999999999999 67776665543322222111 11122346688999999999999999999999999
Q ss_pred HcCCCCch
Q 007991 225 LCHPHLQP 232 (582)
Q Consensus 225 L~hp~f~~ 232 (582)
+.-+||+.
T Consensus 263 ~~~~ff~D 270 (700)
T KOG2137|consen 263 LSIPFFSD 270 (700)
T ss_pred hcccccCC
Confidence 99999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.8e-08 Score=97.61 Aligned_cols=109 Identities=25% Similarity=0.337 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 94 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~G-gsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs 94 (582)
.+.+..+|+++|.++.--.|.-..-+|++. ..-+|+|||++| .++.+++...-...........++.+|=..|.-||.
T Consensus 53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ 131 (229)
T KOG3087|consen 53 TRKRTKQEARLLAKCRALGIPAPRLIFIDT-YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD 131 (229)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceEEEEec-CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh
Confidence 467789999999999754444333234433 345699999976 478888876543334444448899999999999999
Q ss_pred CCceecccCcccEEEcCCCC---eEEeecccchh
Q 007991 95 NHILHRDVKCSNIFLTRDQD---IRLGDFGLAKM 125 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~ 125 (582)
++|||+||..+||+|..+|. +.|+|||++..
T Consensus 132 ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 132 NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999999988764 58999999854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.2e-08 Score=97.65 Aligned_cols=107 Identities=21% Similarity=0.233 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHhcCCCC--eeeeeeEEEec---CcEEEEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 007991 18 RSAHQEMELISRVRNPF--IVEYKDSWVEK---GCYVCIIIGYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 91 (582)
Q Consensus 18 ~~~~rEi~iL~~L~Hpn--IV~l~~~~~~~---~~~l~LVmEy~~Gg-sL~d~Ikk~~~~~lse~~~~~il~QLL~aL~y 91 (582)
..+.+|...+..|..-. +...+.+.... ....+||+|+++|. +|.+++.... ..+......++.++...+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 45788999888885432 33333333321 23468999999874 8999998744 36778889999999999999
Q ss_pred HHHCCceecccCcccEEEcCCC---CeEEeecccchhc
Q 007991 92 LHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKML 126 (582)
Q Consensus 92 LHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~ 126 (582)
||.+||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999987 7999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.9e-08 Score=97.74 Aligned_cols=120 Identities=13% Similarity=0.172 Sum_probs=86.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCC--eeeeeeEEEecC--cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPF--IVEYKDSWVEKG--CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IV~l~~~~~~~~--~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
|++|..+..... .....+.+|+++++.+.+.+ +.+++.+....+ ...|+||||++|.+|.+.+.. ..+++..
T Consensus 25 ~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~ 100 (223)
T cd05154 25 LVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEE 100 (223)
T ss_pred eEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHH
Confidence 678887654432 23456889999999997643 455555433221 256899999999988765532 1466777
Q ss_pred HHHHHHHHHHHHHHHHH--------------------------------------------------------CCceecc
Q 007991 78 LCKWLVQLLMALNYLHA--------------------------------------------------------NHILHRD 101 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs--------------------------------------------------------~gIiHRD 101 (582)
...++.+++.+|.+||+ ..++|+|
T Consensus 101 ~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD 180 (223)
T cd05154 101 RRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGD 180 (223)
T ss_pred HHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECC
Confidence 77777777777777773 2469999
Q ss_pred cCcccEEEcC--CCCeEEeecccchh
Q 007991 102 VKCSNIFLTR--DQDIRLGDFGLAKM 125 (582)
Q Consensus 102 IKP~NILL~~--~g~vKL~DFGla~~ 125 (582)
+++.||+++. ++.+.|+||+.+..
T Consensus 181 ~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 181 YRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CCcccEEEcCCCCcEEEEEecccccc
Confidence 9999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.5e-08 Score=96.58 Aligned_cols=102 Identities=22% Similarity=0.274 Sum_probs=69.8
Q ss_pred HHHHHHHHHHHHHhcCCCC--eeeeeeEEEecCcEEEEEEeecC--CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVRNPF--IVEYKDSWVEKGCYVCIIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNY 91 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~Hpn--IV~l~~~~~~~~~~l~LVmEy~~--GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~y 91 (582)
.+..+.+|.+.|.++..-+ +..++++ ..+ +|||||++ |..+..+... .++.+....++.+++..+..
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~~---~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~ 121 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDY--NRN---VIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIK 121 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEE--ETT---EEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEE--eCC---EEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHH
Confidence 3466789999999998764 4455432 332 49999998 6666554433 22345667788888885555
Q ss_pred -HHHCCceecccCcccEEEcCCCCeEEeecccchhcc
Q 007991 92 -LHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127 (582)
Q Consensus 92 -LHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~ 127 (582)
+|..||+|+||.+.|||++.+ .+.|+|||.+....
T Consensus 122 ~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 122 MLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 579999999999999999877 89999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.8e-07 Score=108.37 Aligned_cols=204 Identities=20% Similarity=0.240 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeeeEEEecCc---EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007991 17 RRSAHQEMELISRVRNPFIVEYKDSWVEKGC---YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 93 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~---~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLH 93 (582)
+....-|+..+..+.|+|++.++.+-.+.-. .+.+..+||.+.++...++..+ ..+...++.+..+++.||.|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH
Confidence 3445668888999999999999987665432 3345678999999999999865 6899999999999999999999
Q ss_pred HCCceecccCcc---cEEEcCCCCeEEe--ecccchhcccccccCcccCCCCCCCcccccCCCCCCC--CcccchhHHHH
Q 007991 94 ANHILHRDVKCS---NIFLTRDQDIRLG--DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK--SDIWSLGCCVY 166 (582)
Q Consensus 94 s~gIiHRDIKP~---NILL~~~g~vKL~--DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k--sDIWSLG~iLy 166 (582)
+....|.-+... +-..+.++.+.+. ||+..+.+..........-...+.++|.+....+..+ .|+|.+|....
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 997666666555 4445566777776 9998888776666666677778899998887776554 69999999999
Q ss_pred hHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 167 EMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 167 ELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
-+..|..+-.... .... -++........+++.+|+.-+.++|+++.+++.|+|...
T Consensus 384 ~~~~~~~i~~~~~---~~~~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 384 QLSQGEDISEKSA---VPVS-------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhcCccccccc---chhh-------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 9888765322111 0110 112222227889999999999999999999999999865
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.2e-08 Score=117.78 Aligned_cols=220 Identities=15% Similarity=0.110 Sum_probs=171.6
Q ss_pred CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEE-ecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHHHHHHHHHHHHHH
Q 007991 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWV-EKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLCKWLVQLLMAL 89 (582)
Q Consensus 13 ~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~-~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~~~~il~QLL~aL 89 (582)
.+-.++....|..-++...|+++...+.-.. ..+...|++++||.+|.++..|-+.- ...+.+.-+-....+.+.+.
T Consensus 1269 sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence 3345566677777778889999887665433 23346789999999999999997631 22344444444445558888
Q ss_pred HHHHHC-----CceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcccchhH
Q 007991 90 NYLHAN-----HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 163 (582)
Q Consensus 90 ~yLHs~-----gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~ 163 (582)
.-+|+. -.+|+++|+-|.+|..+.++|++++|+.+...+ ....+..++++.|+.+++.....++.++|+|..|+
T Consensus 1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred chhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 888865 278999999999999999999999999994433 23456678889999999999999988899999999
Q ss_pred HHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 164 CVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 164 iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
-+|++..|..+|.......+-..+.......++...+++.-.....+|-.....||.-..++..+++..
T Consensus 1429 ~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 999999999998877666666666666666677777888887888888888889999999998888854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2e-06 Score=92.29 Aligned_cols=178 Identities=15% Similarity=0.230 Sum_probs=125.2
Q ss_pred EEEEEEeecCCCC-HHHHH----HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeeccc
Q 007991 48 YVCIIIGYCEGGD-MAEAI----KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122 (582)
Q Consensus 48 ~l~LVmEy~~Ggs-L~d~I----kk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGl 122 (582)
.+.++|-.+.|.. +..++ ++.....+.+.-+.+..+.|+.+...||..|.+-+|+.++|+|+.+++.|.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 3778888887652 22222 122334678999999999999999999999999999999999999999999987443
Q ss_pred chhcccccccCcccCCCCCCCccccc-----CCCCCCCCcccchhHHHHhHhcC-CccccccCHH-----HHHHHHhhcc
Q 007991 123 AKMLISDDLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQ-----ALINKINKSI 191 (582)
Q Consensus 123 a~~~~~~~~~~~~vGTp~Y~APE~l~-----~~~y~~ksDIWSLG~iLyELltG-~~PF~~~~~~-----~l~~kI~~~~ 191 (582)
-....++...-..+|.+.|.+||.-. +..-+...|.|-||++||+|+.| ..||.+.... -....|..+.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 33223444455678999999999643 44456789999999999998765 9999764311 0000111100
Q ss_pred ----------CCC-----CCccccHHHHHHHHHhccC--CCCCCCCHHHHH
Q 007991 192 ----------VAP-----LPTVYSGAFRGLVKSMLRK--NPEFRPSAAELL 225 (582)
Q Consensus 192 ----------~~~-----lp~~~S~~l~~LI~kmL~~--dP~~RpSa~EiL 225 (582)
..+ ....+++.+..|...|+.. ++.-|||++--+
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 111 1234678889999999875 467899987543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.3e-06 Score=82.66 Aligned_cols=110 Identities=11% Similarity=0.098 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHHHhcCCCC--eeeeeeEEEe---cCcEEEEEEeecCC-CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVRNPF--IVEYKDSWVE---KGCYVCIIIGYCEG-GDMAEAIKKANGVHFPEEKLCKWLVQLLMAL 89 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~Hpn--IV~l~~~~~~---~~~~l~LVmEy~~G-gsL~d~Ikk~~~~~lse~~~~~il~QLL~aL 89 (582)
.+..|.+|+..|.+|..-+ +.+....-.. ....-+||+|-+.| .+|.+++....-...++.....++.++...|
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~i 141 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAF 141 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHH
Confidence 4567999999999996432 3333311111 12346789997743 6888888764333567888889999999999
Q ss_pred HHHHHCCceecccCcccEEEcCCCC--eEEeecccchh
Q 007991 90 NYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKM 125 (582)
Q Consensus 90 ~yLHs~gIiHRDIKP~NILL~~~g~--vKL~DFGla~~ 125 (582)
.-||+.|+.|+|+.+.|||++.+|. |+++||.-++.
T Consensus 142 a~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 142 KKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999999999999999999987777 99999987754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.4e-06 Score=83.64 Aligned_cols=67 Identities=21% Similarity=0.362 Sum_probs=52.9
Q ss_pred EEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 48 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 48 ~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
..++||||++|..|.+... +++. +.-.|..++.-||..|++|+|.+|.|++++.++ ++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 4558999999998876532 3332 345677789999999999999999999998655 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-07 Score=104.52 Aligned_cols=210 Identities=21% Similarity=0.307 Sum_probs=148.1
Q ss_pred HHHHHHHHHHhcCCCC-eeeeeeEEEecCcEEEEEEeecCCC-CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007991 19 SAHQEMELISRVRNPF-IVEYKDSWVEKGCYVCIIIGYCEGG-DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 96 (582)
Q Consensus 19 ~~~rEi~iL~~L~Hpn-IV~l~~~~~~~~~~l~LVmEy~~Gg-sL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~g 96 (582)
...-++++|.+++||| .+.+++.+.. +.+.+++|+||.++ +-...+... ...+.+-+.....+.-+.+|+|||+.-
T Consensus 279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~ 356 (829)
T KOG0576|consen 279 SRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSY 356 (829)
T ss_pred hhHHHHHHHHHccCCCCcccccccCCc-ccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhccccccccccc
Confidence 3456899999999999 7777776644 45899999999877 222222111 112444555666777788999999998
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCcccc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~ 176 (582)
-+||| ||+.. ++.+++.||+....+.......+..+|+.++|||+.....+....|.|++|+--.+|.-|.+|-.
T Consensus 357 ~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 357 KVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCcc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 89999 88654 47799999999988877666778899999999999999999999999999998888888877754
Q ss_pred ccCHHHHHHHHhhccCCC-CC--ccccHHHH-HHHHHhccCCCCCCCCHHHHHcCCCCchhhhhh
Q 007991 177 AFDMQALINKINKSIVAP-LP--TVYSGAFR-GLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 177 ~~~~~~l~~kI~~~~~~~-lp--~~~S~~l~-~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~ 237 (582)
.-. .....+..+...+ +. ..++..+. ++...|+...|..|+..-.++.|.+|..--..+
T Consensus 432 ~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 432 SPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred CCc--cccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 311 0000000000000 00 11222233 488899999999999999999888776543333
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=5.6e-06 Score=84.89 Aligned_cols=98 Identities=22% Similarity=0.230 Sum_probs=76.2
Q ss_pred HHHHHHHHHHHHHhcCCC--CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007991 16 ARRSAHQEMELISRVRNP--FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH 93 (582)
Q Consensus 16 ~~~~~~rEi~iL~~L~Hp--nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLH 93 (582)
.+..+++|.++|.+|... .+...+++ +.-.+||||++|..|...- ++.+....++..|+.-+.-+=
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~-----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~ 219 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPIAW-----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY 219 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCcccc-----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH
Confidence 467789999999999765 66666652 2456999999997775332 234555666777777776666
Q ss_pred HCCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 94 ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 94 s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
..||||+|+.+-||+++.||.+.++||--+..
T Consensus 220 ~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 220 RRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred HcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999999999976543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.6e-05 Score=75.34 Aligned_cols=99 Identities=20% Similarity=0.200 Sum_probs=79.1
Q ss_pred HHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHH---HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--
Q 007991 21 HQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA---IKKANGVHFPEEKLCKWLVQLLMALNYLHA-- 94 (582)
Q Consensus 21 ~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~---Ikk~~~~~lse~~~~~il~QLL~aL~yLHs-- 94 (582)
..|.-+|+.+.+ +++.+++|++ + . ++|+||...+++... +.+ ...-++....+++.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G-~-~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---G-R-FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---C-C-EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 458899999987 6999999975 2 2 479999987766421 111 1135899999999999999999998
Q ss_pred -CCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 95 -NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 95 -~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
..+...|++++|+-++.+|++|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45889999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00016 Score=72.76 Aligned_cols=118 Identities=18% Similarity=0.134 Sum_probs=65.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCe--eeeeeEEEecCcEEEEEEeecCCCC-HH--------------HH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFI--VEYKDSWVEKGCYVCIIIGYCEGGD-MA--------------EA 64 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnI--V~l~~~~~~~~~~l~LVmEy~~Ggs-L~--------------d~ 64 (582)
+|+|..+... ....+.+|.++|..+..-.+ .+.+++ .+.+...++|||+++|.+ +. ..
T Consensus 25 ~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~-~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~ 99 (226)
T TIGR02172 25 WMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDL-VEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKI 99 (226)
T ss_pred EEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEE-EecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHH
Confidence 4556655432 12346889999999975444 344443 344556789999999864 11 11
Q ss_pred H----HHhCCC---CCCHHH-HHHHHHH----------HHH-HHHHHHH----CCceecccCcccEEEcCCCCeEEeecc
Q 007991 65 I----KKANGV---HFPEEK-LCKWLVQ----------LLM-ALNYLHA----NHILHRDVKCSNIFLTRDQDIRLGDFG 121 (582)
Q Consensus 65 I----kk~~~~---~lse~~-~~~il~Q----------LL~-aL~yLHs----~gIiHRDIKP~NILL~~~g~vKL~DFG 121 (582)
+ .+-... ...... ...+..+ +.. ...+|.. ..++|+|++|.||+++.++ +.|+||+
T Consensus 100 la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe 178 (226)
T TIGR02172 100 FAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLG 178 (226)
T ss_pred HHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEech
Confidence 1 111110 111010 1111111 111 1222221 2578999999999999888 9999999
Q ss_pred cchh
Q 007991 122 LAKM 125 (582)
Q Consensus 122 la~~ 125 (582)
.+..
T Consensus 179 ~a~~ 182 (226)
T TIGR02172 179 DFGY 182 (226)
T ss_pred hcCc
Confidence 8753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00018 Score=69.94 Aligned_cols=119 Identities=24% Similarity=0.296 Sum_probs=65.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCC--eeeeeeEEE--ecCcEEEEEEeecCCCCHHH--------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPF--IVEYKDSWV--EKGCYVCIIIGYCEGGDMAE-------------- 63 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IV~l~~~~~--~~~~~l~LVmEy~~GgsL~d-------------- 63 (582)
|+||..... .....+.+|+.++..|.... +..++.... ......+++|+|++|..+..
T Consensus 23 ~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~ 98 (239)
T PF01636_consen 23 YVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQL 98 (239)
T ss_dssp EEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHH
T ss_pred EEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccc
Confidence 677776443 45567889999999996443 344554222 22346889999999998887
Q ss_pred --HHHH---h--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHH-------CCceecccCcccE
Q 007991 64 --AIKK---A--NGVHFPEEK---------LCKW------------LVQLLM-ALNYLHA-------NHILHRDVKCSNI 107 (582)
Q Consensus 64 --~Ikk---~--~~~~lse~~---------~~~i------------l~QLL~-aL~yLHs-------~gIiHRDIKP~NI 107 (582)
.+.+ . ....+.... .... +..+.. .+..++. ..++|+|+.+.||
T Consensus 99 ~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Ni 178 (239)
T PF01636_consen 99 GRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNI 178 (239)
T ss_dssp HHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGE
T ss_pred hhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccc
Confidence 1111 0 000111000 0000 111222 2333332 3699999999999
Q ss_pred EEc-CCCCeEEeecccch
Q 007991 108 FLT-RDQDIRLGDFGLAK 124 (582)
Q Consensus 108 LL~-~~g~vKL~DFGla~ 124 (582)
|++ .++.+.|+||+.+.
T Consensus 179 l~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 179 LVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEESSTTEEEE--GTT-E
T ss_pred eeeeccceeEEEecccce
Confidence 999 56667899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00025 Score=71.06 Aligned_cols=29 Identities=21% Similarity=0.186 Sum_probs=26.1
Q ss_pred CceecccCcccEEEcCCCCeEEeecccch
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00035 Score=78.39 Aligned_cols=106 Identities=21% Similarity=0.251 Sum_probs=67.7
Q ss_pred HHHHHHHHHhcC----CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007991 20 AHQEMELISRVR----NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 95 (582)
Q Consensus 20 ~~rEi~iL~~L~----HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~ 95 (582)
+.+|+.-+.+++ +..-+.+=.+|.+--..-.++|||++|..+.+...-.. ..++...+...+.++. +..+=..
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 346666666663 22223333344332234559999999999998843221 1345333333222221 2333448
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
|++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0017 Score=64.37 Aligned_cols=110 Identities=21% Similarity=0.293 Sum_probs=77.1
Q ss_pred EEEEEecccc--------------cCHHHHHHHHHHHHHHHhcC------CCCeeeeeeEEEecCcEEEEEEeecC----
Q 007991 2 YVLKKIRLAR--------------QTDRARRSAHQEMELISRVR------NPFIVEYKDSWVEKGCYVCIIIGYCE---- 57 (582)
Q Consensus 2 yAIKki~~~~--------------~~~~~~~~~~rEi~iL~~L~------HpnIV~l~~~~~~~~~~l~LVmEy~~---- 57 (582)
.+||+.+... ......+...+|+.-..++. +.+|.++++. ++.+.-..+|+|.+.
T Consensus 26 ~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~-veT~~G~Glv~e~I~d~dG 104 (199)
T PF10707_consen 26 LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF-VETNLGLGLVVELIRDADG 104 (199)
T ss_pred eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE-EecCCceEEEEEEEECCCC
Confidence 3678777766 11123456677777777776 7899999995 455666778888863
Q ss_pred --CCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC----CeEEee
Q 007991 58 --GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGD 119 (582)
Q Consensus 58 --GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~D 119 (582)
..+|.++++.. .+++ .+. ..|-.-.+||-+++|+.+||+|.||++...+ .+.|+|
T Consensus 105 ~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 105 NISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 34688888653 3555 333 3444456788999999999999999997653 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00056 Score=69.73 Aligned_cols=100 Identities=16% Similarity=0.147 Sum_probs=68.9
Q ss_pred HHHHHHHHHhcCCC--CeeeeeeEEEecCcEEEEEEeecCCCC-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Q 007991 20 AHQEMELISRVRNP--FIVEYKDSWVEKGCYVCIIIGYCEGGD-MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-N 95 (582)
Q Consensus 20 ~~rEi~iL~~L~Hp--nIV~l~~~~~~~~~~l~LVmEy~~Ggs-L~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs-~ 95 (582)
...|..-|+++..- .+.+.+... ...|||||+.... -.=.|+. ..+....+..+..+++..+.-|=. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~-----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR-----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec-----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 35688888888543 333444321 2348999995331 1111221 123344688888899999888877 8
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
|+||+||..-|||+. ++.+.++|||-+....+
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 999999999999998 88899999998865543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00058 Score=81.00 Aligned_cols=124 Identities=16% Similarity=0.310 Sum_probs=72.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCe--eeeeeEEEecC--cEEEEEEeecCCCCHHH-------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFI--VEYKDSWVEKG--CYVCIIIGYCEGGDMAE------------- 63 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnI--V~l~~~~~~~~--~~l~LVmEy~~GgsL~d------------- 63 (582)
||+|+....... .....+.+|+++|+.|. |.++ .+++.++.+.. +..|+||||++|..+.+
T Consensus 68 ~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~ 146 (822)
T PLN02876 68 YVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRA 146 (822)
T ss_pred EEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHH
Confidence 566665443221 12346889999999996 6654 55555443221 35779999998865321
Q ss_pred -------HHHHhCC------------C--CCCHHHHHHHHHHH---------------HHHHHHHHH-----------CC
Q 007991 64 -------AIKKANG------------V--HFPEEKLCKWLVQL---------------LMALNYLHA-----------NH 96 (582)
Q Consensus 64 -------~Ikk~~~------------~--~lse~~~~~il~QL---------------L~aL~yLHs-----------~g 96 (582)
.+..-.. . .+-..++..|..|. ...+++|.. ..
T Consensus 147 l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~ 226 (822)
T PLN02876 147 IYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTG 226 (822)
T ss_pred HHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcc
Confidence 1111110 0 01122343333322 223566643 24
Q ss_pred ceecccCcccEEEcCC-CC-eEEeecccchhc
Q 007991 97 ILHRDVKCSNIFLTRD-QD-IRLGDFGLAKML 126 (582)
Q Consensus 97 IiHRDIKP~NILL~~~-g~-vKL~DFGla~~~ 126 (582)
+||+|+++.|||++.+ +. +-|+||+++...
T Consensus 227 LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 227 IVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred eEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 9999999999999853 33 578999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00078 Score=67.43 Aligned_cols=30 Identities=20% Similarity=0.283 Sum_probs=25.3
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
+++|+|+++.|||++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 589999999999998665567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00092 Score=74.02 Aligned_cols=162 Identities=22% Similarity=0.259 Sum_probs=109.2
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 007991 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 98 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIi 98 (582)
.+.--.++++.+.|+|..+++++-........+|||++ +.+|.+.++.++.. .++ ++ .+|+.
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~--~~s--------~~-------~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK--DES--------LL-------AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc--hhh--------hc-------ccccc
Confidence 45566788999999999999986555555788999999 69999999875411 111 11 22222
Q ss_pred ecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCcccccc
Q 007991 99 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178 (582)
Q Consensus 99 HRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~ 178 (582)
| -|| ++.+| -++ .. ..+ +.++++|||++|.++.++..|...|...
T Consensus 90 ~-----~~~-------~~~td-~~~---t~---~~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 90 H-----LNI-------IYITD-HFL---TK---YPS----------------PIGPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred e-----ehh-------hhccc-ccc---cc---CCC----------------CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 2 122 23333 000 00 011 1124999999999999999998888776
Q ss_pred CHHHHHHHHhhccCCCC-----------CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 179 DMQALINKINKSIVAPL-----------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 179 ~~~~l~~kI~~~~~~~l-----------p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
...+....+.+....+. -..++..+..++.+|+-..|..||...++++++-|.+.
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 66665555554332221 11256678899999999999999999999999888764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0031 Score=62.67 Aligned_cols=29 Identities=21% Similarity=0.389 Sum_probs=26.1
Q ss_pred CceecccCcccEEEcC-CCCeEEeecccch
Q 007991 96 HILHRDVKCSNIFLTR-DQDIRLGDFGLAK 124 (582)
Q Consensus 96 gIiHRDIKP~NILL~~-~g~vKL~DFGla~ 124 (582)
+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6999999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0086 Score=60.63 Aligned_cols=101 Identities=16% Similarity=0.272 Sum_probs=58.5
Q ss_pred HHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHH--------------HHHHhC-----CCCCCH-HHHH
Q 007991 20 AHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE--------------AIKKAN-----GVHFPE-EKLC 79 (582)
Q Consensus 20 ~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d--------------~Ikk~~-----~~~lse-~~~~ 79 (582)
..+|..+++.+....+++-.- +...+ ++||||++|..+.. .+.+.. +..++. ..+.
T Consensus 38 r~~E~~~l~~l~~~g~~P~~i-~~~~~---~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~ 113 (256)
T TIGR02721 38 RQREYQILQALSALGLAPKPI-LVNEH---WLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIA 113 (256)
T ss_pred HHHHHHHHHHHHhcCCCCceE-EEeCC---EEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 478999999997554443221 22222 58999999876532 222211 111121 2222
Q ss_pred HHHHHH---------HHHHHHHHH--------CCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 80 KWLVQL---------LMALNYLHA--------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 80 ~il~QL---------L~aL~yLHs--------~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
.+..++ ...++.+-. ..++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 114 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 114 HYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred HHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 332222 111222222 2589999999999999877 89999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0035 Score=64.56 Aligned_cols=118 Identities=14% Similarity=0.111 Sum_probs=66.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCC--eeeeeeE-----EEecCcEEEEEEeecCCCCHHH-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPF--IVEYKDS-----WVEKGCYVCIIIGYCEGGDMAE----------- 63 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IV~l~~~-----~~~~~~~l~LVmEy~~GgsL~d----------- 63 (582)
|++|.... . ....+..|+.++..|.+.. +.+++.. +...++..++|++|++|..+..
T Consensus 40 ~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~ 114 (296)
T cd05153 40 YVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGE 114 (296)
T ss_pred EEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHH
Confidence 67777654 1 1245778888888885432 3333321 1122345689999999876521
Q ss_pred HHHHh----CCCC------CCHHHHHH------------HHHHHHHHHHHHHH-------CCceecccCcccEEEcCCCC
Q 007991 64 AIKKA----NGVH------FPEEKLCK------------WLVQLLMALNYLHA-------NHILHRDVKCSNIFLTRDQD 114 (582)
Q Consensus 64 ~Ikk~----~~~~------lse~~~~~------------il~QLL~aL~yLHs-------~gIiHRDIKP~NILL~~~g~ 114 (582)
.+.+. .+.. ........ ....+..++.++.. .+++|+|+.|.|||++.++.
T Consensus 115 ~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~ 194 (296)
T cd05153 115 ALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDEL 194 (296)
T ss_pred HHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCce
Confidence 11110 0000 00010000 11112334455543 47999999999999998877
Q ss_pred eEEeecccch
Q 007991 115 IRLGDFGLAK 124 (582)
Q Consensus 115 vKL~DFGla~ 124 (582)
+.|+||+.+.
T Consensus 195 ~~iIDfe~a~ 204 (296)
T cd05153 195 SGVIDFYFAC 204 (296)
T ss_pred EEEeehhhhc
Confidence 7899999774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0034 Score=70.62 Aligned_cols=77 Identities=22% Similarity=0.348 Sum_probs=56.2
Q ss_pred cEEEEEEeecCCCCHHHH--HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC----CCCeEEeec
Q 007991 47 CYVCIIIGYCEGGDMAEA--IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR----DQDIRLGDF 120 (582)
Q Consensus 47 ~~l~LVmEy~~GgsL~d~--Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~----~g~vKL~DF 120 (582)
..-.|+||||+|..+.++ |.+. .++...+..-+.+.. ++-|=..|++|+|=+|.||+++. ++.+.+.||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 355699999999888765 4443 466665555444443 23444678999999999999994 567999999
Q ss_pred ccchhccc
Q 007991 121 GLAKMLIS 128 (582)
Q Consensus 121 Gla~~~~~ 128 (582)
|+...+..
T Consensus 350 Gl~~~is~ 357 (538)
T KOG1235|consen 350 GLYAVISH 357 (538)
T ss_pred cccccccH
Confidence 99877644
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.028 Score=58.63 Aligned_cols=30 Identities=23% Similarity=0.309 Sum_probs=25.7
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.|+||+|+++.||+++.+..+-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999866556899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0095 Score=62.12 Aligned_cols=30 Identities=23% Similarity=0.293 Sum_probs=27.0
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0034 Score=66.42 Aligned_cols=97 Identities=18% Similarity=0.224 Sum_probs=70.7
Q ss_pred HHHHHHHHHHHHhcC-CCC-eeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007991 17 RRSAHQEMELISRVR-NPF-IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 94 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~-Hpn-IV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs 94 (582)
+-.+.+|...|+.|. |-+ +...++ .+.-|+|||++.|..|.+.-+- .+. ..+...++.-+--|-.
T Consensus 154 Rlaa~kEfafmkaL~e~gfpVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~v-----~d~---~~ly~~lm~~Iv~la~ 220 (465)
T KOG2268|consen 154 RLAATKEFAFMKALYERGFPVPKPID-----HNRHCVVMELVDGYPLRQVRHV-----EDP---PTLYDDLMGLIVRLAN 220 (465)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCccc-----ccceeeHHHhhcccceeeeeec-----CCh---HHHHHHHHHHHHHHHH
Confidence 445678999999996 333 333333 2366799999999998755432 222 3344455566778889
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
+|+||+|+.--||+|+.++.++++||--+...
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechHhhcc
Confidence 99999999999999999999999999765433
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0079 Score=64.53 Aligned_cols=74 Identities=20% Similarity=0.361 Sum_probs=60.5
Q ss_pred ecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeeccc
Q 007991 44 EKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGL 122 (582)
Q Consensus 44 ~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGl 122 (582)
.++.|.|++|++. |++|. .++ .-..+++..|+++.+..++-+... ..-|||+...||||+ +|+|.|+||-+
T Consensus 296 de~~y~yl~~kdh-gt~is-~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 296 DETLYLYLHFKDH-GTPIS-IIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CCceEEEEEEecC-Cceee-eee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 4567899999987 66653 222 235778889999999888888766 789999999999999 99999999999
Q ss_pred chh
Q 007991 123 AKM 125 (582)
Q Consensus 123 a~~ 125 (582)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.014 Score=60.40 Aligned_cols=29 Identities=31% Similarity=0.426 Sum_probs=26.3
Q ss_pred CceecccCcccEEEcCC----CCeEEeecccch
Q 007991 96 HILHRDVKCSNIFLTRD----QDIRLGDFGLAK 124 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~----g~vKL~DFGla~ 124 (582)
+++|+|+.+.|||++.+ +.++|+||+.+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 68999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0091 Score=58.72 Aligned_cols=30 Identities=30% Similarity=0.533 Sum_probs=21.4
Q ss_pred CceecccCcccEEE-cCCCCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFL-TRDQDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL-~~~g~vKL~DFGla~~ 125 (582)
.++|.|+.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.032 Score=59.20 Aligned_cols=32 Identities=19% Similarity=0.272 Sum_probs=28.8
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhcc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~ 127 (582)
.++|+|+++.||+|+.++-+=|+||+++....
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 58999999999999999999999999987653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.052 Score=53.11 Aligned_cols=107 Identities=21% Similarity=0.196 Sum_probs=73.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
+|+|+-+. +..+..+..|+++|..+..-++-+-+..|- ..++.|||+.|-.|.++-... + ++-
T Consensus 48 ~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~-----~----rk~ 110 (201)
T COG2112 48 VALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG-----D----RKH 110 (201)
T ss_pred EEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhcc-----c----HHH
Confidence 34554433 345678999999999999888776443332 233669999998987665531 2 223
Q ss_pred HHHHHHHHHHHHHCCceecccC-cccEEEcCCCCeEEeecccchh
Q 007991 82 LVQLLMALNYLHANHILHRDVK-CSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIK-P~NILL~~~g~vKL~DFGla~~ 125 (582)
+..++..---|-..||-|+.|. |...+|..++++.|+||.-|..
T Consensus 111 l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 111 LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 4456666666778899999985 5555555666999999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.031 Score=57.89 Aligned_cols=31 Identities=26% Similarity=0.342 Sum_probs=25.8
Q ss_pred CceecccCcccEEEcCCCC-eEEeecccchhc
Q 007991 96 HILHRDVKCSNIFLTRDQD-IRLGDFGLAKML 126 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~-vKL~DFGla~~~ 126 (582)
.++|+|+++.|||++.++. .-|+|||.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 569999988643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.1 Score=54.55 Aligned_cols=30 Identities=13% Similarity=0.207 Sum_probs=27.5
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
++||+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.036 Score=56.06 Aligned_cols=86 Identities=17% Similarity=0.205 Sum_probs=61.6
Q ss_pred HHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--C
Q 007991 18 RSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA--N 95 (582)
Q Consensus 18 ~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs--~ 95 (582)
..++.+..++.++ ..|+++... ++..+.++.|+|-... ..-..++.-=+.+|.-.|+ .
T Consensus 103 ~~y~nky~v~Arm--hGilrL~ND---n~~~yGvIlE~Cy~~~---------------i~~~N~i~agi~~L~~fH~~~~ 162 (308)
T PF07387_consen 103 ALYFNKYRVFARM--HGILRLKND---NNYKYGVILERCYKIK---------------INFSNFITAGIKDLMDFHSENQ 162 (308)
T ss_pred hhhhhhhhHHHHh--hheeEeecC---CCceeEEEEeeccCcc---------------cchhHHHHHhHHHHHHhhccCC
Confidence 3567888888887 468888853 5556779999994111 1112222333567788884 3
Q ss_pred CceecccCcccEEEcCCCCeEEeecccc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLA 123 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla 123 (582)
+.+|+|..|+||+-|..|.+||.|=+..
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhhh
Confidence 7999999999999999999999997643
|
The function of this family is unknown. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.13 Score=53.87 Aligned_cols=44 Identities=11% Similarity=-0.011 Sum_probs=31.6
Q ss_pred HHHHHHHHHHHhcCC---CCeeeeeeEEEec--CcEEEEEEeecCCCCH
Q 007991 18 RSAHQEMELISRVRN---PFIVEYKDSWVEK--GCYVCIIIGYCEGGDM 61 (582)
Q Consensus 18 ~~~~rEi~iL~~L~H---pnIV~l~~~~~~~--~~~l~LVmEy~~GgsL 61 (582)
..+..|+..|+.|.. -.+.++++.+... .+.-+||||+++|+++
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 478999999999854 3566666654322 3457899999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.22 Score=52.91 Aligned_cols=28 Identities=21% Similarity=0.433 Sum_probs=24.8
Q ss_pred ceecccCcccEEEcC-CCCeEEeecccch
Q 007991 97 ILHRDVKCSNIFLTR-DQDIRLGDFGLAK 124 (582)
Q Consensus 97 IiHRDIKP~NILL~~-~g~vKL~DFGla~ 124 (582)
++|.|+.+.|||++. ++.++++||+.|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 4689999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.08 Score=56.57 Aligned_cols=29 Identities=24% Similarity=0.457 Sum_probs=25.7
Q ss_pred CceecccCcccEEEcC-CCCeEEeecccch
Q 007991 96 HILHRDVKCSNIFLTR-DQDIRLGDFGLAK 124 (582)
Q Consensus 96 gIiHRDIKP~NILL~~-~g~vKL~DFGla~ 124 (582)
.++|+|+++.|||++. ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6899999999999986 4679999999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.14 Score=55.94 Aligned_cols=29 Identities=28% Similarity=0.478 Sum_probs=24.7
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
..++|||+++.|||++.+ .++++||.++.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 368999999999999776 59999998663
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.08 E-value=0.089 Score=54.37 Aligned_cols=29 Identities=24% Similarity=0.419 Sum_probs=25.5
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.79 Score=56.03 Aligned_cols=31 Identities=35% Similarity=0.505 Sum_probs=26.3
Q ss_pred CCceecccCcccEEEcCCC--CeE-Eeecccchh
Q 007991 95 NHILHRDVKCSNIFLTRDQ--DIR-LGDFGLAKM 125 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g--~vK-L~DFGla~~ 125 (582)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.14 Score=55.27 Aligned_cols=101 Identities=16% Similarity=0.174 Sum_probs=70.7
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHH-HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCC
Q 007991 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA-EAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANH 96 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~-d~Ikk~~~~~lse~~~~~il~QLL~aL~yLH-s~g 96 (582)
-+..|++-|++|+.-.|.-..-+.+. + + .|||+||.+.... -.|+ ...++...+..+-.|++..+.-|- ..+
T Consensus 212 WAEKE~RNLkRl~~aGIP~PePIlLk-~-h-VLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~ 285 (520)
T KOG2270|consen 212 WAEKEMRNLKRLNNAGIPCPEPILLK-N-H-VLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCR 285 (520)
T ss_pred HHHHHHHHHHHHHhcCCCCCCceeee-c-c-eEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhc
Confidence 35789999999987665433333332 1 3 3899999532211 1222 235788888888888888877664 559
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
+||.||.--|+|+ .+|.+.++|.+-+...
T Consensus 286 LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 286 LVHADLSEFNLLY-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred eeccchhhhhheE-ECCEEEEEEccccccC
Confidence 9999999999987 5778999998866433
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.34 E-value=0.18 Score=54.86 Aligned_cols=29 Identities=31% Similarity=0.313 Sum_probs=24.1
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
...+|.|+-+.||+.+. +.++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 46899999999998754 459999998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.01 E-value=2.2 Score=45.12 Aligned_cols=28 Identities=29% Similarity=0.271 Sum_probs=24.0
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3799999999999995 4 58899999775
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.51 E-value=0.6 Score=46.60 Aligned_cols=86 Identities=21% Similarity=0.188 Sum_probs=60.6
Q ss_pred HHHHHHHHHHHhcC---CCCe--eeeeeEEEec-----------------CcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 18 RSAHQEMELISRVR---NPFI--VEYKDSWVEK-----------------GCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 18 ~~~~rEi~iL~~L~---HpnI--V~l~~~~~~~-----------------~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.-|..|.+...+|+ +.++ |+++++..-. .....||.||+.... .+..
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~ 167 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI 167 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch
Confidence 45788888888775 4455 8888866421 113457888776433 1222
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla 123 (582)
.-+.+|+.-|.-+|..||+-+|+++.|.. + -||+|||.+
T Consensus 168 ----~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 168 ----RDIPQMLRDLKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ----hHHHHHHHHHHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 33567788889999999999999999983 3 489999964
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.65 E-value=0.23 Score=51.37 Aligned_cols=50 Identities=28% Similarity=0.274 Sum_probs=37.8
Q ss_pred HHHHHHHHHHHHHHHHHHHC--CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 76 EKLCKWLVQLLMALNYLHAN--HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~--gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
..++..+..+-.++.-+|.. -++|+|+.|+|+|++..|.++|+||..|..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444555555555555555 599999999999999989999999988753
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.35 E-value=0.29 Score=47.89 Aligned_cols=30 Identities=37% Similarity=0.550 Sum_probs=25.7
Q ss_pred CCceecccCcccEEEcCCC-----CeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQ-----DIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g-----~vKL~DFGla~ 124 (582)
..++|||+.+.||++..++ .+.|+||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4699999999999998654 58999999875
|
subfamily of choline kinases |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.86 E-value=0.17 Score=49.86 Aligned_cols=30 Identities=30% Similarity=0.314 Sum_probs=25.8
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
-.+|+|+.|.||+++.+| ++|+||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 369999999999998777 999999988543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=89.62 E-value=1.7 Score=47.97 Aligned_cols=27 Identities=22% Similarity=0.401 Sum_probs=23.3
Q ss_pred CceecccCcccEEEcCCCCeEEeecccc
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLA 123 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla 123 (582)
.++|+||++.|||++.++ .+++|..++
T Consensus 231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 231 ALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred ceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 699999999999998876 888886655
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.44 E-value=0.41 Score=51.18 Aligned_cols=118 Identities=20% Similarity=0.239 Sum_probs=69.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCC---eee---e----eeEEEecCcEEEEEEeecCCCCHHH-----HHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPF---IVE---Y----KDSWVEKGCYVCIIIGYCEGGDMAE-----AIK 66 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn---IV~---l----~~~~~~~~~~l~LVmEy~~GgsL~d-----~Ik 66 (582)
|++|..+.. . ....+.-|+..|..|.-.. .++ + +...... .+.+-|.+|++|..+.. .+.
T Consensus 51 ~iLki~~~~-~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~lf~~l~G~~~~~~~~~~~~~ 125 (331)
T COG2334 51 YILKIYRPG-W---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAALFEYLPGRPLERDDNAEQLE 125 (331)
T ss_pred eEEEEecCC-C---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEEEEecCCcCcCCCCcHHHHH
Confidence 567777665 2 2346778888888884221 111 1 1111111 47888999999988872 111
Q ss_pred H--------------hC----C--CCCCHH----H---------HHHHHHHHHHHHHHHHHC--------C--ceecccC
Q 007991 67 K--------------AN----G--VHFPEE----K---------LCKWLVQLLMALNYLHAN--------H--ILHRDVK 103 (582)
Q Consensus 67 k--------------~~----~--~~lse~----~---------~~~il~QLL~aL~yLHs~--------g--IiHRDIK 103 (582)
. .. + ....+. . -.....++...++.+.+. + +||+|+.
T Consensus 126 ~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~ 205 (331)
T COG2334 126 ELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLH 205 (331)
T ss_pred HHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCC
Confidence 0 00 0 011111 0 011233444555555542 4 9999999
Q ss_pred cccEEEcCCCC-eEEeecccch
Q 007991 104 CSNIFLTRDQD-IRLGDFGLAK 124 (582)
Q Consensus 104 P~NILL~~~g~-vKL~DFGla~ 124 (582)
|.||+++.+.. +-++|||-+.
T Consensus 206 ~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 206 PDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeEcCCCCeeeEEEccccc
Confidence 99999999885 8999999774
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=86.61 E-value=0.99 Score=48.57 Aligned_cols=39 Identities=21% Similarity=0.241 Sum_probs=26.8
Q ss_pred CHHHHHHHHHHHHHHHHHH---H-HCCceecccCcccEEEcCC
Q 007991 74 PEEKLCKWLVQLLMALNYL---H-ANHILHRDVKCSNIFLTRD 112 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yL---H-s~gIiHRDIKP~NILL~~~ 112 (582)
-.+-++.++.|++.-.-.+ - ..+.+|-||||+||||-+.
T Consensus 273 ~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 315 (434)
T PF05445_consen 273 NVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS 315 (434)
T ss_pred HHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence 3555677777776543222 2 4579999999999999543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.95 E-value=1.6 Score=46.81 Aligned_cols=40 Identities=20% Similarity=0.244 Sum_probs=29.1
Q ss_pred CHHHHHHHHHHHHHHHHHHH----HCCceecccCcccEEEcCCC
Q 007991 74 PEEKLCKWLVQLLMALNYLH----ANHILHRDVKCSNIFLTRDQ 113 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLH----s~gIiHRDIKP~NILL~~~g 113 (582)
-.+-++.++.|++.-.-++- ..+.+|-||||.||||-+..
T Consensus 277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 35567778888877654442 34799999999999996543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 582 | ||||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-50 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-36 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-36 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-36 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-33 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-30 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-30 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-27 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-27 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-26 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-26 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-24 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-24 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-22 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-21 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-21 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-21 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-21 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-21 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-21 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-18 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-18 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-18 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-17 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-17 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-13 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-13 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 |
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 362 bits (930), Expect = e-121
Identities = 92/235 (39%), Positives = 150/235 (63%), Gaps = 2/235 (0%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
YV+K+I ++R + + R + +E+ +++ +++P IV+Y++S+ E G + I++ YCEGGD
Sbjct: 51 QYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS-LYIVMDYCEGGD 109
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + I GV F E+++ W VQ+ +AL ++H ILHRD+K NIFLT+D ++LGDF
Sbjct: 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
G+A++L S +LA + +GTP Y+ PE+ + PY +KSDIW+LGC +YE+ K AF+A
Sbjct: 170 GIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234
M+ L+ KI P+ YS R LV + ++NP RPS +L + +
Sbjct: 230 MKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-114
Identities = 85/247 (34%), Positives = 132/247 (53%), Gaps = 9/247 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGG 59
+ V K++ T+ ++ E+ L+ +++P IV Y D +++ + I++ YCEGG
Sbjct: 33 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 60 DMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLH-----ANHILHRDVKCSNIFLTRD 112
D+A I K + EE + + + QL +AL H + +LHRD+K +N+FL
Sbjct: 93 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 113 QDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 171
Q+++LGDFGLA++L D A + VGTP YM PE + + Y KSDIWSLGC +YE+ A
Sbjct: 153 QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212
Query: 172 KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
F AF + L KI + +P YS ++ ML RPS E+L +P +
Sbjct: 213 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
Query: 232 PYVLGIH 238
+ H
Sbjct: 273 EHHHHHH 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-110
Identities = 57/247 (23%), Positives = 115/247 (46%), Gaps = 26/247 (10%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---------------K 45
YV+K+++ + A +E++ ++++ + IV Y W K
Sbjct: 38 TYVIKRVKYNNE------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91
Query: 46 GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCS 105
+ I + +C+ G + + I+K G + + Q+ ++Y+H+ +++RD+K S
Sbjct: 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPS 151
Query: 106 NIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCV 165
NIFL + +++GDFGL L +D + GT YM PE ++ YG + D+++LG +
Sbjct: 152 NIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211
Query: 166 YEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
E+ AF+ + + ++ + L++ +L K PE RP+ +E+L
Sbjct: 212 AELL--HVCDTAFETSKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
Query: 226 CHPHLQP 232
+
Sbjct: 267 RTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = e-107
Identities = 81/247 (32%), Positives = 133/247 (53%), Gaps = 8/247 (3%)
Query: 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
LKK+++ D +AR +E++L+ ++ +P +++Y S++E + I++ + G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNIVLELADAG 117
Query: 60 DMAEAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
D++ IK K PE + K+ VQL AL ++H+ ++HRD+K +N+F+T ++L
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 177
Query: 118 GDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
GD GL + S A S+VGTP YM PE + + Y KSDIWSLGC +YEM+A ++ F
Sbjct: 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237
Query: 177 A--FDMQALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
++ +L KI + PLP+ YS R LV + +PE RP +
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
Query: 234 VLGIHLK 240
L+
Sbjct: 298 CTASSLE 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 1e-96
Identities = 66/256 (25%), Positives = 118/256 (46%), Gaps = 28/256 (10%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----------YV 49
Y +K+IRL + + AR +E++ ++++ +P IV Y ++W+EK Y+
Sbjct: 32 NYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL 90
Query: 50 CIIIGYCEGGDMAEAIKKANGVHFPEEKLC-KWLVQLLMALNYLHANHILHRDVKCSNIF 108
I + C ++ + + + E +C +Q+ A+ +LH+ ++HRD+K SNIF
Sbjct: 91 YIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIF 150
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSV-------------VGTPSYMCPELLADIPYGSK 155
T D +++GDFGL + D+ +V VGT YM PE + Y K
Sbjct: 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK 210
Query: 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 215
DI+SLG ++E+ + + + PL T +V+ ML +P
Sbjct: 211 VDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSP 268
Query: 216 EFRPSAAELLCHPHLQ 231
RP A ++ + +
Sbjct: 269 MERPEAINIIENAVFE 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-94
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 9/233 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+Y +K+ + + R E+ +V ++P V + +W E G + + C G
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQTELC-GP 141
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ + + G PE ++ +L L+AL +LH+ ++H DVK +NIFL +LGD
Sbjct: 142 SLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD 200
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
FGL L + G P YM PELL YG+ +D++SLG + E+ +
Sbjct: 201 FGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
Q L + S R ++ ML +P+ R +A LL P L+
Sbjct: 260 GWQQLRQGY---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-90
Identities = 61/255 (23%), Positives = 115/255 (45%), Gaps = 30/255 (11%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+Y +K+ + ++A +E+ + + ++ +V Y +W E ++ I YC GG
Sbjct: 38 IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-HMLIQNEYCNGG 96
Query: 60 DMAEAIKKANGV--HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI-- 115
+A+AI + + +F E +L L+Q+ L Y+H+ ++H D+K SNIF++R
Sbjct: 97 SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156
Query: 116 -----------------RLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-DIPYGSKSD 157
++GD G + G ++ E+L + + K+D
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKAD 213
Query: 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 217
I++L V + + + D ++I + + +P V S F L+K M+ +PE
Sbjct: 214 IFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPER 270
Query: 218 RPSAAELLCHPHLQP 232
RPSA L+ H L
Sbjct: 271 RPSAMALVKHSVLLS 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 5e-84
Identities = 64/265 (24%), Positives = 116/265 (43%), Gaps = 37/265 (13%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE------------KGCY 48
Y +KKIR T+ + E+ L++ + + ++V Y +W+E K
Sbjct: 33 YYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I + YCE G + + I ++ ++ + Q+L AL+Y+H+ I+HRD+K NIF
Sbjct: 90 LFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF 148
Query: 109 LTRDQDIRLGDFGLAKML---------------ISDDLASSVVGTPSYMCPELLADIP-Y 152
+ +++++GDFGLAK + S D +S +GT Y+ E+L Y
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKS 209
K D++SLG +EM + ++ K+ + +++
Sbjct: 209 NEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266
Query: 210 MLRKNPEFRPSAAELLCHPHLQPYV 234
++ +P RP A LL L
Sbjct: 267 LIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-72
Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 17/233 (7%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
+ + ++ + V K + I + C ++ + + + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVY-LYIQMQLCRKENLKDWMNRRCSLE 159
Query: 73 FPEEKLC-KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 131
E +C +Q+ A+ +LH+ ++HRD+K SNIF T D +++GDFGL + D+
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 132 ASSV-------------VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
+V VGT YM PE + Y K DI+SLG ++E+ +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQM 277
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+ +I + L T +V+ ML +P RP A +++ + +
Sbjct: 278 ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-69
Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 23/259 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCIIIGYCE 57
Y LK+I Q DR A +E ++ +P I+ + + +++ + +
Sbjct: 56 FYALKRILCHEQQDR--EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113
Query: 58 GGDMAEAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
G + I+ K G E+++ L+ + L +HA HRD+K +NI L +
Sbjct: 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173
Query: 116 RLGDFGLAKMLISDDLASS----------VVGTPSYMCPELLADIPY---GSKSDIWSLG 162
L D G S T SY PEL + + ++D+WSLG
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 163 CCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220
C +Y M + + + + + + P +S A L+ SM+ +P RP
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH 293
Query: 221 AAELLCHPH-LQPYVLGIH 238
LL LQP G H
Sbjct: 294 IPLLLSQLEALQPPAPGQH 312
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-63
Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 12/235 (5%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWV---EKGCYVCIIIGYCEGGDM 61
+++ + T R+ +E E++ +++P IV + DSW + + ++ G +
Sbjct: 57 CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQ-DIRLG 118
+K+ + L W Q+L L +LH I+HRD+KC NIF+T +++G
Sbjct: 117 KTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
D GLA + A +V+GTP +M PE+ + Y D+++ G C+ EM+ + +
Sbjct: 175 DLGLATLK-RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232
Query: 179 DMQALINKI--NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
A I + + A V + +++ +R+N + R S +LL H Q
Sbjct: 233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-57
Identities = 70/316 (22%), Positives = 138/316 (43%), Gaps = 29/316 (9%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K + L ++ S E+ +++++ + I+ D + Y+ +++ C
Sbjct: 35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVM-ECGN 92
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
D+ +KK + + +L A++ +H + I+H D+K +N + D ++L
Sbjct: 93 IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI 149
Query: 119 DFGLAKMLISDD---LASSVVGTPSYMCPELLADIP-----------YGSKSDIWSLGCC 164
DFG+A + D + S VGT +YM PE + D+ KSD+WSLGC
Sbjct: 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209
Query: 165 VYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
+Y M+ K F+ + L I+ + P + + ++K L+++P+ R S
Sbjct: 210 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269
Query: 223 ELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFS 282
ELL HP++Q +N + T E + + + + + + +S
Sbjct: 270 ELLAHPYVQIQ----THPVNQMAKGT--TEEMKYVLGQLVGLNSPNSILKAAKTLYEHYS 323
Query: 283 NDRALNPSVSETEQDS 298
+ N S S+T +
Sbjct: 324 GGESHNSSSSKTFEKK 339
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 62/251 (24%), Positives = 118/251 (47%), Gaps = 23/251 (9%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K + L ++ S E+ +++++ + I+ D + Y+ +++ C
Sbjct: 54 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVM-ECGN 111
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
D+ +KK + + +L A++ +H + I+H D+K +N + D ++L
Sbjct: 112 IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI 168
Query: 119 DFGLAKMLISDD---LASSVVGTPSYMCPELLADIP-----------YGSKSDIWSLGCC 164
DFG+A + D + S VGT +YM PE + D+ KSD+WSLGC
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 165 VYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
+Y M+ K F+ + L I+ + P + + ++K L+++P+ R S
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 223 ELLCHPHLQPY 233
ELL HP++Q
Sbjct: 289 ELLAHPYVQIQ 299
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-55
Identities = 67/316 (21%), Positives = 134/316 (42%), Gaps = 29/316 (9%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K + L ++ S E+ +++++ + I+ D + Y+ +++ C
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVM-ECGN 139
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
D+ +KK + + +L A++ +H + I+H D+K +N + D ++L
Sbjct: 140 IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLI 196
Query: 119 DFGLAKMLISDD---LASSVVGTPSYMCPELLADIP-----------YGSKSDIWSLGCC 164
DFG+A + D + S VG +YM PE + D+ KSD+WSLGC
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 165 VYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
+Y M+ K F+ + L I+ + P + + ++K L+++P+ R S
Sbjct: 257 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316
Query: 223 ELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFS 282
ELL HP++Q + E + + + + + + +S
Sbjct: 317 ELLAHPYVQIQ------THPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYS 370
Query: 283 NDRALNPSVSETEQDS 298
+ N S S+T +
Sbjct: 371 GGESHNSSSSKTFEKK 386
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 7e-55
Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 19/233 (8%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
KK+RL +E+ + + +P IV + V +G +V I + EGG + +
Sbjct: 89 KKVRLEVFRV-------EELVACAGLSSPRIVPLYGA-VREGPWVNIFMELLEGGSLGQL 140
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLA 123
IK+ PE++ +L Q L L YLH ILH DVK N+ L+ D L DFG A
Sbjct: 141 IKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 124 KMLISDDLAS------SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
L D L + GT ++M PE++ P +K DIWS C + M +
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 178 FDMQALINKI--NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ L KI + +P + ++ LRK P R SA EL
Sbjct: 259 YFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-53
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 12/232 (5%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K+I + R + H+E+ L +++ IV+Y S + ++ I + GG ++
Sbjct: 53 KEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLGS-FSENGFIKIFMEQVPGGSLSAL 109
Query: 65 IKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGL 122
++ G + E+ + + Q+L L YLH N I+HRD+K N+ + T +++ DFG
Sbjct: 110 LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169
Query: 123 AKMLIS-DDLASSVVGTPSYMCPE--LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
+K L + + GT YM PE YG +DIWSLGC + EM+ K F
Sbjct: 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229
Query: 180 --MQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
A+ K+ V P +P S + + +P+ R A +LL
Sbjct: 230 EPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 31/266 (11%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWV-------EKGCYVCII 52
Y LK RL + R+ QE+ + ++ P IV++ + ++
Sbjct: 55 EYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 53 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLT 110
C+G + K + + + K Q A+ ++H I+HRD+K N+ L+
Sbjct: 113 TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172
Query: 111 RDQDIRLGDFGLAKMLISDDLASS-------------VVGTPSYMCPELL---ADIPYGS 154
I+L DFG A + S TP Y PE++ ++ P G
Sbjct: 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE 232
Query: 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214
K DIW+LGC +Y + ++ F+ ++N P F L+++ML+ N
Sbjct: 233 KQDIWALGCILYLLCFRQHPFEDGAKLRIVNG---KYSIPPHDTQYTVFHSLIRAMLQVN 289
Query: 215 PEFRPSAAELLCHPHLQPYVLGIHLK 240
PE R S AE++ ++ K
Sbjct: 290 PEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-48
Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 7/209 (3%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
QE+ ++S+ +P++ +Y S++ K + II+ Y GG + ++ E ++
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATI 124
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPS 140
L ++L L+YLH+ +HRD+K +N+ L+ +++L DFG+A L + ++ VGTP
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 184
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTVY 199
+M PE++ Y SK+DIWSLG E++ + M+ L I K+ L Y
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNNPPTLEGNY 243
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
S + V++ L K P FRP+A ELL H
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHK 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 70/233 (30%), Positives = 115/233 (49%), Gaps = 15/233 (6%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+++ L +Q + E+ ++ +NP IV Y DS++ G + +++ Y GG + +
Sbjct: 51 RQMNLQQQPKK--ELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDV 107
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
+ + E ++ + L AL +LH+N ++HRD+K NI L D ++L DFG
Sbjct: 108 VTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 125 MLISDDL-ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---M 180
+ + S++VGTP +M PE++ YG K DIWSLG EM + + + +
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPL 222
Query: 181 QALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+AL I + L P S FR + L + E R SA ELL H L+
Sbjct: 223 RALY-LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 11/228 (4%)
Query: 3 VLKK--IRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
VL K + A + RR E+E+ S +R+P I+ + V +I+ Y G
Sbjct: 41 VLFKAQLEKAGVEHQLRR----EVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGT 95
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ ++K + F E++ ++ +L AL+Y H+ ++HRD+K N+ L ++++ DF
Sbjct: 96 VYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
G + + + GT Y+ PE++ + K D+WSLG YE K F+A
Sbjct: 154 GWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
Q +I++ P + R L+ +L+ NP RP E+L HP
Sbjct: 213 QETYKRISRVEFT-FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 67/225 (29%), Positives = 121/225 (53%), Gaps = 8/225 (3%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K + A R + E+++ ++++P I+E + + E YV +++ C G+M
Sbjct: 47 KAMYKAGMVQRVQN----EVKIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRY 101
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
+K F E + ++ Q++ + YLH++ ILHRD+ SN+ LTR+ +I++ DFGLA
Sbjct: 102 LKNRVK-PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLAT 160
Query: 125 MLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
L ++ GTP+Y+ PE+ +G +SD+WSLGC Y + + F ++
Sbjct: 161 QLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+NK+ + +P+ S + L+ +LR+NP R S + +L HP
Sbjct: 221 LNKVVLADYE-MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 13/214 (6%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+E+ ++ + +P +V+Y S+ K + I++ YC G +++ I+ N E+++
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATI 130
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPS 140
L L L YLH +HRD+K NI L + +L DFG+A L ++V+GTP
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTV- 198
+M PE++ +I Y +DIWSLG EM+ K + M+A+ I + P PT
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTN---PPPTFR 246
Query: 199 ----YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+S F VK L K+PE R +A +LL HP
Sbjct: 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 70/231 (30%), Positives = 120/231 (51%), Gaps = 17/231 (7%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K + L +Q R E+ ++ ++ +VE S++ G + +++ + +GG + +
Sbjct: 76 KMMDLRKQQRR--ELLFNEVVIMRDYQHFNVVEMYKSYL-VGEELWVLMEFLQGGALTDI 132
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
+ + V EE++ +L AL YLHA ++HRD+K +I LT D ++L DFG
Sbjct: 133 VSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189
Query: 125 MLISDDLA--SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--- 179
+ S D+ S+VGTP +M PE+++ Y ++ DIWSLG V EM + + F
Sbjct: 190 QI-SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY--FSDSP 246
Query: 180 MQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+QA+ ++ S L S R ++ ML ++P+ R +A ELL HP
Sbjct: 247 VQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-46
Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 49/277 (17%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ K I L R +E++++ +P+IV + ++ G + I + + +GG
Sbjct: 60 VMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGS 117
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGD 119
+ + +KKA PE+ L K + ++ L YL H I+HRDVK SNI + +I+L D
Sbjct: 118 LDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG++ LI D +A+S VGT SYM PE L Y +SDIWS+G + EM+ + D
Sbjct: 176 FGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 180 MQA------------------------------------------LINKINKSIVAPLPT 197
+ L++ I LP+
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
Query: 198 -VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
V+S F+ V L KNP R +L+ H ++
Sbjct: 295 GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 9e-46
Identities = 60/279 (21%), Positives = 102/279 (36%), Gaps = 56/279 (20%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
++I L ++ E+ + +P IV Y+ +++ + ++ + G +
Sbjct: 58 RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELWVVTSFMAYGSAKDL 116
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
I E + L +L AL+Y+H +HR VK S+I ++ D + L
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 125 MLISD--------DLASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCVYEMSAQKAA 174
+IS D V ++ PE+L Y +KSDI+S+G E++
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
Query: 175 FKAFD-MQALINKIN--------------------------------------------K 189
FK Q L+ K+N
Sbjct: 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
Query: 190 SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
S P +S F V+ L++NP+ RPSA+ LL H
Sbjct: 297 SPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 66/261 (25%), Positives = 120/261 (45%), Gaps = 13/261 (4%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+ Q ++ E+ + + + +V + + E +V +++ C + E
Sbjct: 77 SLLLKPHQREKMSM----EISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLEL 131
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
K+ E + +L Q+++ YLH N ++HRD+K N+FL D ++++GDFGLA
Sbjct: 132 HKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189
Query: 125 MLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
+ D + GTP+Y+ PE+L+ + + D+WS+GC +Y + K F+ ++
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP----HLQPYVLGIHL 239
+I K+ +P + L++ ML+ +P RP+ ELL P L I
Sbjct: 250 YLRIKKNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308
Query: 240 KLNGPRRNTFPLEWSDSNFKK 260
PR + P SN K
Sbjct: 309 LTIPPRFSIAPSSLDPSNRKP 329
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 14/242 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K++R + + + +++ ++ P+IV+ +++ V I +
Sbjct: 53 IAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTC- 109
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGD 119
AE +KK PE L K V ++ AL YL H ++HRDVK SNI L I+L D
Sbjct: 110 -AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPE-----LLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
FG++ L+ D G +YM PE Y ++D+WSLG + E++ +
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
Query: 175 FKAFDMQ-ALINKI--NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+K ++ K+ + + P +SG F+ VK L K+ RP +LL H ++
Sbjct: 229 YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288
Query: 232 PY 233
Y
Sbjct: 289 RY 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-45
Identities = 77/221 (34%), Positives = 121/221 (54%), Gaps = 22/221 (9%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
E+E+++ +P+IV+ ++ + I+I +C GG + + + + E ++
Sbjct: 65 VEIEILATCDHPYIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVV 122
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASSVVGTPS 140
Q+L ALN+LH+ I+HRD+K N+ +T + DIRL DFG++ + S +GTP
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 141 YMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSIV 192
+M PE++ D PY K+DIWSLG + EM+ + + M+ L+ KI KS
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLL-KIAKS-- 237
Query: 193 APLPTV-----YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
PT+ +S FR +K L KNPE RPSAA+LL HP
Sbjct: 238 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 6e-45
Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 22 QEMELISRV-RNPFIVEYKDSWVEKGCYVC-----IIIGYCEGGDMAEAIKKANGVHFPE 75
QE+ ++ + + I Y ++++K +++ +C G + + IK G E
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-ASS 134
E + ++L L++LH + ++HRD+K N+ LT + +++L DFG++ L ++
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 135 VVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKIN 188
+GTP +M PE++A D Y KSD+WSLG EM+ M+AL I
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIP 247
Query: 189 KSIVAPLPTV----YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
++ P P + +S F+ ++S L KN RP+ +L+ HP
Sbjct: 248 RN---PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-45
Identities = 57/225 (25%), Positives = 110/225 (48%), Gaps = 9/225 (4%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+ Q ++ E+ + + + +V + + E +V +++ C + E
Sbjct: 51 SLLLKPHQREKMSM----EISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLEL 105
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
K+ E + +L Q+++ YLH N ++HRD+K N+FL D ++++GDFGLA
Sbjct: 106 HKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163
Query: 125 MLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
+ D + GTP+Y+ PE+L+ + + D+WS+GC +Y + K F+ ++
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+I K+ +P + L++ ML+ +P RP+ ELL
Sbjct: 224 YLRIKKNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 13/240 (5%)
Query: 4 LKKIRLARQTDRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG--D 60
+K+IR + ++ +++ + V PF V + + +G V I + +
Sbjct: 37 VKRIRATVNSQE-QKRLLMDLDISMRTVDCPFTVTFYGALFREGD-VWICMELMDTSLDK 94
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGD 119
+ + PE+ L K V ++ AL +LH+ ++HRDVK SN+ + +++ D
Sbjct: 95 FYKQVIDKGQT-IPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD 153
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPE----LLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
FG++ L+ D G YM PE L Y KSDIWSLG + E++ + +
Sbjct: 154 FGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 176 KAFDMQ-ALINKINKSIVAPLPT-VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
++ + ++ + LP +S F L+KN + RP+ EL+ HP +
Sbjct: 214 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 15/243 (6%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISR-VRNPFIVEYKDSWVEKGCYVCIIIGYCEGG--D 60
+K+IR ++ +++++ R P+IV++ + +G I +
Sbjct: 52 VKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-CWICMELMSTSFDK 109
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGD 119
+ + PEE L K + + ALN+L N I+HRD+K SNI L R +I+L D
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD 169
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPE----LLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
FG++ L+ + G YM PE + Y +SD+WSLG +YE++ + +
Sbjct: 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
Query: 176 KAFD-MQALINKINK----SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
++ + + ++ K + +S +F V L K+ RP ELL HP +
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289
Query: 231 QPY 233
Y
Sbjct: 290 LMY 292
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 23/229 (10%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA------NGVHFPE 75
+E++ +S+ +P IV Y S+V + +++ GG + + IK E
Sbjct: 62 KEIQAMSQCHHPNIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLAS-- 133
+ L ++L L YLH N +HRDVK NI L D +++ DFG++ L + +
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 134 ----SVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKI 187
+ VGTP +M PE++ + Y K+DIWS G E++ A + + M+ L+ +
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 188 NKS--------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ Y +FR ++ L+K+PE RP+AAELL H
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 46/279 (16%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDM 61
V I R D R E E++ ++ + IV+ E + +I+ +C G +
Sbjct: 41 VFNNISFLRPVDVQMR----EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96
Query: 62 AEAI-KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD----IR 116
+ + +N PE + L ++ +N+L N I+HR++K NI +D +
Sbjct: 97 YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADI--------PYGSKSDIWSLGCCVYEM 168
L DFG A+ L D+ S+ GT Y+ P++ YG+ D+WS+G Y
Sbjct: 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 169 SAQKAAFKAFDM----QALINKINK--------------------SIVAPLPTVYSGAFR 204
+ F+ F+ + ++ KI S P+ S +
Sbjct: 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ 276
Query: 205 GLVKS----MLRKNPEFRPSAAELLCHPHLQPYVLGIHL 239
L+ +L + E + + H
Sbjct: 277 VLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHH 315
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 8e-43
Identities = 51/228 (22%), Positives = 103/228 (45%), Gaps = 11/228 (4%)
Query: 3 VLKKIRLAR--QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
VL K +L + + RR E+E+ S +R+P I+ + + + +++ + G+
Sbjct: 46 VLFKSQLEKEGVEHQLRR----EIEIQSHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGE 100
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + ++K F E++ ++ +L AL+Y H ++HRD+K N+ + ++++ DF
Sbjct: 101 LYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
G + ++ GT Y+ PE++ + K D+W G YE F +
Sbjct: 159 GWSVH-APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+I + P S + L+ +LR +P R ++ HP
Sbjct: 218 TETHRRIVNVDLK-FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 60/234 (25%), Positives = 114/234 (48%), Gaps = 12/234 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K IR + + +E+ ++ + +P I++ D + +K +++ +GG++
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-NYYLVMECYKGGEL 123
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLG 118
+ I F E + Q+L + YLH ++I+HRD+K N+ ++++D I++
Sbjct: 124 FDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGL+ + + +GT Y+ PE+L Y K D+WS+G ++ + A F
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 179 DMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
Q ++ K+ K V GA + L+K ML+ + + R SA + L HP
Sbjct: 241 TDQEILRKVEKGKYTFDSPEWKNVSEGA-KDLIKQMLQFDSQRRISAQQALEHP 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
Y +K I A ++ + +E+EL+ ++ +P I++ + + I+ GG++
Sbjct: 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGEL 108
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLG 118
+ I K F E + + Q+ + Y+H ++I+HRD+K NI ++++D I++
Sbjct: 109 FDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGL+ + +GT Y+ PE+L Y K D+WS G +Y + + F
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225
Query: 179 DMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ ++ ++ T+ A + L++ ML +P R +A + L HP
Sbjct: 226 NEYDILKRVETGKYAFDLPQWRTISDDA-KDLIRKMLTFHPSLRITATQCLEHP 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 63/215 (29%), Positives = 112/215 (52%), Gaps = 18/215 (8%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
+E+ + ++R+P ++Y+ ++ + +++ YC G ++ ++ E ++
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYL-REHTAWLVMEYCLGS-ASDLLEVHKKP-LQEVEIAAV 159
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY 141
L L YLH+++++HRDVK NI L+ ++LGDFG A ++ A+S VGTP +
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYW 216
Query: 142 MCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPT 197
M PE++ + Y K D+WSLG E++ +K + M AL I ++ P
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN---ESPA 272
Query: 198 V----YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ +S FR V S L+K P+ RP++ LL H
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-41
Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 13/235 (5%)
Query: 2 YVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K I + + + S +E++L+ ++ +P I++ + + +KG Y ++ GG+
Sbjct: 54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-YFYLVGEVYTGGE 112
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ + I F E + + Q+L + Y+H N I+HRD+K N+ ++ +D IR+
Sbjct: 113 LFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRI 170
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGL+ + +GT Y+ PE+L Y K D+WS G +Y + + F
Sbjct: 171 IDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229
Query: 178 FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ ++ K+ K V A + L++ ML P R SA + L H
Sbjct: 230 ANEYDILKKVEKGKYTFELPQWKKVSESA-KDLIRKMLTYVPSMRISARDALDHE 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 32/264 (12%)
Query: 20 AHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78
A +E++L+ P ++ Y + + + I I C + E +++ +
Sbjct: 64 ADREVQLLRESDEHPNVIRYFCT-EKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEP 120
Query: 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDDLA- 132
L Q L +LH+ +I+HRD+K NI ++ + DFGL K L +
Sbjct: 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 133 ---SSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAF--KAFDMQA-- 182
S V GT ++ PE+L++ DI+S GC Y + ++ + K+ QA
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240
Query: 183 LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLN 242
L+ + + P R L++ M+ +P+ RPSA +L HP +
Sbjct: 241 LLGACSLDCLHPEKHE-DVIARELIEKMIAMDPQKRPSAKHVLKHPFFW----------S 289
Query: 243 GPRRNTFPLEWSDSNFKKTRFMEP 266
++ F + SD +K P
Sbjct: 290 LEKQLQFFQDVSD-RIEKESLDGP 312
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 12/214 (5%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81
E+ L+ + +P I++ D + E Y ++ + EGG++ E I + F E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANI 151
Query: 82 LVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLISDDLASSVVGT 138
+ Q+L + YLH ++I+HRD+K NI ++ I++ DFGL+ D +GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 139 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV----AP 194
Y+ PE+L Y K D+WS G +Y + F + Q +I K+ K
Sbjct: 212 AYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 195 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ A + L+K ML + R +A E L
Sbjct: 271 WKNISDEA-KELIKLMLTYDYNKRCTAEEALNSR 303
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-40
Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 14/235 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
++ LK I+ + + E+ ++ ++++ IV +D E + +++ GG+
Sbjct: 36 LFALKCIKKSPAFRDSS--LENEIAVLKKIKHENIVTLED-IYESTTHYYLVMQLVSGGE 92
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ + I + + E+ + Q+L A+ YLH N I+HRD+K N+ +LT +++ I +
Sbjct: 93 LFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMI 150
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGL+KM + + S+ GTP Y+ PE+LA PY D WS+G Y + F
Sbjct: 151 TDFGLSKM-EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
Query: 178 FDMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
L KI + + A + + +L K+P R + + L HP
Sbjct: 210 ETESKLFEKIKEGYYEFESPFWDDISESA-KDFICHLLEKDPNERYTCEKALSHP 263
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 54/265 (20%), Positives = 99/265 (37%), Gaps = 46/265 (17%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-YVCIIIGYCEGGDM 61
V I R D R E E++ ++ + IV+ E + +I+ +C G +
Sbjct: 41 VFNNISFLRPVDVQMR----EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96
Query: 62 AEAI-KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD----IR 116
+ + +N PE + L ++ +N+L N I+HR++K NI +D +
Sbjct: 97 YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADI--------PYGSKSDIWSLGCCVYEM 168
L DFG A+ L D+ S+ GT Y+ P++ YG+ D+WS+G Y
Sbjct: 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
Query: 169 SAQKAAFKAFDMQALINKINKSIVA------------------------PLPTVYSGAFR 204
+ F+ F+ ++ I+ P+ S +
Sbjct: 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ 276
Query: 205 GLVKS----MLRKNPEFRPSAAELL 225
L+ +L + E +
Sbjct: 277 VLLTPVLANILEADQEKCWGFDQFF 301
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 11/236 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
L+K R+ ++ A A E +++ +V + F+V ++ K +C+++ GGD
Sbjct: 214 CKKLEKKRIKKRKGEA--MALNEKQILEKVNSRFVVSLAYAYETKD-ALCLVLTLMNGGD 270
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ I FPE + + ++ L LH I++RD+K NI L IR+ D
Sbjct: 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDL 330
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLA + VGT YM PE++ + Y D W+LGC +YEM A ++ F+
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 181 QALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ ++ + + +S R L +L K+P R SA E+ HP
Sbjct: 391 KIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 16/236 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
Y LK ++ R E+ ++ R+ +P I++ K+ + E + +++ GG+
Sbjct: 80 PYALKVLKKTVDKKIVRT----EIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGE 134
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ + I + ++ E + Q+L A+ YLH N I+HRD+K N+ + T D +++
Sbjct: 135 LFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKI 192
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGL+K++ L +V GTP Y PE+L YG + D+WS+G Y + F
Sbjct: 193 ADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252
Query: 178 -FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
Q + +I V A + LV+ ++ +P+ R + + L HP
Sbjct: 253 ERGDQFMFRRILNCEYYFISPWWDEVSLNA-KDLVRKLIVLDPKKRLTTFQALQHP 307
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 68/239 (28%), Positives = 115/239 (48%), Gaps = 19/239 (7%)
Query: 1 MYVLKKIRLAR--QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+ +L+K + + + R E +++SR+ +PF V+ ++ + + + Y +
Sbjct: 60 IKILEKRHIIKENKVPYVTR----ERDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKN 114
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
G++ + I+K F E + +++ AL YLH I+HRD+K NI L D I++
Sbjct: 115 GELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 172
Query: 119 DFGLAKMLISD---DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
DFG AK+L + A+S VGT Y+ PELL + SD+W+LGC +Y++ A F
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
Query: 176 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP------SAAELLCHP 228
+A + + KI K P + R LV+ +L + R L HP
Sbjct: 233 RAGNEYLIFQKIIKLEYD-FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 59/235 (25%), Positives = 117/235 (49%), Gaps = 13/235 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M + K + + R+ +E++++ + +PF+V S+ ++ + +++ GGD
Sbjct: 45 MKYMNKQKCVER--NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFMVVDLLLGGD 101
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ +++ VHF EE + ++ +L+MAL+YL I+HRD+K NI L + + DF
Sbjct: 102 LRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDF 159
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQKAAF-- 175
+A ML + +++ GT YM PE+ + Y D WSLG YE+ + +
Sbjct: 160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
Query: 176 -KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-PSAAELLCHP 228
+ + +++ ++V P+ +S L+K +L NP+ R +++ P
Sbjct: 220 RSSTSSKEIVHTFETTVV-TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-39
Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
Y +K I A ++ + +E+EL+ ++ +P I++ + + I+ GG++
Sbjct: 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGEL 108
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLG 118
+ I K F E + + Q+ + Y+H ++I+HRD+K NI ++++D I++
Sbjct: 109 FDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGL+ + +GT Y+ PE+L Y K D+WS G +Y + + F
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225
Query: 179 DMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ ++ ++ T+ A + L++ ML +P R +A + L HP
Sbjct: 226 NEYDILKRVETGKYAFDLPQWRTISDDA-KDLIRKMLTFHPSLRITATQCLEHP 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 11/234 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+ K I + + R + +E + ++++P IV DS E+ + ++ GG++
Sbjct: 34 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVFDLVTGGEL 92
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLG 118
E I + E + Q+L ++ Y H+N I+HR++K N+ ++ + ++L
Sbjct: 93 FEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGLA + + GTP Y+ PE+L PY DIW+ G +Y + F
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210
Query: 179 DMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
D L +I TV A + L+ SML NP+ R +A + L P
Sbjct: 211 DQHRLYAQIKAGAYDYPSPEWDTVTPEA-KSLIDSMLTVNPKKRITADQALKVP 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 1e-38
Identities = 59/268 (22%), Positives = 98/268 (36%), Gaps = 18/268 (6%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKD-----SWVEKGCYVCIIIGYCE 57
++ + +R E++++ ++ +P +V ++ + + + YCE
Sbjct: 46 QCRQELSPKNRERWCL----EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 101
Query: 58 GGDMAEAI-KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-- 114
GGD+ + + + N E + L + AL YLH N I+HRD+K NI L
Sbjct: 102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 161
Query: 115 -IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
++ D G AK L +L + VGT Y+ PELL Y D WS G +E
Sbjct: 162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
F + + VY + S + P LQ
Sbjct: 222 PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM 281
Query: 234 VLGIHLKLNGPRRNTFPLEWSDSNFKKT 261
L + +R T P + F+
Sbjct: 282 -----LMWHQRQRGTDPQNPNVGCFQAL 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 52/226 (23%), Positives = 101/226 (44%), Gaps = 6/226 (2%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K + +E+ ++ R+R+P IV + + + I+ Y G +
Sbjct: 66 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRL 124
Query: 65 I-KKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFG 121
+ K E + + +NYLH + I+HR++K N+ + + +++ DFG
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 122 LAKMLISDDLAS-SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD- 179
L+++ S L+S S GTP +M PE+L D P KSD++S G ++E++ + + +
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
Q + K +P + +++ P RPS A ++
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIM 290
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 74/238 (31%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME--LISRVRNPFIVEYKDSW--VEKGCYVCIIIGYC 56
M VLKK + R AH + E ++ V++PFIV+ ++ K + +I+ Y
Sbjct: 50 MKVLKKAMIVRNAKDT---AHTKAERNILEEVKHPFIVDLIYAFQTGGK---LYLILEYL 103
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
GG++ +++ F E+ C +L ++ MAL +LH I++RD+K NI L ++
Sbjct: 104 SGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161
Query: 117 LGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
L DFGL K I D + + GT YM PE+L + D WSLG +Y+M F
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 176 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ + I+KI K + LP + R L+K +L++N R A E+ HP
Sbjct: 222 TGENRKKTIDKILKCKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 13/233 (5%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
+ K R ++ E+E++ + +P I++ + + E + I++ CEGG++
Sbjct: 54 TINKDRSQVPMEQIEA----EIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELL 108
Query: 63 EAI--KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
E I +A G E + + + Q++ AL Y H+ H++H+D+K NI F I++
Sbjct: 109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGLA++ SD+ +++ GT YM PE+ K DIWS G +Y + F
Sbjct: 169 IDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 178 FDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
++ + K A + L+K ML K+PE RPSAA++L H
Sbjct: 228 TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 18/310 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+ K I + + R + +E + ++++P IV DS E+ + ++ GG++
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVFDLVTGGEL 115
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLG 118
E I + E + Q+L ++ Y H+N I+HR++K N+ ++ + ++L
Sbjct: 116 FEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGLA + + GTP Y+ PE+L PY DIW+ G +Y + F
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 179 DMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ--- 231
D L +I TV A + L+ SML NP+ R +A + L P +
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEA-KSLIDSMLTVNPKKRITADQALKVPWICNRE 292
Query: 232 PYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSV 291
IH + F + K + + + + R + PS
Sbjct: 293 RVASAIHRQDTVDCLKKFN---ARRKLKGA-ILTTMIATRNLSNLGRNLLNKKEQGPPST 348
Query: 292 SETEQDSLSS 301
+ +S +
Sbjct: 349 IKESSESSQT 358
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-38
Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 12/236 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
Y I + + R + +E + +++P IV DS E+G + +I GG+
Sbjct: 38 EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-HHYLIFDLVTGGE 96
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ E I ++ E + Q+L A+ + H ++HR++K N+ ++ + ++L
Sbjct: 97 LFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKL 154
Query: 118 GDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
DFGLA + + A GTP Y+ PE+L PYG D+W+ G +Y + F
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214
Query: 177 AFDMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
D L +I TV A + L+ ML NP R +AAE L HP
Sbjct: 215 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEA-KDLINKMLTINPSKRITAAEALKHP 269
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 14/235 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
KKI D R QE+E++ + +P I+ +++ E + +++ C GG+
Sbjct: 36 RRAAKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGE 92
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ E + F E + + +L A+ Y H ++ HRD+K N FLT D ++L
Sbjct: 93 LFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKL 150
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGLA + + VGTP Y+ P++L YG + D WS G +Y + F A
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA 209
Query: 178 FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
++ KI + V A L++ +L K+P+ R ++ + L H
Sbjct: 210 PTDSEVMLKIREGTFTFPEKDWLNVSPQA-ESLIRRLLTKSPKQRITSLQALEHE 263
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 71/238 (29%), Positives = 117/238 (49%), Gaps = 21/238 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME--LISRVRNPFIVEYKDSW--VEKGCYVCIIIGYC 56
M VLKK L R +ME ++ V +PFIV+ ++ K + +I+ +
Sbjct: 57 MKVLKKATLK-----VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK---LYLILDFL 108
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
GGD+ + K V F EE + +L +L +AL++LH+ I++RD+K NI L + I+
Sbjct: 109 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166
Query: 117 LGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
L DFGL+K I + A S GT YM PE++ + +D WS G ++EM F
Sbjct: 167 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 176 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ D + + I K+ + +P S + L++ + ++NP R E+ H
Sbjct: 227 QGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 53/277 (19%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
++ K ++ + + E+ L+ ++ +P I + + ++ Y+C+++ C GG +
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-YICLVMELCHGGHLL 116
Query: 63 EAIKK--------------------------------------ANGVHFPEEKLCKWLVQ 84
+ + + E+ + + Q
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176
Query: 85 LLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDLA-----SSVVG 137
+ AL+YLH I HRD+K N + ++ I+L DFGL+K + ++ G
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 138 TPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--- 192
TP ++ PE+L + YG K D WS G ++ + F + I+++ +
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE 296
Query: 193 -APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ A R L+ ++L +N + R A L HP
Sbjct: 297 NPNYNVLSPLA-RDLLSNLLNRNVDERFDAMRALQHP 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 21/244 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M ++ K + ++ + + E +++ +I + ++ ++ Y+ +++ Y GGD
Sbjct: 91 MKIMNKWDMLKRGEVSCFRE--ERDVLVNGDRRWITQLHFAFQDEN-YLYLVMEYYVGGD 147
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + K G P E +L +++MA++ +H +HRD+K NI L R IRL DF
Sbjct: 148 LLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206
Query: 121 GLAKMLISDDL--ASSVVGTPSYMCPELL-------ADIPYGSKSDIWSLGCCVYEMSAQ 171
G L +D + VGTP Y+ PE+L YG + D W+LG YEM
Sbjct: 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
Query: 172 KAAFKAFDMQALINKI-NKSIVAPLPTVY---SGAFRGLVKSMLRKNPEFR---PSAAEL 224
+ F A KI + LP V R ++ +L PE R A +
Sbjct: 267 QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325
Query: 225 LCHP 228
HP
Sbjct: 326 RTHP 329
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 31/246 (12%)
Query: 3 VLKKIRLARQTDRARRSAH---QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
++ K + A + R A E+E++ ++ +P I++ K+ + + Y I++ EGG
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY--IVLELMEGG 224
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT---RDQDIR 116
++ + + E + Q+L+A+ YLH N I+HRD+K N+ L+ D I+
Sbjct: 225 ELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 282
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEM----- 168
+ DFG +K+L L ++ GTP+Y+ PE+L + Y D WSLG ++
Sbjct: 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 169 --SAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
S + +L ++I V A LVK +L +P+ R +
Sbjct: 343 PFSEHR------TQVSLKDQITSGKYNFIPEVWAEVSEKA-LDLVKKLLVVDPKARFTTE 395
Query: 223 ELLCHP 228
E L HP
Sbjct: 396 EALRHP 401
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-37
Identities = 65/239 (27%), Positives = 115/239 (48%), Gaps = 14/239 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
L K RL ++ A E +++++V + FIV ++ K +C+++ GGD
Sbjct: 215 CKKLNKKRLKKRKGYQ--GAMVEKKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGD 271
Query: 61 MAEAIKKANGVH--FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
+ I + + F E + + Q++ L +LH +I++RD+K N+ L D ++R+
Sbjct: 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRIS 331
Query: 119 DFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
D GLA L + GTP +M PELL Y D ++LG +YEM A + F+A
Sbjct: 332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 178 FDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ ++ + ++ P +S A + +++L+K+PE R S L HP
Sbjct: 392 RGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 58/233 (24%), Positives = 106/233 (45%), Gaps = 12/233 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
Y+ K ++ + TD+ +E+ +++ R+ I+ +S+ E + +I + G D+
Sbjct: 33 YMAKFVK-VKGTDQV--LVKKEISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDI 88
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQDIRLGD 119
E I + E ++ ++ Q+ AL +LH+++I H D++ NI R I++ +
Sbjct: 89 FERIN-TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG A+ L D + P Y PE+ + +D+WSLG VY + + F A
Sbjct: 148 FGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207
Query: 180 MQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
Q +I I + + A V +L K + R +A+E L HP
Sbjct: 208 NQQIIENIMNAEYTFDEEAFKEISIEA-MDFVDRLLVKERKSRMTASEALQHP 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 19/242 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +L K + ++ + A E +++ + +I ++ + + +++ Y GGD
Sbjct: 104 MKILNKWEMLKRAETACFRE--ERDVLVNGDSKWITTLHYAFQDDN-NLYLVMDYYVGGD 160
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + K PEE +L ++++A++ +H H +HRD+K NI + + IRL DF
Sbjct: 161 LLTLLSKFED-RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 219
Query: 121 GLAKMLISDDL--ASSVVGTPSYMCPELLADIP-----YGSKSDIWSLGCCVYEMSAQKA 173
G L+ D +S VGTP Y+ PE+L + YG + D WSLG C+YEM +
Sbjct: 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 174 AFKAFDMQALINKI-NKSIVAPLP---TVYSGAFRGLVKSMLRKNPEFR---PSAAELLC 226
F A + KI N P T S + L++ ++ R +
Sbjct: 280 PFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQNGIEDFKK 338
Query: 227 HP 228
HP
Sbjct: 339 HP 340
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 13/236 (5%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
++ + + +E + +++P IVE +++ G + ++ + +G D+
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG-MLYMVFEFMDGADLC 114
Query: 63 EAI--KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
I + G + E ++ Q+L AL Y H N+I+HRDVK + +++ ++L
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174
Query: 118 GDFGLAKMLISDDLA-SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
G FG+A L L VGTP +M PE++ PYG D+W G ++ + + F
Sbjct: 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
Query: 177 AFDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ L I K + A + LV+ ML +P R + E L HP
Sbjct: 235 GTK-ERLFEGIIKGKYKMNPRQWSHISESA-KDLVRRMLMLDPAERITVYEALNHP 288
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 31/246 (12%)
Query: 3 VLKKIRLARQTDRARRSAH---QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
++ K + A + R A E+E++ ++ +P I++ K+ + + Y I++ EGG
Sbjct: 42 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY--IVLELMEGG 99
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IR 116
++ + + E + Q+L+A+ YLH N I+HRD+K N+ ++++D I+
Sbjct: 100 ELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 157
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADI---PYGSKSDIWSLGCCVYEM----- 168
+ DFG +K+L L ++ GTP+Y+ PE+L + Y D WSLG ++
Sbjct: 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 169 --SAQKAAFKAFDMQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
S + +L ++I V A LVK +L +P+ R +
Sbjct: 218 PFSEHR------TQVSLKDQITSGKYNFIPEVWAEVSEKA-LDLVKKLLVVDPKARFTTE 270
Query: 223 ELLCHP 228
E L HP
Sbjct: 271 EALRHP 276
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 58/235 (24%), Positives = 116/235 (49%), Gaps = 13/235 (5%)
Query: 3 VLKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+KK RL + + +R +E+ ++ +R+P I+ D + E V +I+ GG++
Sbjct: 37 FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGEL 95
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD---IRL 117
+ + + E++ ++L Q+L ++YLH+ I H D+K NI L ++ I+L
Sbjct: 96 FDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFG+A + + + ++ GTP ++ PE++ P G ++D+WS+G Y + + + F
Sbjct: 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213
Query: 178 FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
Q + I+ A + ++ +L K+P+ R + A+ L H
Sbjct: 214 ETKQETLTNISAVNYDFDEEYFSNTSELA-KDFIRRLLVKDPKRRMTIAQSLEHS 267
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 9/213 (4%)
Query: 22 QEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
QE+ ++ ++ +P +V+ + + ++ ++ G + E E++
Sbjct: 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARF 141
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTP 139
+ L+ + YLH I+HRD+K SN+ + D I++ DFG++ SD L S+ VGTP
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 140 SYMCPELLADI--PY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PL 195
++M PE L++ + G D+W++G +Y + F + L +KI + P
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261
Query: 196 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ + L+ ML KNPE R E+ HP
Sbjct: 262 QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 35/249 (14%), Positives = 77/249 (30%), Gaps = 35/249 (14%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG-- 59
+VLK + A + Q ME + +++ + + + ++ G
Sbjct: 98 FVLKVQKPANPWEFYI--GTQLMERLKPSMQHMFMKFYSAHLFQNGS-VLVGELYSYGTL 154
Query: 60 -DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR------- 111
+ K P+ + + +++L + +H I+H D+K N L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214
Query: 112 ----DQDIRLGDFGLA---KMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC 164
+ L D G + K+ + ++ T + C E+L++ P+ + D + +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 165 VYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRG-----LVKSMLRKNPEFRP 219
VY M + + + ML
Sbjct: 275 VYCMLFGTYMKVKNEGGECKPEGL----------FRRLPHLDMWNEFFHVMLNIPDCHHL 324
Query: 220 SAAELLCHP 228
+ +LL
Sbjct: 325 PSLDLLRQK 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 27/191 (14%), Positives = 54/191 (28%), Gaps = 14/191 (7%)
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLV--QLLMALNYLHANHILHRDVKCSNIFLTRD 112
+ + + E L ++ QL+ L + ++H N+F+ D
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD 230
Query: 113 QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEM-- 168
+ LGD + +Y E L + + + W LG +Y +
Sbjct: 231 GRLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 169 ------SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222
++ +L S+ T + L+ L + R
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 223 ELLCHPHLQPY 233
E + P
Sbjct: 349 EAMETPEFLQL 359
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 54/254 (21%), Positives = 114/254 (44%), Gaps = 11/254 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+V K I D+ E+ +++++ +P ++ D++ E + +I+ + GG++
Sbjct: 79 FVAKFINTPYPLDKYT--VKNEISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGEL 135
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQDIRLGD 119
+ I A E ++ ++ Q L ++H + I+H D+K NI + +++ D
Sbjct: 136 FDRIA-AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FGLA L D++ T + PE++ P G +D+W++G Y + + + F D
Sbjct: 195 FGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254
Query: 180 MQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235
+ + + +V A + +K++L+K P R + + L HP L+
Sbjct: 255 DLETLQNVKRCDWEFDEDAFSSVSPEA-KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313
Query: 236 GIHLKLNGPRRNTF 249
+ ++ R N
Sbjct: 314 NLTSRIPSSRYNKI 327
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 68/313 (21%), Positives = 127/313 (40%), Gaps = 15/313 (4%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K+ A + R +E+ ++ +V +P I+ D + E V +I+ GG++ +
Sbjct: 47 KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDF 105
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD---IRLGDF 120
+ + EE+ ++ Q+L +NYLH I H D+K NI L ++ I+L DF
Sbjct: 106 LAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLA + ++ GTP ++ PE++ P G ++D+WS+G Y + + + F
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 181 QALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 236
Q + I A + ++ +L K R + E L HP + P
Sbjct: 224 QETLANITAVSYDFDEEFFSQTSELA-KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282
Query: 237 IHLKLNGPRRNTFPLE--WSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSET 294
+ N + + +K + + + + K+ L S+T
Sbjct: 283 QAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDT 342
Query: 295 EQ-DSLSSTLRGR 306
E+ + L R
Sbjct: 343 EENIARRKALHPR 355
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 56/239 (23%), Positives = 117/239 (48%), Gaps = 13/239 (5%)
Query: 3 VLKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+KK R + + +R +E+ ++ +++P ++ + + E V +I+ GG++
Sbjct: 43 FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGEL 101
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD---IRL 117
+ + + EE+ ++L Q+L + YLH+ I H D+K NI L R+ I++
Sbjct: 102 FDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGLA + + ++ GTP ++ PE++ P G ++D+WS+G Y + + + F
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 178 FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232
Q + ++ + A + ++ +L K+P+ R + + L HP ++P
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALA-KDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 60/240 (25%), Positives = 113/240 (47%), Gaps = 19/240 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +L K + +++D A +E ++++ +P++V+ ++ + Y+ +++ Y GGD
Sbjct: 99 MKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDR-YLYMVMEYMPGGD 155
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + PE+ + ++++AL+ +H+ +HRDVK N+ L + ++L DF
Sbjct: 156 LVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 121 GLAKMLISD--DLASSVVGTPSYMCPELL----ADIPYGSKSDIWSLGCCVYEMSAQKAA 174
G + + + VGTP Y+ PE+L D YG + D WS+G +YEM
Sbjct: 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
Query: 175 FKAFDMQALINKI---NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR---PSAAELLCHP 228
F A + +KI S+ P S + L+ + L + E R E+ H
Sbjct: 273 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHL 331
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 67/234 (28%), Positives = 114/234 (48%), Gaps = 12/234 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +L+K + + + A E ++ R+PF+ K ++ +C ++ Y GG+
Sbjct: 35 MKILRKEVIIAKDEVAHTVT--ESRVLQNTRHPFLTALKYAFQTHDR-LCFVMEYANGGE 91
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + F EE+ + +++ AL YLH+ +++RD+K N+ L +D I++ DF
Sbjct: 92 LFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
GL K ISD + GTP Y+ PE+L D YG D W LG +YEM + F D
Sbjct: 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ L I + P S + L+ +L+K+P+ R A E++ H
Sbjct: 210 HERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 12/232 (5%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K+ A + +R +E+ ++ +V + ++ D + E V +I+ GG++ +
Sbjct: 47 KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDF 105
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD---IRLGDF 120
+ + EE+ ++ Q+L +NYLH I H D+K NI L ++ I+L DF
Sbjct: 106 LAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
GLA + ++ GTP ++ PE++ P G ++D+WS+G Y + + + F
Sbjct: 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 181 QALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
Q + I A + ++ +L K R + E L HP
Sbjct: 224 QETLANITSVSYDFDEEFFSHTSELA-KDFIRKLLVKETRKRLTIQEALRHP 274
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 17/237 (7%)
Query: 5 KKIRLARQTDRA--RRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+ R + +E++++ +V P I++ KD++ E + ++ + G++
Sbjct: 53 TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGEL 111
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ + + V E++ K + LL + LH +I+HRD+K NI L D +I+L DFG
Sbjct: 112 FDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADI------PYGSKSDIWSLGCCVYEMSAQKAAF 175
+ L + V GTPSY+ PE++ YG + D+WS G +Y + A F
Sbjct: 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
Query: 176 KAFDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
++ I + LV L P+ R +A E L HP
Sbjct: 230 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHP 285
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 23/240 (9%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ +K I D+++R +E+E++ R P I+ KD + + G YV ++ +GG+
Sbjct: 50 FAVKII------DKSKRDPTEEIEILLRYGQHPNIITLKDVY-DDGKYVYVVTELMKGGE 102
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD---IR 116
+ + I + F E + L + + YLHA ++HRD+K SNI ++ + IR
Sbjct: 103 LLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160
Query: 117 LGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
+ DFG AK L +++ L + T +++ PE+L Y + DIWSLG +Y M F
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220
Query: 176 KAFDM---QALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ ++ +I +V A + LV ML +P R +AA +L HP
Sbjct: 221 ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA-KDLVSKMLHVDPHQRLTAALVLRHP 279
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 17 RRSAHQEMELISRVRN-PFIVE----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGV 71
A QE++ + P IV Y++ K C + II+ EGG++ I++
Sbjct: 65 SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC-LLIIMECMEGGELFSRIQERGDQ 123
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRLGDFGLAKMLIS 128
F E + + + + A+ +LH+++I HRDVK N+ + ++++D ++L DFG AK
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 129 DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN 188
+ L + TP Y+ PE+L Y D+WSLG +Y + F + QA+ +
Sbjct: 184 NAL-QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 189 KSIVA--------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ I V A + L++ +L+ +P R + + + HP
Sbjct: 243 RRIRLGQYGFPNPEWSEVSEDA-KQLIRLLLKTDPTERLTITQFMNHP 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 58/253 (22%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
KI + + D + E+++I+ ++N + + + V II Y E + +
Sbjct: 79 DKISIKSKYDDFKN----ELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKF 133
Query: 65 IKKANGVH------FPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRL 117
+ + P + + + +L + +Y+H +I HRDVK SNI + ++ ++L
Sbjct: 134 DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKL 193
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIP--YGSKSDIWSLGCCVYEMSAQKAAF 175
DFG ++ ++ + S GT +M PE ++ G+K DIWSLG C+Y M F
Sbjct: 194 SDFGESEYMVDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 176 KA-FDMQALINKINK-------------------SIVAPLPTVYSGAFRGLVKSMLRKNP 215
+ L N I + + +K LRKNP
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNED-IDFLKLFLRKNP 311
Query: 216 EFRPSAAELLCHP 228
R ++ + L H
Sbjct: 312 AERITSEDALKHE 324
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 66/245 (26%), Positives = 120/245 (48%), Gaps = 25/245 (10%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
M VLKK + + +A+ + H E L ++PF+V ++ K + +I+ Y
Sbjct: 87 MKVLKKATIVQ---KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK---LHLILDY 140
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GG++ + + F E ++ ++ ++++AL +LH I++RD+K NI L + +
Sbjct: 141 INGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV 198
Query: 116 RLGDFGLAKMLISD--DLASSVVGTPSYMCPELLADIPYG-SKS-DIWSLGCCVYEMSAQ 171
L DFGL+K ++D + A GT YM P+++ G K+ D WSLG +YE+
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 172 KAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAE 223
+ F + +I++ I+ P P S + L++ +L K+P+ R A E
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 318
Query: 224 LLCHP 228
+ H
Sbjct: 319 IKEHL 323
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 4e-35
Identities = 34/241 (14%), Positives = 67/241 (27%), Gaps = 25/241 (10%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDS---WVEKGCYVCIIIGYCEGGD 60
L+ I+ +Q R +L+ + ++ + +
Sbjct: 130 LRGIKNQKQAKVHLRFIF-PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 61 MAEAI--KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
E + + + +Q++ L LH ++H ++ +I L + + L
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 248
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLAD-----------IPYGSKSDIWSLGCCVYE 167
F D + + PEL A D W+LG +Y
Sbjct: 249 GFEHLVR---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 168 MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+ I +S R L++ LR E R + +
Sbjct: 306 IWCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360
Query: 228 P 228
P
Sbjct: 361 P 361
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-35
Identities = 51/237 (21%), Positives = 107/237 (45%), Gaps = 11/237 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+ K + ++D+ +E++ +S +R+P +V D++ E + +I + GG++
Sbjct: 185 FAAKFVMTPHESDKET--VRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGEL 241
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD-IRLGD 119
E + + E++ +++ Q+ L ++H N+ +H D+K NI F T+ + ++L D
Sbjct: 242 FEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FGL L GT + PE+ P G +D+WS+G Y + + + F +
Sbjct: 301 FGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360
Query: 180 MQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232
+ + + + + ++ +L +P R + + L HP L P
Sbjct: 361 DDETLRNVKSCDWNMDDSAFSGISEDG-KDFIRKLLLADPNTRMTIHQALEHPWLTP 416
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 10/240 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
Y K ++ R+ R E+ ++ + P ++ + + E + +I+ Y GG+
Sbjct: 57 YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGE 115
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRL 117
+ E + + + Q+L + YLH N+I+H D+K NI L+ DI++
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFG+++ + ++GTP Y+ PE+L P + +D+W++G Y + + F
Sbjct: 176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235
Query: 178 FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
D Q I++ V +V A ++S+L KNPE RP+A L H LQ +
Sbjct: 236 EDNQETYLNISQVNVDYSEETFSSVSQLA-TDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 58/256 (22%), Positives = 111/256 (43%), Gaps = 17/256 (6%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K+I ++ R++ E+ +SRV +P IV+ + + VC+++ Y EGG +
Sbjct: 37 KQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNP---VCLVMEYAEGGSLYNV 89
Query: 65 I-KKANGVHFPEEKLCKWLVQLLMALNYLHA---NHILHRDVKCSNIFLTRDQD-IRLGD 119
+ ++ W +Q + YLH+ ++HRD+K N+ L +++ D
Sbjct: 90 LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG A + ++ G+ ++M PE+ Y K D++S G ++E+ ++ F
Sbjct: 150 FGTACDI--QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207
Query: 180 --MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH-PHLQPYVLG 236
++ ++ PL L+ K+P RPS E++ HL Y G
Sbjct: 208 GPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267
Query: 237 IHLKLNGPRRNTFPLE 252
L P +++ P
Sbjct: 268 ADEPLQYPCQHSLPPG 283
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 17/235 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
+ LKK + D +E L +PF+ ++ E + ++ Y
Sbjct: 47 IKALKKDVVLMDDD----VECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN---LFFVMEY 99
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ I+ + F + + ++++ L +LH+ I++RD+K NI L +D I
Sbjct: 100 LNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI 157
Query: 116 RLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
++ DFG+ K + D ++ GTP Y+ PE+L Y D WS G +YEM ++
Sbjct: 158 KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
Query: 175 FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-PSAAELLCHP 228
F D + L + I P + L+ + + PE R ++ HP
Sbjct: 218 FHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 20/238 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
+ VL+K + ++ + H E L+ V++PF+V S+ +K + ++ Y
Sbjct: 68 VKVLQKKAILKKKEEK----HIMSERNVLLKNVKHPFLVGLHFSFQTADK---LYFVLDY 120
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GG++ +++ F E + + ++ AL YLH+ +I++RD+K NI L I
Sbjct: 121 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 178
Query: 116 RLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
L DFGL K I S+ GTP Y+ PE+L PY D W LG +YEM
Sbjct: 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
Query: 175 FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR----PSAAELLCHP 228
F + + + + I + L + + R L++ +L+K+ R E+ H
Sbjct: 239 FYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 34/244 (13%), Positives = 72/244 (29%), Gaps = 21/244 (8%)
Query: 3 VLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVE----YKDSWVEKGCYVCIIIGYC 56
L+ +R + +A+ +L+ + ++ +D WV +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS-RFFLYPRMQS 189
Query: 57 EGGDMAEAIKKANGVH--FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
E + + H + +Q++ L LH ++H ++ +I L +
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 249
Query: 115 IRLGDFGLAKMLISDDLAS--SVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYE 167
+ L F + ++ P +L D W+LG +Y
Sbjct: 250 VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 168 MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+ I +P R L++ LR E R + +
Sbjct: 310 IWCADLPNTDDAALGGSEWI-FRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMET 364
Query: 228 PHLQ 231
P +
Sbjct: 365 PEYE 368
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 5/209 (2%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
+E+ ++ + +P IV+ + E + +I+ Y GG++ + + +G E++
Sbjct: 62 FREVRIMKILNHPNIVKLFEVI-ETEKTLYLIMEYASGGEVFDYLVA-HG-RMKEKEARS 118
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPS 140
Q++ A+ Y H I+HRD+K N+ L D +I++ DFG + + G P
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP 178
Query: 141 YMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVY 199
Y PEL Y G + D+WSLG +Y + + F +++ L ++ + +P
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYM 237
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
S L+K L NP R + +++
Sbjct: 238 STDCENLLKRFLVLNPIKRGTLEQIMKDR 266
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 67/297 (22%), Positives = 118/297 (39%), Gaps = 33/297 (11%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ +K I R + +E+ + P IV+ + + + +++ GG+
Sbjct: 39 FAVKIIS-----KRMEANTQKEITALKLCEGHPNIVKLHEVF-HDQLHTFLVMELLNGGE 92
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ E IKK HF E + + +L+ A++++H ++HRD+K N+ F + + I++
Sbjct: 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 118 GDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-------S 169
DFG A++ D+ + T Y PELL Y D+WSLG +Y M
Sbjct: 151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 170 AQKAAFKAFDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ + ++ KI K V A + L++ +L +P R + L
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA-KDLIQGLLTVDPNKRLKMSGLR 269
Query: 226 CHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFS 282
+ LQ L P + K T F A N+ KR+ F
Sbjct: 270 YNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKAT-FH---AF----NKYKREGFC 318
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 15/235 (6%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+ Q + R + +E ++ +V P I+ DS E ++ ++ G++ +
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFD 189
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ + V E++ + LL A+++LHAN+I+HRD+K NI L + IRL DFG +
Sbjct: 190 YLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 124 KMLISDDLASSVVGTPSYMCPELL------ADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
L + + GTP Y+ PE+L YG + D+W+ G ++ + A F
Sbjct: 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307
Query: 178 FDMQALINKINKSIV----APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
++ I + S + L+ +L+ +PE R +A + L HP
Sbjct: 308 RRQILMLRMIMEGQYQFSSPEWDDRSSTV-KDLISRLLQVDPEARLTAEQALQHP 361
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 62/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVE----YKDSWVEKGCYVCIIIGYC 56
+ LK ++ +ARR E+EL R P IV Y++ + + C + I++
Sbjct: 90 FALKMLQ---DCPKARR----EVELHWRASQCPHIVRIVDVYENLYAGRKC-LLIVMECL 141
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD- 114
+GG++ I+ F E + + + + A+ YLH+ +I HRDVK N+ + ++ +
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 115 -IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
++L DFG AK S + ++ TP Y+ PE+L Y D+WSLG +Y +
Sbjct: 202 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
Query: 174 AFKAFDMQALINKINKSIVA--------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
F + A+ + I V + L++++L+ P R + E +
Sbjct: 262 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-KMLIRNLLKTEPTQRMTITEFM 320
Query: 226 CHP 228
HP
Sbjct: 321 NHP 323
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 51/233 (21%), Positives = 105/233 (45%), Gaps = 11/233 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
K I+ D+ E+ +++++ + +++ D++ E + +++ Y +GG++
Sbjct: 117 LAAKIIKTRGMKDKEE--VKNEISVMNQLDHANLIQLYDAF-ESKNDIVLVMEYVDGGEL 173
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD-IRLGD 119
+ I + E ++ Q+ + ++H +ILH D+K NI + RD I++ D
Sbjct: 174 FDRII-DESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FGLA+ + GTP ++ PE++ +D+WS+G Y + + + F +
Sbjct: 233 FGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
Query: 180 MQALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+N I + A + + +L K +R SA+E L HP
Sbjct: 293 DAETLNNILACRWDLEDEEFQDISEEA-KEFISKLLIKEKSWRISASEALKHP 344
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 21/239 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
+ +LKK + + D +E L + PF+ + + +++ + ++ Y
Sbjct: 50 VKILKKDVVIQDDD----VECTMVEKRVLALPGKPPFLTQLHSCFQTMDR---LYFVMEY 102
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ I++ F E + ++ + L +L + I++RD+K N+ L + I
Sbjct: 103 VNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI 160
Query: 116 RLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
++ DFG+ K I D + GTP Y+ PE++A PYG D W+ G +YEM A +A
Sbjct: 161 KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
Query: 175 FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
F+ D L I + V P S + K ++ K+P R ++ H
Sbjct: 221 FEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 63/233 (27%), Positives = 114/233 (48%), Gaps = 13/233 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M VLKK + R + E ++S V +PFI+ ++ + + +I+ Y EGG+
Sbjct: 36 MKVLKKEIVVRLKQVEH--TNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGE 92
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ ++K+ FP + ++ +AL YLH+ I++RD+K NI L ++ I++ DF
Sbjct: 93 LFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF 150
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
G AK + D+ ++ GTP Y+ PE+++ PY D WS G +YEM A F +
Sbjct: 151 GFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
KI + + P ++ + L+ ++ ++ R ++ HP
Sbjct: 209 MKTYEKILNAELR-FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 66/235 (28%), Positives = 113/235 (48%), Gaps = 13/235 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +LKK + + + A E ++ R+PF+ K S+ +C ++ Y GG+
Sbjct: 178 MKILKKEVIVAKDEVA--HTLTENRVLQNSRHPFLTALKYSFQTHDR-LCFVMEYANGGE 234
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLTRDQDIRLGD 119
+ + + F E++ + +++ AL+YLH+ +++RD+K N+ L +D I++ D
Sbjct: 235 LFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITD 292
Query: 120 FGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
FGL K I D + GTP Y+ PE+L D YG D W LG +YEM + F
Sbjct: 293 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR----PS-AAELLCHP 228
D + L I + P + L+ +L+K+P+ R A E++ H
Sbjct: 353 DHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 54/220 (24%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
M +L K ++ + ++ H E ++ V PF+V+ + S+ + + +++ Y G
Sbjct: 71 MKILDKQKVVKL----KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLYMVMEYVAG 125
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
G+M +++ F E + Q+++ YLH+ +++RD+K N+ + + I++
Sbjct: 126 GEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFG AK + ++ GTP + PE++ Y D W+LG +YEM+A F A
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218
+ KI V P+ +S + L++++L+ + R
Sbjct: 242 QPIQIYEKIVSGKVR-FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 45/237 (18%), Positives = 98/237 (41%), Gaps = 19/237 (8%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+ I + R + ++ +E+ + R+ +V + + + II C+G +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL-AIITSLCKGRTLYSV 119
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
++ + K + +++ + YLHA ILH+D+K N+F + + + DFGL
Sbjct: 120 VRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 125 MLISDDLA------SSVVGTPSYMCPELL---------ADIPYGSKSDIWSLGCCVYEMS 169
+ G ++ PE++ +P+ SD+++LG YE+
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 170 AQKAAFKAFDMQALINKINKSIVAPLPTV-YSGAFRGLVKSMLRKNPEFRPSAAELL 225
A++ FK +A+I ++ + L + ++ E RP+ +L+
Sbjct: 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 1e-33
Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 15/238 (6%)
Query: 1 MYVLKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
M L K R+ +Q + + + L+S PFIV ++ + I+ GG
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGG 277
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ + + F E + + ++++ L ++H +++RD+K +NI L +R+ D
Sbjct: 278 DLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 335
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
GLA S + VGT YM PE+L + Y S +D +SLGC ++++ + F+
Sbjct: 336 LGLACD-FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 179 ---DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
D + V LP +S R L++ +L+++ R A E+ P
Sbjct: 395 KTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 69/350 (19%), Positives = 126/350 (36%), Gaps = 60/350 (17%)
Query: 6 KIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K L D A E++L++ + P ++ Y S ++ I + C ++ +
Sbjct: 45 KRMLIDFCDIALM----EIKLLTESDDHPNVIRYYCS-ETTDRFLYIALELC-NLNLQDL 98
Query: 65 IKK-----ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--------- 110
++ N E L Q+ + +LH+ I+HRD+K NI ++
Sbjct: 99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158
Query: 111 ----RDQDIRLGDFGLAKMLISDDLA-----SSVVGTPSYMCPELLADI-------PYGS 154
+ I + DFGL K L S + ++ GT + PELL +
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218
Query: 155 KSDIWSLGCCVYEM-SAQKAAFKA-FDMQALINKIN---KSIVAPLPTVYSGAFRGLVKS 209
DI+S+GC Y + S K F + ++ I + + L+
Sbjct: 219 SIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ 278
Query: 210 MLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAI 269
M+ +P RP+A ++L HP ++ F L+ SD + P A+
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLFW----------PKSKKLEFLLKVSD-RLEIENRDPPSAL 327
Query: 270 SIHSNREKRQSFSNDRALNPSVSETEQDSLSSTLRGRAFGNYMNQKFKEL 319
+ + + +T D+L + Y + K +L
Sbjct: 328 LMKFDAGSDFVIPSGDW-TVKFDKTFMDNL------ERYRKYHSSKLMDL 370
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 57/236 (24%), Positives = 110/236 (46%), Gaps = 13/236 (5%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+KIR + +R E++ + R+P I++ +++ Y GG++ +
Sbjct: 47 QKIRSLDVVGKIKR----EIQNLKLFRHPHIIKLYQVI-STPTDFFMVMEYVSGGELFDY 101
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
I K +G E + + Q+L A++Y H + ++HRD+K N+ L + ++ DFGL+
Sbjct: 102 ICK-HG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159
Query: 125 MLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
M+ + + G+P+Y PE+++ Y G + DIWS G +Y + F + L
Sbjct: 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP----HLQPYVL 235
KI + +P + + L+ ML+ +P R + ++ H L Y+
Sbjct: 220 FKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 39/238 (16%), Positives = 93/238 (39%), Gaps = 23/238 (9%)
Query: 5 KKIRLARQTDRARRSA-----HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
K + L +E+ ++S + +P IV+ +++ + G
Sbjct: 50 KSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCG 106
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQD--- 114
D+ + + ++ + + + Y+ + I+HRD++ NIFL +
Sbjct: 107 DLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP 165
Query: 115 --IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA--DIPYGSKSDIWSLGCCVYEMSA 170
++ DFGL++ S S ++G +M PE + + Y K+D +S +Y +
Sbjct: 166 VCAKVADFGLSQQ--SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
Query: 171 QKAAFK---AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ F ++ + + + +P R +++ +P+ RP + ++
Sbjct: 224 GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 19/235 (8%)
Query: 5 KKIRLARQTDRARRSA--HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
K R D ++ QE +L + +++P I+ + +++ C+++ + GG +
Sbjct: 36 KAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLN 94
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH---ILHRDVKCSNIFLTRDQD----- 114
+ P + L W VQ+ +NYLH I+HRD+K SNI + + +
Sbjct: 95 RVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151
Query: 115 ---IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 171
+++ DFGLA+ S G ++M PE++ + SD+WS G ++E+
Sbjct: 152 NKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210
Query: 172 KAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ F+ D + + P+P+ F L++ +P RPS +L
Sbjct: 211 EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 55/232 (23%), Positives = 106/232 (45%), Gaps = 14/232 (6%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
K + + T + ++ E+ ++ + R+ I+ + + I+ +CEG +
Sbjct: 52 KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQL-AIVTQWCEGSSLYHH 109
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
+ + F +KL Q ++YLHA I+HRD+K +NIFL D +++GDFGLA
Sbjct: 110 LHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 125 M---LISDDLASSVVGTPSYMCPELLAD---IPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
+ G+ +M PE++ PY +SD+++ G +YE+ + +
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
Query: 179 D-MQALINKINKSIVAP-LPTVYSGAFRGLVKSMLR---KNPEFRPSAAELL 225
+ +I + + ++P L V S + + + M K + RPS +L
Sbjct: 229 NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 68/291 (23%), Positives = 120/291 (41%), Gaps = 18/291 (6%)
Query: 3 VLKKIRLARQTDRARRSAHQ---EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+KK ++ + E+ ++SRV + I++ D + +G + ++ + G
Sbjct: 56 FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL 115
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+ I + + E QL+ A+ YL I+HRD+K NI + D I+L D
Sbjct: 116 DLFAFIDR-HP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAF 178
FG A L L + GT Y PE+L PY G + ++WSLG +Y + ++ F
Sbjct: 174 FGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 238
+ + ++ + P P + S LV +L+ PE R + +L+ P + V
Sbjct: 234 E------ETVEAAIHP-PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD 286
Query: 239 LKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNP 289
R P +S +E S+ S+ + Q +
Sbjct: 287 YTWEEVFRVNKP----ESGVLSAASLEMGNRSL-SDVAQAQELCGGEGHHH 332
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 22/240 (9%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
+ VLKK + + D E L +PF+ + + ++ + ++ +
Sbjct: 53 VKVLKKDVILQDDD----VECTMTEKRILSLARNHPFLTQLFCCFQTPDR---LFFVMEF 105
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ I+K+ F E + + +++ AL +LH I++RD+K N+ L +
Sbjct: 106 VNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHC 163
Query: 116 RLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
+L DFG+ K I + ++ GTP Y+ PE+L ++ YG D W++G +YEM A
Sbjct: 164 KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 175 FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR------PSAAELLCHP 228
F+A + L I V PT G++KS + KNP R +L HP
Sbjct: 224 FEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 32/228 (14%), Positives = 84/228 (36%), Gaps = 11/228 (4%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYK-DSWVEKGCYVCIIIGYCEGGDMAE 63
K +++ + R R ++E + +P ++ + +I + G +
Sbjct: 39 KVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN 98
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHA--NHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ + + + K+ + + + +LH I + ++ + D R+
Sbjct: 99 VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD 158
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGS---KSDIWSLGCCVYEMSAQKAAFKAF 178
+ S + P+++ PE L P + +D+WS ++E+ ++ F
Sbjct: 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
Query: 179 D-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
M+ + + + +P S L+K + ++P RP ++
Sbjct: 215 SNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIV 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 9/232 (3%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSW-VEKGCYVCIIIGYCEGGDM 61
+LKK +L R + +E++L+ R+R+ +++ D E+ + +++ YC G M
Sbjct: 37 ILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-M 94
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
E + FP + + QL+ L YLH+ I+H+D+K N+ LT +++ G
Sbjct: 95 QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALG 154
Query: 122 LA---KMLISDDLASSVVGTPSYMCPELLADI-PY-GSKSDIWSLGCCVYEMSAQKAAFK 176
+A +DD + G+P++ PE+ + + G K DIWS G +Y ++ F+
Sbjct: 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
++ L I K A +P L+K ML P R S ++ H
Sbjct: 215 GDNIYKLFENIGKGSYA-IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 42/263 (15%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
Y +K I R+R +E+E++ + + ++E + + E+ ++ GG
Sbjct: 41 YAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLELIEFF-EEEDRFYLVFEKMRGGS 97
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD--IRL 117
+ I K HF E + + + AL++LH I HRD+K NI +Q +++
Sbjct: 98 ILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKI 155
Query: 118 GDFGLAKML--------ISDDLASSVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCC 164
DF L + IS + G+ YM PE++ Y + D+WSLG
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 165 VY-----------EMSAQKAAFKAFDMQALINKINKSIVA--------PLPTVYSGAFRG 205
+Y + + A N + +SI + A +
Sbjct: 216 LYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAA-KD 274
Query: 206 LVKSMLRKNPEFRPSAAELLCHP 228
L+ +L ++ + R SAA++L HP
Sbjct: 275 LISKLLVRDAKQRLSAAQVLQHP 297
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 4e-32
Identities = 68/261 (26%), Positives = 104/261 (39%), Gaps = 37/261 (14%)
Query: 4 LKKIRLARQTDRARR---SAHQEMEL---ISRVRNPFIVEYKD----SWVEKGCYVCIII 53
LK +R+ S +E+ L + +P +V D S ++ V ++
Sbjct: 39 LKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVF 98
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
+ + D+ + KA P E + + Q L L++LHAN I+HRD+K NI +T
Sbjct: 99 EHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 157
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
++L DFGLA++ + VV T Y PE+L Y + D+WS+GC EM +K
Sbjct: 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
Query: 174 AFKAFDMQALINKI-------NKSI---VAPLP----------------TVYSGAFRGLV 207
F + KI + LP + L+
Sbjct: 218 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLL 277
Query: 208 KSMLRKNPEFRPSAAELLCHP 228
ML NP R SA L H
Sbjct: 278 LEMLTFNPHKRISAFRALQHS 298
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 5e-32
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK + ++ A +E+ ++ ++++P +V + + K + ++ YC+ +
Sbjct: 33 IKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR-LHLVFEYCDH-TVLH 90
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ + PE + Q L A+N+ H ++ +HRDVK NI +T+ I+L DFG A
Sbjct: 91 ELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA 149
Query: 124 KML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
++L D V T Y PE L+ D YG D+W++GC E+ + +
Sbjct: 150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209
Query: 182 ALINKINKSIVAPLPTVYSG-----AFRG-------------------------LVKSML 211
+ I K++ +P F G L+K L
Sbjct: 210 DQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 212 RKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFP 250
+P R + +LL H PY I + + + P
Sbjct: 270 HMDPTERLTCEQLLHH----PYFENIREIEDLAKEHDKP 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 34/256 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LK+IRL + + +A +E+ L+ + +P IV D + C + ++ + E D+ +
Sbjct: 50 LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-LTLVFEFMEK-DLKK 107
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ + N + ++ +L QLL + + H + ILHRD+K N+ + D ++L DFGLA
Sbjct: 108 VLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
Query: 124 KML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+ I + V T Y P+ L+ Y + DIWS+GC EM K F
Sbjct: 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226
Query: 182 ALINKI-------NKSI---VAPLPTVYSGAFRG-------------------LVKSMLR 212
+ KI N V LP F+ L+ +ML
Sbjct: 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLC 286
Query: 213 KNPEFRPSAAELLCHP 228
+P R SA + + HP
Sbjct: 287 FDPNKRISARDAMNHP 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/257 (22%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+KK + ++ A +E++L+ ++R+ +V + +K ++ + + + +
Sbjct: 55 IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-WYLVFEFVDH-TILD 112
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
++ + + K+L Q++ + + H+++I+HRD+K NI +++ ++L DFG A
Sbjct: 113 DLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
Query: 124 KML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+ L ++ V T Y PE L+ D+ YG D+W++GC V EM + F
Sbjct: 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231
Query: 182 ALINKINKSIVAPLPTVYSG-----AFRG-------------------------LVKSML 211
+ I + +P F G L K L
Sbjct: 232 DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL 291
Query: 212 RKNPEFRPSAAELLCHP 228
+P+ RP AELL H
Sbjct: 292 HIDPDKRPFCAELLHHD 308
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 17/237 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 57
+ +LKK + + D +E L + PF+ + + + ++ Y
Sbjct: 371 VKILKKDVVIQDDD----VECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFVMEYVN 425
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
GGD+ I++ F E + ++ + L +L + I++RD+K N+ L + I++
Sbjct: 426 GGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 483
Query: 118 GDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
DFG+ K I + GTP Y+ PE++A PYG D W+ G +YEM A +A F+
Sbjct: 484 ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
D L I + V P S + K ++ K+P R ++ H
Sbjct: 544 GEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 31/249 (12%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
M V+KK + D + E +PF+V + + + +I Y
Sbjct: 39 MKVVKKELVNDDED----IDWVQTEKHVFEQASNHPFLVGLHSCFQTESR---LFFVIEY 91
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ +++ PEE + ++ +ALNYLH I++RD+K N+ L + I
Sbjct: 92 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 149
Query: 116 RLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
+L D+G+ K + D S+ GTP+Y+ PE+L YG D W+LG ++EM A ++
Sbjct: 150 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
Query: 175 FKAF---------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR------P 219
F L I + + +P S ++KS L K+P+ R
Sbjct: 210 FDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGCHPQT 268
Query: 220 SAAELLCHP 228
A++ HP
Sbjct: 269 GFADIQGHP 277
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 34/258 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMEL---ISRVRNPFIVEYKD----SWVEKGCYVCIIIGYC 56
LK++R+ + S +E+ + + +P +V D S ++ + ++ +
Sbjct: 42 LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
+ D+ + K P E + + QLL L++LH++ ++HRD+K NI +T I+
Sbjct: 102 DQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
L DFGLA++ +SVV T Y PE+L Y + D+WS+GC EM +K F+
Sbjct: 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220
Query: 177 AFDMQALINKI-------------------NKSIVAPLPTVYSGAFRG-------LVKSM 210
+ KI ++ + L+
Sbjct: 221 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 280
Query: 211 LRKNPEFRPSAAELLCHP 228
L NP R SA L HP
Sbjct: 281 LTFNPAKRISAYSALSHP 298
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 13/232 (5%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
++ R + ++ E+ + + + +V++ E + + YC GG++
Sbjct: 39 IVDMKRAVDCPENIKK----EICINKMLNHENVVKFYGHRREGN-IQYLFLEYCSGGELF 93
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+ I+ G PE ++ QL+ + YLH I HRD+K N+ L ++++ DFGL
Sbjct: 94 DRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151
Query: 123 AKMLIS---DDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAF-KA 177
A + + L + + GT Y+ PELL + D+WS G + M A + + +
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211
Query: 178 FDMQALINKINKSIVAPLPTVY-SGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
D + + P A L+ +L +NP R + ++
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 31/249 (12%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEME---LISRVRNPFIVEYKDSW--VEKGCYVCIIIGY 55
M V+KK + D + E +PF+V + + + +I Y
Sbjct: 82 MRVVKKELVNDDED----IDWVQTEKHVFEQASNHPFLVGLHSCFQTESR---LFFVIEY 134
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
GGD+ +++ PEE + ++ +ALNYLH I++RD+K N+ L + I
Sbjct: 135 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 192
Query: 116 RLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
+L D+G+ K + D S+ GTP+Y+ PE+L YG D W+LG ++EM A ++
Sbjct: 193 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
Query: 175 FKAF---------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR------P 219
F L I + + +P S ++KS L K+P+ R
Sbjct: 253 FDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGCHPQT 311
Query: 220 SAAELLCHP 228
A++ HP
Sbjct: 312 GFADIQGHP 320
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 61/256 (23%), Positives = 107/256 (41%), Gaps = 35/256 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LKKIRL ++ + + +E+ ++ +++ IV+ D K + ++ + + D+ +
Sbjct: 31 LKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFEHLDQ-DLKK 88
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ G +L+QLL + Y H +LHRD+K N+ + R+ ++++ DFGLA
Sbjct: 89 LLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
Query: 124 KML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+ I + + T Y P+ L+ Y + DIWS+GC EM F
Sbjct: 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
Query: 182 ALINKI-------NKSI---VAPLPTVYSGAF-------------------RGLVKSMLR 212
+ +I N V LP Y F L+ ML+
Sbjct: 208 DQLMRIFRILGTPNSKNWPNVTELPK-YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLK 266
Query: 213 KNPEFRPSAAELLCHP 228
+P R +A + L H
Sbjct: 267 LDPNQRITAKQALEHA 282
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 50/230 (21%), Positives = 101/230 (43%), Gaps = 26/230 (11%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIV------EYKDSWVEKGCYVCIIIGYC 56
VLK + + + A E + ++ V +P IV E+ D + Y I++ Y
Sbjct: 110 VLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY--IVMEYV 166
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
G + + + P + +L+++L AL+YLH+ +++ D+K NI LT +Q ++
Sbjct: 167 GGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LK 221
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
L D G + + + GTP + PE++ P +DI+++G + ++
Sbjct: 222 LIDLGAVSRI---NSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-SAAELL 225
+ L P+ Y ++ L++ + +P R +A E+
Sbjct: 278 GRYVDGLPED------DPVLKTY-DSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 53/225 (23%), Positives = 110/225 (48%), Gaps = 10/225 (4%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+ ++ + R R E+ + +R+P I++ D + ++I Y GG++ +
Sbjct: 45 QLLKKSDMHMRVER----EISYLKLLRHPHIIKLYDVI-TTPTDIVMVIEYA-GGELFDY 98
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
I + E++ ++ Q++ A+ Y H + I+HRD+K N+ L + ++++ DFGL+
Sbjct: 99 IVE-KK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156
Query: 125 MLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
++ + + G+P+Y PE++ Y G + D+WS G +Y M + F + L
Sbjct: 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
K+N + +P S + L++ M+ +P R + E+ P
Sbjct: 217 FKKVNSCVY-VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 11/178 (6%)
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
G D+A +++ + + Q+ AL+ HA HRDVK NI ++ D
Sbjct: 115 LINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF 172
Query: 115 IRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQK 172
L DFG+A + L + VGT YM PE ++ ++DI++L C +YE
Sbjct: 173 AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
Query: 173 AAFKAFDMQALINK-INKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFR-PSAAELL 225
++ D +++ IN++I P P + AF ++ + KNPE R + +L
Sbjct: 233 PPYQG-DQLSVMGAHINQAIPRPSTVRPGI-PVAFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 9/225 (4%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64
+KIR + RR E++ + R+P I++ + +++ Y GG++ +
Sbjct: 52 QKIRSLDVVGKIRR----EIQNLKLFRHPHIIKLYQVI-STPSDIFMVMEYVSGGELFDY 106
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
I K NG E++ + Q+L ++Y H + ++HRD+K N+ L + ++ DFGL+
Sbjct: 107 ICK-NG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164
Query: 125 MLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL 183
M+ + + G+P+Y PE+++ Y G + DIWS G +Y + F + L
Sbjct: 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224
Query: 184 INKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
KI I P + + L+K ML+ +P R + ++ H
Sbjct: 225 FKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 57/276 (20%), Positives = 116/276 (42%), Gaps = 25/276 (9%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
V+ L R + +R+ +E++++ + +P ++++ + K + I Y +GG +
Sbjct: 37 VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-LYKDKRLNFITEYIKGGTLR 95
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
IK +P + + + + YLH+ +I+HRD+ N + ++++ + DFGL
Sbjct: 96 GIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL 154
Query: 123 AKMLISDDLAS---------------SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYE 167
A++++ + +VVG P +M PE++ Y K D++S G + E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214
Query: 168 MSAQKAAFKAFDM--QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ + A + + + P +F + +PE RPS +L
Sbjct: 215 IIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL- 273
Query: 226 CHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKT 261
L+ + + L G LE D F +T
Sbjct: 274 -EHWLET----LRMHLAGHLPLGPQLEQLDRGFWET 304
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 13/232 (5%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
++ R + ++ E+ + + + +V++ E + + YC GG++
Sbjct: 39 IVDMKRAVDCPENIKK----EICINKMLNHENVVKFYGHRREGN-IQYLFLEYCSGGELF 93
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGL 122
+ I+ G PE ++ QL+ + YLH I HRD+K N+ L ++++ DFGL
Sbjct: 94 DRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151
Query: 123 AKMLIS---DDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAF-KA 177
A + + L + + GT Y+ PELL + D+WS G + M A + + +
Sbjct: 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211
Query: 178 FDMQALINKINKSIVAPLPTVY-SGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
D + + P A L+ +L +NP R + ++
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 16/292 (5%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWL 82
E+ +R+P IV +K+ + ++ II+ Y GG++ E I A F E++ +
Sbjct: 66 EIINHRSLRHPNIVRFKEVILTPT-HLAIIMEYASGGELYERICNAGR--FSEDEARFFF 122
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFLTRDQ--DIRLGDFGLAKMLISDDLASSVVGTPS 140
QLL ++Y H+ I HRD+K N L +++ DFG +K + S VGTP+
Sbjct: 123 QQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182
Query: 141 YMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-----P 194
Y+ PE+L Y G +D+WS G +Y M F+ + K + I++ P
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP 242
Query: 195 LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP----HLQPYVLGIHLKLNGPRRNTFP 250
S L+ + +P R S E+ H +L ++ + + P
Sbjct: 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQP 302
Query: 251 LEWSDSNFKKTR-FMEPEAISIHSNREKRQSFSNDRALNPSVSETEQDSLSS 301
++ D+ + P + + + D ++ SE+E D SS
Sbjct: 303 MQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSS 354
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 10/212 (4%)
Query: 21 HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
+E+ S++ + IV D E CY +++ Y EG ++E I+ +G +
Sbjct: 59 EREVHNSSQLSHQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIES-HG-PLSVDTAIN 115
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGT 138
+ Q+L + + H I+HRD+K NI + ++ +++ DFG+AK L L + V+GT
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
Query: 139 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK-INKSIVAPLPT 197
Y PE +DI+S+G +YEM + F ++ K I S+
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235
Query: 198 VYSG---AFRGLVKSMLRKNPEFRP-SAAELL 225
V + ++ K+ R + E+
Sbjct: 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMK 267
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 66/256 (25%), Positives = 115/256 (44%), Gaps = 34/256 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LK++RL + SA +E+ L+ +++ IV D + ++ +C+ D+ +
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVFEFCDQ-DLKK 89
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
NG E + +L QLL L + H+ ++LHRD+K N+ + R+ +++L +FGLA
Sbjct: 90 YFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
Query: 124 KML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDM 180
+ I S+ V T Y P+ L Y + D+WS GC E+ +A + F D+
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208
Query: 181 QALINKI-------NKSI---VAPLP------------------TVYSGAFRGLVKSMLR 212
+ +I + + LP + R L++++L+
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
Query: 213 KNPEFRPSAAELLCHP 228
NP R SA E L HP
Sbjct: 269 CNPVQRISAEEALQHP 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 35/256 (13%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
LK+IRL + A +A +E+ L+ +++ IV D + + ++ Y + D+ +
Sbjct: 32 LKEIRL-EHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLVFEYLDK-DLKQ 88
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLA 123
+ G + +L QLL L Y H +LHRD+K N+ + +++L DFGLA
Sbjct: 89 YLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
Query: 124 KML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ 181
+ I + V T Y P+ LL Y ++ D+W +GC YEM+ + F ++
Sbjct: 148 RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207
Query: 182 ALINKI-------NKSI---VAPLPTVYSGAF-------------------RGLVKSMLR 212
++ I + + + + L+ +L+
Sbjct: 208 EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQ 267
Query: 213 KNPEFRPSAAELLCHP 228
R SA + + HP
Sbjct: 268 FEGRNRISAEDAMKHP 283
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 63/261 (24%), Positives = 105/261 (40%), Gaps = 40/261 (15%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE 63
+K+IRL + + +A +E+ L+ +++ I+E K + +I Y E D+ +
Sbjct: 64 IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-LHLIFEYAEN-DLKK 121
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRLG 118
+ K + +L QL+ +N+ H+ LHRD+K N+ L+ +++G
Sbjct: 122 YMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179
Query: 119 DFGLAKML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
DFGLA+ I + + T Y PE LL Y + DIWS+ C EM + F
Sbjct: 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
Query: 177 AFDMQALINKI-----------------------------NKSIVAPLPTVYSGAFRGLV 207
+ KI K++ L + L+
Sbjct: 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLL 299
Query: 208 KSMLRKNPEFRPSAAELLCHP 228
+ML +P R SA L HP
Sbjct: 300 TAMLEMDPVKRISAKNALEHP 320
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 20/237 (8%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGYCEG-GD 60
+ R E+ L+ +V + ++ D W E+ +I+ E D
Sbjct: 81 ISDWGELPNGTRVPM----EVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQD 135
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGD 119
+ + I + G EE + Q+L A+ + H +LHRD+K NI + +++L D
Sbjct: 136 LFDFITE-RG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAF 178
FG L+ D + + GT Y PE + Y G + +WSLG +Y+M F+
Sbjct: 194 FGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH- 251
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235
+I + V S + L++ L P RP+ E+ HP +Q +L
Sbjct: 252 -----DEEIIRGQVF-FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
Y +G + + + G ++ + + ALN+ H N I+HRDVK +NI ++
Sbjct: 97 YVDGVTLRDIVHT-EG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 154
Query: 115 IRLGDFGLAKMLISDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
+++ DFG+A+ + + ++V+GT Y+ PE ++SD++SLGC +YE+
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 171 QKAAFKAFD--MQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRP-SAAEL 224
+ F D + + + + P + S +V L KNPE R +AAE+
Sbjct: 215 GEPPFTG-DSPVSVAYQHVREDPIPPSARHEGL-SADLDAVVLKALAKNPENRYQTAAEM 272
Query: 225 L 225
Sbjct: 273 R 273
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 40/263 (15%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE---GGD 60
LK+++L + +A +E+ L+ +++ IV D + + ++ + +
Sbjct: 35 LKEVKL-DSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK-LTLVFEFMDNDLKKY 92
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
M + + QLL L + H N ILHRD+K N+ + + ++LGDF
Sbjct: 93 MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF 152
Query: 121 GLAKML-ISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
GLA+ I + SS V T Y P+ L+ Y + DIWS GC + EM K F
Sbjct: 153 GLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212
Query: 179 DMQALINKI---------------------------------NKSIVAPLPTVYSGAFRG 205
+ + + I + + G
Sbjct: 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD 272
Query: 206 LVKSMLRKNPEFRPSAAELLCHP 228
+ +L+ NP+ R SA + L HP
Sbjct: 273 FLHGLLQLNPDMRLSAKQALHHP 295
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 48/270 (17%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIG-------YC 56
LKK+ + + + +A +E++++ +++ +V + K G +C
Sbjct: 47 LKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
E D+A + V F ++ + + LL L Y+H N ILHRD+K +N+ +TRD ++
Sbjct: 107 EH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164
Query: 117 LGDFGLAKM------LISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMS 169
L DFGLA+ + + VV T Y PE LL + YG D+W GC + EM
Sbjct: 165 LADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
Query: 170 AQKAAFKAFDMQALINKI-------NKSI---VAPLPTVYSGAFRG-------------- 205
+ + Q + I + V
Sbjct: 224 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV 283
Query: 206 -------LVKSMLRKNPEFRPSAAELLCHP 228
L+ +L +P R + + L H
Sbjct: 284 RDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 55/243 (22%), Positives = 100/243 (41%), Gaps = 46/243 (18%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVE----YKDSWVEKGCYVCIIIGYC 56
+ LK ++ +ARR E+EL R P IV Y++ + + C + I++
Sbjct: 46 FALKMLQ---DCPKARR----EVELHWRASQCPHIVRIVDVYENLYAGRKC-LLIVMECL 97
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI-FLTRDQD- 114
+GG++ I+ F E + + + + A+ YLH+ +I HRDVK N+ + ++ +
Sbjct: 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 157
Query: 115 -IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
++L DFG A E + Y D+WSLG +Y +
Sbjct: 158 ILKLTDFGFA--------------------KETTGE-KYDKSCDMWSLGVIMYILLCGYP 196
Query: 174 AFKAFDMQALINKINKSIVA--------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
F + A+ + I V + L++++L+ P R + E +
Sbjct: 197 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-KMLIRNLLKTEPTQRMTITEFM 255
Query: 226 CHP 228
HP
Sbjct: 256 NHP 258
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/262 (23%), Positives = 112/262 (42%), Gaps = 45/262 (17%)
Query: 4 LKKIRLARQTDR---ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+KKI+L +++ R+A +E++L+ + +P I+ D++ K + ++ + E D
Sbjct: 40 IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-ISLVFDFMET-D 97
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ IK N + + +++ L L YLH + ILHRD+K +N+ L + ++L DF
Sbjct: 98 LEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 156
Query: 121 GLAKMLIS--DDLASSVVGTPSYMCPELLADIPYGSKS-----DIWSLGCCVYEMSAQKA 173
GLAK S VV T Y PELL +G++ D+W++GC + E+ +
Sbjct: 157 GLAKSFGSPNRAYTHQVV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLLRVP 211
Query: 174 AFKAFDMQALINKI-------NKSI---VAPLP----------TVYSGAFRG-------L 206
+ +I + + LP F L
Sbjct: 212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271
Query: 207 VKSMLRKNPEFRPSAAELLCHP 228
++ + NP R +A + L
Sbjct: 272 IQGLFLFNPCARITATQALKMK 293
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 59/260 (22%), Positives = 104/260 (40%), Gaps = 20/260 (7%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN----PFIVEYKDSWVEKGCYVCIIIGY-C 56
+ + L + E+ L+ +V P ++ D W E +++
Sbjct: 63 VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFETQEGFMLVLERPL 121
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQDI 115
D+ + I + G E + Q++ A+ + H+ ++HRD+K NI + R
Sbjct: 122 PAQDLFDYITE-KG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179
Query: 116 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAA 174
+L DFG L+ D+ + GT Y PE ++ Y + +WSLG +Y+M
Sbjct: 180 KLIDFGSGA-LLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
Query: 175 FKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234
F+ +I ++ + P S L++ L P RPS E+L P +Q
Sbjct: 239 FER------DQEILEAEL-HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
Query: 235 LGIHLKLNGPRRNTFPLEWS 254
+ L + PL WS
Sbjct: 292 EDVPLNPSKGGPA--PLAWS 309
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 55/278 (19%)
Query: 4 LKKIRLA--RQTDRARRSAHQEMELISRVRNPFIVEYKD-----SWVEKGCYVCIIIGYC 56
+KK+ QT A+R A++E+ L+ V + I+ + +E+ V I++
Sbjct: 55 IKKLSRPFQNQTH-AKR-AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
+ ++ + I+ E++ L Q+L + +LH+ I+HRD+K SNI + D ++
Sbjct: 113 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
+ DFGLA+ + + + V T Y PE++ + Y DIWS+GC + EM F
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227
Query: 177 AFD--------MQAL-------INKINKSIVA-----------PLPTVYSGAFRG----- 205
D ++ L + K+ ++ ++
Sbjct: 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 206 ----------LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L+ ML + R S E L HP++ +
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 47/251 (18%), Positives = 87/251 (34%), Gaps = 54/251 (21%)
Query: 22 QEMELISRVRNPFIVEY-------KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74
E+ +R+ I+ + SW + + +I Y E G + + +K
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQ----LYLITDYHENGSLYDYLKSTT---LD 132
Query: 75 EEKLCKWLVQLLMALNYLHA--------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126
+ + K + L +LH I HRD+K NI + ++ + D GLA
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 127 IS-----DDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCVYEMSAQKAAF 175
IS D ++ VGT YM PE+L +D++S G ++E++ + +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 176 KAFD-----------MQALINKINKSIVA-----PLPTVYSG-----AFRGLVKSMLRKN 214
+ + + + P +S L+ N
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 215 PEFRPSAAELL 225
P R +A +
Sbjct: 313 PASRLTALRVK 323
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 48/257 (18%)
Query: 14 DRARRSAHQEME--LISRVRNPFIVEYKDSWVEKGCYV---CIIIGYCEGGDMAEAIKKA 68
R RS +E E +R+ I+ + + + ++ Y E G + + + +
Sbjct: 75 SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY 134
Query: 69 NGVHFPEEKLCKWLVQLLMALNYLHANH--------ILHRDVKCSNIFLTRDQDIRLGDF 120
E + K + L +LH I HRD+K NI + ++ + D
Sbjct: 135 T---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 121 GLAKMLIS-----DDLASSVVGTPSYMCPELL------ADIPYGSKSDIWSLGCCVYEMS 169
GLA S D + VGT YM PE+L ++DI+++G +E++
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 170 AQKAAFKAFD-----------MQALINKINKSIVA-----PLPTVYSG-----AFRGLVK 208
+ + + + ++ K + +P + +++
Sbjct: 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 209 SMLRKNPEFRPSAAELL 225
N R +A +
Sbjct: 312 ECWYANGAARLTALRIK 328
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 52/277 (18%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE------ 57
+KKI L + A +E+++I R+ + IV+ + G + +G
Sbjct: 41 IKKIVLTDPQS-VKH-ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 58 ------GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-T 110
D+A +++ EE ++ QLL L Y+H+ ++LHRD+K +N+F+ T
Sbjct: 99 IVQEYMETDLANVLEQGP---LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT 155
Query: 111 RDQDIRLGDFGLAKMLISDDLASSV----VGTPSYMCPE-LLADIPYGSKSDIWSLGCCV 165
D +++GDFGLA+++ + T Y P LL+ Y D+W+ GC
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 166 YEMSAQKAAFK-------------------AFDMQALINKINKSIVA-------PLPTVY 199
EM K F D Q L++ I I PL +
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275
Query: 200 SGAFRG---LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
G R ++ +L +P R +A E L HP++ Y
Sbjct: 276 PGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 49/261 (18%), Positives = 94/261 (36%), Gaps = 56/261 (21%)
Query: 14 DRARRSAHQEMEL--ISRVRNPFIVEY-------KDSWVEKGCYVCIIIGYCEGGDMAEA 64
R +S +E EL +R+ I+ + + S + + +I Y E G + +
Sbjct: 41 SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ----LWLITHYHEMGSLYDY 96
Query: 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANH--------ILHRDVKCSNIFLTRDQDIR 116
++ + ++ + L +LH I HRD+K NI + ++
Sbjct: 97 LQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153
Query: 117 LGDFGLAKMLIS-----DDLASSVVGTPSYMCPELLADIP------YGSKSDIWSLGCCV 165
+ D GLA M D + VGT YM PE+L + + DIW+ G +
Sbjct: 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
Query: 166 YEMSAQKAAFKAFD-----------MQALINKINKSIVA-----PLPTVYSG-----AFR 204
+E++ + + + + K + +P + +
Sbjct: 214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA 273
Query: 205 GLVKSMLRKNPEFRPSAAELL 225
L+K +NP R +A +
Sbjct: 274 KLMKECWYQNPSARLTALRIK 294
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 69/350 (19%), Positives = 136/350 (38%), Gaps = 62/350 (17%)
Query: 4 LKKIRLA--RQTDRARRSAHQEMELISRVRNPFIVEYKD-----SWVEKGCYVCIIIGYC 56
+KK+ QT A+R A++E+ L+ V + I+ + +E+ V +++
Sbjct: 92 IKKLSRPFQNQTH-AKR-AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
+ ++ + I+ E++ L Q+L + +LH+ I+HRD+K SNI + D ++
Sbjct: 150 DA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
+ DFGLA+ + + + V T Y PE++ + Y DIWS+GC + EM K F
Sbjct: 205 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 177 AFD--------MQAL-------INKINKSIVA-----------PLPTVYSGAFRG----- 205
D ++ L + K+ ++ P ++ +
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 206 ----------LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSD 255
L+ ML +P R S + L HP++ + + +
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW----YDPAEVEAPPPQIYDKQL 380
Query: 256 SNFKKTRFMEPEAI---SIHSNREKRQSFSNDRALNPSVSETEQDSLSST 302
+ T E I ++S + + + + +SL +
Sbjct: 381 DEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPS 430
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 46/206 (22%), Positives = 80/206 (38%), Gaps = 33/206 (16%)
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
D+A+ I + + + ++ +L+ L+ LH ++HRD+ NI L + DI + D
Sbjct: 119 DLAQVIH-DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
F LA+ +D + V Y PE ++ + D+WS GC + EM +KA F+
Sbjct: 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 179 D-------------------MQALINKINKSIVA---------PLPTVYSGA---FRGLV 207
+ + + + V A L+
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297
Query: 208 KSMLRKNPEFRPSAAELLCHPHLQPY 233
ML NP+ R S + L HP+ +
Sbjct: 298 AKMLEFNPQRRISTEQALRHPYFESL 323
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 35/194 (18%)
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
+ +C +L Q+L L Y+H+ ++LHRD+K SN+ L D+++ DFGLA++ D +
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 135 V----VGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------- 179
V T Y PE +L Y DIWS+GC + EM + + F
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246
Query: 180 ---------MQALINKINKSIVAPLP--------TVYSGAFRG---LVKSMLRKNPEFRP 219
+ +IN ++ + LP ++ A L+ ML NP R
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
Query: 220 SAAELLCHPHLQPY 233
+ L HP+L+ Y
Sbjct: 307 EVEQALAHPYLEQY 320
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 57/277 (20%), Positives = 107/277 (38%), Gaps = 59/277 (21%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKD---SWVEKGCYVCIIIGYCEG 58
V+K ++ + + +R E++++ +R P I+ D V + ++ +
Sbjct: 65 VVKILKPV-KKKKIKR----EIKILENLRGGPNIITLADIVKDPVSRTPA--LVFEHVNN 117
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRL 117
D + + + + ++ ++L AL+Y H+ I+HRDVK N+ + + +RL
Sbjct: 118 TDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQKAAFK 176
D+GLA+ + V + + PELL D S D+WSLGC + M +K F
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF- 231
Query: 177 AF-------------------DMQALINKINKSIV------------APLPTVYSGAFRG 205
F D+ I+K N + +
Sbjct: 232 -FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH 290
Query: 206 --------LVKSMLRKNPEFRPSAAELLCHPHLQPYV 234
+ +LR + + R +A E + HP+ V
Sbjct: 291 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 33/190 (17%)
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
EEK+ + Q+L L Y+H+ ++HRD+K N+ + D ++++ DFGLA+ ++
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTGY 183
Query: 135 VVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------- 179
VV T Y PE +L+ + Y DIWS+GC + EM K FK D
Sbjct: 184 VV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242
Query: 180 -----MQALINKINKSIVAPLP--------TVYSGA---FRGLVKSMLRKNPEFRPSAAE 223
+Q L +K KS + LP ++ A L++ ML + + R +AA+
Sbjct: 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
Query: 224 LLCHPHLQPY 233
L HP +P+
Sbjct: 303 ALTHPFFEPF 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 34/187 (18%)
Query: 79 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
++L+ Q+L L Y+H+ I+HRD+K SN+ + D ++++ DFGLA+ + D + V
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVA 191
Query: 138 TPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD----------------- 179
T Y PE +L + Y DIWS+GC + E+ + F D
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 180 --MQALINKINKSIVAPLP--------TVYSGA---FRGLVKSMLRKNPEFRPSAAELLC 226
++ + ++ ++ + L V+ GA L++ ML + + R +AA+ L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311
Query: 227 HPHLQPY 233
H + Y
Sbjct: 312 HAYFAQY 318
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 33/183 (18%)
Query: 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY 141
+ Q+L L Y+HA I+HRD+K N+ + D ++++ DFGLA+ ++ VV T Y
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMTGYVV-TRWY 191
Query: 142 MCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-------------------MQ 181
PE +L + Y DIWS+GC + EM K FK D +Q
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 182 ALINKINKSIVAPLP--------TVYSGA---FRGLVKSMLRKNPEFRPSAAELLCHPHL 230
L + K+ + LP ++ + A L++ ML + E R +A E L HP+
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 231 QPY 233
+
Sbjct: 312 ESL 314
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 62/273 (22%), Positives = 111/273 (40%), Gaps = 47/273 (17%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------CYVCIIIGYCE 57
+KK+ + R Q M+ ++ + +P IV+ + + G Y+ +++ Y
Sbjct: 53 IKKVIQDPRF--RNR-ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP 109
Query: 58 GGDMAEAIK--KANGVHFPEEKLCKWLVQLLMALNYLHAN--HILHRDVKCSNIFL-TRD 112
+ + V P + +L QL+ ++ LH ++ HRD+K N+ + D
Sbjct: 110 D-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD 168
Query: 113 QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL-LADIPYGSKSDIWSLGCCVYEMSAQ 171
++L DFG AK L + + + + Y PEL + Y + DIWS+GC EM
Sbjct: 169 GTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
Query: 172 KAAFKAFD--------MQAL-------INKINKSIVA---------PLPTVYSGAFRG-- 205
+ F+ + ++ L + K+N S P V+S
Sbjct: 229 EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDA 288
Query: 206 -----LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L+ ++L+ PE R E LCHP+
Sbjct: 289 KEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 46/268 (17%)
Query: 4 LKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCE 57
+KK+ R +R E++++ V++P +V+ K + G ++ +++ Y
Sbjct: 69 IKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 58 GGDMAEAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD- 114
+ A + P + ++ QLL +L Y+H+ I HRD+K N+ L
Sbjct: 122 E-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV 180
Query: 115 IRLGDFGLAKMLISDDLASSVVGTPSYMCPEL-LADIPYGSKSDIWSLGCCVYEMSAQKA 173
++L DFG AK+LI+ + S + + Y PEL Y + DIWS GC + E+ +
Sbjct: 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
Query: 174 AFK---AFDMQALINKI-------------NKSIVAPLPTV----YSGAFRG-------- 205
F D I K+ + P + +S FR
Sbjct: 241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAID 300
Query: 206 LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L+ +L P R +A E LCHP
Sbjct: 301 LISRLLEYTPSARLTAIEALCHPFFDEL 328
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 64/361 (17%), Positives = 120/361 (33%), Gaps = 81/361 (22%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEG---- 58
LK+I SA +E+ L+ +++P ++ + ++ V ++ Y E
Sbjct: 53 LKQIE----GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWH 108
Query: 59 --GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-- 114
+ V P + L Q+L ++YLHAN +LHRD+K +NI + +
Sbjct: 109 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168
Query: 115 --IRLGDFGLAKMLISD-----DLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVY 166
+++ D G A++ S DL VV T Y PE LL Y DIW++GC
Sbjct: 169 GRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFA 227
Query: 167 EMSAQKAAFKA----------------------------------------------FDM 180
E+ + F F
Sbjct: 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 287
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ--PYVLGIH 238
N + L++ +L +P R ++ + + P+ P
Sbjct: 288 NTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL----- 342
Query: 239 LKLNGPRRNTF-PLEWSDSNFKKTRFMEPEAISIHSNREKRQSFSNDRALNPSVSETEQD 297
P + F + + EP+ N++++Q ++ ++
Sbjct: 343 -----PTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSH 397
Query: 298 S 298
+
Sbjct: 398 T 398
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 46/268 (17%)
Query: 4 LKKIRL-ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCE 57
+KK+ R +R E++++ ++ + IV + + G Y+ +++ Y
Sbjct: 84 IKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136
Query: 58 GGDMAEAIK--KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
+ + P + ++ QL +L Y+H+ I HRD+K N+ L D +
Sbjct: 137 E-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 116 -RLGDFGLAKMLISDDLASSVVGTPSYMCPEL-LADIPYGSKSDIWSLGCCVYEMSAQKA 173
+L DFG AK L+ + S + + Y PEL Y S D+WS GC + E+ +
Sbjct: 196 LKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
Query: 174 AFKAFD--------MQAL-------INKIN-KSIVAPLPTV----YSGAFRG-------- 205
F ++ L I ++N P + ++ FR
Sbjct: 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315
Query: 206 LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L +L P R + E H
Sbjct: 316 LCSRLLEYTPTARLTPLEACAHSFFDEL 343
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 44/199 (22%)
Query: 79 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSV-- 135
++ + Q L A+ LH ++++HRD+K SN+ + + D+++ DFGLA+++ +S
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 136 ---------VGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA-------- 177
V T Y PE +L Y D+WS GC + E+ ++ F
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 178 ------------FDMQALINKINKSIVAPLP--------TVYSGAFRG---LVKSMLRKN 214
D++ + + + + LP ++ L++ ML +
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293
Query: 215 PEFRPSAAELLCHPHLQPY 233
P R +A E L HP+LQ Y
Sbjct: 294 PAKRITAKEALEHPYLQTY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 45/254 (17%), Positives = 87/254 (34%), Gaps = 60/254 (23%)
Query: 22 QEMELISRVRNPFIVEY-------KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74
E+ + +++ I+++ V+ +I + E G +++ +K
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDL----WLITAFHEKGSLSDFLKANV---VS 119
Query: 75 EEKLCKWLVQLLMALNYLHAN----------HILHRDVKCSNIFLTRDQDIRLGDFGLAK 124
+LC + L YLH + I HRD+K N+ L + + DFGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 125 MLISDDLA---SSVVGTPSYMCPELL-----ADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
+ A VGT YM PE+L + D++++G ++E++++ A
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 177 AF-------------------DMQALI------NKINKSIVAPLPTVYSGAFRGLVKSML 211
DMQ ++ + ++
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECW 296
Query: 212 RKNPEFRPSAAELL 225
+ E R SA +
Sbjct: 297 DHDAEARLSAGCVG 310
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 60/285 (21%), Positives = 103/285 (36%), Gaps = 76/285 (26%)
Query: 3 VLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY---VCIIIGYCE-- 57
+L+++ A T A+ I++ D + KG V ++ E
Sbjct: 68 LLQRVNDADNTKEDSMGAN------------HILKLLDHFNHKGPNGVHVVMV---FEVL 112
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQD-- 114
G ++ IKK P + + QLL+ L+Y+H I+H D+K N+ +
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172
Query: 115 ----IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA 170
I++ D G A D+ ++ + T Y PE+L P+G +DIWS C ++E+
Sbjct: 173 NLIQIKIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 171 QKAAFKA-------------------------------------FDMQALINKINKSIVA 193
F+ F+ + L+ I+K
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 194 PLPTV----------YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
PL V + + ML+ +P R A L+ HP
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 30/180 (16%)
Query: 84 QLLMALNYLHANHILHRDVKCSNIFL-TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYM 142
QL A+ ++H+ I HRD+K N+ + ++D ++L DFG AK LI + + + + + Y
Sbjct: 149 QLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR 208
Query: 143 CPEL-LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------- 194
PEL L Y D+WS+GC E+ K F + +I + + P
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR 268
Query: 195 ---------LPTV----YSGAFRG--------LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
PT+ + L++ +LR P+ R + E + HP
Sbjct: 269 MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 46/261 (17%), Positives = 86/261 (32%), Gaps = 63/261 (24%)
Query: 22 QEMELISRVRNPFIVEY-----KDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76
+ + + + + I + + + + Y +++ Y G + + +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLHT---SDWV 111
Query: 77 KLCKWLVQLLMALNYLHANH---------ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI 127
C+ + L YLH I HRD+ N+ + D + DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 128 SDDLA---------SSVVGTPSYMCPELLADI-------PYGSKSDIWSLGCCVYEMSAQ 171
+ L S VGT YM PE+L + D+++LG +E+ +
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 172 KAAFKAF---------------------DMQALINKINKSIVAPLPTVY---SGAFRGLV 207
DMQ L+ + P + S A R L
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREKQRPKFPEAWKENSLAVRSLK 289
Query: 208 KSMLR---KNPEFRPSAAELL 225
+++ ++ E R +A
Sbjct: 290 ETIEDCWDQDAEARLTAQXAE 310
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 70/225 (31%)
Query: 79 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
+++V QL+ + YLH+ +LHRD+K SNI L + +++ DFGL++ ++ ++ +
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 138 TPS----------------------YMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
Y PE LL Y D+WSLGC + E+ K
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 175 FK-------------------AFDMQALINKINKSIVAPLPTVYSGAFRG---------- 205
F D++++ + K+++ L
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290
Query: 206 -----------------LVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L+ +L+ NP R SA + L HP + +
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 22 QEMELISRVRNPFIVE-YKDSWVEKGCYVC------IIIGYCEGGDMAEAIKKANGVHFP 74
E +++ V NP + G +C +I G + + +++ + +
Sbjct: 66 DEAYVMASVDNPHVCRLL-------G--ICLTSTVQLITQLMPFGCLLDYVRE-HKDNIG 115
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
+ L W VQ+ +NYL ++HRD+ N+ + Q +++ DFGLAK+L +++
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 135 VVGT--P-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
G P +M E + Y +SD+WS G V+E+
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 16/168 (9%)
Query: 11 RQTDRARRSAHQEMELISRVR------NPFIVEYKDSWVEKGCYVCIIIGYCE--GGDMA 62
R R R A +E+ ++ +R ++ +++ + ++C+ E ++
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN-HICMT---FELLSMNLY 186
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQDIRLGDF 120
E IKK F + K+ +L L+ LH N I+H D+K NI L I++ DF
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
G + + + + Y PE++ YG D+WSLGC + E+
Sbjct: 247 GSSC--YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 63/337 (18%), Positives = 109/337 (32%), Gaps = 117/337 (34%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN--------PFIVEYKDSWVEK---GCYVC 50
+V K+ + + +A E+ L+ VRN +V+ D + G ++C
Sbjct: 64 FVAMKV--VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121
Query: 51 IIIGYCE--GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNI 107
++ E G + + I K+N P + K + Q+L L+YLH I+H D+K NI
Sbjct: 122 MV---FEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178
Query: 108 FLTRDQ-------------------------------------------------DIRLG 118
L+ ++ +++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
D G A + + T Y E+L Y + +DIWS C +E++ F+
Sbjct: 239 DLGNAC--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 179 D-------------MQALINKINKSIVA----------------------------PLPT 197
+ L+ K+ + ++ L
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 198 VYSG------AFRGLVKSMLRKNPEFRPSAAELLCHP 228
Y F + ML PE R +AAE L HP
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGV 71
T+ R +E+E++ +++ IV+YK G + +I+ Y G + + ++K +
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKE 140
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 131
KL ++ Q+ + YL +HRD+ NI + + +++GDFGL K ++ D
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDK 199
Query: 132 ASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYEM 168
V P + PE L + + SD+WS G +YE+
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGV 71
T+ R +E+E++ +++ IV+YK G + +I+ Y G + + ++K +
Sbjct: 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKE 109
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 131
KL ++ Q+ + YL +HRD+ NI + + +++GDFGL K ++ D
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDK 168
Query: 132 ASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYEM 168
V P + PE L + + SD+WS G +YE+
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 39/161 (24%), Positives = 77/161 (47%), Gaps = 6/161 (3%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGV 71
+E+E++ + + IV+YK E G + +I+ + G + E + K N
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKN 121
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-D 130
++ K+ VQ+ ++YL + +HRD+ N+ + + +++GDFGL K + +D +
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 131 LASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ S + PE L + SD+WS G ++E+
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 37/152 (24%), Positives = 79/152 (51%), Gaps = 6/152 (3%)
Query: 22 QEMELISRVRNPFIVEYKD-SWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80
+E++++ + + FIV+Y+ S+ + +++ Y G + + +++ + +L
Sbjct: 73 REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLL 131
Query: 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVG 137
+ Q+ + YL + +HRD+ NI + + +++ DFGLAK+L D +
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 138 TP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+P + PE L+D + +SD+WS G +YE+
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 22 QEMELISRVRNPFIVEYKDSWVEKGCY-VC------IIIGYCEGGDMAEAIKKANGVHFP 74
E +++ V NP + +C +I G + + +++ + +
Sbjct: 66 DEAYVMASVDNPHVCR---------LLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIG 115
Query: 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASS 134
+ L W VQ+ +NYL ++HRD+ N+ + Q +++ DFGLAK+L +++
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 135 VVGT--P-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
G P +M E + Y +SD+WS G V+E+
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 18/170 (10%)
Query: 11 RQTDRARRSAHQEMELISRVRNP------FIVEYKDSWVEKGCYVCIIIGYCE--GGDMA 62
+ A E+ L+ + +IV K ++ + ++C++ E ++
Sbjct: 88 KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN-HLCLV---FEMLSYNLY 143
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN--HILHRDVKCSNIFLT--RDQDIRLG 118
+ ++ N K+ Q+ AL +L I+H D+K NI L + I++
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
DFG + + + Y PE+L +PY D+WSLGC + EM
Sbjct: 204 DFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 24/222 (10%), Positives = 55/222 (24%), Gaps = 43/222 (19%)
Query: 10 ARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN 69
+SR+ P + D V ++ + GG + E +
Sbjct: 72 DDVLQETLSRTL----RLSRIDKPGVARVLD-VVHTRAGGLVVAEWIRGGSLQEVADTSP 126
Query: 70 GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD 129
P + + + L A + H + S + ++ D D+ L
Sbjct: 127 S---PVGAI-RAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174
Query: 130 DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD----MQALIN 185
M + DI +G +Y + + +
Sbjct: 175 -----------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 186 KINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
+ P + + ++ + R ++ L
Sbjct: 217 DTAGQPIEPADIDRDI-PFQISAVAARSVQGDGGIRSASTLL 257
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 40/162 (24%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-VCIIIGYCEGGDMAEAIKKANGV 71
+ R QE++++ + + I++YK + G + +++ Y G + + + + +
Sbjct: 73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-- 130
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL 131
+L + Q+ + YLHA H +HRD+ N+ L D+ +++GDFGLAK + +
Sbjct: 131 -IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGH 188
Query: 132 ASSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYEM 168
V + PE L + + SD+WS G +YE+
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 69/298 (23%), Positives = 116/298 (38%), Gaps = 83/298 (27%)
Query: 11 RQTDRARRSAHQEMELISRVR-----NPFIVEYKDSWVEKGCYVCIIIGYCE--GGDMAE 63
R + RSA E +++ +++ N IV+Y ++ ++C+I E G + E
Sbjct: 69 RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD-HMCLI---FEPLGPSLYE 124
Query: 64 AIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT------------- 110
I + N F E + + +++L ALNYL + H D+K NI L
Sbjct: 125 IITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184
Query: 111 ------------RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158
+ I+L DFG A D S++ T Y PE++ ++ + SD+
Sbjct: 185 VTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDM 242
Query: 159 WSLGCCVYEMSAQKAAFKAFD-------MQALINKINKSIVA------------------ 193
WS GC + E+ F+ + M+++I I K+++
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 194 PLPTVYSG--------------------AFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
P S F + S+L+ +P RPS AELL H L+
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 38/186 (20%), Positives = 78/186 (41%), Gaps = 3/186 (1%)
Query: 43 VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV 102
+ II + G++ + +++ N L Q+ A+ YL + +HR++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 103 KCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADIPYGSKSDIWS 160
N + + +++ DFGL++++ D + PE LA + KSD+W+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 161 LGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 219
G ++E + + + D+ + + K P L+++ + NP RP
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 464
Query: 220 SAAELL 225
S AE+
Sbjct: 465 SFAEIH 470
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 30/123 (24%), Positives = 59/123 (47%), Gaps = 4/123 (3%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ ++ Y G + + +++ + + L W VQ+ + YL + ++HR++ N+
Sbjct: 89 LQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 165
L +++ DFG+A +L DD P +M E + Y +SD+WS G V
Sbjct: 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
Query: 166 YEM 168
+E+
Sbjct: 208 WEL 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 31/124 (25%), Positives = 58/124 (46%), Gaps = 5/124 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ ++ G + + ++K + HF L ++ VQ+ + YL + +HRD+ N+
Sbjct: 95 MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153
Query: 109 LTRDQDIRLGDFGLAKMLISDD---LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCC 164
L +++GDFGL + L +D + P ++ PE L + SD W G
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213
Query: 165 VYEM 168
++EM
Sbjct: 214 LWEM 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 37/180 (20%), Positives = 78/180 (43%), Gaps = 3/180 (1%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I+ Y G + + +K G + +L Q+ + Y+ + +HRD++ +NI
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADIPYGSKSDIWSLGCCVY 166
+ + ++ DFGLA+++ ++ + PE + KSD+WS G +
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 167 E-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
E + + + + +++++ + P P + L+ RK PE RP+ L
Sbjct: 373 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 432
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 7/182 (3%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I++ +GGD ++ G + L + + + YL + +HRD+ N
Sbjct: 187 IYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY----MCPELLADIPYGSKSDIWSLGCC 164
+T +++ DFG+++ +D + ++ G PE L Y S+SD+WS G
Sbjct: 246 VTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
Query: 165 VYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
++E S + + Q + K P P + A L++ P RPS +
Sbjct: 305 LWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFST 364
Query: 224 LL 225
+
Sbjct: 365 IY 366
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 43/229 (18%), Positives = 87/229 (37%), Gaps = 23/229 (10%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
E ++ +P ++ + +++ Y + GD+ I+ +
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHN 124
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 132
+ L + +Q+ + YL + +HRD+ N L +++ DFGLA+ + +
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
Query: 133 SSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINK 186
S T + +M E L + +KSD+WS G ++E M+ + + +
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244
Query: 187 INKSIVAPLP-----TVYSGAFRGLVKSMLR---KNPEFRPSAAELLCH 227
+ + P +Y ML+ E RPS +EL+
Sbjct: 245 LLQGRRLLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSR 285
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 58/288 (20%), Positives = 104/288 (36%), Gaps = 76/288 (26%)
Query: 11 RQTDRARRSAHQEMELISRVRN--PF----IVEYKDSWVEKGCYVCIIIGYCE--GGDMA 62
R + R +A E+ ++ +++ V D + G ++CI E G +
Sbjct: 54 RNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-HMCIA---FELLGKNTF 109
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT------------ 110
E +K+ N +P + QL AL +LH N + H D+K NI
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 111 -------RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 163
++ IR+ DFG A + +++V T Y PE++ ++ + D+WS+GC
Sbjct: 170 SCEEKSVKNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227
Query: 164 CVYEMSAQKAAFKAFD-------MQALINKINKSIVA-------------PLPTVYSGAF 203
++E F+ + M+ ++ I ++ S
Sbjct: 228 ILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287
Query: 204 RG-----------------------LVKSMLRKNPEFRPSAAELLCHP 228
L++ ML +P R + AE L HP
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 4/179 (2%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
V II+ C G++ ++ L + QL AL YL + +HRD+ N+
Sbjct: 465 VWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVG-TP-SYMCPELLADIPYGSKSDIWSLGCCVY 166
++ + ++LGDFGL++ + + G P +M PE + + S SD+W G C++
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 167 E-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224
E + F+ +I +I P+P L+ +P RP EL
Sbjct: 584 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 45/238 (18%), Positives = 78/238 (32%), Gaps = 83/238 (34%)
Query: 79 CKWLV-QLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137
K ++ LL+ N++H + I+HRD+K +N L +D +++ DFGLA+ + S+ + V
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 138 TPS-----------------------YMCPE-LLADIPYGSKSDIWSLGCCVYEM----- 168
Y PE +L Y DIWS GC E+
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 169 ------SAQKAAFKAF------------------------------------DMQALINK 186
+ + F D++ +
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310
Query: 187 INKSIVAPLPTVYSGAFRGL-----------VKSMLRKNPEFRPSAAELLCHPHLQPY 233
+ P + ++SML+ NP R + + L HP+L+
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 42/229 (18%), Positives = 87/229 (37%), Gaps = 23/229 (10%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
E ++ +P ++ + +++ Y + GD+ I+ +
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHN 188
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 132
+ L + +Q+ + +L + +HRD+ N L +++ DFGLA+ + +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248
Query: 133 SSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINK 186
S T + +M E L + +KSD+WS G ++E M+ + + +
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308
Query: 187 INKSIVAPLP-----TVYSGAFRGLVKSMLR---KNPEFRPSAAELLCH 227
+ + P +Y ML+ E RPS +EL+
Sbjct: 309 LLQGRRLLQPEYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSR 349
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 76/288 (26%)
Query: 11 RQTDRARRSAHQEMELISRVRNP------FIVEYKDSWVEKGCYVCIIIGYCE--GGDMA 62
+ DR +A E++++ + V+ + + G ++CI+ E G
Sbjct: 49 KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG-HICIV---FELLGLSTY 104
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT------------ 110
+ IK+ + F + + K Q+ ++N+LH+N + H D+K NI
Sbjct: 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 111 -------RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 163
+ DI++ DFG A + S++V T Y PE++ + + D+WS+GC
Sbjct: 165 KRDERTLINPDIKVVDFGSA-TYDDEHH-STLVSTRHYRAPEVILALGWSQPCDVWSIGC 222
Query: 164 CVYEMSAQKAAFKAFD-------MQALINKINKSIVA----------------------- 193
+ E F D M+ ++ + K ++
Sbjct: 223 ILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282
Query: 194 -------PLPTVYSG------AFRGLVKSMLRKNPEFRPSAAELLCHP 228
PL L++ ML +P R + E L HP
Sbjct: 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHP 330
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 30/124 (24%), Positives = 59/124 (47%), Gaps = 5/124 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ +++ GG + + + P + + L Q+ M + YL + +HR++ N+
Sbjct: 410 LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468
Query: 109 LTRDQDIRLGDFGLAKMLISDDLA-SSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 164
L ++ DFGL+K L +DD ++ P + PE + + S+SD+WS G
Sbjct: 469 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 528
Query: 165 VYEM 168
++E
Sbjct: 529 MWEA 532
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 14/88 (15%)
Query: 89 LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 145
+N+LH NH +HRD+K +NI L ++ DFGLA+ + S +VGT +YM PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 146 LLADIPY--G---SKSDIWSLGCCVYEM 168
G KSDI+S G + E+
Sbjct: 206 ------ALRGEITPKSDIYSFGVVLLEI 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 37/180 (20%), Positives = 78/180 (43%), Gaps = 3/180 (1%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I+ Y G + + +K G + +L Q+ + Y+ + +HRD++ +NI
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY--MCPELLADIPYGSKSDIWSLGCCVY 166
+ + ++ DFGLA+++ ++ + PE + KSD+WS G +
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 167 E-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
E + + + + +++++ + P P + L+ RK PE RP+ L
Sbjct: 456 ELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 515
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 34/159 (21%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 22 QEMELISRVRNPFIVE-----YKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA----NGVH 72
+E + +P + + + + +I+ + + GD+ + + N +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 132
P + L +++V + + YL + + +HRD+ N L D + + DFGL++ + S D
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 133 SSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ P ++ E LAD Y SD+W+ G ++E+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 46/165 (27%)
Query: 23 EMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC-EGGDMA---EAIKKAN------GVH 72
E+E +S R+P +V +IG+C E +M + ++ N G
Sbjct: 85 EIETLSFCRHPHLVS--------------LIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 73 FPEEKLCKWLVQLLMA------LNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126
P + W +L + L+YLH I+HRDVK NI L + ++ DFG++K
Sbjct: 131 LPTMSM-SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 127 ISDD---LASSVVGTPSYMCPELLADIPYGS------KSDIWSLG 162
D L++ V GT Y+ PE Y KSD++S G
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPE------YFIKGRLTEKSDVYSFG 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 31/124 (25%), Positives = 59/124 (47%), Gaps = 5/124 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ +++ GG + + + P + + L Q+ M + YL + +HRD+ N+
Sbjct: 84 LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142
Query: 109 LTRDQDIRLGDFGLAKMLISDDLA-SSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 164
L ++ DFGL+K L +DD ++ P + PE + + S+SD+WS G
Sbjct: 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVT 202
Query: 165 VYEM 168
++E
Sbjct: 203 MWEA 206
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 43/186 (23%), Positives = 81/186 (43%), Gaps = 11/186 (5%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
II + G++ + +++ N L Q+ A+ YL + +HRD+ N
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 165
+ + +++ DFGL++ L++ D ++ G P + PE LA + KSD+W+ G +
Sbjct: 144 VGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202
Query: 166 YE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSA 221
+E + + + D+ + + K P G + + M NP RPS
Sbjct: 203 WEIATYGMSPYPGIDLSQVYELLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSF 259
Query: 222 AELLCH 227
AE+
Sbjct: 260 AEIHQA 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 32/123 (26%), Positives = 61/123 (49%), Gaps = 5/123 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
II+ G++ +++ N L + +Q+ A+ YL + + +HRD+ NI
Sbjct: 87 TWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 165
+ + ++LGDFGL++ I D+ T P +M PE + + + SD+W C+
Sbjct: 146 VASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCM 204
Query: 166 YEM 168
+E+
Sbjct: 205 WEI 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 12/185 (6%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I+ Y G + ++ +G +L + + + +L ++ +HRD+ N
Sbjct: 78 IYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 165
+ RD +++ DFG+ + + DD S VGT P + PE+ Y SKSD+W+ G +
Sbjct: 137 VDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 166 YE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSA 221
+E S K + + ++ K+++ P A + + M + PE RP+
Sbjct: 196 WEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTF 252
Query: 222 AELLC 226
+LL
Sbjct: 253 QQLLS 257
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 34/122 (27%), Positives = 60/122 (49%), Gaps = 3/122 (2%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
V II+ C G++ ++ L + QL AL YL + +HRD+ N+
Sbjct: 90 VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCVY 166
++ + ++LGDFGL++ + + G P +M PE + + S SD+W G C++
Sbjct: 149 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 208
Query: 167 EM 168
E+
Sbjct: 209 EI 210
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 30/124 (24%), Positives = 62/124 (50%), Gaps = 6/124 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+++ E G + + +++ H ++ + + + Q+ M + YL ++ +HRD+ N+
Sbjct: 92 WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 149
Query: 109 LTRDQDIRLGDFGLAKMLISD-DLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 164
L ++ DFGL+K L +D + + P + PE + + SKSD+WS G
Sbjct: 150 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209
Query: 165 VYEM 168
++E
Sbjct: 210 MWEA 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 30/122 (24%), Positives = 61/122 (50%), Gaps = 2/122 (1%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ II Y E G + + +K +G+ KL Q+ + ++ + +HRD++ +NI
Sbjct: 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCVY 166
++ ++ DFGLA+++ ++ + P + PE + + KSD+WS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 167 EM 168
E+
Sbjct: 202 EI 203
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 31/161 (19%), Positives = 69/161 (42%), Gaps = 6/161 (3%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
+ + +E L+ + +P ++ + +++ Y GD+ + I+ +
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRN 120
Query: 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA 132
+ L + +Q+ + YL +HRD+ N L +++ DFGLA+ ++ +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 133 SSVVGTPS-----YMCPELLADIPYGSKSDIWSLGCCVYEM 168
S + + E L + +KSD+WS G ++E+
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 34/185 (18%), Positives = 62/185 (33%), Gaps = 48/185 (25%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY--------VCIIIGYCEGGDM--- 61
+ R R E ++ +V +I+ GD+
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVR---------LLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 62 -----AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
K+ + ++ + YL+AN +HRD+ N + D ++
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178
Query: 117 LGDFGLAKMLISDDLASSVVGTPSY-------------MCPELLADIPYGSKSDIWSLGC 163
+GDFG+ + + D Y M PE L D + + SD+WS G
Sbjct: 179 IGDFGMTRDIYETD----------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228
Query: 164 CVYEM 168
++E+
Sbjct: 229 VLWEI 233
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+C++ + E G +++ ++ F E L + + + YL ++HRD+ N
Sbjct: 78 ICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 165
+ +Q I++ DFG+ + + DD +S GT P + PE+ + Y SKSD+WS G +
Sbjct: 137 VGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
Query: 166 YE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVKSMLR---KNPE 216
+E S K ++ ++ I+ P VY M + PE
Sbjct: 196 WEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ--------IMNHCWRERPE 247
Query: 217 FRPSAAELLC 226
RP+ + LL
Sbjct: 248 DRPAFSRLLR 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 58/326 (17%), Positives = 111/326 (34%), Gaps = 101/326 (30%)
Query: 4 LKKIRLA--RQTDRARRSAHQEMELISRVRNPFIVEYKD----SWVEKGCYVCIIIGYCE 57
+KKI D +R +E+ +++R+ + +V+ D VEK + +++ +
Sbjct: 83 IKKILRVFEDLID-CKR-ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD 140
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
D + + V+ E + L LL+ + Y+H+ ILHRD+K +N + +D +++
Sbjct: 141 S-DFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKV 197
Query: 118 GDFGLAKMLISDDLASSVVGTPS----------------------------YMCPE-LLA 148
DFGLA+ + + +S + Y PE +L
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257
Query: 149 DIPYGSKSDIWSLGCCVYEM-----------SAQKAAFKAFDMQAL-------------- 183
Y D+WS+GC E+ + + F L
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHT 317
Query: 184 ------INKINKSIVAP----LPTVYSGAFRGLVKSM----------------------L 211
+N I + P + + + ++ L
Sbjct: 318 RGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLL 377
Query: 212 RK----NPEFRPSAAELLCHPHLQPY 233
++ NP R + E L HP +
Sbjct: 378 KRMLVFNPNKRITINECLAHPFFKEV 403
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 15/177 (8%)
Query: 5 KKIRLARQTDRARRSAHQEMELISRVRNPFIVE------YKDSWVEKGCYVCIIIGYCEG 58
K ++L + R E + +P ++ S +I+ + +
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM--VILPFMKY 125
Query: 59 GDMAEAIKK----ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD 114
GD+ + H P + L K++V + + + YL + LHRD+ N L D
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185
Query: 115 IRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ + DFGL+K + S D P ++ E LAD Y SKSD+W+ G ++E+
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 12/186 (6%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
V I+ Y E G + ++K + F +L L + + YL +HRD+ NI
Sbjct: 121 VMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 179
Query: 109 LTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCC 164
+ + ++ DFGL ++L D + A + G + PE +A + S SD+WS G
Sbjct: 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 165 VYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPS 220
++E MS + + Q +I +++ P P L + ML K+ RP
Sbjct: 240 LWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP---MDCPAALYQLMLDCWQKDRNNRPK 296
Query: 221 AAELLC 226
+++
Sbjct: 297 FEQIVS 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 42/185 (22%), Positives = 82/185 (44%), Gaps = 12/185 (6%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
I+ Y E G + ++ + F +L L + + YL +HRD+ N+
Sbjct: 125 AMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183
Query: 109 LTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCC 164
+ + ++ DFGL+++L D D A + G + PE +A + S SD+WS G
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 165 VYE-MSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPS 220
++E ++ + + + +I+ + + P P G L + ML K+ RP
Sbjct: 244 MWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP---MGCPHALHQLMLDCWHKDRAQRPR 300
Query: 221 AAELL 225
++++
Sbjct: 301 FSQIV 305
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 29/122 (23%), Positives = 60/122 (49%), Gaps = 2/122 (1%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ II + G + + +K G P KL + Q+ + ++ + +HRD++ +NI
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT-P-SYMCPELLADIPYGSKSDIWSLGCCVY 166
++ ++ DFGLA+++ ++ + P + PE + + KSD+WS G +
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 376
Query: 167 EM 168
E+
Sbjct: 377 EI 378
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 38/199 (19%), Positives = 71/199 (35%), Gaps = 40/199 (20%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
++ + + G + +KK N + QL A+++L N ++H +V NI
Sbjct: 87 NILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNIL 145
Query: 109 LTRDQD--------IRLGDFGLAKMLISDDLASSVVGTPSY------MCPELLAD-IPYG 153
L R++D I+L D G++ ++ D + PE + +
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITVLPKD---------ILQERIPWVPPECIENPKNLN 196
Query: 154 SKSDIWSLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP---TVYSGAFRGLVKS 209
+D WS G ++E S A D Q + P P + +
Sbjct: 197 LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELAN--------L 248
Query: 210 MLR---KNPEFRPSAAELL 225
+ P+ RPS ++
Sbjct: 249 INNCMDYEPDHRPSFRAII 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 22/195 (11%)
Query: 43 VEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDV 102
K + II Y G + +++ F ++L + + A+ YL + LHRD+
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 103 KCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIW 159
N + +++ DFGL++ + DD +S VG+ P + PE+L + SKSDIW
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 160 SLGCCVYE-MSAQKAAFKAFDMQALINKINKSIVAPLP-----TVYSGAFRGLVKSMLR- 212
+ G ++E S K ++ F I + + P VY+ M
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT--------IMYSC 257
Query: 213 --KNPEFRPSAAELL 225
+ + RP+ LL
Sbjct: 258 WHEKADERPTFKILL 272
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 3/100 (3%)
Query: 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD- 130
E L + Q+ + +L + +HRD+ NI L+ +++ DFGLA+ + D
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 131 -LASSVVGTP-SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ P +M PE + D Y +SD+WS G ++E+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 17/85 (20%)
Query: 89 LNYLH--AN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMC 143
L YLH + I+HRDVK +NI L + + +GDFGLAK++ D + ++V GT ++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 144 PELLADIPYGS------KSDIWSLG 162
PE Y S K+D++ G
Sbjct: 204 PE------YLSTGKSSEKTDVFGYG 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 39/181 (21%), Positives = 78/181 (43%), Gaps = 34/181 (18%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY--------VCIIIGYCEGGDMAE- 63
T AR+ +E EL++ +++ IV+ Y + ++ Y + GD+ +
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVK---------FYGVCGDGDPLIMVFEYMKHGDLNKF 107
Query: 64 -------AIKKANGVHFPEEKLCKWLVQLLMAL------NYLHANHILHRDVKCSNIFLT 110
A+ +G + L +A YL + H +HRD+ N +
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 167
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYE 167
+ +++GDFG+++ + S D T +M PE + + ++SD+WS G ++E
Sbjct: 168 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227
Query: 168 M 168
+
Sbjct: 228 I 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 5/124 (4%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ II Y E G + + +++ F +L L + + YL + +HRD+ NI
Sbjct: 121 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179
Query: 109 LTRDQDIRLGDFGLAKMLISD-DLASSVVGTPS---YMCPELLADIPYGSKSDIWSLGCC 164
+ + ++ DFGL+++L D + + G + PE ++ + S SD+WS G
Sbjct: 180 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 239
Query: 165 VYEM 168
++E+
Sbjct: 240 MWEV 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 43/184 (23%), Positives = 78/184 (42%), Gaps = 41/184 (22%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE--------A 64
++ AR+ +E EL++ +++ IV + +G + ++ Y GD+ A
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFGV-CTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 65 IKKANGVHFPEEKLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIRL 117
A G L L QLL +A YL H +HRD+ N + + +++
Sbjct: 142 KLLAGGEDVAPGPLG--LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199
Query: 118 GDFGLAKMLISDDLASSVVGTPSY-------------MCPELLADIPYGSKSDIWSLGCC 164
GDFG+++ + S D Y M PE + + ++SD+WS G
Sbjct: 200 GDFGMSRDIYSTD----------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 165 VYEM 168
++E+
Sbjct: 250 LWEI 253
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/240 (21%), Positives = 89/240 (37%), Gaps = 43/240 (17%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-VC-------IIIGYCEGGDMAEA 64
+++ E +IS+ + IV C V I++ GGD+
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVR---------CIGVSLQSLPRFILMELMAGGDLKSF 123
Query: 65 IKKANGVHFPEEKLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQD--- 114
+++ L ++ LL +A YL NH +HRD+ N LT
Sbjct: 124 LRETRPRPSQPSSLA--MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181
Query: 115 IRLGDFGLAKMLISDDLASSVVGTPSY-----MCPELLADIPYGSKSDIWSLGCCVYE-M 168
++GDFG+A+ + G + M PE + + SK+D WS G ++E
Sbjct: 182 AKIGDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 169 SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAAELL 225
S + + Q ++ + P G + M + PE RP+ A +L
Sbjct: 240 SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIIL 296
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 35/175 (20%), Positives = 71/175 (40%), Gaps = 22/175 (12%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAE--------- 63
R E L +R+++P +V V K + +I YC GD+ E
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLGV-VTKDQPLSMIFSYCSHGDLHEFLVMRSPHS 110
Query: 64 AIKKANGVHFPEEKLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDIR 116
+ + + L + + YL ++H++H+D+ N+ + +++
Sbjct: 111 DVGSTDDDRTVKSALE--PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 168
Query: 117 LGDFGLAKMLISDDLASSVVGTP---SYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ D GL + + + D + + +M PE + + SDIWS G ++E+
Sbjct: 169 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 27/232 (11%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72
+++ E +IS+ + IV + I++ GGD+ +++
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIGV-SLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 73 FPEEKLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGL 122
L ++ LL +A YL NH +HRD+ N LT ++GDFG+
Sbjct: 173 SQPSSLA--MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 123 AKMLISDDLASSVVGTPSY-----MCPELLADIPYGSKSDIWSLGCCVYE-MSAQKAAFK 176
A+ + G + M PE + + SK+D WS G ++E S +
Sbjct: 231 ARDIYRAG--YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAAELL 225
+ Q ++ + P G + M + PE RP+ A +L
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIIL 337
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 31/123 (25%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 49 VCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ I+ Y G + + ++ + L K+ + + A+ YL N+ +HRD+ N+
Sbjct: 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCCV 165
++ D ++ DFGL K + +S+ P + PE L + + +KSD+WS G +
Sbjct: 150 VSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204
Query: 166 YEM 168
+E+
Sbjct: 205 WEI 207
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 31/124 (25%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 48 YVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
+ I+ Y G + + ++ + L K+ + + A+ YL N+ +HRD+ N+
Sbjct: 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320
Query: 108 FLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMCPELLADIPYGSKSDIWSLGCC 164
++ D ++ DFGL K + +S+ P + PE L + + +KSD+WS G
Sbjct: 321 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 165 VYEM 168
++E+
Sbjct: 376 LWEI 379
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 8e-12
Identities = 35/191 (18%), Positives = 74/191 (38%), Gaps = 46/191 (24%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDM---------- 61
+ R E ++ +V +P +++ Y + + +I+ Y + G +
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLY--GACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 62 ------------AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL 109
+ ++ + L + Q+ + YL ++HRD+ NI +
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV 183
Query: 110 TRDQDIRLGDFGLAKMLISDDLASSVVGTPSY------------MCPELLADIPYGSKSD 157
+ +++ DFGL++ + +D SY M E L D Y ++SD
Sbjct: 184 AEGRKMKISDFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 158 IWSLGCCVYEM 168
+WS G ++E+
Sbjct: 235 VWSFGVLLWEI 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 37/185 (20%), Positives = 74/185 (40%), Gaps = 40/185 (21%)
Query: 13 TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM---------A 62
T R+ E++++ + + +V + + G + +I+ +C+ G++
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 63 EAIKKANGVHFPEEKLCKWLVQLL-MAL------NYLHANHILHRDVKCSNIFLTRDQDI 115
K ++ L L L+ + +L + +HRD+ NI L+ +
Sbjct: 130 FVPYKVAPEDLYKDFLT--LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 187
Query: 116 RLGDFGLAKMLISDDLASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGC 163
++ DFGLA+ + D Y M PE + D Y +SD+WS G
Sbjct: 188 KICDFGLARDIYKDP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 164 CVYEM 168
++E+
Sbjct: 239 LLWEI 243
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 38/191 (19%), Positives = 68/191 (35%), Gaps = 46/191 (24%)
Query: 13 TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM----------- 61
+ + +E L++ NP IV+ G +C++ Y GD+
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGV-CAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 62 -----AEAIKKANGVHFPEEKLCKWLVQLLMAL------NYLHANHILHRDVKCSNIFLT 110
+ V P QL +A YL +HRD+ N +
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208
Query: 111 RDQDIRLGDFGLAKMLISDDLASSVVGTPSY-------------MCPELLADIPYGSKSD 157
+ +++ DFGL++ + S D Y M PE + Y ++SD
Sbjct: 209 ENMVVKIADFGLSRNIYSAD----------YYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 158 IWSLGCCVYEM 168
+W+ G ++E+
Sbjct: 259 VWAYGVVLWEI 269
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 33/144 (22%)
Query: 49 VCIIIGYCEGGDM------------AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 96
V +I YC GD+ + L + Q+ + +L + +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY------------MCP 144
+HRDV N+ LT ++GDFGLA+ +++D +Y M P
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------NYIVKGNARLPVKWMAP 235
Query: 145 ELLADIPYGSKSDIWSLGCCVYEM 168
E + D Y +SD+WS G ++E+
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEI 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 38/184 (20%), Positives = 73/184 (39%), Gaps = 39/184 (21%)
Query: 13 TDRARRSAHQEMELISRV-RNPFIVE-YKDSWVEKGCYVCIIIGYCEGGDM--------- 61
T++ EME++ + ++ I+ + + +I+ Y G++
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLL--GACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 62 -----AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
+ I + + L QL + YL + +HRD+ N+ +T + ++
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243
Query: 117 LGDFGLAKMLISDDLASSVVGTPSY------------MCPELLADIPYGSKSDIWSLGCC 164
+ DFGLA+ + + D Y M PE L D Y +SD+WS G
Sbjct: 244 IADFGLARDINNID---------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 165 VYEM 168
++E+
Sbjct: 295 MWEI 298
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 33/146 (22%), Positives = 59/146 (40%), Gaps = 35/146 (23%)
Query: 49 VCIIIGYCEGGDM--------------AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 94
+ +I+ Y G++ + I + + L QL + YL +
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY------------M 142
+HRD+ N+ +T + +++ DFGLA+ + + D Y M
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---------YYKKTTNGRLPVKWM 226
Query: 143 CPELLADIPYGSKSDIWSLGCCVYEM 168
PE L D Y +SD+WS G ++E+
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 35/148 (23%), Positives = 63/148 (42%), Gaps = 37/148 (25%)
Query: 49 VCIIIGYCEGGDM----------------AEAIKKANGVHFPEEKLCKWLVQLLMALNYL 92
+I YC GD+ + AI + + + E L + Q+ + +L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 93 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY----------- 141
+ + +HRD+ NI LT + ++ DFGLA+ + +D +Y
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---------NYVVKGNARLPVK 212
Query: 142 -MCPELLADIPYGSKSDIWSLGCCVYEM 168
M PE + + Y +SD+WS G ++E+
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 39/148 (26%)
Query: 49 VCIIIGYCEGGDM---------AEAIKKANGVHFPEEKLCKWLVQLL-MAL------NYL 92
+ +I+ Y G++ N H PEE+L L+ A YL
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS--SKDLVSCAYQVARGMEYL 207
Query: 93 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY----------- 141
+ +HRD+ N+ +T D +++ DFGLA+ + D Y
Sbjct: 208 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---------YYKKTTNGRLPVK 258
Query: 142 -MCPELLADIPYGSKSDIWSLGCCVYEM 168
M PE L D Y +SD+WS G ++E+
Sbjct: 259 WMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 42/152 (27%)
Query: 50 CIIIGYCEGGDM------------AEAIKKANGVHFPEEKLCKWL--VQLL-MAL----- 89
+I YC GD+ + I+ N EE+ L LL A
Sbjct: 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184
Query: 90 -NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSY------- 141
+L +HRD+ N+ +T + +++ DFGLA+ ++SD +Y
Sbjct: 185 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNAR 235
Query: 142 -----MCPELLADIPYGSKSDIWSLGCCVYEM 168
M PE L + Y KSD+WS G ++E+
Sbjct: 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 33/145 (22%), Positives = 55/145 (37%), Gaps = 24/145 (16%)
Query: 43 VEKGCYVCIIIGYCEGGDM---------AEAIKKANGVHFPEEKLCKWLVQLL-MAL--- 89
E Y+ + I Y G++ E + L QLL A
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHFAADVA 152
Query: 90 ---NYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGT--P-SYMC 143
+YL +HRD+ NI + + ++ DFGL++ ++ P +M
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 209
Query: 144 PELLADIPYGSKSDIWSLGCCVYEM 168
E L Y + SD+WS G ++E+
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 27/115 (23%), Positives = 51/115 (44%), Gaps = 11/115 (9%)
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-TRDQD-IRLGDF 120
+ I +AN F + + + +++L L Y+H + +H D+K SN+ L ++ D + L D+
Sbjct: 139 QKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 121 GLAKMLISD--------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCVY 166
GLA + D GT + + + + D+ LG C +
Sbjct: 199 GLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 30/143 (20%), Positives = 55/143 (38%), Gaps = 12/143 (8%)
Query: 35 IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA 94
I V + Y +++ G + A+ + E + + +LL AL +LH
Sbjct: 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE 177
Query: 95 NHILHRDVKCSNIFLTRDQD--IRLGDFGLAK--------MLISDDLASSVVGTPSYMCP 144
N +H +V NIF+ + + L +G A + + S G ++
Sbjct: 178 NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM 237
Query: 145 ELLADIPYGSKSDIWSLG-CCVY 166
+L +SD+ SLG C +
Sbjct: 238 DLHKGCGPSRRSDLQSLGYCMLK 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGD 119
E + F + + Q++ + Y+H+ + +HRDVK N + + + + D
Sbjct: 92 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151
Query: 120 FGLAKMLISD--------DLASSVVGTPSYMCPELLADIPYGSKSDIWSLG 162
FGLAK ++ GT Y I + D+ SLG
Sbjct: 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 11/95 (11%)
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFL-TRDQD-IRLGDFGLAKMLISD--------DLA 132
+++L L Y+H N +H D+K +N+ L ++ D + L D+GL+ + +
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 133 SSVVGTPSYMCPELLADIPYGSKSDIWSLG-CCVY 166
GT + + + +SD+ LG C +
Sbjct: 218 KGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 24/111 (21%), Positives = 42/111 (37%), Gaps = 11/111 (9%)
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGD 119
E + + + Q++ + ++H+ LHRD+K N + + + + D
Sbjct: 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149
Query: 120 FGLAK--------MLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLG 162
FGLAK I ++ GT Y I + D+ SLG
Sbjct: 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG 200
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 8e-07
Identities = 33/226 (14%), Positives = 57/226 (25%), Gaps = 48/226 (21%)
Query: 37 EYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH 96
K + I++ + GG +++ L QL +L A+
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASL 181
Query: 97 -ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155
HRD+ N+ L + +L K SS + + I Y
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGK--------SSTIPSCGLQVSI----IDYTLS 229
Query: 156 SDIWSLGCCVYEMSAQKAAF--------KAFDMQALINKINKSIVAPLPTVY-------- 199
++S + F + + N P V
Sbjct: 230 RLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK 289
Query: 200 ---------------SGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230
+ ++ R F SA +LLC L
Sbjct: 290 MLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-SATDLLCQHSL 334
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 9e-07
Identities = 51/335 (15%), Positives = 83/335 (24%), Gaps = 134/335 (40%)
Query: 31 RNPFIVEYKDSWVEKGCY------------VCIIIG--YCEGGDMAEAIKKANGVHFPEE 76
+ F + W+ + I + D + IK
Sbjct: 179 KMDFKI----FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIH 228
Query: 77 KLCKWLVQLLMALNYLHANHILHRDV-----------KCSNIFLTRDQDI---------- 115
+ L +LL + Y + +L +V C + TR + +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 116 --RLGDFG-----------LAKML--ISDDLASSVVGT-P---SYMCPELLADIPYGSKS 156
L L K L DL V+ T P S + E + D
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-IIAESIRDGL----- 341
Query: 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN-- 214
W +K + L I S+ P Y F L S+ +
Sbjct: 342 ATWD-----N--------WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL--SVFPPSAH 386
Query: 215 -PEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFM--------- 264
P LL ++ W D +
Sbjct: 387 IPT------ILLS-------LI-----------------WFDVIKSDVMVVVNKLHKYSL 416
Query: 265 -----EPEAISIHS-NREKRQSFSNDRALNPSVSE 293
+ ISI S E + N+ AL+ S+ +
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 59/476 (12%), Positives = 120/476 (25%), Gaps = 141/476 (29%)
Query: 166 YEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLR---KNPEFRPSAA 222
+E + +K D +++ + V V+ M + E
Sbjct: 9 FETGEHQYQYK--D---ILSVFEDAFVDNFDCKD-------VQDMPKSILSKEEID---- 52
Query: 223 ELLCHPH--LQPYVLGIHLKLNGPRR-NTFPLEWSDSNFK------KTRFMEPEAISIHS 273
++ L L F E N+K KT +P ++
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 274 NREKRQSFSNDRALNP-SVSETEQDSLSSTLRGRAFGNYMNQKFKELSIG---VVHEELG 329
++ + +++++ +VS + LR Q EL ++ LG
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQP---YLKLR---------QALLELRPAKNVLIDGVLG 160
Query: 330 VDMSTTPNVCNAGKTPRLTPAKVSATPRRQATPSKNTH---IGSKR--DSLPI------S 378
+GKT + V + + Q + + +++
Sbjct: 161 -----------SGKTW-VA-LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 379 HNPGGKPSRPARRASLPLTTTRASESHYQPITCIMKSPDVS--------VNAPRIDKIAE 430
SR +++ L S + ++KS V +
Sbjct: 208 QIDPNWTSRSDHSSNIKLRI----HSIQAELRRLLKSKPYENCLLVLLNVQNAKA--WNA 261
Query: 431 FPLASSEDPLLPIPKTSSTSACCSSSSPDSIDCSI---TKDKCTIQVMDRTASRPNFVVH 487
F ++ C I T+ K + + + H
Sbjct: 262 F----------------------------NLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 488 TTHG-----------TIQNGSEFSEPNPATGVSS-HSSL--ESQHRRFDTSSF--QQRAE 531
+ + P + S+ ES T +
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 532 ALEGLLEFSARLL----QQERFEELGVLLKPFGPEKVS-PRET--AIWLAKSFKET 580
L ++E S +L ++ F+ L V P P IW +
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVIKSDV 404
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 25/93 (26%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 83 VQLLMALNYLHANHILHRDVKCSNIFL-----TRDQDIRLGDFGLAKMLISDDLAS---- 133
+QL+ + Y+H+ ++++RDVK N + Q I + DF LAK I +
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY 171
Query: 134 ----SVVGTPSYMCPELLADIPYGSKSDIWSLG 162
S+ GT YM + D+ +LG
Sbjct: 172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALG 204
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 13/113 (11%)
Query: 63 EAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRL 117
E + G F + + Q+L + +H +++RD+K N + R I +
Sbjct: 93 EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152
Query: 118 GDFGLAKMLISDDLAS--------SVVGTPSYMCPELLADIPYGSKSDIWSLG 162
DFG+ K ++ GT YM + D+ +LG
Sbjct: 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.8 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.88 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.2 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.28 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.29 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=462.08 Aligned_cols=231 Identities=39% Similarity=0.777 Sum_probs=215.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++........++.+.+|+++|++|+|||||+++++|.++ ..+|||||||+||+|.++|...++..++|..++.
T Consensus 51 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~ 129 (350)
T 4b9d_A 51 QYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129 (350)
T ss_dssp EEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHH
T ss_pred EEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHH
Confidence 389999998888888889999999999999999999999988764 5899999999999999999887666789999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ....+.+||+.|||||++.+..|+.++|||
T Consensus 130 ~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~Diw 209 (350)
T 4b9d_A 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIW 209 (350)
T ss_dssp HHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHH
Confidence 9999999999999999999999999999999999999999999877543 234568999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|||++|.+||.+.+..+++.+|......+++..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 210 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 210 ALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 9999999999999999999999999999888877888899999999999999999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=450.38 Aligned_cols=232 Identities=29% Similarity=0.489 Sum_probs=207.5
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++....... ...+.+.+|+++|++|+|||||+++++|.++ .++|||||||+||+|.++|++.+ .++|..++
T Consensus 59 ~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~ 135 (311)
T 4aw0_A 59 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIG--SFDETCTR 135 (311)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHHHcC--CCCHHHHH
Confidence 38999997654322 3356799999999999999999999988654 58999999999999999999865 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+... ....+.|||+.|||||++.+..|+.++
T Consensus 136 ~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~ 215 (311)
T 4aw0_A 136 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 215 (311)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHH
T ss_pred HHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHH
Confidence 99999999999999999999999999999999999999999999876432 345678999999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH------HHcCCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE------LLCHPHL 230 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E------iL~hp~f 230 (582)
|||||||++|+|++|.+||.+.+..+++.+|..... .+|..+|+++++||.+||++||++|+|++| |++||||
T Consensus 216 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F 294 (311)
T 4aw0_A 216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294 (311)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCc
Confidence 999999999999999999999999999998877654 467889999999999999999999999887 6899999
Q ss_pred chhhhh
Q 007991 231 QPYVLG 236 (582)
Q Consensus 231 ~~~~~~ 236 (582)
+.+.|.
T Consensus 295 ~~idw~ 300 (311)
T 4aw0_A 295 ESVTWE 300 (311)
T ss_dssp TTCCCT
T ss_pred CCCCHH
Confidence 876544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=449.00 Aligned_cols=226 Identities=30% Similarity=0.536 Sum_probs=204.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++....... .+.+.+|+.+|++|+|||||+++++|..+ ..+|||||||+||+|.+++.+. .+++..++.
T Consensus 101 ~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~ 174 (346)
T 4fih_A 101 LVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHT---RMNEEQIAA 174 (346)
T ss_dssp EEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECCCTTEEHHHHHHHS---CCCHHHHHH
T ss_pred EEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHH
Confidence 48999997755432 35688999999999999999999998765 5899999999999999999863 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ....+.+||+.|||||++.+..|+.++|||
T Consensus 175 ~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiW 254 (346)
T 4fih_A 175 VCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 254 (346)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHH
Confidence 9999999999999999999999999999999999999999999877543 456788999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|||++|.+||.+.+..+++..|....... .+..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 255 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 99999999999999999999999888887765433 34568999999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=431.61 Aligned_cols=227 Identities=26% Similarity=0.503 Sum_probs=191.3
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... ...+.+.+|+++|++|+|||||+++++|..+ ..+||||||| +|+|.+++.+.+ .+++..++
T Consensus 40 ~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~ 115 (275)
T 3hyh_A 40 KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIMVIEYA-GNELFDYIVQRD--KMSEQEAR 115 (275)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECC-CEEHHHHHHHSC--SCCHHHHH
T ss_pred EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHH
Confidence 38999998765433 4467899999999999999999999988654 5899999999 789999998754 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDI 158 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.........+.+||+.|||||++.+..| +.++||
T Consensus 116 ~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~Di 195 (275)
T 3hyh_A 116 RFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDV 195 (275)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHH
T ss_pred HHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhh
Confidence 9999999999999999999999999999999999999999999988776666778999999999999998886 579999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|.+||.+.+...++..+..... .+|..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 196 wSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 196 WSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY-TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999998888876543 477889999999999999999999999999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=430.34 Aligned_cols=227 Identities=25% Similarity=0.536 Sum_probs=199.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec---CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~---~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||++.........++.+.+|+.+|++|+|||||+++++|... +..+|||||||+||+|.+++++.+ .+++..+
T Consensus 54 vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~ 131 (290)
T 3fpq_A 54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVL 131 (290)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHH
Confidence 89999988888888888999999999999999999999998642 457899999999999999998865 7999999
Q ss_pred HHHHHHHHHHHHHHHHCC--ceecccCcccEEEcC-CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
+.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+... .....+.+||+.|||||++.+ .|+.+
T Consensus 132 ~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~ 209 (290)
T 3fpq_A 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDES 209 (290)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTH
T ss_pred HHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC-CCCcH
Confidence 999999999999999999 999999999999985 7899999999998643 344567899999999999876 69999
Q ss_pred CcccchhHHHHhHhcCCcccccc-CHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~-~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+|||||||++|||++|.+||.+. +...+...+.....+ .++..+++++++||.+||++||++|||++|+|+||||++
T Consensus 210 ~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999764 455566666554332 345668899999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=451.86 Aligned_cols=226 Identities=30% Similarity=0.536 Sum_probs=204.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++...... .++.+.+|+.+|++|+|||||+++++|... ..+|||||||+||+|.++++.. .+++..++.
T Consensus 178 ~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~ 251 (423)
T 4fie_A 178 LVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTHT---RMNEEQIAA 251 (423)
T ss_dssp EEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHS---CCCHHHHHH
T ss_pred EEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHH
Confidence 4899999875543 246689999999999999999999998765 5899999999999999999863 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+... ....+.|||+.|||||++.+..|+.++|||
T Consensus 252 ~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiW 331 (423)
T 4fie_A 252 VCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 331 (423)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHH
Confidence 9999999999999999999999999999999999999999999876543 456788999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|||++|.+||.+.+..+++..|....... .+..+|+++++||.+||++||++|+|++|||+||||+.
T Consensus 332 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 99999999999999999999999888887665433 34578999999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=442.37 Aligned_cols=232 Identities=28% Similarity=0.478 Sum_probs=201.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++...........+.+|+++|++|+|||||+++++|..+ ..+|||||||+||+|.++|++.+ .+++..++.
T Consensus 54 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~ 130 (304)
T 3ubd_A 54 LYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKF 130 (304)
T ss_dssp EEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHH
T ss_pred EEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 389999977554333344688999999999999999999988765 58999999999999999999865 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... .....+.+||+.|||||++.+..|+.++|||
T Consensus 131 ~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw 210 (304)
T 3ubd_A 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210 (304)
T ss_dssp HHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHH
T ss_pred HHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCccc
Confidence 999999999999999999999999999999999999999999986543 3456678999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
||||++|||++|.+||.+.+..+++.+|..... ++|..+|+++++||.+||++||++||| ++|+++||||+.+.
T Consensus 211 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 211 SFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred chHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 999999999999999999999999988876543 567889999999999999999999998 58999999999765
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
|.
T Consensus 290 w~ 291 (304)
T 3ubd_A 290 WN 291 (304)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=431.31 Aligned_cols=216 Identities=31% Similarity=0.431 Sum_probs=188.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.... ..+|+.+|++|+|||||+++++|.++ ..+|||||||+||+|.++|++.+ .+++..++.
T Consensus 85 ~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~ 154 (336)
T 4g3f_A 85 QCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGSLGQLIKQMG--CLPEDRALY 154 (336)
T ss_dssp EEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHH
Confidence 389999987543 24799999999999999999988764 58999999999999999999865 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhccccc------ccCcccCCCCCCCcccccCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDD------LASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~------~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.... .....+||+.|||||++.+..|+
T Consensus 155 ~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 155 YLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp HHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC
Confidence 999999999999999999999999999999998 69999999998765432 22346899999999999999999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.++|||||||++|||++|.+||.+.+...++.+|..... ..++..+++.+.+||.+||++||.+|||+.|+++
T Consensus 235 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999999999999999999998877777777765443 2356789999999999999999999999999853
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=427.54 Aligned_cols=231 Identities=28% Similarity=0.435 Sum_probs=201.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||+++.........+.+.+|+++|++|+|||||++++++.. ....+|||||||+ |+|.+++.+.+ .+++
T Consensus 81 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~ 157 (398)
T 4b99_A 81 QVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTL 157 (398)
T ss_dssp EEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCH
T ss_pred EEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCH
Confidence 48999998887777778889999999999999999999998753 2357999999995 67999998644 7999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-----cccCcccCCCCCCCcccccCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-----DLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-----~~~~~~vGTp~Y~APE~l~~~ 150 (582)
..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+... ....+++||++|||||++.+.
T Consensus 158 ~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~ 237 (398)
T 4b99_A 158 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237 (398)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCC
Confidence 999999999999999999999999999999999999999999999999876432 345678999999999998875
Q ss_pred -CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC------------------------------Cccc
Q 007991 151 -PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------------------PTVY 199 (582)
Q Consensus 151 -~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l------------------------------p~~~ 199 (582)
.|+.++||||+||++|||++|.+||.+.+..+++..|......+. ...+
T Consensus 238 ~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (398)
T 4b99_A 238 HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGA 317 (398)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTC
T ss_pred CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCC
Confidence 468999999999999999999999999999888888765433221 1236
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 200 S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
++++.+||.+||++||.+|+|++|+|+||||+.+.
T Consensus 318 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 318 DRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 88999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=411.24 Aligned_cols=229 Identities=28% Similarity=0.476 Sum_probs=183.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCc-----------EEEEEEeecCCCCHHHHHHHhC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----------YVCIIIGYCEGGDMAEAIKKAN 69 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~-----------~l~LVmEy~~GgsL~d~Ikk~~ 69 (582)
.||||+++... .+..++.+.+|+.+|++|+|||||+++++|.+.+. ++|||||||+||+|.+++....
T Consensus 32 ~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~ 110 (299)
T 4g31_A 32 NYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC 110 (299)
T ss_dssp EEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC
T ss_pred EEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC
Confidence 38999998654 45667889999999999999999999999986543 5899999999999999998643
Q ss_pred C-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-------------ccCcc
Q 007991 70 G-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-------------LASSV 135 (582)
Q Consensus 70 ~-~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-------------~~~~~ 135 (582)
. ...++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...+.
T Consensus 111 ~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (299)
T 4g31_A 111 TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190 (299)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------------------
T ss_pred CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCc
Confidence 2 124567789999999999999999999999999999999999999999999998765432 12356
Q ss_pred cCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccC-HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCC
Q 007991 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 136 vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~-~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~d 214 (582)
+||+.|||||++.+..|+.++|||||||++|||++ ||.... ....+..+.....++.....++.+.+||.+||++|
T Consensus 191 ~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp -CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSS
T ss_pred ccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 89999999999999999999999999999999996 675432 22333444443333334456778899999999999
Q ss_pred CCCCCCHHHHHcCCCCchh
Q 007991 215 PEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 215 P~~RpSa~EiL~hp~f~~~ 233 (582)
|++|||+.|+|+||||+.+
T Consensus 268 P~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 268 PMERPEAINIIENAVFEDL 286 (299)
T ss_dssp GGGSCCHHHHHTSGGGCCC
T ss_pred hhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=405.47 Aligned_cols=226 Identities=22% Similarity=0.418 Sum_probs=203.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------C
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-----------G 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-----------~ 70 (582)
||||+++.. +....+.|.+|+++|++|+|||||++++++.+. ..+|||||||+||+|.++|++.+ .
T Consensus 46 vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~ 122 (299)
T 4asz_A 46 VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPP 122 (299)
T ss_dssp EEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CC
T ss_pred EEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCC
Confidence 899999753 566778899999999999999999999988764 47899999999999999998642 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccc
Q 007991 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELL 147 (582)
Q Consensus 71 ~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l 147 (582)
..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++...... .....+||+.|||||++
T Consensus 123 ~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 202 (299)
T 4asz_A 123 TELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 202 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHH
Confidence 469999999999999999999999999999999999999999999999999998765433 23346799999999999
Q ss_pred cCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.+..|+.++|||||||++|||++ |+.||.+.+..+++..+......+.|..+++++.+||.+||+.||++|||++||+
T Consensus 203 ~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~- 281 (299)
T 4asz_A 203 MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH- 281 (299)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-
T ss_pred cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH-
Confidence 99999999999999999999998 8999999999999999988887788999999999999999999999999999995
Q ss_pred CCCCch
Q 007991 227 HPHLQP 232 (582)
Q Consensus 227 hp~f~~ 232 (582)
.|++.
T Consensus 282 -~~L~~ 286 (299)
T 4asz_A 282 -TLLQN 286 (299)
T ss_dssp -HHHHH
T ss_pred -HHHHH
Confidence 35544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=405.93 Aligned_cols=223 Identities=20% Similarity=0.364 Sum_probs=194.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
||||+++.. +...++.|.+|+++|++|+|||||++++++.+. ..+|||||||+||+|.+++++..
T Consensus 74 vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~ 150 (329)
T 4aoj_A 74 VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150 (329)
T ss_dssp EEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHTSSCC----------
T ss_pred EEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCcHHHHHHhcCcccccccccccc
Confidence 899999753 456778899999999999999999999988654 47899999999999999997642
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcc
Q 007991 70 -GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 145 (582)
Q Consensus 70 -~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE 145 (582)
...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++...... .....+||+.|||||
T Consensus 151 ~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE 230 (329)
T 4aoj_A 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230 (329)
T ss_dssp -CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChh
Confidence 2358999999999999999999999999999999999999999999999999998764432 234578999999999
Q ss_pred cccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 146 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 146 ~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
++.+..|+.++|||||||+||||++ |+.||.+.+..+++..+......+.|..+++++.+||.+||+.||++|||++||
T Consensus 231 ~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 231 SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred hhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 9999999999999999999999998 899999999999999998887778889999999999999999999999999999
Q ss_pred HcC
Q 007991 225 LCH 227 (582)
Q Consensus 225 L~h 227 (582)
+++
T Consensus 311 ~~~ 313 (329)
T 4aoj_A 311 HAR 313 (329)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=400.65 Aligned_cols=223 Identities=23% Similarity=0.423 Sum_probs=188.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++....+....+.|.+|+.+|++|+|||||++++++.+ ..+|||||||+||+|.++|.... ..+++..+..|
T Consensus 61 vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i 137 (307)
T 3omv_A 61 VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDI 137 (307)
T ss_dssp EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHH
T ss_pred EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHH
Confidence 7999999888888888999999999999999999999997643 35789999999999999998643 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccC---CCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLAD---IPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~---~~y~~k 155 (582)
+.||+.||+|||++|||||||||+||||+.++++||+|||+|+..... ......+||+.|||||++.+ .+|+.+
T Consensus 138 ~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k 217 (307)
T 3omv_A 138 ARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217 (307)
T ss_dssp HHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred HHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcH
Confidence 999999999999999999999999999999999999999999875432 23456799999999999964 358999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHH-HHHHHhhccCC----CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQA-LINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~-l~~kI~~~~~~----~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||||+||||++|+.||.+.+... +...+...... .++..+++.+.+||.+||+.||++|||+.||+.+
T Consensus 218 sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999998866444 34444443322 2456789999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=407.21 Aligned_cols=222 Identities=23% Similarity=0.329 Sum_probs=182.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++..... ...+.+|+++|+.+ +|||||+++++|... .++|||||||+||+|.++++ .+++..++.
T Consensus 52 vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~ 121 (361)
T 4f9c_A 52 IALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DHVVIAMPYLEHESFLDILN-----SLSFQEVRE 121 (361)
T ss_dssp EEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TEEEEEEECCCCCCHHHHHT-----TCCHHHHHH
T ss_pred EEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CEEEEEEeCCCcccHHHHHc-----CCCHHHHHH
Confidence 89999866433 24578999999998 699999999988664 58999999999999999984 489999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccc-----------------------------c
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISD-----------------------------D 130 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~-----------------------------~ 130 (582)
|++||+.||+|||++||+||||||+||||+.+ +++||+|||+|+..... .
T Consensus 122 ~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (361)
T 4f9c_A 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQ 201 (361)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------------
T ss_pred HHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999887 79999999999754321 1
Q ss_pred ccCcccCCCCCCCcccccCCC-CCCCCcccchhHHHHhHhcCCcccc-ccCHHHHHHHHhhcc-----------------
Q 007991 131 LASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFK-AFDMQALINKINKSI----------------- 191 (582)
Q Consensus 131 ~~~~~vGTp~Y~APE~l~~~~-y~~ksDIWSLG~iLyELltG~~PF~-~~~~~~l~~kI~~~~----------------- 191 (582)
...+.+||++|||||++.+.+ |+.++||||+||++|||++|++||. +.+..+++..|....
T Consensus 202 ~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~ 281 (361)
T 4f9c_A 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSIL 281 (361)
T ss_dssp ----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEE
T ss_pred cccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccc
Confidence 234568999999999998764 8999999999999999999999984 444444443332110
Q ss_pred ------------------------------------CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 192 ------------------------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 192 ------------------------------------~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.......+|+++++||.+||++||++|+|++|+|+||||++.
T Consensus 282 ~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 282 CSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp ESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 001234578999999999999999999999999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=401.16 Aligned_cols=224 Identities=20% Similarity=0.377 Sum_probs=200.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
||||+++.... ...++.|.+|+.+|++|+|||||++++++... ..+|||||||++|+|.++|....
T Consensus 59 VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~ 136 (308)
T 4gt4_A 59 VAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136 (308)
T ss_dssp EEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----C
T ss_pred EEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-CEEEEEEEcCCCCcHHHHHHhhCcccccccccccc
Confidence 89999976543 34557899999999999999999999988654 47899999999999999997532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCc
Q 007991 70 --GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCP 144 (582)
Q Consensus 70 --~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~AP 144 (582)
...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++...... .....+||+.||||
T Consensus 137 ~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 216 (308)
T 4gt4_A 137 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216 (308)
T ss_dssp CEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence 1358999999999999999999999999999999999999999999999999998765432 34567899999999
Q ss_pred ccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 145 ELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 145 E~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
|++.+..|+.++|||||||+||||++ |..||.+.+..+++..+......+.|..++..+.+|+..||+.||++|||+.|
T Consensus 217 E~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~e 296 (308)
T 4gt4_A 217 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 296 (308)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999999999999999999998 89999999999999999888888889999999999999999999999999999
Q ss_pred HHcC
Q 007991 224 LLCH 227 (582)
Q Consensus 224 iL~h 227 (582)
|+++
T Consensus 297 i~~~ 300 (308)
T 4gt4_A 297 IHSR 300 (308)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=430.62 Aligned_cols=244 Identities=24% Similarity=0.415 Sum_probs=202.6
Q ss_pred CEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQ----TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~----~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
+||||+++.... .........+++.+++.++|||||+++++|... .++|||||||.||+|.++|.+.+ .|+|.
T Consensus 216 ~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~lylVmEy~~GGdL~~~l~~~~--~l~E~ 292 (689)
T 3v5w_A 216 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHG--VFSEA 292 (689)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHC--CCCHH
T ss_pred EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CEEEEEEecCCCCcHHHHHHhcC--CCCHH
Confidence 489999976432 222333344567788888999999999998765 58999999999999999999865 79999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc-CCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-DIPYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~-~~~y~~k 155 (582)
.++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+... ...+.|||+.|||||++. +..|+.+
T Consensus 293 ~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~ 371 (689)
T 3v5w_A 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSS 371 (689)
T ss_dssp HHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcH
Confidence 99999999999999999999999999999999999999999999999876543 456789999999999996 4679999
Q ss_pred CcccchhHHHHhHhcCCcccccc---CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~---~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~h 227 (582)
+|||||||+||||++|.+||.+. +...+...+... ...+|..+|+++++||.+||++||.+|++ ++||++|
T Consensus 372 vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 99999999999999999999764 334444444433 34577889999999999999999999998 8999999
Q ss_pred CCCchhhhhhhc--ccCCCCCCCC
Q 007991 228 PHLQPYVLGIHL--KLNGPRRNTF 249 (582)
Q Consensus 228 p~f~~~~~~~~~--~~~~p~~~~~ 249 (582)
|||+.+.|.... .+..|..+..
T Consensus 451 pfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 451 PFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp GGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred ccccCCCHHHHHcCCCCcCccCCC
Confidence 999987765532 3344544433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=428.00 Aligned_cols=229 Identities=21% Similarity=0.400 Sum_probs=205.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.. +..+|||||||+||+|.++|.+.. ..+++..++.
T Consensus 184 ~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~ 259 (573)
T 3uto_A 184 NFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVE 259 (573)
T ss_dssp EEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHH
T ss_pred EEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHH
Confidence 38999997643 3456789999999999999999999998865 468999999999999999997543 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC--CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~--g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
|++||+.||+|||++||+||||||+|||++.+ |++||+|||+++.+.......+.+||+.|||||++.+..|+.++||
T Consensus 260 ~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~Di 339 (573)
T 3uto_A 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 339 (573)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHH
T ss_pred HHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHH
Confidence 99999999999999999999999999999865 8999999999998877777778899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||||++|||++|.+||.+.+..+++..|...... ..+..+|+++++||.+||++||.+|||++|+|+||||++.
T Consensus 340 WSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 340 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999999999999999998888765432 2235689999999999999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=399.42 Aligned_cols=225 Identities=19% Similarity=0.387 Sum_probs=198.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++... .....+.+.+|+++|.+++| ||||+++++|.+.+..+|||||||+||+|.++|+...
T Consensus 97 VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~ 175 (353)
T 4ase_A 97 VAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 175 (353)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----
T ss_pred EEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccch
Confidence 7899987644 34556789999999999976 8999999998877778999999999999999998642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.+.... .....+||+.|||
T Consensus 176 ~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymA 255 (353)
T 4ase_A 176 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 255 (353)
T ss_dssp --CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC
T ss_pred hhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccC
Confidence 2348999999999999999999999999999999999999999999999999998765432 2346789999999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCH-HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDM-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
||++.+..|+.++|||||||+||||++ |..||.+.+. ..+...+......+.|..+++++.+||.+||+.||++|||+
T Consensus 256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~ 335 (353)
T 4ase_A 256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 335 (353)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCH
Confidence 999999999999999999999999998 9999988663 45556666777777888999999999999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
.||++|
T Consensus 336 ~eil~~ 341 (353)
T 4ase_A 336 SELVEH 341 (353)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=379.21 Aligned_cols=228 Identities=22% Similarity=0.423 Sum_probs=209.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+++|+.++||||+++++++.. +..+|+||||++|++|.+++...+ .+++..++.+
T Consensus 43 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~ 119 (328)
T 3fe3_A 43 VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSK 119 (328)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHH
T ss_pred EEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 8999998887778888889999999999999999999998765 458999999999999999998765 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC-CCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG-SKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~-~ksDIWS 160 (582)
+.||+.||+|||++||+||||||+|||++.++++||+|||++............+||+.|+|||++.+..+. .++||||
T Consensus 120 ~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 199 (328)
T 3fe3_A 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199 (328)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHH
T ss_pred HHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhh
Confidence 999999999999999999999999999999999999999999887666667788999999999999988875 7899999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||++|+|++|..||.+.+...+...+..... .+|..++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 200 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 200 LGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999999988888876543 4677899999999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=375.64 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=214.0
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .....+.+.+|+.+|+.++||||++++++|... ..+|+|||||+||+|.+++.+.. .+++..++
T Consensus 32 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~ 108 (337)
T 1o6l_A 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRER--VFTEERAR 108 (337)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHH
T ss_pred EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence 389999976432 112345688999999999999999999988654 58999999999999999998765 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ........+||+.|+|||++.+..|+.++||
T Consensus 109 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 188 (337)
T 1o6l_A 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188 (337)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHH
T ss_pred HHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhc
Confidence 999999999999999999999999999999999999999999998643 3334567899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~ 233 (582)
|||||++|||++|.+||.+.+...+...+.... ..+|..+++++.+||.+||+.||.+|+ +++||++||||+..
T Consensus 189 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999999999888888876654 346778999999999999999999999 99999999999876
Q ss_pred hhhhhc--ccCCCCCCCCCCCCCCcccc
Q 007991 234 VLGIHL--KLNGPRRNTFPLEWSDSNFK 259 (582)
Q Consensus 234 ~~~~~~--~~~~p~~~~~~~~~~~s~~~ 259 (582)
.+.... .+..|..+......+.++|+
T Consensus 268 ~~~~~~~~~~~pp~~p~~~~~~d~~~f~ 295 (337)
T 1o6l_A 268 NWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp CHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred CHHHHHhCCCCCCCCCCCCCcchhhccc
Confidence 554332 23344444443334444443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=381.62 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=210.7
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .....+.+.+|+.+|..+ +||||++++++|... ..+|+|||||.||+|.+++.+.. .+++..+
T Consensus 50 ~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~ 126 (353)
T 3txo_A 50 LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLFFVMEFVNGGDLMFHIQKSR--RFDEARA 126 (353)
T ss_dssp EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 389999976432 223456788999999998 699999999988654 58999999999999999998865 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ........+||+.|+|||++.+..|+.++|
T Consensus 127 ~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 206 (353)
T 3txo_A 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVD 206 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHH
T ss_pred HHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccC
Confidence 9999999999999999999999999999999999999999999998643 333456789999999999999888999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH------HHHHcCCCCc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA------AELLCHPHLQ 231 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa------~EiL~hp~f~ 231 (582)
||||||++|||++|.+||.+.+..+++..|..... .++..++..+.+||.+||++||.+|+++ +||++||||+
T Consensus 207 iwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 207 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred CCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 99999999999999999999999999988876544 3677799999999999999999999998 9999999999
Q ss_pred hhhhhhh--cccCCCCCCCCCCCCCCccccc
Q 007991 232 PYVLGIH--LKLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 232 ~~~~~~~--~~~~~p~~~~~~~~~~~s~~~~ 260 (582)
...|... ..+..|..+......+.++|+.
T Consensus 286 ~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~ 316 (353)
T 3txo_A 286 EIDWAQLNHRQIEPPFRPRIKSREDVSNFDP 316 (353)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCSTTCCTTSCH
T ss_pred CCCHHHHhcCcCCCCccCCCCCcccccccCc
Confidence 8655443 2334455444444444445543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=381.07 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=212.5
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++...... ...+.+.+|+.+|.++ +|||||+++++|... ..+|+|||||.||+|.+++.+.. .+++..+
T Consensus 79 ~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~ 155 (396)
T 4dc2_A 79 IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHA 155 (396)
T ss_dssp EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEEEEEEcCCCCcHHHHHHHcC--CCCHHHH
Confidence 38999998765433 3446688999999887 899999999988654 58999999999999999998865 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhc-ccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~-~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.. .......+.+||+.|+|||++.+..|+.++|
T Consensus 156 ~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~D 235 (396)
T 4dc2_A 156 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 235 (396)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHH
Confidence 999999999999999999999999999999999999999999999863 3344567789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCcccccc---------CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH------H
Q 007991 158 IWSLGCCVYEMSAQKAAFKAF---------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA------A 222 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~---------~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa------~ 222 (582)
||||||++|||++|.+||... ....+...+... ...+|..++.++++||.+||+.||.+|+++ +
T Consensus 236 iwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 314 (396)
T 4dc2_A 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 314 (396)
T ss_dssp HHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHH
T ss_pred HHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHH
Confidence 999999999999999999643 223344444443 345778899999999999999999999984 8
Q ss_pred HHHcCCCCchhhhhhhc--ccCCCCCCCCCCCCCCcccccc
Q 007991 223 ELLCHPHLQPYVLGIHL--KLNGPRRNTFPLEWSDSNFKKT 261 (582)
Q Consensus 223 EiL~hp~f~~~~~~~~~--~~~~p~~~~~~~~~~~s~~~~~ 261 (582)
||++||||+.+.|.... .+..|..+......+.++|+..
T Consensus 315 ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~ 355 (396)
T 4dc2_A 315 DIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQ 355 (396)
T ss_dssp HHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHH
T ss_pred HHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChh
Confidence 99999999987655432 3345666655555666666543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=368.09 Aligned_cols=233 Identities=27% Similarity=0.509 Sum_probs=201.5
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .....+.+.+|+.+|.++ +|||||+++++|... ..+|+|||||+||+|.+++.+.. .+++..+
T Consensus 36 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~ 112 (345)
T 3a8x_A 36 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHA 112 (345)
T ss_dssp EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 389999987553 445667889999999998 899999999988654 58999999999999999998765 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ........+||+.|+|||++.+..|+.++|
T Consensus 113 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 192 (345)
T 3a8x_A 113 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 192 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHh
Confidence 9999999999999999999999999999999999999999999998643 334466789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccc---------cCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH------H
Q 007991 158 IWSLGCCVYEMSAQKAAFKA---------FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA------A 222 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~---------~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa------~ 222 (582)
||||||++|||++|.+||.. .....+...+... ...+|..++..+++||.+||+.||.+|+++ +
T Consensus 193 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 271 (345)
T 3a8x_A 193 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271 (345)
T ss_dssp HHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHH
Confidence 99999999999999999975 2334445555443 345678899999999999999999999985 8
Q ss_pred HHHcCCCCchhhhhh
Q 007991 223 ELLCHPHLQPYVLGI 237 (582)
Q Consensus 223 EiL~hp~f~~~~~~~ 237 (582)
|+++||||+.+.|..
T Consensus 272 ~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 272 DIQGHPFFRNVDWDM 286 (345)
T ss_dssp HHHTSGGGTTCCHHH
T ss_pred HHhcCCccCCCCHHH
Confidence 999999999866544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=387.32 Aligned_cols=230 Identities=27% Similarity=0.416 Sum_probs=194.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++..........+.+.+|+.+|+.++|||||+++++|...+ ..+|+||||+++ +|.+.+.. .+++.
T Consensus 90 vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~ 164 (464)
T 3ttj_A 90 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHE 164 (464)
T ss_dssp EEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHH
T ss_pred EEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHH
Confidence 899999887777788889999999999999999999999986443 478999999965 57776653 48999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.+++||+.||+|||++||+||||||+||||+.++++||+|||+++...........+||++|+|||++.+..|+.++
T Consensus 165 ~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 244 (464)
T 3ttj_A 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244 (464)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTH
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHH
Confidence 99999999999999999999999999999999999999999999999887766667788999999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc--------------------------------------
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV-------------------------------------- 198 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~-------------------------------------- 198 (582)
|||||||++|+|++|++||.+.+..+++.+|......+.+..
T Consensus 245 DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (464)
T 3ttj_A 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324 (464)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccc
Confidence 999999999999999999999998888777765443321110
Q ss_pred ---ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhh
Q 007991 199 ---YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 199 ---~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
.++++++||.+||+.||++|||++|+|+||||+.+...
T Consensus 325 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 15679999999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.32 Aligned_cols=230 Identities=26% Similarity=0.440 Sum_probs=203.3
Q ss_pred EEEEEecccccCH----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||.++...... ...+.+.+|+.+|++++||||++++++|.. +..+|+|||||+||+|.+++...+ .+++..
T Consensus 40 ~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~ 116 (361)
T 2yab_A 40 YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTDVVLILELVSGGELFDFLAQKE--SLSEEE 116 (361)
T ss_dssp EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHTTCS--CCBHHH
T ss_pred EEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHH
Confidence 8999997754322 135678999999999999999999998765 458999999999999999997643 799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC----CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
+..++.||+.||+|||++||+||||||+|||++.++ ++||+|||++............+||+.|+|||++.+..|+
T Consensus 117 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (361)
T 2yab_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCC
Confidence 999999999999999999999999999999998877 7999999999887666566778999999999999999999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.++|||||||++|+|++|.+||.+.+..+++..+....... .+..++..+++||.+||..||.+|||++|+|+||||
T Consensus 197 ~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 197 LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 99999999999999999999999999988888887654332 224689999999999999999999999999999999
Q ss_pred chhh
Q 007991 231 QPYV 234 (582)
Q Consensus 231 ~~~~ 234 (582)
+...
T Consensus 277 ~~~~ 280 (361)
T 2yab_A 277 TPVD 280 (361)
T ss_dssp SCSS
T ss_pred CCCc
Confidence 8543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.36 Aligned_cols=232 Identities=25% Similarity=0.505 Sum_probs=204.6
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... ...+.+.+|+.+|+.++||||++++++|... ..+|+|||||+||+|.+++.+.. .+++..++
T Consensus 33 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~ 109 (318)
T 1fot_A 33 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAK 109 (318)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHH
T ss_pred EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence 38999987643211 2345678999999999999999999988654 58999999999999999998754 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.... .....+||+.|+|||++.+..|+.++|||
T Consensus 110 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 187 (318)
T 1fot_A 110 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWW 187 (318)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHH
T ss_pred HHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchh
Confidence 9999999999999999999999999999999999999999999986543 34567999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~~ 234 (582)
||||++|+|++|..||.+.+....+.++.... ..++..++.++.+||.+||..||.+|+ +++++++||||+...
T Consensus 188 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 188 SFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 99999999999999999999888888877654 346778999999999999999999999 999999999999866
Q ss_pred hhhh
Q 007991 235 LGIH 238 (582)
Q Consensus 235 ~~~~ 238 (582)
+...
T Consensus 267 ~~~~ 270 (318)
T 1fot_A 267 WEKL 270 (318)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=372.10 Aligned_cols=228 Identities=26% Similarity=0.444 Sum_probs=204.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+.+|++|+|||||+++++|... ...|+|||||.||+|.+.+.... .+++..+..+
T Consensus 57 ~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~ 133 (362)
T 2bdw_A 57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVARE--FYSEADASHC 133 (362)
T ss_dssp EEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHH
T ss_pred EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence 89999988777777788899999999999999999999987654 58999999999999999998643 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||++.++ .+||+|||++............+||+.|+|||++.+..|+.++||
T Consensus 134 ~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 213 (362)
T 2bdw_A 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDI 213 (362)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhH
Confidence 99999999999999999999999999998754 499999999987766555667899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|.+||.+.+...+...+....... ....+++++.+||.+||+.||.+||+++++|+||||+.
T Consensus 214 wslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 214 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999888888876654322 22468999999999999999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=370.36 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=213.6
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... ...+.+.+|+.+|+.++||||++++++|.. +..+|+|||||+||+|.+++.+.+ .+++..++
T Consensus 68 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~ 144 (350)
T 1rdq_E 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHAR 144 (350)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHH
T ss_pred EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence 38999986643211 234678899999999999999999998865 458999999999999999999865 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++..... ....+||+.|+|||++.+..|+.++|||
T Consensus 145 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diw 222 (350)
T 1rdq_E 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWW 222 (350)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEe
Confidence 99999999999999999999999999999999999999999999866432 4567999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~~ 234 (582)
||||++|+|++|.+||.+.+...++..+.... ..++..++..+.+||.+||+.||.+|++ ++||++||||+...
T Consensus 223 slG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred cccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 99999999999999999999988888887664 3467789999999999999999999998 99999999998765
Q ss_pred hhhhc--ccCCCCCCCCCCCCCCcccc
Q 007991 235 LGIHL--KLNGPRRNTFPLEWSDSNFK 259 (582)
Q Consensus 235 ~~~~~--~~~~p~~~~~~~~~~~s~~~ 259 (582)
+.... .+..|..+......+.++|+
T Consensus 302 w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 302 WIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp HHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred HHHHhhccCCCCCCCCCCCcccccccc
Confidence 54322 33344444443334444444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=358.78 Aligned_cols=225 Identities=29% Similarity=0.508 Sum_probs=198.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++....... .+.+.+|+.+|++++||||++++++|... ..+|+|||||+|++|.+++.+. .+++..+..+
T Consensus 48 vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 121 (297)
T 3fxz_A 48 VAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAV 121 (297)
T ss_dssp EEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHH
T ss_pred EEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEEC-CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHH
Confidence 8999997655433 35688999999999999999999988765 4889999999999999999874 5899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..|+.++||||
T Consensus 122 ~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 201 (297)
T 3fxz_A 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201 (297)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHH
T ss_pred HHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHH
Confidence 999999999999999999999999999999999999999998766543 2345678999999999999999999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||.+.+.......+..... ...+..++..+.+||.+||+.||++|||++|+|+||||+.
T Consensus 202 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 202 LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 99999999999999998887776665544332 3346678999999999999999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.73 Aligned_cols=231 Identities=26% Similarity=0.402 Sum_probs=197.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++..........+.+.+|+.+|+++. |||||+++++|...+ ..+|+|||||+ ++|.++++.. .+++..+
T Consensus 36 ~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~ 111 (388)
T 3oz6_A 36 VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHK 111 (388)
T ss_dssp EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHH
T ss_pred EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHH
Confidence 3899999887777788888999999999997 999999999987543 47899999996 6999999873 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc----------------------ccccCccc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS----------------------DDLASSVV 136 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~----------------------~~~~~~~v 136 (582)
+.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ......++
T Consensus 112 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (388)
T 3oz6_A 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191 (388)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CC
T ss_pred HHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCc
Confidence 99999999999999999999999999999999999999999999976532 12234579
Q ss_pred CCCCCCCcccccC-CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--------------------
Q 007991 137 GTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-------------------- 195 (582)
Q Consensus 137 GTp~Y~APE~l~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-------------------- 195 (582)
||++|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+....+..+......+.
T Consensus 192 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 271 (388)
T 3oz6_A 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK 271 (388)
T ss_dssp CGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHH
T ss_pred ccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCc
Confidence 9999999999976 6799999999999999999999999999998888777754433221
Q ss_pred --------------------------CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 196 --------------------------PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 196 --------------------------p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
+..+++++.+||.+||+.||.+|||++|+|+||||+.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 272 EKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp HHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred ccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 1256889999999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.29 Aligned_cols=254 Identities=24% Similarity=0.434 Sum_probs=212.2
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++..... ....+.+.+|+.+|..+ +||||++++++|... ..+|+|||||.||+|.+++.+.+ .+++..+
T Consensus 47 ~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~ 123 (353)
T 2i0e_A 47 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHA 123 (353)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHH
Confidence 3899999764321 12346688999999998 799999999988654 58999999999999999998765 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ........+||+.|+|||++.+..|+.++|
T Consensus 124 ~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 203 (353)
T 2i0e_A 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 203 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHH
T ss_pred HHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCccc
Confidence 9999999999999999999999999999999999999999999998643 333456789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~ 232 (582)
||||||++|||++|.+||.+.+..+++..|..... .+|..++.++.+||.+||..||.+|+ ++++|++||||+.
T Consensus 204 iwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999999999999999988888876543 46778999999999999999999999 4799999999997
Q ss_pred hhhhhh--cccCCCCCCCCCCCCCCcccc
Q 007991 233 YVLGIH--LKLNGPRRNTFPLEWSDSNFK 259 (582)
Q Consensus 233 ~~~~~~--~~~~~p~~~~~~~~~~~s~~~ 259 (582)
+.|... ..+..|..+..... +.++|+
T Consensus 283 ~~w~~l~~~~~~~p~~p~~~~~-~~~~f~ 310 (353)
T 2i0e_A 283 IDWEKLERKEIQPPYKPKACGR-NAENFD 310 (353)
T ss_dssp CCHHHHHTTCSCCSCCCCCCCC---CHHH
T ss_pred CCHHHHHhCCCCCCcCCCCCCc-chhhcc
Confidence 655443 23334444433333 444444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=374.19 Aligned_cols=256 Identities=24% Similarity=0.447 Sum_probs=206.5
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++..... ....+.+.+|..+|..+ +||||++++++|... ..+|+|||||+||+|.+++.+.+ .+++..+
T Consensus 44 ~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~ 120 (345)
T 1xjd_A 44 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRA 120 (345)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence 3899999764321 12345678899999987 899999999988654 58999999999999999998765 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.... .......+||+.|+|||++.+..|+.++|
T Consensus 121 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (345)
T 1xjd_A 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 200 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhh
Confidence 99999999999999999999999999999999999999999999986432 33456789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH-HHHcCCCCchhhhh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA-ELLCHPHLQPYVLG 236 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~-EiL~hp~f~~~~~~ 236 (582)
||||||++|||++|.+||.+.+..+++..+.... ..++..++.++++||.+||..||.+||++. +|++||||+.+.|.
T Consensus 201 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 9999999999999999999999998888887654 346778999999999999999999999998 99999999986654
Q ss_pred hhc--ccCCCCCCCCCCCCCCccccc
Q 007991 237 IHL--KLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 237 ~~~--~~~~p~~~~~~~~~~~s~~~~ 260 (582)
... .+..|..+......+.++|+.
T Consensus 280 ~l~~~~~~~p~~p~~~~~~d~~~f~~ 305 (345)
T 1xjd_A 280 ELERKEIDPPFRPKVKSPFDCSNFDK 305 (345)
T ss_dssp HHHTTCSCC-----------------
T ss_pred HHhhCCCCCCcCCCCCCcchhhhcch
Confidence 432 233444444443444455544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.43 Aligned_cols=233 Identities=24% Similarity=0.385 Sum_probs=195.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+.+|++++|||||+++++|... ..+|+|||||+|++|.+++.......+++..++.
T Consensus 54 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 132 (389)
T 3gni_B 54 YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY 132 (389)
T ss_dssp EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHH
T ss_pred EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHH
Confidence 389999998887788888999999999999999999999988765 5899999999999999999986555799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc--------cccCcccCCCCCCCcccccC--C
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--------DLASSVVGTPSYMCPELLAD--I 150 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--------~~~~~~vGTp~Y~APE~l~~--~ 150 (582)
|+.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ......+||+.|+|||++.+ .
T Consensus 133 ~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 212 (389)
T 3gni_B 133 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212 (389)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSS
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCC
Confidence 9999999999999999999999999999999999999999988654322 12334589999999999987 5
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---------------------------------------
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI--------------------------------------- 191 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~--------------------------------------- 191 (582)
.|+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 213 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (389)
T 3gni_B 213 GYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRP 292 (389)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------
T ss_pred CCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCcccc
Confidence 79999999999999999999999998765444333222111
Q ss_pred ------CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 192 ------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 192 ------~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
..+.+..+++.+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 293 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 293 SNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 1123456889999999999999999999999999999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=379.93 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=204.7
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++.... .......+.+|+.+|+.++||||++++++|... ..+|+|||||+||+|.+++.... .+++..++
T Consensus 175 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 251 (446)
T 4ejn_A 175 YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRER--VFSEDRAR 251 (446)
T ss_dssp EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHH
T ss_pred EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHH
Confidence 389999976432 333456778999999999999999999988765 58999999999999999998765 79999999
Q ss_pred HHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 80 KWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
.|+.||+.||+|||+ +||+||||||+||||+.++++||+|||+++.... .......+||+.|+|||++.+..|+.++|
T Consensus 252 ~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 331 (446)
T 4ejn_A 252 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331 (446)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHH
T ss_pred HHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccc
Confidence 999999999999998 9999999999999999999999999999986433 33456789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||.+.+...+...+..... .++..+++++.+||.+||+.||.+|| +++|+|+||||+.
T Consensus 332 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999999999999998888888766543 46778999999999999999999999 9999999999998
Q ss_pred hhhhhhc--ccCCCCCCCCCCCCCCccccc
Q 007991 233 YVLGIHL--KLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 233 ~~~~~~~--~~~~p~~~~~~~~~~~s~~~~ 260 (582)
+.++... .+..|..+....+.+.+.|++
T Consensus 411 ~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~ 440 (446)
T 4ejn_A 411 IVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440 (446)
T ss_dssp CCHHHHHTTCSCCSCCCSCSSTTCCTTC--
T ss_pred CCHHHHhhCcCCCCccCCCCCccchhhcch
Confidence 7655432 333444444444444444544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=380.96 Aligned_cols=257 Identities=23% Similarity=0.400 Sum_probs=213.2
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... ...+.+.+|+.+|+.++|||||+++++|.. +.++|+|||||+||+|.++++.. .+++..++
T Consensus 96 ~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~ 171 (410)
T 3v8s_A 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWAR 171 (410)
T ss_dssp EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHH
T ss_pred EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHH
Confidence 38999986532111 112347899999999999999999998865 45899999999999999999864 58999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCC----CC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIP----YG 153 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~----y~ 153 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++...... ...+.+||+.|+|||++.+.. |+
T Consensus 172 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~ 251 (410)
T 3v8s_A 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251 (410)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEE
T ss_pred HHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCC
Confidence 999999999999999999999999999999999999999999998765443 345789999999999998765 78
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc---cCCCCCccccHHHHHHHHHhccCCCCC--CCCHHHHHcCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS---IVAPLPTVYSGAFRGLVKSMLRKNPEF--RPSAAELLCHP 228 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~---~~~~lp~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~hp 228 (582)
.++|||||||++|||++|.+||.+.+...++.+|... ...+....++.++++||.+||+.+|.+ |++++||++||
T Consensus 252 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 8999999999999999999999999999888888653 233444579999999999999999988 99999999999
Q ss_pred CCchhhhh--hhcccCCCCCCCCCCCCCCcccccc
Q 007991 229 HLQPYVLG--IHLKLNGPRRNTFPLEWSDSNFKKT 261 (582)
Q Consensus 229 ~f~~~~~~--~~~~~~~p~~~~~~~~~~~s~~~~~ 261 (582)
||+...|. .......|..+......+.++|+..
T Consensus 332 ~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~ 366 (410)
T 3v8s_A 332 FFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDL 366 (410)
T ss_dssp GGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCC
T ss_pred cccCCCHHHHhhcccCCCCCCcCCCccchhhcCCc
Confidence 99975433 2233455666665555666666543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=361.87 Aligned_cols=232 Identities=28% Similarity=0.503 Sum_probs=193.5
Q ss_pred CEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ--TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~--~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .......+.+|+.+|++++||||++++++|... ..+|+|||||+|++|.+++...+ .+++..+
T Consensus 47 ~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 123 (327)
T 3a62_A 47 IFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELFMQLEREG--IFMEDTA 123 (327)
T ss_dssp EEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-SCEEEEEECCTTEEHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-CEEEEEEeCCCCCcHHHHHHhCC--CCCHHHH
Confidence 389999977543 223456688999999999999999999988654 58899999999999999998765 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.... .......+||+.|+|||++.+..++.++|
T Consensus 124 ~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 203 (327)
T 3a62_A 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVD 203 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHH
T ss_pred HHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCccc
Confidence 99999999999999999999999999999999999999999999976433 23455678999999999999989999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||.+.+.......+..... .++..++..+++||.+||..||.+|| +++|+++||||+.
T Consensus 204 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 204 WWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred chhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999999999998888887766543 46778999999999999999999999 8999999999987
Q ss_pred hhhh
Q 007991 233 YVLG 236 (582)
Q Consensus 233 ~~~~ 236 (582)
+.+.
T Consensus 283 ~~~~ 286 (327)
T 3a62_A 283 INWE 286 (327)
T ss_dssp CCHH
T ss_pred CCHH
Confidence 6544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=377.86 Aligned_cols=229 Identities=27% Similarity=0.426 Sum_probs=204.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|++..........+.+.+|+.+|++++|||||+++++|.+ +...|+|||||.||+|.+.+...+ .+++..+..+
T Consensus 39 ~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i 115 (444)
T 3soa_A 39 YAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHC 115 (444)
T ss_dssp EEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHH
T ss_pred EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence 7999998877767777889999999999999999999998765 458999999999999999998754 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... .....+||+.|+|||++.+..|+.++|
T Consensus 116 ~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~D 195 (444)
T 3soa_A 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 195 (444)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccc
Confidence 999999999999999999999999999984 5789999999997765432 345679999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||||||++|+|++|.+||.+.+...+...+...... +....+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 196 IwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 196 LWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred cHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999998888888765432 2234689999999999999999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=370.90 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=202.3
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHH-HHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMEL-ISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~i-L~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++..... ....+.+.+|..+ ++.++|||||+++++|... ..+|+|||||.||+|.+++.+.. .+++..+
T Consensus 65 ~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~ 141 (373)
T 2r5t_A 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHLQRER--CFLEPRA 141 (373)
T ss_dssp EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHH
Confidence 3899999776543 2344567778877 5778999999999988654 58999999999999999998765 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ........+||+.|+|||++.+..|+.++|
T Consensus 142 ~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (373)
T 2r5t_A 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVD 221 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhh
Confidence 9999999999999999999999999999999999999999999998643 334566789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH----HHHHcCCCCchh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA----AELLCHPHLQPY 233 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa----~EiL~hp~f~~~ 233 (582)
||||||++|||++|.+||.+.+..+++..|..... .++..++..+++||.+||+.||.+|+++ ++|++||||+..
T Consensus 222 iwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 222 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred hHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999999999999999988888876533 4567799999999999999999999986 799999999986
Q ss_pred hhhhh--cccCCCCCCCCCCCCCCccccc
Q 007991 234 VLGIH--LKLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 234 ~~~~~--~~~~~p~~~~~~~~~~~s~~~~ 260 (582)
.|... ..+..|..+......+.++|+.
T Consensus 301 ~w~~l~~~~~~pp~~p~~~~~~d~~~f~~ 329 (373)
T 2r5t_A 301 NWDDLINKKITPPFNPNVSGPNDLRHFDP 329 (373)
T ss_dssp CHHHHHTTCSCCSCCCSCCC---------
T ss_pred CHHHHHhCCCCCCCCCCCCCcchhhhcCc
Confidence 55443 2233444444433344444543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=360.00 Aligned_cols=230 Identities=27% Similarity=0.421 Sum_probs=190.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+.+|++++||||+++++++.. +..+|+|||||+ ++|.+++.... ..+++..++.
T Consensus 47 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~ 123 (311)
T 3niz_A 47 IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKI 123 (311)
T ss_dssp EEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHH
T ss_pred EEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHH
Confidence 38999998776666667789999999999999999999998765 458899999997 58888887643 4699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksDI 158 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++||
T Consensus 124 ~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 203 (311)
T 3niz_A 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203 (311)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHh
Confidence 9999999999999999999999999999999999999999999876432 23455689999999999876 568999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-----------------------------CccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-----------------------------PTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-----------------------------p~~~S~~l~~LI~k 209 (582)
|||||++|+|++|.+||.+....+....+......+. ...+++++.+||.+
T Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (311)
T 3niz_A 204 WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN 283 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHH
Confidence 9999999999999999988776666555543222211 12367899999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.||.+|||++|+|+||||+..
T Consensus 284 ~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 284 MLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HcCCChhHCCCHHHHhcCcccccC
Confidence 999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=360.36 Aligned_cols=229 Identities=24% Similarity=0.448 Sum_probs=200.6
Q ss_pred EEEEEecccccCH----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||.+....... ...+.+.+|+.+|++|+||||++++++|.. +..+|+|||||+|++|.+++.... .+++..
T Consensus 39 ~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 115 (326)
T 2y0a_A 39 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEKE--SLTEEE 115 (326)
T ss_dssp EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHTTSS--CCBHHH
T ss_pred EEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEEcCCCCCHHHHHHhcC--CcCHHH
Confidence 8999997654322 135678999999999999999999998765 458999999999999999997643 699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC----CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++............+||+.|+|||++.+..|+
T Consensus 116 ~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 195 (326)
T 2y0a_A 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCC
Confidence 999999999999999999999999999999999887 7999999999877655556678899999999999998999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.++|||||||++|+|++|..||.+....+....+....... .+..++..+.+||.+||..||.+|||++|+|+||||
T Consensus 196 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 99999999999999999999999988888777765543321 124578999999999999999999999999999999
Q ss_pred chh
Q 007991 231 QPY 233 (582)
Q Consensus 231 ~~~ 233 (582)
+..
T Consensus 276 ~~~ 278 (326)
T 2y0a_A 276 KPK 278 (326)
T ss_dssp SCC
T ss_pred cCC
Confidence 753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=352.48 Aligned_cols=230 Identities=27% Similarity=0.474 Sum_probs=194.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+.+|++++||||+++++++... ..+|+|||||+| +|.+.+.... ..+++..++.
T Consensus 29 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~ 105 (292)
T 3o0g_A 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKS 105 (292)
T ss_dssp EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHH
T ss_pred eEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHH
Confidence 389999988777667778899999999999999999999988654 589999999975 6666666533 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCC-CCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP-YGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~-y~~ksDI 158 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+.. |+.++||
T Consensus 106 ~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 185 (292)
T 3o0g_A 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHH
Confidence 9999999999999999999999999999999999999999999876433 3345678999999999998766 8999999
Q ss_pred cchhHHHHhHhcCCcc-ccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~P-F~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~k 209 (582)
|||||++|+|++|..| |.+.+..+....+......+ ....++..+++||.+
T Consensus 186 wslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (292)
T 3o0g_A 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265 (292)
T ss_dssp HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHH
Confidence 9999999999977555 77777777766664422211 122478999999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.||++|||++|+|+||||+.+
T Consensus 266 ~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 266 LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HhccChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.23 Aligned_cols=231 Identities=30% Similarity=0.412 Sum_probs=195.8
Q ss_pred CEEEEEecccccCH---HHHHHHHHHHHHHHhcC---CCCeeeeeeEEEecCc----EEEEEEeecCCCCHHHHHHHhCC
Q 007991 1 MYVLKKIRLARQTD---RARRSAHQEMELISRVR---NPFIVEYKDSWVEKGC----YVCIIIGYCEGGDMAEAIKKANG 70 (582)
Q Consensus 1 lyAIKki~~~~~~~---~~~~~~~rEi~iL~~L~---HpnIV~l~~~~~~~~~----~l~LVmEy~~GgsL~d~Ikk~~~ 70 (582)
.||||+++...... .....+.+|+.+++++. ||||+++++++...+. .+|+||||+. ++|.+++.....
T Consensus 36 ~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~ 114 (308)
T 3g33_A 36 FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP 114 (308)
T ss_dssp EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT
T ss_pred EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC
Confidence 38999997644221 12245667888877775 9999999999876543 6899999996 699999998665
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCC
Q 007991 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 71 ~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~ 150 (582)
..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+.
T Consensus 115 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 194 (308)
T 3g33_A 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS 194 (308)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCC
Confidence 56999999999999999999999999999999999999999999999999999877666666778999999999999999
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC--------------------------CccccHHHH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL--------------------------PTVYSGAFR 204 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l--------------------------p~~~S~~l~ 204 (582)
.|+.++|||||||++|+|++|.+||.+.+......++......+. ...+++.+.
T Consensus 195 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (308)
T 3g33_A 195 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGA 274 (308)
T ss_dssp CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHH
T ss_pred CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHH
Confidence 999999999999999999999999999988887777654322111 124788999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+||.+||+.||.+|||++|+|+||||+.
T Consensus 275 ~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 275 QLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred HHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 9999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.50 Aligned_cols=234 Identities=26% Similarity=0.515 Sum_probs=201.3
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.+....... ...+.+.+|+.+|+.++|||||+++++|... ..+|+|||||.||+|.++++... .+++..++
T Consensus 42 ~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~ 118 (384)
T 4fr4_A 42 MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHLQQNV--HFKEETVK 118 (384)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHTTC--CCCHHHHH
T ss_pred EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHH
Confidence 38999987643221 2346788999999999999999999988755 58999999999999999998743 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC---CCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD---IPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~---~~y~~ks 156 (582)
.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++...........+||+.|+|||++.+ ..|+.++
T Consensus 119 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 198 (384)
T 4fr4_A 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198 (384)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTH
T ss_pred HHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccc
Confidence 9999999999999999999999999999999999999999999988766666778899999999999974 4589999
Q ss_pred cccchhHHHHhHhcCCccccc---cCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-HHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKA---FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-AAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~---~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-a~EiL~hp~f~~ 232 (582)
|||||||++|+|++|..||.. .....+...+... ....+..++..+.+||.+||+.||.+||+ ++++++||||+.
T Consensus 199 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred eeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999999999999999999974 3444555544433 34567789999999999999999999998 999999999998
Q ss_pred hhhhhh
Q 007991 233 YVLGIH 238 (582)
Q Consensus 233 ~~~~~~ 238 (582)
+.|...
T Consensus 278 ~~w~~~ 283 (384)
T 4fr4_A 278 INWDAV 283 (384)
T ss_dssp CCHHHH
T ss_pred CCHHHH
Confidence 665443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=379.60 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=212.3
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... .....+.+|+.+|..++||||++++++|... ..+|+|||||.||+|.+++.+.. ..+++..++
T Consensus 101 ~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~ 178 (437)
T 4aw2_A 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMAR 178 (437)
T ss_dssp EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHH
T ss_pred EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHH
Confidence 38999986532211 1123478999999999999999999988654 58999999999999999998742 369999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCccccc-----CCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLA-----DIPY 152 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~-----~~~y 152 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++...... .....+||+.|+|||++. ...|
T Consensus 179 ~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~ 258 (437)
T 4aw2_A 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258 (437)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEE
T ss_pred HHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCC
Confidence 999999999999999999999999999999999999999999997664433 234579999999999987 5568
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCC---ccccHHHHHHHHHhccCCCCC--CCCHHHHHc
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLP---TVYSGAFRGLVKSMLRKNPEF--RPSAAELLC 226 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp---~~~S~~l~~LI~kmL~~dP~~--RpSa~EiL~ 226 (582)
+.++|||||||++|||++|.+||.+.+..+++.+|.... ...+| ..+++++++||.+||..+|++ |++++|+++
T Consensus 259 ~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 999999999999999999999999999888888875432 12233 458999999999999998888 999999999
Q ss_pred CCCCchhhhhhhcccCCCCCCCCCCCCCCccccc
Q 007991 227 HPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKK 260 (582)
Q Consensus 227 hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~~~ 260 (582)
||||+.+.|........|..+......+.++|+.
T Consensus 339 Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~ 372 (437)
T 4aw2_A 339 HPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDV 372 (437)
T ss_dssp SGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCC
T ss_pred CCccCCCCHHHHhhCCCCCCCcCCCccchhhcCC
Confidence 9999987766555555565555555555555543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=374.85 Aligned_cols=233 Identities=24% Similarity=0.369 Sum_probs=187.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||++..........+.+.+|+++|++|+|||||+++++|...+ ..+|+||||+ +++|.++++... .+++.
T Consensus 80 ~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~ 156 (458)
T 3rp9_A 80 VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTEL 156 (458)
T ss_dssp EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHH
T ss_pred EEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC--CCCHH
Confidence 3899999887777777888999999999999999999999886432 5799999998 589999998643 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---------------------------
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--------------------------- 129 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--------------------------- 129 (582)
.++.|++||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus 157 ~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (458)
T 3rp9_A 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236 (458)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-------------------
T ss_pred HHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccc
Confidence 99999999999999999999999999999999999999999999999875422
Q ss_pred -cccCcccCCCCCCCcccc-cCCCCCCCCcccchhHHHHhHhc-----------CCccccccCH----------------
Q 007991 130 -DLASSVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSA-----------QKAAFKAFDM---------------- 180 (582)
Q Consensus 130 -~~~~~~vGTp~Y~APE~l-~~~~y~~ksDIWSLG~iLyELlt-----------G~~PF~~~~~---------------- 180 (582)
.....++||++|+|||++ .+..|+.++|||||||++|||++ |.++|.+.+.
T Consensus 237 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~ 316 (458)
T 3rp9_A 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFH 316 (458)
T ss_dssp --------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------
T ss_pred cccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccccc
Confidence 123457899999999986 56679999999999999999998 7788866541
Q ss_pred ----HHHHHHHhhccCCC------------------------------CCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 181 ----QALINKINKSIVAP------------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 181 ----~~l~~kI~~~~~~~------------------------------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.+.+..|......+ ....++.++.+||.+||.+||++|||++|+|+
T Consensus 317 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 317 TRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 12222222111111 11245899999999999999999999999999
Q ss_pred CCCCchhhhh
Q 007991 227 HPHLQPYVLG 236 (582)
Q Consensus 227 hp~f~~~~~~ 236 (582)
||||+.+.+.
T Consensus 397 Hp~f~~~~~~ 406 (458)
T 3rp9_A 397 HPFFKEVRIA 406 (458)
T ss_dssp SGGGTTTCCG
T ss_pred CHhhhhcCCC
Confidence 9999986544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=362.09 Aligned_cols=227 Identities=24% Similarity=0.357 Sum_probs=200.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+... ......+.+|+.+|+.++||||++++++|... ..+|+|||||+|++|.+++... +..+++..+..+
T Consensus 33 ~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i 107 (321)
T 1tki_A 33 YMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTS-AFELNEREIVSY 107 (321)
T ss_dssp EEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHH
T ss_pred EEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHH
Confidence 789988753 23456789999999999999999999988654 5899999999999999999764 336999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcC--CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~--~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++. ++.+||+|||++............+||+.|+|||++.+..++.++|||
T Consensus 108 ~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 187 (321)
T 1tki_A 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHH
Confidence 999999999999999999999999999997 789999999999887665556678899999999999998899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||||++|+|++|.+||.+.+...+...+........ ...++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus 188 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 188 SLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999998888888766544322 23589999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=362.36 Aligned_cols=221 Identities=19% Similarity=0.254 Sum_probs=174.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||+++.... .....+.|+.++.+++|||||++++++..++ ..+|||||||+||+|.++++.. .++++.
T Consensus 28 ~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~ 101 (303)
T 3hmm_A 28 EVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEG 101 (303)
T ss_dssp EEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHH
T ss_pred EEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHH
Confidence 389999965432 2233456777778999999999999988654 3789999999999999999874 589999
Q ss_pred HHHHHHHHHHHHHHHHHC--------CceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCc
Q 007991 78 LCKWLVQLLMALNYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCP 144 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~--------gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~AP 144 (582)
+..++.|++.||+|||++ |||||||||+||||+.++++||+|||+++...... .....+||+.||||
T Consensus 102 ~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAP 181 (303)
T 3hmm_A 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCH
Confidence 999999999999999987 99999999999999999999999999998765432 22346899999999
Q ss_pred ccccCC------CCCCCCcccchhHHHHhHhcCCcccccc---------------CHHHHHHHHhhc-cCCCCCcc----
Q 007991 145 ELLADI------PYGSKSDIWSLGCCVYEMSAQKAAFKAF---------------DMQALINKINKS-IVAPLPTV---- 198 (582)
Q Consensus 145 E~l~~~------~y~~ksDIWSLG~iLyELltG~~PF~~~---------------~~~~l~~kI~~~-~~~~lp~~---- 198 (582)
|++.+. .|+.++|||||||++|||++|.+||... ....+...+... ..+.+|..
T Consensus 182 E~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~ 261 (303)
T 3hmm_A 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261 (303)
T ss_dssp HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSS
T ss_pred HHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccch
Confidence 999764 3667899999999999999998766321 223344333332 23344443
Q ss_pred -ccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 199 -YSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 199 -~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.+..+.+|+.+||+.||++|||+.||++.
T Consensus 262 ~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 262 EALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 33578899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=376.59 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=205.2
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... ...+.+.+|+.+|..++||||++++++|... .++|+|||||.||+|.+++.+.+ ..+++..++
T Consensus 88 ~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~ 165 (412)
T 2vd5_A 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMAR 165 (412)
T ss_dssp EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHH
T ss_pred EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHH
Confidence 38999997533211 2234578999999999999999999988654 58999999999999999998753 369999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCccccc-------CC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLA-------DI 150 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~-------~~ 150 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++....... ....+||+.|+|||++. ..
T Consensus 166 ~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~ 245 (412)
T 2vd5_A 166 FYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245 (412)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCS
T ss_pred HHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCC
Confidence 9999999999999999999999999999999999999999999987654332 34579999999999987 35
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc----CCCCCccccHHHHHHHHHhccCCCCCC---CCHHH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI----VAPLPTVYSGAFRGLVKSMLRKNPEFR---PSAAE 223 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~----~~~lp~~~S~~l~~LI~kmL~~dP~~R---pSa~E 223 (582)
.|+.++|||||||++|||++|.+||.+.+..+++.+|.... ....+..++.++++||.+||. +|.+| ++++|
T Consensus 246 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~e 324 (412)
T 2vd5_A 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324 (412)
T ss_dssp EECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHH
T ss_pred CCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 68999999999999999999999999999888888776422 122346799999999999999 99998 59999
Q ss_pred HHcCCCCchhhhhhhcccCCCCCCCCCCCCCCcccc
Q 007991 224 LLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFK 259 (582)
Q Consensus 224 iL~hp~f~~~~~~~~~~~~~p~~~~~~~~~~~s~~~ 259 (582)
|++||||+.+.|........|..+......+.++|+
T Consensus 325 i~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~ 360 (412)
T 2vd5_A 325 FRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFD 360 (412)
T ss_dssp HHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC
T ss_pred HhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccC
Confidence 999999998766544333344444443333444443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=345.20 Aligned_cols=228 Identities=27% Similarity=0.457 Sum_probs=204.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+.++++++||||+++++++.. +...|+||||+.|++|.+.+.... .+++..+..+
T Consensus 34 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~ 110 (284)
T 3kk8_A 34 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHC 110 (284)
T ss_dssp EEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred EEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence 7999998887778888889999999999999999999998765 458899999999999999998765 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||++.++. +||+|||++.............||+.|+|||++.+..++.++||
T Consensus 111 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (284)
T 3kk8_A 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDI 190 (284)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHH
T ss_pred HHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccch
Confidence 999999999999999999999999999987765 99999999987766655667889999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|..||.+.+.......+...... +....+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 191 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 191 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred HHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 99999999999999999999988888777655432 223468999999999999999999999999999999965
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.94 Aligned_cols=232 Identities=26% Similarity=0.396 Sum_probs=189.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++..........+.+.+|+.+|+.++||||+++++++...+ ..+|+|||||+ ++|.+.+.. .+++.
T Consensus 53 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~ 127 (371)
T 2xrw_A 53 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHE 127 (371)
T ss_dssp EEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHH
T ss_pred EEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHH
Confidence 899999887777777888999999999999999999999887543 37899999996 578888863 58999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..|+.++
T Consensus 128 ~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 207 (371)
T 2xrw_A 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTH
T ss_pred HHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchH
Confidence 99999999999999999999999999999999999999999999999877655556678999999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC----------------------------------------
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP---------------------------------------- 196 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp---------------------------------------- 196 (582)
|||||||++|+|++|..||.+.+....+..+......+.+
T Consensus 208 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (371)
T 2xrw_A 208 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287 (371)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccc
Confidence 9999999999999999999999887777776554332211
Q ss_pred -ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhhh
Q 007991 197 -TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 238 (582)
Q Consensus 197 -~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~~ 238 (582)
...+..+++||.+||+.||.+|||++|+|+||||+.+.....
T Consensus 288 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 330 (371)
T 2xrw_A 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 330 (371)
T ss_dssp HHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHH
T ss_pred cccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccc
Confidence 012678999999999999999999999999999987654433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=349.92 Aligned_cols=228 Identities=24% Similarity=0.411 Sum_probs=190.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.........+.+.+|+.+|++++||||+++++++... ..+|+||||+.+ +|.+++.... ..+++..++.+
T Consensus 29 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~ 105 (288)
T 1ob3_A 29 FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSF 105 (288)
T ss_dssp EEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHH
T ss_pred EEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHH
Confidence 89999987655444456788999999999999999999988654 588999999974 9999998643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-CCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~-~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+. .++.++|||
T Consensus 106 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 185 (288)
T 1ob3_A 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185 (288)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHH
Confidence 999999999999999999999999999999999999999999876432 234456899999999999764 589999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHHhc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKSML 211 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~kmL 211 (582)
||||++|+|++|.+||.+.+..+....+......+ ....++..+.+||.+||
T Consensus 186 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 265 (288)
T 1ob3_A 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265 (288)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHc
Confidence 99999999999999999888777666654321110 12347899999999999
Q ss_pred cCCCCCCCCHHHHHcCCCCch
Q 007991 212 RKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 212 ~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+.||++|||++|+|+||||+.
T Consensus 266 ~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 266 KLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCcccCCCHHHHhcCcchhh
Confidence 999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=349.91 Aligned_cols=230 Identities=26% Similarity=0.424 Sum_probs=191.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+.+|++++||||+++++++... ...|+|||||+|++|.+++.... .+++..+..+
T Consensus 31 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i 107 (311)
T 4agu_A 31 VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSI 107 (311)
T ss_dssp EEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHH
T ss_pred EEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHH
Confidence 89999988777777788899999999999999999999988654 58999999999999999887643 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccC-CCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLAD-IPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~-~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+.|+|||++.+ ..++.++|||
T Consensus 108 ~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 187 (311)
T 4agu_A 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVW 187 (311)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHH
T ss_pred HHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhH
Confidence 99999999999999999999999999999999999999999977653 233456789999999999876 5689999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------C------------CccccHHHHHHHHH
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------L------------PTVYSGAFRGLVKS 209 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------l------------p~~~S~~l~~LI~k 209 (582)
||||++|+|++|.+||.+.+..+....+....... + ...++..+.+||.+
T Consensus 188 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 267 (311)
T 4agu_A 188 AIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKG 267 (311)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHH
Confidence 99999999999999999888776665554321110 0 13478899999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchhh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||..||.+|||++|+|+||||+...
T Consensus 268 ~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 268 CLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp HCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HccCChhhcCCHHHHhcChHHHhcc
Confidence 9999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=362.45 Aligned_cols=229 Identities=28% Similarity=0.433 Sum_probs=200.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++..........+.+.+|+++|++++||||+++++++...+ ..+|+||||+ |++|.++++.. .+++
T Consensus 52 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~ 127 (367)
T 1cm8_A 52 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGE 127 (367)
T ss_dssp EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCH
T ss_pred EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCH
Confidence 3899999887777778889999999999999999999999887543 3569999999 89999999873 6899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .....+||++|+|||++.+ ..|+.
T Consensus 128 ~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 205 (367)
T 1cm8_A 128 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQ 205 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCT
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCCh
Confidence 99999999999999999999999999999999999999999999999986543 3456789999999999887 67999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l~ 204 (582)
++|||||||++|+|++|.+||.+.+..+.+..+......+ +...+++.+.
T Consensus 206 ~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (367)
T 1cm8_A 206 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 285 (367)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 9999999999999999999999988877776664432221 2235689999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
+||.+||..||.+|||++|+|+||||+.+..
T Consensus 286 ~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 286 NLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 9999999999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=341.62 Aligned_cols=227 Identities=25% Similarity=0.442 Sum_probs=200.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|++....... .+.+.+|+++|++++||||+++++++.. +...|+||||++|++|.+++.... .+++..+..+
T Consensus 37 ~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i 111 (277)
T 3f3z_A 37 RAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVMELCTGGELFERVVHKR--VFRESDAARI 111 (277)
T ss_dssp EEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHH
T ss_pred EEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 7899887654432 4578999999999999999999998765 458999999999999999998754 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||++............+||+.|+|||++.+. ++.++||
T Consensus 112 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di 190 (277)
T 3f3z_A 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDE 190 (277)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhe
Confidence 9999999999999999999999999999 77889999999999877666666778999999999998764 8999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC---ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP---TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp---~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
|||||++|+|++|..||...+..+....+......... ..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 191 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 191 WSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999988888877665443222 15899999999999999999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=361.05 Aligned_cols=230 Identities=27% Similarity=0.480 Sum_probs=193.4
Q ss_pred EEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHH
Q 007991 2 YVLKKIRLARQ---TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~---~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~ 76 (582)
||||++..... .....+.+.+|+.+|+.++||||++++++|... ..+|+|||||+|++|.+.+.+. .+..+++.
T Consensus 52 vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~ 130 (351)
T 3c0i_A 52 FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130 (351)
T ss_dssp EEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHH
T ss_pred EEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHH
Confidence 89999865321 111346789999999999999999999988664 5899999999999999888653 23458999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhccccc-ccCcccCCCCCCCcccccCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y 152 (582)
.++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++.+..|
T Consensus 131 ~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 210 (351)
T 3c0i_A 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY 210 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCC
Confidence 99999999999999999999999999999999987665 9999999998765443 3456789999999999999999
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+.++|||||||++|+|++|..||.+.. ..+...+........ +..++..+++||.+||..||.+|||+.|+|+|||
T Consensus 211 ~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 211 GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 999999999999999999999998864 344555544333222 2457999999999999999999999999999999
Q ss_pred Cchh
Q 007991 230 LQPY 233 (582)
Q Consensus 230 f~~~ 233 (582)
|+..
T Consensus 290 ~~~~ 293 (351)
T 3c0i_A 290 LKER 293 (351)
T ss_dssp HHTH
T ss_pred hcCC
Confidence 9753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=353.47 Aligned_cols=231 Identities=26% Similarity=0.437 Sum_probs=194.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC----CCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----GVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----~~~lse~~ 77 (582)
||||+++.... ....+.+.+|+.+|++++||||+++++++.. +..+|+|||||+ ++|.+++.... ...+++..
T Consensus 33 vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~ 109 (317)
T 2pmi_A 33 VALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNL 109 (317)
T ss_dssp EEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHH
T ss_pred EEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHH
Confidence 89999976542 2233567899999999999999999998765 458999999997 69999997642 13589999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSK 155 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~k 155 (582)
++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.+
T Consensus 110 ~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 189 (317)
T 2pmi_A 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTS 189 (317)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcH
Confidence 9999999999999999999999999999999999999999999999876432 23456789999999999976 468999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---------------------------------CCccccHH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------------------------LPTVYSGA 202 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---------------------------------lp~~~S~~ 202 (582)
+|||||||++|+|++|.+||.+.+..+....+......+ .+..++.+
T Consensus 190 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (317)
T 2pmi_A 190 IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGN 269 (317)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHH
Confidence 999999999999999999999988877776664322111 12257889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 203 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 203 l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
+.+||.+||+.||++|||++|+|+||||+.+..
T Consensus 270 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 270 LMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred HHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 999999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=367.57 Aligned_cols=233 Identities=27% Similarity=0.396 Sum_probs=189.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++.........+.+.+|+++|++++||||+++++++...+ ..+|+||||++ ++|.++++.. ..+++.
T Consensus 53 ~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~ 129 (432)
T 3n9x_A 53 NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEE 129 (432)
T ss_dssp EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHH
T ss_pred EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHH
Confidence 3899999887777777889999999999999999999999887553 57999999995 6999999864 369999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------------------ccC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----------------------LAS 133 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----------------------~~~ 133 (582)
.++.|++||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ...
T Consensus 130 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (432)
T 3n9x_A 130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------------------------
T ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhcccc
Confidence 999999999999999999999999999999999999999999999998764321 236
Q ss_pred cccCCCCCCCcccc-cCCCCCCCCcccchhHHHHhHhc-----------CCccccccC-----------------HHHHH
Q 007991 134 SVVGTPSYMCPELL-ADIPYGSKSDIWSLGCCVYEMSA-----------QKAAFKAFD-----------------MQALI 184 (582)
Q Consensus 134 ~~vGTp~Y~APE~l-~~~~y~~ksDIWSLG~iLyELlt-----------G~~PF~~~~-----------------~~~l~ 184 (582)
.++||++|+|||++ ....|+.++|||||||++|||++ |.++|.+.+ ..+.+
T Consensus 210 ~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql 289 (432)
T 3n9x_A 210 SHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQL 289 (432)
T ss_dssp -CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHH
T ss_pred CCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHH
Confidence 78999999999986 56679999999999999999997 555665543 12222
Q ss_pred HHHhhccCCC------------------------------CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 185 NKINKSIVAP------------------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 185 ~kI~~~~~~~------------------------------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
..|......+ ....+++++.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 290 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 290 NIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 2222111111 0134799999999999999999999999999999999865
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 370 ~~ 371 (432)
T 3n9x_A 370 KK 371 (432)
T ss_dssp CT
T ss_pred Cc
Confidence 43
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=355.98 Aligned_cols=229 Identities=26% Similarity=0.383 Sum_probs=184.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+.+|+.+|++++||||+++++++... ..+|+|||||+ ++|.+++.... .+++..++.
T Consensus 61 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~ 136 (329)
T 3gbz_A 61 TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKS 136 (329)
T ss_dssp EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHH
T ss_pred eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHH
Confidence 389999988776666677888999999999999999999987654 58999999997 59999998754 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcC-----CCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-CCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTR-----DQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYG 153 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-----~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~-~y~ 153 (582)
++.||+.||+|||++||+||||||+||||+. ++.+||+|||++...... ......+||+.|+|||++.+. .|+
T Consensus 137 i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 216 (329)
T 3gbz_A 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYS 216 (329)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCC
T ss_pred HHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCC
Confidence 9999999999999999999999999999954 445999999999876433 334556889999999999874 489
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-----------------------------CccccHHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-----------------------------PTVYSGAFR 204 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-----------------------------p~~~S~~l~ 204 (582)
.++|||||||++|+|++|.+||.+.+..+....+......+. +..+++++.
T Consensus 217 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (329)
T 3gbz_A 217 TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGL 296 (329)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHH
Confidence 999999999999999999999999888777766654322211 112678999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+||.+||+.||.+|||++|+|+||||+..
T Consensus 297 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 297 DLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 99999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.27 Aligned_cols=228 Identities=27% Similarity=0.471 Sum_probs=188.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----------------------------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----------------------------------- 46 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----------------------------------- 46 (582)
||||+++... .+...+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 34 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (332)
T 3qd2_B 34 YAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKI 112 (332)
T ss_dssp EEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------
T ss_pred EEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccce
Confidence 8999998654 3345678999999999999999999999986543
Q ss_pred ---------------------cEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCc
Q 007991 47 ---------------------CYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKC 104 (582)
Q Consensus 47 ---------------------~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP 104 (582)
.++|+|||||+|++|.+++..... ...++..+..++.||+.||.|||++||+||||||
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 192 (332)
T 3qd2_B 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192 (332)
T ss_dssp -------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred eeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCc
Confidence 258999999999999999987432 2356777999999999999999999999999999
Q ss_pred ccEEEcCCCCeEEeecccchhccccc-------------ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcC
Q 007991 105 SNIFLTRDQDIRLGDFGLAKMLISDD-------------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 171 (582)
Q Consensus 105 ~NILL~~~g~vKL~DFGla~~~~~~~-------------~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG 171 (582)
+||||+.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 193 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 272 (332)
T 3qd2_B 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272 (332)
T ss_dssp GGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSC
T ss_pred ccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHc
Confidence 99999999999999999998765432 23456899999999999999999999999999999999999
Q ss_pred CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 172 KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 172 ~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
..|+... ......+...........+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 273 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 273 FSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred CCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 8775432 2233333333333233456788999999999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=350.73 Aligned_cols=230 Identities=25% Similarity=0.421 Sum_probs=201.6
Q ss_pred EEEEEecccccCHH----HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDR----ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~----~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||.++....... ..+.+.+|+.+|++++||||+++++++.. +..+|+||||++|++|.+++.... .+++..
T Consensus 40 vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 116 (321)
T 2a2a_A 40 YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTDVVLILELVSGGELFDFLAQKE--SLSEEE 116 (321)
T ss_dssp EEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTCS--CEEHHH
T ss_pred EEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHH
Confidence 79999976543221 35678999999999999999999998765 458999999999999999998643 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC----CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++............+||+.|+|||++.+..++
T Consensus 117 ~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (321)
T 2a2a_A 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196 (321)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCC
Confidence 999999999999999999999999999999999988 7999999999877665556677899999999999999999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.++|||||||++|+|++|..||.+.+..+....+........ +..++..+.+||.+||..||.+|||++|+|+||||
T Consensus 197 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 197 LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 999999999999999999999999988888777765443221 24578999999999999999999999999999999
Q ss_pred chhh
Q 007991 231 QPYV 234 (582)
Q Consensus 231 ~~~~ 234 (582)
+...
T Consensus 277 ~~~~ 280 (321)
T 2a2a_A 277 TPVD 280 (321)
T ss_dssp SCSS
T ss_pred cCCC
Confidence 8643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=362.98 Aligned_cols=230 Identities=22% Similarity=0.350 Sum_probs=201.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.... ...+.+.+|+.+|++|+|||||+++++|... ..+|+|||||+|++|.+++.... ..+++..+..+
T Consensus 117 vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i 192 (373)
T 2x4f_A 117 LAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDGGELFDRIIDES-YNLTELDTILF 192 (373)
T ss_dssp EEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHH
T ss_pred EEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 79999876433 4557899999999999999999999987654 58999999999999999987643 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEE--cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFL--TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL--~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...........+||+.|+|||++.+..++.++|||
T Consensus 193 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 272 (373)
T 2x4f_A 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272 (373)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHH
Confidence 9999999999999999999999999999 55678999999999887666666677899999999999988899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
||||++|+|++|..||.+.+..+.+..+........ ...+++++++||.+||+.||.+|||++|+|+||||+....
T Consensus 273 slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 273 SVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 999999999999999999988888777765443221 2458999999999999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=366.14 Aligned_cols=226 Identities=24% Similarity=0.495 Sum_probs=196.0
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++....... .....+.+|+.+|+.++||||+++++++... ..+|+||||+ +|+|.+++...+ .+++..++.
T Consensus 37 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~ 112 (336)
T 3h4j_B 37 VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRR 112 (336)
T ss_dssp EEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHH
T ss_pred EEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHH
Confidence 7999987543221 1235789999999999999999999987654 5899999999 789999998765 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDIW 159 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++|||
T Consensus 113 i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 192 (336)
T 3h4j_B 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192 (336)
T ss_dssp HHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHH
T ss_pred HHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchh
Confidence 999999999999999999999999999999999999999999988777666778899999999999988776 6899999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|..||.+.....+...+... ...++..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 193 slG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 193 SCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 9999999999999999887654444333322 23467779999999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=349.36 Aligned_cols=212 Identities=25% Similarity=0.469 Sum_probs=184.6
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007991 17 RRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHAN 95 (582)
Q Consensus 17 ~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~ 95 (582)
.+.+.+|+++|++++||||+++++++... +..+|+||||+++++|.+++.. ..+++..+..++.||+.||+|||++
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45689999999999999999999988753 5689999999999999886543 3699999999999999999999999
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCC---CCCCCcccchhHHHHhHhcC
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP---YGSKSDIWSLGCCVYEMSAQ 171 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~---y~~ksDIWSLG~iLyELltG 171 (582)
||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999999999999999999999999876543 2345678999999999998765 36789999999999999999
Q ss_pred CccccccCHHHHHHHHhhccC-CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 172 KAAFKAFDMQALINKINKSIV-APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 172 ~~PF~~~~~~~l~~kI~~~~~-~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
..||.+.+...+...+..... .+....+++.+.+||.+||..||++|||++|+|+||||+
T Consensus 237 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 237 QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 999999888777777655432 233456899999999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.54 Aligned_cols=231 Identities=25% Similarity=0.405 Sum_probs=201.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...........+.+|+.+|+.++|||||+++++|.. +..+|+|||||.||+|.+.+.... .+++..+..+
T Consensus 65 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i 141 (494)
T 3lij_A 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVI 141 (494)
T ss_dssp EEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred EEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence 7999998765544456778999999999999999999998865 458999999999999999998765 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCC---CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||++.. +.+||+|||++............+||+.|+|||++.+ .|+.++||
T Consensus 142 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~Di 220 (494)
T 3lij_A 142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDV 220 (494)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHH
T ss_pred HHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhH
Confidence 9999999999999999999999999999764 4599999999988776666677899999999999864 69999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
|||||++|+|++|.+||.+.+..++...+....... .+..+++.+++||.+||+.||.+|||++|+|+||||+....
T Consensus 221 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 999999999999999999999998888887655432 22458999999999999999999999999999999987654
Q ss_pred h
Q 007991 236 G 236 (582)
Q Consensus 236 ~ 236 (582)
.
T Consensus 301 ~ 301 (494)
T 3lij_A 301 K 301 (494)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=389.95 Aligned_cols=234 Identities=24% Similarity=0.453 Sum_probs=205.9
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .....+.+.+|+.+|..+ +||+|+.++++|.. ...+||||||++||+|.+++++.+ .+++..+
T Consensus 368 ~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~ 444 (674)
T 3pfq_A 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHA 444 (674)
T ss_dssp EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHH
Confidence 389999976432 112345678899999988 69999999987754 458999999999999999999865 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcc-cccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLI-SDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~-~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++... ......+.+||+.|+|||++.+..|+.++|
T Consensus 445 ~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~D 524 (674)
T 3pfq_A 445 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 524 (674)
T ss_dssp HHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHH
T ss_pred HHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccce
Confidence 9999999999999999999999999999999999999999999998643 334566789999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH-----HHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA-----AELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa-----~EiL~hp~f~~ 232 (582)
||||||+||||++|.+||.+.+..+++..|..... .+|..++.++++||.+||++||.+|+++ +||++||||+.
T Consensus 525 vwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred EechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999999999999999999998876543 4678899999999999999999999997 99999999998
Q ss_pred hhhhhh
Q 007991 233 YVLGIH 238 (582)
Q Consensus 233 ~~~~~~ 238 (582)
+.|...
T Consensus 604 i~w~~l 609 (674)
T 3pfq_A 604 IDWEKL 609 (674)
T ss_dssp CCHHHH
T ss_pred CCHHHH
Confidence 665443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=373.53 Aligned_cols=228 Identities=27% Similarity=0.511 Sum_probs=198.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++............+.+|+.+|++++|||||++++++.. +..+|+|||||.|++|.+.+.... .+++..++.+
T Consensus 50 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i 126 (486)
T 3mwu_A 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARI 126 (486)
T ss_dssp EEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred EEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence 8999997644333345678999999999999999999998765 458999999999999999998765 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEc---CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLT---RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~---~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||++ .++.+||+|||++............+||+.|+|||++.+ .|+.++||
T Consensus 127 ~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di 205 (486)
T 3mwu_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDV 205 (486)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHH
T ss_pred HHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhH
Confidence 99999999999999999999999999995 456799999999988766666677899999999999986 59999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||||++|+|++|.+||.+.+..++...+...... +.+..+++.+++||.+||+.||.+|||+.++|+||||+.+
T Consensus 206 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 99999999999999999999998888888665432 2235689999999999999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.71 Aligned_cols=227 Identities=27% Similarity=0.442 Sum_probs=180.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++...... .+.+.+|+.+++.++|||||++++++... ..+|+|||||.||+|.+++...+ .+++..++.
T Consensus 47 ~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 120 (361)
T 3uc3_A 47 LVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIMEYASGGELYERICNAG--RFSEDEARF 120 (361)
T ss_dssp EEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 3899999764432 24578999999999999999999988754 58999999999999999998765 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCC--eEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC-Cc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK-SD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~--vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k-sD 157 (582)
++.||+.||+|||++||+||||||+||||+.++. +||+|||+++...........+||+.|+|||++.+..+..+ +|
T Consensus 121 i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 200 (361)
T 3uc3_A 121 FFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200 (361)
T ss_dssp HHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeee
Confidence 9999999999999999999999999999988765 99999999986555555567789999999999988887655 89
Q ss_pred ccchhHHHHhHhcCCccccccCH----HHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDM----QALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~----~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||.+... ......+.... ..+....+++.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 201 iwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred eehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 99999999999999999987443 34444443322 22333468999999999999999999999999999999965
Q ss_pred h
Q 007991 233 Y 233 (582)
Q Consensus 233 ~ 233 (582)
.
T Consensus 281 ~ 281 (361)
T 3uc3_A 281 N 281 (361)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.51 Aligned_cols=225 Identities=28% Similarity=0.486 Sum_probs=198.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++..... ..+.+.+|+.+|++++||||++++++|... ...|+||||++|++|.+++... .+++..+..+
T Consensus 73 vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i 146 (321)
T 2c30_A 73 VAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQV---RLNEEQIATV 146 (321)
T ss_dssp EEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHH
T ss_pred EEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHH
Confidence 899999765433 346788999999999999999999988765 4899999999999999998753 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.++||||
T Consensus 147 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 226 (321)
T 2c30_A 147 CEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226 (321)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHH
Confidence 9999999999999999999999999999999999999999997765432 345678999999999999989999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||.+.+.......+....... .+..+++.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 227 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 227 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999988887777776554332 23458999999999999999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.47 Aligned_cols=232 Identities=36% Similarity=0.654 Sum_probs=206.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~ 77 (582)
.||||++..........+.+.+|+.+|++++||||+++++++.. .+..+|+||||++|++|.+++.... ...+++..
T Consensus 33 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 112 (279)
T 2w5a_A 33 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112 (279)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHH
T ss_pred EEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHH
Confidence 37999998877778888899999999999999999999998764 3568999999999999999997642 34599999
Q ss_pred HHHHHHHHHHHHHHHHHCC-----ceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC
Q 007991 78 LCKWLVQLLMALNYLHANH-----ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~g-----IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~ 151 (582)
+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..
T Consensus 113 ~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (279)
T 2w5a_A 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-
T ss_pred HHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCC
Confidence 9999999999999999999 9999999999999999999999999998765432 234568999999999999989
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
++.++|||||||++|+|++|..||...+...+...+.......++..++..+.+||.+||+.||.+||+++|+|+|+|+.
T Consensus 193 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 99999999999999999999999999998888888887777778888999999999999999999999999999999997
Q ss_pred h
Q 007991 232 P 232 (582)
Q Consensus 232 ~ 232 (582)
+
T Consensus 273 ~ 273 (279)
T 2w5a_A 273 E 273 (279)
T ss_dssp G
T ss_pred h
Confidence 5
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=364.12 Aligned_cols=224 Identities=27% Similarity=0.431 Sum_probs=179.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHH-hcCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELIS-RVRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~-~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||+++.. ..+.+|+.++. .++||||++++++|.. ++.++|||||||+||+|.+++.......+++..
T Consensus 90 vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~ 162 (400)
T 1nxk_A 90 FALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162 (400)
T ss_dssp EEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHH
T ss_pred EEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHH
Confidence 899998642 34678898874 4589999999998764 245899999999999999999876555699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+++...........+||+.|+|||++.+..|+.
T Consensus 163 ~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 242 (400)
T 1nxk_A 163 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242 (400)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSS
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCC
Confidence 9999999999999999999999999999999998 7889999999998776555566789999999999999999999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHH----HHHHHhhccC---CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQA----LINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~----l~~kI~~~~~---~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
++|||||||++|+|++|..||.+.+... +...+..... .+....++.++.+||.+||+.||.+|||++|+|+|
T Consensus 243 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 243 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999997654221 2233332221 12235689999999999999999999999999999
Q ss_pred CCCch
Q 007991 228 PHLQP 232 (582)
Q Consensus 228 p~f~~ 232 (582)
|||..
T Consensus 323 p~~~~ 327 (400)
T 1nxk_A 323 PWIMQ 327 (400)
T ss_dssp HHHHT
T ss_pred ccccC
Confidence 99964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.34 Aligned_cols=227 Identities=21% Similarity=0.415 Sum_probs=199.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+.... ......+.+|+.+|++|+|||||+++++|.. +..+|+|||||.||+|.+++... +..+++..+..+
T Consensus 79 ~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i 154 (387)
T 1kob_A 79 FVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINY 154 (387)
T ss_dssp EEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHH
T ss_pred EEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHH
Confidence 7889887643 3345678999999999999999999998865 45899999999999999999764 336899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcC--CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~--~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||++. ++.+||+|||++............+||+.|+|||++.+..++.++|||
T Consensus 155 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 234 (387)
T 1kob_A 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234 (387)
T ss_dssp HHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHH
T ss_pred HHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEe
Confidence 999999999999999999999999999974 467999999999887665555667899999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|..||.+.+.......+...... .....++.++.+||.+||..||.+|||++|+|+||||+.
T Consensus 235 SlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 235 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred eHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence 9999999999999999999888877777654322 233568999999999999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.71 Aligned_cols=227 Identities=27% Similarity=0.483 Sum_probs=196.3
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+....... .....+.+|+.++++++||||+++++++.. +...|+||||+++++|.+++.... .+++..+..
T Consensus 37 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~ 113 (279)
T 3fdn_A 37 LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLS--KFDEQRTAT 113 (279)
T ss_dssp EEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 7899886543222 234678999999999999999999998765 458999999999999999998765 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....+||+.|+|||++.+..++.++||||
T Consensus 114 ~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (279)
T 3fdn_A 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWS 192 (279)
T ss_dssp HHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHH
T ss_pred HHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHh
Confidence 9999999999999999999999999999999999999999998654433 245678999999999999999999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||++|+|++|..||...+.......+.... ..++..+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 193 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 193 LGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 9999999999999999999888887776543 34677899999999999999999999999999999999763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.96 Aligned_cols=228 Identities=29% Similarity=0.483 Sum_probs=188.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~~ 79 (582)
||||++...... ...+.+.+|+++|++++||||+++++++.. +...|+|||||+|++|.+.+... .+..+++..+.
T Consensus 50 ~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 127 (285)
T 3is5_A 50 RVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127 (285)
T ss_dssp EEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHH
T ss_pred EEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHH
Confidence 789988765432 234678999999999999999999998765 45899999999999999998653 23479999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++............+||+.|+|||++.+ .++.++
T Consensus 128 ~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~ 206 (285)
T 3is5_A 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKC 206 (285)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CCCHHH
T ss_pred HHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCCccc
Confidence 999999999999999999999999999999 4457899999999987766656667889999999999864 688999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|+|++|..||.+.+.......+....... ....+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 207 Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999998888777665443221 22347899999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=353.94 Aligned_cols=227 Identities=22% Similarity=0.385 Sum_probs=188.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++...... ...+.+.+|+.+++.++||||+++++++.. +...|+|||||+|++|.+++.... .+++..++.+
T Consensus 35 vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 110 (323)
T 3tki_A 35 VAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRF 110 (323)
T ss_dssp EEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHH
T ss_pred EEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHH
Confidence 899998765432 334678899999999999999999998765 458999999999999999997643 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCC-CCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPY-GSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y-~~ksD 157 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++...... ......+||+.|+|||++.+..+ +.++|
T Consensus 111 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 190 (323)
T 3tki_A 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190 (323)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHH
T ss_pred HHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCccc
Confidence 999999999999999999999999999999999999999999765422 23456789999999999988775 67899
Q ss_pred ccchhHHHHhHhcCCccccccCHH--HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQ--ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~--~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||||++|+|++|..||...+.. ............+....++..+.+||.+||..||.+|||++|+|+||||+.
T Consensus 191 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp HHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 999999999999999999865543 222222222233334678999999999999999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=349.76 Aligned_cols=223 Identities=29% Similarity=0.502 Sum_probs=191.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-----CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-----NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-----HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||+++. .....+.+.+|+.+|+.+. |||||+++++|... ..+|+||||| |++|.+++.......+++.
T Consensus 63 vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~ 137 (360)
T 3llt_A 63 YAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137 (360)
T ss_dssp EEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-TEEEEEECCC-CCBHHHHHHHTTTCCCCHH
T ss_pred EEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-CeeEEEEcCC-CCCHHHHHHhcCCCCCCHH
Confidence 89999864 3455567889999999997 99999999988765 5899999999 9999999998765679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC-------------------------CCCeEEeecccchhcccccc
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-------------------------DQDIRLGDFGLAKMLISDDL 131 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-------------------------~g~vKL~DFGla~~~~~~~~ 131 (582)
.++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++..... .
T Consensus 138 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~ 215 (360)
T 3llt_A 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--Y 215 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--C
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--C
Confidence 99999999999999999999999999999999975 78899999999975433 3
Q ss_pred cCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC----------------
Q 007991 132 ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------------- 195 (582)
Q Consensus 132 ~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---------------- 195 (582)
....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 295 (360)
T 3llt_A 216 HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295 (360)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGE
T ss_pred CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCcccc
Confidence 4567899999999999999999999999999999999999999998887776666544322110
Q ss_pred ---------C--------------------ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 196 ---------P--------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 196 ---------p--------------------~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+ ...++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 296 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp ETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0 11237788999999999999999999999999995
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=337.58 Aligned_cols=227 Identities=26% Similarity=0.541 Sum_probs=196.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec---CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~---~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||+|++..........+.+.+|+.+|++++||||++++++|... +..+|+||||++|++|.+++.... .+++..+
T Consensus 54 va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 131 (290)
T 1t4h_A 54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVL 131 (290)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHH
Confidence 78999988777888888999999999999999999999988652 568999999999999999998764 6899999
Q ss_pred HHHHHHHHHHHHHHHHCC--ceecccCcccEEEc-CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANH--ILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
..|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... .....+||+.|+|||++.+ .++.+
T Consensus 132 ~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~ 209 (290)
T 1t4h_A 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDES 209 (290)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTH
T ss_pred HHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc-cCCCc
Confidence 999999999999999999 99999999999998 7889999999999754432 3455789999999998875 58999
Q ss_pred CcccchhHHHHhHhcCCcccccc-CHHHHHHHHhhccC-CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIV-APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~-~~~~l~~kI~~~~~-~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+|||||||++|+|++|..||... +.......+..... ...+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 210 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred chHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999874 44444444444322 2245567889999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=353.72 Aligned_cols=233 Identities=26% Similarity=0.438 Sum_probs=198.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++............+.+|+.+|+.+. ||||++++++|.. +..+|+|||||.|++|.+++.......+++..++
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 134 (327)
T 3lm5_A 56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134 (327)
T ss_dssp EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHH
T ss_pred EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHH
Confidence 3899999876655555678999999999995 6999999998765 4589999999999999999876545579999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++............+||+.|+|||++.+..++.++
T Consensus 135 ~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 214 (327)
T 3lm5_A 135 RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTAT 214 (327)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHH
T ss_pred HHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchh
Confidence 99999999999999999999999999999998 789999999999877665556677899999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccC---CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~---~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||||||++|+|++|..||.+.+.......+..... ......++..+.+||.+||+.||.+|||++++|+||||+.+
T Consensus 215 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 215 DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999988887776655432 23345689999999999999999999999999999999864
Q ss_pred h
Q 007991 234 V 234 (582)
Q Consensus 234 ~ 234 (582)
.
T Consensus 295 ~ 295 (327)
T 3lm5_A 295 D 295 (327)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=372.44 Aligned_cols=229 Identities=27% Similarity=0.485 Sum_probs=202.1
Q ss_pred EEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++...... ....+.+.+|+.+|++++|||||+++++|.. +..+|+|||||.|++|.+.+.... .+++..++.
T Consensus 54 ~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 130 (484)
T 3nyv_A 54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAAR 130 (484)
T ss_dssp EEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHH
T ss_pred EEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 899999765432 2345678999999999999999999998765 458999999999999999998754 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++............+||+.|+|||++.+ .|+.++|
T Consensus 131 i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~D 209 (484)
T 3nyv_A 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCD 209 (484)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHH
T ss_pred HHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcce
Confidence 99999999999999999999999999999 4678899999999988766665667789999999999977 6999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||||||++|+|++|.+||.+.+..++...+...... +.+..+++.+++||.+||+.||.+|||++|+|+||||+.+.
T Consensus 210 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 210 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred eHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999999999999999999999998888888765433 22356899999999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=374.49 Aligned_cols=227 Identities=23% Similarity=0.458 Sum_probs=202.4
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++...... ...+.+.+|+.+|+.++||||+++++++... ..+|+|||||+||+|.+++.+.+ .+++..++.
T Consensus 44 vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~ 120 (476)
T 2y94_A 44 VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVSGGELFDYICKNG--RLDEKESRR 120 (476)
T ss_dssp EEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHH
T ss_pred EEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 8999997643211 2346789999999999999999999987654 58999999999999999998643 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDIW 159 (582)
++.||+.||+|||++||+||||||+|||++.++++||+|||++..........+.+||+.|+|||++.+..+ +.++|||
T Consensus 121 i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 200 (476)
T 2y94_A 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 200 (476)
T ss_dssp HHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceeh
Confidence 999999999999999999999999999999999999999999988766666677899999999999998776 6799999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|..||.+.+...+..++..... ..+..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus 201 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred hhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 999999999999999999988888888876543 457779999999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=335.29 Aligned_cols=225 Identities=28% Similarity=0.441 Sum_probs=191.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~ 77 (582)
.||||+++...........+.+|+.++..+ +||||+++++++... ...|+|||||+|++|.+++.... ...+++..
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 116 (289)
T 1x8b_A 38 IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116 (289)
T ss_dssp EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHH
T ss_pred eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEEecCCCcHHHHHHhhcccccCCCHHH
Confidence 389999988766666677889999999999 999999999988655 58999999999999999998642 13689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-------------------CeEEeecccchhcccccccCcccCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-------------------DIRLGDFGLAKMLISDDLASSVVGT 138 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-------------------~vKL~DFGla~~~~~~~~~~~~vGT 138 (582)
++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ....||
T Consensus 117 ~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt 193 (289)
T 1x8b_A 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGD 193 (289)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCC
Confidence 999999999999999999999999999999998544 7999999999766543 345699
Q ss_pred CCCCCcccccCC-CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCC
Q 007991 139 PSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEF 217 (582)
Q Consensus 139 p~Y~APE~l~~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~ 217 (582)
+.|+|||++.+. .++.++|||||||++|+|++|.+++...+. ...+.......++..+++.+.+||.+||..||.+
T Consensus 194 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 270 (289)
T 1x8b_A 194 SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPER 270 (289)
T ss_dssp GGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred ccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCccc
Confidence 999999999875 566799999999999999999988765433 3445555566678889999999999999999999
Q ss_pred CCCHHHHHcCCCCch
Q 007991 218 RPSAAELLCHPHLQP 232 (582)
Q Consensus 218 RpSa~EiL~hp~f~~ 232 (582)
|||+.|+|+||||+.
T Consensus 271 Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 271 RPSAMALVKHSVLLS 285 (289)
T ss_dssp SCCHHHHHTCTTC--
T ss_pred CCCHHHHhhChHhhh
Confidence 999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=343.29 Aligned_cols=226 Identities=25% Similarity=0.414 Sum_probs=184.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++..... ...+.+.+|+++|.++ +||||+++++++... ..+|+|||||+|++|.+++.... .+++..++.
T Consensus 41 vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 115 (316)
T 2ac3_A 41 YAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVFEKMRGGSILSHIHKRR--HFNELEASV 115 (316)
T ss_dssp EEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHH
Confidence 89999976533 2346789999999995 799999999988664 58999999999999999998764 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhcccc--------cccCcccCCCCCCCcccccC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISD--------DLASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~--------~~~~~~vGTp~Y~APE~l~~ 149 (582)
++.||+.||+|||++||+||||||+|||++.++. +||+|||++...... ......+||+.|+|||++.+
T Consensus 116 i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhc
Confidence 9999999999999999999999999999998876 999999998765321 12234679999999999875
Q ss_pred -----CCCCCCCcccchhHHHHhHhcCCccccccC---------------HHHHHHHHhhccCCCCC----ccccHHHHH
Q 007991 150 -----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---------------MQALINKINKSIVAPLP----TVYSGAFRG 205 (582)
Q Consensus 150 -----~~y~~ksDIWSLG~iLyELltG~~PF~~~~---------------~~~l~~kI~~~~~~~lp----~~~S~~l~~ 205 (582)
..|+.++|||||||++|+|++|..||.+.. ...+...+...... ++ ..++..+++
T Consensus 196 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~ 274 (316)
T 2ac3_A 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKD 274 (316)
T ss_dssp TSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHH
T ss_pred ccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-cCchhcccCCHHHHH
Confidence 458899999999999999999999997653 23344555444322 23 357899999
Q ss_pred HHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 206 LVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 206 LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||.+||..||.+|||++|+|+||||+..
T Consensus 275 li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 275 LISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 9999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=380.28 Aligned_cols=235 Identities=28% Similarity=0.466 Sum_probs=202.7
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++....... .....+.+|+.+|++++|||||+++++|... ..+|+|||||+||+|.+++...+...+++..++
T Consensus 211 ~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~ 289 (576)
T 2acx_A 211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289 (576)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHH
T ss_pred EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHH
Confidence 38999997643221 2345678999999999999999999988654 589999999999999999987655569999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++...........+||+.|+|||++.+..|+.++|||
T Consensus 290 ~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~Diw 369 (576)
T 2acx_A 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369 (576)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHH
T ss_pred HHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHH
Confidence 99999999999999999999999999999999999999999999877655555667999999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccC----HHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCC
Q 007991 160 SLGCCVYEMSAQKAAFKAFD----MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHL 230 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~----~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f 230 (582)
||||++|||++|.+||.+.+ ...+...+.. ....++..++.++++||.+||+.||.+|+ +++||++||||
T Consensus 370 SLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp HHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred HHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence 99999999999999998753 3444444443 33446778999999999999999999999 89999999999
Q ss_pred chhhhhh
Q 007991 231 QPYVLGI 237 (582)
Q Consensus 231 ~~~~~~~ 237 (582)
+...+..
T Consensus 449 ~~i~w~~ 455 (576)
T 2acx_A 449 KKLNFKR 455 (576)
T ss_dssp TTCCHHH
T ss_pred ccCCHHH
Confidence 9865543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.85 Aligned_cols=224 Identities=26% Similarity=0.475 Sum_probs=176.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++... ..+.+.+|+.+|++++||||++++++|.. +..+|+||||++|++|.+++...+ .+++..+..+
T Consensus 81 vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 153 (349)
T 2w4o_A 81 YALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLELVTGGELFDRIVEKG--YYSERDAADA 153 (349)
T ss_dssp EEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHH
T ss_pred EEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence 8999987543 23568899999999999999999998865 458999999999999999998643 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+||||+. ++.+||+|||+++...........+||+.|+|||++.+..++.++||
T Consensus 154 ~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 233 (349)
T 2w4o_A 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233 (349)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHH
T ss_pred HHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccch
Confidence 999999999999999999999999999976 78999999999987766555667889999999999999899999999
Q ss_pred cchhHHHHhHhcCCccccccCHHH-HHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQA-LINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~-l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|..||.+..... +...+...... +....++..+.+||.+||..||++|||+.|+|+||||+.
T Consensus 234 wslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp HHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 999999999999999997655433 55555443322 334568999999999999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.17 Aligned_cols=229 Identities=27% Similarity=0.443 Sum_probs=200.4
Q ss_pred EEEEEecccccCH-----------HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC
Q 007991 2 YVLKKIRLARQTD-----------RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG 70 (582)
Q Consensus 2 yAIKki~~~~~~~-----------~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~ 70 (582)
||||++....... ...+.+.+|+.+|++|+|||||+++++|.. +..+|+|||||+||+|.+++....
T Consensus 64 ~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~- 141 (504)
T 3q5i_A 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIINRH- 141 (504)
T ss_dssp EEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHS-
T ss_pred EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEEEecCCCCcHHHHHHHcC-
Confidence 7999997654322 235678999999999999999999998765 558999999999999999998765
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccccccCcccCCCCCCCcccc
Q 007991 71 VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL 147 (582)
Q Consensus 71 ~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l 147 (582)
.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++............+||+.|+|||++
T Consensus 142 -~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 220 (504)
T 3q5i_A 142 -KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220 (504)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHH
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHh
Confidence 699999999999999999999999999999999999999876 6999999999887666666778999999999998
Q ss_pred cCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+........ +..+++++++||.+||+.||.+|||++|+
T Consensus 221 ~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 221 KK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp TT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 75 699999999999999999999999999999998888876654321 24689999999999999999999999999
Q ss_pred HcCCCCchhh
Q 007991 225 LCHPHLQPYV 234 (582)
Q Consensus 225 L~hp~f~~~~ 234 (582)
|+||||+.+.
T Consensus 300 l~h~~~~~~~ 309 (504)
T 3q5i_A 300 LNSRWIKKYA 309 (504)
T ss_dssp HTSHHHHHTC
T ss_pred hcCHhhhhch
Confidence 9999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.24 Aligned_cols=229 Identities=26% Similarity=0.417 Sum_probs=193.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-------CcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------GCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-------~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||++............+.+|+.+|++++||||+++++++... +..+|+|||||+ ++|.+.+.... ..++
T Consensus 45 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~ 122 (351)
T 3mi9_A 45 VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFT 122 (351)
T ss_dssp EEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTT-SCCC
T ss_pred EEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCC
Confidence 89999977665555556788999999999999999999988764 347899999997 58888887643 3699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-----ccccCcccCCCCCCCcccccC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-----DDLASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-----~~~~~~~vGTp~Y~APE~l~~ 149 (582)
+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+||+.|+|||++.+
T Consensus 123 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcC
Confidence 999999999999999999999999999999999999999999999999976542 223355789999999999876
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc------------------------------
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV------------------------------ 198 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~------------------------------ 198 (582)
..|+.++|||||||++|+|++|.+||.+.+.......+........+..
T Consensus 203 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (351)
T 3mi9_A 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 282 (351)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHH
T ss_pred CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhc
Confidence 4589999999999999999999999999988877776654332221111
Q ss_pred -ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 199 -YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 199 -~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
.++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 283 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 283 VRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp HCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred cCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 2678999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.63 Aligned_cols=227 Identities=25% Similarity=0.481 Sum_probs=198.4
Q ss_pred EEEEEeccccc--C----HHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQ--T----DRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~--~----~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||+++.... . ....+.+.+|+.+|+++ +||||++++++|.. ....|+||||++|++|.+++.... .++
T Consensus 122 vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~--~l~ 198 (365)
T 2y7j_A 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-SSFMFLVFDLMRKGELFDYLTEKV--ALS 198 (365)
T ss_dssp EEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-SSEEEEEECCCTTCBHHHHHHHHS--SCC
T ss_pred EEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-CCEEEEEEEeCCCCcHHHHHHhcC--CCC
Confidence 89999976542 2 23467789999999999 79999999998765 458999999999999999998754 699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-----
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD----- 149 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~----- 149 (582)
+..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.........+||+.|+|||++.+
T Consensus 199 ~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 278 (365)
T 2y7j_A 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTT
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhcccccccc
Confidence 999999999999999999999999999999999999999999999999987766666677899999999999863
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
..|+.++|||||||++|+|++|..||.+.+.......+........ +..++..+.+||.+||..||++|||++++|
T Consensus 279 ~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 358 (365)
T 2y7j_A 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358 (365)
T ss_dssp SCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 3588899999999999999999999999888777777765443321 245788999999999999999999999999
Q ss_pred cCCCCc
Q 007991 226 CHPHLQ 231 (582)
Q Consensus 226 ~hp~f~ 231 (582)
+||||+
T Consensus 359 ~hp~f~ 364 (365)
T 2y7j_A 359 QHPFFE 364 (365)
T ss_dssp HSGGGC
T ss_pred cCcccC
Confidence 999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.78 Aligned_cols=233 Identities=24% Similarity=0.436 Sum_probs=191.7
Q ss_pred EEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh----------
Q 007991 2 YVLKKIRLAR---QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA---------- 68 (582)
Q Consensus 2 yAIKki~~~~---~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~---------- 68 (582)
||||.+.... ......+.+.+|+.+|++++||||++++++|.. +...|+|||||+||+|.+++...
T Consensus 54 vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~ 132 (345)
T 3hko_A 54 RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132 (345)
T ss_dssp EEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEE
T ss_pred EEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-CCeEEEEEeCCCCCcHHHHHHHhhccccccccc
Confidence 7899886542 234456789999999999999999999998865 45899999999999999998521
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC--CeEEe
Q 007991 69 ----------------------------NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ--DIRLG 118 (582)
Q Consensus 69 ----------------------------~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g--~vKL~ 118 (582)
....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~ 212 (345)
T 3hko_A 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212 (345)
T ss_dssp EEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEEC
T ss_pred ccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEe
Confidence 011246888999999999999999999999999999999998777 89999
Q ss_pred ecccchhccccc-----ccCcccCCCCCCCcccccC--CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc
Q 007991 119 DFGLAKMLISDD-----LASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI 191 (582)
Q Consensus 119 DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~--~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~ 191 (582)
|||++....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 213 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 292 (345)
T 3hko_A 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292 (345)
T ss_dssp CCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred eccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc
Confidence 999998653321 2346789999999999975 678999999999999999999999999988888777765544
Q ss_pred CCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 192 VAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 192 ~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
.... ...+++.+.+||.+||+.||.+||++.++|+||||+.+..
T Consensus 293 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred cccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 3222 2347999999999999999999999999999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=337.12 Aligned_cols=230 Identities=29% Similarity=0.503 Sum_probs=200.4
Q ss_pred EEEEEeccccc-------CHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCC
Q 007991 2 YVLKKIRLARQ-------TDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHF 73 (582)
Q Consensus 2 yAIKki~~~~~-------~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~l 73 (582)
||||+++.... ....++.+.+|+.+|+++. ||||+++++++.. +...|+||||++|++|.+++.... .+
T Consensus 45 vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~ 121 (298)
T 1phk_A 45 YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEKV--TL 121 (298)
T ss_dssp EEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHS--SC
T ss_pred EEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc-CCeEEEEEeccCCCcHHHHHhccC--CC
Confidence 89999976542 1235677899999999996 9999999998754 568999999999999999998754 68
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc-----
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA----- 148 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~----- 148 (582)
++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.
T Consensus 122 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 201 (298)
T 1phk_A 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhcccccc
Confidence 999999999999999999999999999999999999999999999999998776655566778999999999985
Q ss_pred -CCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 149 -DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 149 -~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
...++.++|||||||++|+|++|..||.+.+.......+...... +....++..+.+||.+||..||.+|||++|+
T Consensus 202 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 456888999999999999999999999998888777776554432 2224689999999999999999999999999
Q ss_pred HcCCCCchhh
Q 007991 225 LCHPHLQPYV 234 (582)
Q Consensus 225 L~hp~f~~~~ 234 (582)
|+||||+.+.
T Consensus 282 l~h~~~~~~~ 291 (298)
T 1phk_A 282 LAHPFFQQYV 291 (298)
T ss_dssp TTSGGGCTTC
T ss_pred HhChHhhhcc
Confidence 9999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.58 Aligned_cols=230 Identities=25% Similarity=0.394 Sum_probs=192.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++..........+.+.+|+.+|++++||||+++++++... ...|+||||++|++|.+++.... .+++..+..
T Consensus 52 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~ 128 (331)
T 4aaa_A 52 IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLVFEFVDHTILDDLELFPN--GLDYQVVQK 128 (331)
T ss_dssp EEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHH
T ss_pred eEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEEEecCCcchHHHHHhhcc--CCCHHHHHH
Confidence 389999988777777888899999999999999999999988654 58999999999999988876543 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-CCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~-~y~~ksDI 158 (582)
++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ......+||+.|+|||++.+. .++.++||
T Consensus 129 ~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 208 (331)
T 4aaa_A 129 YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDV 208 (331)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHH
T ss_pred HHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHH
Confidence 9999999999999999999999999999999999999999999765432 334567899999999999875 68999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------C------------CccccHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------L------------PTVYSGAFRGLVK 208 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------l------------p~~~S~~l~~LI~ 208 (582)
|||||++|+|++|.+||.+.+..+....+....... + ...+++.+.+||.
T Consensus 209 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 288 (331)
T 4aaa_A 209 WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAK 288 (331)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHH
Confidence 999999999999999999888766655543221110 0 1247899999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCchh
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+||+.||.+|||++|+|+||||+..
T Consensus 289 ~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 289 KCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HHhccCcccCCCHHHHhcCchhccC
Confidence 9999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.35 Aligned_cols=223 Identities=29% Similarity=0.519 Sum_probs=191.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+..... ...+|+++|.++ +||||++++++|.. +..+|+|||||+||+|.+++.+.+ .+++..++.
T Consensus 50 ~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~ 120 (342)
T 2qr7_A 50 FAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVTELMKGGELLDKILRQK--FFSEREASA 120 (342)
T ss_dssp EEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHH
T ss_pred EEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence 89999976543 245789999888 79999999998765 568999999999999999998754 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC-C---CeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD-Q---DIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g---~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
++.||+.||+|||++||+||||||+|||+..+ + .+||+|||+++..... ......+||+.|+|||++.+..|+.+
T Consensus 121 ~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 200 (342)
T 2qr7_A 121 VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200 (342)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCc
Confidence 99999999999999999999999999998543 3 4999999999876443 34557799999999999988889999
Q ss_pred CcccchhHHHHhHhcCCccccc---cCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKA---FDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~---~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+|||||||++|+|++|..||.+ ....++...+...... ..+..+++.+++||.+||..||++||+++++|+|||
T Consensus 201 ~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 201 CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred cCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 9999999999999999999975 4566677776654432 234568999999999999999999999999999999
Q ss_pred Cchh
Q 007991 230 LQPY 233 (582)
Q Consensus 230 f~~~ 233 (582)
|..+
T Consensus 281 ~~~~ 284 (342)
T 2qr7_A 281 IVHW 284 (342)
T ss_dssp HHTG
T ss_pred ecCc
Confidence 9654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=349.42 Aligned_cols=223 Identities=26% Similarity=0.436 Sum_probs=171.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++... ....+.+|+.+|+.+. ||||++++++|.. +...|+|||||+||+|.+++.... .+++..++.
T Consensus 39 vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 110 (325)
T 3kn6_A 39 FAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGGELFERIKKKK--HFSETEASY 110 (325)
T ss_dssp EEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHH
T ss_pred EEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHH
Confidence 899998653 2356789999999997 9999999998765 458999999999999999998754 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ......+||+.|+|||++.+..|+.++
T Consensus 111 i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 190 (325)
T 3kn6_A 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190 (325)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHH
T ss_pred HHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCcc
Confidence 999999999999999999999999999998776 7999999999865433 334567899999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCH-------HHHHHHHhhccCCCCC---ccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDM-------QALINKINKSIVAPLP---TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~-------~~l~~kI~~~~~~~lp---~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||||++|+|++|..||.+.+. .++...+......... ..+++++++||.+||..||.+|||++|+++
T Consensus 191 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred chHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 999999999999999999986543 4556666554432221 358999999999999999999999999999
Q ss_pred CCCCch
Q 007991 227 HPHLQP 232 (582)
Q Consensus 227 hp~f~~ 232 (582)
||||+.
T Consensus 271 h~w~~~ 276 (325)
T 3kn6_A 271 NEWLQD 276 (325)
T ss_dssp CGGGCT
T ss_pred Chhhcc
Confidence 999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=336.72 Aligned_cols=230 Identities=25% Similarity=0.453 Sum_probs=195.9
Q ss_pred EEEEEecccccCHH----HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDR----ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~----~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||.++....... ..+.+.+|+.+|++++||||+++++++.. +...|+||||++|++|.+++.... .+++..
T Consensus 33 ~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 109 (283)
T 3bhy_A 33 YAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDVVLILELVSGGELFDFLAEKE--SLTEDE 109 (283)
T ss_dssp EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHS--SCCHHH
T ss_pred eehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeEEEEEeecCCCcHHHHHHhcC--CCCHHH
Confidence 78999876543321 35678999999999999999999998765 458999999999999999998754 689999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC----CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.............||+.|+|||++.+..++
T Consensus 110 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 189 (283)
T 3bhy_A 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLG 189 (283)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCC
Confidence 999999999999999999999999999999999887 7999999999876655555667899999999999998999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.++|||||||++|+|++|..||.+.+.......+....... .+..++..+.+||.+||..||.+||+++++|+||||
T Consensus 190 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 190 LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 99999999999999999999999988888777765543321 124578999999999999999999999999999999
Q ss_pred chhh
Q 007991 231 QPYV 234 (582)
Q Consensus 231 ~~~~ 234 (582)
+...
T Consensus 270 ~~~~ 273 (283)
T 3bhy_A 270 KAIR 273 (283)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.46 Aligned_cols=228 Identities=24% Similarity=0.387 Sum_probs=183.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++..........+.+.+|+.+|+.++||||+++++++... ...+|+||||+ |++|.++++.. .+++.
T Consensus 57 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~ 132 (367)
T 2fst_X 57 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDD 132 (367)
T ss_dssp EEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C---CCCHH
T ss_pred EEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC---CCCHH
Confidence 89999988777777788899999999999999999999988643 24689999999 79999998762 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~k 155 (582)
.++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ....+||++|+|||++.+ ..|+.+
T Consensus 133 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~ 210 (367)
T 2fst_X 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQT 210 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTT
T ss_pred HHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCch
Confidence 99999999999999999999999999999999999999999999999865432 456789999999999887 679999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC------------------------------CccccHHHHH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------------------PTVYSGAFRG 205 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l------------------------------p~~~S~~l~~ 205 (582)
+|||||||++|+|++|.+||.+.+..+.+..+......+. ...+++.+.+
T Consensus 211 ~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 290 (367)
T 2fst_X 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 290 (367)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHH
Confidence 9999999999999999999999888777766654322210 1235788999
Q ss_pred HHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 206 LVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 206 LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
||.+||+.||.+|||++|+|+||||+.+..
T Consensus 291 Ll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 291 LLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=349.09 Aligned_cols=227 Identities=26% Similarity=0.460 Sum_probs=188.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCC--CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~H--pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++..........+.+.+|+.+|+++.| +||+++++++.. +..+|+|||| .+++|.+++.... .+++..+
T Consensus 35 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~ 110 (343)
T 3dbq_A 35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVMEC-GNIDLNSWLKKKK--SIDPWER 110 (343)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECC-CSEEHHHHHHHSC--CCCHHHH
T ss_pred EEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHH
Confidence 38999999887778888899999999999987 999999998765 4589999995 5899999999854 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC------
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD------ 149 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~------ 149 (582)
+.|+.||+.||+|||++||+||||||+||||+ ++.+||+|||+++...... .....+||+.|+|||++.+
T Consensus 111 ~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 189 (343)
T 3dbq_A 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189 (343)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC----
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccc
Confidence 99999999999999999999999999999996 6789999999998764432 2346789999999999864
Q ss_pred -----CCCCCCCcccchhHHHHhHhcCCccccccC-HHHHH-HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 150 -----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 150 -----~~y~~ksDIWSLG~iLyELltG~~PF~~~~-~~~l~-~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
..|+.++|||||||++|+|++|..||.... ..... ..+.......++...+..+.+||.+||+.||.+|||+.
T Consensus 190 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 269 (343)
T 3dbq_A 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269 (343)
T ss_dssp -------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 668889999999999999999999997643 22222 32333344456777889999999999999999999999
Q ss_pred HHHcCCCCch
Q 007991 223 ELLCHPHLQP 232 (582)
Q Consensus 223 EiL~hp~f~~ 232 (582)
|+|+||||+.
T Consensus 270 e~l~hp~~~~ 279 (343)
T 3dbq_A 270 ELLAHPYVQI 279 (343)
T ss_dssp HHHTSHHHHS
T ss_pred HHHhCccccc
Confidence 9999999963
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=355.88 Aligned_cols=227 Identities=26% Similarity=0.425 Sum_probs=177.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHhC-------CCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKAN-------GVH 72 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~~-------~~~ 72 (582)
.||||++...... ..+.+|+.+|++|+|||||+++++|.. .+..+|+||||++ ++|.+++.... ...
T Consensus 50 ~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~ 124 (405)
T 3rgf_A 50 DYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQ 124 (405)
T ss_dssp CEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------
T ss_pred EEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccC
Confidence 4899999765544 357789999999999999999999875 4568999999996 68888886421 224
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEE----cCCCCeEEeecccchhcccc----cccCcccCCCCCCCc
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLISD----DLASSVVGTPSYMCP 144 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL----~~~g~vKL~DFGla~~~~~~----~~~~~~vGTp~Y~AP 144 (582)
+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..... ......+||+.|+||
T Consensus 125 l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 204 (405)
T 3rgf_A 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204 (405)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCc
Confidence 9999999999999999999999999999999999999 67789999999999876432 234567899999999
Q ss_pred ccccCC-CCCCCCcccchhHHHHhHhcCCccccccCHH---------HHHHHHhhccCCCCC------------------
Q 007991 145 ELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---------ALINKINKSIVAPLP------------------ 196 (582)
Q Consensus 145 E~l~~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~---------~l~~kI~~~~~~~lp------------------ 196 (582)
|++.+. .|+.++|||||||++|+|++|.+||.+.... +.+..+......+..
T Consensus 205 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 284 (405)
T 3rgf_A 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD 284 (405)
T ss_dssp HHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHH
T ss_pred hhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhh
Confidence 999874 4899999999999999999999999765432 333333322222111
Q ss_pred -------------------ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 197 -------------------TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 197 -------------------~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
...+..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~ 339 (405)
T 3rgf_A 285 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339 (405)
T ss_dssp CCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred ccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence 112778999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.78 Aligned_cols=228 Identities=22% Similarity=0.439 Sum_probs=190.8
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+....... ...+.+.+|+.+|+.++||||+++++++.. +...|+||||++|++|.+++.... .+++..+..
T Consensus 39 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 115 (276)
T 2h6d_A 39 VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFMVMEYVSGGELFDYICKHG--RVEEMEARR 115 (276)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHH
T ss_pred EEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHH
Confidence 7899986643211 234678999999999999999999998765 458999999999999999998764 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-CCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY-GSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y-~~ksDIW 159 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++|||
T Consensus 116 ~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 195 (276)
T 2h6d_A 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195 (276)
T ss_dssp HHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHH
Confidence 999999999999999999999999999999999999999999987766555566789999999999988765 5799999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||||++|+|++|..||...+...+...+.... ..++..++..+.+||.+||+.||.+|||++++++||||+..
T Consensus 196 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 196 SCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 99999999999999999988888887776654 34677789999999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=342.54 Aligned_cols=231 Identities=28% Similarity=0.419 Sum_probs=197.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc---CCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L---~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||+++...........+.+|+.+++.+ +||||+++++++.. .+..+|+||||+. |+|.+++.......++
T Consensus 40 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~ 118 (326)
T 1blx_A 40 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP 118 (326)
T ss_dssp EEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSC
T ss_pred EEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCC
Confidence 79999977554433334567788888777 89999999998862 4468999999997 6999999986655699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..++.
T Consensus 119 ~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 198 (326)
T 1blx_A 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCc
Confidence 99999999999999999999999999999999999999999999999998766555566788999999999999989999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--------------------------CCCccccHHHHHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------------------------PLPTVYSGAFRGLVK 208 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--------------------------~lp~~~S~~l~~LI~ 208 (582)
++|||||||++|+|++|.+||.+.+.......+...... .+...++..+++||.
T Consensus 199 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (326)
T 1blx_A 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 278 (326)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHH
Confidence 999999999999999999999998887777666532211 123457899999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCchh
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+||..||.+|||+.|+|+||||+..
T Consensus 279 ~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 279 KCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHcCCCcccCCCHHHHhcCcccccc
Confidence 9999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=354.08 Aligned_cols=228 Identities=25% Similarity=0.460 Sum_probs=194.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-----------------------------------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK----------------------------------- 45 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~----------------------------------- 45 (582)
.||||++..... ...+|+++|+.++|||||+++++|...
T Consensus 34 ~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 107 (383)
T 3eb0_A 34 RFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107 (383)
T ss_dssp EEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------------------
T ss_pred EEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccC
Confidence 389999865432 234799999999999999999988542
Q ss_pred --CcEEEEEEeecCCCCHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEc-CCCCeEEeec
Q 007991 46 --GCYVCIIIGYCEGGDMAEAIKK--ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDF 120 (582)
Q Consensus 46 --~~~l~LVmEy~~GgsL~d~Ikk--~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~-~~g~vKL~DF 120 (582)
+.++|+|||||+ ++|.+.+.. ..+..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Df 186 (383)
T 3eb0_A 108 SQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186 (383)
T ss_dssp --CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEEC
Confidence 346899999997 588887764 2345799999999999999999999999999999999999998 5789999999
Q ss_pred ccchhcccccccCcccCCCCCCCcccccCC-CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-----
Q 007991 121 GLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----- 194 (582)
Q Consensus 121 Gla~~~~~~~~~~~~vGTp~Y~APE~l~~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----- 194 (582)
|+++...........+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 187 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp TTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 999887666667778999999999998765 48999999999999999999999999988877776665432221
Q ss_pred -----------------------CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 195 -----------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 195 -----------------------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
++..++.++.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 34457899999999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=371.75 Aligned_cols=235 Identities=28% Similarity=0.486 Sum_probs=201.0
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~ 77 (582)
.||||+++...... ...+.+.+|+.+|++++||||++++++|... ..+|+|||||+||+|.+++.... ...+++..
T Consensus 212 ~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~ 290 (543)
T 3c4z_A 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290 (543)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHH
T ss_pred EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEEEEeccCCCHHHHHHHhhcccccccHHH
Confidence 38999997644322 2345788999999999999999999987654 58999999999999999998643 34699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++...... .....+||+.|+|||++.+..|+.++
T Consensus 291 ~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 370 (543)
T 3c4z_A 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370 (543)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHH
T ss_pred HHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHH
Confidence 99999999999999999999999999999999999999999999998765443 34456999999999999999999999
Q ss_pred cccchhHHHHhHhcCCcccccc----CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~----~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~h 227 (582)
|||||||++|||++|.+||.+. ....+...+.... ..++..++..+.+||.+||+.||.+||+ +++|++|
T Consensus 371 DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 371 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred hcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 9999999999999999999875 3455666555433 3467789999999999999999999995 5999999
Q ss_pred CCCchhhhhh
Q 007991 228 PHLQPYVLGI 237 (582)
Q Consensus 228 p~f~~~~~~~ 237 (582)
|||+.+.|..
T Consensus 450 pff~~i~w~~ 459 (543)
T 3c4z_A 450 PLFRDISWRQ 459 (543)
T ss_dssp GGGTTCCHHH
T ss_pred ccccCCCHHH
Confidence 9999865543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=343.07 Aligned_cols=225 Identities=27% Similarity=0.470 Sum_probs=185.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..............+|+..+.++ +||||++++++|.. +..+|+||||| +++|.+++...+ ..+++..++
T Consensus 84 ~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~ 160 (311)
T 3p1a_A 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVW 160 (311)
T ss_dssp EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHH
T ss_pred EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHH
Confidence 389999988777676666677777777666 89999999998765 45899999999 789999988754 469999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.++.||+.||+|||++||+||||||+||||+.++.+||+|||++............+||+.|+|||++.+ .++.++|||
T Consensus 161 ~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 239 (311)
T 3p1a_A 161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVF 239 (311)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHH
T ss_pred HHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHH
Confidence 9999999999999999999999999999999999999999999987766555667789999999999887 799999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|||++|..+|.+... ...+.... ...++..++..+.+||.+||+.||++|||++|+|+||||+.
T Consensus 240 slG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 240 SLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999666554332 22222222 11234568999999999999999999999999999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.21 Aligned_cols=227 Identities=25% Similarity=0.507 Sum_probs=201.8
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.+.... .....++.+.+|+.+++.++||||+++++++.. +..+|+|||||+|++|.+++.... .+++..+..
T Consensus 69 ~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~ 145 (335)
T 2owb_A 69 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARY 145 (335)
T ss_dssp EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHH
T ss_pred EEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHH
Confidence 7899887654 345677889999999999999999999998765 458999999999999999998754 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++.++|||
T Consensus 146 i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 225 (335)
T 2owb_A 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 225 (335)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999999876432 334567899999999999998999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|..||......+....+.... ..++..++..+.+||.+||+.||.+||+++|+|+||||..
T Consensus 226 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999988877777665543 3467789999999999999999999999999999999965
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=349.93 Aligned_cols=229 Identities=24% Similarity=0.409 Sum_probs=185.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.... ......+.+|+.+|++++||||+++++++... ..+|+|||||+ ++|.+++...+ ..+++..++.+
T Consensus 30 vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~ 105 (324)
T 3mtl_A 30 VALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLF 105 (324)
T ss_dssp EEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHH
T ss_pred EEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHH
Confidence 89999976442 22223456899999999999999999987654 57899999996 69999998753 46999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccC-CCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLAD-IPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~-~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+ ..|+.++|||
T Consensus 106 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 185 (324)
T 3mtl_A 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMW 185 (324)
T ss_dssp HHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHH
Confidence 999999999999999999999999999999999999999999765432 23445689999999999876 5689999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC-----------------------------CccccHHHHHHHHHh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL-----------------------------PTVYSGAFRGLVKSM 210 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l-----------------------------p~~~S~~l~~LI~km 210 (582)
||||++|+|++|.+||.+.+..+....+......+. ...++.++.+||.+|
T Consensus 186 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 265 (324)
T 3mtl_A 186 GVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKL 265 (324)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHH
Confidence 999999999999999999988887777655333221 124678999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCCchhh
Q 007991 211 LRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
|+.||.+|||++|+|+||||....
T Consensus 266 L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 266 LQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp SCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cCcCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=337.57 Aligned_cols=227 Identities=21% Similarity=0.408 Sum_probs=198.9
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++....... ...+.+.+|+.++++++||||+++++++.. +...|+||||+++++|.+++...+ .+++..+..
T Consensus 42 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 118 (284)
T 2vgo_A 42 MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSAT 118 (284)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHH
Confidence 7899886543221 224678999999999999999999998765 458999999999999999998765 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+..++.++||||
T Consensus 119 ~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 197 (284)
T 2vgo_A 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWC 197 (284)
T ss_dssp HHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHH
T ss_pred HHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhh
Confidence 9999999999999999999999999999999999999999998655432 345678999999999999989999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||++|+|++|..||...+.......+.... ..++..++..+.+||.+||..||.+||+++++++||||+..
T Consensus 198 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 198 AGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 9999999999999999988887777665543 34677899999999999999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=359.29 Aligned_cols=227 Identities=22% Similarity=0.374 Sum_probs=188.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHH--hCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKK--ANGVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk--~~~~~l 73 (582)
.||||++..... ...+|+++|++|+|||||+++++|... ..++++||||+. ++|.+++.. .....+
T Consensus 81 ~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l 153 (420)
T 1j1b_A 81 LVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTL 153 (420)
T ss_dssp EEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCC
T ss_pred EEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCC
Confidence 389999865432 245799999999999999999988642 236789999996 467766653 234579
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccccccCcccCCCCCCCcccccCC-C
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-P 151 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~-~ 151 (582)
++..++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++..........++||+.|+|||++.+. .
T Consensus 154 ~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 233 (420)
T 1j1b_A 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233 (420)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSS
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCC
Confidence 999999999999999999999999999999999999966 56899999999877666666678999999999998764 6
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAF 203 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l 203 (582)
|+.++|||||||++|||++|++||.+.+..+.+..+......+ ++..++.++
T Consensus 234 ~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 313 (420)
T 1j1b_A 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 313 (420)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHH
T ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHH
Confidence 9999999999999999999999999988776665554321111 223568999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 204 RGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 204 ~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
.+||.+||.+||.+||++.|+|+||||+.+.
T Consensus 314 ~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 314 IALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 9999999999999999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.03 Aligned_cols=227 Identities=25% Similarity=0.507 Sum_probs=201.5
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||+|.+.... ......+.+.+|+.+++.++||||+++++++.. +...|+||||++|++|.+++.... .+++..+..
T Consensus 43 ~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~ 119 (294)
T 2rku_A 43 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARY 119 (294)
T ss_dssp EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHH
T ss_pred EEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 7899887654 345667889999999999999999999998765 458999999999999999998754 689999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++.++|||
T Consensus 120 i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 199 (294)
T 2rku_A 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 199 (294)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999999775432 334557899999999999998899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|..||......+....+.... ..++..++..+.+||.+||+.||++|||++|+|+||||..
T Consensus 200 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 99999999999999999988887777665543 3467789999999999999999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.70 Aligned_cols=225 Identities=27% Similarity=0.482 Sum_probs=195.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.... ...+.+.+|+.+|++++||||+++++++.. +..+|+||||++|++|.+++...+ .+++..+..+
T Consensus 37 vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 111 (304)
T 2jam_A 37 FALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQLVSGGELFDRILERG--VYTEKDASLV 111 (304)
T ss_dssp EEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHH
T ss_pred EEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHH
Confidence 79999976432 233568899999999999999999998765 458999999999999999998765 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .....+||+.|+|||++.+..++.++||
T Consensus 112 ~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (304)
T 2jam_A 112 IQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDC 190 (304)
T ss_dssp HHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHH
T ss_pred HHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhH
Confidence 9999999999999999999999999999 77889999999998754432 3445689999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|..||.+.....+...+...... +.+..++..+.+||.+||..||.+||+++|+|+||||+.
T Consensus 191 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 191 WSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999888888877665432 344678999999999999999999999999999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.92 Aligned_cols=228 Identities=32% Similarity=0.506 Sum_probs=193.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++... .....+.+.+|+.+|++++||||+++++++... ..+|+|||||+|++|.+++.... .+++..+..+
T Consensus 61 va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 136 (360)
T 3eqc_A 61 MARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKV 136 (360)
T ss_dssp EEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHH
T ss_pred EEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence 7899887653 456678899999999999999999999988764 58999999999999999998865 6899999999
Q ss_pred HHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||+. ||+||||||+||||+.++.+||+|||++...... .....+||+.|+|||++.+..++.++||||
T Consensus 137 ~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 215 (360)
T 3eqc_A 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWS 215 (360)
T ss_dssp HHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHH
Confidence 99999999999996 9999999999999999999999999999766433 345678999999999999999999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHH------------------------------------------HhhccCCCC-Cc
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINK------------------------------------------INKSIVAPL-PT 197 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~k------------------------------------------I~~~~~~~l-p~ 197 (582)
|||++|+|++|..||...+...+... +........ ..
T Consensus 216 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (360)
T 3eqc_A 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295 (360)
T ss_dssp HHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTT
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcc
Confidence 99999999999999987665443222 222222222 23
Q ss_pred cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 198 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 198 ~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
.++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 296 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 296 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 4789999999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=336.97 Aligned_cols=228 Identities=29% Similarity=0.543 Sum_probs=170.8
Q ss_pred EEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+....... ...+.+.+|+.++++++||||+++++++.. +...|+||||+++++|.+++... ...+++..++.
T Consensus 39 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 116 (278)
T 3cok_A 39 VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARH 116 (278)
T ss_dssp EEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHH
T ss_pred EEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHH
Confidence 7899986533211 224678999999999999999999998765 45899999999999999999864 34699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++.++|||
T Consensus 117 ~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 196 (278)
T 3cok_A 117 FMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVW 196 (278)
T ss_dssp HHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHH
T ss_pred HHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHH
Confidence 9999999999999999999999999999999999999999999765432 233457899999999999998899999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|..||...........+... ....+..++.++.+||.+||+.||.+|||++++|+||||+.
T Consensus 197 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 197 SLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp HHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred HHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 9999999999999999877655554444322 23456778999999999999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.65 Aligned_cols=236 Identities=24% Similarity=0.392 Sum_probs=188.6
Q ss_pred EEEEEeccccc---------CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec----CcEEEEEEeecCCCCHHHHHHHh
Q 007991 2 YVLKKIRLARQ---------TDRARRSAHQEMELISRVRNPFIVEYKDSWVEK----GCYVCIIIGYCEGGDMAEAIKKA 68 (582)
Q Consensus 2 yAIKki~~~~~---------~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~----~~~l~LVmEy~~GgsL~d~Ikk~ 68 (582)
||||++..... .....+.+.+|+.+|++++||||+++++++... ...+|+||||+. |+|.+.+...
T Consensus 49 vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~ 127 (362)
T 3pg1_A 49 VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ 127 (362)
T ss_dssp EEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT
T ss_pred EEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc
Confidence 89999866432 334557899999999999999999999988643 347999999997 6888888764
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc
Q 007991 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 148 (582)
Q Consensus 69 ~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~ 148 (582)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.
T Consensus 128 -~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (362)
T 3pg1_A 128 -RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206 (362)
T ss_dssp -TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHT
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhc
Confidence 3469999999999999999999999999999999999999999999999999998766655566788999999999987
Q ss_pred C-CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-------------------------------CC
Q 007991 149 D-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-------------------------------LP 196 (582)
Q Consensus 149 ~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-------------------------------lp 196 (582)
+ ..++.++|||||||++|+|++|..||.+.+.......+......+ ..
T Consensus 207 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (362)
T 3pg1_A 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV 286 (362)
T ss_dssp TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHS
T ss_pred CCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhC
Confidence 7 678999999999999999999999999988777766654322111 12
Q ss_pred ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhhhc
Q 007991 197 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHL 239 (582)
Q Consensus 197 ~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~~~ 239 (582)
..+++.+.+||.+||+.||.+|||++|+|+||||+.+......
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 329 (362)
T 3pg1_A 287 PTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329 (362)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGG
T ss_pred CCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccc
Confidence 3468889999999999999999999999999999986544433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.91 Aligned_cols=229 Identities=29% Similarity=0.464 Sum_probs=193.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++.... .....+.+.+|+++|++++||||+++++++.... ..+|+||||++ ++|.++++.. .+++..
T Consensus 55 vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~ 129 (364)
T 3qyz_A 55 VAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDH 129 (364)
T ss_dssp EEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHH
T ss_pred EEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHH
Confidence 8999997533 4556678899999999999999999999886443 47899999996 6999999863 599999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccC-CCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLAD-IPY 152 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~-~~y 152 (582)
++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... .....+||+.|+|||++.+ ..+
T Consensus 130 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 209 (364)
T 3qyz_A 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209 (364)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSC
T ss_pred HHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCC
Confidence 99999999999999999999999999999999999999999999998664332 2345689999999998754 458
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHH
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGA 202 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~ 202 (582)
+.++|||||||++|+|++|.+||.+.+..+.+..+......+ +...++.+
T Consensus 210 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (364)
T 3qyz_A 210 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289 (364)
T ss_dssp STHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHH
T ss_pred CcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHH
Confidence 999999999999999999999998887666665554322211 11346889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 203 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 203 l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
+.+||.+||+.||.+|||++|+|+||||+.+..
T Consensus 290 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 999999999999999999999999999988643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=336.44 Aligned_cols=231 Identities=26% Similarity=0.436 Sum_probs=178.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~ 78 (582)
.||||+++.........+.+.++..+++.++||||+++++++... ...|+||||++ |+|.+++... .+..+++..+
T Consensus 34 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~ 111 (290)
T 3fme_A 34 IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111 (290)
T ss_dssp EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHH
T ss_pred EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHH
Confidence 389999987665555666667777779999999999999988754 47899999997 5888877642 3457999999
Q ss_pred HHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccc----cCCCCC
Q 007991 79 CKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL----ADIPYG 153 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l----~~~~y~ 153 (582)
+.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.............||+.|+|||++ .+..++
T Consensus 112 ~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 191 (290)
T 3fme_A 112 GKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191 (290)
T ss_dssp HHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CC
T ss_pred HHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCC
Confidence 99999999999999998 9999999999999999999999999999877666555667899999999996 556788
Q ss_pred CCCcccchhHHHHhHhcCCcccccc-CH-HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAF-DM-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~-~~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
.++|||||||++|+|++|..||... .. ..+...+........+..++..+.+||.+||+.||++|||++|+|+||||+
T Consensus 192 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 9999999999999999999999853 33 333333333333333456899999999999999999999999999999997
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
..
T Consensus 272 ~~ 273 (290)
T 3fme_A 272 LH 273 (290)
T ss_dssp HH
T ss_pred cC
Confidence 53
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=350.45 Aligned_cols=222 Identities=27% Similarity=0.429 Sum_probs=191.7
Q ss_pred CEEEEEecccccCHH------HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCC-CHHHHHHHhCCCCC
Q 007991 1 MYVLKKIRLARQTDR------ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG-DMAEAIKKANGVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~~------~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~Gg-sL~d~Ikk~~~~~l 73 (582)
.||||.++....... ..+.+.+|+.+|++++||||++++++|.. +..+|+||||+.+| +|.+++.... .+
T Consensus 51 ~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e~~~~g~~l~~~~~~~~--~l 127 (335)
T 3dls_A 51 EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-QGFFQLVMEKHGSGLDLFAFIDRHP--RL 127 (335)
T ss_dssp EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTSCBHHHHHHTCC--CC
T ss_pred EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-CCEEEEEEEeCCCCccHHHHHHhcC--CC
Confidence 389999987543222 33457789999999999999999998765 45899999999766 9999998754 69
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY- 152 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y- 152 (582)
++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..+
T Consensus 128 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 207 (335)
T 3dls_A 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207 (335)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCC
Confidence 9999999999999999999999999999999999999999999999999988776666677899999999999988876
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+.++|||||||++|+|++|..||..... . .......+..++.++.+||.+||+.||++|||++++|+||||+.
T Consensus 208 ~~~~DiwslG~il~el~~g~~pf~~~~~------~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 208 GPELEMWSLGVTLYTLVFEENPFCELEE------T-VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred CCcccchhHHHHHHHHHhCCCchhhHHH------H-HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 7889999999999999999999976431 1 11223346678999999999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.56 Aligned_cols=230 Identities=24% Similarity=0.460 Sum_probs=196.5
Q ss_pred EEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQT--DRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~--~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||.++..... ....+.+.+|+.+|++++||||+++++++.. .+..+|+|||||+++ |.+++.......+++..+
T Consensus 33 ~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~ 111 (305)
T 2wtk_C 33 RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQA 111 (305)
T ss_dssp EEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHH
T ss_pred EEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHH
Confidence 789988764321 2345779999999999999999999998753 345789999999866 888888766667999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc---ccccCcccCCCCCCCcccccCCC--CC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPELLADIP--YG 153 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~---~~~~~~~vGTp~Y~APE~l~~~~--y~ 153 (582)
..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........||+.|+|||++.+.. ++
T Consensus 112 ~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 191 (305)
T 2wtk_C 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191 (305)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEES
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCc
Confidence 99999999999999999999999999999999999999999999976542 22334567999999999998654 36
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.++|||||||++|+|++|..||.+.+...+...+.... ..++..++..+.+||.+||..||.+|||++|+++||||+..
T Consensus 192 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 192 FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 78999999999999999999999999888887776654 34677899999999999999999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.17 Aligned_cols=227 Identities=26% Similarity=0.473 Sum_probs=190.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~--HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||++..........+.+.+|+.+|++|. |||||++++++... ..+|+||| +.+++|.+++.... .+++..+
T Consensus 82 ~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~ 157 (390)
T 2zmd_A 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKK--SIDPWER 157 (390)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEE-CCSEEHHHHHHHCS--SCCHHHH
T ss_pred EEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEEEEe-cCCCCHHHHHHhcC--CCCHHHH
Confidence 3899999887777788889999999999997 59999999987655 57999999 55899999998754 7899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC------
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD------ 149 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~------ 149 (582)
+.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++...... .....+||+.|+|||++.+
T Consensus 158 ~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 236 (390)
T 2zmd_A 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236 (390)
T ss_dssp HHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-----
T ss_pred HHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccccc
Confidence 99999999999999999999999999999995 6889999999998764332 2356789999999999865
Q ss_pred -----CCCCCCCcccchhHHHHhHhcCCccccccC-HHHHHHHHh-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 150 -----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALINKIN-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 150 -----~~y~~ksDIWSLG~iLyELltG~~PF~~~~-~~~l~~kI~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
..|+.++|||||||++|+|++|.+||.... ....+..+. ......++...+..+.+||.+||+.||.+|||+.
T Consensus 237 ~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 316 (390)
T 2zmd_A 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316 (390)
T ss_dssp -------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHH
Confidence 368889999999999999999999998653 323333333 3334456677889999999999999999999999
Q ss_pred HHHcCCCCch
Q 007991 223 ELLCHPHLQP 232 (582)
Q Consensus 223 EiL~hp~f~~ 232 (582)
|+|+||||+.
T Consensus 317 ell~hp~~~~ 326 (390)
T 2zmd_A 317 ELLAHPYVQI 326 (390)
T ss_dssp HHHTSHHHHS
T ss_pred HHhhCcCccc
Confidence 9999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.88 Aligned_cols=224 Identities=22% Similarity=0.413 Sum_probs=189.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~~~ 80 (582)
||||++..........+.+.+|+++|++++||||+++++++... ..+|+|||||+|++|.+++.+... ..+++..+..
T Consensus 63 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 141 (309)
T 3p86_A 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141 (309)
T ss_dssp EEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHH
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHH
Confidence 79999988877777788899999999999999999999987654 478999999999999999986431 1389999999
Q ss_pred HHHHHHHHHHHHHHCC--ceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|
T Consensus 142 i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (309)
T 3p86_A 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221 (309)
T ss_dssp HHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHH
T ss_pred HHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhh
Confidence 9999999999999999 9999999999999999999999999997654332 244678999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHh-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|+|++|..||.+.+.......+. ......++..+++.+.+||.+||+.||.+|||++++++
T Consensus 222 iwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 222 VYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999998888777664 33445677889999999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.29 Aligned_cols=228 Identities=25% Similarity=0.422 Sum_probs=188.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHH-hCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKK-ANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk-~~~~~lse 75 (582)
||+|++..... ...+|+++|+.++|||||+++++|...+ .++|+|||||.++.+..+... .....+++
T Consensus 67 ~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~ 140 (394)
T 4e7w_A 67 VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140 (394)
T ss_dssp EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCH
T ss_pred EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCH
Confidence 67888754332 2347999999999999999999886543 358899999976544333321 12347999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEc-CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCC-CCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYG 153 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~-~y~ 153 (582)
..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+++..........++||+.|+|||++.+. .|+
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (394)
T 4e7w_A 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCC
Confidence 99999999999999999999999999999999999 7899999999999887666666778999999999998765 589
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRG 205 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~ 205 (582)
.++|||||||++|+|++|.+||.+.+..+.+..+......+ ++..+++++.+
T Consensus 221 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (394)
T 4e7w_A 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAID 300 (394)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHH
Confidence 99999999999999999999999988777666654432111 22347889999
Q ss_pred HHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 206 LVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 206 LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 301 LISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 999999999999999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.11 Aligned_cols=228 Identities=25% Similarity=0.426 Sum_probs=189.1
Q ss_pred EEEEEecccccCH---HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTD---RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~---~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||+++...... ...+.+.+|+.+|++++||||++++++|.. +...|+||||+++ +|.+++... ...+++..+
T Consensus 38 vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~ 114 (346)
T 1ua2_A 38 VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFMET-DLEVIIKDN-SLVLTPSHI 114 (346)
T ss_dssp EEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHH
T ss_pred EEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHH
Confidence 8999997644322 223568899999999999999999998765 4578999999975 898888764 346899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC-CCCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYGSKS 156 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~-~y~~ks 156 (582)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+. .|+.++
T Consensus 115 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 194 (346)
T 1ua2_A 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 194 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHH
T ss_pred HHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchh
Confidence 999999999999999999999999999999999999999999999876433 334567899999999999764 588999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---------------------------CccccHHHHHHHHH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------------------------PTVYSGAFRGLVKS 209 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---------------------------p~~~S~~l~~LI~k 209 (582)
|||||||++|+|++|.+||.+.+..+.+..+......+. ...++..+.+||.+
T Consensus 195 DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (346)
T 1ua2_A 195 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG 274 (346)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHH
T ss_pred hhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHH
Confidence 999999999999999999999888777776654322111 13467899999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCch
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||..||.+|||++|+|+||||+.
T Consensus 275 ~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 275 LFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp HHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HhccChhhCCCHHHHhcChhhhc
Confidence 99999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.61 Aligned_cols=224 Identities=20% Similarity=0.374 Sum_probs=198.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++... .....+.+.+|+.+|+++ +|||||++++++... ..+|+|||||+||+|.+++....
T Consensus 116 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 193 (370)
T 2psq_A 116 VAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193 (370)
T ss_dssp EEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHTCCC---------
T ss_pred EEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC-CCEEEEEEcCCCCCHHHHHHhhCCcccccccccc
Confidence 8999997653 455667899999999999 899999999987654 57899999999999999998753
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|
T Consensus 194 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~a 273 (370)
T 2psq_A 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273 (370)
T ss_dssp --CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCC
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceEC
Confidence 1358999999999999999999999999999999999999999999999999998654332 2334567889999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..|+.++|||||||++|||++ |..||.+.+..++...+........+..++..+.+||.+||..||.+||++.
T Consensus 274 PE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 353 (370)
T 2psq_A 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 353 (370)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999999999999999999999998 9999999988888888877777778888999999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
|++++
T Consensus 354 ell~~ 358 (370)
T 2psq_A 354 QLVED 358 (370)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=336.03 Aligned_cols=226 Identities=30% Similarity=0.562 Sum_probs=202.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ...+.+.+|+.+|++++||||+++++++... ..+|+||||++|++|.+++... .+++..+..+
T Consensus 50 vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~ 124 (303)
T 3a7i_A 50 VAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPG---PLDETQIATI 124 (303)
T ss_dssp EEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHH
T ss_pred EEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHH
Confidence 799999765432 3356789999999999999999999988765 5899999999999999999752 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.++||||
T Consensus 125 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 204 (303)
T 3a7i_A 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 204 (303)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred HHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHH
Confidence 9999999999999999999999999999999999999999997765433 345678999999999999989999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...........+.......++..++..+.+||.+||..||.+|||++++|+||||..
T Consensus 205 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 205 LGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 999999999999999998888877777766666677889999999999999999999999999999999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.86 Aligned_cols=225 Identities=24% Similarity=0.370 Sum_probs=191.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc------CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV------RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L------~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||+++. .....+.+.+|+.+|+.+ +|+||++++++|... ..+|+||||+. ++|.+++.......+++
T Consensus 125 vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~~~~~~~~~~ 199 (429)
T 3kvw_A 125 VALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NHICMTFELLS-MNLYELIKKNKFQGFSL 199 (429)
T ss_dssp EEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TEEEEEECCCC-CBHHHHHHHTTTCCCCH
T ss_pred EEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-CeEEEEEeccC-CCHHHHHHhccCCCCCH
Confidence 89999975 345556788899999988 567999999988665 58999999995 79999999876566999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCC--eEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~--vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||++..... .....+||+.|+|||++.+..|+
T Consensus 200 ~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 277 (429)
T 3kvw_A 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYG 277 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCC
T ss_pred HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCCC
Confidence 999999999999999999999999999999999999987 99999999965432 34567999999999999999999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---------------------------------------
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--------------------------------------- 194 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--------------------------------------- 194 (582)
.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 278 ~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (429)
T 3kvw_A 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357 (429)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCE
T ss_pred chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccccccccc
Confidence 99999999999999999999999988877766654322111
Q ss_pred -------------------CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 195 -------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 195 -------------------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
++...++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 358 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp ECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred ccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 111237889999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.48 Aligned_cols=231 Identities=18% Similarity=0.349 Sum_probs=186.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcE-----EEEEEeecCCCCHHHHHHHhC----CCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY-----VCIIIGYCEGGDMAEAIKKAN----GVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~-----l~LVmEy~~GgsL~d~Ikk~~----~~~ 72 (582)
||||.++.........+.+.+|+++|++++||||+++++++...+.. .|+||||+.|++|.+++.... ...
T Consensus 54 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~ 133 (323)
T 3qup_A 54 VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133 (323)
T ss_dssp EEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCC
T ss_pred EEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccc
Confidence 79999987665556678899999999999999999999988765422 389999999999999997542 125
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~ 149 (582)
+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... .....+++.|+|||++.+
T Consensus 134 ~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence 89999999999999999999999999999999999999999999999999987644332 224456778999999999
Q ss_pred CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-------H
Q 007991 150 IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-------A 221 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-------a 221 (582)
..++.++|||||||++|+|++ |.+||.+.+...+...+........+..+++.+.+||.+||+.||.+||| +
T Consensus 214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999999 99999998888888888777777778889999999999999999999999 7
Q ss_pred HHHHcCCCCch
Q 007991 222 AELLCHPHLQP 232 (582)
Q Consensus 222 ~EiL~hp~f~~ 232 (582)
++++.|+|+..
T Consensus 294 ~~~l~~~~~~~ 304 (323)
T 3qup_A 294 ENILGHLSVLS 304 (323)
T ss_dssp HHHHHC-----
T ss_pred HHHHHHhhhcC
Confidence 77888988864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.09 Aligned_cols=233 Identities=25% Similarity=0.467 Sum_probs=192.8
Q ss_pred CEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQ--TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||+++.... .....+.+.+|+++|+++ +||||+++++++... ..+|+|||||+|++|.+++.... .+++..
T Consensus 84 ~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 160 (355)
T 1vzo_A 84 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRE--RFTEHE 160 (355)
T ss_dssp EEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHHHHS--CCCHHH
T ss_pred EEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-ceEEEEeecCCCCCHHHHHHHcC--CCCHHH
Confidence 379999875432 112334577899999999 699999999987654 58999999999999999998765 699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc--cccCcccCCCCCCCcccccC--CCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELLAD--IPYG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--~~~~~~vGTp~Y~APE~l~~--~~y~ 153 (582)
+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ......+||+.|+|||++.+ ..++
T Consensus 161 ~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 240 (355)
T 1vzo_A 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240 (355)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCC
Confidence 9999999999999999999999999999999999999999999999765432 23445789999999999985 3478
Q ss_pred CCCcccchhHHHHhHhcCCcccccc----CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAEL 224 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~----~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~Ei 224 (582)
.++|||||||++|+|++|..||... ....+...+.. ...+++..++..+.+||.+||..||.+|| +++|+
T Consensus 241 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el 319 (355)
T 1vzo_A 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319 (355)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH
T ss_pred chhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH
Confidence 8999999999999999999999643 33344444433 23456778999999999999999999999 99999
Q ss_pred HcCCCCchhhhhh
Q 007991 225 LCHPHLQPYVLGI 237 (582)
Q Consensus 225 L~hp~f~~~~~~~ 237 (582)
++||||+.+.+..
T Consensus 320 l~h~~f~~~~~~~ 332 (355)
T 1vzo_A 320 KEHLFFQKINWDD 332 (355)
T ss_dssp HTSGGGTTCCHHH
T ss_pred HcCcchhcCChhH
Confidence 9999998765443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.04 Aligned_cols=229 Identities=27% Similarity=0.493 Sum_probs=200.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++..........+.+.+|+.+|++++||||+++++++.. +..+|+||||+.|++|.+.+.... .+++..+..+
T Consensus 50 valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 126 (287)
T 2wei_A 50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARI 126 (287)
T ss_dssp EEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHH
T ss_pred EEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHH
Confidence 7999997766555556789999999999999999999998765 458999999999999999998755 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCC---CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.............||+.|+|||++.+ .++.++||
T Consensus 127 ~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di 205 (287)
T 2wei_A 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDV 205 (287)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHH
T ss_pred HHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhh
Confidence 9999999999999999999999999999764 4699999999987765555566789999999999876 48899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-CC--CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-~l--p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
|||||++|+|++|..||.+.+...+...+...... +. ...++..+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 206 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 206 WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999888887777655432 22 246899999999999999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.75 Aligned_cols=223 Identities=24% Similarity=0.397 Sum_probs=186.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||+++... .+.+.+|+.+|+++. ||||+++++++... ....|+||||+.+++|.++++ .+++..++
T Consensus 64 vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~ 133 (330)
T 3nsz_A 64 VVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIR 133 (330)
T ss_dssp EEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHH
T ss_pred EEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-----hCCHHHHH
Confidence 7999987532 356889999999997 99999999988753 457899999999999999885 38899999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ksD 157 (582)
.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...........+||+.|+|||++.+ ..++.++|
T Consensus 134 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 213 (330)
T 3nsz_A 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213 (330)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhh
Confidence 9999999999999999999999999999999777 899999999987766666677899999999999987 66899999
Q ss_pred ccchhHHHHhHhcCCccccc-cCHHHHHHHHhh-------------cc-----------------------CCCCCcccc
Q 007991 158 IWSLGCCVYEMSAQKAAFKA-FDMQALINKINK-------------SI-----------------------VAPLPTVYS 200 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~-~~~~~l~~kI~~-------------~~-----------------------~~~lp~~~S 200 (582)
||||||++|+|++|..||.. .+..+....+.. .. ....+..++
T Consensus 214 iwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (330)
T 3nsz_A 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 293 (330)
T ss_dssp HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCC
T ss_pred HHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCC
Confidence 99999999999999999843 232222222111 00 011123379
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 201 GAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 201 ~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 294 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 294 PEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 9999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=329.77 Aligned_cols=228 Identities=22% Similarity=0.377 Sum_probs=191.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ...+.+.+|+.+++.++||||+++++++.. +...|+||||++|++|.+++.... .+++..+..+
T Consensus 35 vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 110 (276)
T 2yex_A 35 VAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRF 110 (276)
T ss_dssp EEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHH
T ss_pred EEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHH
Confidence 799998765433 345778999999999999999999998765 458899999999999999987533 6899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCC-CCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPY-GSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y-~~ksD 157 (582)
+.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ......+||+.|+|||++.+..+ +.++|
T Consensus 111 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 190 (276)
T 2yex_A 111 FHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190 (276)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHH
T ss_pred HHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcch
Confidence 999999999999999999999999999999999999999999765432 23456789999999999987765 67899
Q ss_pred ccchhHHHHhHhcCCccccccCHH-HHHHHHhh-ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINK-SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~-~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||||||++|+|++|..||...... .....+.. ....+....++..+.+||.+||..||.+|||++|+++||||+..
T Consensus 191 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 999999999999999999875532 12222222 22223345689999999999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=347.42 Aligned_cols=227 Identities=27% Similarity=0.442 Sum_probs=192.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCc-----EEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~-----~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++..........+.+.+|+.+|+.++||||++++++|...+. .+|+||||+. ++|.+++.. .+++
T Consensus 69 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~ 143 (371)
T 4exu_A 69 KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSE 143 (371)
T ss_dssp EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCH
T ss_pred EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCH
Confidence 38999998877778888899999999999999999999998875542 2489999996 688877743 5999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~ 154 (582)
..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .....+||+.|+|||++.+ ..++.
T Consensus 144 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 221 (371)
T 4exu_A 144 EKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQ 221 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCT
T ss_pred HHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCc
Confidence 99999999999999999999999999999999999999999999999986543 2456789999999999987 67999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~l~ 204 (582)
++|||||||++|+|++|..||.+.+..+.+..+......+ +...+++.+.
T Consensus 222 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (371)
T 4exu_A 222 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAA 301 (371)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHH
T ss_pred HHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHH
Confidence 9999999999999999999999988777666654322211 1234689999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||.+||+.||.+|||++|+|+||||+++.
T Consensus 302 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 302 DLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 999999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=335.04 Aligned_cols=225 Identities=24% Similarity=0.391 Sum_probs=191.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCC------eeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPF------IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn------IV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||+++.. ....+.+.+|+.+++.++|++ |++++++|... ..+|+||||+ +++|.+++.......+++
T Consensus 43 vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~-~~~l~~~l~~~~~~~~~~ 117 (339)
T 1z57_A 43 VAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-GHICIVFELL-GLSTYDFIKENGFLPFRL 117 (339)
T ss_dssp EEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTTTCCCCH
T ss_pred EEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-CcEEEEEcCC-CCCHHHHHHhcCCCCCcH
Confidence 789998643 455678899999999997654 99999987654 5899999999 899999999876567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC-------------------CCCeEEeecccchhcccccccCccc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-------------------DQDIRLGDFGLAKMLISDDLASSVV 136 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-------------------~g~vKL~DFGla~~~~~~~~~~~~v 136 (582)
..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..... .....+
T Consensus 118 ~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 195 (339)
T 1z57_A 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLV 195 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSC
T ss_pred HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--cccccc
Confidence 999999999999999999999999999999999987 66899999999976433 345678
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-----------------------
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA----------------------- 193 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~----------------------- 193 (582)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 196 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 275 (339)
T 1z57_A 196 STRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWD 275 (339)
T ss_dssp SCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCC
T ss_pred CCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccc
Confidence 999999999999999999999999999999999999999988876655544332211
Q ss_pred --------------------CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 194 --------------------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 194 --------------------~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
......++.+.+||.+||+.||.+|||++|+|+||||+.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 276 EHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred ccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 0122346789999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=328.63 Aligned_cols=221 Identities=22% Similarity=0.431 Sum_probs=197.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+.+|++++||||+++++++... ...|+||||++|++|.+++.... ..+++..+..+
T Consensus 37 vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 111 (269)
T 4hcu_A 37 VAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGM 111 (269)
T ss_dssp EEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHH
T ss_pred EEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHH
Confidence 7999998765544 4688999999999999999999987654 47899999999999999998643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||
T Consensus 112 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (269)
T 4hcu_A 112 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191 (269)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhH
Confidence 9999999999999999999999999999999999999999998664332 23445677889999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||.+.+.......+........+..++..+.+||.+||+.||.+||+++++++|
T Consensus 192 slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 192 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999 999999999999988888877777788899999999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.42 Aligned_cols=226 Identities=27% Similarity=0.523 Sum_probs=194.8
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .....+.+.+|+.+|++++|||||+++++|... ...|+|||||. |+|.+++.... ..+++..+.
T Consensus 81 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~ 157 (348)
T 1u5q_A 81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIA 157 (348)
T ss_dssp EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHH
T ss_pred EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHH
Confidence 389999977543 344567899999999999999999999988765 58999999996 68888887543 369999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc---CCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~~~y~~ks 156 (582)
.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....+||+.|+|||++. ...|+.++
T Consensus 158 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 234 (348)
T 1u5q_A 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 234 (348)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHH
T ss_pred HHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHH
Confidence 9999999999999999999999999999999999999999999976543 34578999999999984 56789999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|||++|.+||.+.+.......+...... ..+..+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 235 DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 235 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 9999999999999999999988877666665544333 235568999999999999999999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=337.75 Aligned_cols=228 Identities=26% Similarity=0.497 Sum_probs=189.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||.+...... .+.+.+|+.+|+++ +||||+++++++... +..+|+||||++|++|.+++....+..+++
T Consensus 52 vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 128 (326)
T 2x7f_A 52 AAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128 (326)
T ss_dssp EEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCH
T ss_pred EEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCH
Confidence 799998764432 35688999999999 799999999998764 468999999999999999998765557999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc-----C
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA-----D 149 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~-----~ 149 (582)
..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++. +
T Consensus 129 ~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 208 (326)
T 2x7f_A 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC------
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccC
Confidence 999999999999999999999999999999999999999999999999765432 2344568999999999987 5
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
..++.++|||||||++|+|++|..||.+.+.......+...... ..+..++..+.+||.+||..||.+||+++++|+||
T Consensus 209 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp --CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred cCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 56889999999999999999999999988877766665544332 23456899999999999999999999999999999
Q ss_pred CCch
Q 007991 229 HLQP 232 (582)
Q Consensus 229 ~f~~ 232 (582)
||+.
T Consensus 289 ~~~~ 292 (326)
T 2x7f_A 289 FIRD 292 (326)
T ss_dssp HHHC
T ss_pred HHhh
Confidence 9975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=341.66 Aligned_cols=230 Identities=23% Similarity=0.348 Sum_probs=191.1
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++.... .......+.+|+.++++++||||+++++++...+ ...|+|||||+|++|.+++...+ .+++.
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~ 116 (311)
T 3ork_A 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPK 116 (311)
T ss_dssp EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHH
T ss_pred eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHH
Confidence 389999987543 4456778999999999999999999999887543 25699999999999999998765 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y 152 (582)
.+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... .....+||+.|+|||++.+..+
T Consensus 117 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (311)
T 3ork_A 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCC
Confidence 999999999999999999999999999999999999999999999998664332 2334679999999999999999
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+.++|||||||++|+|++|..||.+.+.......+......+ ....++.++.+||.+||+.||.+||++.++|.|+|
T Consensus 197 ~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 197 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 999999999999999999999999988877766554443322 12458999999999999999999999999999988
Q ss_pred Cch
Q 007991 230 LQP 232 (582)
Q Consensus 230 f~~ 232 (582)
++.
T Consensus 277 ~~~ 279 (311)
T 3ork_A 277 VRV 279 (311)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.93 Aligned_cols=224 Identities=19% Similarity=0.321 Sum_probs=197.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN------------ 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~------------ 69 (582)
||||.++... .....+.+.+|+.+|++++||||+++++++.. +..+|+|||||+|++|.+++....
T Consensus 80 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 157 (343)
T 1luf_A 80 VAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157 (343)
T ss_dssp EEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHTCC-----------
T ss_pred EEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-CCceEEEEecCCCCcHHHHHHHhCcccccccccccc
Confidence 7999987643 45667789999999999999999999998765 457899999999999999998742
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCccc
Q 007991 70 ----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVV 136 (582)
Q Consensus 70 ----------~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~v 136 (582)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 237 (343)
T 1luf_A 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA 237 (343)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CC
T ss_pred cccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCc
Confidence 1469999999999999999999999999999999999999999999999999998764332 234567
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCC
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 215 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP 215 (582)
||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+..++..+.+||.+||..||
T Consensus 238 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 317 (343)
T 1luf_A 238 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 317 (343)
T ss_dssp BCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence 8899999999998899999999999999999998 999999999988888888777777888899999999999999999
Q ss_pred CCCCCHHHHHcC
Q 007991 216 EFRPSAAELLCH 227 (582)
Q Consensus 216 ~~RpSa~EiL~h 227 (582)
.+||++.+++++
T Consensus 318 ~~Rps~~~~~~~ 329 (343)
T 1luf_A 318 ADRPSFCSIHRI 329 (343)
T ss_dssp GGSCCHHHHHHH
T ss_pred ccCCCHHHHHHH
Confidence 999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=332.06 Aligned_cols=228 Identities=33% Similarity=0.570 Sum_probs=190.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|++..... ...+.+.+|+.+|+.++||||+++++++... ...|+|||||+|++|.+++.... ..+++..+..+
T Consensus 47 ~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~ 122 (302)
T 2j7t_A 47 AAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVV 122 (302)
T ss_dssp EEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHH
T ss_pred EEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHH
Confidence 78888865432 3346788999999999999999999988754 57899999999999999998743 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccc-----cCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELL-----ADIPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l-----~~~~y~~k 155 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++ .+..++.+
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 202 (302)
T 2j7t_A 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 202 (302)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTH
T ss_pred HHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchh
Confidence 999999999999999999999999999999999999999997654322 233456899999999998 46678899
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC--CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~--lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+|||||||++|+|++|..||...+.......+....... .+..++..+.+||.+||..||.+|||++++++||||+..
T Consensus 203 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 203 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred hhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 999999999999999999999988877776665544332 356789999999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.78 Aligned_cols=225 Identities=19% Similarity=0.392 Sum_probs=194.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||+++... .....+.+.+|+++|.++ +|||||+++++|...+..+|+|||||.||+|.+++.....
T Consensus 55 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 133 (359)
T 3vhe_A 55 VAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA 133 (359)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----
T ss_pred EEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccc
Confidence 8999997643 345567899999999999 7899999999988777779999999999999999987532
Q ss_pred ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007991 71 ------------------------------------------------------VHFPEEKLCKWLVQLLMALNYLHANH 96 (582)
Q Consensus 71 ------------------------------------------------------~~lse~~~~~il~QLL~aL~yLHs~g 96 (582)
..+++..+..|+.||+.||.|||++|
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ 213 (359)
T 3vhe_A 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 213 (359)
T ss_dssp --------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 12899999999999999999999999
Q ss_pred ceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CC
Q 007991 97 ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QK 172 (582)
Q Consensus 97 IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~ 172 (582)
|+||||||+||||+.++.+||+|||++....... ......||+.|+|||++.+..|+.++|||||||++|+|++ |.
T Consensus 214 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 293 (359)
T 3vhe_A 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293 (359)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence 9999999999999999999999999998654322 2345678999999999999899999999999999999998 99
Q ss_pred ccccccCH-HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 173 AAFKAFDM-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 173 ~PF~~~~~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.||.+... ..+...+........+..+++++.+||.+||..||.+|||++|+++|
T Consensus 294 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99987663 34445555555666788899999999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.57 Aligned_cols=225 Identities=30% Similarity=0.559 Sum_probs=195.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++...... +.+.+|+.+|++++||||+++++++... ..+|+||||++|++|.+++.... ..+++..+..+
T Consensus 57 vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i 130 (314)
T 3com_A 57 VAIKQVPVESDL----QEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATI 130 (314)
T ss_dssp EEEEEEETTSCC----HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHH
T ss_pred EEEEecCchHHH----HHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 799999765432 4578999999999999999999988764 58899999999999999998543 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||
T Consensus 131 ~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 210 (314)
T 3com_A 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWS 210 (314)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHH
T ss_pred HHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHH
Confidence 9999999999999999999999999999999999999999997654432 344568999999999999989999999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||++|+|++|..||...+.......+...... ..+..++..+.+||.+||..||.+|||++++|+||||+.
T Consensus 211 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 211 LGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 999999999999999988876665555443322 235668999999999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=338.71 Aligned_cols=227 Identities=21% Similarity=0.366 Sum_probs=187.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~ 78 (582)
.||||+++..... ...+.+.+|+++|++++||||+++++++...+ ...|+|||||+|++|.+++..... ..+++..+
T Consensus 36 ~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (319)
T 4euu_A 36 LFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (319)
T ss_dssp EEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHH
T ss_pred EEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHH
Confidence 3899999764322 22456789999999999999999999887543 378999999999999999987432 23999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEE----cCCCCeEEeecccchhcccccccCcccCCCCCCCccccc------
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA------ 148 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL----~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~------ 148 (582)
..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...........+||+.|+|||++.
T Consensus 115 ~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 194 (319)
T 4euu_A 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194 (319)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCC
T ss_pred HHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccc
Confidence 9999999999999999999999999999999 777889999999998876666666788999999999986
Q ss_pred --CCCCCCCCcccchhHHHHhHhcCCcccccc----CHHHHHHHHhhccCC------------------------CCCcc
Q 007991 149 --DIPYGSKSDIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVA------------------------PLPTV 198 (582)
Q Consensus 149 --~~~y~~ksDIWSLG~iLyELltG~~PF~~~----~~~~l~~kI~~~~~~------------------------~lp~~ 198 (582)
+..|+.++|||||||++|+|++|..||... ...+++..+...... .+...
T Consensus 195 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (319)
T 4euu_A 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG 274 (319)
T ss_dssp CCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHH
T ss_pred cccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchh
Confidence 567899999999999999999999999642 223444444332211 12334
Q ss_pred ccHHHHHHHHHhccCCCCCCCCHHHHHcCC
Q 007991 199 YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228 (582)
Q Consensus 199 ~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp 228 (582)
++..+.+||.+||+.||++|||++|+|+||
T Consensus 275 ~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 275 LQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 677899999999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=344.96 Aligned_cols=225 Identities=27% Similarity=0.436 Sum_probs=185.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC--------CCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR--------NPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKAN 69 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~--------HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~ 69 (582)
.||||+++.. ....+.+.+|+.+|+++. |+||++++++|.. .+.++|+||||+ +++|.+.+....
T Consensus 64 ~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~ 139 (397)
T 1wak_A 64 FVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN 139 (397)
T ss_dssp EEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT
T ss_pred EEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc
Confidence 3899999643 455678899999999996 7889999998873 346899999999 677777777655
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCC-----------------------------------
Q 007991 70 GVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQ----------------------------------- 113 (582)
Q Consensus 70 ~~~lse~~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g----------------------------------- 113 (582)
...+++..++.|+.||+.||+|||++ ||+||||||+||||+.++
T Consensus 140 ~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (397)
T 1wak_A 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219 (397)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccc
Confidence 45799999999999999999999999 999999999999999876
Q ss_pred --------------CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccC
Q 007991 114 --------------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179 (582)
Q Consensus 114 --------------~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~ 179 (582)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+
T Consensus 220 ~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp TSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 7999999999766433 455689999999999999999999999999999999999999997544
Q ss_pred ------HHHHHHHHhhccC-----------------------------------------CCCCccccHHHHHHHHHhcc
Q 007991 180 ------MQALINKINKSIV-----------------------------------------APLPTVYSGAFRGLVKSMLR 212 (582)
Q Consensus 180 ------~~~l~~kI~~~~~-----------------------------------------~~lp~~~S~~l~~LI~kmL~ 212 (582)
.......+..... ..++...+..+.+||.+||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 377 (397)
T 1wak_A 298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377 (397)
T ss_dssp CSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhc
Confidence 2222222211111 01234456789999999999
Q ss_pred CCCCCCCCHHHHHcCCCCc
Q 007991 213 KNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 213 ~dP~~RpSa~EiL~hp~f~ 231 (582)
.||++|||++|+|+||||+
T Consensus 378 ~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 378 LIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SSGGGSCCHHHHHTSGGGG
T ss_pred cChhhcCCHHHHhhCcccc
Confidence 9999999999999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=339.76 Aligned_cols=223 Identities=21% Similarity=0.379 Sum_probs=196.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++... .....+.+.+|+.+|++++||||+++++++.. +...|+|||||+|++|.++++... ..+++..+..+
T Consensus 80 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 156 (325)
T 3kul_A 80 VAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGM 156 (325)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHH
T ss_pred EEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHH
Confidence 8999997643 45667889999999999999999999998754 457899999999999999997643 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..++.++|
T Consensus 157 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 236 (325)
T 3kul_A 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASD 236 (325)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHH
Confidence 9999999999999999999999999999999999999999998764432 122345677899999999889999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|+|++ |..||.+.....+...+......+.+..++..+.+||..||..||.+|||+.++++.
T Consensus 237 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 237 VWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999998 999999999999999888887778888999999999999999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.42 Aligned_cols=229 Identities=28% Similarity=0.471 Sum_probs=180.2
Q ss_pred EEEEEecccccC------HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQT------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~------~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||++...... ......+.+|+.+|++++|||||++++++. . ..+|+|||||.|++|.+++.... .+++
T Consensus 163 vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~ 238 (419)
T 3i6u_A 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A-EDYYIVLELMEGGELFDKVVGNK--RLKE 238 (419)
T ss_dssp EEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S-SEEEEEEECCTTCBGGGGTSSSC--CCCH
T ss_pred EEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-CceEEEEEcCCCCcHHHHHhccC--CCCH
Confidence 899998764321 122345889999999999999999999764 3 35789999999999999887643 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC---CeEEeecccchhcccccccCcccCCCCCCCcccccC---
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ---DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--- 149 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g---~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~--- 149 (582)
..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...........+||+.|+|||++.+
T Consensus 239 ~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 318 (419)
T 3i6u_A 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318 (419)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCC
Confidence 99999999999999999999999999999999997654 499999999998776666677899999999999863
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCCCCC---ccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPLP---TVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~lp---~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
..|+.++|||||||++|+|++|.+||.+.... .+...+........+ ..+++.+.+||.+||+.||.+|||++|+|
T Consensus 319 ~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 56788999999999999999999999765432 233344433332222 35799999999999999999999999999
Q ss_pred cCCCCchhh
Q 007991 226 CHPHLQPYV 234 (582)
Q Consensus 226 ~hp~f~~~~ 234 (582)
+||||+...
T Consensus 399 ~hp~~~~~~ 407 (419)
T 3i6u_A 399 RHPWLQDED 407 (419)
T ss_dssp HSGGGCCHH
T ss_pred CCcccCChh
Confidence 999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=335.20 Aligned_cols=224 Identities=19% Similarity=0.360 Sum_probs=197.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG----------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~----------- 70 (582)
||||+++... .....+.+.+|+.+|++++||||+++++++... ...|+|||||+|++|.+++.....
T Consensus 56 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (314)
T 2ivs_A 56 VAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133 (314)
T ss_dssp EEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHTTTSTTEEC-----
T ss_pred EEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-CceEEEEeecCCCCHHHHHHHHhhccCCccccccc
Confidence 7899987543 456667899999999999999999999987654 578999999999999999987532
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCccc
Q 007991 71 -----------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVV 136 (582)
Q Consensus 71 -----------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~v 136 (582)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 213 (314)
T 2ivs_A 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGR 213 (314)
T ss_dssp -----------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCC
T ss_pred ccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCC
Confidence 238999999999999999999999999999999999999999999999999997654332 233456
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCC
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNP 215 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP 215 (582)
||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....+...+........+..+++.+.+||.+||..||
T Consensus 214 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 214 IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp SCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCCh
Confidence 7888999999998889999999999999999999 999999988888888887777777788899999999999999999
Q ss_pred CCCCCHHHHHcC
Q 007991 216 EFRPSAAELLCH 227 (582)
Q Consensus 216 ~~RpSa~EiL~h 227 (582)
.+||++++++++
T Consensus 294 ~~Rps~~~l~~~ 305 (314)
T 2ivs_A 294 DKRPVFADISKD 305 (314)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.79 Aligned_cols=229 Identities=28% Similarity=0.469 Sum_probs=186.1
Q ss_pred EEEEEecccccC------HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQT------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~------~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||.+...... ......+.+|+.+|++++||||+++++++... ..|+||||++|++|.+++.... .+++
T Consensus 38 vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~--~~~~ 113 (322)
T 2ycf_A 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGELFDKVVGNK--RLKE 113 (322)
T ss_dssp EEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEEEECCTTEETHHHHSTTC--CCCH
T ss_pred EEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--ceEEEEecCCCCcHHHHHhccC--CCCH
Confidence 899998764321 22345688999999999999999999987543 3789999999999999997643 7999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhcccccccCcccCCCCCCCccccc---C
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA---D 149 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~---~ 149 (582)
..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++............+||+.|+|||++. .
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 193 (322)
T 2ycf_A 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 193 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCC
Confidence 999999999999999999999999999999999987765 9999999998765554455678999999999974 5
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
..++.++|||||||++|+|++|..||...... .+...+........ +..++..+.+||.+||..||.+||+++++|
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 194 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp TTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 66889999999999999999999999765432 23333333332222 245789999999999999999999999999
Q ss_pred cCCCCchhh
Q 007991 226 CHPHLQPYV 234 (582)
Q Consensus 226 ~hp~f~~~~ 234 (582)
+||||+...
T Consensus 274 ~h~~~~~~~ 282 (322)
T 2ycf_A 274 RHPWLQDED 282 (322)
T ss_dssp TSGGGCCHH
T ss_pred hCcCcCCHH
Confidence 999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=346.08 Aligned_cols=227 Identities=20% Similarity=0.306 Sum_probs=199.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-----CCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-----VHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-----~~lse~ 76 (582)
||||+++.. ........+.+|+.+|++++|||||++++++... ...|+|||||+||+|.+++..... ..+++.
T Consensus 104 vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 181 (367)
T 3l9p_A 104 VAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181 (367)
T ss_dssp EEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHH
T ss_pred EEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCEEEEEeCCCCCHHHHHHhhccccCccccccHH
Confidence 799998753 3455566789999999999999999999987654 467899999999999999987542 358999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhcccc---cccCcccCCCCCCCcccccCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~ 150 (582)
.+..++.||+.||+|||++||+||||||+||||+.+|. +||+|||+++..... ......+||+.|+|||++.+.
T Consensus 182 ~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 261 (367)
T 3l9p_A 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261 (367)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC
Confidence 99999999999999999999999999999999996654 999999999865332 234456789999999999988
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
.|+.++|||||||++|||++ |.+||.+.+..++...+........+..++..+.+||.+||+.||.+||++++|+++.+
T Consensus 262 ~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 262 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999998 99999999999999888887777778889999999999999999999999999999855
Q ss_pred C
Q 007991 230 L 230 (582)
Q Consensus 230 f 230 (582)
+
T Consensus 342 ~ 342 (367)
T 3l9p_A 342 Y 342 (367)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=328.60 Aligned_cols=228 Identities=27% Similarity=0.494 Sum_probs=189.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-CCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~lse~~~~~ 80 (582)
||||.+..... ...+.+.+|+.+++.++||||+++++++... ...|+||||++|++|.+++.... ...+++..+..
T Consensus 50 vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (295)
T 2clq_A 50 IAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126 (295)
T ss_dssp EEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHH
T ss_pred EEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHH
Confidence 78999876532 4456789999999999999999999988655 58999999999999999998753 23567999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcC-CCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCC--CCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP--YGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~--y~~ks 156 (582)
++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .......||+.|+|||++.+.. ++.++
T Consensus 127 ~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 206 (295)
T 2clq_A 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206 (295)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHH
T ss_pred HHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHH
Confidence 9999999999999999999999999999988 899999999999765432 2344678999999999997643 78899
Q ss_pred cccchhHHHHhHhcCCccccccCHHH--HHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQA--LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~--l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|+|++|..||....... ............++..++..+.+||.+||..||++||+++++|+||||+.
T Consensus 207 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp HHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 99999999999999999997654322 22222233445567889999999999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.86 Aligned_cols=222 Identities=22% Similarity=0.316 Sum_probs=185.1
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+.... ......+.+.+|+.++++++||||+++++++.. +..+|+|||||+|++|.+++...+ .+++..+..
T Consensus 39 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~ 115 (294)
T 4eqm_A 39 VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAIN 115 (294)
T ss_dssp EEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHH
T ss_pred EEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHH
Confidence 7999986643 445667889999999999999999999998754 458999999999999999998865 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.++||
T Consensus 116 ~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 195 (294)
T 4eqm_A 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDI 195 (294)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHH
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhH
Confidence 99999999999999999999999999999999999999999998765432 2345689999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----CCccccHHHHHHHHHhccCCCCCCC-CHHHHHc
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----LPTVYSGAFRGLVKSMLRKNPEFRP-SAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----lp~~~S~~l~~LI~kmL~~dP~~Rp-Sa~EiL~ 226 (582)
|||||++|+|++|..||.+.+......+........ .+..+++.+.++|.+||..||.+|| +++++++
T Consensus 196 ~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~ 268 (294)
T 4eqm_A 196 YSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268 (294)
T ss_dssp HHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHH
Confidence 999999999999999999988776655544333222 3456899999999999999999998 5555543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=333.55 Aligned_cols=230 Identities=30% Similarity=0.531 Sum_probs=176.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh------CCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA------NGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~------~~~~lse 75 (582)
||||++..... ....+.+.+|+.+|++++||||+++++++...+ ..|+||||++|++|.+++... ....+++
T Consensus 43 vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 120 (303)
T 2vwi_A 43 VAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120 (303)
T ss_dssp EEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCH
T ss_pred EEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEEEehhccCCchHHHHHHHhhccccccCCCCH
Confidence 78998866433 234567889999999999999999999887654 789999999999999999752 2335899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc------cccCcccCCCCCCCcccccC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD------DLASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~------~~~~~~vGTp~Y~APE~l~~ 149 (582)
..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+
T Consensus 121 ~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 999999999999999999999999999999999999999999999999765432 12345689999999999875
Q ss_pred -CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---------CCCccccHHHHHHHHHhccCCCCCCC
Q 007991 150 -IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---------PLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 150 -~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---------~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
..++.++|||||||++|+|++|..||.................. .....++..+.+||.+||+.||.+||
T Consensus 201 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 280 (303)
T 2vwi_A 201 VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280 (303)
T ss_dssp HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc
Confidence 56889999999999999999999999877655444333322211 12346789999999999999999999
Q ss_pred CHHHHHcCCCCchh
Q 007991 220 SAAELLCHPHLQPY 233 (582)
Q Consensus 220 Sa~EiL~hp~f~~~ 233 (582)
+++++++||||+..
T Consensus 281 s~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 281 TAAELLRHKFFQKA 294 (303)
T ss_dssp CHHHHHTSTTC---
T ss_pred CHHHHhhChhhhcC
Confidence 99999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=325.78 Aligned_cols=221 Identities=19% Similarity=0.378 Sum_probs=196.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+++|++++||||+++++++.. +...|+||||++|++|.+++...+ ..+++..+..+
T Consensus 35 vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 109 (268)
T 3sxs_A 35 VAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEM 109 (268)
T ss_dssp EEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHH
T ss_pred EEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHH
Confidence 7999998765543 468899999999999999999998754 457899999999999999998753 35999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||
T Consensus 110 ~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (268)
T 3sxs_A 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189 (268)
T ss_dssp HHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhH
Confidence 9999999999999999999999999999999999999999998664432 22334566789999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||...+.......+........+..+++.+.+||..||+.||.+|||+++++++
T Consensus 190 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999998 999999999988888888777777788899999999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.82 Aligned_cols=229 Identities=25% Similarity=0.364 Sum_probs=190.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec----CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK----GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~----~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||++... ........+.+|+.+|++++||||+++++++... ....|+||||+. ++|.+++... .+++.
T Consensus 38 ~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~ 112 (353)
T 2b9h_A 38 IVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDD 112 (353)
T ss_dssp EEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHH
T ss_pred EEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHH
Confidence 3899999653 3455667788999999999999999999976543 257899999996 6999999873 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----------ccCcccCCCCCCCcc
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----------LASSVVGTPSYMCPE 145 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----------~~~~~vGTp~Y~APE 145 (582)
.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||
T Consensus 113 ~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (353)
T 2b9h_A 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCe
Confidence 999999999999999999999999999999999999999999999997654321 123468999999999
Q ss_pred cccC-CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------
Q 007991 146 LLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------ 194 (582)
Q Consensus 146 ~l~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------ 194 (582)
++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......+
T Consensus 193 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (353)
T 2b9h_A 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272 (353)
T ss_dssp HHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred eeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh
Confidence 8764 678999999999999999999999999988766655543221111
Q ss_pred -CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 195 -LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 195 -lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
....++..+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 1135789999999999999999999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.41 Aligned_cols=226 Identities=27% Similarity=0.443 Sum_probs=191.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCc-----EEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----YVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~-----~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++..........+.+.+|+.+|+.++||||+++++++...+. .+|+||||+. ++|.+++.. .+++.
T Consensus 52 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~ 126 (353)
T 3coi_A 52 VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEE 126 (353)
T ss_dssp EEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHH
T ss_pred EEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCHH
Confidence 8999998877777778899999999999999999999998875432 3589999996 688777643 58999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-CCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y~~k 155 (582)
.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||++.+ ..++.+
T Consensus 127 ~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~ 204 (353)
T 3coi_A 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQT 204 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTT
T ss_pred HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCch
Confidence 99999999999999999999999999999999999999999999999765432 445789999999999877 678999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccC------------------------------CCCCccccHHHHH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIV------------------------------APLPTVYSGAFRG 205 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~------------------------------~~lp~~~S~~l~~ 205 (582)
+|||||||++|+|++|..||.+.+..+.+..+..... ......++..+.+
T Consensus 205 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
T 3coi_A 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD 284 (353)
T ss_dssp HHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHH
Confidence 9999999999999999999999887766655533211 1123467899999
Q ss_pred HHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 206 LVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 206 LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||.+||..||.+|||++++|+||||+.+.
T Consensus 285 li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 285 LLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 99999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.30 Aligned_cols=221 Identities=20% Similarity=0.354 Sum_probs=197.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+++|++++||||+++++++.. +..+|+||||++|++|.+++.... ..+++..+..+
T Consensus 51 vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 125 (283)
T 3gen_A 51 VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEM 125 (283)
T ss_dssp EEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHH
T ss_pred EEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHH
Confidence 7999998765543 468899999999999999999998755 457899999999999999998733 26999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 205 (283)
T 3gen_A 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205 (283)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999998664432 23345677889999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||...+.......+........+..+++.+.+||.+||+.||.+|||++++++|
T Consensus 206 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999998 999999999999888888877777788899999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.84 Aligned_cols=224 Identities=20% Similarity=0.380 Sum_probs=200.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||+++.. ......+.+.+|+++|+++ +|||||++++++... ..+|+|||||+||+|.+++.....
T Consensus 104 vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 181 (382)
T 3tt0_A 104 VAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181 (382)
T ss_dssp EEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCC
T ss_pred EEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC-CceEEEEEecCCCcHHHHHHHhcccccccccccc
Confidence 789998765 3456667899999999999 999999999987654 478999999999999999987541
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 71 ----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 71 ----~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|
T Consensus 182 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~a 261 (382)
T 3tt0_A 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 261 (382)
T ss_dssp SSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSC
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeC
Confidence 359999999999999999999999999999999999999999999999999998664432 2344567889999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+..+++++.+||.+||+.||++|||++
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 341 (382)
T 3tt0_A 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 341 (382)
T ss_dssp HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999999999999999999999999 9999999999999888888777778888999999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
|++++
T Consensus 342 ell~~ 346 (382)
T 3tt0_A 342 QLVED 346 (382)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=329.21 Aligned_cols=222 Identities=24% Similarity=0.413 Sum_probs=185.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.. ......+.+.+|+.+|++++||||+++++++. +...|+||||+.+++|.+++.... ..+++..+..+
T Consensus 46 vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 121 (281)
T 1mp8_A 46 VAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILY 121 (281)
T ss_dssp EEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHH
T ss_pred EEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 788887654 34566788999999999999999999999863 346789999999999999998743 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+|+.|+|||++.+..++.++|||
T Consensus 122 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 201 (281)
T 1mp8_A 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 201 (281)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHH
T ss_pred HHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCch
Confidence 99999999999999999999999999999999999999999987654332 2344667889999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||.+....+....+......+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 202 slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 202 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999996 999999888888888887777777888899999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.72 Aligned_cols=226 Identities=30% Similarity=0.435 Sum_probs=189.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEE-------------ecCcEEEEEEeecCCCCHHHHHHHh
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWV-------------EKGCYVCIIIGYCEGGDMAEAIKKA 68 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~-------------~~~~~l~LVmEy~~GgsL~d~Ikk~ 68 (582)
||||++... .....+.+.+|+.+|++++||||+++++++. ......|+||||++ |+|.+++...
T Consensus 39 vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~ 115 (320)
T 2i6l_A 39 VAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG 115 (320)
T ss_dssp EEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC
T ss_pred EEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC
Confidence 899998754 4566778999999999999999999999763 23468999999997 6999998652
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEc-CCCCeEEeecccchhcccc----cccCcccCCCCCCC
Q 007991 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISD----DLASSVVGTPSYMC 143 (582)
Q Consensus 69 ~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~----~~~~~~vGTp~Y~A 143 (582)
.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...... .......||+.|+|
T Consensus 116 ---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 192 (320)
T 2i6l_A 116 ---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192 (320)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCC
T ss_pred ---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccC
Confidence 689999999999999999999999999999999999997 4678999999999865422 22345678999999
Q ss_pred cccccC-CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------
Q 007991 144 PELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------------------- 194 (582)
Q Consensus 144 PE~l~~-~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---------------------------- 194 (582)
||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 193 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (320)
T 2i6l_A 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272 (320)
T ss_dssp HHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHH
T ss_pred cHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChh
Confidence 998865 678999999999999999999999999888777666554332110
Q ss_pred -CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 195 -LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 195 -lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
....++..+.+||.+||+.||.+|||++|+|+||||+.+
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 123578999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.38 Aligned_cols=225 Identities=15% Similarity=0.104 Sum_probs=181.0
Q ss_pred CEEEEEecccc-cCHHHHHHHHHHH---HHHHhcCCCCeeeee-------eEEEecCc----------------EEEEEE
Q 007991 1 MYVLKKIRLAR-QTDRARRSAHQEM---ELISRVRNPFIVEYK-------DSWVEKGC----------------YVCIII 53 (582)
Q Consensus 1 lyAIKki~~~~-~~~~~~~~~~rEi---~iL~~L~HpnIV~l~-------~~~~~~~~----------------~l~LVm 53 (582)
.||||+++... ......+.+.+|+ ++|++++|||||+++ +++...+. ..|+||
T Consensus 100 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~ 179 (377)
T 3byv_A 100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179 (377)
T ss_dssp EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEE
T ss_pred EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEE
Confidence 38999997643 3334567899999 556666899999998 55443321 378999
Q ss_pred eecCCCCHHHHHHHhCCCCCCH-------HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 54 GYCEGGDMAEAIKKANGVHFPE-------EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 54 Ey~~GgsL~d~Ikk~~~~~lse-------~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
||| +|+|.+++...+ .+++ ..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 180 E~~-~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~ 256 (377)
T 3byv_A 180 PRM-QSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256 (377)
T ss_dssp ECC-SEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred ecc-CCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheec
Confidence 999 689999998753 3444 888889999999999999999999999999999999999999999999854
Q ss_pred ccccccCcccCCCCCCCcccccCC-----------CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC
Q 007991 127 ISDDLASSVVGTPSYMCPELLADI-----------PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL 195 (582)
Q Consensus 127 ~~~~~~~~~vGTp~Y~APE~l~~~-----------~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l 195 (582)
.. .....+| +.|+|||++.+. .|+.++|||||||++|||++|..||.+.+.......+. ..
T Consensus 257 ~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----~~ 328 (377)
T 3byv_A 257 GA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----RS 328 (377)
T ss_dssp TC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----SS
T ss_pred CC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----hh
Confidence 32 3456688 999999999887 79999999999999999999999998766444333322 22
Q ss_pred CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhh
Q 007991 196 PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLG 236 (582)
Q Consensus 196 p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~ 236 (582)
+..+++.+.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus 329 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 329 CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 35689999999999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.35 Aligned_cols=229 Identities=25% Similarity=0.419 Sum_probs=189.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC------cEEEEEEeecCCCCHHHHHHH--hCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG------CYVCIIIGYCEGGDMAEAIKK--ANGVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~------~~l~LVmEy~~GgsL~d~Ikk--~~~~~l 73 (582)
||||++..... ......+|++.+..++||||++++++|...+ .++|+|||||.| +|.+.+.. .....+
T Consensus 51 vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 126 (360)
T 3e3p_A 51 VAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP 126 (360)
T ss_dssp EEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCC
T ss_pred EEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCC
Confidence 89998855322 2235677888999999999999999987533 358999999975 55555443 234478
Q ss_pred CHHHHHHHHHHHHHHHHHHH--HCCceecccCcccEEEcC-CCCeEEeecccchhcccccccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLH--ANHILHRDVKCSNIFLTR-DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLH--s~gIiHRDIKP~NILL~~-~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||++............+||+.|+|||++.+.
T Consensus 127 ~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCC
Confidence 99999999999999999999 999999999999999997 899999999999887766666678899999999998765
Q ss_pred C-CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-------------------------------CCcc
Q 007991 151 P-YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-------------------------------LPTV 198 (582)
Q Consensus 151 ~-y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-------------------------------lp~~ 198 (582)
. ++.++|||||||++|+|++|.+||.+.+....+..+......+ ....
T Consensus 207 ~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
T 3e3p_A 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286 (360)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhcc
Confidence 4 8999999999999999999999999988877776664422111 1223
Q ss_pred ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 199 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 199 ~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 287 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 287 DAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp THHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 578999999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.79 Aligned_cols=227 Identities=25% Similarity=0.403 Sum_probs=189.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCC------eeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPF------IVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hpn------IV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||.++. .....+.+.+|+.+|++++|++ ++.+++++... ..+|+||||+ +++|.+.+.......+++
T Consensus 48 vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~lv~e~~-~~~l~~~l~~~~~~~~~~ 122 (355)
T 2eu9_A 48 VALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-GHMCIAFELL-GKNTFEFLKENNFQPYPL 122 (355)
T ss_dssp EEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTTTCCCCH
T ss_pred EEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-CeEEEEEecc-CCChHHHHHhccCCCCCH
Confidence 78999864 3455678899999999998765 88888877654 5899999999 778888887765567999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEE-------------------cCCCCeEEeecccchhcccccccCccc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFL-------------------TRDQDIRLGDFGLAKMLISDDLASSVV 136 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL-------------------~~~g~vKL~DFGla~~~~~~~~~~~~v 136 (582)
..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..... .....+
T Consensus 123 ~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 200 (355)
T 2eu9_A 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIV 200 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSC
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCc
Confidence 9999999999999999999999999999999999 5678899999999976433 345678
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---------------------- 194 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---------------------- 194 (582)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 201 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 280 (355)
T 2eu9_A 201 ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 280 (355)
T ss_dssp SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCC
T ss_pred CCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccc
Confidence 9999999999999999999999999999999999999999888766555443322110
Q ss_pred ---------------------CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhh
Q 007991 195 ---------------------LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235 (582)
Q Consensus 195 ---------------------lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~ 235 (582)
.....+..+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 281 ENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred cccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 01123568899999999999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.16 Aligned_cols=225 Identities=28% Similarity=0.538 Sum_probs=181.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec------------CcEEEEEEeecCCCCHHHHHHHhC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK------------GCYVCIIIGYCEGGDMAEAIKKAN 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~------------~~~l~LVmEy~~GgsL~d~Ikk~~ 69 (582)
||||+++. .....+.+.+|+.+|++++||||++++++|... +..+|+|||||+|++|.+++...
T Consensus 34 vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 109 (303)
T 1zy4_A 34 YAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE- 109 (303)
T ss_dssp EEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-
T ss_pred EEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-
Confidence 79999864 345567899999999999999999999988653 45889999999999999999874
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---------------cccCc
Q 007991 70 GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---------------DLASS 134 (582)
Q Consensus 70 ~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---------------~~~~~ 134 (582)
+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 110 ~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (303)
T 1zy4_A 110 NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189 (303)
T ss_dssp CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC---------------------
T ss_pred ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccccc
Confidence 346889999999999999999999999999999999999999999999999999765421 22345
Q ss_pred ccCCCCCCCcccccCC-CCCCCCcccchhHHHHhHhcCCcccc-ccCHHHHHHHHhhcc---CCCCCccccHHHHHHHHH
Q 007991 135 VVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAFK-AFDMQALINKINKSI---VAPLPTVYSGAFRGLVKS 209 (582)
Q Consensus 135 ~vGTp~Y~APE~l~~~-~y~~ksDIWSLG~iLyELltG~~PF~-~~~~~~l~~kI~~~~---~~~lp~~~S~~l~~LI~k 209 (582)
.+||+.|+|||++.+. .++.++|||||||++|+|++ ||. +.+.......+.... ...++..++..+.+||.+
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 266 (303)
T 1zy4_A 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL 266 (303)
T ss_dssp ----CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHH
T ss_pred CCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHH
Confidence 6899999999999865 68999999999999999998 443 334444444444322 223445577889999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.||.+|||++++|+||||+..
T Consensus 267 ~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 267 LIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhcCcccCcCHHHHhCCCCcCCC
Confidence 999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.98 Aligned_cols=229 Identities=27% Similarity=0.440 Sum_probs=195.0
Q ss_pred EEEEEecccccCHH---------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHH--
Q 007991 2 YVLKKIRLARQTDR---------------ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA-- 64 (582)
Q Consensus 2 yAIKki~~~~~~~~---------------~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~-- 64 (582)
||||++........ ..+.+.+|+.+|++++||||+++++++... ...|+||||++|++|.++
T Consensus 57 vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~ 135 (348)
T 2pml_X 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-DEVYIIYEYMENDSILKFDE 135 (348)
T ss_dssp EEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS-SEEEEEEECCTTCBSSEESS
T ss_pred EEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEeccCCCcHHHHHH
Confidence 78999876432211 126789999999999999999999987654 589999999999999998
Q ss_pred ----HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCC
Q 007991 65 ----IKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTP 139 (582)
Q Consensus 65 ----Ikk~~~~~lse~~~~~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp 139 (582)
+.......+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++...... ......||+
T Consensus 136 ~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 214 (348)
T 2pml_X 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTY 214 (348)
T ss_dssp SEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCG
T ss_pred HhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCc
Confidence 665435579999999999999999999999 99999999999999999999999999999876443 455678999
Q ss_pred CCCCcccccCC-CCCC-CCcccchhHHHHhHhcCCccccccCH-HHHHHHHhhccCCCCC-------------------c
Q 007991 140 SYMCPELLADI-PYGS-KSDIWSLGCCVYEMSAQKAAFKAFDM-QALINKINKSIVAPLP-------------------T 197 (582)
Q Consensus 140 ~Y~APE~l~~~-~y~~-ksDIWSLG~iLyELltG~~PF~~~~~-~~l~~kI~~~~~~~lp-------------------~ 197 (582)
.|+|||++.+. .++. ++|||||||++|+|++|..||..... .++...+..... .++ .
T Consensus 215 ~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 293 (348)
T 2pml_X 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNN 293 (348)
T ss_dssp GGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------
T ss_pred CccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCc-CCccchhhhhccccccccccchh
Confidence 99999999887 6666 99999999999999999999988766 666666654432 233 5
Q ss_pred cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 198 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 198 ~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.++..+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 294 ~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 294 FLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 689999999999999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.98 Aligned_cols=224 Identities=20% Similarity=0.370 Sum_probs=192.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
+|||.+.... .....+.+.+|+.+|+++ +||||+++++++... ..+|+|||||+|++|.+++....
T Consensus 55 v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 132 (327)
T 1fvr_A 55 AAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132 (327)
T ss_dssp EEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHH
T ss_pred eeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceEEEEecCCCCCHHHHHHhccccccccccccc
Confidence 4888886532 334556789999999999 899999999988654 58999999999999999998642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccc
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~ 146 (582)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+++.|+|||+
T Consensus 133 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 212 (327)
T 1fvr_A 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 212 (327)
T ss_dssp TTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHH
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhh
Confidence 24689999999999999999999999999999999999999999999999999975544334445677899999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
+.+..++.++|||||||++|+|++ |..||.+.+...+...+........+..++..+.+||.+||..||.+|||+++++
T Consensus 213 ~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 292 (327)
T 1fvr_A 213 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292 (327)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 998889999999999999999998 9999999999988888887766677888999999999999999999999999999
Q ss_pred cC
Q 007991 226 CH 227 (582)
Q Consensus 226 ~h 227 (582)
++
T Consensus 293 ~~ 294 (327)
T 1fvr_A 293 VS 294 (327)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.71 Aligned_cols=227 Identities=20% Similarity=0.357 Sum_probs=195.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.........+.+.+|+.+++.++||||+++++++ . +...|+||||++|++|.+++.... .+++..+..+
T Consensus 47 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i 122 (291)
T 1xbb_A 47 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL 122 (291)
T ss_dssp EEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHH
Confidence 78999987665556678899999999999999999999987 3 346789999999999999998753 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....|++.|+|||++.+..++.++|
T Consensus 123 ~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 202 (291)
T 1xbb_A 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 202 (291)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHH
T ss_pred HHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhh
Confidence 99999999999999999999999999999999999999999976643321 22345678899999999888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
||||||++|+|++ |..||.+.+...+...+........+..++..+.+||.+||+.||.+||++.++++. ++.++
T Consensus 203 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~~~ 278 (291)
T 1xbb_A 203 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR--LRNYY 278 (291)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH--HHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHHH
Confidence 9999999999999 999999999888888887777777788899999999999999999999999999873 44443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=327.52 Aligned_cols=230 Identities=28% Similarity=0.462 Sum_probs=181.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.........+.+..+..+++.++||||+++++++... ..+|+||||+ ++.+..+.... ...+++..+..
T Consensus 52 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~ 128 (318)
T 2dyl_A 52 VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIAMELM-GTCAEKLKKRM-QGPIPERILGK 128 (318)
T ss_dssp EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHH
T ss_pred EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHH
Confidence 389999987765555556666677789999999999999988654 5899999999 66777666653 34699999999
Q ss_pred HHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc-----CCCCCC
Q 007991 81 WLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-----DIPYGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~-----~~~y~~ 154 (582)
++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.............||+.|+|||++. ...++.
T Consensus 129 ~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 208 (318)
T 2dyl_A 129 MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCT
T ss_pred HHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCcc
Confidence 999999999999995 99999999999999999999999999998776555556678999999999984 456888
Q ss_pred CCcccchhHHHHhHhcCCccccc-cCHHHHHHHHhhccCCCCC--ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKA-FDMQALINKINKSIVAPLP--TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~-~~~~~l~~kI~~~~~~~lp--~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
++|||||||++|+|++|..||.. .........+.......++ ..++..+.+||.+||..||.+||+++++|+||||+
T Consensus 209 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 99999999999999999999987 3445555555554433333 45899999999999999999999999999999998
Q ss_pred hh
Q 007991 232 PY 233 (582)
Q Consensus 232 ~~ 233 (582)
.+
T Consensus 289 ~~ 290 (318)
T 2dyl_A 289 RY 290 (318)
T ss_dssp HH
T ss_pred hc
Confidence 64
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.83 Aligned_cols=234 Identities=14% Similarity=0.149 Sum_probs=175.0
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhc--CCCCeeeee-------eEEEecC----------------cEEEEEEe
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRV--RNPFIVEYK-------DSWVEKG----------------CYVCIIIG 54 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L--~HpnIV~l~-------~~~~~~~----------------~~l~LVmE 54 (582)
.||||+++...... ...+.+.+|+.+++.| +||||++++ +++...+ ..+|||||
T Consensus 89 ~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 168 (371)
T 3q60_A 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168 (371)
T ss_dssp EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEEC
T ss_pred eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEec
Confidence 38999998876533 4567788885555555 699988755 4443222 45899999
Q ss_pred ecCCCCHHHHHHHhCCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 55 YCEGGDMAEAIKKANGVHFPEEKL------CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 55 y~~GgsL~d~Ikk~~~~~lse~~~------~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
||+ |+|.+++...+. .+++... ..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 169 ~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 169 AAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp CCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred CCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 998 899999987532 3455555 56779999999999999999999999999999999999999999986543
Q ss_pred ccccCcccCCCCCCCcccccC--CCCCCCCcccchhHHHHhHhcCCccccccCHHHH--HHHH------hhccCCCCCcc
Q 007991 129 DDLASSVVGTPSYMCPELLAD--IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKI------NKSIVAPLPTV 198 (582)
Q Consensus 129 ~~~~~~~vGTp~Y~APE~l~~--~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l--~~kI------~~~~~~~lp~~ 198 (582)
. .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+...... +..+ ......+.+..
T Consensus 247 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (371)
T 3q60_A 247 R--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324 (371)
T ss_dssp E--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSC
T ss_pred C--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccC
Confidence 2 225667799999999987 6799999999999999999999999987642210 0000 00111223357
Q ss_pred ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhhh
Q 007991 199 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIH 238 (582)
Q Consensus 199 ~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~~ 238 (582)
+++.+.+||.+||+.||++|||++++|+||||+...+...
T Consensus 325 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp CCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence 8999999999999999999999999999999998765544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=321.55 Aligned_cols=222 Identities=14% Similarity=0.287 Sum_probs=195.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.........+.+.+|+.+|++++||||+++++++... +...|+||||++||+|.+++....+..+++..+..
T Consensus 36 ~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 115 (271)
T 3kmu_A 36 IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115 (271)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHH
T ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHH
Confidence 79999998887888888999999999999999999999988654 25789999999999999999986555699999999
Q ss_pred HHHHHHHHHHHHHHCC--ceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC---C
Q 007991 81 WLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS---K 155 (582)
Q Consensus 81 il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~---k 155 (582)
++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.... ....+||+.|+|||++.+..++. +
T Consensus 116 i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~ 191 (271)
T 3kmu_A 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRS 191 (271)
T ss_dssp HHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHH
T ss_pred HHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCch
Confidence 9999999999999999 9999999999999999999999988875432 33467899999999998766554 7
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHh-hccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN-KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~-~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||||++|+|++|..||.+.+.......+. ......++..++..+.+||.+||+.||.+|||++++++.
T Consensus 192 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 192 ADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999888777765554 444556778899999999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.56 Aligned_cols=219 Identities=20% Similarity=0.368 Sum_probs=195.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... ..+.+.+|+.+|++++|||||++++++...+..+|+|||||+||+|.++++..+...+++..+..+
T Consensus 219 vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 294 (450)
T 1k9a_A 219 VAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294 (450)
T ss_dssp EEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHH
T ss_pred EEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 8999997654 345789999999999999999999998877668999999999999999999876555899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||
T Consensus 295 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl 372 (450)
T 1k9a_A 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF 372 (450)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 999999999999999999999999999999999999999999754332 233477899999999999999999999999
Q ss_pred hHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 162 GCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 162 G~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||++|||++ |..||.+.+..++...+......+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 373 G~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 373 GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999998 99999998888888888777777788899999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.60 Aligned_cols=226 Identities=24% Similarity=0.352 Sum_probs=188.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CC-----CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NP-----FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-Hp-----nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||||+++.. ....+.+.+|+.+++.+. |+ +|+.++++|... ..+|+||||+. ++|.+++.......+++
T Consensus 82 vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~~~~~~~~~~ 156 (382)
T 2vx3_A 82 VAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-NHLCLVFEMLS-YNLYDLLRNTNFRGVSL 156 (382)
T ss_dssp EEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-TEEEEEEECCC-CBHHHHHHHTTTSCCCH
T ss_pred EEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-CceEEEEecCC-CCHHHHHhhcCcCCCCH
Confidence 899999743 345567889999999986 44 499999987765 58999999995 69999999865556999
Q ss_pred HHHHHHHHHHHHHHHHHH--HCCceecccCcccEEEcC--CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCC
Q 007991 76 EKLCKWLVQLLMALNYLH--ANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLH--s~gIiHRDIKP~NILL~~--~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~ 151 (582)
..++.++.||+.||.||| +.||+||||||+||||+. ++.+||+|||+++.... .....+||+.|+|||++.+..
T Consensus 157 ~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~ 234 (382)
T 2vx3_A 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP 234 (382)
T ss_dssp HHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCC
Confidence 999999999999999999 579999999999999954 67899999999987643 345678999999999999999
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC-----------------c-----------------
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-----------------T----------------- 197 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp-----------------~----------------- 197 (582)
|+.++|||||||++|+|++|.+||.+.+..+.+..+......+.. .
T Consensus 235 ~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (382)
T 2vx3_A 235 YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKP 314 (382)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCC
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCC
Confidence 999999999999999999999999998888777766543221100 0
Q ss_pred -----------------------------cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 198 -----------------------------VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 198 -----------------------------~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
..+..+.+||.+||+.||++|||++|+|+||||+...
T Consensus 315 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 315 PGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred cchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 0014789999999999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=328.73 Aligned_cols=226 Identities=22% Similarity=0.374 Sum_probs=191.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCc----EEEEEEeecCCCCHHHHHHHh----CCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC----YVCIIIGYCEGGDMAEAIKKA----NGVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~----~l~LVmEy~~GgsL~d~Ikk~----~~~~l 73 (582)
||||.++.........+.+.+|+.+|++++||||+++++++...+. ..|+||||+++++|.+++... ....+
T Consensus 65 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~ 144 (313)
T 3brb_A 65 VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144 (313)
T ss_dssp EEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCC
T ss_pred EEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccC
Confidence 8999998877777778889999999999999999999998876442 458999999999999999642 33469
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+++.|+|||++.+.
T Consensus 145 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 224 (313)
T 3brb_A 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSS
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC
Confidence 999999999999999999999999999999999999999999999999998764432 22345678899999999999
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++.++|||||||++|+|++ |.+||.+.....+...+........+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 225 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999 999999988888888777776777788899999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.55 Aligned_cols=221 Identities=22% Similarity=0.428 Sum_probs=196.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++....... +.+.+|+.++++++||||+++++++... ...|+||||++|++|.+++.... ..+++..+..+
T Consensus 35 vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 109 (267)
T 3t9t_A 35 VAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGM 109 (267)
T ss_dssp EEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHH
T ss_pred EEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccC-CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHH
Confidence 7999998765543 5688999999999999999999987654 47899999999999999998753 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||
T Consensus 110 ~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (267)
T 3t9t_A 110 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189 (267)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchh
Confidence 9999999999999999999999999999999999999999998664322 23345678889999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||.+.+.......+........+..++..+.+||.+||..||.+||++++++++
T Consensus 190 slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 190 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999 899999999888888888776666778899999999999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=326.21 Aligned_cols=224 Identities=17% Similarity=0.289 Sum_probs=195.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.. ......+.+.+|+.+|++++||||+++++++...+...|+||||++|++|.+++... +..+++..+..+
T Consensus 56 ~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i 133 (298)
T 3f66_A 56 CAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGF 133 (298)
T ss_dssp EEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHH
T ss_pred EEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHH
Confidence 688888753 345566789999999999999999999998777777889999999999999999864 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++
T Consensus 134 ~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (298)
T 3f66_A 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 213 (298)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHH
Confidence 9999999999999999999999999999999999999999998654332 23345678899999999998999999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|+|++ |.+||.+.+..+....+........+..+++.+.+||.+||..||.+|||++|+++.
T Consensus 214 Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 214 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999 788888888777777777776667788899999999999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.19 Aligned_cols=221 Identities=21% Similarity=0.413 Sum_probs=183.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++.. ......+.+.+|+++|++++||||+++++++... ...|+|||||+|++|.++++... ..+++..+..+
T Consensus 38 va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 113 (310)
T 3s95_A 38 MVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSF 113 (310)
T ss_dssp EEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHH
T ss_pred EEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHH
Confidence 78998854 3556778899999999999999999999988764 58999999999999999998743 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---------------cCcccCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---------------ASSVVGTPSYMCPEL 146 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---------------~~~~vGTp~Y~APE~ 146 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||++........ ....+||+.|+|||+
T Consensus 114 ~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 193 (310)
T 3s95_A 114 AKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193 (310)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHH
Confidence 99999999999999999999999999999999999999999976543321 125689999999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHH--HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALI--NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~--~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
+.+..++.++|||||||++|+|++|..||......... ..+........+..+++.+.+||.+||+.||++|||++++
T Consensus 194 ~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999999999999999998653211000 0000011122456788999999999999999999999999
Q ss_pred Hc
Q 007991 225 LC 226 (582)
Q Consensus 225 L~ 226 (582)
++
T Consensus 274 ~~ 275 (310)
T 3s95_A 274 EH 275 (310)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.94 Aligned_cols=224 Identities=20% Similarity=0.354 Sum_probs=197.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--------CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--------GVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--------~~~l 73 (582)
||||.++... .......+.+|+.+|++++||||+++++++.. +...|+|||||+|++|.+++.... ...+
T Consensus 58 vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 135 (322)
T 1p4o_A 58 VAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135 (322)
T ss_dssp EEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCC
T ss_pred EEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCc
Confidence 7899887543 44556779999999999999999999998755 457889999999999999997632 1357
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......||+.|+|||++.+.
T Consensus 136 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (322)
T 1p4o_A 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 215 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC
Confidence 999999999999999999999999999999999999999999999999998664432 23345678999999999988
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++.++|||||||++|+|++ |..||.+.+...+...+........+..++..+.+||.+||..||.+|||+.|+++|
T Consensus 216 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 216 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999 899999999888888887776667788899999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.14 Aligned_cols=227 Identities=25% Similarity=0.404 Sum_probs=185.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-----------CCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-----------NPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKK 67 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk 67 (582)
||||+++. .....+.+.+|+.+|+++. |+||+++++++...+ .++++||||+ |++|.+++..
T Consensus 47 vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~ 122 (373)
T 1q8y_A 47 VAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK 122 (373)
T ss_dssp EEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHH
T ss_pred EEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHH
Confidence 79999864 3345677899999999987 899999999887542 3889999999 9999999998
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcC------CCCeEEeecccchhcccccccCcccCCCC
Q 007991 68 ANGVHFPEEKLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTR------DQDIRLGDFGLAKMLISDDLASSVVGTPS 140 (582)
Q Consensus 68 ~~~~~lse~~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~------~g~vKL~DFGla~~~~~~~~~~~~vGTp~ 140 (582)
.....+++..+..++.||+.||+|||++ ||+||||||+||||+. .+.+||+|||++..... .....+||+.
T Consensus 123 ~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~ 200 (373)
T 1q8y_A 123 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTRE 200 (373)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGG
T ss_pred hhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCcc
Confidence 6655799999999999999999999998 9999999999999954 34799999999976543 2445689999
Q ss_pred CCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCH------HHHHHHHhhcc-----------------------
Q 007991 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM------QALINKINKSI----------------------- 191 (582)
Q Consensus 141 Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~------~~l~~kI~~~~----------------------- 191 (582)
|+|||++.+..++.++|||||||++|+|++|..||.+.+. ......+....
T Consensus 201 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 280 (373)
T 1q8y_A 201 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 280 (373)
T ss_dssp GCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred ccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcch
Confidence 9999999999999999999999999999999999986542 12222221110
Q ss_pred ------------------CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 192 ------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 192 ------------------~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
...++..++..+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 1123445678999999999999999999999999999998744
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=324.41 Aligned_cols=222 Identities=19% Similarity=0.350 Sum_probs=197.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+.... ...+.+.+|+.+|++++||||+++++++... ..+|+||||++|++|.+++.......+++..+..+
T Consensus 41 vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i 116 (288)
T 3kfa_A 41 VAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116 (288)
T ss_dssp EEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHH
T ss_pred EEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHH
Confidence 7899987533 2456789999999999999999999987654 57899999999999999999866667999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||
T Consensus 117 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 196 (288)
T 3kfa_A 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196 (288)
T ss_dssp HHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999998765432 23345678899999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |.+||.+.+.......+........+..+++.+.+||.+||..||.+|||++++++.
T Consensus 197 slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 197 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 99999999999 999999988888888887777777788899999999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.40 Aligned_cols=222 Identities=20% Similarity=0.343 Sum_probs=196.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... .....+.+.+|+++|++++||||+++++++ .. ...|+||||++|++|.+++... ...+++..+..+
T Consensus 40 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 115 (287)
T 1u59_A 40 VAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAEL 115 (287)
T ss_dssp EEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHH
T ss_pred EEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC-CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHH
Confidence 7899987653 456677899999999999999999999987 33 4588999999999999999753 346999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|
T Consensus 116 ~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 195 (287)
T 1u59_A 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 195 (287)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhh
Confidence 9999999999999999999999999999999999999999998764332 123446788999999999888999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|+|++ |..||.+.+..++...+........+..+++.+.+||.+||..||.+||++.+++++
T Consensus 196 i~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999998 999999988888888887777677788899999999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=333.52 Aligned_cols=222 Identities=22% Similarity=0.379 Sum_probs=190.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++... .....+.+.+|+.+|++++||||+++++++... ..++|+||+.+|+|.+++.... ..+++..+..|
T Consensus 47 vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~ 122 (327)
T 3poz_A 47 VAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNW 122 (327)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHH
T ss_pred EEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 5788876533 234457789999999999999999999988754 3678999999999999998743 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc---cCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~---~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+||||+.++++||+|||+++....... .....||+.|+|||++.+..|+.++||
T Consensus 123 ~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 202 (327)
T 3poz_A 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 202 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhh
Confidence 99999999999999999999999999999999999999999987654332 233466889999999999999999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|+|++ |..||.+.....+...+......+.+..++..+.+||.+||+.||.+||++.+++++
T Consensus 203 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred hhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999 999999988888877777777777888899999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.59 Aligned_cols=224 Identities=21% Similarity=0.375 Sum_probs=187.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++... ....++.+.+|+.+|++++||||+++++++.. +..+|+|||||+|++|.+++.+. +..+++..+..
T Consensus 75 ~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~ 151 (373)
T 2qol_A 75 SVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVG 151 (373)
T ss_dssp CEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHH
T ss_pred eEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHH
Confidence 38999997653 45667889999999999999999999998765 45789999999999999999874 34699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....+++.|+|||++.+..++.++
T Consensus 152 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (373)
T 2qol_A 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchh
Confidence 999999999999999999999999999999999999999999987654321 1223457789999999998999999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|||++ |..||.+.+..++...+......+.+..++..+.+||..||+.||.+||+++++++.
T Consensus 232 Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 99999999999987 999999999988888887777677778899999999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.87 Aligned_cols=223 Identities=23% Similarity=0.400 Sum_probs=185.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++... .....+.+.+|+.+|++++||||+++++++... ...+|+|||||+|++|.+++.... ..+++..+..
T Consensus 42 vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 118 (295)
T 3ugc_A 42 VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQ 118 (295)
T ss_dssp EEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHH
T ss_pred EEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHH
Confidence 899998753 456667899999999999999999999987643 246889999999999999998753 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......|+..|+|||++.+..++.++
T Consensus 119 ~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (295)
T 3ugc_A 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVAS 198 (295)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHH
Confidence 99999999999999999999999999999999999999999998764432 22344577789999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHH----------------HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQ----------------ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~----------------~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
|||||||++|+|++|..||...... .+...+......+.+..+++.+.+||.+||..||.+|||
T Consensus 199 Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 278 (295)
T 3ugc_A 199 DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 278 (295)
T ss_dssp HHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCC
Confidence 9999999999999999888643321 233444445556678889999999999999999999999
Q ss_pred HHHHHcC
Q 007991 221 AAELLCH 227 (582)
Q Consensus 221 a~EiL~h 227 (582)
++|+++.
T Consensus 279 ~~el~~~ 285 (295)
T 3ugc_A 279 FRDLALR 285 (295)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=322.31 Aligned_cols=222 Identities=23% Similarity=0.387 Sum_probs=192.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... .....+.+.+|+.+|++++||||+++++++... ..|+||||+.|++|.+++.... ..+++..+..+
T Consensus 43 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 118 (281)
T 3cc6_A 43 VAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE--PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLY 118 (281)
T ss_dssp EEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS--SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHH
T ss_pred EEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHH
Confidence 7889887653 455667899999999999999999999986533 4689999999999999998754 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||
T Consensus 119 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 198 (281)
T 3cc6_A 119 SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVW 198 (281)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccH
Confidence 9999999999999999999999999999999999999999998764432 23345678899999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||...........+......+.+..+++.+.+||.+||..||.+||++.|++++
T Consensus 199 slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 199 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 99999999998 999998877777777777766677788899999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=322.72 Aligned_cols=224 Identities=17% Similarity=0.317 Sum_probs=197.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+... ......+.+.+|+.+|++++||||+++++++...+...|+||||+.+++|.+++... +..+++..+..+
T Consensus 52 ~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i 129 (298)
T 3pls_A 52 CAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISF 129 (298)
T ss_dssp EEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHH
T ss_pred eeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHH
Confidence 788888653 345566789999999999999999999999887766668999999999999999873 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||.+.+..++.++
T Consensus 130 ~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 209 (298)
T 3pls_A 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKS 209 (298)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhh
Confidence 9999999999999999999999999999999999999999997654322 23456788899999999999999999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|+|++ |.+||...+...+...+......+.+..+++.+.+||.+||..||.+|||++++++.
T Consensus 210 Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 210 DVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999 677788888777778787777777888899999999999999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.48 Aligned_cols=224 Identities=21% Similarity=0.346 Sum_probs=188.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||.++... .....+.+.+|+.+|+++ +||||+++++++... ..+|+|||||+||+|.+++.....
T Consensus 78 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 155 (344)
T 1rjb_A 78 VAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155 (344)
T ss_dssp EEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred EEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-CccEEEEecCCCCcHHHHHhhccccccccccchh
Confidence 7999997543 334557899999999999 899999999987654 578999999999999999987532
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCccc
Q 007991 71 -----------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVV 136 (582)
Q Consensus 71 -----------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~v 136 (582)
..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 156 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 235 (344)
T 1rjb_A 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235 (344)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEE
T ss_pred hhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCcc
Confidence 237999999999999999999999999999999999999999999999999998664432 234567
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHH-HHHHHhhccCCCCCccccHHHHHHHHHhccCC
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA-LINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~-l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~d 214 (582)
||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..... +...+......+.+..+++.+.+||.+||..|
T Consensus 236 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 236 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 7889999999998899999999999999999998 999998776443 33444555555667789999999999999999
Q ss_pred CCCCCCHHHHHcC
Q 007991 215 PEFRPSAAELLCH 227 (582)
Q Consensus 215 P~~RpSa~EiL~h 227 (582)
|.+|||+.++++|
T Consensus 316 p~~Rps~~~l~~~ 328 (344)
T 1rjb_A 316 SRKRPSFPNLTSF 328 (344)
T ss_dssp GGGSCCHHHHHHH
T ss_pred chhCcCHHHHHHH
Confidence 9999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=325.22 Aligned_cols=219 Identities=21% Similarity=0.373 Sum_probs=186.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... ..+.+.+|+.+|++++||||+++++++...+..+|+||||++|++|.+++.......+++..+..+
T Consensus 47 vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 122 (278)
T 1byg_A 47 VAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122 (278)
T ss_dssp EEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHH
T ss_pred EEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHH
Confidence 7899987543 346788999999999999999999987776667899999999999999998754334899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccch
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSL 161 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSL 161 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....+++.|+|||++.+..++.++|||||
T Consensus 123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 200 (278)
T 1byg_A 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF 200 (278)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHH
Confidence 999999999999999999999999999999999999999998765432 334578899999999998899999999999
Q ss_pred hHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 162 GCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 162 G~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||++|+|++ |..||...+..++...+........+..+++.+.+||.+||..||.+||++.++++
T Consensus 201 G~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 201 GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999998 99999988888877777776666778889999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=328.68 Aligned_cols=225 Identities=19% Similarity=0.392 Sum_probs=194.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||.++... .....+.+.+|+.+|.++ +||||+++++++...+..+|+|||||+|++|.+++.....
T Consensus 60 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 138 (316)
T 2xir_A 60 VAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138 (316)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-----
T ss_pred EEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccch
Confidence 7999987654 345567899999999999 6899999999988777779999999999999999987532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 71 ----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 71 ----~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|
T Consensus 139 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a 218 (316)
T 2xir_A 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 218 (316)
T ss_dssp --CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC
T ss_pred hhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecC
Confidence 128999999999999999999999999999999999999999999999999998654332 2345678899999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCH-HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDM-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
||++.+..++.++|||||||++|+|++ |..||.+... ..+...+........+..+++.+.++|..||..||.+|||+
T Consensus 219 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 298 (316)
T 2xir_A 219 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298 (316)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999999899999999999999999998 9999987653 34445555555566777899999999999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
+++++|
T Consensus 299 ~ell~~ 304 (316)
T 2xir_A 299 SELVEH 304 (316)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=319.93 Aligned_cols=217 Identities=25% Similarity=0.506 Sum_probs=187.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe---------------cCcEEEEEEeecCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---------------KGCYVCIIIGYCEGGDMAEAIK 66 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~---------------~~~~l~LVmEy~~GgsL~d~Ik 66 (582)
||||+++... +.+.+|+++|++++||||++++++|.. ....+|+|||||++++|.+++.
T Consensus 39 vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 112 (284)
T 2a19_B 39 YVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112 (284)
T ss_dssp EEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHh
Confidence 7999997653 256789999999999999999998753 2346899999999999999998
Q ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccc
Q 007991 67 KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146 (582)
Q Consensus 67 k~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~ 146 (582)
...+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............||+.|+|||+
T Consensus 113 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 192 (284)
T 2a19_B 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ 192 (284)
T ss_dssp HGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHH
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhh
Confidence 76556799999999999999999999999999999999999999999999999999987766555666789999999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
+.+..++.++|||||||++|+|++|..||.... .....+.. ..++..++..+.+||.+||..||.+|||+.|+++
T Consensus 193 ~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 193 ISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp HHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999899999999999999999999998875432 22333332 2356678999999999999999999999999999
Q ss_pred CCC
Q 007991 227 HPH 229 (582)
Q Consensus 227 hp~ 229 (582)
|.+
T Consensus 268 ~l~ 270 (284)
T 2a19_B 268 TLT 270 (284)
T ss_dssp HHH
T ss_pred HHH
Confidence 854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.68 Aligned_cols=223 Identities=20% Similarity=0.322 Sum_probs=195.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++.. ......+.+.+|+++|++++|||||++++++... ..+|+|||||+||+|.++++..+ ..+++..+..+
T Consensus 142 vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~ 218 (377)
T 3cbl_A 142 VAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQM 218 (377)
T ss_dssp EEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHH
T ss_pred EEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 899998754 3455667889999999999999999999987654 47899999999999999998753 35899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccccc---CcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLA---SSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~---~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ....+++.|+|||++.+..|+.++||
T Consensus 219 ~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 298 (377)
T 3cbl_A 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298 (377)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHH
T ss_pred HHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhH
Confidence 999999999999999999999999999999999999999999765432211 22345678999999998889999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|||++ |..||.+.+.......+......+.+..+++.+.+||.+||+.||++|||++++++.
T Consensus 299 wslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999999999998 999999999888888888777777888899999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=324.96 Aligned_cols=224 Identities=20% Similarity=0.356 Sum_probs=191.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||.++... .....+.+.+|+.+|+++ +||||+++++++... ...|+|||||+||+|.+++.....
T Consensus 56 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 133 (313)
T 1t46_A 56 VAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133 (313)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHTTTTC--------
T ss_pred hHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-CCcEEEEecCCCCCHHHHHHhccccccccccccc
Confidence 7899997653 345567899999999999 999999999987654 478899999999999999987542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCC
Q 007991 71 ------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSY 141 (582)
Q Consensus 71 ------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y 141 (582)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|
T Consensus 134 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y 213 (313)
T 1t46_A 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213 (313)
T ss_dssp ------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGG
T ss_pred ccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCccee
Confidence 248999999999999999999999999999999999999999999999999998765432 23345678899
Q ss_pred CCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHH-HHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC
Q 007991 142 MCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQA-LINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 142 ~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~-l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
+|||++.+..++.++|||||||++|+|++ |..||.+..... ....+........+..++..+.+||.+||..||.+||
T Consensus 214 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 214 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred eChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc
Confidence 99999998899999999999999999998 999998766433 3333444444556677999999999999999999999
Q ss_pred CHHHHHcC
Q 007991 220 SAAELLCH 227 (582)
Q Consensus 220 Sa~EiL~h 227 (582)
|++|++++
T Consensus 294 s~~ell~~ 301 (313)
T 1t46_A 294 TFKQIVQL 301 (313)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.85 Aligned_cols=223 Identities=20% Similarity=0.348 Sum_probs=191.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... .......+.+|+.+|++++||||+++++++.. +...|+|||||+|++|.+++.... ..+++..+..+
T Consensus 76 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 152 (333)
T 1mqb_A 76 VAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGM 152 (333)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHH
T ss_pred EEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHH
Confidence 7899987643 45666789999999999999999999998754 457899999999999999998743 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|+.|+|||++.+..++.++|
T Consensus 153 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 232 (333)
T 1mqb_A 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 232 (333)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhh
Confidence 9999999999999999999999999999999999999999998764432 122345678899999999989999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|+|++ |..||.+.+..++...+......+.+..++..+.+||.+||+.||.+||++.+++++
T Consensus 233 i~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 233 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999998 999999999888888888776677788899999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=326.19 Aligned_cols=226 Identities=27% Similarity=0.477 Sum_probs=186.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC--CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~--HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||++..........+.+.+|+.+|+++. |+||+++++++... ..+|+||| +.+++|.+++.... .+++..+.
T Consensus 55 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~ 130 (313)
T 3cek_A 55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWLKKKK--SIDPWERK 130 (313)
T ss_dssp EEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHH
T ss_pred EEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-CEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHH
Confidence 899999887777778889999999999997 59999999987654 58999999 45899999998754 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccC-------
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLAD------- 149 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~------- 149 (582)
.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... .....+||+.|+|||++.+
T Consensus 131 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 209 (313)
T 3cek_A 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209 (313)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC-----
T ss_pred HHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccccc
Confidence 9999999999999999999999999999996 5889999999998764332 2345689999999999875
Q ss_pred ----CCCCCCCcccchhHHHHhHhcCCccccccC-HHHHH-HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 150 ----IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD-MQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 150 ----~~y~~ksDIWSLG~iLyELltG~~PF~~~~-~~~l~-~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
..++.++|||||||++|+|++|..||.... ..... ..+.......++..++..+.+||.+||..||.+||+++|
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (313)
T 3cek_A 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289 (313)
T ss_dssp -----CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHH
Confidence 468889999999999999999999997653 22222 223333344567778999999999999999999999999
Q ss_pred HHcCCCCch
Q 007991 224 LLCHPHLQP 232 (582)
Q Consensus 224 iL~hp~f~~ 232 (582)
+|+||||+.
T Consensus 290 ll~h~~~~~ 298 (313)
T 3cek_A 290 LLAHPYVQI 298 (313)
T ss_dssp HHTSHHHHC
T ss_pred HhcCccccC
Confidence 999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.25 Aligned_cols=227 Identities=20% Similarity=0.308 Sum_probs=197.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-----CCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-----VHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-----~~lse~ 76 (582)
||||.+... ........+.+|+.+|++++||||+++++++... ...|+|||||+|++|.+++..... ..+++.
T Consensus 63 vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 140 (327)
T 2yfx_A 63 VAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140 (327)
T ss_dssp EEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHH
T ss_pred EEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-CCcEEEEecCCCCcHHHHHHhhcccccccccccHH
Confidence 899998743 3455667889999999999999999999987654 467899999999999999987532 348999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC---CCeEEeecccchhccccc---ccCcccCCCCCCCcccccCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~ 150 (582)
.+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++....... ......||+.|+|||++.+.
T Consensus 141 ~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 220 (327)
T 2yfx_A 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG 220 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC
Confidence 999999999999999999999999999999999954 459999999998654332 23456789999999999988
Q ss_pred CCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 151 PYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
.++.++|||||||++|+|++ |..||...+...+...+........+..++..+.+||.+||..||.+||+++++++|.|
T Consensus 221 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 221 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 99999999999999999998 99999999988888888777767778889999999999999999999999999999866
Q ss_pred C
Q 007991 230 L 230 (582)
Q Consensus 230 f 230 (582)
+
T Consensus 301 ~ 301 (327)
T 2yfx_A 301 Y 301 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=347.58 Aligned_cols=220 Identities=17% Similarity=0.349 Sum_probs=195.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++..... .+.+.+|+.+|++|+|||||++++++. +..+|+|||||.+|+|.++++...+..+++..+..|
T Consensus 215 vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 289 (454)
T 1qcf_A 215 VAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289 (454)
T ss_dssp EEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHH
T ss_pred EEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 899999875443 467899999999999999999999765 346889999999999999998654446899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......++..|+|||++....|+.++|||
T Consensus 290 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 369 (454)
T 1qcf_A 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369 (454)
T ss_dssp HHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHH
Confidence 9999999999999999999999999999999999999999998764332 22344567889999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|||++ |..||.+.+..++...+......+.+..+++.+.+||.+||..||++|||+++|+.
T Consensus 370 slG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 370 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999 99999999999988888887777788889999999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=320.16 Aligned_cols=221 Identities=19% Similarity=0.362 Sum_probs=194.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++..... .+.+.+|+++|++++||||+++++++.. ...|+||||+.|++|.+++....+..+++..+..+
T Consensus 40 vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i 114 (279)
T 1qpc_A 40 VAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114 (279)
T ss_dssp EEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHH
T ss_pred EEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHH
Confidence 789999765443 3578999999999999999999997653 35789999999999999997644346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|||
T Consensus 115 ~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 194 (279)
T 1qpc_A 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194 (279)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhH
Confidence 9999999999999999999999999999999999999999998765432 22345678899999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|+|++ |..||.+.+..++...+........+..++..+.+||.+||..||++|||++++++.
T Consensus 195 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263 (279)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 99999999999 999999999888888887776666778899999999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.29 Aligned_cols=224 Identities=20% Similarity=0.372 Sum_probs=197.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||.++... .....+.+.+|+.+|+++ +||||+++++++.. +..+|+|||||+|++|.+++.....
T Consensus 70 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 147 (334)
T 2pvf_A 70 VAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147 (334)
T ss_dssp EEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC---
T ss_pred EEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-CCceEEEEECCCCCcHHHHHHHhcccccccccccc
Confidence 7899987643 456667899999999999 89999999998765 4578999999999999999986431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 71 ----VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 71 ----~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|
T Consensus 148 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 227 (334)
T 2pvf_A 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 227 (334)
T ss_dssp -----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCC
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeC
Confidence 248999999999999999999999999999999999999999999999999998664432 2334567889999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||++.+..++.++|||||||++|+|++ |..||.+.+..++...+........+..++..+.+||.+||..||.+||+++
T Consensus 228 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 307 (334)
T 2pvf_A 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 307 (334)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999988889999999999999999999 9999999999888888877777777888999999999999999999999999
Q ss_pred HHHcC
Q 007991 223 ELLCH 227 (582)
Q Consensus 223 EiL~h 227 (582)
|++++
T Consensus 308 ell~~ 312 (334)
T 2pvf_A 308 QLVED 312 (334)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=319.10 Aligned_cols=221 Identities=25% Similarity=0.536 Sum_probs=179.0
Q ss_pred EEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTD--RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~--~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
||||+++...... ...+.+.+|+++++.++||||+++++++.. +...|+||||++|++|.+++.. ..+++..+.
T Consensus 33 vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~ 108 (271)
T 3dtc_A 33 VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVMEFARGGPLNRVLSG---KRIPPDILV 108 (271)
T ss_dssp EEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEEEEECCTTEEHHHHHTS---SCCCHHHHH
T ss_pred EEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHH
Confidence 7899887654332 335678999999999999999999998765 4578999999999999999864 269999999
Q ss_pred HHHHHHHHHHHHHHHCC---ceecccCcccEEEcC--------CCCeEEeecccchhcccccccCcccCCCCCCCccccc
Q 007991 80 KWLVQLLMALNYLHANH---ILHRDVKCSNIFLTR--------DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA 148 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~g---IiHRDIKP~NILL~~--------~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~ 148 (582)
.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++....... .....||+.|+|||++.
T Consensus 109 ~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~ 187 (271)
T 3dtc_A 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIR 187 (271)
T ss_dssp HHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhc
Confidence 99999999999999999 999999999999986 6789999999998654432 33568999999999999
Q ss_pred CCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhc-cCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKS-IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~-~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+..++.++|||||||++|+|++|..||.+.+.......+... ...+.+..+++.+.+||.+||+.||.+|||+.|++++
T Consensus 188 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 989999999999999999999999999998877766555433 3455678899999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.28 Aligned_cols=223 Identities=21% Similarity=0.395 Sum_probs=192.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++... .....+.+.+|+++|++++||||+++++++.. .+..+|+|||||+|++|.+++....+ .+++..+..
T Consensus 55 vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~ 131 (327)
T 3lxl_A 55 VAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLL 131 (327)
T ss_dssp EEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHH
T ss_pred EEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHH
Confidence 899998764 45566789999999999999999999998774 45689999999999999999987533 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
|+.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......||+.|+|||++.+..++.++
T Consensus 132 i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 211 (327)
T 3lxl_A 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS 211 (327)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHH
Confidence 99999999999999999999999999999999999999999998664332 23445788889999999988899999
Q ss_pred cccchhHHHHhHhcCCccccccCH---------------HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDM---------------QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~---------------~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
|||||||++|+|++|..||..... ..+...+......+.+..+++.+.+||.+||+.||.+|||+
T Consensus 212 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 291 (327)
T 3lxl_A 212 DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF 291 (327)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCH
Confidence 999999999999999999865443 23344455555666778899999999999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
+|++++
T Consensus 292 ~ell~~ 297 (327)
T 3lxl_A 292 SALGPQ 297 (327)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=322.91 Aligned_cols=223 Identities=21% Similarity=0.376 Sum_probs=187.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.... ....+.+.+|+.+|++++||||+++++++...+ ..+|+||||++|++|.+++.... ..+++..+..
T Consensus 53 vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 130 (302)
T 4e5w_A 53 VAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLK 130 (302)
T ss_dssp EEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHH
T ss_pred EEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHH
Confidence 89999976542 234467899999999999999999999887653 56899999999999999997654 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......||..|+|||++.+..++.++
T Consensus 131 ~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 210 (302)
T 4e5w_A 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIAS 210 (302)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcch
Confidence 99999999999999999999999999999999999999999998765432 23456788889999999988899999
Q ss_pred cccchhHHHHhHhcCCcccccc---------------CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAF---------------DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~---------------~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
|||||||++|+|++|..||... ....+...+......+.+..+++.+.+||.+||+.||.+|||+
T Consensus 211 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 290 (302)
T 4e5w_A 211 DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290 (302)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred hHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCH
Confidence 9999999999999998876422 2334445555555666788899999999999999999999999
Q ss_pred HHHHc
Q 007991 222 AELLC 226 (582)
Q Consensus 222 ~EiL~ 226 (582)
+++++
T Consensus 291 ~~ll~ 295 (302)
T 4e5w_A 291 QNLIE 295 (302)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.35 Aligned_cols=223 Identities=23% Similarity=0.464 Sum_probs=179.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.........+.+.+|+.+|++++||||+++++++ . +..+++|||||+|++|.+++.... ..+++..+..+
T Consensus 49 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 125 (289)
T 3og7_A 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T-APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDI 125 (289)
T ss_dssp EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C-SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHH
T ss_pred eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c-CCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHH
Confidence 79999998888888888999999999999999999999853 3 346889999999999999997543 46999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc---ccccCcccCCCCCCCccccc---CCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS---DDLASSVVGTPSYMCPELLA---DIPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~---~~~~~~~vGTp~Y~APE~l~---~~~y~~k 155 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........||+.|+|||++. +..++.+
T Consensus 126 ~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 205 (289)
T 3og7_A 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHH
T ss_pred HHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcc
Confidence 99999999999999999999999999999999999999999976543 22334568999999999986 5668889
Q ss_pred CcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCC----CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVA----PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~----~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||||++|+|++|..||.+.... .+...+...... .+...+++.+.+||.+||+.||.+|||++++++.
T Consensus 206 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999999875443 344444333322 2344688999999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=340.72 Aligned_cols=224 Identities=17% Similarity=0.285 Sum_probs=186.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++... .....+.+.+|+.+|++++||||+++++++...+...|+||||++||+|.++++.. +..+++..+..+
T Consensus 120 vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i 197 (373)
T 3c1x_A 120 CAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGF 197 (373)
T ss_dssp EEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHH
T ss_pred EEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHH
Confidence 6888887543 33456789999999999999999999998876666889999999999999999864 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..++.++
T Consensus 198 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 277 (373)
T 3c1x_A 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 277 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHH
Confidence 9999999999999999999999999999999999999999998654332 12345677889999999999999999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|||++ |.+||.+.+..++...+........+..++..+.+||.+||..||++||+++|++++
T Consensus 278 DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 278 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999 789998877666666676666666778899999999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.10 Aligned_cols=221 Identities=19% Similarity=0.350 Sum_probs=196.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.++..... .+.+.+|+.+|++++|||||++++++... ..+|||||||.||+|.++++......+++..+..|
T Consensus 248 vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i 323 (495)
T 1opk_A 248 VAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323 (495)
T ss_dssp EEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHH
T ss_pred EEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC-CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHH
Confidence 899999765443 45789999999999999999999987654 47899999999999999999866567999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......++..|+|||++.+..|+.++|||
T Consensus 324 ~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvw 403 (495)
T 1opk_A 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403 (495)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHH
Confidence 9999999999999999999999999999999999999999998764332 22334567789999999988899999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|||++ |..||.+.+...+...+......+.+..++..+.+||.+||+.||.+|||+.+|++
T Consensus 404 SlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999998 99999998888888888777777778889999999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.56 Aligned_cols=221 Identities=22% Similarity=0.413 Sum_probs=190.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.. ......+.+.+|+++|++++||||+++++++... ...+|+|||||++++|.+++... .+++..+..
T Consensus 63 vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~ 138 (318)
T 3lxp_A 63 VAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLL 138 (318)
T ss_dssp EEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHH
T ss_pred EEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHH
Confidence 899999765 3456678899999999999999999999988765 46899999999999999999864 489999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++
T Consensus 139 i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 218 (318)
T 3lxp_A 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS 218 (318)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHH
Confidence 99999999999999999999999999999999999999999998765432 23445788889999999988899999
Q ss_pred cccchhHHHHhHhcCCccccccCHH---------------HHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQ---------------ALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~---------------~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
|||||||++|+|++|..||...... .+...+......+.+..++..+.+||.+||+.||.+|||+
T Consensus 219 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 298 (318)
T 3lxp_A 219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTF 298 (318)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCH
Confidence 9999999999999999999754322 2333444555666778899999999999999999999999
Q ss_pred HHHHc
Q 007991 222 AELLC 226 (582)
Q Consensus 222 ~EiL~ 226 (582)
+|+++
T Consensus 299 ~ell~ 303 (318)
T 3lxp_A 299 ENLIP 303 (318)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99996
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.66 Aligned_cols=217 Identities=20% Similarity=0.317 Sum_probs=184.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ...+.+.+|+.+|++++||||+++++++... ...|+|||||+|++|.+++.... ..+++..+..+
T Consensus 43 va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i 118 (289)
T 4fvq_A 43 VLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCG-DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEV 118 (289)
T ss_dssp EEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHH
T ss_pred hhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHH
Confidence 78888865433 3446789999999999999999999987654 47789999999999999998753 34899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCC--------eEEeecccchhcccccccCcccCCCCCCCcccccC-CCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--------IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPY 152 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~--------vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y 152 (582)
+.||+.||.|||++||+||||||+|||++.++. +||+|||++...... ....||+.|+|||++.+ ..+
T Consensus 119 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~ 195 (289)
T 4fvq_A 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNL 195 (289)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGC
T ss_pred HHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCC
Confidence 999999999999999999999999999999887 999999998765432 34568999999999987 678
Q ss_pred CCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 153 GSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+.++|||||||++|+|++ |.+||...+.......... ...++..++..+.+||.+||+.||.+|||++++++|
T Consensus 196 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999 5677777776655544433 334566678999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=358.03 Aligned_cols=222 Identities=19% Similarity=0.345 Sum_probs=196.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.........+.+.+|+++|++|+|||||++++++. .+ .+|+|||||+||+|.+++.... .+++..+..|
T Consensus 399 vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~-~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i 474 (635)
T 4fl3_A 399 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE-SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL 474 (635)
T ss_dssp EEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS-SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC-CEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHH
Confidence 899999887666666788999999999999999999999774 33 5789999999999999998743 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.... ......||+.|+|||++.+..|+.++|
T Consensus 475 ~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sD 554 (635)
T 4fl3_A 475 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 554 (635)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHH
Confidence 9999999999999999999999999999999999999999998765432 123345678899999999999999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|||++ |..||.+.+..++...+........+..++.++.+||..||..||++||++++|++.
T Consensus 555 vwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 555 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999998 999999999999999888888778888999999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=328.15 Aligned_cols=231 Identities=27% Similarity=0.458 Sum_probs=166.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHH-HHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHH---hCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEME-LISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKK---ANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~-iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk---~~~~~lse~ 76 (582)
.||||+++.... ......+.+|+. +++.++||||+++++++... ...|+||||+. ++|.+++.. .....+++.
T Consensus 49 ~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~ 125 (327)
T 3aln_A 49 IMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125 (327)
T ss_dssp EEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHH
T ss_pred EEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEEEeecC-CChHHHHHHHHhhhcccCcHH
Confidence 389999987544 334445556665 78888999999999988765 58899999997 488887764 224478999
Q ss_pred HHHHHHHHHHHHHHHHHHC-CceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccc----cCCC
Q 007991 77 KLCKWLVQLLMALNYLHAN-HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELL----ADIP 151 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~-gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l----~~~~ 151 (582)
.+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.............||+.|+|||++ .+..
T Consensus 126 ~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 205 (327)
T 3aln_A 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------
T ss_pred HHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCC
Confidence 9999999999999999999 9999999999999999999999999999877655445556899999999998 4567
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCCCC----CccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAPL----PTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~l----p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
++.++|||||||++|+|++|..||.+.... +....+.......+ ...++..+.+||.+||..||.+||++.++++
T Consensus 206 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 899999999999999999999999875422 22222222222222 2358999999999999999999999999999
Q ss_pred CCCCchhh
Q 007991 227 HPHLQPYV 234 (582)
Q Consensus 227 hp~f~~~~ 234 (582)
||||..+.
T Consensus 286 hp~~~~~~ 293 (327)
T 3aln_A 286 HPFILMYE 293 (327)
T ss_dssp SHHHHHHH
T ss_pred ChHHHHhH
Confidence 99997654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.27 Aligned_cols=226 Identities=26% Similarity=0.397 Sum_probs=160.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||++... .... ......++.++||||++++++|.. .+..+|+|||||+||+|.+++.+..+..+++..
T Consensus 56 ~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~ 129 (336)
T 3fhr_A 56 KCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129 (336)
T ss_dssp EEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHH
T ss_pred EEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHH
Confidence 3899998653 2222 223344677799999999998864 245789999999999999999986656799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC---CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD---QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~---g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..... ......+||+.|+|||++.+..|+.
T Consensus 130 ~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ 208 (336)
T 3fhr_A 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDK 208 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCCCc
Confidence 99999999999999999999999999999999864 4599999999976543 2345678999999999998888999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHH----HHhh---ccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALIN----KINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~----kI~~---~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
++|||||||++|+|++|..||.......... .+.. ....+....++..+.+||.+||..||.+|||++|+|+|
T Consensus 209 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 209 SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999997766544321 1111 11222335689999999999999999999999999999
Q ss_pred CCCchh
Q 007991 228 PHLQPY 233 (582)
Q Consensus 228 p~f~~~ 233 (582)
|||+..
T Consensus 289 p~~~~~ 294 (336)
T 3fhr_A 289 PWINQS 294 (336)
T ss_dssp HHHHTG
T ss_pred cccccc
Confidence 999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=319.88 Aligned_cols=223 Identities=24% Similarity=0.334 Sum_probs=181.9
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++..... .....+.+.+|+.++++++||||+++++++... ..+|+||||++|++|.+++.... .+++..+.
T Consensus 61 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 137 (309)
T 2h34_A 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAV 137 (309)
T ss_dssp EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCCCEEHHHHHHHHC--SCCHHHHH
T ss_pred EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHH
Confidence 389999976543 455678899999999999999999999987664 58999999999999999998764 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..++.++|
T Consensus 138 ~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 217 (309)
T 2h34_A 138 AIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217 (309)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCH
T ss_pred HHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHh
Confidence 999999999999999999999999999999999999999999997765432 234568999999999999989999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCC-CHHHHHc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRP-SAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~Rp-Sa~EiL~ 226 (582)
||||||++|+|++|..||.+.+...+...+...... ..+..++..+.+||.+||..||++|| +++++++
T Consensus 218 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 218 IYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999999988776555555443322 24566899999999999999999999 8998886
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.38 Aligned_cols=222 Identities=20% Similarity=0.338 Sum_probs=190.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.+..... ....+.+.+|+.++++++||||+++++++. +...|+||||+.||+|.+++.... ..+++..+..|
T Consensus 45 v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 120 (325)
T 3kex_A 45 VCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNW 120 (325)
T ss_dssp EEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHH
T ss_pred EEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHH
Confidence 67777754332 122345778999999999999999999764 346889999999999999998642 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||+|||++||+||||||+|||++.++++||+|||+++...... ......||+.|+|||++.+..++.++||
T Consensus 121 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 200 (325)
T 3kex_A 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV 200 (325)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHh
Confidence 9999999999999999999999999999999999999999998764432 2345678889999999998899999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|+|++ |..||.+.....+...+........+..++..+.+||.+||..||.+||++.+++++
T Consensus 201 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 201 WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999 999999988888888887777777788899999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=317.25 Aligned_cols=219 Identities=19% Similarity=0.397 Sum_probs=183.2
Q ss_pred EEEEEecccccCHH--HH---HHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDR--AR---RSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~--~~---~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++........ .. +.+.+|+.+|++++||||+++++++.... ++||||++|++|.+.+.... ..+++.
T Consensus 47 vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~lv~e~~~~~~L~~~l~~~~-~~~~~~ 122 (287)
T 4f0f_A 47 VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKA-HPIKWS 122 (287)
T ss_dssp EEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT---EEEEECCTTCBHHHHHHCTT-SCCCHH
T ss_pred EEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC---eEEEEecCCCCHHHHHhccc-CCccHH
Confidence 89999976544322 11 67899999999999999999999875433 59999999999999997643 469999
Q ss_pred HHHHHHHHHHHHHHHHHHCC--ceecccCcccEEEcCCCC-----eEEeecccchhcccccccCcccCCCCCCCccccc-
Q 007991 77 KLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA- 148 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~-----vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~- 148 (582)
.+..++.||+.||+|||++| |+||||||+|||++.++. +||+|||+++.... .....+||+.|+|||++.
T Consensus 123 ~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSC
T ss_pred HHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhcc
Confidence 99999999999999999999 999999999999998876 99999999975433 344578999999999984
Q ss_pred -CCCCCCCCcccchhHHHHhHhcCCccccccCHHHH--HHHH-hhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHH
Q 007991 149 -DIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQAL--INKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAEL 224 (582)
Q Consensus 149 -~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l--~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~Ei 224 (582)
...++.++|||||||++|+|++|..||........ ...+ .......++..+++.+.+||.+||+.||.+|||++++
T Consensus 201 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 280 (287)
T 4f0f_A 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280 (287)
T ss_dssp SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 45578899999999999999999999976553322 3333 2334455778899999999999999999999999999
Q ss_pred Hc
Q 007991 225 LC 226 (582)
Q Consensus 225 L~ 226 (582)
++
T Consensus 281 l~ 282 (287)
T 4f0f_A 281 VK 282 (287)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.12 Aligned_cols=220 Identities=20% Similarity=0.366 Sum_probs=190.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++..... .+.+.+|+.+|++|+||||+++++++.. ..+|+|||||+||+|.++++...+..+++..+..+
T Consensus 211 vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i 285 (452)
T 1fmk_A 211 VAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285 (452)
T ss_dssp EEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHH
T ss_pred EEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHH
Confidence 799999875543 3578999999999999999999998754 46889999999999999998654456999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......++..|+|||++.+..++.++|||
T Consensus 286 ~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvw 365 (452)
T 1fmk_A 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365 (452)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHH
Confidence 9999999999999999999999999999999999999999998764332 12334567889999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||++|||++ |..||.+....++...+......+.+..+++.+.+||.+||+.||++|||+++|++
T Consensus 366 slG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999 99999999998888888887777788899999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.89 Aligned_cols=217 Identities=19% Similarity=0.256 Sum_probs=182.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.+...... +.+.+|+.+|++| +||||+++++++.. +...|+||||+ |++|.+++... +..+++..+..
T Consensus 37 vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~ 109 (330)
T 2izr_A 37 VAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLM 109 (330)
T ss_dssp EEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHH
T ss_pred EEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHH
Confidence 899998765432 3578999999999 99999999998766 45899999999 99999999875 34799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCC-----eEEeecccchhcccccc--------cCcccCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDDL--------ASSVVGTPSYMCPELL 147 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~-----vKL~DFGla~~~~~~~~--------~~~~vGTp~Y~APE~l 147 (582)
++.||+.||+|||++||+||||||+||||+.++. +||+|||+++....... ....+||+.|+|||++
T Consensus 110 i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (330)
T 2izr_A 110 IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTH 189 (330)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHH
Confidence 9999999999999999999999999999999887 99999999987544321 2467899999999999
Q ss_pred cCCCCCCCCcccchhHHHHhHhcCCcccccc---CHHHHHHHHhhccCC-C---CCccccHHHHHHHHHhccCCCCCCCC
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIVA-P---LPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELltG~~PF~~~---~~~~l~~kI~~~~~~-~---lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
.+..++.++|||||||++|+|++|..||.+. ...+.+..+...... + +...++ ++.+||..||..||.+||+
T Consensus 190 ~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~ 268 (330)
T 2izr_A 190 LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPD 268 (330)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCC
T ss_pred cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999874 444444444322211 1 122345 9999999999999999999
Q ss_pred HHHHHc
Q 007991 221 AAELLC 226 (582)
Q Consensus 221 a~EiL~ 226 (582)
+++|++
T Consensus 269 ~~~l~~ 274 (330)
T 2izr_A 269 YDYLRK 274 (330)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.75 Aligned_cols=225 Identities=35% Similarity=0.624 Sum_probs=181.4
Q ss_pred EEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHHH
Q 007991 2 YVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~-~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~~ 78 (582)
||||+++... ......+.+.+|+.+|++++||||+++++++... ...|+||||+++++|.+++... .+..+++..+
T Consensus 60 vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 138 (310)
T 2wqm_A 60 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138 (310)
T ss_dssp EEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHH
T ss_pred EEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHH
Confidence 8999997643 4556778899999999999999999999988765 4899999999999999999752 3446899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..++.++|
T Consensus 139 ~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (310)
T 2wqm_A 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218 (310)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHH
T ss_pred HHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhh
Confidence 9999999999999999999999999999999999999999999997664432 234568999999999999989999999
Q ss_pred ccchhHHHHhHhcCCcccccc--CHHHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 158 IWSLGCCVYEMSAQKAAFKAF--DMQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~--~~~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||||++|+|++|..||.+. +...+...+......+.+ ..++.++.+||.+||..||.+|||+++++++
T Consensus 219 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999654 344555555544443333 5689999999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.97 Aligned_cols=222 Identities=22% Similarity=0.385 Sum_probs=188.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||+|.++.... ....+.+.+|+.+|++++||||+++++++...+ .++|+||+.+|+|.+++.... ..+++..+..|
T Consensus 47 v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i 122 (327)
T 3lzb_A 47 VAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNW 122 (327)
T ss_dssp EEEEEECCCSS-CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHH
T ss_pred EEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHH
Confidence 57777765432 234567899999999999999999999887543 779999999999999998753 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..|+.++||
T Consensus 123 ~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 202 (327)
T 3lzb_A 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 202 (327)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHH
Confidence 9999999999999999999999999999999999999999998764332 2234456788999999999999999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|+|++ |..||.+.....+...+......+.+..++..+.+||.+||..||.+||+++|+++.
T Consensus 203 ~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999 999999988888888887777777888899999999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.75 Aligned_cols=226 Identities=24% Similarity=0.325 Sum_probs=176.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++..... ..+.+|+++|+++ +|||||++++++.. +..+|||||||. |+|.+++.... ..+.+..+..
T Consensus 51 vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~ 122 (432)
T 3p23_A 51 VAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPIT 122 (432)
T ss_dssp EEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHH
T ss_pred EEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHH
Confidence 89999966433 2357899999999 79999999998765 458999999995 69999998754 3456667789
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcC---CC--CeEEeecccchhcccc----cccCcccCCCCCCCccccc---
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQ--DIRLGDFGLAKMLISD----DLASSVVGTPSYMCPELLA--- 148 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g--~vKL~DFGla~~~~~~----~~~~~~vGTp~Y~APE~l~--- 148 (582)
++.||+.||+|||++||+||||||+||||+. ++ .+||+|||+++..... ......+||+.|+|||++.
T Consensus 123 i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 202 (432)
T 3p23_A 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202 (432)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC-
T ss_pred HHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhccc
Confidence 9999999999999999999999999999953 23 5789999999876533 2344578999999999997
Q ss_pred CCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 149 DIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 149 ~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
...++.++|||||||++|+|++ |.+||...........+...... ..+...+..+++||.+||+.||.+|||++++|
T Consensus 203 ~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 203 KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp --CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 4567789999999999999999 99999766544433322221111 12234567799999999999999999999999
Q ss_pred cCCCCchhhh
Q 007991 226 CHPHLQPYVL 235 (582)
Q Consensus 226 ~hp~f~~~~~ 235 (582)
+||||....+
T Consensus 283 ~hp~f~~~~~ 292 (432)
T 3p23_A 283 KHPFFWSLEK 292 (432)
T ss_dssp TSTTTCCHHH
T ss_pred hCccccChHH
Confidence 9999987554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=325.38 Aligned_cols=224 Identities=19% Similarity=0.385 Sum_probs=189.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||.++... .....+.+.+|+.+|+++ +||||+++++++... ..+|+|||||+||+|.+++....
T Consensus 79 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 156 (333)
T 2i1m_A 79 VAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156 (333)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHHHHHHSCC-----
T ss_pred HHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-CceEEEEecCCCCcHHHHHHHhcccccccccccc
Confidence 7888887654 345567899999999999 899999999987654 47899999999999999998642
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcc
Q 007991 70 -GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPE 145 (582)
Q Consensus 70 -~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE 145 (582)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||
T Consensus 157 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 236 (333)
T 2i1m_A 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 236 (333)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred cccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHH
Confidence 2358999999999999999999999999999999999999999999999999998654332 233456788999999
Q ss_pred cccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHH-HHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 146 LLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 146 ~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~-~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
++.+..++.++|||||||++|+|++ |..||.+....... ..+........+..++..+.+||..||+.||.+|||+++
T Consensus 237 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 316 (333)
T 2i1m_A 237 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 316 (333)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 9998899999999999999999998 99999876544333 333444445567778999999999999999999999999
Q ss_pred HHcC
Q 007991 224 LLCH 227 (582)
Q Consensus 224 iL~h 227 (582)
++++
T Consensus 317 l~~~ 320 (333)
T 2i1m_A 317 ICSF 320 (333)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=317.85 Aligned_cols=223 Identities=19% Similarity=0.343 Sum_probs=186.9
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.... .....+.+.+|++++++++||||+++++++...+ .++||||+.+++|.+++.... ..+++..+..
T Consensus 49 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 125 (291)
T 1u46_A 49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSR 125 (291)
T ss_dssp EEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHH
T ss_pred EEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--ceeeEecccCCCHHHHHHhcc-CCcCHHHHHH
Confidence 78888876543 2355678999999999999999999999876543 789999999999999998753 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++
T Consensus 126 ~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 205 (291)
T 1u46_A 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 205 (291)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchh
Confidence 99999999999999999999999999999999999999999997764332 22345678899999999988899999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhcc-CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSI-VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~-~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|+|++ |..||.+.+...+...+.... ..+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 206 Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 206 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999 999999998888877775433 345567799999999999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.06 Aligned_cols=221 Identities=19% Similarity=0.301 Sum_probs=179.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||++.... .......+|+.+|++++|||||++++++...+ ..+|+|||||++|+|.++++.. .+++..
T Consensus 49 ~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~ 122 (322)
T 3soc_A 49 YVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNE 122 (322)
T ss_dssp EEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHH
T ss_pred EEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHH
Confidence 38999996543 33445677999999999999999999988653 4689999999999999999874 599999
Q ss_pred HHHHHHHHHHHHHHHHHC----------CceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCc
Q 007991 78 LCKWLVQLLMALNYLHAN----------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCP 144 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~----------gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~AP 144 (582)
+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... .....+||+.|+||
T Consensus 123 ~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP 202 (322)
T 3soc_A 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202 (322)
T ss_dssp HHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCH
Confidence 999999999999999999 99999999999999999999999999997764432 23446899999999
Q ss_pred ccccCC-----CCCCCCcccchhHHHHhHhcCCcccccc----------------CHHHHHHHHhhccCCC-CCcc----
Q 007991 145 ELLADI-----PYGSKSDIWSLGCCVYEMSAQKAAFKAF----------------DMQALINKINKSIVAP-LPTV---- 198 (582)
Q Consensus 145 E~l~~~-----~y~~ksDIWSLG~iLyELltG~~PF~~~----------------~~~~l~~kI~~~~~~~-lp~~---- 198 (582)
|++.+. .++.++|||||||++|+|++|..||.+. ....+...+......+ ++..
T Consensus 203 E~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (322)
T 3soc_A 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH 282 (322)
T ss_dssp HHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSS
T ss_pred hhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCcccccccc
Confidence 999873 4556789999999999999999999653 2233333332222222 2221
Q ss_pred -ccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 199 -YSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 199 -~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.+..+.+||.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 283 AGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34569999999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=319.84 Aligned_cols=225 Identities=23% Similarity=0.370 Sum_probs=184.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHh--CCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKA--NGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse 75 (582)
.||||++... .....+.+.+|+.+++.++||||+++++++.. .....|+||||+.+++|.+++... .+..+++
T Consensus 56 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 133 (317)
T 2buj_A 56 FYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133 (317)
T ss_dssp EEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCH
T ss_pred EEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCH
Confidence 3899988653 45566789999999999999999999998873 235889999999999999999863 2347999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----------ccCcccCCCCCCCcc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----------LASSVVGTPSYMCPE 145 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----------~~~~~vGTp~Y~APE 145 (582)
..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||
T Consensus 134 ~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 213 (317)
T 2buj_A 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHh
Confidence 9999999999999999999999999999999999999999999999887543211 112356899999999
Q ss_pred cccCCC---CCCCCcccchhHHHHhHhcCCccccccCH--HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 146 LLADIP---YGSKSDIWSLGCCVYEMSAQKAAFKAFDM--QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 146 ~l~~~~---y~~ksDIWSLG~iLyELltG~~PF~~~~~--~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
++.+.. ++.++|||||||++|+|++|..||..... ......+......+.+..++..+.+||.+||+.||.+||+
T Consensus 214 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 293 (317)
T 2buj_A 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH 293 (317)
T ss_dssp GSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCC
Confidence 997654 68899999999999999999999964211 1122233333344455678999999999999999999999
Q ss_pred HHHHHcC
Q 007991 221 AAELLCH 227 (582)
Q Consensus 221 a~EiL~h 227 (582)
+++++++
T Consensus 294 ~~~ll~~ 300 (317)
T 2buj_A 294 IPLLLSQ 300 (317)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.52 Aligned_cols=223 Identities=23% Similarity=0.335 Sum_probs=183.3
Q ss_pred EEEEEecccccCH----HHHHHHHHHHHHHHhc----CCCCeeeeeeEEEecCcEEEEEEee-cCCCCHHHHHHHhCCCC
Q 007991 2 YVLKKIRLARQTD----RARRSAHQEMELISRV----RNPFIVEYKDSWVEKGCYVCIIIGY-CEGGDMAEAIKKANGVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~----~~~~~~~rEi~iL~~L----~HpnIV~l~~~~~~~~~~l~LVmEy-~~GgsL~d~Ikk~~~~~ 72 (582)
||||++....... .....+.+|+.++.++ +||||+++++++... ...|+|||| +.+++|.+++.... .
T Consensus 59 vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~~L~~~l~~~~--~ 135 (312)
T 2iwi_A 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-EGFMLVLERPLPAQDLFDYITEKG--P 135 (312)
T ss_dssp EEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC------CEEEEECCSSEEEHHHHHHHHC--S
T ss_pred EEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-CeEEEEEEecCCCCCHHHHHHhcC--C
Confidence 8999997655433 2234567899999999 899999999987654 478899999 78999999998864 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEc-CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~ 151 (582)
+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++.+..
T Consensus 136 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 214 (312)
T 2iwi_A 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQ 214 (312)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCC
Confidence 89999999999999999999999999999999999999 7899999999999876543 345678999999999998766
Q ss_pred CC-CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 152 YG-SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 152 y~-~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
+. .++|||||||++|+|++|..||..... +.. ....++..++..+.+||.+||..||++|||++|+|+||||
T Consensus 215 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 215 YHALPATVWSLGILLYDMVCGDIPFERDQE------ILE-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred CCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 64 589999999999999999999976431 111 1234567799999999999999999999999999999999
Q ss_pred chhhh
Q 007991 231 QPYVL 235 (582)
Q Consensus 231 ~~~~~ 235 (582)
+....
T Consensus 288 ~~~~~ 292 (312)
T 2iwi_A 288 QTPAE 292 (312)
T ss_dssp CC---
T ss_pred cCchh
Confidence 86543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=349.01 Aligned_cols=220 Identities=20% Similarity=0.366 Sum_probs=195.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++..... .+.+.+|+++|++|+|||||++++++.. ..+|||||||++|+|.++++...+..+++..+..|
T Consensus 294 vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i 368 (535)
T 2h8h_A 294 VAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368 (535)
T ss_dssp EEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHH
T ss_pred EEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHH
Confidence 799999875543 3578999999999999999999998754 46889999999999999998654446999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......++..|+|||++.+..|+.++|||
T Consensus 369 ~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvw 448 (535)
T 2h8h_A 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448 (535)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHH
Confidence 9999999999999999999999999999999999999999998764332 22344567889999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||+||||++ |..||.+....++...+......+.+..++..+.+||.+||+.||++|||+++|++
T Consensus 449 SlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999 99999999998888888877777778889999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.03 Aligned_cols=223 Identities=17% Similarity=0.221 Sum_probs=182.0
Q ss_pred CEEEEEecccccCHH---------HHHHHHHHHHHHHhcCCCCeeeeeeEEEec---CcEEEEEEeecCCCCHHHHHHHh
Q 007991 1 MYVLKKIRLARQTDR---------ARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIKKA 68 (582)
Q Consensus 1 lyAIKki~~~~~~~~---------~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~---~~~l~LVmEy~~GgsL~d~Ikk~ 68 (582)
.||||++........ ....+.+|+.+++.++||||+++++++... +.+.|+||||| |++|.+++...
T Consensus 67 ~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 145 (345)
T 2v62_A 67 RHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN 145 (345)
T ss_dssp CEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG
T ss_pred eEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc
Confidence 478998876543111 113467899999999999999999988763 57899999999 99999999875
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC--CeEEeecccchhccccc--------ccCcccCC
Q 007991 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ--DIRLGDFGLAKMLISDD--------LASSVVGT 138 (582)
Q Consensus 69 ~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g--~vKL~DFGla~~~~~~~--------~~~~~vGT 138 (582)
+ .+++..+..++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...... .....+||
T Consensus 146 ~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt 223 (345)
T 2v62_A 146 G--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223 (345)
T ss_dssp G--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSC
T ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCC
Confidence 5 799999999999999999999999999999999999999887 99999999997654322 12456899
Q ss_pred CCCCCcccccCCCCCCCCcccchhHHHHhHhcCCcccccc--CHHHHHHHHhhccCCCCCc---------cccHHHHHHH
Q 007991 139 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF--DMQALINKINKSIVAPLPT---------VYSGAFRGLV 207 (582)
Q Consensus 139 p~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~--~~~~l~~kI~~~~~~~lp~---------~~S~~l~~LI 207 (582)
+.|+|||++.+..++.++|||||||++|+|++|..||.+. +...... ........++. .++..+.+||
T Consensus 224 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 302 (345)
T 2v62_A 224 IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT-AKTNLLDELPQSVLKWAPSGSSCCEIAQFL 302 (345)
T ss_dssp TTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH-HHHHHHHTTTHHHHHHSCTTSCCHHHHHHH
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH-HHHhhcccccHHHHhhccccccHHHHHHHH
Confidence 9999999999999999999999999999999999999652 2222221 11111111222 6889999999
Q ss_pred HHhccCCCCCCCCHHHHHcC
Q 007991 208 KSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 208 ~kmL~~dP~~RpSa~EiL~h 227 (582)
..||..||++||++++|++.
T Consensus 303 ~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 303 VCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcCcccCCCHHHHHHH
Confidence 99999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.79 Aligned_cols=219 Identities=15% Similarity=0.158 Sum_probs=183.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++...... +.+.+|+.+++.+ +|+||+++++++.. +...|+||||+ |++|.+++...+ ..+++..+..
T Consensus 38 vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~ 110 (298)
T 1csn_A 38 VAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAM 110 (298)
T ss_dssp EEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHH
T ss_pred EEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHH
Confidence 799988654332 3578899999999 79999999987754 56899999999 999999998753 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCC-----eEEeecccchhccccc--------ccCcccCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-----IRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELL 147 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~-----vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l 147 (582)
++.||+.||+|||++||+||||||+|||++.++. +||+|||++....... .....+||+.|+|||++
T Consensus 111 i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (298)
T 1csn_A 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 190 (298)
T ss_dssp HHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhh
Confidence 9999999999999999999999999999988776 9999999998765432 23567899999999999
Q ss_pred cCCCCCCCCcccchhHHHHhHhcCCcccccc---CHHHHHHHHhhccC-C---CCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 148 ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF---DMQALINKINKSIV-A---PLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 148 ~~~~y~~ksDIWSLG~iLyELltG~~PF~~~---~~~~l~~kI~~~~~-~---~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
.+..++.++|||||||++|+|++|..||.+. .....+..+..... . .+...+++.+.+||..||+.||.+||+
T Consensus 191 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~ 270 (298)
T 1csn_A 191 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 270 (298)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCC
Confidence 9999999999999999999999999999874 33444444332211 1 123468999999999999999999999
Q ss_pred HHHHHcC
Q 007991 221 AAELLCH 227 (582)
Q Consensus 221 a~EiL~h 227 (582)
+++|++.
T Consensus 271 ~~~l~~~ 277 (298)
T 1csn_A 271 YDYLQGL 277 (298)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.85 Aligned_cols=220 Identities=16% Similarity=0.231 Sum_probs=183.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... +.+.+|+.+++.+.|++++..+..+...+...|+||||+ +++|.+++.... ..+++..+..+
T Consensus 37 vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i 110 (296)
T 3uzp_A 37 VAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLL 110 (296)
T ss_dssp EEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHH
T ss_pred EEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHH
Confidence 899998765443 357899999999999998888887777778999999999 999999998643 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhcccccc--------cCcccCCCCCCCcccccCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDDL--------ASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~~--------~~~~vGTp~Y~APE~l~~~ 150 (582)
+.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+.
T Consensus 111 ~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (296)
T 3uzp_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 190 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCC
Confidence 9999999999999999999999999999 4788999999999987654322 3467899999999999999
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCH---HHHHHHHhhcc-CC---CCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDM---QALINKINKSI-VA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~---~~l~~kI~~~~-~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
.++.++|||||||++|+|++|..||.+.+. ...+..+.... .. .++..+++.+.+||.+||+.||.+|||+++
T Consensus 191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 270 (296)
T 3uzp_A 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 270 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHH
Confidence 999999999999999999999999986431 12222222111 11 123568999999999999999999999999
Q ss_pred HHcC
Q 007991 224 LLCH 227 (582)
Q Consensus 224 iL~h 227 (582)
+++.
T Consensus 271 l~~~ 274 (296)
T 3uzp_A 271 LRQL 274 (296)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=329.51 Aligned_cols=224 Identities=16% Similarity=0.208 Sum_probs=178.7
Q ss_pred CEEEEEecccccCHH---------HHHHHHHHHHHHHhcCCCCeeeeeeEEEec---CcEEEEEEeecCCCCHHHHHHHh
Q 007991 1 MYVLKKIRLARQTDR---------ARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIKKA 68 (582)
Q Consensus 1 lyAIKki~~~~~~~~---------~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~---~~~l~LVmEy~~GgsL~d~Ikk~ 68 (582)
.||||.+........ ....+.+|+..+..++||||+++++++... ..+.||||||| |++|.+++...
T Consensus 67 ~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~ 145 (364)
T 3op5_A 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN 145 (364)
T ss_dssp SEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT
T ss_pred ceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc
Confidence 479999876542111 012345677788888999999999988754 25789999999 99999999874
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEc--CCCCeEEeecccchhcccccc--------cCcccCC
Q 007991 69 NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDDL--------ASSVVGT 138 (582)
Q Consensus 69 ~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~--~~g~vKL~DFGla~~~~~~~~--------~~~~vGT 138 (582)
+..+++..+..|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+++....... ....+||
T Consensus 146 -~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt 224 (364)
T 3op5_A 146 -AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224 (364)
T ss_dssp -TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCC
Confidence 34699999999999999999999999999999999999999 889999999999977543321 2345699
Q ss_pred CCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCCC---------CCccccHHHHHHHH
Q 007991 139 PSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAP---------LPTVYSGAFRGLVK 208 (582)
Q Consensus 139 p~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~---------lp~~~S~~l~~LI~ 208 (582)
+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ............. ....++.++.+||.
T Consensus 225 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 304 (364)
T 3op5_A 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYME 304 (364)
T ss_dssp TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHH
T ss_pred CCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHH
Confidence 9999999999999999999999999999999999999864221 1111111100000 12467899999999
Q ss_pred HhccCCCCCCCCHHHHHc
Q 007991 209 SMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~ 226 (582)
.||..||.+||++++|++
T Consensus 305 ~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 305 TVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCCCCCCCHHHHHH
Confidence 999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=351.43 Aligned_cols=221 Identities=19% Similarity=0.337 Sum_probs=192.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.... ....+.+.+|+++|++++|||||++++++.. ..+|+|||||.||+|.+++... ...+++..+..|
T Consensus 366 vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i 441 (613)
T 2ozo_A 366 VAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAEL 441 (613)
T ss_dssp EEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHH
T ss_pred EEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHH
Confidence 79999976532 2345779999999999999999999998764 3589999999999999999764 346999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc----cCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL----ASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~----~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... .....+++.|+|||++.+..|+.++|
T Consensus 442 ~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sD 521 (613)
T 2ozo_A 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 521 (613)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHH
Confidence 99999999999999999999999999999999999999999987643321 12334568999999999889999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||+||||++ |..||.+.+..++...+......+.+..+++.+.+||..||..||++||++++|++
T Consensus 522 vwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999998 99999999988888888887777788889999999999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=327.61 Aligned_cols=223 Identities=24% Similarity=0.329 Sum_probs=182.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~~~ 79 (582)
||||++..... ...+.+.+|+.+|++++||||+++++++.. +...|+||||++|++|.+++.... ...+++..+.
T Consensus 66 vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 142 (321)
T 2qkw_B 66 VALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142 (321)
T ss_dssp EEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHH
T ss_pred EEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHH
Confidence 78998876543 345678999999999999999999998755 457899999999999999987543 2358999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..++.++
T Consensus 143 ~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 222 (321)
T 2qkw_B 143 EICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS 222 (321)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHH
T ss_pred HHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCccc
Confidence 99999999999999999999999999999999999999999999764322 223456799999999999888999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHH---H----HHHhhc---------cCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQAL---I----NKINKS---------IVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l---~----~kI~~~---------~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
|||||||++|+|++|..||.+...... . ...... ....++..++..+.+||.+||+.||++|||
T Consensus 223 Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 302 (321)
T 2qkw_B 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302 (321)
T ss_dssp HHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred chHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC
Confidence 999999999999999999965432111 1 111111 111233446778999999999999999999
Q ss_pred HHHHHcC
Q 007991 221 AAELLCH 227 (582)
Q Consensus 221 a~EiL~h 227 (582)
+.|++++
T Consensus 303 ~~ell~~ 309 (321)
T 2qkw_B 303 MGDVLWK 309 (321)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=325.20 Aligned_cols=219 Identities=20% Similarity=0.263 Sum_probs=182.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeee---------------eeeEEEecCcEEEEEEeecCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVE---------------YKDSWVEKGCYVCIIIGYCEGGDMAEAI 65 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~---------------l~~~~~~~~~~l~LVmEy~~GgsL~d~I 65 (582)
.||||.+... +.+.+|+.+|++++||||++ +++++...+...|+||||| |++|.+++
T Consensus 77 ~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 148 (352)
T 2jii_A 77 KFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL 148 (352)
T ss_dssp CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHH
T ss_pred eEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHH
Confidence 4899998754 35789999999999999987 5676666677999999999 99999999
Q ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC--CeEEeecccchhccccc--------ccCcc
Q 007991 66 KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ--DIRLGDFGLAKMLISDD--------LASSV 135 (582)
Q Consensus 66 kk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g--~vKL~DFGla~~~~~~~--------~~~~~ 135 (582)
....+..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... .....
T Consensus 149 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~ 228 (352)
T 2jii_A 149 DVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228 (352)
T ss_dssp HHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTT
T ss_pred HhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccc
Confidence 975344799999999999999999999999999999999999999998 89999999997654332 12445
Q ss_pred cCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccC--HHHHHHHHhhc--cCCCC------CccccHHHHH
Q 007991 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD--MQALINKINKS--IVAPL------PTVYSGAFRG 205 (582)
Q Consensus 136 vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~--~~~l~~kI~~~--~~~~l------p~~~S~~l~~ 205 (582)
.||+.|+|||++.+..++.++|||||||++|+|++|..||.... ...+....... ....+ ...++..+.+
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 308 (352)
T 2jii_A 229 EGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQK 308 (352)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHH
T ss_pred cCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHH
Confidence 89999999999999999999999999999999999999998763 33333332211 11111 1246899999
Q ss_pred HHHHhccCCCCCCCCHHHHHcC
Q 007991 206 LVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 206 LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||.+||..||.+||+++++++.
T Consensus 309 li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 309 YLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHhCChhhCCCHHHHHHH
Confidence 9999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.07 Aligned_cols=219 Identities=17% Similarity=0.251 Sum_probs=181.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ..+.+|+.+++.++|++++..+..+...+...|+||||+ +++|.+++.... ..+++..+..+
T Consensus 37 vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i 110 (296)
T 4hgt_A 37 VAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLL 110 (296)
T ss_dssp EEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHH
T ss_pred EEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHH
Confidence 789987554332 357889999999999999988888877788999999999 999999998643 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhccccc--------ccCcccCCCCCCCcccccCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l~~~ 150 (582)
+.||+.||.|||++||+||||||+|||| +.++.+||+|||++....... ......||+.|+|||++.+.
T Consensus 111 ~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (296)
T 4hgt_A 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 190 (296)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC
Confidence 9999999999999999999999999999 788999999999998765432 23356899999999999999
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHH---HHHHHHhhc-cCCC---CCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ---ALINKINKS-IVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~---~l~~kI~~~-~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
.++.++|||||||++|+|++|..||.+.+.. ..+..+... ...+ ....+++.+.+||..||+.||++|||+++
T Consensus 191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 270 (296)
T 4hgt_A 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 270 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHH
Confidence 9999999999999999999999999764321 112222111 1111 23567899999999999999999999999
Q ss_pred HHc
Q 007991 224 LLC 226 (582)
Q Consensus 224 iL~ 226 (582)
+++
T Consensus 271 l~~ 273 (296)
T 4hgt_A 271 LRQ 273 (296)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.87 Aligned_cols=222 Identities=24% Similarity=0.360 Sum_probs=187.4
Q ss_pred EEEEEecccccCH----HHHHHHHHHHHHHHhcC--CCCeeeeeeEEEecCcEEEEEEeecCC-CCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTD----RARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEG-GDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIV~l~~~~~~~~~~l~LVmEy~~G-gsL~d~Ikk~~~~~ls 74 (582)
||||+++...... ...+.+.+|+.+|+++. |+||+++++++... ..+++||||+.+ ++|.+++.... .++
T Consensus 71 vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~~L~~~l~~~~--~l~ 147 (320)
T 3a99_A 71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQDLFDFITERG--ALQ 147 (320)
T ss_dssp EEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEEEHHHHHHHHC--SCC
T ss_pred EEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-CcEEEEEEcCCCCccHHHHHhccC--CCC
Confidence 8999997754332 12245678999999996 59999999987654 588999999976 99999998754 689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEc-CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC-
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY- 152 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y- 152 (582)
+..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++...... ......||+.|+|||++.+..+
T Consensus 148 ~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 226 (320)
T 3a99_A 148 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYH 226 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCC
Confidence 999999999999999999999999999999999999 6789999999999876543 3456789999999999987665
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+.++|||||||++|+|++|..||..... +... ...++..++..+.+||.+||..||.+|||++|+++||||+.
T Consensus 227 ~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 227 GRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CccchHHhHHHHHHHHHHCCCCCCChhh------hhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 6789999999999999999999976431 1111 22356678999999999999999999999999999999987
Q ss_pred hh
Q 007991 233 YV 234 (582)
Q Consensus 233 ~~ 234 (582)
..
T Consensus 300 ~~ 301 (320)
T 3a99_A 300 VL 301 (320)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.75 Aligned_cols=217 Identities=24% Similarity=0.470 Sum_probs=178.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~~~ 80 (582)
||||++... ...+.+.+|+++|++++||||+++++++.+ ..|+||||++|++|.+++..... ..+++..+..
T Consensus 34 vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 106 (307)
T 2eva_A 34 VAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106 (307)
T ss_dssp EEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHH
T ss_pred EEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHH
Confidence 789988643 345678999999999999999999997642 37899999999999999986432 2478999999
Q ss_pred HHHHHHHHHHHHHH---CCceecccCcccEEEcCCCC-eEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHA---NHILHRDVKCSNIFLTRDQD-IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs---~gIiHRDIKP~NILL~~~g~-vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...... .....||+.|+|||++.+..++.++
T Consensus 107 ~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~ 184 (307)
T 2eva_A 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKC 184 (307)
T ss_dssp HHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHH
T ss_pred HHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHH
Confidence 99999999999999 89999999999999999887 799999999765432 3345799999999999999999999
Q ss_pred cccchhHHHHhHhcCCcccccc--CHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAF--DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~--~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|+|++|..||... ....+...+......+.+..++..+.+||.+||+.||.+|||+++++++
T Consensus 185 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999754 3334444455555566777899999999999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=337.21 Aligned_cols=225 Identities=25% Similarity=0.364 Sum_probs=171.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCC-----CC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH-----FP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~-----ls 74 (582)
.||||++.... .+.+.+|+.+|+++ +|||||++++++.. +..+|||||||. |+|.+++....... .+
T Consensus 41 ~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~ 113 (434)
T 2rio_A 41 PVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113 (434)
T ss_dssp EEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCCS-EEHHHHHHTC-----------
T ss_pred EEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecCC-CCHHHHHhccCCCchhhhhcc
Confidence 38999986643 24578999999986 89999999998754 468999999995 69999998643111 13
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-------------CCeEEeecccchhccccc-----ccCccc
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-------------QDIRLGDFGLAKMLISDD-----LASSVV 136 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-------------g~vKL~DFGla~~~~~~~-----~~~~~v 136 (582)
+..+..++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++...... .....+
T Consensus 114 ~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~ 193 (434)
T 2rio_A 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193 (434)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-------------
T ss_pred chhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCC
Confidence 33457899999999999999999999999999999764 379999999998765432 123568
Q ss_pred CCCCCCCcccccC-------CCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCC-----CCccccHHH
Q 007991 137 GTPSYMCPELLAD-------IPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAP-----LPTVYSGAF 203 (582)
Q Consensus 137 GTp~Y~APE~l~~-------~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~-----lp~~~S~~l 203 (582)
||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..... ...+......+ ....++.++
T Consensus 194 gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~ 272 (434)
T 2rio_A 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SNIIRGIFSLDEMKCLHDRSLIAEA 272 (434)
T ss_dssp -CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HHHHHTCCCCCCCTTCCCHHHHHHH
T ss_pred CCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HHHhcCCCCcccccccccccchHHH
Confidence 9999999999975 568999999999999999998 999997654332 11122211111 122467899
Q ss_pred HHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 204 RGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 204 ~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 273 ~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 273 TDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 999999999999999999999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.59 Aligned_cols=218 Identities=22% Similarity=0.347 Sum_probs=173.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHh--cCCCCeeeeeeEEEec---CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEK---GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~--L~HpnIV~l~~~~~~~---~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++.... ...+.+|.+++.. ++||||+++++++... +..+|+||||+++|+|.++++.. .+++.
T Consensus 34 vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~ 105 (301)
T 3q4u_A 34 VAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTV 105 (301)
T ss_dssp EEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHH
T ss_pred EEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHH
Confidence 8999986532 2445667777766 8999999999987643 35789999999999999999643 69999
Q ss_pred HHHHHHHHHHHHHHHHH--------HCCceecccCcccEEEcCCCCeEEeecccchhcccccc-----cCcccCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLH--------ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-----ASSVVGTPSYMC 143 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLH--------s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-----~~~~vGTp~Y~A 143 (582)
.+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++....... ....+||+.|+|
T Consensus 106 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 185 (301)
T 3q4u_A 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185 (301)
T ss_dssp HHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeC
Confidence 99999999999999999 99999999999999999999999999999976543321 334589999999
Q ss_pred cccccCC------CCCCCCcccchhHHHHhHhcC----------Ccccccc-----CHHHHHHHHhhc-cCCCCCc----
Q 007991 144 PELLADI------PYGSKSDIWSLGCCVYEMSAQ----------KAAFKAF-----DMQALINKINKS-IVAPLPT---- 197 (582)
Q Consensus 144 PE~l~~~------~y~~ksDIWSLG~iLyELltG----------~~PF~~~-----~~~~l~~kI~~~-~~~~lp~---- 197 (582)
||++.+. .++.++|||||||++|||++| ..||... ....+...+... ....++.
T Consensus 186 PE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (301)
T 3q4u_A 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFS 265 (301)
T ss_dssp HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGG
T ss_pred hhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhcc
Confidence 9999876 345689999999999999999 8888542 222222222221 1222232
Q ss_pred -cccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 198 -VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 198 -~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++..+.+||.+||+.||.+|||++++++.
T Consensus 266 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 266 DPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 256789999999999999999999999863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.26 Aligned_cols=224 Identities=23% Similarity=0.363 Sum_probs=183.8
Q ss_pred EEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-CCCCCHHHH
Q 007991 2 YVLKKIRLAR--QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN-GVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~--~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~lse~~~ 78 (582)
||||++.... ......+.+.+|+.+|++++||||+++++++... ...|+||||++|++|.+++.... ...+++..+
T Consensus 57 vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 135 (307)
T 2nru_A 57 VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135 (307)
T ss_dssp EEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHH
T ss_pred EEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-CceEEEEEecCCCcHHHHHHhccCCCCCCHHHH
Confidence 7899987643 3345667899999999999999999999987654 47889999999999999997532 346999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+ .++.+
T Consensus 136 ~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~ 214 (307)
T 2nru_A 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPK 214 (307)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTH
T ss_pred HHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCcc
Confidence 9999999999999999999999999999999999999999999987654321 2345689999999999876 57899
Q ss_pred CcccchhHHHHhHhcCCccccccCHHH----HHHHHhh----------ccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQA----LINKINK----------SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~----l~~kI~~----------~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
+|||||||++|+|++|.+||....... +...+.. ......+..++..+.+||.+||..||.+|||+
T Consensus 215 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 294 (307)
T 2nru_A 215 SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294 (307)
T ss_dssp HHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred chhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCH
Confidence 999999999999999999997654322 1111111 11122344567889999999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
++++++
T Consensus 295 ~~l~~~ 300 (307)
T 2nru_A 295 KKVQQL 300 (307)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=332.50 Aligned_cols=226 Identities=21% Similarity=0.366 Sum_probs=185.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCC-CCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANG-VHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~-~~lse~~~ 78 (582)
.||||+++..... ...+.+.+|+++|++++||||+++++++...+ ...|+|||||+||+|.+++..... ..+++..+
T Consensus 36 ~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 114 (396)
T 4eut_A 36 LFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (396)
T ss_dssp EEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHH
T ss_pred EEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHH
Confidence 3899999764321 22456789999999999999999999887544 378999999999999999986432 23999999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEE----cCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC-----
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFL----TRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD----- 149 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL----~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~----- 149 (582)
+.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...........+||+.|+|||++.+
T Consensus 115 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 194 (396)
T 4eut_A 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194 (396)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--
T ss_pred HHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhcccccc
Confidence 9999999999999999999999999999999 7777899999999988766666667889999999999865
Q ss_pred ---CCCCCCCcccchhHHHHhHhcCCcccccc----CHHHHHHHHhhccCC------------------------CCCcc
Q 007991 150 ---IPYGSKSDIWSLGCCVYEMSAQKAAFKAF----DMQALINKINKSIVA------------------------PLPTV 198 (582)
Q Consensus 150 ---~~y~~ksDIWSLG~iLyELltG~~PF~~~----~~~~l~~kI~~~~~~------------------------~lp~~ 198 (582)
..|+.++|||||||++|+|++|..||... ...+.+..+...... .+...
T Consensus 195 ~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 274 (396)
T 4eut_A 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG 274 (396)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHH
T ss_pred ccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchH
Confidence 45778999999999999999999999742 223444444332211 12234
Q ss_pred ccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 199 YSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 199 ~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
++..+.+||.+||+.||++|+++++++++
T Consensus 275 ~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 275 LQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 66789999999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.01 Aligned_cols=223 Identities=21% Similarity=0.377 Sum_probs=187.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.........+.+.+|+.++++++||||+++++++... ..+|+||||++|++|.+++... +..+++..+..+
T Consensus 58 ~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i 135 (319)
T 2y4i_B 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQI 135 (319)
T ss_dssp EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHH
T ss_pred EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHH
Confidence 78999987665555556788999999999999999999988755 4789999999999999999864 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc------ccccCcccCCCCCCCcccccC------
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS------DDLASSVVGTPSYMCPELLAD------ 149 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~------~~~~~~~vGTp~Y~APE~l~~------ 149 (582)
+.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ........||+.|+|||++.+
T Consensus 136 ~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 214 (319)
T 2y4i_B 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214 (319)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--
T ss_pred HHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhcccccc
Confidence 99999999999999999999999999998 78999999999875431 122344579999999999864
Q ss_pred ---CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCC-ccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 150 ---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLP-TVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 150 ---~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp-~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
..++.++|||||||++|+|++|..||...........+......... ..++..+.+||.+||..||.+|||+++++
T Consensus 215 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 45788999999999999999999999999988887777665544333 35889999999999999999999999999
Q ss_pred cC
Q 007991 226 CH 227 (582)
Q Consensus 226 ~h 227 (582)
+.
T Consensus 295 ~~ 296 (319)
T 2y4i_B 295 DM 296 (319)
T ss_dssp HH
T ss_pred HH
Confidence 73
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.99 Aligned_cols=220 Identities=27% Similarity=0.472 Sum_probs=165.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEE-------ecCcEEEEEEeecCCCCHHHHHHHh-CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWV-------EKGCYVCIIIGYCEGGDMAEAIKKA-NGVH 72 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~-------~~~~~l~LVmEy~~GgsL~d~Ikk~-~~~~ 72 (582)
||||++... .....+.+.+|+.+|+++. ||||+++++++. .....+|+|||||. |+|.+++... ....
T Consensus 56 vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~ 132 (337)
T 3ll6_A 56 YALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGP 132 (337)
T ss_dssp EEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCS
T ss_pred EEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCC
Confidence 899988553 3455678899999999996 999999999885 34457899999995 7999988752 2346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCC--ceecccCcccEEEcCCCCeEEeecccchhcccccc-------------cCcccC
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-------------ASSVVG 137 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-------------~~~~vG 137 (582)
+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++........ ....+|
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (337)
T 3ll6_A 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccC
Confidence 999999999999999999999999 99999999999999999999999999987643321 124579
Q ss_pred CCCCCCcccc---cCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCC
Q 007991 138 TPSYMCPELL---ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 138 Tp~Y~APE~l---~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~d 214 (582)
|+.|+|||++ .+..++.++|||||||++|+|++|..||.......+.. .....+.+..++..+.+||.+||+.|
T Consensus 213 t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~ 289 (337)
T 3ll6_A 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN---GKYSIPPHDTQYTVFHSLIRAMLQVN 289 (337)
T ss_dssp -----------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSS
T ss_pred CCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc---CcccCCcccccchHHHHHHHHHccCC
Confidence 9999999998 56678899999999999999999999998765544332 22333445667888999999999999
Q ss_pred CCCCCCHHHHHcC
Q 007991 215 PEFRPSAAELLCH 227 (582)
Q Consensus 215 P~~RpSa~EiL~h 227 (582)
|.+||+++|+++|
T Consensus 290 p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 290 PEERLSIAEVVHQ 302 (337)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.73 Aligned_cols=225 Identities=21% Similarity=0.324 Sum_probs=180.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--CCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--GVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--~~~lse~~~ 78 (582)
.||||++...... .....+.+|+.+|++++||||+++++++... ...|+|||||.||+|.+++.... ...+++..+
T Consensus 56 ~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 133 (326)
T 3uim_A 56 LVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133 (326)
T ss_dssp CEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHH
T ss_pred EEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC-CceEEEEEeccCCCHHHHHHhccccCCCCCHHHH
Confidence 4899999765432 2223688999999999999999999987654 47789999999999999998743 234999999
Q ss_pred HHHHHHHHHHHHHHHHC---CceecccCcccEEEcCCCCeEEeecccchhcccc--cccCcccCCCCCCCcccccCCCCC
Q 007991 79 CKWLVQLLMALNYLHAN---HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD--DLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~---gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~--~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..++
T Consensus 134 ~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (326)
T 3uim_A 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213 (326)
T ss_dssp HHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEEC
T ss_pred HHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCC
Confidence 99999999999999999 9999999999999999999999999999866432 234456799999999999888899
Q ss_pred CCCcccchhHHHHhHhcCCccccccCH-----HHHHHHHhhcc-------------CCCCCccccHHHHHHHHHhccCCC
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDM-----QALINKINKSI-------------VAPLPTVYSGAFRGLVKSMLRKNP 215 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~-----~~l~~kI~~~~-------------~~~lp~~~S~~l~~LI~kmL~~dP 215 (582)
.++|||||||++|+|++|..||..... ......+.... ....+...+..+.+||..||+.||
T Consensus 214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 293 (326)
T 3uim_A 214 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293 (326)
T ss_dssp HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCG
T ss_pred ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCC
Confidence 999999999999999999999953211 01111111100 111233355789999999999999
Q ss_pred CCCCCHHHHHcC
Q 007991 216 EFRPSAAELLCH 227 (582)
Q Consensus 216 ~~RpSa~EiL~h 227 (582)
.+|||+.|+++|
T Consensus 294 ~~Rps~~ell~~ 305 (326)
T 3uim_A 294 MERPKMSEVVRM 305 (326)
T ss_dssp GGSCCHHHHHHH
T ss_pred ccCCCHHHHHHH
Confidence 999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.69 Aligned_cols=223 Identities=24% Similarity=0.405 Sum_probs=186.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-cEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-CYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||+++.. .....+.+.+|+.+|++++||||+++++++...+ ..+|+||||++|++|.+++.... ..+++..+..
T Consensus 73 vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 149 (326)
T 2w1i_A 73 VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQ 149 (326)
T ss_dssp EEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHH
T ss_pred EEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHH
Confidence 799998764 3455678999999999999999999999876543 46889999999999999998753 3589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......++..|+|||++.+..++.++
T Consensus 150 i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 229 (326)
T 2w1i_A 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVAS 229 (326)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchh
Confidence 99999999999999999999999999999999999999999998765432 12345677789999999988899999
Q ss_pred cccchhHHHHhHhcCCccccccCH----------------HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDM----------------QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS 220 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~----------------~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS 220 (582)
|||||||++|+|++|..||..... ..+...+......+.+..++..+.+||.+||..||.+|||
T Consensus 230 Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 309 (326)
T 2w1i_A 230 DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS 309 (326)
T ss_dssp HHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred hHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcC
Confidence 999999999999999998864321 1222333344445667789999999999999999999999
Q ss_pred HHHHHcC
Q 007991 221 AAELLCH 227 (582)
Q Consensus 221 a~EiL~h 227 (582)
+.|+++.
T Consensus 310 ~~el~~~ 316 (326)
T 2w1i_A 310 FRDLALR 316 (326)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=310.25 Aligned_cols=219 Identities=21% Similarity=0.345 Sum_probs=173.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHh--cCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~--L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||++..... ....+|.+++.. ++||||+++++++.... ..+|+|||||+||+|.++++.. .+++
T Consensus 62 ~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~ 133 (337)
T 3mdy_A 62 KVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDA 133 (337)
T ss_dssp EEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCH
T ss_pred eEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCH
Confidence 389999864322 234455555555 49999999999887653 5899999999999999999864 5899
Q ss_pred HHHHHHHHHHHHHHHHHHHC--------CceecccCcccEEEcCCCCeEEeecccchhcccccc-----cCcccCCCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHAN--------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL-----ASSVVGTPSYM 142 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~--------gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~-----~~~~vGTp~Y~ 142 (582)
..+..++.|++.||.|||++ ||+||||||+||||+.++.+||+|||++........ ....+||+.|+
T Consensus 134 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 213 (337)
T 3mdy_A 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCccee
Confidence 99999999999999999999 999999999999999999999999999976543321 23568999999
Q ss_pred CcccccCCCCCCC------CcccchhHHHHhHhcC----------Ccccccc-----CHHHHHHHHhh-ccCCCCCc---
Q 007991 143 CPELLADIPYGSK------SDIWSLGCCVYEMSAQ----------KAAFKAF-----DMQALINKINK-SIVAPLPT--- 197 (582)
Q Consensus 143 APE~l~~~~y~~k------sDIWSLG~iLyELltG----------~~PF~~~-----~~~~l~~kI~~-~~~~~lp~--- 197 (582)
|||++.+..+... +|||||||++|||++| ..||... ........+.. .....++.
T Consensus 214 aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (337)
T 3mdy_A 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293 (337)
T ss_dssp CHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred ChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccch
Confidence 9999988776665 9999999999999999 6666542 22222222222 12223333
Q ss_pred --cccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 198 --VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 198 --~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++..+.+||.+||+.||.+|||++++++|
T Consensus 294 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 466789999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.78 Aligned_cols=214 Identities=16% Similarity=0.209 Sum_probs=174.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC---CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh---CCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA---NGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~---HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~---~~~~ls 74 (582)
.||||+++... ...+.+|+++++.++ |+||+.+++++...+ ..|+|||||+||+|.+++... ....++
T Consensus 97 ~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~ 170 (365)
T 3e7e_A 97 KFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMP 170 (365)
T ss_dssp CEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS-CEEEEECCCCSCBHHHHHHHHHTSTTCSCC
T ss_pred EEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC-CcEEEEeccCCCcHHHHHHHhhcccccCCC
Confidence 48999997643 246788888888887 899999999887654 788999999999999999853 234699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC-----------CCCeEEeecccchhcc---cccccCcccCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-----------DQDIRLGDFGLAKMLI---SDDLASSVVGTPS 140 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-----------~g~vKL~DFGla~~~~---~~~~~~~~vGTp~ 140 (582)
+..++.|+.||+.||+|||++||+||||||+||||+. ++.+||+|||+++... ........+||+.
T Consensus 171 ~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 250 (365)
T 3e7e_A 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTS
T ss_pred HHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCC
Confidence 9999999999999999999999999999999999998 8999999999996543 2334566789999
Q ss_pred CCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-
Q 007991 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP- 219 (582)
Q Consensus 141 Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp- 219 (582)
|+|||++.+..|+.++|||||||++|||++|..||......... + ..... ....++.+.+++..||+.+|.+|+
T Consensus 251 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~-~~~~~--~~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--P-EGLFR--RLPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp CCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--E-CSCCT--TCSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred CCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--e-chhcc--ccCcHHHHHHHHHHHcCCCCCCcch
Confidence 99999999999999999999999999999999999654321100 0 00111 113477899999999999999995
Q ss_pred CHHHHH
Q 007991 220 SAAELL 225 (582)
Q Consensus 220 Sa~EiL 225 (582)
+++++.
T Consensus 326 ~~~~l~ 331 (365)
T 3e7e_A 326 SLDLLR 331 (365)
T ss_dssp CHHHHH
T ss_pred HHHHHH
Confidence 455443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=343.04 Aligned_cols=222 Identities=24% Similarity=0.419 Sum_probs=193.7
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.. ..+...+.+.+|+.+|++++|||||++++++.+ ..+|+|||||+||+|.++++.. +..+++..+..+
T Consensus 421 vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i 496 (656)
T 2j0j_A 421 VAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILY 496 (656)
T ss_dssp EEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHH
T ss_pred EEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHH
Confidence 788887654 345667889999999999999999999998743 3588999999999999999874 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||
T Consensus 497 ~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 576 (656)
T 2j0j_A 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 576 (656)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHH
Confidence 99999999999999999999999999999999999999999987644322 2335677899999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|||++ |.+||.+.+..++...+......+.+..++..+.+||.+||..||.+|||+.++++.
T Consensus 577 SlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 577 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999996 999999999999888888877777888999999999999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.73 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=166.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHH-HhcCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELI-SRVRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL-~~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||.++.. ..+.+|+.++ +.++||||++++++|.. .+..+|+|||||+|++|.+++....+..+++.
T Consensus 45 ~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 117 (299)
T 3m2w_A 45 KFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117 (299)
T ss_dssp EEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHH
T ss_pred EEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHH
Confidence 3899998642 3467899988 66689999999998765 24689999999999999999998766679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
.+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.... +..|+
T Consensus 118 ~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~ 176 (299)
T 3m2w_A 118 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYD 176 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGG
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCC
Confidence 99999999999999999999999999999999998 7889999999986432 23577
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCC----ccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLP----TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp----~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.++|||||||++|+|++|..||.+.+.......+.... ...++ ..++.++.+||.+||+.||.+|||++|+|+
T Consensus 177 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 177 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 89999999999999999999998766544322221111 11122 457999999999999999999999999999
Q ss_pred CCCCch
Q 007991 227 HPHLQP 232 (582)
Q Consensus 227 hp~f~~ 232 (582)
||||+.
T Consensus 257 hp~~~~ 262 (299)
T 3m2w_A 257 HPWIMQ 262 (299)
T ss_dssp SHHHHT
T ss_pred Chhhcc
Confidence 999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.26 Aligned_cols=218 Identities=20% Similarity=0.307 Sum_probs=179.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHh--cCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISR--VRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~--L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||||++.... .+.+.+|++++.. ++||||+++++++...+ ..+|+||||+++|+|.+++.+. .+++.
T Consensus 68 vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~ 139 (342)
T 1b6c_B 68 VAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVE 139 (342)
T ss_dssp EEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHH
T ss_pred EEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHH
Confidence 7999986532 3567889999988 78999999999887654 3789999999999999999874 58999
Q ss_pred HHHHHHHHHHHHHHHHH--------HCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLH--------ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMC 143 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLH--------s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~A 143 (582)
.+..++.||+.||.||| +.||+||||||+||||+.++.+||+|||++....... .....+||+.|+|
T Consensus 140 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~a 219 (342)
T 1b6c_B 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219 (342)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCC
Confidence 99999999999999999 8999999999999999999999999999997765433 2355689999999
Q ss_pred cccccCCC------CCCCCcccchhHHHHhHhcC----------Ccccccc-----CHHHHHHHHhhc-cCCCCCc----
Q 007991 144 PELLADIP------YGSKSDIWSLGCCVYEMSAQ----------KAAFKAF-----DMQALINKINKS-IVAPLPT---- 197 (582)
Q Consensus 144 PE~l~~~~------y~~ksDIWSLG~iLyELltG----------~~PF~~~-----~~~~l~~kI~~~-~~~~lp~---- 197 (582)
||++.+.. ++.++|||||||++|+|++| ..||... ....+...+... ....++.
T Consensus 220 PE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (342)
T 1b6c_B 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 299 (342)
T ss_dssp HHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGT
T ss_pred HhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccc
Confidence 99998753 33689999999999999999 7788654 334444444332 2233333
Q ss_pred -cccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 198 -VYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 198 -~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.++..+.+||..||+.||.+|||++++++|
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 300 CEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 345689999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=328.14 Aligned_cols=220 Identities=16% Similarity=0.225 Sum_probs=182.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++...... ..+.+|+++++.|.|++++..+..|...+.+.||||||| |++|.+++.... ..+++..++.
T Consensus 34 ~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~ 107 (483)
T 3sv0_A 34 EVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLM 107 (483)
T ss_dssp EEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHH
T ss_pred EEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHH
Confidence 3899988765443 247889999999998776666666666777999999999 999999998643 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEE---cCCCCeEEeecccchhcccccc--------cCcccCCCCCCCcccccC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFL---TRDQDIRLGDFGLAKMLISDDL--------ASSVVGTPSYMCPELLAD 149 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL---~~~g~vKL~DFGla~~~~~~~~--------~~~~vGTp~Y~APE~l~~ 149 (582)
|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....... ....+||+.|+|||++.+
T Consensus 108 i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 187 (483)
T 3sv0_A 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187 (483)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC
Confidence 99999999999999999999999999999 6889999999999987654321 236789999999999999
Q ss_pred CCCCCCCcccchhHHHHhHhcCCccccccC---HHHHHHHHhhcc----CCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 150 IPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSI----VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 150 ~~y~~ksDIWSLG~iLyELltG~~PF~~~~---~~~l~~kI~~~~----~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
..++.++|||||||+||+|++|..||.+.. ....+.++.... ...++..++.++.+||..||..||++||+++
T Consensus 188 ~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~ 267 (483)
T 3sv0_A 188 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYS 267 (483)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHH
Confidence 999999999999999999999999998743 333333332221 1122356789999999999999999999999
Q ss_pred HHHc
Q 007991 223 ELLC 226 (582)
Q Consensus 223 EiL~ 226 (582)
+|++
T Consensus 268 el~~ 271 (483)
T 3sv0_A 268 YLKR 271 (483)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=311.18 Aligned_cols=220 Identities=18% Similarity=0.259 Sum_probs=167.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||++..... .......|+..+..++||||+++++.+.. ....+|+|||||+||+|.++++.. .+++.
T Consensus 38 ~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~ 111 (336)
T 3g2f_A 38 PVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWV 111 (336)
T ss_dssp EEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHH
T ss_pred EEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchh
Confidence 389999975432 11222344555566899999999975542 334789999999999999999875 46899
Q ss_pred HHHHHHHHHHHHHHHHHHC---------CceecccCcccEEEcCCCCeEEeecccchhcccc---------cccCcccCC
Q 007991 77 KLCKWLVQLLMALNYLHAN---------HILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---------DLASSVVGT 138 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~---------gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---------~~~~~~vGT 138 (582)
.+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+++..... ......+||
T Consensus 112 ~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt 191 (336)
T 3g2f_A 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191 (336)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSC
T ss_pred HHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCc
Confidence 9999999999999999999 9999999999999999999999999999765432 123356899
Q ss_pred CCCCCcccccC-------CCCCCCCcccchhHHHHhHhcCCcccc-ccC-----------------HHHHHHHHhh-ccC
Q 007991 139 PSYMCPELLAD-------IPYGSKSDIWSLGCCVYEMSAQKAAFK-AFD-----------------MQALINKINK-SIV 192 (582)
Q Consensus 139 p~Y~APE~l~~-------~~y~~ksDIWSLG~iLyELltG~~PF~-~~~-----------------~~~l~~kI~~-~~~ 192 (582)
+.|+|||++.+ ..++.++|||||||++|||++|..||. +.. ...+...+.. ...
T Consensus 192 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (336)
T 3g2f_A 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR 271 (336)
T ss_dssp GGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC
T ss_pred cceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccC
Confidence 99999999987 345678999999999999999966653 211 1111111111 112
Q ss_pred CCCCcc------ccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 193 APLPTV------YSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 193 ~~lp~~------~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
..++.. ++..+.+||.+||+.||++|||++|+++
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 272 PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 223332 4568999999999999999999999976
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.14 Aligned_cols=218 Identities=17% Similarity=0.171 Sum_probs=173.9
Q ss_pred CEEEEEeccccc------CHHHHHHHHHHHHHHHhcC---------CCCeeeeeeEEEe---------------------
Q 007991 1 MYVLKKIRLARQ------TDRARRSAHQEMELISRVR---------NPFIVEYKDSWVE--------------------- 44 (582)
Q Consensus 1 lyAIKki~~~~~------~~~~~~~~~rEi~iL~~L~---------HpnIV~l~~~~~~--------------------- 44 (582)
.||||+++.... .....+.+.+|+.+|+.|+ |||||+++++++.
T Consensus 45 ~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~ 124 (336)
T 2vuw_A 45 PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124 (336)
T ss_dssp EEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCC
T ss_pred eEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccc
Confidence 389999987642 2233467889999999996 7777777776542
Q ss_pred --------cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCcccEEEcCCC--
Q 007991 45 --------KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVKCSNIFLTRDQ-- 113 (582)
Q Consensus 45 --------~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLH-s~gIiHRDIKP~NILL~~~g-- 113 (582)
.+..+|||||||.+|++.+.+.+ ..+++..++.|+.||+.||+||| ++||+||||||+||||+.++
T Consensus 125 ~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~ 201 (336)
T 2vuw_A 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK 201 (336)
T ss_dssp SSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCS
T ss_pred cccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCc
Confidence 15689999999999977666644 26899999999999999999999 99999999999999999987
Q ss_pred ------------------CeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccchhHH-HHhHhcCCcc
Q 007991 114 ------------------DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCC-VYEMSAQKAA 174 (582)
Q Consensus 114 ------------------~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWSLG~i-LyELltG~~P 174 (582)
.+||+|||+++.... ...+||+.|+|||++.+.. +.++||||||++ .++++.|..|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p 276 (336)
T 2vuw_A 202 KLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHP 276 (336)
T ss_dssp EEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCT
T ss_pred ceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCC
Confidence 899999999987653 2468999999999998766 889999998877 7889999999
Q ss_pred ccccCH-HHHHHHHhhccCC------CCCccccHHHHHHHHHhccCCCCCCCCHHHHH-cCCCCc
Q 007991 175 FKAFDM-QALINKINKSIVA------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL-CHPHLQ 231 (582)
Q Consensus 175 F~~~~~-~~l~~kI~~~~~~------~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL-~hp~f~ 231 (582)
|.+... ..+...+...... +.+..+++++++||.+||++| |++|+| +||||+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 277 YSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred CcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 976432 2223333321111 112347899999999999987 999999 999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=342.52 Aligned_cols=236 Identities=24% Similarity=0.343 Sum_probs=192.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-----cCcEEEEEEeecCCCCHHHHHHHhC-CCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-----KGCYVCIIIGYCEGGDMAEAIKKAN-GVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-----~~~~l~LVmEy~~GgsL~d~Ikk~~-~~~ls 74 (582)
.||||+++.. ......+.+.+|+++|++++||||+++++++.. .+...|+|||||+||+|.+++.... ...++
T Consensus 41 ~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~ls 119 (676)
T 3qa8_A 41 QVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119 (676)
T ss_dssp CEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCC
T ss_pred EEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCC
Confidence 4899998764 356667889999999999999999999987543 2557889999999999999998743 23589
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCC---eEEeecccchhcccccccCcccCCCCCCCcccccCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~---vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~ 151 (582)
+..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++............+||+.|+|||++.+..
T Consensus 120 e~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 199 (676)
T 3qa8_A 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKK 199 (676)
T ss_dssp SSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSC
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCC
Confidence 9999999999999999999999999999999999998775 9999999998876666667789999999999999999
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHH---------Hh------hc----c----CCCCCccccHHHHHHHH
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINK---------IN------KS----I----VAPLPTVYSGAFRGLVK 208 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~k---------I~------~~----~----~~~lp~~~S~~l~~LI~ 208 (582)
++.++|||||||++|+|++|..||........+.. +. .. . ...+...+++.+.+||.
T Consensus 200 ~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~ 279 (676)
T 3qa8_A 200 YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279 (676)
T ss_dssp CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHH
Confidence 99999999999999999999999976533221100 00 00 0 01123347889999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCchhhhhh
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~~~~~~ 237 (582)
+||..||.+|||++++|.||||+.+..-.
T Consensus 280 ~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 280 CMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp HHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred HHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 99999999999999999999998754333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=319.48 Aligned_cols=228 Identities=14% Similarity=0.095 Sum_probs=175.3
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCC-CCe---------eeeeeE------------EEec----CcEEEEEE
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRN-PFI---------VEYKDS------------WVEK----GCYVCIII 53 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~H-pnI---------V~l~~~------------~~~~----~~~l~LVm 53 (582)
.||||+++.... .....+.+.+|+.+++.+.| .|+ +..++. +... ...+|++|
T Consensus 105 ~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (413)
T 3dzo_A 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184 (413)
T ss_dssp EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEE
T ss_pred ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEe
Confidence 389999985433 22345779999999999987 211 111111 1110 12356777
Q ss_pred eecCCCCHHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc
Q 007991 54 GYCEGGDMAEAIKKA-----NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS 128 (582)
Q Consensus 54 Ey~~GgsL~d~Ikk~-----~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~ 128 (582)
+++ +++|.++++.. .+..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 185 ~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 185 PRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp ECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred ehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 776 79999999621 233578889999999999999999999999999999999999999999999999876544
Q ss_pred ccccCcccCCCCCCCcccc----------cCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCcc
Q 007991 129 DDLASSVVGTPSYMCPELL----------ADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTV 198 (582)
Q Consensus 129 ~~~~~~~vGTp~Y~APE~l----------~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~ 198 (582)
. ....+| +.|+|||++ ....|+.++|||||||++|+|++|+.||.+.+.......+.. ....
T Consensus 264 ~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~-----~~~~ 335 (413)
T 3dzo_A 264 S--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR-----SCKN 335 (413)
T ss_dssp E--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS-----SCCC
T ss_pred c--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh-----hccc
Confidence 3 556788 999999999 555688899999999999999999999987664433322211 2246
Q ss_pred ccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhh
Q 007991 199 YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 237 (582)
Q Consensus 199 ~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~ 237 (582)
+++.+.+||.+||+.||++||++.++|+||||+.....+
T Consensus 336 ~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 336 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 789999999999999999999999999999998765443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=330.64 Aligned_cols=213 Identities=21% Similarity=0.300 Sum_probs=174.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCc----EEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC----YVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~----~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||++... ......+.+.+|+.+|++++|||||++++++...+. ..|||||||+|++|.+++.. .+++..
T Consensus 109 vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~ 183 (681)
T 2pzi_A 109 VVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAE 183 (681)
T ss_dssp EEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHH
T ss_pred EEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHH
Confidence 799988753 345667789999999999999999999998876543 27999999999999987764 699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+..|+.||+.||.|||++||+||||||+||||+.+ .+||+|||+++..... ...+||+.|+|||++.+. ++.++|
T Consensus 184 ~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sD 258 (681)
T 2pzi_A 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATD 258 (681)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCcee
Confidence 99999999999999999999999999999999875 8999999999876443 567899999999998765 488999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
||||||++|+|++|.+||.+.....+ ........+++.+.+||.+||+.||.+||+..++|.|+|+.
T Consensus 259 i~slG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 259 IYTVGRTLAALTLDLPTRNGRYVDGL-------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHHHHSCCCEETTEECSSC-------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhhhHHHHHHHHhCCCCCcccccccc-------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999875321100 00001112467899999999999999999988888887764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.48 Aligned_cols=194 Identities=13% Similarity=0.116 Sum_probs=159.5
Q ss_pred EEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||.++.... .....+.+.+|+.++.+++||||+++++++... ...|+|||||+|++|.++++. ...+..+..
T Consensus 59 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~ 133 (286)
T 3uqc_A 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVVAEWIRGGSLQEVADT----SPSPVGAIR 133 (286)
T ss_dssp EEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCEEEHHHHHTT----CCCHHHHHH
T ss_pred EEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEEEEecCCCCHHHHHhc----CCChHHHHH
Confidence 89999987654 356678899999999999999999999988665 589999999999999999954 245667899
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
|+.||+.||+|||++||+||||||+||||+.+|.+||+++| |++ +++.++||||
T Consensus 134 i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------------~~~-------~~~~~~Di~s 187 (286)
T 3uqc_A 134 AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMP-------DANPQDDIRG 187 (286)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------------CCT-------TCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------------ccC-------CCCchhHHHH
Confidence 99999999999999999999999999999999999998544 333 3788999999
Q ss_pred hhHHHHhHhcCCccccccCHHHHHH---HHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 161 LGCCVYEMSAQKAAFKAFDMQALIN---KINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 161 LG~iLyELltG~~PF~~~~~~~l~~---kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||++|+|++|..||.+.+....+. +....... .....+++.+.+||.+||+.||.+| |++|+++.
T Consensus 188 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999998765322110 00000000 1234588999999999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=307.82 Aligned_cols=209 Identities=16% Similarity=0.130 Sum_probs=147.4
Q ss_pred CEEEEEeccccc--------CHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCC
Q 007991 1 MYVLKKIRLARQ--------TDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGV 71 (582)
Q Consensus 1 lyAIKki~~~~~--------~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~ 71 (582)
.|++|.+..... .+..++.+.+|+++|+++ .|+||+++++++. ++..+|||||||+|++|.++|++.+
T Consensus 261 ~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-d~~~~yLVMEyv~G~~L~d~i~~~~-- 337 (569)
T 4azs_A 261 DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-NAQSGWLVMEKLPGRLLSDMLAAGE-- 337 (569)
T ss_dssp SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-CSSEEEEEEECCCSEEHHHHHHTTC--
T ss_pred eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-ECCEEEEEEecCCCCcHHHHHHhCC--
Confidence 489999876421 234567899999999999 6999999999765 5569999999999999999998754
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCC
Q 007991 72 HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 72 ~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~ 150 (582)
.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..... ....+.+||+.|||||++.+
T Consensus 338 ~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g- 413 (569)
T 4azs_A 338 EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE- 413 (569)
T ss_dssp CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---
T ss_pred CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-
Confidence 57765 47899999999999999999999999999999999999999999876543 34567899999999999987
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
.+...+|+|++|+++|+|.++..+|.. .+... +. ....+..++..++..+|..|+.......++|.
T Consensus 414 ~~~~~~d~~s~g~~~~~l~~~~~~~~~--------~l~~~-----~~-~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 414 NKSWNGFWRSAPVHPFNLPQPWSNWLY--------AVWQE-----PV-ERWNFVLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp ---------------CCCCTTHHHHHH--------HHHTS-----CG-GGCSHHHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred CCCCcccccccccchhhhccccchhHH--------HhhcC-----CC-CCCcHHHHHHHHhCCCCCCCCChhhhccchhH
Confidence 466789999999999999887665421 11110 11 11124567777777888777765554444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=238.64 Aligned_cols=161 Identities=19% Similarity=0.232 Sum_probs=129.9
Q ss_pred EEEEEecccccC-H-----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIRLARQT-D-----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~~~~~~-~-----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
+|+|++...... . ...+.+.+|+++|++++||||+.+..++... ...|||||||+|++|.+++.+
T Consensus 362 ~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lVmE~~~ggsL~~~l~~-------- 432 (540)
T 3en9_A 362 VIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-DNKRIMMSYINGKLAKDVIED-------- 432 (540)
T ss_dssp EEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-TTTEEEEECCCSEEHHHHSTT--------
T ss_pred EEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-CccEEEEECCCCCCHHHHHHH--------
Confidence 577776443321 1 1346689999999999999999555444443 356899999999999999875
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--------ccCcccCCCCCCCcccc
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELL 147 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l 147 (582)
+..|+.||+.||+|||++||+||||||+|||++. ++||+|||+++...... .....+||+.|||||++
T Consensus 433 --~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~ 508 (540)
T 3en9_A 433 --NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW 508 (540)
T ss_dssp --CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred --HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHH
Confidence 5689999999999999999999999999999998 99999999998775432 12467999999999999
Q ss_pred cC--CCCCCCCcccchhHHHHhHhcCCccc
Q 007991 148 AD--IPYGSKSDIWSLGCCVYEMSAQKAAF 175 (582)
Q Consensus 148 ~~--~~y~~ksDIWSLG~iLyELltG~~PF 175 (582)
.. ..|+..+|+|+.++-..+.+.++.+|
T Consensus 509 ~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 509 ERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 86 56888899999988777776665544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.1e-20 Score=186.72 Aligned_cols=122 Identities=16% Similarity=0.184 Sum_probs=95.8
Q ss_pred CEEEEEecccccCH----------------HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHH
Q 007991 1 MYVLKKIRLARQTD----------------RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEA 64 (582)
Q Consensus 1 lyAIKki~~~~~~~----------------~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~ 64 (582)
.||||.++...... ..+..+.+|+.+|++++ | +++++.+.. ...|+|||||+|++|.+
T Consensus 116 ~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~--~~~~lvmE~~~g~~L~~- 189 (282)
T 1zar_A 116 ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW--EGNAVLMELIDAKELYR- 189 (282)
T ss_dssp EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE--ETTEEEEECCCCEEGGG-
T ss_pred EEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec--cceEEEEEecCCCcHHH-
Confidence 38999997644322 24677999999999999 4 666665433 34589999999999987
Q ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCc
Q 007991 65 IKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP 144 (582)
Q Consensus 65 Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~AP 144 (582)
+. . .....++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++ ++..|+||
T Consensus 190 l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~------------~~~~~~a~ 248 (282)
T 1zar_A 190 VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV------------EVGEEGWR 248 (282)
T ss_dssp CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE------------ETTSTTHH
T ss_pred cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe------------ECCCCCHH
Confidence 32 1 23457999999999999999999999999999999 9999999999985 34467899
Q ss_pred ccccC
Q 007991 145 ELLAD 149 (582)
Q Consensus 145 E~l~~ 149 (582)
|++..
T Consensus 249 e~l~r 253 (282)
T 1zar_A 249 EILER 253 (282)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=9.8e-16 Score=153.54 Aligned_cols=97 Identities=13% Similarity=0.171 Sum_probs=77.7
Q ss_pred HHHHHHHHHHHhcCCCCe--eeeeeEEEecCcEEEEEEeecCC-C----CHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 007991 18 RSAHQEMELISRVRNPFI--VEYKDSWVEKGCYVCIIIGYCEG-G----DMAEAIKKANGVHFPEEKLCKWLVQLLMALN 90 (582)
Q Consensus 18 ~~~~rEi~iL~~L~HpnI--V~l~~~~~~~~~~l~LVmEy~~G-g----sL~d~Ikk~~~~~lse~~~~~il~QLL~aL~ 90 (582)
..+.+|+.+|.+|.|++| ..+++ . ...||||||+.+ | .|.+++.. .++..+..++.||+.||.
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~--~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYT--Y---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEE--E---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEE--c---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHH
Confidence 468899999999998864 23332 2 235799999942 3 77766432 235678899999999999
Q ss_pred HHH-HCCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 91 YLH-ANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 91 yLH-s~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
||| +.||+||||||+|||++. .++|+|||++...
T Consensus 185 ~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 185 RLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999 999999999999999988 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.4e-12 Score=139.24 Aligned_cols=96 Identities=13% Similarity=0.141 Sum_probs=71.9
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 007991 19 SAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHIL 98 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs~gIi 98 (582)
.+.+|...|.+|.+.++.-.. .+.... .+|||||++|++|.++. ....+..++.||+.+|.|||++|||
T Consensus 159 ~A~kE~~nL~rL~~~gv~vp~-p~~~~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 159 AAIKEFAFMKALYEEGFPVPE-PIAQSR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp HHHHHHHHHHHHHHTTCSCCC-EEEEET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCCe-eeeccC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCc
Confidence 346788889888655543222 222222 26999999999885432 2234567889999999999999999
Q ss_pred ecccCcccEEEcCCCC----------eEEeecccchh
Q 007991 99 HRDVKCSNIFLTRDQD----------IRLGDFGLAKM 125 (582)
Q Consensus 99 HRDIKP~NILL~~~g~----------vKL~DFGla~~ 125 (582)
||||||.||||+.+|. +.|+||+-+..
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999999998873 89999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=8e-10 Score=109.35 Aligned_cols=113 Identities=14% Similarity=0.121 Sum_probs=85.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||......... ...+.+|+.+|+.|. +.++.++++++.. +...|+||||++|.+|.+.+. +......
T Consensus 40 ~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~ 109 (263)
T 3tm0_A 40 LYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLMSEADGVLCSEEYE-------DEQSPEK 109 (263)
T ss_dssp EEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCSSEEHHHHCC-------TTTCHHH
T ss_pred EEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEEEecCCeehhhccC-------CcccHHH
Confidence 6888886532111 235889999999995 5667778876654 458899999999999986531 1223347
Q ss_pred HHHHHHHHHHHHHH-----------------------------------------------------------CCceecc
Q 007991 81 WLVQLLMALNYLHA-----------------------------------------------------------NHILHRD 101 (582)
Q Consensus 81 il~QLL~aL~yLHs-----------------------------------------------------------~gIiHRD 101 (582)
++.++..+|..||+ .+++|+|
T Consensus 110 ~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgD 189 (263)
T 3tm0_A 110 IIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGD 189 (263)
T ss_dssp HHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSS
T ss_pred HHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCC
Confidence 78899999999998 4589999
Q ss_pred cCcccEEEcCCCCeEEeecccch
Q 007991 102 VKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 102 IKP~NILL~~~g~vKL~DFGla~ 124 (582)
+++.|||++.++.+.|+||+.+.
T Consensus 190 l~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 190 LGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCcEEEECCcEEEEEEchhcc
Confidence 99999999876556799999774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3.2e-09 Score=108.00 Aligned_cols=167 Identities=15% Similarity=0.194 Sum_probs=109.6
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCe--eeeeeEEEecC--cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFI--VEYKDSWVEKG--CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnI--V~l~~~~~~~~--~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
||+|..+. ......+.+|+++|+.|. +..+ ..++......+ ...|+||+|++|..|.+.... .++.+
T Consensus 43 ~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~ 114 (304)
T 3sg8_A 43 FIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQ 114 (304)
T ss_dssp EEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHH
T ss_pred EEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHH
Confidence 67777543 245577899999999984 3332 23332211112 234789999999998765443 47888
Q ss_pred HHHHHHHHHHHHHHHHHH----------------------------------------------------------CCce
Q 007991 77 KLCKWLVQLLMALNYLHA----------------------------------------------------------NHIL 98 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs----------------------------------------------------------~gIi 98 (582)
....++.|+...|..||+ ..++
T Consensus 115 ~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~ 194 (304)
T 3sg8_A 115 SQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLI 194 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEE
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeE
Confidence 888899999999999986 1379
Q ss_pred ecccCcccEEEcC--CCCeEEeecccchhcccccccCcccCCCCC---CCcccccC--CCCC------------CCCccc
Q 007991 99 HRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDLASSVVGTPSY---MCPELLAD--IPYG------------SKSDIW 159 (582)
Q Consensus 99 HRDIKP~NILL~~--~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y---~APE~l~~--~~y~------------~ksDIW 159 (582)
|+|+++.||+++. .+.+.|+||+.+....... .......+ ..|+.... ..|. ...+.|
T Consensus 195 HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~ 271 (304)
T 3sg8_A 195 HNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYW 271 (304)
T ss_dssp CSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred eCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHH
Confidence 9999999999998 4568899999886542210 01111111 23332110 0011 125889
Q ss_pred chhHHHHhHhcCCccccccC
Q 007991 160 SLGCCVYEMSAQKAAFKAFD 179 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~ 179 (582)
++|.++|.+.+|.++|....
T Consensus 272 ~l~~~~~~~~~g~~~~~~~g 291 (304)
T 3sg8_A 272 SFEKIIYGKEYGYMDWYEEG 291 (304)
T ss_dssp HHHHHHHHHHTTCHHHHHHH
T ss_pred HHHHHHHHHHcCCHHHHHHH
Confidence 99999999999998875444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.80 E-value=5.5e-09 Score=101.92 Aligned_cols=108 Identities=17% Similarity=0.159 Sum_probs=77.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCe--eeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFI--VEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnI--V~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
|+||...... ...+.+|+.+|+.+.+.++ .+++..+.. +...|+||||++|.+|. . . .... .
T Consensus 47 ~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i~G~~l~--~---~--~~~~---~ 110 (264)
T 1nd4_A 47 LFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDLL--S---S--HLAP---A 110 (264)
T ss_dssp EEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEETT--T---S--CCCH---H
T ss_pred EEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEecCCcccC--c---C--cCCH---h
Confidence 6788765431 2357899999999975554 447765544 34688999999998883 1 1 1121 2
Q ss_pred HHHHHHHHHHHHHHHCC----------------------------------------------------------ceecc
Q 007991 80 KWLVQLLMALNYLHANH----------------------------------------------------------ILHRD 101 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~g----------------------------------------------------------IiHRD 101 (582)
.++.++...|..||+.. ++|+|
T Consensus 111 ~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD 190 (264)
T 1nd4_A 111 EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGD 190 (264)
T ss_dssp HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSS
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCC
Confidence 45667777777777643 99999
Q ss_pred cCcccEEEcCCCCeEEeecccchh
Q 007991 102 VKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 102 IKP~NILL~~~g~vKL~DFGla~~ 125 (582)
++|.|||++.++.+.|+|||.+..
T Consensus 191 l~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 191 ACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCcEEEECCcEEEEEcchhccc
Confidence 999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.78 E-value=5.3e-09 Score=108.73 Aligned_cols=120 Identities=10% Similarity=0.167 Sum_probs=86.1
Q ss_pred EEEEEec--ccccCHHHHHHHHHHHHHHHhcCC--CCeeeeeeEEEecC--cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 2 YVLKKIR--LARQTDRARRSAHQEMELISRVRN--PFIVEYKDSWVEKG--CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 2 yAIKki~--~~~~~~~~~~~~~rEi~iL~~L~H--pnIV~l~~~~~~~~--~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
||+|+.. .... ......+.+|+.+|+.|.. ..+.+++..+...+ +..|+||||++|..+.+.. -..+++
T Consensus 64 ~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~ 138 (359)
T 3dxp_A 64 YVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSP 138 (359)
T ss_dssp EEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCH
T ss_pred EEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCH
Confidence 5666665 3221 1223578899999999984 44667776554331 3478999999998874311 124678
Q ss_pred HHHHHHHHHHHHHHHHHHH----------------------------------------------------------CCc
Q 007991 76 EKLCKWLVQLLMALNYLHA----------------------------------------------------------NHI 97 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs----------------------------------------------------------~gI 97 (582)
.....++.++..+|..||. .++
T Consensus 139 ~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l 218 (359)
T 3dxp_A 139 AERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSI 218 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEE
T ss_pred HHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceE
Confidence 8889999999999999997 369
Q ss_pred eecccCcccEEEcCCCC--eEEeecccchhc
Q 007991 98 LHRDVKCSNIFLTRDQD--IRLGDFGLAKML 126 (582)
Q Consensus 98 iHRDIKP~NILL~~~g~--vKL~DFGla~~~ 126 (582)
+|+|+++.|||++.++. +.|+||+.+...
T Consensus 219 vHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 219 VHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp ECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred EeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 99999999999998764 689999988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.5e-06 Score=86.04 Aligned_cols=117 Identities=16% Similarity=0.179 Sum_probs=79.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCC---CeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNP---FIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||+|.-+ .......+.+|+++|+.|.+. .+..++.+....++..|+||||++|..|.+..-. .++....
T Consensus 42 ~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~ 113 (306)
T 3tdw_A 42 WVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAK 113 (306)
T ss_dssp EEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHH
T ss_pred EEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHH
Confidence 6777642 234557899999999999753 2444554443334567799999999988764321 2445555
Q ss_pred HHHHHHHHHHHHHHHHC------------------------------------------------------------Cce
Q 007991 79 CKWLVQLLMALNYLHAN------------------------------------------------------------HIL 98 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~------------------------------------------------------------gIi 98 (582)
..++.|+...|..||+. .++
T Consensus 114 ~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~ 193 (306)
T 3tdw_A 114 DRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLI 193 (306)
T ss_dssp HHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEE
T ss_pred HHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeE
Confidence 55555555555555532 359
Q ss_pred ecccCcccEEEcC---CCC-eEEeecccchhc
Q 007991 99 HRDVKCSNIFLTR---DQD-IRLGDFGLAKML 126 (582)
Q Consensus 99 HRDIKP~NILL~~---~g~-vKL~DFGla~~~ 126 (582)
|+|+++.|||++. ++. +.|+||+.+...
T Consensus 194 HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 194 HGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred eCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 9999999999987 455 489999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=4.3e-05 Score=75.33 Aligned_cols=112 Identities=14% Similarity=0.092 Sum_probs=77.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
|++|.-... ....+.+|+.+|+.|.. -.+.+++.++.. +...|+|||+++|.++.+..... ......
T Consensus 53 ~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~~~~~~~~~~------~~~~~~ 120 (272)
T 4gkh_A 53 LFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGKTAFQVLEEY------PDSGEN 120 (272)
T ss_dssp EEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSEEHHHHHHHC------GGGHHH
T ss_pred EEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCccccccccCC------HHHHHH
Confidence 566665432 34568899999999853 234456665544 45788999999999988766542 122234
Q ss_pred HHHHHHHHHHHHHHC----------------------------------------------------------Cceeccc
Q 007991 81 WLVQLLMALNYLHAN----------------------------------------------------------HILHRDV 102 (582)
Q Consensus 81 il~QLL~aL~yLHs~----------------------------------------------------------gIiHRDI 102 (582)
+..++...|.-||.. .++|+|+
T Consensus 121 ~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl 200 (272)
T 4gkh_A 121 IVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDF 200 (272)
T ss_dssp HHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCC
T ss_pred HHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCC
Confidence 555666666666621 2789999
Q ss_pred CcccEEEcCCCCeEEeecccchh
Q 007991 103 KCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 103 KP~NILL~~~g~vKL~DFGla~~ 125 (582)
++.|||++.++.+-|+||+.+..
T Consensus 201 ~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 201 SLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCeEEEECCeEEEEEECccccc
Confidence 99999999877677999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00021 Score=72.34 Aligned_cols=30 Identities=20% Similarity=0.337 Sum_probs=27.3
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00046 Score=67.97 Aligned_cols=123 Identities=19% Similarity=0.118 Sum_probs=83.9
Q ss_pred CCHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccC
Q 007991 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVG 137 (582)
Q Consensus 59 gsL~d~Ikk~~~~~lse~~~~~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vG 137 (582)
.+|.++++..+ ..++|++++.+++|.+.+|.-+-. ..-..+=+-|..|+|..+|.|.+.+ +.+. ..
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 47999999865 479999999999999999877622 1222344557999999999988764 1110 12
Q ss_pred CCCCCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccC
Q 007991 138 TPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRK 213 (582)
Q Consensus 138 Tp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~ 213 (582)
...+.+||... ...+.+.-|||||++||.-+--.. ....+..+|+.+..||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL------------------~e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL------------------KENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC------------------CTTEEECCCHHHHHHHHHHTTC
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC------------------CcccchhhCHHHHHHHHHHHhc
Confidence 23567888763 234567889999999998765433 2234556899999999999866
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=7.8e-05 Score=76.82 Aligned_cols=31 Identities=16% Similarity=0.309 Sum_probs=26.0
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4699999999999999644578999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0017 Score=68.02 Aligned_cols=29 Identities=21% Similarity=0.398 Sum_probs=25.1
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
..++|+|+++.|||++.+ .++|+||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 579999999999999876 49999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0016 Score=66.33 Aligned_cols=32 Identities=25% Similarity=0.349 Sum_probs=27.5
Q ss_pred CCceecccCcccEEEcCC----CCeEEeecccchhc
Q 007991 95 NHILHRDVKCSNIFLTRD----QDIRLGDFGLAKML 126 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~----g~vKL~DFGla~~~ 126 (582)
..++|+|+++.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999875 67999999988644
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0036 Score=62.98 Aligned_cols=29 Identities=21% Similarity=0.386 Sum_probs=25.0
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
.++|+|+.+.||+ ..++.+.|+||+.+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5677899999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0028 Score=63.99 Aligned_cols=41 Identities=29% Similarity=0.386 Sum_probs=31.0
Q ss_pred HHHHHHHHHH-------CCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 85 LLMALNYLHA-------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 85 LL~aL~yLHs-------~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
+...+++++. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3344555553 3699999999999998776568999997753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0066 Score=64.19 Aligned_cols=103 Identities=15% Similarity=0.149 Sum_probs=65.1
Q ss_pred HHHHHHHHHHHhcCCCCee-eeeeEEEecCcEEEEEEeecCCCCHH--------------HHHHHhCC------CCC--C
Q 007991 18 RSAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCIIIGYCEGGDMA--------------EAIKKANG------VHF--P 74 (582)
Q Consensus 18 ~~~~rEi~iL~~L~HpnIV-~l~~~~~~~~~~l~LVmEy~~GgsL~--------------d~Ikk~~~------~~l--s 74 (582)
..+.+|..+++.|...++. ++++. ..+. +||||++|..|. +.+.+... ... -
T Consensus 98 ~~~~rE~~vl~~L~~~gv~P~ll~~--~~~g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 98 DSLVLESVMFAILAERSLGPQLYGV--FPEG---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHTTSSCCEEEE--ETTE---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEE--cCCc---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 4566999999988644443 34433 2332 899999975542 22222111 111 2
Q ss_pred HHHHHHHHHHHHH-------------------HHHHHH----H----CCceecccCcccEEEcCC----CCeEEeecccc
Q 007991 75 EEKLCKWLVQLLM-------------------ALNYLH----A----NHILHRDVKCSNIFLTRD----QDIRLGDFGLA 123 (582)
Q Consensus 75 e~~~~~il~QLL~-------------------aL~yLH----s----~gIiHRDIKP~NILL~~~----g~vKL~DFGla 123 (582)
+.++..|+.|+-. .++.|. . ..++|+|+.+.|||++.+ +.+.|+||..+
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 4667777765532 233333 2 259999999999999887 68999999987
Q ss_pred hh
Q 007991 124 KM 125 (582)
Q Consensus 124 ~~ 125 (582)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 53
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.20 E-value=0.022 Score=57.42 Aligned_cols=29 Identities=28% Similarity=0.260 Sum_probs=25.0
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccchh
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 899999987753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.02 Score=58.76 Aligned_cols=54 Identities=6% Similarity=-0.105 Sum_probs=38.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC---CCCeeeeeeEEEecCcEEEEEEeecCCCCH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR---NPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~---HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL 61 (582)
|++|.-... ....+.+|+..|+.|. ...+.+++..... +...|+||||++|..+
T Consensus 62 ~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 62 VFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCCCCC
T ss_pred EEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccCCCC
Confidence 577766542 2457889999999984 2456677765443 4578999999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.038 Score=56.84 Aligned_cols=32 Identities=16% Similarity=0.360 Sum_probs=28.0
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
.+++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999877543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.46 E-value=0.037 Score=59.13 Aligned_cols=30 Identities=30% Similarity=0.448 Sum_probs=24.9
Q ss_pred CceecccCcccEEEcCC----------------------------CCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFLTRD----------------------------QDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~----------------------------g~vKL~DFGla~~ 125 (582)
.++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 58999999999999885 6799999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.98 E-value=0.054 Score=58.60 Aligned_cols=36 Identities=14% Similarity=0.123 Sum_probs=24.7
Q ss_pred HHHHHHHHhcCCCCee-eeeeEEEecCcEEEEEEeecCCCCH
Q 007991 21 HQEMELISRVRNPFIV-EYKDSWVEKGCYVCIIIGYCEGGDM 61 (582)
Q Consensus 21 ~rEi~iL~~L~HpnIV-~l~~~~~~~~~~l~LVmEy~~GgsL 61 (582)
.+|+.+|..|...++. ++++.+ .+. +||||++|..|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~--~~G---~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFF--TNG---RIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEE--TTE---EEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEe--CCe---EEEEeeCCccC
Confidence 5899999999765554 455543 332 59999987443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.028 Score=59.44 Aligned_cols=33 Identities=18% Similarity=0.308 Sum_probs=28.4
Q ss_pred HHCCceecccCcccEEEcCCCCeEEeecccchhc
Q 007991 93 HANHILHRDVKCSNIFLTRDQDIRLGDFGLAKML 126 (582)
Q Consensus 93 Hs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~ 126 (582)
+...++|+|+++.|||++.++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 356799999999999998877 999999988643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.70 E-value=0.15 Score=50.54 Aligned_cols=24 Identities=21% Similarity=0.185 Sum_probs=20.1
Q ss_pred CceecccCcccEEEcCCCCeEEeec
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDF 120 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DF 120 (582)
.++|+|+++.||+++.+| ..++|-
T Consensus 189 ~LvHGDlw~gNvl~~~~g-~~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDG-AVVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETTE-EEECSC
T ss_pred eeeecCCCCCcEEEcCCC-eEEEec
Confidence 599999999999999988 446663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.91 E-value=0.11 Score=54.81 Aligned_cols=29 Identities=31% Similarity=0.476 Sum_probs=24.6
Q ss_pred ceecccCcccEEE------cCCCCeEEeecccchh
Q 007991 97 ILHRDVKCSNIFL------TRDQDIRLGDFGLAKM 125 (582)
Q Consensus 97 IiHRDIKP~NILL------~~~g~vKL~DFGla~~ 125 (582)
++|+|+.+.|||+ +.++.++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.29 E-value=0.3 Score=50.26 Aligned_cols=29 Identities=31% Similarity=0.414 Sum_probs=24.4
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
+++|+|+++.|||++.++ +.|+||+.+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 599999999999997655 99999997753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 582 | ||||
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 9e-65
Identities = 84/237 (35%), Positives = 129/237 (54%), Gaps = 9/237 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGG 59
+ V K++ T+ ++ E+ L+ +++P IV Y D +++ + I++ YCEGG
Sbjct: 31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90
Query: 60 DMAEAIKKA--NGVHFPEEKLCKWLVQLLMALNYLH-----ANHILHRDVKCSNIFLTRD 112
D+A I K + EE + + + QL +AL H + +LHRD+K +N+FL
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150
Query: 113 QDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ 171
Q+++LGDFGLA++L D A + VGTP YM PE + + Y KSDIWSLGC +YE+ A
Sbjct: 151 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210
Query: 172 KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
F AF + L KI + +P YS ++ ML RPS E+L +P
Sbjct: 211 MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-60
Identities = 60/232 (25%), Positives = 113/232 (48%), Gaps = 6/232 (2%)
Query: 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+ LK + A+ + +E+E+ S +R+P I+ + + V +I+ Y G
Sbjct: 33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-RVYLILEYAPLG 91
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ ++K + F E++ ++ +L AL+Y H+ ++HRD+K N+ L ++++ D
Sbjct: 92 TVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 149
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG + +++ GT Y+ PE++ + K D+WSLG YE K F+A
Sbjct: 150 FGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
Q +I++ + P + R L+ +L+ NP RP E+L HP +
Sbjct: 209 YQETYKRISR-VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-59
Identities = 72/239 (30%), Positives = 119/239 (49%), Gaps = 12/239 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ K I + + E+++++ +P IV+ D++ + + I+I +C GG
Sbjct: 39 LAAAKVIDTKSEEELED--YMVEIDILASCDHPNIVKLLDAFYYEN-NLWILIEFCAGGA 95
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + E ++ Q L ALNYLH N I+HRD+K NI T D DI+L DF
Sbjct: 96 VDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF 154
Query: 121 GLAKMLISD-DLASSVVGTPSYMCPELLA-----DIPYGSKSDIWSLGCCVYEMSAQKAA 174
G++ S +GTP +M PE++ D PY K+D+WSLG + EM+ +
Sbjct: 155 GVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
Query: 175 FKAFDMQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+ ++ KI KS L P+ +S F+ +K L KN + R + ++LL HP +
Sbjct: 215 HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (503), Expect = 8e-59
Identities = 57/299 (19%), Positives = 127/299 (42%), Gaps = 18/299 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
++V K I D+ E+ +++++ +P ++ D++ +K + +I+ + GG+
Sbjct: 56 VFVAKFINTPYPLDKYT--VKNEISIMNQLHHPKLINLHDAFEDKY-EMVLILEFLSGGE 112
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLG 118
+ + I E ++ ++ Q L ++H + I+H D+K NI + +++
Sbjct: 113 LFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGLA L D++ T + PE++ P G +D+W++G Y + + + F
Sbjct: 172 DFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231
Query: 179 DMQALINKINKSIVAPLPTVYSG---AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235
D + + + +S + +K++L+K P R + + L HP L+
Sbjct: 232 DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291
Query: 236 GIHLKLNGPRRNTFP-------LEWSDSNFKKTRFMEPEAISIHSNREKR--QSFSNDR 285
+ ++ R N +W R ++ H +E + S+ + +
Sbjct: 292 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRK 350
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 197 bits (502), Expect = 1e-58
Identities = 56/285 (19%), Positives = 117/285 (41%), Gaps = 9/285 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ K + ++D+ +E++ +S +R+P +V D++ + + +I + GG+
Sbjct: 53 NFAAKFVMTPHESDKET--VRKEIQTMSVLRHPTLVNLHDAFEDDN-EMVMIYEFMSGGE 109
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLG 118
+ E + + E++ +++ Q+ L ++H N+ +H D+K NI T + ++L
Sbjct: 110 LFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 168
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
DFGL L GT + PE+ P G +D+WS+G Y + + + F
Sbjct: 169 DFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228
Query: 179 DMQALINKINKSIVAPLPTVYSG---AFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235
+ + + + +SG + ++ +L +P R + + L HP L P
Sbjct: 229 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
Query: 236 GIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQS 280
R T + + + P I + R+
Sbjct: 289 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-56
Identities = 53/237 (22%), Positives = 107/237 (45%), Gaps = 14/237 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K + + T + ++ E+ ++ + R+ I+ + + I+ +CEG +
Sbjct: 33 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTAPQLAIVTQWCEGSSL 90
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ F KL Q ++YLHA I+HRD+K +NIFL D +++GDFG
Sbjct: 91 YHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 122 LAKMLISDD---LASSVVGTPSYMCPELL---ADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
LA + + G+ +M PE++ PY +SD+++ G +YE+ + +
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209
Query: 176 KAFD-MQALINKINKSIVAP----LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+ +I + + ++P + + A + L+ L+K + RP ++L
Sbjct: 210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-56
Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 9/234 (3%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
++++ L +Q + E+ ++ +NP IV Y DS++ + +++ Y GG
Sbjct: 47 EVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEYLAGGS 103
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + + E ++ + L AL +LH+N ++HRD+K NI L D ++L DF
Sbjct: 104 LTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 121 GLAKML-ISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
G + S++VGTP +M PE++ YG K DIWSLG EM + + +
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 180 MQALINKINKSIVAPL--PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
+ I + L P S FR + L + E R SA ELL H L+
Sbjct: 221 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (478), Expect = 4e-56
Identities = 70/251 (27%), Positives = 115/251 (45%), Gaps = 20/251 (7%)
Query: 1 MYVLKKIRL-------ARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCII 52
Y +K I + A + R + +E++++ +V P I++ KD E + ++
Sbjct: 30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLV 88
Query: 53 IGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD 112
+ G++ + + + V E++ K + LL + LH +I+HRD+K NI L D
Sbjct: 89 FDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 146
Query: 113 QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA------DIPYGSKSDIWSLGCCVY 166
+I+L DFG + L + V GTPSY+ PE++ YG + D+WS G +Y
Sbjct: 147 MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206
Query: 167 EMSAQKAAFKAFDMQALINKI---NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
+ A F ++ I N +P YS + LV L P+ R +A E
Sbjct: 207 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266
Query: 224 LLCHPHLQPYV 234
L HP Q YV
Sbjct: 267 ALAHPFFQQYV 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-56
Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 12/238 (5%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSW---VEKGCYVCIIIGYCEG 58
+++ + T R+ +E E++ +++P IV + DSW V+ + ++
Sbjct: 37 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS 96
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH--ILHRDVKCSNIFLT-RDQDI 115
G + +K+ + L W Q+L L +LH I+HRD+KC NIF+T +
Sbjct: 97 GTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 154
Query: 116 RLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAF 175
++GD GLA + A +V+GTP +M PE+ + Y D+++ G C+ EM+ + +
Sbjct: 155 KIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212
Query: 176 KAFDMQALINKINKSIVAP--LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
A I + S V P V + +++ +R+N + R S +LL H Q
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (480), Expect = 6e-56
Identities = 63/233 (27%), Positives = 117/233 (50%), Gaps = 11/233 (4%)
Query: 1 MYVLKKIRLA-RQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+ +KK+ + +Q++ + +E+ + ++R+P ++Y+ ++ + +++ YC G
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-TAWLVMEYCLGS 100
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
E ++ L L YLH+++++HRDVK NI L+ ++LGD
Sbjct: 101 ASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD 158
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLA---DIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
FG A ++ A+S VGTP +M PE++ + Y K D+WSLG E++ +K
Sbjct: 159 FGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
Query: 177 AFDMQALINKINKSIVAPL-PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
+ + + I ++ L +S FR V S L+K P+ RP++ LL H
Sbjct: 216 NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 49/274 (17%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
K I L + R +E++++ +P+IV + ++ G + I + + +GG +
Sbjct: 34 MARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSL 91
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLH-ANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ +KKA PE+ L K + ++ L YL + I+HRDVK SNI + +I+L DF
Sbjct: 92 DQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149
Query: 121 GLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDM 180
G++ L D +A+S VGT SYM PE L Y +SDIWS+G + EM+ + D
Sbjct: 150 GVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 181 Q------------------------------------------ALINKINKSIVAPLPT- 197
+ L++ I LP+
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268
Query: 198 VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
V+S F+ V L KNP R +L+ H ++
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-54
Identities = 52/237 (21%), Positives = 99/237 (41%), Gaps = 10/237 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K + + R D +E+ + + + +V++ +G + + YC GG+
Sbjct: 32 AVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGE 89
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + I+ + PE ++ QL+ + YLH I HRD+K N+ L ++++ DF
Sbjct: 90 LFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDF 147
Query: 121 GLAKMLISDD---LASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFK 176
GLA + ++ L + + GT Y+ PELL + D+WS G + M A + +
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 177 AFD--MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
Q + K A L+ +L +NP R + ++
Sbjct: 208 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-54
Identities = 65/285 (22%), Positives = 121/285 (42%), Gaps = 13/285 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
Y+ K +++ + TD+ +E+ +++ R+ I+ +S+ + +I + G D
Sbjct: 32 TYMAKFVKV-KGTDQVL--VKKEISILNIARHRNILHLHESFESME-ELVMIFEFISGLD 87
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD--IRLG 118
+ E I + E ++ ++ Q+ AL +LH+++I H D++ NI + I++
Sbjct: 88 IFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146
Query: 119 DFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
+FG A+ L D + P Y PE+ + +D+WSLG VY + + F A
Sbjct: 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206
Query: 179 DMQALINKINKSIVAPLPTVY---SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVL 235
Q +I I + + S V +L K + R +A+E L HP L+ +
Sbjct: 207 TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 236 GIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQS 280
+ K+ R + + KK M A I R
Sbjct: 267 RVSTKV---IRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQ 308
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 2e-53
Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 13/273 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ +K I + S E+ ++ ++++P IV D + G ++ +I+ GG+
Sbjct: 36 LVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGG-HLYLIMQLVSGGE 93
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRL 117
+ + I + + E + + Q+L A+ YLH I+HRD+K N+ + I +
Sbjct: 94 LFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMI 151
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFGL+KM + S+ GTP Y+ PE+LA PY D WS+G Y + F
Sbjct: 152 SDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211
Query: 178 FDMQALINKINKSIV---APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234
+ L +I K+ +P S + + ++ ++ K+PE R + + L HP +
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
Query: 235 L---GIHLKLNGPRRNTFPLEWSDSNFKKTRFM 264
IH ++ + F F T +
Sbjct: 272 ALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVV 304
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-53
Identities = 67/243 (27%), Positives = 117/243 (48%), Gaps = 10/243 (4%)
Query: 1 MYVLKKIRLAR-QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
Y +K + + +E +++SR+ +PF V+ ++ + + + Y + G
Sbjct: 35 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNG 93
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ + I+K F E + +++ AL YLH I+HRD+K NI L D I++ D
Sbjct: 94 ELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 120 FGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
FG AK+L + A+S VGT Y+ PELL + SD+W+LGC +Y++ A F+
Sbjct: 152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ--PYV 234
A + + KI K P + R LV+ +L + R E+ + L+ P+
Sbjct: 212 AGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
Query: 235 LGI 237
+
Sbjct: 271 ESV 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-52
Identities = 47/227 (20%), Positives = 101/227 (44%), Gaps = 7/227 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K I+ D ++ E +++++R+ +V+ VE+ + I+ Y G +
Sbjct: 33 VAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ ++ + L K+ + + A+ YL N+ +HRD+ N+ ++ D ++ DFG
Sbjct: 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 148
Query: 122 LAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAFDM 180
L K S + + PE L + + +KSD+WS G ++E+ S + + +
Sbjct: 149 LTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206
Query: 181 QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+ ++ ++ K P A ++K+ + RPS +L
Sbjct: 207 KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 26/304 (8%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSW---VEKGCYVCIIIGYC 56
+ LK ++ + R E+EL R + P IV D + + I++
Sbjct: 39 KFALKMLQDCPKARR-------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-- 114
+GG++ I+ F E + + + + A+ YLH+ +I HRDVK N+ T +
Sbjct: 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151
Query: 115 -IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
++L DFG AK S + ++ TP Y+ PE+L Y D+WSLG +Y +
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
Query: 174 AFKAFDMQALINKINKSIVA-------PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226
F + A+ + I P + S + L++++L+ P R + E +
Sbjct: 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
Query: 227 HPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAI-SIHSNREKRQSFSNDR 285
H P+++ P + L+ ++ + A+ ++ + E+ + +
Sbjct: 272 H----PWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIED 327
Query: 286 ALNP 289
A NP
Sbjct: 328 ASNP 331
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-49
Identities = 43/229 (18%), Positives = 93/229 (40%), Gaps = 9/229 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ + E ++ ++ NP+IV + +++ E G +
Sbjct: 37 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM--LVMEMAELGPL 94
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +++ H ++ + + + Q+ M + YL ++ +HRD+ N+ L ++ DFG
Sbjct: 95 NKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 152
Query: 122 LAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFK 176
L+K L +D+ + + PE + + SKSD+WS G ++E S + ++
Sbjct: 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ + K P L+ + E RP A +
Sbjct: 213 GMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-49
Identities = 57/273 (20%), Positives = 115/273 (42%), Gaps = 10/273 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K++R A + +A + E +++ V NP + + +I G +
Sbjct: 41 VAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCL 97
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +++ + + + L W VQ+ +NYL ++HRD+ N+ + Q +++ DFG
Sbjct: 98 LDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 156
Query: 122 LAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKA 177
LAK+L +++ A +M E + Y +SD+WS G V+E+ + +
Sbjct: 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216
Query: 178 FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGI 237
+ + + K P P + + ++ + + RP EL+
Sbjct: 217 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
Query: 238 HLKLNGPRRNTFPLEWSDSNFKKTRFMEPEAIS 270
+L + G R P +DSNF + M+ E +
Sbjct: 277 YLVIQGDERMHLPSP-TDSNFYR-ALMDEEDMD 307
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-49
Identities = 47/229 (20%), Positives = 100/229 (43%), Gaps = 8/229 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K I+ ++ +E +++ + + +V+ ++ + II Y G +
Sbjct: 31 VAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCL 86
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+++ F ++L + + A+ YL + LHRD+ N + +++ DFG
Sbjct: 87 LNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 122 LAKMLISDDLASS--VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
L++ ++ D+ SS + PE+L + SKSDIW+ G ++E+ S K ++ F
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
I + + P + S ++ S + + RP+ LL +
Sbjct: 206 TNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 5e-49
Identities = 45/229 (19%), Positives = 91/229 (39%), Gaps = 9/229 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ + +E +++ ++ NP+IV + + +++ GG +
Sbjct: 39 VAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPL 95
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ + P + + L Q+ M + YL + +HRD+ N+ L ++ DFG
Sbjct: 96 HKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154
Query: 122 LAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFK 176
L+K L +DD S+ + PE + + S+SD+WS G ++E S + +K
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
++ I + P L+ E RP +
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 47/235 (20%), Positives = 102/235 (43%), Gaps = 10/235 (4%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ + A QE +++ ++R+ +V+ E+ Y I+ Y G +
Sbjct: 44 VAIKTLKPGTMSPEAFL---QEAQVMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSL 98
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +K G + +L Q+ + Y+ + +HRD++ +NI + + ++ DFG
Sbjct: 99 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158
Query: 122 LAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
LA+++ ++ + PE + KSD+WS G + E+ + + +
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
+ +++++ + P P + L+ RK PE RP+ L L+ Y
Sbjct: 219 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL--QAFLEDY 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-48
Identities = 43/227 (18%), Positives = 96/227 (42%), Gaps = 8/227 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ Q + + E L+ ++++ +V ++ Y II Y E G +
Sbjct: 40 VAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIY--IITEYMENGSL 94
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +K +G+ KL Q+ + ++ + +HRD++ +NI ++ ++ DFG
Sbjct: 95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 122 LAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
LA+++ ++ + PE + + KSD+WS G + E+ + + +
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+I + + P L++ ++ PE RP+ L
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 56/244 (22%), Positives = 115/244 (47%), Gaps = 14/244 (5%)
Query: 1 MYVLKKIRLAR----QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 56
Y K I+ R + +R +E+ ++ +++P ++ + + K V +I+
Sbjct: 37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-DVILILELV 95
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD-- 114
GG++ + + + EE+ ++L Q+L + YLH+ I H D+K NI L
Sbjct: 96 AGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153
Query: 115 --IRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQK 172
I++ DFGLA + + ++ GTP ++ PE++ P G ++D+WS+G Y + +
Sbjct: 154 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
Query: 173 AAFKAFDMQALINKINK---SIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229
+ F Q + ++ + S + ++ +L K+P+ R + + L HP
Sbjct: 214 SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 230 LQPY 233
++P
Sbjct: 274 IKPK 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-47
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 8/235 (3%)
Query: 1 MYVLKKIR--LARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+ +K ++ + D + ++ L +PF+ ++ K + ++ Y G
Sbjct: 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFFVMEYLNG 87
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
GD+ I+ + F + + ++++ L +LH+ I++RD+K NI L +D I++
Sbjct: 88 GDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIA 145
Query: 119 DFGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKA 177
DFG+ K + D ++ GTP Y+ PE+L Y D WS G +YEM ++ F
Sbjct: 146 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
Query: 178 FDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA-ELLCHPHLQ 231
D + L + I P + L+ + + PE R ++ HP +
Sbjct: 206 QDEEELFHSIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-47
Identities = 50/229 (21%), Positives = 104/229 (45%), Gaps = 8/229 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K IR ++ +E E++ ++ +P +V+ +E+ +C++ + E G +
Sbjct: 32 VAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEFMEHGCL 87
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
++ + F E L + + + YL ++HRD+ N + +Q I++ DFG
Sbjct: 88 SD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 122 LAKMLISDDLASS--VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
+ + ++ D SS + PE+ + Y SKSD+WS G ++E+ S K ++
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
++ I+ P + S ++ ++ PE RP+ + LL
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 2e-46
Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 13/238 (5%)
Query: 2 YVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEK---GCYVCIIIGYCE 57
+K +R D +E + + + +P IV D+ + G I++ Y +
Sbjct: 35 VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 94
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
G + + + ++ + + ALN+ H N I+HRDVK +NI ++ +++
Sbjct: 95 GVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 152
Query: 118 GDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
DFG+A+ + ++V+GT Y+ PE ++SD++SLGC +YE+ +
Sbjct: 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
Query: 174 AFKAFDMQALINKINKSIVAPLPTV---YSGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
F ++ + + P S +V L KNPE R A +
Sbjct: 213 PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 49/254 (19%), Positives = 98/254 (38%), Gaps = 28/254 (11%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGG 59
+ V K+ + R + E+++++++ + IV + G + +I YC G
Sbjct: 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYG 126
Query: 60 DMAEAIKKANGVH---------------------FPEEKLCKWLVQLLMALNYLHANHIL 98
D+ ++ E L + Q+ + +L +
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 186
Query: 99 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSK 155
HRD+ N+ +T + +++ DFGLA+ ++SD + + +M PE L + Y K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 156 SDIWSLGCCVYEM-SAQKAAFKAFDMQALINKI-NKSIVAPLPTVYSGAFRGLVKSMLRK 213
SD+WS G ++E+ S + + A K+ P + +++S
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 214 NPEFRPSAAELLCH 227
+ RPS L
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 65/264 (24%), Positives = 107/264 (40%), Gaps = 34/264 (12%)
Query: 1 MYVLKKIRLARQTDRARRSAHQE---MELISRVRNPFIVEYKDSWV----EKGCYVCIII 53
LK++R+ + S +E + + +P +V D ++ + ++
Sbjct: 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
+ + + + K P E + + QLL L++LH++ ++HRD+K NI +T
Sbjct: 95 EHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKA 173
I+L DFGLA++ +SVV T Y PE+L Y + D+WS+GC EM +K
Sbjct: 154 QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
Query: 174 AFKAFDMQALINKINKSIVAP--------------------------LPTVYSGAFRGLV 207
F+ + KI I P T + L+
Sbjct: 214 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273
Query: 208 KSMLRKNPEFRPSAAELLCHPHLQ 231
L NP R SA L HP+ Q
Sbjct: 274 LKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 3e-45
Identities = 58/237 (24%), Positives = 111/237 (46%), Gaps = 12/237 (5%)
Query: 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
Y +K ++ + + E ++S V +PFI+ ++ + +I+ Y EGG
Sbjct: 31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI-FMIMDYIEGG 89
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ ++ FP + ++ +AL YLH+ I++RD+K NI L ++ I++ D
Sbjct: 90 ELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 147
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG AK + D+ ++ GTP Y+ PE+++ PY D WS G +YEM A F +
Sbjct: 148 FGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHPHLQ 231
KI + + P ++ + L+ ++ ++ R ++ HP +
Sbjct: 206 TMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (409), Expect = 3e-45
Identities = 65/320 (20%), Positives = 133/320 (41%), Gaps = 23/320 (7%)
Query: 1 MYVLKKIRLAR----QTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYC 56
MY +K + R Q + + + L+S PFIV ++ + I+
Sbjct: 31 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLM 89
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
GGD+ + + F E + + ++++ L ++H +++RD+K +NI L +R
Sbjct: 90 NGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 147
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAF 175
+ D GLA S + VGT YM PE+L + Y S +D +SLGC ++++ + F
Sbjct: 148 ISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206
Query: 176 KAFDM--QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHP 228
+ + I+++ ++ LP +S R L++ +L+++ R A E+ P
Sbjct: 207 RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266
Query: 229 HLQPYVL-GIHLKLNGP------RRNTFPLEWSDSNFKKTRFMEPEAISIHSNREKRQSF 281
+ + L+ P + +F + + + +
Sbjct: 267 FFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL 326
Query: 282 SNDRALNPSVSETEQDSLSS 301
+ V+ET D++++
Sbjct: 327 TISERWQQEVAETVFDTINA 346
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-45
Identities = 44/231 (19%), Positives = 92/231 (39%), Gaps = 10/231 (4%)
Query: 2 YVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K ++ + A +E+ + + + ++ + ++ G
Sbjct: 39 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGS 96
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + ++K G HF L ++ VQ+ + YL + +HRD+ N+ L +++GDF
Sbjct: 97 LLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155
Query: 121 GLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAF 175
GL + L +D + ++ PE L + SD W G ++EM + + +
Sbjct: 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215
Query: 176 KAFDMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ +++KI+K P P ++ PE RP+ L
Sbjct: 216 IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-44
Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 11/235 (4%)
Query: 1 MYVLKKIRLARQTDR-ARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
Y +K +R + E ++ R+PF+ K ++ +C ++ Y GG
Sbjct: 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANGG 90
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
++ + + F EE+ + +++ AL YLH+ +++RD+K N+ L +D I++ D
Sbjct: 91 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 148
Query: 120 FGLAKMLISDD-LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
FGL K ISD + GTP Y+ PE+L D YG D W LG +YEM + F
Sbjct: 149 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHP 228
D + L I + P S + L+ +L+K+P+ R A E++ H
Sbjct: 209 DHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 7/229 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K + +D R QE + + +P IV+ E V II+ C G++
Sbjct: 38 VAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGEL 94
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
++ L + QL AL YL + +HRD+ N+ ++ + ++LGDFG
Sbjct: 95 RSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153
Query: 122 LAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
L++ + AS +M PE + + S SD+W G C++E+ F+
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+I +I P+P L+ +P RP EL
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 2e-44
Identities = 43/227 (18%), Positives = 96/227 (42%), Gaps = 7/227 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ +E ++ +++P +V+ + + II + G++
Sbjct: 45 VAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL 100
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +++ N L Q+ A+ YL + +HRD+ N + + +++ DFG
Sbjct: 101 LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 122 LAKMLISDDLASS--VVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFKAF 178
L++++ D + + PE LA + KSD+W+ G ++E+ + + +
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 179 DMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
D+ + + K P L+++ + NP RPS AE+
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 3e-44
Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 10/232 (4%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K ++ T++ RR E ++ + +P ++ + + V II + E G
Sbjct: 56 FVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PVMIITEFMENGS 113
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ +++ +G F +L L + + YL + +HRD+ NI + + ++ DF
Sbjct: 114 LDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF 172
Query: 121 GLAKMLISDDLASSV------VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKA 173
GL++ L D + + PE + + S SD+WS G ++E+ S +
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
Query: 174 AFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ Q +IN I + P P A L+ +K+ RP +++
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-44
Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ LKKIRL +T+ +A +E+ L+ + +P IV+ D + ++ D
Sbjct: 29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQD 86
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
+ + + + P + +L QLL L + H++ +LHRD+K N+ + + I+L DF
Sbjct: 87 LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 121 GLAKMLISDD-LASSVVGTPSYMCPELLADIPY-GSKSDIWSLGCCVYEMSAQKAAFKAF 178
GLA+ + V T Y PE+L Y + DIWSLGC EM ++A F
Sbjct: 147 GLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206
Query: 179 DMQALINKINKSIVAPLPTVYSG----------------------------AFRGLVKSM 210
+ +I +++ P V+ G R L+ M
Sbjct: 207 SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 211 LRKNPEFRPSAAELLCHPHLQPYVLGI-HLKL 241
L +P R SA L HP Q + HL+L
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDVTKPVPHLRL 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-44
Identities = 47/240 (19%), Positives = 97/240 (40%), Gaps = 18/240 (7%)
Query: 4 LKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMA 62
+K+++ D R E+E++ ++ + P I+ + +G Y+ + I Y G++
Sbjct: 42 IKRMKEYASKD-DHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLL 99
Query: 63 EAIKK--------------ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIF 108
+ ++K + ++L + + ++YL +HRD+ NI
Sbjct: 100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159
Query: 109 LTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM 168
+ + ++ DFGL++ + +M E L Y + SD+WS G ++E+
Sbjct: 160 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 169 -SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
S + L K+ + P L++ R+ P RPS A++L
Sbjct: 220 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 5e-44
Identities = 45/251 (17%), Positives = 90/251 (35%), Gaps = 28/251 (11%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
M +K ++ D + +E L++ NP IV+ +C++ Y GD
Sbjct: 45 MVAVKMLKEEASADM-QADFQREAALMAEFDNPNIVKLLGVCAVGK-PMCLLFEYMAYGD 102
Query: 61 MAEAIKK----------------------ANGVHFPEEKLCKWLVQLLMALNYLHANHIL 98
+ E ++ + Q+ + YL +
Sbjct: 103 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162
Query: 99 HRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSK 155
HRD+ N + + +++ DFGL++ + S D + +M PE + Y ++
Sbjct: 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222
Query: 156 SDIWSLGCCVYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214
SD+W+ G ++E+ S + + +I + + P L++ K
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 282
Query: 215 PEFRPSAAELL 225
P RPS +
Sbjct: 283 PADRPSFCSIH 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-43
Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 18/243 (7%)
Query: 1 MYVLKKIRLARQTDRA----RRSAHQEMELISRVRN--PFIVEYKDSWVEKGCYVCIIIG 54
+K + R +D E+ L+ +V + ++ D + + +I+
Sbjct: 31 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF-VLILE 89
Query: 55 YCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ- 113
E G EE + Q+L A+ + H +LHRD+K NI + ++
Sbjct: 90 RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 148
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKS-DIWSLGCCVYEMSAQK 172
+++L DFG L+ D + + GT Y PE + Y +S +WSLG +Y+M
Sbjct: 149 ELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
Query: 173 AAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232
F+ +I + V S + L++ L P RP+ E+ HP +Q
Sbjct: 208 IPFEHD------EEIIRGQV-FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
Query: 233 YVL 235
+L
Sbjct: 261 VLL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-43
Identities = 37/232 (15%), Positives = 85/232 (36%), Gaps = 8/232 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K + + E ++ +P ++ + +++ Y + GD+
Sbjct: 58 CAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ + + L + +Q+ + +L + +HRD+ N L +++ DFG
Sbjct: 117 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 122 LAKMLISDDLAS-----SVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAF 175
LA+ + + S +M E L + +KSD+WS G ++E+ + +
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 176 KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227
+ + + + P ++ E RPS +EL+
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-43
Identities = 61/263 (23%), Positives = 111/263 (42%), Gaps = 35/263 (13%)
Query: 1 MYVLKKIRLARQT---DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCE 57
+ +KKI+L ++ D R+A +E++L+ + +P I+ D++ K + ++ + E
Sbjct: 25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVFDFME 83
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
E I K N + + +++ L L YLH + ILHRD+K +N+ L + ++L
Sbjct: 84 T--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 141
Query: 118 GDFGLAKMLISD-DLASSVVGTPSYMCPELLADI-PYGSKSDIWSLGCCVYEMSAQKAAF 175
DFGLAK S + V T Y PELL YG D+W++GC + E+ +
Sbjct: 142 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 201
Query: 176 KAFDMQALINKINKSIVAPLPTVY---------------------------SGAFRGLVK 208
+ +I +++ P + L++
Sbjct: 202 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261
Query: 209 SMLRKNPEFRPSAAELLCHPHLQ 231
+ NP R +A + L +
Sbjct: 262 GLFLFNPCARITATQALKMKYFS 284
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-43
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 46/284 (16%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-------CYVCIII 53
LKK+ + + + +A +E++++ +++ +V + K + ++
Sbjct: 37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96
Query: 54 GYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ 113
+CE V F ++ + + LL L Y+H N ILHRD+K +N+ +TRD
Sbjct: 97 DFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154
Query: 114 DIRLGDFGLAKMLISDDLA-----SSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYE 167
++L DFGLA+ + ++ V T Y PELL + YG D+W GC + E
Sbjct: 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214
Query: 168 MSAQKAAFKAFDMQALINKINKSIVAPLPTVY---------------------------- 199
M + + Q + I++ + P V+
Sbjct: 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274
Query: 200 ---SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLK 240
L+ +L +P R + + L H + LK
Sbjct: 275 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 318
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 1e-42
Identities = 54/261 (20%), Positives = 103/261 (39%), Gaps = 33/261 (12%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ LKKIRL ++ + + +E+ ++ +++ IV+ D K + ++ + +
Sbjct: 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQDL 86
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
G +L+QLL + Y H +LHRD+K N+ + R+ ++++ DF
Sbjct: 87 KKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 121 GLAKMLISDDLAS-SVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQKAAFKAF 178
GLA+ + T Y P++L Y + DIWS+GC EM F
Sbjct: 145 GLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
Query: 179 DMQALINKINKSIVAPLPTVY----------------------------SGAFRGLVKSM 210
+ +I + + P + + L+ M
Sbjct: 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264
Query: 211 LRKNPEFRPSAAELLCHPHLQ 231
L+ +P R +A + L H + +
Sbjct: 265 LKLDPNQRITAKQALEHAYFK 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 52/269 (19%), Positives = 97/269 (36%), Gaps = 42/269 (15%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGY 55
+ +KK+ + +R ++E++++ ++ + IV + + G Y+ +++ Y
Sbjct: 47 LVAIKKVL------QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 56 CEGGDMAEAIKKAN-GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-Q 113
A + P + ++ QL +L Y+H+ I HRD+K N+ L D
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 160
Query: 114 DIRLGDFGLAKMLISDDLASSVVGTPSYMCP-ELLADIPYGSKSDIWSLGCCVYEMSAQK 172
++L DFG AK L+ + S + + Y P + Y S D+WS GC + E+ +
Sbjct: 161 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
Query: 173 AAFKAFDMQALINKINKSIVAPLPTVY----------------------------SGAFR 204
F + +I K + P
Sbjct: 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280
Query: 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L +L P R + E H
Sbjct: 281 ALCSRLLEYTPTARLTPLEACAHSFFDEL 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 1e-41
Identities = 50/234 (21%), Positives = 100/234 (42%), Gaps = 12/234 (5%)
Query: 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
Y +K + + + E ++ V PF+V+ + S+ + ++ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ + F E + Q+++ YLH+ +++RD+K N+ + + I++ D
Sbjct: 128 MFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD 179
FG AK + ++ GTP + PE++ Y D W+LG +YEM+A F A
Sbjct: 185 FGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
Query: 180 MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR-----PSAAELLCHP 228
+ KI V P+ +S + L++++L+ + R ++ H
Sbjct: 243 PIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-41
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 42/271 (15%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCY---VCIIIGYCE 57
+KKI +R +E++++ R R+ I+ D ++ +
Sbjct: 35 RVAIKKISPFEHQTYCQR-TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRL 117
G D+ + +K H + +C +L Q+L L Y+H+ ++LHRD+K SN+ L D+++
Sbjct: 94 GADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 150
Query: 118 GDFGLAKMLISD----DLASSVVGTPSYMCPELLA-DIPYGSKSDIWSLGCCVYEMSAQK 172
DFGLA++ D + V T Y PE++ Y DIWS+GC + EM + +
Sbjct: 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
Query: 173 AAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGA 202
F +N I + +P L
Sbjct: 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 270
Query: 203 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233
L+ ML NP R + L HP+L+ Y
Sbjct: 271 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-41
Identities = 48/229 (20%), Positives = 99/229 (43%), Gaps = 8/229 (3%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ A T++ R E ++ + + I+ + + + II Y E G +
Sbjct: 39 VAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-PMMIITEYMENGAL 96
Query: 62 AEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFG 121
+ +++ +G F +L L + + YL + +HRD+ NI + + ++ DFG
Sbjct: 97 DKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155
Query: 122 LAKMLISDDLA----SSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM-SAQKAAFK 176
L+++L D A S + PE ++ + S SD+WS G ++E+ + + +
Sbjct: 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215
Query: 177 AFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
++ IN P P A L+ ++ RP A+++
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 60/245 (24%), Positives = 117/245 (47%), Gaps = 16/245 (6%)
Query: 1 MYVLKKIRLARQTDRARRSAH--QEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEG 58
+Y +K ++ A +A+ + H E +++ +R + + + +I+ Y G
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLG 118
G++ + + F E ++ ++ ++++AL +LH I++RD+K NI L + + L
Sbjct: 114 GELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171
Query: 119 DFGLAKMLISDDL--ASSVVGTPSYMCPELL--ADIPYGSKSDIWSLGCCVYEMSAQKAA 174
DFGL+K ++D+ A GT YM P+++ D + D WSLG +YE+ +
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
Query: 175 FKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLC 226
F + +I++ I+ P P S + L++ +L K+P+ R A E+
Sbjct: 232 FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 227 HPHLQ 231
H Q
Sbjct: 292 HLFFQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 43/242 (17%), Positives = 94/242 (38%), Gaps = 19/242 (7%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDM 61
+K ++ T++ EME++ + + + + +I+ Y G++
Sbjct: 48 VAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 62 AEAIK--------------KANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNI 107
E ++ + L Q+ + YL + +HRD+ N+
Sbjct: 107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166
Query: 108 FLTRDQDIRLGDFGLAKMLISDDLASS---VVGTPSYMCPELLADIPYGSKSDIWSLGCC 164
+T D +++ DFGLA+ + D +M PE L D Y +SD+WS G
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 165 VYEM-SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223
++E+ + + + ++ L + + P+ + +++ P RP+ +
Sbjct: 227 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286
Query: 224 LL 225
L+
Sbjct: 287 LV 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 4e-40
Identities = 34/243 (13%), Positives = 75/243 (30%), Gaps = 24/243 (9%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K + + + E ++ ++ + +G Y +++
Sbjct: 34 EVAIKLECVKTKHPQLHI----ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL 89
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQD---IRL 117
+ F + + Q++ + Y+H+ + +HRDVK N + + + +
Sbjct: 90 EDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 147
Query: 118 GDFGLAKMLISDDL--------ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMS 169
DFGLAK ++ GT Y I + D+ SLG + +
Sbjct: 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207
Query: 170 AQKAAFKAFDMQALINKINKSIVAPLPTV-------YSGAFRGLVKSMLRKNPEFRPSAA 222
++ K + + T Y F + + +P +
Sbjct: 208 LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267
Query: 223 ELL 225
L
Sbjct: 268 YLR 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-40
Identities = 44/246 (17%), Positives = 93/246 (37%), Gaps = 19/246 (7%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K ++ R + LI + +V + + G + +I+ +C+ G+
Sbjct: 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 61 MAEAIKKANGV--------------HFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSN 106
++ ++ E L + Q+ + +L + +HRD+ N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164
Query: 107 IFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSLGC 163
I L+ +++ DFGLA+ + D +M PE + D Y +SD+WS G
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 164 CVYEM-SAQKAAFKAFD-MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221
++E+ S + + + ++ + P + + P RP+
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 222 AELLCH 227
+EL+ H
Sbjct: 285 SELVEH 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 62/297 (20%), Positives = 113/297 (38%), Gaps = 51/297 (17%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----YVCIIIGYC 56
+KK+ Q + A++E+ L+ V + I+ + + + V +++
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
+ E++ L Q+L + +LH+ I+HRD+K SNI + D ++
Sbjct: 105 DANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFK 176
+ DFGLA+ + + + V T Y PE++ + Y DIWS+GC + EM K F
Sbjct: 160 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 177 AFDMQALINKINKSIVAPLPTVY------------------------------------- 199
D NK+ + + P P
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 200 ----SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLE 252
+ R L+ ML +P R S + L HP++ + ++ P+ L+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLD 336
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-39
Identities = 61/265 (23%), Positives = 110/265 (41%), Gaps = 34/265 (12%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+ LK++RL + SA +E+ L+ +++ IV D + +
Sbjct: 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDF 120
E + +L QLL L + H+ ++LHRD+K N+ + R+ +++L +F
Sbjct: 89 KYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANF 145
Query: 121 GLAKML-ISDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEM-SAQKAAFKA 177
GLA+ I S+ V T Y P++L Y + D+WS GC E+ +A + F
Sbjct: 146 GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205
Query: 178 FDMQALINKINKSIVAPLPTVY----------------------------SGAFRGLVKS 209
D+ + +I + + P + + R L+++
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 210 MLRKNPEFRPSAAELLCHPHLQPYV 234
+L+ NP R SA E L HP+ +
Sbjct: 266 LLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-39
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 46/301 (15%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC-----YVCIIIGY 55
+KK+ Q++ + A++E+ L+ +R+ ++ D + +++ +
Sbjct: 45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104
Query: 56 CEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDI 115
G D+ + +K E+++ + Q+L L Y+HA I+HRD+K N+ + D ++
Sbjct: 105 M-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 160
Query: 116 RLGDFGLAKMLISDDLASSVVGTPSYMCPE-LLADIPYGSKSDIWSLGCCVYEMSAQKAA 174
++ DFGLA+ D + V T Y PE +L + Y DIWS+GC + EM K
Sbjct: 161 KILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
Query: 175 FKAFDMQALINKINKSIVAP------------------------------LPTVYSGAFR 204
FK D + +I K P + T S
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278
Query: 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFM 264
L++ ML + E R +A E L HP+ + +H + P+ + + D + +
Sbjct: 279 NLLEKMLVLDAEQRVTAGEALAHPYFES----LHDTEDEPQVQKYDDSFDDVDRTLDEWK 334
Query: 265 E 265
Sbjct: 335 R 335
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 46/246 (18%), Positives = 100/246 (40%), Gaps = 24/246 (9%)
Query: 2 YVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K ++ + R + E++++S + N IV + G +I YC GD
Sbjct: 56 VAVKMLKPSAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGG-PTLVITEYCCYGD 113
Query: 61 MAEAIKK----------------ANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKC 104
+ +++ + + E L + Q+ + +L + + +HRD+
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173
Query: 105 SNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDIWSL 161
NI LT + ++ DFGLA+ + +D + + +M PE + + Y +SD+WS
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 162 GCCVYEMSAQKAAFKAFD--MQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP 219
G ++E+ + ++ I + P ++K+ +P RP
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 220 SAAELL 225
+ +++
Sbjct: 294 TFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 45/237 (18%), Positives = 96/237 (40%), Gaps = 14/237 (5%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K + A + R R E ++ +V V +G +I+ GD
Sbjct: 52 RVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGD 109
Query: 61 MAEAIKKANGVH--------FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD 112
+ ++ K+ + ++ + YL+AN +HRD+ N + D
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169
Query: 113 QDIRLGDFGLAKMLISDDL---ASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYEM- 168
+++GDFG+ + + D + +M PE L D + + SD+WS G ++E+
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 169 SAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225
+ + ++ + ++ + + + P L++ + NP+ RPS E++
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 138 bits (349), Expect = 3e-37
Identities = 53/269 (19%), Positives = 105/269 (39%), Gaps = 51/269 (18%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGC-YVCIIIGYCEG 58
V+K ++ + ++ +E++++ +R P I+ D + ++ +
Sbjct: 62 KVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116
Query: 59 GDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRL 117
D + + + + ++ ++L AL+Y H+ I+HRDVK N+ + + +RL
Sbjct: 117 TDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171
Query: 118 GDFGLAKMLISDDLASSVVGTPSYMCPELLADIP-YGSKSDIWSLGCCVYEMSAQKAAFK 176
D+GLA+ + V + + PELL D Y D+WSLGC + M +K F
Sbjct: 172 IDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 177 A----FDMQALINKI---------------------------------NKSIVAPLPTVY 199
+D I K+ + + + +
Sbjct: 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291
Query: 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHP 228
S + +LR + + R +A E + HP
Sbjct: 292 SPEALDFLDKLLRYDHQSRLTAREAMEHP 320
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (340), Expect = 2e-36
Identities = 34/244 (13%), Positives = 68/244 (27%), Gaps = 26/244 (10%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGD 60
+K + R E + + + ++G + ++I G
Sbjct: 32 QVAIKFEPRRSDAPQLRD----EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GP 85
Query: 61 MAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR-----DQDI 115
E + G F + + Q+L + +H +++RD+K N + R I
Sbjct: 86 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 145
Query: 116 RLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVYE 167
+ DFG+ K ++ GT YM + D+ +LG
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 205
Query: 168 MSAQKAAFKAFDMQALINKINKSIVAPLPTV-------YSGAFRGLVKSMLRKNPEFRPS 220
++ K + T + F + + P
Sbjct: 206 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265
Query: 221 AAEL 224
L
Sbjct: 266 YDYL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-36
Identities = 43/268 (16%), Positives = 93/268 (34%), Gaps = 49/268 (18%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGC---YVCIIIGYCE 57
+K + R E+ +R+ I+ + + + + ++ Y E
Sbjct: 28 EVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 58 GGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHA--------NHILHRDVKCSNIFL 109
G + + + + E + K + L +LH I HRD+K NI +
Sbjct: 85 HGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141
Query: 110 TRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLAD------IPYGSKSDI 158
++ + D GLA S + VGT YM PE+L D ++DI
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 159 WSLGCCVYEMSAQKAAFKAFD---------------MQALINKINKSIVAP-LPTVYSG- 201
+++G +E++ + + + ++ + + + + P +P +
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 202 ----AFRGLVKSMLRKNPEFRPSAAELL 225
+++ N R +A +
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 57/300 (19%), Positives = 119/300 (39%), Gaps = 44/300 (14%)
Query: 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYV----CIIIGYC 56
+KK+ Q+ + ++E+ L+ +++ ++ D + ++ +
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 57 EGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIR 116
G D+ +K ++ + + Q+L L Y+H+ I+HRD+K SN+ + D +++
Sbjct: 105 MGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 161
Query: 117 LGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPYGSKSDIWSLGCCVYEMSAQKAAF 175
+ DFGLA+ DD + V T Y PE++ + + Y DIWS+GC + E+ + F
Sbjct: 162 ILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 176 KAFDMQALINKINKSIVAPLPTVY------------------------------SGAFRG 205
D + I + + P + +
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 206 LVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHLKLNGPRRNTFPLEWSDSNFKKTRFME 265
L++ ML + + R +AA+ L H + Y H + P + + + + +
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYFAQY----HDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 2e-25
Identities = 55/292 (18%), Positives = 101/292 (34%), Gaps = 62/292 (21%)
Query: 2 YVLKKIRLARQTDRA--------RRSAHQEMELISRVRNPFIVEYKDSWVE--KGCYVCI 51
+K +R + A +R + + I++ D + +
Sbjct: 41 VAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV 100
Query: 52 IIGYCEGGDMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANH-ILHRDVKCSNIFLT 110
++ G ++ IKK P + + QLL+ L+Y+H I+H D+K N+ +
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160
Query: 111 RD----QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWSLGCCVY 166
I++ L D+ ++ + T Y PE+L P+G +DIWS C ++
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220
Query: 167 EMSAQKAAFKA-------------------------------------FDMQALINKINK 189
E+ F+ F+ + L+ I+K
Sbjct: 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 280
Query: 190 SIVAPLPTV----------YSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231
PL V + + ML+ +P R A L+ HP L+
Sbjct: 281 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.3 bits (179), Expect = 1e-15
Identities = 25/178 (14%), Positives = 59/178 (33%), Gaps = 25/178 (14%)
Query: 2 YVLKKIRLARQTDRARRSA--HQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGG 59
V+K ++ + + + + ++ E++ +G V + +
Sbjct: 27 CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNA 86
Query: 60 DMAEAIKKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGD 119
+ E I E + L +L + + I+H D+ N+ ++ ++ I + D
Sbjct: 87 VLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 145
Query: 120 FGLAKMLISDDLASSVVGTPSYMCPELLA-DI---------PYGSKSDIWSLGCCVYE 167
F + V E+L D+ Y ++ DI S + +
Sbjct: 146 FPQS------------VEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 582 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.24 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=417.01 Aligned_cols=230 Identities=37% Similarity=0.666 Sum_probs=198.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHh--CCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKA--NGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~--~~~~lse~~ 77 (582)
.||||+++....++...+.+.+|+++|++++|||||+++++|.+. +..+|||||||+||+|.+++.+. .+..+++..
T Consensus 31 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~ 110 (269)
T d2java1 31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 110 (269)
T ss_dssp EEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHH
T ss_pred EEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHH
Confidence 489999998888888888999999999999999999999998753 45789999999999999999753 234799999
Q ss_pred HHHHHHHHHHHHHHHHHCC-----ceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC
Q 007991 78 LCKWLVQLLMALNYLHANH-----ILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP 151 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~g-----IiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~ 151 (582)
++.|+.||+.||+|||++| |+||||||+||||+.++.+||+|||+++...... .....+||+.|||||++.+..
T Consensus 111 ~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 190 (269)
T d2java1 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 190 (269)
T ss_dssp HHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCC
Confidence 9999999999999999976 9999999999999999999999999998875443 456789999999999999999
Q ss_pred CCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCC
Q 007991 152 YGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHL 230 (582)
Q Consensus 152 y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f 230 (582)
|+.++|||||||++|||++|.+||.+.+..++..++......+++..+|+++.+||.+||+.||.+|||++|||+|||+
T Consensus 191 ~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999999999998887777888999999999999999999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=415.83 Aligned_cols=227 Identities=27% Similarity=0.489 Sum_probs=203.8
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++......+ ...+.+.+|+++|++++|||||+++++|.++ ..+|||||||+||+|.+++.+.+ .+++..++
T Consensus 33 ~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~ 109 (263)
T d2j4za1 33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQKLS--KFDEQRTA 109 (263)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHHhhcC--CCCHHHHH
Confidence 38999997644322 3456789999999999999999999988754 58999999999999999998765 69999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... .....+||+.|||||++.+..|+.++|||
T Consensus 110 ~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~Diw 188 (263)
T d2j4za1 110 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188 (263)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHH
T ss_pred HHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhh
Confidence 99999999999999999999999999999999999999999999866543 34567899999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||++|+|++|++||.+.+..+++..+.... ..+|..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 189 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 189 SLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred hHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999888886654 3467889999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=415.34 Aligned_cols=225 Identities=29% Similarity=0.508 Sum_probs=200.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++...... .+.+.+|+++|++++|||||+++++|... .++|||||||+||+|.+++.+. .+++..++.
T Consensus 47 ~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~ 120 (293)
T d1yhwa1 47 EVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET---CMDEGQIAA 120 (293)
T ss_dssp EEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHH
T ss_pred EEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEEC-CEEEEEEEecCCCcHHHHhhcc---CCCHHHHHH
Confidence 38999998755433 46789999999999999999999988765 4899999999999999988763 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.+... ......+||+.|+|||++.+..|+.++|||
T Consensus 121 i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 200 (293)
T d1yhwa1 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200 (293)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhcee
Confidence 9999999999999999999999999999999999999999999876543 345677899999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccC--CCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIV--APLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~--~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
||||++|+|++|.+||.+.+.......+..... ...+..+++++++||.+||+.||++|||++|+|+||||+
T Consensus 201 SlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred hHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 999999999999999999887777666654432 334677999999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=419.53 Aligned_cols=232 Identities=28% Similarity=0.508 Sum_probs=208.0
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++..... ....+.+.+|+.+|++++|||||+++++|.+. .++|+|||||+||+|.+++.+.+ .++|..++
T Consensus 32 ~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~ 108 (337)
T d1o6la_ 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRER--VFTEERAR 108 (337)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHH
T ss_pred EEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccceeccCCCchhhhhhccc--CCcHHHHH
Confidence 4899999764322 22356788999999999999999999988765 58999999999999999999865 78999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc-ccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS-DDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~-~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.... .......+||+.|+|||++.+..|+.++||
T Consensus 109 ~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~Di 188 (337)
T d1o6la_ 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188 (337)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHH
T ss_pred HHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcc
Confidence 9999999999999999999999999999999999999999999987644 445667899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp~f~~~ 233 (582)
|||||++|||++|.+||.+.+..++...+.... ..+|..+|+++++||.+||++||.+|++ ++||++||||+..
T Consensus 189 wSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999999999999999988887765 3578889999999999999999999994 9999999999875
Q ss_pred hhh
Q 007991 234 VLG 236 (582)
Q Consensus 234 ~~~ 236 (582)
.+.
T Consensus 268 ~~~ 270 (337)
T d1o6la_ 268 NWQ 270 (337)
T ss_dssp CHH
T ss_pred CHH
Confidence 443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=416.16 Aligned_cols=232 Identities=29% Similarity=0.491 Sum_probs=202.3
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++..... +...+.+.+|+++|++|+|||||+++++|.++ ..+|+|||||+||+|.+++...+ .+++..++
T Consensus 35 ~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~ 111 (288)
T d1uu3a_ 35 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIG--SFDETCTR 111 (288)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHH
T ss_pred EEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEEEEccCCCCHHHhhhccC--CCCHHHHH
Confidence 3899999764322 23456789999999999999999999988654 58999999999999999998865 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+... ....+.+||+.|||||++.+..|+.++
T Consensus 112 ~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~ 191 (288)
T d1uu3a_ 112 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191 (288)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHH
T ss_pred HHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCccc
Confidence 99999999999999999999999999999999999999999999876433 234567899999999999999999999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHH------HHcCCCC
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAE------LLCHPHL 230 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E------iL~hp~f 230 (582)
|||||||++|+|++|.+||.+.+..+++.+|.... ..+|..+++++++||.+||+.||.+|||++| +++||||
T Consensus 192 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff 270 (288)
T d1uu3a_ 192 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270 (288)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred ceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCcc
Confidence 99999999999999999999999999888887654 3467889999999999999999999999987 6889999
Q ss_pred chhhhh
Q 007991 231 QPYVLG 236 (582)
Q Consensus 231 ~~~~~~ 236 (582)
+.+.|+
T Consensus 271 ~~i~w~ 276 (288)
T d1uu3a_ 271 ESVTWE 276 (288)
T ss_dssp TTCCCT
T ss_pred CCCCHH
Confidence 876544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=405.09 Aligned_cols=226 Identities=25% Similarity=0.540 Sum_probs=198.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
||||++.........++.+.+|+++|++|+|||||+++++|.. .+..+|+|||||+||+|.+++.+.. .+++..+
T Consensus 37 va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~ 114 (270)
T d1t4ha_ 37 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVL 114 (270)
T ss_dssp EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHH
Confidence 7999998887788888899999999999999999999999864 2467899999999999999998865 7999999
Q ss_pred HHHHHHHHHHHHHHHHCC--ceecccCcccEEEc-CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 79 CKWLVQLLMALNYLHANH--ILHRDVKCSNIFLT-RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~g--IiHRDIKP~NILL~-~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
+.|+.||+.||+|||++| |+||||||+||||+ .++.+||+|||+++.... ....+.+||+.|||||++.+ .|+.+
T Consensus 115 ~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~ 192 (270)
T d1t4ha_ 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDES 192 (270)
T ss_dssp HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTH
T ss_pred HHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCC-CCCCc
Confidence 999999999999999999 99999999999997 478999999999976433 34557899999999999876 69999
Q ss_pred CcccchhHHHHhHhcCCcccccc-CHHHHHHHHhhccCC-CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAF-DMQALINKINKSIVA-PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~-~~~~l~~kI~~~~~~-~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+|||||||++|||++|..||.+. +...+...+...... .++..+++++++||.+||+.||++|||++|+|+||||+
T Consensus 193 ~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999764 455566666554332 34556889999999999999999999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=412.35 Aligned_cols=228 Identities=22% Similarity=0.369 Sum_probs=190.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.... ....+.+.+|+++|++|+|||||+++++|.++ ..+|||||||+||+|.+++++.. .+++..++.
T Consensus 32 ~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~ 107 (271)
T d1nvra_ 32 AVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQR 107 (271)
T ss_dssp EEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHH
T ss_pred EEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHH
Confidence 389999977543 23456789999999999999999999988765 58999999999999999997643 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccCCCC-CCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLADIPY-GSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~~~y-~~ks 156 (582)
|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+..... ......+||+.|||||++.+..| +.++
T Consensus 108 i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~ 187 (271)
T d1nvra_ 108 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187 (271)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHH
T ss_pred HHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCce
Confidence 9999999999999999999999999999999999999999999876433 23556899999999999988876 5789
Q ss_pred cccchhHHHHhHhcCCccccccCHHH-HHHHH-hhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQA-LINKI-NKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~-l~~kI-~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|||++|.+||....... ....+ ........+..+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 188 DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred eeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 99999999999999999997654332 22222 222233334678999999999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-50 Score=413.33 Aligned_cols=228 Identities=28% Similarity=0.489 Sum_probs=183.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||.+....... ....+.+|+.+|++|+|||||+++++|.. +..+|||||||+||+|.+++.+.+ .+++..++.
T Consensus 36 ~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~ 111 (307)
T d1a06a_ 36 LVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIMQLVSGGELFDRIVEKG--FYTERDASR 111 (307)
T ss_dssp EEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHH
T ss_pred EEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHH
Confidence 38999997655432 34578899999999999999999998765 458999999999999999998754 799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEc---CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLT---RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~---~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
|+.||+.||+|||++||+||||||+|||+. .++.+||+|||+++.........+.+||+.|||||++.+..|+.++|
T Consensus 112 ~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~D 191 (307)
T d1a06a_ 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191 (307)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHH
T ss_pred HHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHH
Confidence 999999999999999999999999999995 47889999999998877666677889999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
||||||++|+|++|.+||.+.+..++...+...... +.+..+|+++++||.+||++||++|||++|+|+||||+.
T Consensus 192 iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999988888888765432 344678999999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=410.53 Aligned_cols=228 Identities=31% Similarity=0.523 Sum_probs=199.4
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.... ...+.+.+|+++|++|+|||||+++++|... ..+|||||||+||+|.+++.+.. ..+++..++.
T Consensus 39 ~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~ 114 (288)
T d2jfla1 39 LAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLELE-RPLTESQIQV 114 (288)
T ss_dssp EEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHH
T ss_pred EEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHH
Confidence 389999976533 3456789999999999999999999988765 58999999999999999987653 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCccccc-----CCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLA-----DIPYGS 154 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~-----~~~y~~ 154 (582)
|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..... ....+.+||+.|||||++. +..|+.
T Consensus 115 i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~ 194 (288)
T d2jfla1 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194 (288)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTT
T ss_pred HHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCCh
Confidence 9999999999999999999999999999999999999999999765433 2345789999999999984 456899
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
++|||||||++|+|++|.+||.+.+..+++.++...... ..+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 195 k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 195 KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred hhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999998888887777665433 335678999999999999999999999999999999963
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=413.75 Aligned_cols=228 Identities=32% Similarity=0.538 Sum_probs=191.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++... .+...+.+.+|+.+|++|+|||||+++++|..+ ..+|||||||+||+|.+++.+.+ .+++..++.
T Consensus 33 ~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~ 108 (322)
T d1s9ja_ 33 VMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAG--RIPEQILGK 108 (322)
T ss_dssp EEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHH
T ss_pred EEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHH
Confidence 48999998654 344567899999999999999999999988765 58999999999999999998865 699999999
Q ss_pred HHHHHHHHHHHHHH-CCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 81 WLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 81 il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
++.||+.||+|||+ +||+||||||+||||+.+|++||+|||+|+..... ...+.+||++|||||++.+..|+.++|||
T Consensus 109 ~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiW 187 (322)
T d1s9ja_ 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIW 187 (322)
T ss_dssp HHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHH
T ss_pred HHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHH
Confidence 99999999999997 59999999999999999999999999999876543 35578999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHH------------------------------------------HHHHhhccCCCCC-
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQAL------------------------------------------INKINKSIVAPLP- 196 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l------------------------------------------~~kI~~~~~~~lp- 196 (582)
||||++|||++|+.||.+.+.... ...+.......++
T Consensus 188 SlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (322)
T d1s9ja_ 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267 (322)
T ss_dssp HHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCB
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcc
Confidence 999999999999999976542211 1111111111222
Q ss_pred ccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 197 TVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 197 ~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
..+|.++++||.+||+.||.+|||++|+|+||||+..
T Consensus 268 ~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 268 GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 2378999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=402.59 Aligned_cols=232 Identities=24% Similarity=0.441 Sum_probs=204.8
Q ss_pred CEEEEEecccccCH----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++...... ...+.+.+|+.+|++|+|||||+++++|.+. ..+|||||||+||+|.++|.+.+ .+++.
T Consensus 37 ~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~gg~L~~~i~~~~--~l~~~ 113 (293)
T d1jksa_ 37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELFDFLAEKE--SLTEE 113 (293)
T ss_dssp EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS--SCCHH
T ss_pred EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCccccchhcccc--ccchh
Confidence 38999997654322 2457899999999999999999999988654 58999999999999999998865 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC----CeEEeecccchhcccccccCcccCCCCCCCcccccCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ----DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g----~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y 152 (582)
.++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..........+.+||+.|+|||++.+..|
T Consensus 114 ~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~ 193 (293)
T d1jksa_ 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193 (293)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCC
Confidence 9999999999999999999999999999999999876 499999999988876666778899999999999999999
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCC
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPH 229 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~ 229 (582)
+.++|||||||++|||++|..||.+.+..+.+..+....... .+..+|..+++||.+||+.||.+|||++|+|+|||
T Consensus 194 ~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 999999999999999999999999999998888886654332 23468999999999999999999999999999999
Q ss_pred Cchhhh
Q 007991 230 LQPYVL 235 (582)
Q Consensus 230 f~~~~~ 235 (582)
|++..+
T Consensus 274 ~~~~~~ 279 (293)
T d1jksa_ 274 IKPKDT 279 (293)
T ss_dssp TCC---
T ss_pred cCCCCh
Confidence 986443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-49 Score=412.14 Aligned_cols=229 Identities=21% Similarity=0.401 Sum_probs=203.9
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||++.... ....+.+.+|+.+|++|+|||||+++++|.++ ..+|||||||+||+|.+++.+..+ .+++..++.
T Consensus 53 ~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~ 128 (350)
T d1koaa2 53 NFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVE 128 (350)
T ss_dssp EEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTCTTS-CBCHHHHHH
T ss_pred EEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCCHHHHHHhhcC-CCCHHHHHH
Confidence 38999997654 34567899999999999999999999988765 589999999999999999965433 699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcC--CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTR--DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~--~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+++.+.......+.+||+.|||||++.+..|+.++||
T Consensus 129 i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~Di 208 (350)
T d1koaa2 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 208 (350)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHH
T ss_pred HHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhh
Confidence 9999999999999999999999999999964 57899999999998877666778899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|||||++|+|++|..||.+.+..+++..+....... ....+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 209 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 209 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999998888887654332 234589999999999999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.4e-49 Score=413.53 Aligned_cols=228 Identities=21% Similarity=0.420 Sum_probs=204.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++... ....+.+.+|+.+|++|+|||||+++++|.+ +..+|||||||+||+|.+.+.+. +..+++..++.
T Consensus 56 ~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~ 131 (352)
T d1koba_ 56 VFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVIN 131 (352)
T ss_dssp EEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHH
T ss_pred EEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHH
Confidence 38999997654 3445788999999999999999999998865 45899999999999999988764 34699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEc--CCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLT--RDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~--~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.+.........+||+.|+|||++.+..|+.++||
T Consensus 132 i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 211 (352)
T d1koba_ 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 211 (352)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHH
T ss_pred HHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccch
Confidence 999999999999999999999999999998 568999999999998877777778899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|.+||.+.+..+++..+...... ..+..+|+++++||.+||++||.+|||++|+|+||||+.
T Consensus 212 wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 212 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999888888765432 234568999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-49 Score=406.45 Aligned_cols=230 Identities=26% Similarity=0.519 Sum_probs=205.7
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++...... ...+.+.+|+.+|++++|||||+++++|... ..+|+|||||+||+|.+++.... .+++..++
T Consensus 31 ~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~ 107 (316)
T d1fota_ 31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAK 107 (316)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHTS--SCCHHHHH
T ss_pred EEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeEeeecCCccccccccccc--cccccHHH
Confidence 38999997643322 2356789999999999999999999988754 58999999999999999998755 68999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.... ...+.+||+.|||||++.+..|+.++|||
T Consensus 108 ~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~~~~Diw 185 (316)
T d1fota_ 108 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWW 185 (316)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHH
T ss_pred HHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--ccccccCcccccCHHHHcCCCCCchhhcc
Confidence 9999999999999999999999999999999999999999999987644 34568999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~~ 234 (582)
||||++|+|++|..||.+.+..++..++..... .+|..++++++++|.+||++||.+|+ |+++||+||||+++.
T Consensus 186 SlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 186 SFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 999999999999999999999998888876543 46778999999999999999999996 999999999999865
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 265 ~~ 266 (316)
T d1fota_ 265 WE 266 (316)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-49 Score=405.29 Aligned_cols=226 Identities=27% Similarity=0.503 Sum_probs=198.8
Q ss_pred CEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||+++..... ....+.+.+|+++|++|+|||||+++++|... ..+|+|||||.||+|..++...+ .+++..++
T Consensus 42 ~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~ 118 (309)
T d1u5ra_ 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCLGSASDLLEVHKK--PLQEVEIA 118 (309)
T ss_dssp EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHHTS--CCCHHHHH
T ss_pred EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEEEecCCCchHHHHHhCC--CCCHHHHH
Confidence 3899999876544 45667899999999999999999999988765 58999999999999987776643 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC---CCCCCCC
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD---IPYGSKS 156 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~---~~y~~ks 156 (582)
.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ....+||+.|||||++.+ ..|+.++
T Consensus 119 ~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~ 195 (309)
T d1u5ra_ 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKV 195 (309)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHH
T ss_pred HHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchh
Confidence 9999999999999999999999999999999999999999999986543 346789999999999864 4589999
Q ss_pred cccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC-CCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP-LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~-lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||||++|||++|..||.+.+..+.+..+....... .+..+|+.+++||.+||+.||.+|||++|+|+||||..
T Consensus 196 DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 99999999999999999999988887777776554433 45568999999999999999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=409.17 Aligned_cols=230 Identities=23% Similarity=0.440 Sum_probs=204.9
Q ss_pred CEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTD-RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~-~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||++....... ...+.+.+|+++|+.++|||||+++++|... ..+|+|||||.||+|.+++.+.+ .+++..++
T Consensus 68 ~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~ 144 (350)
T d1rdqe_ 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLRRIG--RFSEPHAR 144 (350)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHC--CCCHHHHH
T ss_pred EEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-cccccccccccccchhhhHhhcC--CCCHHHHH
Confidence 38999997543222 3346789999999999999999999988654 58999999999999999998865 79999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.... ...+.+||+.|||||++.+..|+.++|||
T Consensus 145 ~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~Diw 222 (350)
T d1rdqe_ 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWW 222 (350)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHH
T ss_pred HHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCCCCCcccccc
Confidence 9999999999999999999999999999999999999999999987653 34568999999999999999999999999
Q ss_pred chhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHHcCCCCchhh
Q 007991 160 SLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELLCHPHLQPYV 234 (582)
Q Consensus 160 SLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL~hp~f~~~~ 234 (582)
||||++|+|++|.+||.+.+...++.++..... ..+..+++++.+||.+||++||.+|+ |+++||+||||+...
T Consensus 223 SlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred chhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 999999999999999999999988888876654 46778999999999999999999994 999999999998754
Q ss_pred hh
Q 007991 235 LG 236 (582)
Q Consensus 235 ~~ 236 (582)
+.
T Consensus 302 ~~ 303 (350)
T d1rdqe_ 302 WI 303 (350)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-48 Score=394.53 Aligned_cols=231 Identities=29% Similarity=0.491 Sum_probs=204.0
Q ss_pred CEEEEEecccccC-------HHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCC
Q 007991 1 MYVLKKIRLARQT-------DRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVH 72 (582)
Q Consensus 1 lyAIKki~~~~~~-------~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ 72 (582)
.||||+++..... ...++.+.+|+.+|++|+ |||||+++++|.+ +.++|||||||+||+|.++|+..+ .
T Consensus 30 ~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~ivmE~~~~g~L~~~l~~~~--~ 106 (277)
T d1phka_ 30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEKV--T 106 (277)
T ss_dssp EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEECCTTCBHHHHHHHHS--S
T ss_pred EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-CcceEEEEEcCCCchHHHHHHhcC--C
Confidence 4899999775432 234567899999999997 9999999998865 569999999999999999998865 6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccC---
Q 007991 73 FPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD--- 149 (582)
Q Consensus 73 lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~--- 149 (582)
+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+
T Consensus 107 l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~ 186 (277)
T d1phka_ 107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 186 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhcccc
Confidence 99999999999999999999999999999999999999999999999999998776666677899999999998853
Q ss_pred ---CCCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 150 ---IPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 150 ---~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
..|+.++||||+||++|+|++|..||.+.+.......+...... +....+|+++++||.+||+.||.+|||++|
T Consensus 187 ~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 34788999999999999999999999999988888877655432 233479999999999999999999999999
Q ss_pred HHcCCCCchhh
Q 007991 224 LLCHPHLQPYV 234 (582)
Q Consensus 224 iL~hp~f~~~~ 234 (582)
||+||||++|+
T Consensus 267 il~h~~~~~~~ 277 (277)
T d1phka_ 267 ALAHPFFQQYV 277 (277)
T ss_dssp HTTSGGGCTTC
T ss_pred HHcCHHHHHhC
Confidence 99999998763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=396.14 Aligned_cols=229 Identities=24% Similarity=0.403 Sum_probs=190.7
Q ss_pred CEEEEEecccccCH---HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTD---RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~---~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||+++...... ...+.+.+|+.+|++++|||||+++++|..+ .++|||||||.|+++..++.. +..+++..
T Consensus 25 ~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~ 101 (299)
T d1ua2a_ 25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMETDLEVIIKDN--SLVLTPSH 101 (299)
T ss_dssp EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSEEHHHHHTTC--CSSCCSSH
T ss_pred EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-CceeehhhhhcchHHhhhhhc--ccCCCHHH
Confidence 38999997754432 2346789999999999999999999988665 579999999988877766553 34799999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccC-CCCCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLAD-IPYGSK 155 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~-~~y~~k 155 (582)
++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+ ..|+.+
T Consensus 102 ~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 181 (299)
T d1ua2a_ 102 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHH
T ss_pred HHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChh
Confidence 99999999999999999999999999999999999999999999998765433 4456799999999999865 458999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---------------------------CccccHHHHHHHH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------------------------PTVYSGAFRGLVK 208 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---------------------------p~~~S~~l~~LI~ 208 (582)
+|||||||++|||++|.+||.+.+..+++.+|......+. ...+++++.+||.
T Consensus 182 ~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 261 (299)
T d1ua2a_ 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 261 (299)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHH
T ss_pred hhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHH
Confidence 9999999999999999999999998888777754322111 1246889999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCch
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
+||+.||++|||++|+|+||||+.
T Consensus 262 ~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 262 GLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp HHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HHccCChhhCcCHHHHhCCHhhCC
Confidence 999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=398.26 Aligned_cols=231 Identities=24% Similarity=0.460 Sum_probs=201.9
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHH-hcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELIS-RVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~-~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++.... .+...+.+.+|+.+|. .++|||||+++++|.++ ..+|||||||+||+|.+++.... .+++..+
T Consensus 29 ~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~ 105 (320)
T d1xjda_ 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRA 105 (320)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHHHHS--SCCHHHH
T ss_pred EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeEEEeecCCCcHHHHhhccC--CCCHHHH
Confidence 389999976432 1223345667777665 68999999999988665 58999999999999999998865 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++..... ......+||+.|+|||++.+..|+.++|
T Consensus 106 ~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 185 (320)
T d1xjda_ 106 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 185 (320)
T ss_dssp HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhh
Confidence 999999999999999999999999999999999999999999999865433 3455679999999999999999999999
Q ss_pred ccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH-HHHcCCCCchhhh
Q 007991 158 IWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA-ELLCHPHLQPYVL 235 (582)
Q Consensus 158 IWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~-EiL~hp~f~~~~~ 235 (582)
||||||++|+|++|..||.+.+..++..++.... ..+|..+|+++.+||.+||+.||.+||++. ++++||||+.+.+
T Consensus 186 iwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 9999999999999999999999999988887654 457788999999999999999999999995 8999999987543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=389.98 Aligned_cols=231 Identities=28% Similarity=0.386 Sum_probs=198.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc---CCCCeeeeeeEEEe----cCcEEEEEEeecCCCCHHHHHHHhCCCCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV---RNPFIVEYKDSWVE----KGCYVCIIIGYCEGGDMAEAIKKANGVHFP 74 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L---~HpnIV~l~~~~~~----~~~~l~LVmEy~~GgsL~d~Ikk~~~~~ls 74 (582)
||||+++.....+.....+.+|+.+|+.| +|||||+++++|.. .+.++|++||||.|+.+...... ....++
T Consensus 36 vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~ 114 (305)
T d1blxa_ 36 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVP 114 (305)
T ss_dssp EEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSC
T ss_pred EEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc-cCCCCC
Confidence 79999987665554445567888887776 79999999998863 34589999999987766544443 455799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGS 154 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ 154 (582)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+.+|+.
T Consensus 115 ~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~ 194 (305)
T d1blxa_ 115 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCCh
Confidence 99999999999999999999999999999999999999999999999998877667778899999999999999999999
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC--------------------------CCCccccHHHHHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA--------------------------PLPTVYSGAFRGLVK 208 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~--------------------------~lp~~~S~~l~~LI~ 208 (582)
++|||||||++|||++|.+||.+.+..+.+..+...... .++..+++.+.+||.
T Consensus 195 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 274 (305)
T d1blxa_ 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274 (305)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHH
Confidence 999999999999999999999999888877776432211 123457899999999
Q ss_pred HhccCCCCCCCCHHHHHcCCCCchh
Q 007991 209 SMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 209 kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
+||++||++|||++|+|+||||++.
T Consensus 275 ~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 275 KCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHCcCChhHCcCHHHHhcChhhcCc
Confidence 9999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=389.25 Aligned_cols=225 Identities=19% Similarity=0.333 Sum_probs=196.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.....+...+.+.+|+++|++|+|||||++++++.. + ..|||||||+||+|.+++++.. .+++..+..|
T Consensus 37 vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i 112 (277)
T d1xbba_ 37 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL 112 (277)
T ss_dssp EEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred EEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHH
Confidence 8999998766666677889999999999999999999998743 3 4679999999999999998754 6999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|||||++.+..|+.++|
T Consensus 113 ~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 192 (277)
T d1xbba_ 113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192 (277)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHH
T ss_pred HHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhh
Confidence 9999999999999999999999999999999999999999998764332 233467899999999999989999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH---cCCCC
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL---CHPHL 230 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL---~hp~f 230 (582)
||||||++|||++ |.+||.+.+..++...+......+.|..+++++.+||.+||+.||++|||+++|+ +|+|+
T Consensus 193 iwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999997 8999999999999988888877788899999999999999999999999999984 55443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=400.57 Aligned_cols=225 Identities=27% Similarity=0.448 Sum_probs=189.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEe---cCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVE---KGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~---~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++.. ..+.+|+.++.++ +|||||+++++|.. .+.++|||||||+||+|.++|++.+...++|.
T Consensus 39 ~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~ 111 (335)
T d2ozaa1 39 KFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 111 (335)
T ss_dssp EEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHH
T ss_pred EEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHH
Confidence 3899999642 3577899987655 89999999998864 24689999999999999999998666679999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYG 153 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~ 153 (582)
.++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...........+||+.|||||++.+..|+
T Consensus 112 ~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 112 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGS
T ss_pred HHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCC
Confidence 99999999999999999999999999999999986 457999999999988777777788999999999999999999
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhcc---CCCCC----ccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSI---VAPLP----TVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~---~~~lp----~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
.++|||||||++|+|++|.+||.+.+.......+.... ...++ ..+|+++++||.+||+.||++|||++|+|+
T Consensus 192 ~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99999999999999999999998876544433332211 11122 358999999999999999999999999999
Q ss_pred CCCCch
Q 007991 227 HPHLQP 232 (582)
Q Consensus 227 hp~f~~ 232 (582)
||||+.
T Consensus 272 hp~~~~ 277 (335)
T d2ozaa1 272 HPWIMQ 277 (335)
T ss_dssp SHHHHT
T ss_pred CHHhhC
Confidence 999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=396.51 Aligned_cols=227 Identities=24% Similarity=0.356 Sum_probs=201.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.... ....+.+|+++|++++|||||+++++|.+. .++|||||||+||+|.++|++.+ ..+++..++.
T Consensus 32 ~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~ 106 (321)
T d1tkia_ 32 TYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSA-FELNEREIVS 106 (321)
T ss_dssp EEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHH
T ss_pred EEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHH
Confidence 389999977532 235688999999999999999999988665 58999999999999999998643 3699999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCC--CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRD--QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~--g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...........+||+.|+|||.+.+..|+.++||
T Consensus 107 i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~Di 186 (321)
T d1tkia_ 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDM 186 (321)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhc
Confidence 99999999999999999999999999999865 4799999999988776666777899999999999999999999999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC---CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|||||++|+|++|.+||.+.+..+++..|........ +..+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 187 WSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 9999999999999999999999999888876544321 2358999999999999999999999999999999965
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.8e-47 Score=398.33 Aligned_cols=233 Identities=24% Similarity=0.433 Sum_probs=194.0
Q ss_pred CEEEEEecccccCH----HHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTD----RARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~----~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||++....... .......+|+.+|+.++|||||+++++|... ..+|||||||+||+|.++|.+.. .+++.
T Consensus 31 ~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~~ivmE~~~gg~L~~~l~~~~--~~~e~ 107 (364)
T d1omwa3 31 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHG--VFSEA 107 (364)
T ss_dssp EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHC--SCCHH
T ss_pred EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEEEEEEEecCCCcHHHHHHhcc--cccHH
Confidence 38999997543222 2222334557888888999999999988655 58999999999999999998865 68999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccccc-CCCCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLA-DIPYGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~-~~~y~~k 155 (582)
.++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... .....+||+.|+|||++. +..|+.+
T Consensus 108 ~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~ 186 (364)
T d1omwa3 108 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSS 186 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred HHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcc
Confidence 99999999999999999999999999999999999999999999999876543 355679999999999986 4569999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHH--HhhccCCCCCccccHHHHHHHHHhccCCCCCCCC-----HHHHHcCC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINK--INKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPS-----AAELLCHP 228 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~k--I~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpS-----a~EiL~hp 228 (582)
+|||||||++|||++|..||.+.+....... ........++..+|+++++||.+||++||.+||| ++||++||
T Consensus 187 ~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred cchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence 9999999999999999999987553332222 2223344567789999999999999999999999 89999999
Q ss_pred CCchhhhhh
Q 007991 229 HLQPYVLGI 237 (582)
Q Consensus 229 ~f~~~~~~~ 237 (582)
||+...+..
T Consensus 267 ~f~~i~~~~ 275 (364)
T d1omwa3 267 FFRSLDWQM 275 (364)
T ss_dssp GGTTCCHHH
T ss_pred cccCCCHHH
Confidence 999865543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=384.60 Aligned_cols=231 Identities=29% Similarity=0.456 Sum_probs=192.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.....+...+.+.+|+++|++++|||||+++++|... ..+|+|||||. +.+.+++.......+++..++.
T Consensus 29 ~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~ 106 (298)
T d1gz8a_ 29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKS 106 (298)
T ss_dssp EEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHH
T ss_pred EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEEeecC-CchhhhhhhhcccCCCHHHHHH
Confidence 389999987665555667899999999999999999999988764 58999999996 5556666555556799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-cccCcccCCCCCCCcccccCCC-CCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-DLASSVVGTPSYMCPELLADIP-YGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-~~~~~~vGTp~Y~APE~l~~~~-y~~ksDI 158 (582)
|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.... ++.++||
T Consensus 107 ~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~Di 186 (298)
T d1gz8a_ 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186 (298)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccc
Confidence 9999999999999999999999999999999999999999999877543 3455679999999999987766 4789999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHHh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKSM 210 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~km 210 (582)
|||||++|+|++|+.||.+.+..+...++......+ ....++.++.+||.+|
T Consensus 187 wSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~m 266 (298)
T d1gz8a_ 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266 (298)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred cccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHH
Confidence 999999999999999999988777766654321111 0124678999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCCchh
Q 007991 211 LRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
|+.||++|||++|||+||||+..
T Consensus 267 L~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 267 LHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCChhHCcCHHHHhCCHhhccC
Confidence 99999999999999999999753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-46 Score=383.40 Aligned_cols=223 Identities=22% Similarity=0.384 Sum_probs=189.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||++.... .+..++.+.+|+++|++|+|||||++++++... ..+|+|||||+||+|.+++.... ..+++..+..|
T Consensus 57 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i 133 (299)
T d1jpaa_ 57 VAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGM 133 (299)
T ss_dssp EEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHH
T ss_pred EEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHH
Confidence 6788876543 456677899999999999999999999988654 57899999999999999988743 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc------cCcccCCCCCCCcccccCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL------ASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~------~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... .....||+.|||||++.+..|+.+
T Consensus 134 ~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 213 (299)
T d1jpaa_ 134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHH
T ss_pred HHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcc
Confidence 99999999999999999999999999999999999999999987654322 123467899999999999999999
Q ss_pred CcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||||++|||++ |.+||.+....++...+......+.+..++..+.+||.+||+.||++|||+.||+++
T Consensus 214 sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 214 SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999997 899999999999999998887778888999999999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=380.91 Aligned_cols=223 Identities=24% Similarity=0.448 Sum_probs=188.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.........+.+.+|+.+|++++|||||++++++.+ ..+|||||||+||+|.+++...+ ..+++..+..|
T Consensus 33 vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i 109 (276)
T d1uwha_ 33 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDI 109 (276)
T ss_dssp EEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHH
T ss_pred EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHH
Confidence 7999998877777778899999999999999999999986543 35789999999999999998643 36999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc---cccCcccCCCCCCCcccccC---CCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD---DLASSVVGTPSYMCPELLAD---IPYGSK 155 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~---~~~~~~vGTp~Y~APE~l~~---~~y~~k 155 (582)
+.||+.||+|||++|||||||||+||||+.++++||+|||+++..... ......+||+.|||||++.+ ..|+.+
T Consensus 110 ~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ 189 (276)
T d1uwha_ 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189 (276)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHH
T ss_pred HHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCch
Confidence 999999999999999999999999999999999999999999876432 23456789999999999864 358899
Q ss_pred CcccchhHHHHhHhcCCccccccCHH-HHHHHHhhccCCC----CCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQ-ALINKINKSIVAP----LPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~-~l~~kI~~~~~~~----lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
+|||||||++|||++|..||.+.+.. .+...+......+ .+..+++.+.+||.+||+.||++|||++||+++
T Consensus 190 sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999886644 3444444443332 456689999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=374.37 Aligned_cols=221 Identities=21% Similarity=0.426 Sum_probs=189.1
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+++|++++|||||++++++..++ .+|+|||||++|+|.+++... ...+++..+..|
T Consensus 32 vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i 106 (263)
T d1sm2a_ 32 VAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGM 106 (263)
T ss_dssp EEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHH
T ss_pred EEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHH
Confidence 8999998755543 46899999999999999999999887654 788999999999999998864 346899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||
T Consensus 107 ~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVw 186 (263)
T d1sm2a_ 107 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186 (263)
T ss_dssp HHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhc
Confidence 9999999999999999999999999999999999999999998765443 23346899999999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|||++ |.+||...+..++...+........|..+++++.+||.+||+.||++|||++||++|
T Consensus 187 S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999998 688888889988999888887777888999999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-46 Score=379.63 Aligned_cols=222 Identities=19% Similarity=0.350 Sum_probs=197.6
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++..... .+.+.+|+++|++|+|||||+++++|.+. ..+|||||||++|+|.+++.+.....+++..+..
T Consensus 44 ~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~ 119 (287)
T d1opja_ 44 TVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119 (287)
T ss_dssp EEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHH
T ss_pred EEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC-CeeEEEeecccCcchHHHhhhccccchHHHHHHH
Confidence 3899999765443 35789999999999999999999988654 4788999999999999999887667899999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..|+.++||
T Consensus 120 i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~Di 199 (287)
T d1opja_ 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199 (287)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHH
T ss_pred HHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhh
Confidence 99999999999999999999999999999999999999999998765433 2334568999999999999999999999
Q ss_pred cchhHHHHhHhcC-CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 159 WSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 159 WSLG~iLyELltG-~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||++|||++| .++|.+.+...+...+......+.+..+++.+.+||.+||+.||++|||++||++
T Consensus 200 wS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999985 5667788888888888887777888899999999999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=378.50 Aligned_cols=221 Identities=20% Similarity=0.343 Sum_probs=197.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++... .....+.+.+|+++|++++|||||++++++.. + .+|||||||+||+|.+++... ...+++..+..|
T Consensus 39 vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i 114 (285)
T d1u59a_ 39 VAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAEL 114 (285)
T ss_dssp EEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHH
T ss_pred EEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHH
Confidence 8999997653 45667889999999999999999999998753 3 478999999999999998653 336999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... .....+||+.|+|||++.+..|+.++|
T Consensus 115 ~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 194 (285)
T d1u59a_ 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194 (285)
T ss_dssp HHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccch
Confidence 9999999999999999999999999999999999999999998765432 233567899999999999889999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|||++ |..||.+.+..++...+..+...+.|..+++++.+||.+||..||++|||+.+|++
T Consensus 195 VwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999997 99999999888888888888878888999999999999999999999999998853
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4e-46 Score=377.22 Aligned_cols=229 Identities=23% Similarity=0.364 Sum_probs=191.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.....+...+.+.+|+.+|++++|||||+++++|... ...|++|||+.++.+..+.+.. ..+++..++.
T Consensus 28 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~ 104 (286)
T d1ob3a_ 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKS 104 (286)
T ss_dssp EEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSEEHHHHHHTST--TCCCHHHHHH
T ss_pred EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-CceeEEEEeehhhhHHHHHhhc--CCcchhhhHH
Confidence 489999988665555567899999999999999999999988765 4788999999877666665543 3799999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCC-CCCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADI-PYGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~-~y~~ksDI 158 (582)
++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... .....+|++.|+|||.+.+. .++.++||
T Consensus 105 i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~Di 184 (286)
T d1ob3a_ 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184 (286)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred HHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceee
Confidence 99999999999999999999999999999999999999999998765433 34566899999999998764 46899999
Q ss_pred cchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHHh
Q 007991 159 WSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFRGLVKSM 210 (582)
Q Consensus 159 WSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~~LI~km 210 (582)
|||||++|||++|++||.+.+..+.+.++......+ ....+++.+.+||++|
T Consensus 185 wslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 264 (286)
T d1ob3a_ 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264 (286)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHH
T ss_pred hhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHH
Confidence 999999999999999999988877766654322111 1344788999999999
Q ss_pred ccCCCCCCCCHHHHHcCCCCch
Q 007991 211 LRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 211 L~~dP~~RpSa~EiL~hp~f~~ 232 (582)
|+.||++|||++|+|+||||++
T Consensus 265 L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 265 LKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCChhHCcCHHHHhcCcccCc
Confidence 9999999999999999999973
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=376.88 Aligned_cols=224 Identities=18% Similarity=0.366 Sum_probs=198.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+.+|++++|||||++++++.+ + .+|+|||||++|+|.+++....+..+++..+..|
T Consensus 40 vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i 114 (272)
T d1qpca_ 40 VAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114 (272)
T ss_dssp EEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHH
T ss_pred EEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-C-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHH
Confidence 8999998755543 568999999999999999999997643 3 4689999999999999886655456999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|||||++.+..|+.++|||
T Consensus 115 ~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvw 194 (272)
T d1qpca_ 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194 (272)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhh
Confidence 9999999999999999999999999999999999999999998765433 34456899999999999988999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc--CCCC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC--HPHL 230 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~--hp~f 230 (582)
||||++|||++ |.+||...+..++...+......+.|..+++++.+||.+||+.||++|||++||++ |+||
T Consensus 195 S~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 99999999998 57778888888888988888777888899999999999999999999999999987 4444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=382.42 Aligned_cols=224 Identities=21% Similarity=0.340 Sum_probs=190.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCC----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANG---------- 70 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~---------- 70 (582)
||||++..... ......+.+|+.+|.++ +|||||+++++|... ..+|+|||||+||+|.++|+....
T Consensus 70 vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (325)
T d1rjba_ 70 VAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147 (325)
T ss_dssp EEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred EEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence 68888865432 34456789999999998 899999999988655 478999999999999999986432
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCccc
Q 007991 71 -----------VHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVV 136 (582)
Q Consensus 71 -----------~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~v 136 (582)
..+++..+..|+.||+.||+|||++|||||||||+|||++.++++||+|||+|+...... ...+.+
T Consensus 148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 227 (325)
T d1rjba_ 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 227 (325)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEE
T ss_pred cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeecccc
Confidence 248999999999999999999999999999999999999999999999999998765433 234677
Q ss_pred CCCCCCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHH-HHHHhhccCCCCCccccHHHHHHHHHhccCC
Q 007991 137 GTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQAL-INKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 137 GTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l-~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~d 214 (582)
||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+.... ...+......+.|..+++++++||.+||+.|
T Consensus 228 gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~d 307 (325)
T d1rjba_ 228 LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307 (325)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence 8999999999999999999999999999999997 8999988765444 4444555566778889999999999999999
Q ss_pred CCCCCCHHHHHcC
Q 007991 215 PEFRPSAAELLCH 227 (582)
Q Consensus 215 P~~RpSa~EiL~h 227 (582)
|++|||++||++|
T Consensus 308 P~~RPt~~ei~~~ 320 (325)
T d1rjba_ 308 SRKRPSFPNLTSF 320 (325)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=379.18 Aligned_cols=228 Identities=28% Similarity=0.424 Sum_probs=197.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC-----cEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG-----CYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~-----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||+++....++...+.+.+|+++|++++|||||+++++|...+ .++|+||||| |.+|..+++.. .+++
T Consensus 45 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~ 120 (346)
T d1cm8a_ 45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGE 120 (346)
T ss_dssp EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCH
T ss_pred EEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---cccH
Confidence 3899999988788888889999999999999999999999987543 3679999999 78888888753 6999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCC-CCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGS 154 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~-~y~~ 154 (582)
..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....+||+.|+|||++.+. .++.
T Consensus 121 ~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~ 198 (346)
T d1cm8a_ 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQ 198 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCT
T ss_pred HHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCc
Confidence 99999999999999999999999999999999999999999999999986643 35668999999999998764 5789
Q ss_pred CCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCC------------------------------CCCccccHHHH
Q 007991 155 KSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVA------------------------------PLPTVYSGAFR 204 (582)
Q Consensus 155 ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~------------------------------~lp~~~S~~l~ 204 (582)
++|||||||++|+|++|.+||.+.+....+..+...... .....+++.+.
T Consensus 199 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 278 (346)
T d1cm8a_ 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278 (346)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHH
T ss_pred cchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHH
Confidence 999999999999999999999988876665544332111 12245789999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||.+||..||.+|||++|||+||||+...
T Consensus 279 dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 279 NLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 999999999999999999999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=376.67 Aligned_cols=223 Identities=24% Similarity=0.360 Sum_probs=187.8
Q ss_pred CEEEEEecccccCH----HHHHHHHHHHHHHHhcC--CCCeeeeeeEEEecCcEEEEEEeecCC-CCHHHHHHHhCCCCC
Q 007991 1 MYVLKKIRLARQTD----RARRSAHQEMELISRVR--NPFIVEYKDSWVEKGCYVCIIIGYCEG-GDMAEAIKKANGVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIV~l~~~~~~~~~~l~LVmEy~~G-gsL~d~Ikk~~~~~l 73 (582)
.||||+++.....+ .....+.+|+.+|++++ |||||+++++|... ..+|+||||+.+ +++.+++.+.. .+
T Consensus 31 ~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~~~~lv~e~~~~~~~l~~~~~~~~--~l 107 (273)
T d1xwsa_ 31 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQDLFDFITERG--AL 107 (273)
T ss_dssp EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEEEHHHHHHHHC--SC
T ss_pred EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-CeEEEEEEeccCcchHHHHHhccC--CC
Confidence 38999997654322 11234678999999997 89999999987654 589999999976 68888888765 79
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCC-CCeEEeecccchhcccccccCcccCCCCCCCcccccCCCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRD-QDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~-g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y 152 (582)
++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ....+.+||+.|+|||++.+..|
T Consensus 108 ~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCB
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCC
Confidence 999999999999999999999999999999999999865 7899999999976543 34567899999999999987665
Q ss_pred -CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCc
Q 007991 153 -GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQ 231 (582)
Q Consensus 153 -~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~ 231 (582)
+.++|||||||++|+|++|..||.+.+ .+... ...++..+|+++++||.+||+.||++|||++|+|+||||+
T Consensus 187 ~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 259 (273)
T d1xwsa_ 187 HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259 (273)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred CCcccccccceeeehhHhhCCCCCCCch------HHhhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 567999999999999999999998643 22222 2346678999999999999999999999999999999998
Q ss_pred hhh
Q 007991 232 PYV 234 (582)
Q Consensus 232 ~~~ 234 (582)
+..
T Consensus 260 ~~~ 262 (273)
T d1xwsa_ 260 DVL 262 (273)
T ss_dssp SCC
T ss_pred CCC
Confidence 643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-44 Score=365.63 Aligned_cols=224 Identities=24% Similarity=0.375 Sum_probs=187.2
Q ss_pred CEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQ-TDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~-~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++.... .....+.+.+|+++|++++|||||++++++...+ ..+|||||||+|++|.+++...+ .+++.
T Consensus 34 ~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~ 111 (277)
T d1o6ya_ 34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPK 111 (277)
T ss_dssp EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHH
T ss_pred EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHH
Confidence 389999987554 4566778999999999999999999999987653 46899999999999999998765 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc----cccCcccCCCCCCCcccccCCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD----DLASSVVGTPSYMCPELLADIPY 152 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~----~~~~~~vGTp~Y~APE~l~~~~y 152 (582)
.++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||++...... ......+||+.|||||++.+..|
T Consensus 112 ~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 191 (277)
T d1o6ya_ 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCC
Confidence 99999999999999999999999999999999999999999999998765332 24556789999999999999999
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC---CCccccHHHHHHHHHhccCCCCCCC-CHHHHHc
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP---LPTVYSGAFRGLVKSMLRKNPEFRP-SAAELLC 226 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~---lp~~~S~~l~~LI~kmL~~dP~~Rp-Sa~EiL~ 226 (582)
+.++|||||||++|+|++|.+||.+.+..++..++......+ ....+|+.+.+||.+||++||.+|| |++++++
T Consensus 192 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 192 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 999999999999999999999999998888776665543322 3456899999999999999999998 6666653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=380.58 Aligned_cols=228 Identities=23% Similarity=0.358 Sum_probs=190.7
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEe-----cCcEEEEEEeecCCCCHHHHHHH-hCCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVE-----KGCYVCIIIGYCEGGDMAEAIKK-ANGVHFP 74 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~-----~~~~l~LVmEy~~GgsL~d~Ikk-~~~~~ls 74 (582)
.||||+++.... .+.+|+++|++|+|||||+++++|.. +..++|||||||+++.+..+... .....++
T Consensus 47 ~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~ 120 (350)
T d1q5ka_ 47 LVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120 (350)
T ss_dssp EEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCC
T ss_pred EEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCC
Confidence 489999976543 23579999999999999999999864 23578999999976544433321 2344799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccC-CCC
Q 007991 75 EEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLAD-IPY 152 (582)
Q Consensus 75 e~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~-~~y 152 (582)
+..++.|++||+.||+|||++||+||||||+||||+.++ .+||+|||+++.........+.+||+.|+|||.+.+ ..|
T Consensus 121 ~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (350)
T d1q5ka_ 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCC
Confidence 999999999999999999999999999999999999876 899999999988877777778899999999998765 568
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC----------------------------CCccccHHHH
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP----------------------------LPTVYSGAFR 204 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~----------------------------lp~~~S~~l~ 204 (582)
+.++|||||||++|||++|.+||...+..+.+..+......+ ....+++++.
T Consensus 201 ~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 280 (350)
T d1q5ka_ 201 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280 (350)
T ss_dssp CTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHH
T ss_pred CcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHH
Confidence 999999999999999999999999888777766654321110 1234789999
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 205 GLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 205 ~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+||.+||+.||++|||+.|+|+||||+++.
T Consensus 281 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 281 ALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 999999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=365.95 Aligned_cols=221 Identities=20% Similarity=0.361 Sum_probs=199.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+.+|++++|||||++++++.++ ..+|+|||||++|+|.+++.... ..+++..+..|
T Consensus 31 vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i 105 (258)
T d1k2pa_ 31 VAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEM 105 (258)
T ss_dssp EEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHH
T ss_pred EEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHH
Confidence 8999998765543 4689999999999999999999988655 47899999999999999987643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccc--cCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDL--ASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~--~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....||+.|+|||++.+..|+.++|||
T Consensus 106 ~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiw 185 (258)
T d1k2pa_ 106 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185 (258)
T ss_dssp HHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeec
Confidence 99999999999999999999999999999999999999999987654332 3346789999999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|||++ |+.||.+.+..++..++......+.|..++.++.+||.+||+.||++|||+++||+|
T Consensus 186 S~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999998 899999999999999998888888899999999999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=368.64 Aligned_cols=222 Identities=24% Similarity=0.417 Sum_probs=188.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.. ..+..++.+.+|+.+|++++|||||++++++.+ ..+|+|||||++|+|.+++.... ..+++..+..+
T Consensus 38 vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~ 113 (273)
T d1mp8a_ 38 VAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILY 113 (273)
T ss_dssp EEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHH
T ss_pred EEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHH
Confidence 678887654 345667889999999999999999999998743 46889999999999999887643 36899999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..|+.++|||
T Consensus 114 ~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~Diw 193 (273)
T d1mp8a_ 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVW 193 (273)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHH
T ss_pred HHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccc
Confidence 9999999999999999999999999999999999999999998765432 33456789999999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
||||++|||++ |.+||.+.+..++..++......+++..+++.+.+||.+||..||++|||++||++|
T Consensus 194 SlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 194 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999987 899999999989998888888778899999999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=377.25 Aligned_cols=234 Identities=26% Similarity=0.390 Sum_probs=189.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-----CcEEEEEEeecCCCCHHHHHHHhCCCCCCH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-----GCYVCIIIGYCEGGDMAEAIKKANGVHFPE 75 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-----~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse 75 (582)
.||||+++....+....+.+.+|+.+|++++|||||+++++|... ..++|+|||||.|+ +.+.+.. .+++
T Consensus 44 ~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~~----~~~~ 118 (355)
T d2b1pa1 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM----ELDH 118 (355)
T ss_dssp EEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTS----CCCH
T ss_pred EEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhhc----CCCH
Confidence 389999998877788888899999999999999999999998643 46999999999655 4444432 6899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCC
Q 007991 76 EKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSK 155 (582)
Q Consensus 76 ~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~k 155 (582)
..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...........+||+.|+|||++.+..|+.+
T Consensus 119 ~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~ 198 (355)
T d2b1pa1 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTT
T ss_pred HHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCC
Confidence 99999999999999999999999999999999999999999999999988777777778899999999999999999999
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC----------------------------------------
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL---------------------------------------- 195 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l---------------------------------------- 195 (582)
+||||+||++|+|++|++||.+.+......++......+.
T Consensus 199 ~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (355)
T d2b1pa1 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSH
T ss_pred cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccccccc
Confidence 9999999999999999999998887776665543222110
Q ss_pred -CccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhhhhhhc
Q 007991 196 -PTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYVLGIHL 239 (582)
Q Consensus 196 -p~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~~~~~~ 239 (582)
....++++++||++||..||++||||+|||+||||+.+......
T Consensus 279 ~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~ 323 (355)
T d2b1pa1 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEV 323 (355)
T ss_dssp HHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHH
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccc
Confidence 11246789999999999999999999999999999986544333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=364.64 Aligned_cols=222 Identities=20% Similarity=0.356 Sum_probs=190.8
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++... .+.....+.+|+.+|++|+|||||++++++... ..+++|||||.+++|.+++.... ..+++..+..|
T Consensus 39 vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i 115 (283)
T d1mqba_ 39 VAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGM 115 (283)
T ss_dssp EEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHH
T ss_pred EEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-CceEEEEEecccCcchhhhhccc-ccccHHHHHHH
Confidence 7999997644 455567799999999999999999999988655 47889999999999999888753 46999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCCc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKSD 157 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ksD 157 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|||||++.+..|+.++|
T Consensus 116 ~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sD 195 (283)
T d1mqba_ 116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195 (283)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHH
T ss_pred HHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCccc
Confidence 9999999999999999999999999999999999999999998764432 223457899999999999999999999
Q ss_pred ccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 158 IWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 158 IWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
||||||++|||++ |.+||.+.+..++...+......+.+..++..+.+||.+||+.||++|||+.||++
T Consensus 196 I~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999998 57777888888888888888888888899999999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=371.61 Aligned_cols=230 Identities=25% Similarity=0.378 Sum_probs=188.0
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec-------CcEEEEEEeecCCCCHHHHHHHhCCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK-------GCYVCIIIGYCEGGDMAEAIKKANGVHF 73 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~-------~~~l~LVmEy~~GgsL~d~Ikk~~~~~l 73 (582)
.||||+++.....+...+.+.+|+++|++++||||+++++++... +..+|+|||||.++.+..... ....+
T Consensus 37 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~ 114 (318)
T d3blha1 37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKF 114 (318)
T ss_dssp EEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC--TTCCC
T ss_pred EEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh--ccccc
Confidence 389999987766666667889999999999999999999987642 346899999997666554433 33479
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccc-----cccCcccCCCCCCCccccc
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISD-----DLASSVVGTPSYMCPELLA 148 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~-----~~~~~~vGTp~Y~APE~l~ 148 (582)
++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..... ....+.+||+.|+|||++.
T Consensus 115 ~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 194 (318)
T d3blha1 115 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194 (318)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHT
T ss_pred ccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHc
Confidence 99999999999999999999999999999999999999999999999999765432 2344578999999999987
Q ss_pred CC-CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCCCc------------------------------
Q 007991 149 DI-PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPLPT------------------------------ 197 (582)
Q Consensus 149 ~~-~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~lp~------------------------------ 197 (582)
+. .|+.++|||||||++|||++|++||.+.+.......+......+.+.
T Consensus 195 ~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T d3blha1 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274 (318)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHH
T ss_pred CCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhcc
Confidence 54 68999999999999999999999999988877766665433221111
Q ss_pred -cccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCch
Q 007991 198 -VYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQP 232 (582)
Q Consensus 198 -~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~ 232 (582)
..++.+.+||.+||+.||++|+|++|+|+||||+.
T Consensus 275 ~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 275 YVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 13678899999999999999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=368.45 Aligned_cols=225 Identities=19% Similarity=0.361 Sum_probs=193.5
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++...... +.+.+|+.+|++++|||||++++++.+ + .+|+|||||++|+|.+++.......+++..+..+
T Consensus 44 vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i 118 (285)
T d1fmka3 44 VAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118 (285)
T ss_dssp EEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHH
T ss_pred EEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-C-CeEEEEEecCCCchhhhhhhcccccchHHHHHHH
Confidence 8999998765543 578999999999999999999998754 3 4689999999999999987654447999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc--ccCcccCCCCCCCcccccCCCCCCCCccc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD--LASSVVGTPSYMCPELLADIPYGSKSDIW 159 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~--~~~~~vGTp~Y~APE~l~~~~y~~ksDIW 159 (582)
+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||
T Consensus 119 ~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~ 198 (285)
T d1fmka3 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 198 (285)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhh
Confidence 9999999999999999999999999999999999999999998764433 23446799999999999999999999999
Q ss_pred chhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc--CCCCc
Q 007991 160 SLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC--HPHLQ 231 (582)
Q Consensus 160 SLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~--hp~f~ 231 (582)
||||++|||++ |.++|.+....+++..+......+.+..+++++++||.+||+.||++|||+++|+. ++||.
T Consensus 199 S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 199 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 99999999998 57777888888888888888777889999999999999999999999999999987 66664
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=369.37 Aligned_cols=222 Identities=22% Similarity=0.376 Sum_probs=193.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++... .....+.+.+|+.+|++++|||||++++++.++ ..+++|||+.+|+|.+.+... ...+++..+..|
T Consensus 41 vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i 116 (317)
T d1xkka_ 41 VAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNW 116 (317)
T ss_dssp EEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHH
T ss_pred EEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeeEEEEeccCCccccccccc-ccCCCHHHHHHH
Confidence 7888887543 234567899999999999999999999988754 466889999999999988875 447999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCCCCCCCCcc
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADIPYGSKSDI 158 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~~y~~ksDI 158 (582)
+.||+.||+|||++||+||||||+||||+.++++||+|||+++...... ......||+.|+|||++.+..|+.++||
T Consensus 117 ~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDv 196 (317)
T d1xkka_ 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 196 (317)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhh
Confidence 9999999999999999999999999999999999999999998865433 2334578999999999999999999999
Q ss_pred cchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 159 WSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 159 WSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||++|||++ |.+||.+.+..++...+......+.|..+++.+.+||.+||..||.+|||+.||+.|
T Consensus 197 wS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 999999999998 899999988888888888877778888999999999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=359.41 Aligned_cols=230 Identities=26% Similarity=0.421 Sum_probs=196.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++.....+...+.+.+|+.+|++++|||||+++++|... ...++||+|+.|++|..++...+ .+++..++.
T Consensus 29 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~ 105 (292)
T d1unla_ 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKS 105 (292)
T ss_dssp EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHH
T ss_pred EEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-cceeEEeeecccccccccccccc--ccchhHHHH
Confidence 389999988777677788999999999999999999999988665 58899999999999988887643 789999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-ccCcccCCCCCCCcccccCCC-CCCCCcc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-LASSVVGTPSYMCPELLADIP-YGSKSDI 158 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-~~~~~vGTp~Y~APE~l~~~~-y~~ksDI 158 (582)
++.|++.||+|||++||+||||||+||||+.++++||+|||+++...... ......+++.|+|||++.+.. ++.++||
T Consensus 106 ~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di 185 (292)
T d1unla_ 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred HHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhc
Confidence 99999999999999999999999999999999999999999998765433 344567788999999987665 6899999
Q ss_pred cchhHHHHhHhcCCcc-ccccCHHHHHHHHhhccCC----------------------------CCCccccHHHHHHHHH
Q 007991 159 WSLGCCVYEMSAQKAA-FKAFDMQALINKINKSIVA----------------------------PLPTVYSGAFRGLVKS 209 (582)
Q Consensus 159 WSLG~iLyELltG~~P-F~~~~~~~l~~kI~~~~~~----------------------------~lp~~~S~~l~~LI~k 209 (582)
|||||++|||++|..| |.+.+..+.+.++...... .....+++.+.+||.+
T Consensus 186 wSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~ 265 (292)
T d1unla_ 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265 (292)
T ss_dssp HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHH
T ss_pred cccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHH
Confidence 9999999999999877 5666766666665432211 1233468899999999
Q ss_pred hccCCCCCCCCHHHHHcCCCCchh
Q 007991 210 MLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 210 mL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||+.||.+|||++|+|+||||+++
T Consensus 266 mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 266 LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HccCChhHCcCHHHHhcChhhcCC
Confidence 999999999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=369.53 Aligned_cols=228 Identities=29% Similarity=0.468 Sum_probs=189.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC----cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG----CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~----~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
||||+++... .....+.+.+|+.+|++|+|||||++++++.... .++|++ +|+.||+|.++++.. .+++..
T Consensus 36 vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~---~l~~~~ 110 (345)
T d1pmea_ 36 VAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQ---HLSNDH 110 (345)
T ss_dssp EEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHC---CCCHHH
T ss_pred EEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhcC---CCCHHH
Confidence 8999997644 4556678999999999999999999999886542 235554 556699999999864 699999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCccccc-CCCC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLA-DIPY 152 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~-~~~y 152 (582)
++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...... .....+||+.|+|||++. +..|
T Consensus 111 i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 190 (345)
T d1pmea_ 111 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSC
T ss_pred HHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCC
Confidence 99999999999999999999999999999999999999999999997654332 345678999999999984 4567
Q ss_pred CCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCC------------------------------CCccccHH
Q 007991 153 GSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAP------------------------------LPTVYSGA 202 (582)
Q Consensus 153 ~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~------------------------------lp~~~S~~ 202 (582)
+.++||||+||++|+|++|..||.+.+..+....+......+ ....++.+
T Consensus 191 ~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 270 (345)
T d1pmea_ 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 270 (345)
T ss_dssp STHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHH
T ss_pred CchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHH
Confidence 899999999999999999999998887665554443211111 12346789
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 203 FRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 203 l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 271 ~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 271 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 99999999999999999999999999998643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=365.98 Aligned_cols=221 Identities=20% Similarity=0.370 Sum_probs=190.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
.||||+++... ..+.+.+|+++|++|+|||||++++++.+.+..+|+|||||++|+|.+++.+.....+++..+..
T Consensus 32 ~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~ 107 (262)
T d1byga_ 32 KVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107 (262)
T ss_dssp EEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHH
T ss_pred EEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHH
Confidence 38999997543 34678999999999999999999998877666789999999999999999775444589999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCCCCCCCcccc
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIPYGSKSDIWS 160 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~y~~ksDIWS 160 (582)
|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+..|+.++||||
T Consensus 108 i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwS 185 (262)
T d1byga_ 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWS 185 (262)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHh
Confidence 9999999999999999999999999999999999999999999875433 44567899999999999889999999999
Q ss_pred hhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 161 LGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 161 LG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||++|||++ |.+||...+..++...+......+++..+++++.+||.+||..||.+|||+.+++++
T Consensus 186 fG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 186 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999997 799999999989999998888888899999999999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=364.88 Aligned_cols=225 Identities=19% Similarity=0.385 Sum_probs=184.9
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++.... ....+.+.+|+.++.++ +|+|||.+++++...+..+|+|||||+||+|.++++...
T Consensus 46 vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (299)
T d1ywna1 46 VAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124 (299)
T ss_dssp EEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC------
T ss_pred EEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchh
Confidence 79999876443 44456778888888877 588999999988877778999999999999999997642
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..|+.||+.||+|||++||+||||||+||||+.++++||+|||+++...... .....+||+.|||
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 204 (299)
T d1ywna1 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 204 (299)
T ss_dssp -----CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCC
T ss_pred hhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccc
Confidence 2358999999999999999999999999999999999999999999999999998764332 3445789999999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhcC-CccccccCH-HHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDM-QALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSA 221 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELltG-~~PF~~~~~-~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa 221 (582)
||++.+..|+.++|||||||++|||++| .+||.+.+. ..+...+......+.+..+++++.+||.+||+.||++|||+
T Consensus 205 PE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 205 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 9999999999999999999999999986 678877654 34455566666677888899999999999999999999999
Q ss_pred HHHHcC
Q 007991 222 AELLCH 227 (582)
Q Consensus 222 ~EiL~h 227 (582)
+||++|
T Consensus 285 ~eil~~ 290 (299)
T d1ywna1 285 SELVEH 290 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-44 Score=365.38 Aligned_cols=224 Identities=20% Similarity=0.367 Sum_probs=195.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHh------------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKA------------ 68 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~------------ 68 (582)
||||+++.... +...+.+.+|+++|.++ +|||||+++++|..+ ..+|+|||||+||+|.++|++.
T Consensus 40 vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~ 117 (309)
T d1fvra_ 40 AAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117 (309)
T ss_dssp EEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHH
T ss_pred EEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEEEEEecCCCcHHHHHhhccccccchhhhcc
Confidence 67788764433 34567799999999999 799999999988765 5899999999999999999754
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCccc
Q 007991 69 --NGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPEL 146 (582)
Q Consensus 69 --~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~ 146 (582)
.+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............||..|+|||.
T Consensus 118 ~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~ 197 (309)
T d1fvra_ 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 197 (309)
T ss_dssp TTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHH
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHH
Confidence 235799999999999999999999999999999999999999999999999999987665555566789999999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhcC-CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHH
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELL 225 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELltG-~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL 225 (582)
+.+..|+.++|||||||++|||++| .+||.+.+..++...+......+.+..+++++.+||.+||+.||++|||++||+
T Consensus 198 l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil 277 (309)
T d1fvra_ 198 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277 (309)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999999999999999986 578999999999999988777778889999999999999999999999999999
Q ss_pred cC
Q 007991 226 CH 227 (582)
Q Consensus 226 ~h 227 (582)
+|
T Consensus 278 ~~ 279 (309)
T d1fvra_ 278 VS 279 (309)
T ss_dssp HH
T ss_pred HH
Confidence 87
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=370.43 Aligned_cols=228 Identities=23% Similarity=0.367 Sum_probs=192.1
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEec----CcEEEEEEeecCCCCHHHHHHHhCCCCCCHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEK----GCYVCIIIGYCEGGDMAEAIKKANGVHFPEE 76 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~----~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~ 76 (582)
.||||+++....+....+.+.+|+++|++|+|||||+++++|... +...+++|+||.||+|.+++... .+++.
T Consensus 45 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~ 121 (348)
T d2gfsa1 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDD 121 (348)
T ss_dssp EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHH
T ss_pred EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHH
Confidence 389999998877777788899999999999999999999988632 22345567777899999999653 69999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCcccccCCC-CCCC
Q 007991 77 KLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADIP-YGSK 155 (582)
Q Consensus 77 ~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~~-y~~k 155 (582)
.++.|+.||+.||+|||++||+||||||+|||++.+|.+|++|||++..... ...+.+||+.|+|||++.+.. ++.+
T Consensus 122 ~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~ 199 (348)
T d2gfsa1 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQT 199 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTT
T ss_pred HHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--ccccccccccccCchhhcCCccCCcc
Confidence 9999999999999999999999999999999999999999999999976543 355678999999999877654 6889
Q ss_pred CcccchhHHHHhHhcCCccccccCHHHHHHHHhhccCCCC------------------------------CccccHHHHH
Q 007991 156 SDIWSLGCCVYEMSAQKAAFKAFDMQALINKINKSIVAPL------------------------------PTVYSGAFRG 205 (582)
Q Consensus 156 sDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~~~~~~l------------------------------p~~~S~~l~~ 205 (582)
+|||||||++|+|++|.+||.+.+.......+......+. ...+++.+++
T Consensus 200 ~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 279 (348)
T d2gfsa1 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279 (348)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHH
T ss_pred cchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHH
Confidence 9999999999999999999999888777776654332211 1247889999
Q ss_pred HHHHhccCCCCCCCCHHHHHcCCCCchh
Q 007991 206 LVKSMLRKNPEFRPSAAELLCHPHLQPY 233 (582)
Q Consensus 206 LI~kmL~~dP~~RpSa~EiL~hp~f~~~ 233 (582)
||.+||+.||.+|||++|+|+||||+++
T Consensus 280 li~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 280 LLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-43 Score=359.97 Aligned_cols=224 Identities=19% Similarity=0.319 Sum_probs=198.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
+||||+++.. ......+.+.+|+++|++++||||+++++++... ..+++||||+++|+|.+++....
T Consensus 45 ~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 122 (301)
T d1lufa_ 45 MVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122 (301)
T ss_dssp EEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHTCC----------
T ss_pred EEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-CceEEEEEecCCCcHHHHHHhcCccccccccccc
Confidence 3899999764 3456678899999999999999999999988654 57889999999999999997532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcc
Q 007991 70 -----------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSV 135 (582)
Q Consensus 70 -----------~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~ 135 (582)
...+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+++...... ...+.
T Consensus 123 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~ 202 (301)
T d1lufa_ 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 202 (301)
T ss_dssp ------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----C
T ss_pred cchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCC
Confidence 2348999999999999999999999999999999999999999999999999998764432 33457
Q ss_pred cCCCCCCCcccccCCCCCCCCcccchhHHHHhHhcC-CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCC
Q 007991 136 VGTPSYMCPELLADIPYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKN 214 (582)
Q Consensus 136 vGTp~Y~APE~l~~~~y~~ksDIWSLG~iLyELltG-~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~d 214 (582)
+||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++...+......+.+..+++++.+||..||+.|
T Consensus 203 ~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~ 282 (301)
T d1lufa_ 203 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 282 (301)
T ss_dssp CBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCC
Confidence 899999999999999999999999999999999988 5789999999999999888888888899999999999999999
Q ss_pred CCCCCCHHHHHc
Q 007991 215 PEFRPSAAELLC 226 (582)
Q Consensus 215 P~~RpSa~EiL~ 226 (582)
|++|||+.||++
T Consensus 283 P~~RPt~~ev~~ 294 (301)
T d1lufa_ 283 PADRPSFCSIHR 294 (301)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=365.45 Aligned_cols=224 Identities=24% Similarity=0.391 Sum_probs=185.5
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEec-CcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEK-GCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKL 78 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~-~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~ 78 (582)
.||||+++... .+.+.+|+++|+++. ||||++++++|... +..+|+|||||.+++|..+.+ .+++..+
T Consensus 62 ~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i 131 (328)
T d3bqca1 62 KVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDI 131 (328)
T ss_dssp EEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHH
T ss_pred EEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHH
Confidence 38999997543 356889999999995 99999999988743 457999999999999876532 5899999
Q ss_pred HHHHHHHHHHHHHHHHCCceecccCcccEEEcCCC-CeEEeecccchhcccccccCcccCCCCCCCcccccCC-CCCCCC
Q 007991 79 CKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQ-DIRLGDFGLAKMLISDDLASSVVGTPSYMCPELLADI-PYGSKS 156 (582)
Q Consensus 79 ~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g-~vKL~DFGla~~~~~~~~~~~~vGTp~Y~APE~l~~~-~y~~ks 156 (582)
+.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+++...........+||+.|+|||.+.+. .|+.++
T Consensus 132 ~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 211 (328)
T d3bqca1 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211 (328)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHH
T ss_pred HHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCccc
Confidence 99999999999999999999999999999999765 5999999999887776677788999999999998765 479999
Q ss_pred cccchhHHHHhHhcCCccccccC-HHHHHHHHhhc------------------------------------cCCCCCccc
Q 007991 157 DIWSLGCCVYEMSAQKAAFKAFD-MQALINKINKS------------------------------------IVAPLPTVY 199 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF~~~~-~~~l~~kI~~~------------------------------------~~~~lp~~~ 199 (582)
||||+||++|+|++|..||.... .......+... ........+
T Consensus 212 DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (328)
T d3bqca1 212 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 291 (328)
T ss_dssp HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGC
T ss_pred chhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccC
Confidence 99999999999999999996543 22222221110 001122347
Q ss_pred cHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 200 SGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 200 S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
++++.+||++||++||.+|||++|+|+||||+...
T Consensus 292 s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 292 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 89999999999999999999999999999998643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=358.77 Aligned_cols=223 Identities=20% Similarity=0.382 Sum_probs=200.4
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC-----------
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN----------- 69 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~----------- 69 (582)
||||+++... .......+.+|...+.++ +|||||+++++|.++ ..+|+|||||++|+|.++|....
T Consensus 48 vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~ 125 (299)
T d1fgka_ 48 VAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125 (299)
T ss_dssp EEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEECCCTTCBHHHHHHTTSCC---------
T ss_pred EEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-CeEEEEEEccCCCcHHHHHHhhcCCccccccccc
Confidence 7999997654 455667889999999998 799999999988754 57899999999999999997643
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCC
Q 007991 70 ---GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMC 143 (582)
Q Consensus 70 ---~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~A 143 (582)
...+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+++...... .....+||+.|+|
T Consensus 126 ~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 205 (299)
T d1fgka_ 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205 (299)
T ss_dssp ---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSC
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhh
Confidence 2358999999999999999999999999999999999999999999999999998765443 2345789999999
Q ss_pred cccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHH
Q 007991 144 PELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAA 222 (582)
Q Consensus 144 PE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~ 222 (582)
||.+.+..|+.++|||||||++|||++ |.+||.+.+...+...+......+.+..+++.+.+||.+||+.||.+|||+.
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ 285 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999999999999999999997 7999999999999999888888888899999999999999999999999999
Q ss_pred HHHc
Q 007991 223 ELLC 226 (582)
Q Consensus 223 EiL~ 226 (582)
||++
T Consensus 286 eil~ 289 (299)
T d1fgka_ 286 QLVE 289 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=367.90 Aligned_cols=231 Identities=25% Similarity=0.460 Sum_probs=193.9
Q ss_pred CEEEEEeccccc--CHHHHHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQ--TDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~--~~~~~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||+++.... .....+.+.+|+++|++++| |||+++++++... ..+|+|||||.||+|.+++...+ .+++..
T Consensus 54 ~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~ 130 (322)
T d1vzoa_ 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRE--RFTEHE 130 (322)
T ss_dssp EEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHHHHS--CCCHHH
T ss_pred EEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-CceeeeeecccccHHHHHHHhcc--cccHHH
Confidence 389999976432 22334568899999999977 7999999977654 58999999999999999998865 688999
Q ss_pred HHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccc--ccccCcccCCCCCCCcccccCCC--CC
Q 007991 78 LCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLIS--DDLASSVVGTPSYMCPELLADIP--YG 153 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~--~~~~~~~vGTp~Y~APE~l~~~~--y~ 153 (582)
++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .....+..|++.|++||.+.+.. ++
T Consensus 131 ~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~ 210 (322)
T d1vzoa_ 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 210 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred HHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCC
Confidence 999999999999999999999999999999999999999999999986543 23455678999999999997643 67
Q ss_pred CCCcccchhHHHHhHhcCCccccccCHHHHHHHHh---hccCCCCCccccHHHHHHHHHhccCCCCCCC-----CHHHHH
Q 007991 154 SKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKIN---KSIVAPLPTVYSGAFRGLVKSMLRKNPEFRP-----SAAELL 225 (582)
Q Consensus 154 ~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~---~~~~~~lp~~~S~~l~~LI~kmL~~dP~~Rp-----Sa~EiL 225 (582)
.++|||||||+||+|++|..||.+.+.......+. .....+++..+++++.+||.+||+.||.+|+ |++|+|
T Consensus 211 ~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 79999999999999999999998765433333332 2334556778999999999999999999998 589999
Q ss_pred cCCCCchhh
Q 007991 226 CHPHLQPYV 234 (582)
Q Consensus 226 ~hp~f~~~~ 234 (582)
+||||+++.
T Consensus 291 ~Hpff~~i~ 299 (322)
T d1vzoa_ 291 EHLFFQKIN 299 (322)
T ss_dssp TSGGGTTCC
T ss_pred cCHhhcCCC
Confidence 999998754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=357.51 Aligned_cols=222 Identities=20% Similarity=0.361 Sum_probs=187.7
Q ss_pred EEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQT-DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~-~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
||||++...... +...+.+.+|+.+|++++|||||++++++.+ + .+|+|||||++|+|.+.+....+ .+++..+..
T Consensus 39 vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~-~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~ 115 (273)
T d1u46a_ 39 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P-PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSR 115 (273)
T ss_dssp EEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHH
T ss_pred EEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c-chheeeeeecCcchhhhhhcccC-CCCHHHHHH
Confidence 789998765443 3456789999999999999999999998854 3 56899999999999998877543 599999999
Q ss_pred HHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 81 WLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 81 il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... ......|+..|+|||++.+..|+.++
T Consensus 116 ~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 195 (273)
T d1u46a_ 116 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195 (273)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcch
Confidence 99999999999999999999999999999999999999999998764432 23345678899999999999999999
Q ss_pred cccchhHHHHhHhc-CCccccccCHHHHHHHHhhc-cCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007991 157 DIWSLGCCVYEMSA-QKAAFKAFDMQALINKINKS-IVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLC 226 (582)
Q Consensus 157 DIWSLG~iLyELlt-G~~PF~~~~~~~l~~kI~~~-~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~ 226 (582)
|||||||++|||++ |.+||.+.+..++..++... ...+.+..+++.+++||.+||..||++|||++||++
T Consensus 196 Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999997 89999999999998888654 345667889999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=356.32 Aligned_cols=224 Identities=17% Similarity=0.278 Sum_probs=192.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||+++.. ......+.+.+|+++|++|+|||||++++++...+..+|+|||||++|+|.+++... ...+++..+..+
T Consensus 58 vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i 135 (311)
T d1r0pa_ 58 CAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGF 135 (311)
T ss_dssp EEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHH
T ss_pred EEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccc-cccchHHHHHHH
Confidence 789999753 356667889999999999999999999999887777899999999999999998864 346789999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCcccccCCCCCCCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCPELLADIPYGSKS 156 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~APE~l~~~~y~~ks 156 (582)
+.|++.||.|||+.||+||||||+||||+.++.+||+|||+++...... ......||+.|+|||.+....++.++
T Consensus 136 ~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks 215 (311)
T d1r0pa_ 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 215 (311)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChh
Confidence 9999999999999999999999999999999999999999998764432 23346789999999999999999999
Q ss_pred cccchhHHHHhHhcCCccc-cccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 157 DIWSLGCCVYEMSAQKAAF-KAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 157 DIWSLG~iLyELltG~~PF-~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
|||||||++|||++|..|| ...+..++...+..+.....|..+++.+.+||.+||..||++||++.||++|
T Consensus 216 DI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 216 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999965555 4555556667777777777788899999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=352.67 Aligned_cols=224 Identities=19% Similarity=0.341 Sum_probs=199.3
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC--------CCCC
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN--------GVHF 73 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~--------~~~l 73 (582)
||||+++.. ........+.+|+++|++++|||||++++++..+ ..+++|||||.+|+|.+++.... ...+
T Consensus 53 VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~ 130 (308)
T d1p4oa_ 53 VAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130 (308)
T ss_dssp EEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCC
T ss_pred EEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-CceeEEEeecCCCCHHHHHHhcccccccccccCCC
Confidence 799999764 3556677899999999999999999999988654 47899999999999999986531 1347
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCCCCCcccccCC
Q 007991 74 PEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 74 se~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~Y~APE~l~~~ 150 (582)
++..+..++.|++.||.|||+++|+||||||+||||+.++++||+|||+++...... .....+||+.|+|||.+.+.
T Consensus 131 ~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~ 210 (308)
T d1p4oa_ 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210 (308)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC
Confidence 899999999999999999999999999999999999999999999999998765432 23445789999999999999
Q ss_pred CCCCCCcccchhHHHHhHhcC-CccccccCHHHHHHHHhhccCCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQ-KAAFKAFDMQALINKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG-~~PF~~~~~~~l~~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
.|+.++|||||||++|||++| .+||.+.+..+.+..+......+.+..+++.+.+||.+||+.||++|||+++|+++
T Consensus 211 ~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 211 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999998 68999999999999888877777888999999999999999999999999999973
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=350.11 Aligned_cols=224 Identities=20% Similarity=0.353 Sum_probs=193.3
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhC----------
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRV-RNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKAN---------- 69 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L-~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~---------- 69 (582)
.||||+++... .......+.+|+.+++++ +|||||++++++... ..+|+|||||+||+|.+++++..
T Consensus 55 ~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~ 132 (311)
T d1t46a_ 55 TVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132 (311)
T ss_dssp EEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHHTTTTC-------
T ss_pred EEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-CEEEEEEEcCCCCCHHHHHHhcccccccccccc
Confidence 38999998754 355667899999999999 699999999988654 47899999999999999998643
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhccccc---ccCcccCCCC
Q 007991 70 ------GVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD---LASSVVGTPS 140 (582)
Q Consensus 70 ------~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~---~~~~~vGTp~ 140 (582)
...+++..+..|+.||+.||+|||++||+||||||+|||++.++++||+|||+++...... .....+||+.
T Consensus 133 ~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~ 212 (311)
T d1t46a_ 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212 (311)
T ss_dssp -------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGG
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChH
Confidence 2358999999999999999999999999999999999999999999999999998765432 3345789999
Q ss_pred CCCcccccCCCCCCCCcccchhHHHHhHhc-CCccccccCHHHHH-HHHhhccCCCCCccccHHHHHHHHHhccCCCCCC
Q 007991 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSA-QKAAFKAFDMQALI-NKINKSIVAPLPTVYSGAFRGLVKSMLRKNPEFR 218 (582)
Q Consensus 141 Y~APE~l~~~~y~~ksDIWSLG~iLyELlt-G~~PF~~~~~~~l~-~kI~~~~~~~lp~~~S~~l~~LI~kmL~~dP~~R 218 (582)
|+|||++.+..++.++|||||||++|||++ |.++|.+.+....+ ..+........+..+++.+.+||.+||+.||++|
T Consensus 213 y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 292 (311)
T d1t46a_ 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292 (311)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHC
Confidence 999999999999999999999999999998 78888776664444 4445556666778899999999999999999999
Q ss_pred CCHHHHHc
Q 007991 219 PSAAELLC 226 (582)
Q Consensus 219 pSa~EiL~ 226 (582)
||+++|++
T Consensus 293 Ps~~~il~ 300 (311)
T d1t46a_ 293 PTFKQIVQ 300 (311)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-39 Score=329.02 Aligned_cols=218 Identities=17% Similarity=0.226 Sum_probs=175.2
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCKW 81 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~i 81 (582)
||||.+...... ..+.+|+++++.++|+++|.++..+...+...++||||| +++|.+.+... +..+++..+..+
T Consensus 35 vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~ 108 (299)
T d1ckia_ 35 VAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLL 108 (299)
T ss_dssp EEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHH
T ss_pred EEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHH
Confidence 899998765433 347889999999998887777777777777999999999 67777777653 347999999999
Q ss_pred HHHHHHHHHHHHHCCceecccCcccEEEcC---CCCeEEeecccchhccccc--------ccCcccCCCCCCCcccccCC
Q 007991 82 LVQLLMALNYLHANHILHRDVKCSNIFLTR---DQDIRLGDFGLAKMLISDD--------LASSVVGTPSYMCPELLADI 150 (582)
Q Consensus 82 l~QLL~aL~yLHs~gIiHRDIKP~NILL~~---~g~vKL~DFGla~~~~~~~--------~~~~~vGTp~Y~APE~l~~~ 150 (582)
+.|++.||+|||++||+||||||+|||++. +..+||+|||+++...... .....+||+.|||||++.+.
T Consensus 109 ~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 188 (299)
T d1ckia_ 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188 (299)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB
T ss_pred HHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC
Confidence 999999999999999999999999999864 4469999999998765432 23467899999999999999
Q ss_pred CCCCCCcccchhHHHHhHhcCCccccccCHHHHHHHHhh----ccCC---CCCccccHHHHHHHHHhccCCCCCCCCHHH
Q 007991 151 PYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQALINKINK----SIVA---PLPTVYSGAFRGLVKSMLRKNPEFRPSAAE 223 (582)
Q Consensus 151 ~y~~ksDIWSLG~iLyELltG~~PF~~~~~~~l~~kI~~----~~~~---~lp~~~S~~l~~LI~kmL~~dP~~RpSa~E 223 (582)
.|+.++|||||||++|||++|..||...........+.. .... .+...+++++.+||.+||+.||++||++++
T Consensus 189 ~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~ 268 (299)
T d1ckia_ 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 268 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH
T ss_pred CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999999999999999999999987655443322211 1111 134568999999999999999999999986
Q ss_pred HH
Q 007991 224 LL 225 (582)
Q Consensus 224 iL 225 (582)
|.
T Consensus 269 i~ 270 (299)
T d1ckia_ 269 LR 270 (299)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=332.57 Aligned_cols=221 Identities=19% Similarity=0.251 Sum_probs=172.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecC---cEEEEEEeecCCCCHHHHHHHhCCCCCCHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFIVEYKDSWVEKG---CYVCIIIGYCEGGDMAEAIKKANGVHFPEEK 77 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~---~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~ 77 (582)
.||||+++.... .....++|+..+.+++|||||++++++...+ ..+|+|||||++|+|.+++++. .+++..
T Consensus 28 ~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~ 101 (303)
T d1vjya_ 28 EVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEG 101 (303)
T ss_dssp EEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHH
T ss_pred EEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHH
Confidence 389999965432 2223345666677899999999999988654 3789999999999999999874 589999
Q ss_pred HHHHHHHHHHHHHHHHH--------CCceecccCcccEEEcCCCCeEEeecccchhccccc-----ccCcccCCCCCCCc
Q 007991 78 LCKWLVQLLMALNYLHA--------NHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDD-----LASSVVGTPSYMCP 144 (582)
Q Consensus 78 ~~~il~QLL~aL~yLHs--------~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~-----~~~~~vGTp~Y~AP 144 (582)
+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+++...... .....+||+.|+||
T Consensus 102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aP 181 (303)
T d1vjya_ 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCCh
Confidence 99999999999999996 599999999999999999999999999998764432 23457899999999
Q ss_pred ccccCCC------CCCCCcccchhHHHHhHhcCCcccccc---------------CHHHHHHHHhhcc-CCCCCccc---
Q 007991 145 ELLADIP------YGSKSDIWSLGCCVYEMSAQKAAFKAF---------------DMQALINKINKSI-VAPLPTVY--- 199 (582)
Q Consensus 145 E~l~~~~------y~~ksDIWSLG~iLyELltG~~PF~~~---------------~~~~l~~kI~~~~-~~~lp~~~--- 199 (582)
|++.+.. ++.++|||||||+||||++|.+||... ....+...+.... .++++..+
T Consensus 182 E~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 261 (303)
T d1vjya_ 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261 (303)
T ss_dssp HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGC
T ss_pred hhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCCh
Confidence 9987643 566899999999999999998877321 2223333332222 22333332
Q ss_pred --cHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007991 200 --SGAFRGLVKSMLRKNPEFRPSAAELLCH 227 (582)
Q Consensus 200 --S~~l~~LI~kmL~~dP~~RpSa~EiL~h 227 (582)
...+.+|+.+||+.||++|||+.||+++
T Consensus 262 ~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 262 EALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 3468899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-37 Score=316.75 Aligned_cols=219 Identities=15% Similarity=0.166 Sum_probs=178.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRN-PFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLC 79 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~H-pnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~ 79 (582)
.||||.+...... ..+.+|+++++.|.| +||+.+++++.. +...|+||||| |++|.++++..+ ..+++..+.
T Consensus 32 ~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~ 104 (293)
T d1csna_ 32 QVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVA 104 (293)
T ss_dssp EEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHH
T ss_pred EEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEEec-CCCHHHHHHhhc-cchhhHHHH
Confidence 3899988654332 346789999999976 889998887654 56889999999 799999988743 469999999
Q ss_pred HHHHHHHHHHHHHHHCCceecccCcccEEEcC-----CCCeEEeecccchhcccc--------cccCcccCCCCCCCccc
Q 007991 80 KWLVQLLMALNYLHANHILHRDVKCSNIFLTR-----DQDIRLGDFGLAKMLISD--------DLASSVVGTPSYMCPEL 146 (582)
Q Consensus 80 ~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~-----~g~vKL~DFGla~~~~~~--------~~~~~~vGTp~Y~APE~ 146 (582)
.++.|++.||+|||++||+||||||+||||+. ++.+||+|||+++..... ......+||+.|||||+
T Consensus 105 ~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~ 184 (293)
T d1csna_ 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184 (293)
T ss_dssp HHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHH
Confidence 99999999999999999999999999999975 567999999999875432 12345789999999999
Q ss_pred ccCCCCCCCCcccchhHHHHhHhcCCccccccC---HHHHHHHHhhcc----CCCCCccccHHHHHHHHHhccCCCCCCC
Q 007991 147 LADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFD---MQALINKINKSI----VAPLPTVYSGAFRGLVKSMLRKNPEFRP 219 (582)
Q Consensus 147 l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~---~~~l~~kI~~~~----~~~lp~~~S~~l~~LI~kmL~~dP~~Rp 219 (582)
+.+..|+.++|||||||++|||++|..||.+.. ......++.... ...+...+++++.+++..|+..+|++||
T Consensus 185 ~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred hcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 999999999999999999999999999997543 223333332211 1123356889999999999999999999
Q ss_pred CHHHHHc
Q 007991 220 SAAELLC 226 (582)
Q Consensus 220 Sa~EiL~ 226 (582)
+++.+.+
T Consensus 265 ~y~~l~~ 271 (293)
T d1csna_ 265 DYDYLQG 271 (293)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9888754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-37 Score=318.05 Aligned_cols=229 Identities=24% Similarity=0.380 Sum_probs=176.8
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcC-----------CCCeeeeeeEEEec-CcEEEEEEeecCCC-CHHHHHHH
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVR-----------NPFIVEYKDSWVEK-GCYVCIIIGYCEGG-DMAEAIKK 67 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIV~l~~~~~~~-~~~l~LVmEy~~Gg-sL~d~Ikk 67 (582)
.||||+++.. ....+.+.+|+.+|+.++ |+|||++++++... ....+++|+++.++ ........
T Consensus 40 ~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (362)
T d1q8ya_ 40 HVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK 116 (362)
T ss_dssp EEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH
T ss_pred EEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccc
Confidence 3899999753 344567889999999886 47899999987643 35667777776544 44444444
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCcccEEEcCCCC------eEEeecccchhcccccccCcccCCCC
Q 007991 68 ANGVHFPEEKLCKWLVQLLMALNYLHA-NHILHRDVKCSNIFLTRDQD------IRLGDFGLAKMLISDDLASSVVGTPS 140 (582)
Q Consensus 68 ~~~~~lse~~~~~il~QLL~aL~yLHs-~gIiHRDIKP~NILL~~~g~------vKL~DFGla~~~~~~~~~~~~vGTp~ 140 (582)
.....+++..++.++.||+.||+|||+ .||+||||||+||||+.++. ++|+|||.+..... .....+||+.
T Consensus 117 ~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~ 194 (362)
T d1q8ya_ 117 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTRE 194 (362)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGG
T ss_pred ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--cccccccccc
Confidence 455679999999999999999999998 89999999999999987754 99999999876543 3466789999
Q ss_pred CCCcccccCCCCCCCCcccchhHHHHhHhcCCccccccCHH------HHHHHHhhcc-----------------------
Q 007991 141 YMCPELLADIPYGSKSDIWSLGCCVYEMSAQKAAFKAFDMQ------ALINKINKSI----------------------- 191 (582)
Q Consensus 141 Y~APE~l~~~~y~~ksDIWSLG~iLyELltG~~PF~~~~~~------~l~~kI~~~~----------------------- 191 (582)
|+|||++.+..|+.++||||+||++++|++|+.||...+.. +....+....
T Consensus 195 y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~ 274 (362)
T d1q8ya_ 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274 (362)
T ss_dssp GCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred ccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchh
Confidence 99999999999999999999999999999999999754321 1111110000
Q ss_pred ------------------CCCCCccccHHHHHHHHHhccCCCCCCCCHHHHHcCCCCchhh
Q 007991 192 ------------------VAPLPTVYSGAFRGLVKSMLRKNPEFRPSAAELLCHPHLQPYV 234 (582)
Q Consensus 192 ------------------~~~lp~~~S~~l~~LI~kmL~~dP~~RpSa~EiL~hp~f~~~~ 234 (582)
........++++.+||.+||.+||.+|||++|+|+||||++..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0112234578899999999999999999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.74 E-value=5e-19 Score=167.28 Aligned_cols=142 Identities=15% Similarity=0.163 Sum_probs=101.8
Q ss_pred EEEEEecccccC----------------HHHHHHHHHHHHHHHhcCCCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHH
Q 007991 2 YVLKKIRLARQT----------------DRARRSAHQEMELISRVRNPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAI 65 (582)
Q Consensus 2 yAIKki~~~~~~----------------~~~~~~~~rEi~iL~~L~HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~I 65 (582)
||||.++..... ......+.+|+..|.++.|.+++..++. ..+ +++|||+++..+.
T Consensus 27 vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~--~~~---~lvme~~~~~~~~--- 98 (191)
T d1zara2 27 CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW--EGN---AVLMELIDAKELY--- 98 (191)
T ss_dssp EEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE--ETT---EEEEECCCCEEGG---
T ss_pred EEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe--cCC---EEEEEeecccccc---
Confidence 899987653221 1123456789999999999999987764 222 6999999876542
Q ss_pred HHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCcccEEEcCCCCeEEeecccchhcccccccCcccCCCCCCCc-
Q 007991 66 KKANGVHFPEEKLCKWLVQLLMALNYLHANHILHRDVKCSNIFLTRDQDIRLGDFGLAKMLISDDLASSVVGTPSYMCP- 144 (582)
Q Consensus 66 kk~~~~~lse~~~~~il~QLL~aL~yLHs~gIiHRDIKP~NILL~~~g~vKL~DFGla~~~~~~~~~~~~vGTp~Y~AP- 144 (582)
.+++..+..++.||+.+|+|||++||+||||||+|||++.++ ++|+|||+|....+... .. |...
T Consensus 99 ------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~-~~------~l~rd 164 (191)
T d1zara2 99 ------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW-RE------ILERD 164 (191)
T ss_dssp ------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTSTTH-HH------HHHHH
T ss_pred ------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCCCc-HH------HHHHH
Confidence 356667788999999999999999999999999999998654 99999999876543211 00 1100
Q ss_pred -c---cccCCCCCCCCcccchhHHH
Q 007991 145 -E---LLADIPYGSKSDIWSLGCCV 165 (582)
Q Consensus 145 -E---~l~~~~y~~ksDIWSLG~iL 165 (582)
+ .+..+.|+.++|+||+.--+
T Consensus 165 ~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 165 VRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcccHHHHHHHH
Confidence 0 01235688999999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.61 E-value=5.5e-05 Score=71.85 Aligned_cols=114 Identities=13% Similarity=0.117 Sum_probs=69.0
Q ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCeeeeeeEEEecCcEEEEEEeecCCCCHHHHHHHhCCCCCCHHHHHH
Q 007991 2 YVLKKIRLARQTDRARRSAHQEMELISRVR-NPFIVEYKDSWVEKGCYVCIIIGYCEGGDMAEAIKKANGVHFPEEKLCK 80 (582)
Q Consensus 2 yAIKki~~~~~~~~~~~~~~rEi~iL~~L~-HpnIV~l~~~~~~~~~~l~LVmEy~~GgsL~d~Ikk~~~~~lse~~~~~ 80 (582)
|+||........ ....+.+|..+|..|. +-.+.+++.+. +.++..|+||++++|..+.+.... ... ...
T Consensus 40 ~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-~~~~~~~lv~~~l~G~~~~~~~~~----~~~---~~~ 109 (263)
T d1j7la_ 40 LYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-RHDGWSNLLMSEADGVLCSEEYED----EQS---PEK 109 (263)
T ss_dssp EEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEEEEECCSSEEHHHHTTT----CSC---HHH
T ss_pred EEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-ecCCceEEEEEecccccccccccc----ccc---HHH
Confidence 456665432211 1234678999988885 22244555543 445688999999999887654321 011 111
Q ss_pred HHHHHHHHHHHHH-----------------------------------------------------HC------Cceecc
Q 007991 81 WLVQLLMALNYLH-----------------------------------------------------AN------HILHRD 101 (582)
Q Consensus 81 il~QLL~aL~yLH-----------------------------------------------------s~------gIiHRD 101 (582)
++.++...|..|| .. .++|+|
T Consensus 110 ~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD 189 (263)
T d1j7la_ 110 IIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGD 189 (263)
T ss_dssp HHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSC
T ss_pred HHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEee
Confidence 2233333333333 11 379999
Q ss_pred cCcccEEEcCCCCeEEeecccchh
Q 007991 102 VKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 102 IKP~NILL~~~g~vKL~DFGla~~ 125 (582)
+.|.|||++.++.+-|+||+.+..
T Consensus 190 ~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 190 LGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCcceeecCCceEEEeechhccc
Confidence 999999998776667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.34 E-value=0.00011 Score=69.42 Aligned_cols=30 Identities=20% Similarity=0.185 Sum_probs=25.6
Q ss_pred CceecccCcccEEEcCCCCeEEeecccchh
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAKM 125 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~~ 125 (582)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 389999999999998876678999997743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.69 E-value=0.00057 Score=69.80 Aligned_cols=28 Identities=21% Similarity=0.389 Sum_probs=24.8
Q ss_pred CceecccCcccEEEcCCCCeEEeecccch
Q 007991 96 HILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 96 gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.++|+|+++.|||++.++ ++|+||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998765 8999998774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.23 E-value=0.0036 Score=61.69 Aligned_cols=57 Identities=14% Similarity=0.154 Sum_probs=35.2
Q ss_pred CEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCe--eeee----eEEEecCcEEEEEEeecCCCC
Q 007991 1 MYVLKKIRLARQTDRARRSAHQEMELISRVRNPFI--VEYK----DSWVEKGCYVCIIIGYCEGGD 60 (582)
Q Consensus 1 lyAIKki~~~~~~~~~~~~~~rEi~iL~~L~HpnI--V~l~----~~~~~~~~~l~LVmEy~~Ggs 60 (582)
.||+|..+....+.. .+..|+..|..|....| +... +.....+.+.+.+++|+.|..
T Consensus 48 ~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 48 RFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred EEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 388999887665543 56778988888853221 1111 111233457889999998643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.34 E-value=0.0077 Score=60.82 Aligned_cols=38 Identities=8% Similarity=0.100 Sum_probs=25.4
Q ss_pred HHHHHHHHHHhcCCCCee-eeeeEEEecCcEEEEEEeecCCCCH
Q 007991 19 SAHQEMELISRVRNPFIV-EYKDSWVEKGCYVCIIIGYCEGGDM 61 (582)
Q Consensus 19 ~~~rEi~iL~~L~HpnIV-~l~~~~~~~~~~l~LVmEy~~GgsL 61 (582)
...+|..+++.+.-.++. ++++.+ .+ .+||||++|..|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~--~~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIF--SG---GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEE--TT---EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEc--CC---ceEEEEeccccC
Confidence 356899999998655555 455433 33 379999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.24 E-value=0.02 Score=55.21 Aligned_cols=30 Identities=30% Similarity=0.367 Sum_probs=26.8
Q ss_pred CCceecccCcccEEEcCCCCeEEeecccch
Q 007991 95 NHILHRDVKCSNIFLTRDQDIRLGDFGLAK 124 (582)
Q Consensus 95 ~gIiHRDIKP~NILL~~~g~vKL~DFGla~ 124 (582)
.|+||+|+.+.||+++.++..-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999874
|